Citrus Sinensis ID: 040812
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 300 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RXG3 | 348 | Mitogen-activated protein | no | no | 0.793 | 0.683 | 0.420 | 4e-51 | |
| O80397 | 366 | Mitogen-activated protein | no | no | 0.806 | 0.661 | 0.417 | 5e-49 | |
| Q9S7U9 | 363 | Mitogen-activated protein | no | no | 0.8 | 0.661 | 0.372 | 4e-37 | |
| Q5QN75 | 355 | Mitogen-activated protein | no | no | 0.796 | 0.673 | 0.379 | 1e-36 | |
| Q9FJV0 | 356 | Mitogen-activated protein | no | no | 0.79 | 0.665 | 0.356 | 2e-33 | |
| Q24324 | 396 | Dual specificity mitogen- | yes | no | 0.793 | 0.601 | 0.348 | 4e-33 | |
| Q94A06 | 354 | Mitogen-activated protein | no | no | 0.8 | 0.677 | 0.357 | 8e-33 | |
| P32491 | 506 | MAP kinase kinase MKK2/SS | yes | no | 0.85 | 0.503 | 0.334 | 1e-31 | |
| O54748 | 491 | Serine/threonine-protein | yes | no | 0.75 | 0.458 | 0.345 | 2e-30 | |
| P33886 | 605 | Protein kinase wis1 OS=Sc | yes | no | 0.793 | 0.393 | 0.344 | 3e-30 |
| >sp|Q8RXG3|M2K5_ARATH Mitogen-activated protein kinase kinase 5 OS=Arabidopsis thaliana GN=MKK5 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 201 bits (512), Expect = 4e-51, Method: Compositional matrix adjust.
Identities = 113/269 (42%), Positives = 157/269 (58%), Gaps = 31/269 (11%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSP 112
LS+LE++ +G G GGTV+KV H T +ALKV+ + Q E+ ILR + P
Sbjct: 67 LSELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHEDTVRRQICREIEILRSVDHP 126
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
+VKCH +F +GE+ +L+E+MD GSLE E + +SRQ+L GL Y+H R
Sbjct: 127 NVVKCHDMFDH-NGEIQVLLEFMDQGSLE----GAHIWQEQELADLSRQILSGLAYLHRR 181
Query: 173 NIVHRDIKPANVLINE----------------KMEHPCGYSC---LYESGEARHR--KHG 211
+IVHRDIKP+N+LIN + PC S Y S E + HG
Sbjct: 182 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 241
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
Y+G+A D+WS GV+++E Y+G +PF ++ D+ SLM AIC +PP P +S++FR
Sbjct: 242 RYDGYAGDVWSLGVSILEFYLGRFPFAV-SRQGDWASLMCAICMSQPPEAPATASQEFRH 300
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFLADA 300
F+ CCLQ DP KRW+A QLL HPF+ A
Sbjct: 301 FVSCCLQ-SDPPKRWSAQQLLQHPFILKA 328
|
Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2 |
| >sp|O80397|M2K4_ARATH Mitogen-activated protein kinase kinase 4 OS=Arabidopsis thaliana GN=MKK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 114/273 (41%), Positives = 157/273 (57%), Gaps = 31/273 (11%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQ 108
E S L + +G G GGTV+KV H+ + LYALKV+ + Q E+ ILR
Sbjct: 72 EAKNYSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETVRRQICREIEILRD 131
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
N P +VKCH++F + +GE+ +L+E+MD GSLE E + +SRQ+L GL Y
Sbjct: 132 VNHPNVVKCHEMFDQ-NGEIQVLLEFMDKGSLE----GAHVWKEQQLADLSRQILSGLAY 186
Query: 169 MHSRNIVHRDIKPANVLINE----------------KMEHPCGYSC---LYESGEARHR- 208
+HSR+IVHRDIKP+N+LIN + PC S Y S E +
Sbjct: 187 LHSRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTD 246
Query: 209 -KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267
G Y+G+A DIWS GV+++E Y+G +PF ++ D+ SLM AIC +PP P +S
Sbjct: 247 LNQGKYDGYAGDIWSLGVSILEFYLGRFPF-PVSRQGDWASLMCAICMSQPPEAPATASP 305
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
+FR FI CCLQ+ +P KR +A QLL HPF+ A
Sbjct: 306 EFRHFISCCLQR-EPGKRRSAMQLLQHPFILRA 337
|
Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 155 bits (391), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 99/266 (37%), Positives = 148/266 (55%), Gaps = 26/266 (9%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN---PQELNILRQTNSP 112
LS L+ ++V+G+G+ G V V+HK T +ALKV+Q + QEL I + + P
Sbjct: 67 LSDLDMVKVIGKGSSGVVQLVQHKWTGQFFALKVIQLNIDEAIRKAIAQELKINQSSQCP 126
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM-HS 171
+V +Q F +G +S+++EYMD GSL ++KS + + + I RQVL+GL Y+ H
Sbjct: 127 NLVTSYQSFYD-NGAISLILEYMDGGSLADFLKSVKAIPDSYLSAIFRQVLQGLIYLHHD 185
Query: 172 RNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKH-GGYN------------G 215
R+I+HRD+KP+N+LIN + E G S + + G YN G
Sbjct: 186 RHIIHRDLKPSNLLINHRGEVKITDFGVSTVMTNTAGLANTFVGTYNYMSPERIVGNKYG 245
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS---LMLAICFREPPSLPECS-SEKFRD 271
+DIWS G+ ++E G +P+ P QE + S LM AI + PP+LP + S +
Sbjct: 246 NKSDIWSLGLVVLECATGKFPYAPPNQEETWTSVFELMEAIVDQPPPALPSGNFSPELSS 305
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
FI CLQK DP+ R +A +L+ HPFL
Sbjct: 306 FISTCLQK-DPNSRSSAKELMEHPFL 330
|
May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (387), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 101/266 (37%), Positives = 152/266 (57%), Gaps = 27/266 (10%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSP 112
+ LE +QV+G+G+GG V VRHK LYALK +Q + Q EL I + T +
Sbjct: 68 MDDLEMIQVIGKGSGGIVQLVRHKWVGTLYALKGIQMNIQEAVRKQIVQELKINQATQNA 127
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM-HS 171
+IV CHQ F +G + +++EYMD GSL +K + E + + +QVL+GL Y+ H
Sbjct: 128 HIVLCHQSFYH-NGVIYLVLEYMDRGSLADIIKQVKTILEPYLAVLCKQVLEGLLYLHHE 186
Query: 172 RNIVHRDIKPANVLINEKME---HPCGYSCLYESGEA-RHRKHGGYN------------G 215
R+++HRDIKP+N+L+N K E G S + S R G YN
Sbjct: 187 RHVIHRDIKPSNLLVNRKGEVKITDFGVSAVLASSMGQRDTFVGTYNYMAPERISGSSYD 246
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS---LMLAICFREPPSLP-ECSSEKFRD 271
+ +DIWS G+ ++E +G +P++ P + +LS L+ AI + PPS P + S +F
Sbjct: 247 YKSDIWSLGLVILECAIGRFPYI-PSEGEGWLSFYELLEAIVDQPPPSAPADQFSPEFCA 305
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
FI C+QK DP++R +AS+LL+HPF+
Sbjct: 306 FISSCIQK-DPAERMSASELLNHPFI 330
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 143 bits (361), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 94/264 (35%), Positives = 147/264 (55%), Gaps = 27/264 (10%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNS-PYI 114
LE ++V+G+G+GG V VRHK +A+KV+Q + Q EL I + ++ P++
Sbjct: 70 LETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQASSQCPHV 129
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RN 173
V C+ F +G S+++EYMD GSL ++ + E + + +QVL GL Y+H+ R+
Sbjct: 130 VVCYHSFYH-NGAFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLVYLHNERH 188
Query: 174 IVHRDIKPANVLINEKME---HPCGYSC-LYESGEARHRKHGGYN------------GFA 217
++HRDIKP+N+L+N K E G S L S R G YN ++
Sbjct: 189 VIHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERISGSTYDYS 248
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQE---PDFLSLMLAICFREPPSLP-ECSSEKFRDFI 273
+DIWS G++++E +G +P+LE + P F L+ AI PP+ P + S +F F+
Sbjct: 249 SDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFSPEFCSFV 308
Query: 274 RCCLQKGDPSKRWTASQLLSHPFL 297
C+QK DP R ++ LLSHPF+
Sbjct: 309 SACIQK-DPPARASSLDLLSHPFI 331
|
Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q24324|DSOR1_DROME Dual specificity mitogen-activated protein kinase kinase dSOR1 OS=Drosophila melanogaster GN=Dsor1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 142 bits (357), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 100/287 (34%), Positives = 144/287 (50%), Gaps = 49/287 (17%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYI 114
LEKL LG GNGG V KVRH T + A K++ + Q EL +L + N P+I
Sbjct: 86 DLEKLGELGSGNGGVVMKVRHTHTHLIMARKLIHLEVKPAIKKQILRELKVLHECNFPHI 145
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN- 173
V + F GE+SI MEYMD GSL++ +K GR+ E I+ I+ VLKGL Y+ +
Sbjct: 146 VGFYGAFYS-DGEISICMEYMDGGSLDLILKRAGRIPESILGRITLAVLKGLSYLRDNHA 204
Query: 174 IVHRDIKPANVLINEKME-HPCGYSCLYESGE----------------ARHRKHGGYNGF 216
I+HRD+KP+N+L+N E C + SG+ + R G +
Sbjct: 205 IIHRDVKPSNILVNSSGEIKICDFGV---SGQLIDSMANSFVGTRSYMSPERLQGTHYSV 261
Query: 217 AADIWSFGVTMMELYMGYYPF-------LE------------PGQEPDFLSL--MLAICF 255
+DIWS G++++E+ +G YP LE P EP +++ +L
Sbjct: 262 QSDIWSLGLSLVEMAIGMYPIPPPNTATLESIFADNAEESGQPTDEPRAMAIFELLDYIV 321
Query: 256 REPPSLPE--CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
EPP E S +F+DF+ CL+K P +R LLSHP++ A
Sbjct: 322 NEPPPKLEHKIFSTEFKDFVDICLKK-QPDERADLKTLLSHPWIRKA 367
|
Required downstream of Raf in the sevenless (sev), torso (tor), and Drosophila EGF receptor homolog (DER) signal transduction pathways. Involved in both positive regulation (at the posterior terminus) and negative regulation (at the anterior domain) of tll, as in other terminal class gene products, maybe via the ERK-A kinase. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 140 bits (354), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 95/266 (35%), Positives = 143/266 (53%), Gaps = 26/266 (9%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN---PQELNILRQTNSP 112
L+ LE ++V+G+G+ G V V+HK T +ALKV+Q + QEL I + P
Sbjct: 65 LADLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCP 124
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM-HS 171
Y+V C+Q F +G VSI++E+MD GSL +K G++ E+++ I ++VL+GL Y+ H
Sbjct: 125 YLVSCYQSFYH-NGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHE 183
Query: 172 RNIVHRDIKPANVLINEKME---HPCGYSCLYESGEAR-------------HRKHGGYNG 215
R I+HRD+KP+N+LIN + E G S + S + R G
Sbjct: 184 RRIIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYS 243
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS---LMLAICFREPPSLP-ECSSEKFRD 271
+DIWS G+ ++E G +P+ P + + S L+ AI PP P S +F
Sbjct: 244 NKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCS 303
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
FI C+QK DP R +A +LL H F+
Sbjct: 304 FISQCVQK-DPRDRKSAKELLEHKFV 328
|
May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|P32491|MKK2_YEAST MAP kinase kinase MKK2/SSP33 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=MKK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 137 bits (344), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 102/305 (33%), Positives = 151/305 (49%), Gaps = 50/305 (16%)
Query: 36 VSCPNLVH--------TEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYAL 87
+SC NL+ EA +G D ++ L +LG+G GG+V K R K ++AL
Sbjct: 186 ISCSNLIQGKDVDQLEEEAWRFGHLKD---EITTLGILGEGAGGSVAKCRLKNGKKVFAL 242
Query: 88 KVMQCDRGTPPNPQ-----ELNILRQTNSPYIVKCHQIFT-KPSGEVSILMEYMDAGSLE 141
K + T P Q EL + S YIV+ + +FT + S + I MEYM SLE
Sbjct: 243 KTINT-MNTDPEYQKQIFRELQFNKSFKSDYIVQYYGMFTDEQSSSIYIAMEYMGGKSLE 301
Query: 142 I----YVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-HPCGY 196
+K GR+SE +I I+ VL+GL Y+H R ++HRDIKP N+L+NEK E C +
Sbjct: 302 ATYKNLLKRGGRISERVIGKIAESVLRGLSYLHERKVIHRDIKPQNILLNEKGEIKLCDF 361
Query: 197 SCLYESGEARH----------------RKHGGYNGFAADIWSFGVTMMELYMGYYPF--- 237
SGEA + R G D+WS G+T++E+ G +PF
Sbjct: 362 GV---SGEAVNSLAMTFTGTSFYMAPERIQGQPYSVTCDVWSLGLTLLEVAGGRFPFESD 418
Query: 238 -LEPGQEP-DFLSLMLAIC--FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
+ P + L+++L ++ P L S+ FR FI CL+K D +R + Q+L
Sbjct: 419 KITQNVAPIELLTMILTFSPQLKDEPELDISWSKTFRSFIDYCLKK-DARERPSPRQMLK 477
Query: 294 HPFLA 298
HP++
Sbjct: 478 HPWIV 482
|
Serine/threonine protein kinase involved in a signal transduction pathway that play a role in yeast cell morphogenesis and cell growth. This pathway seems to starts by SMP3; then involves the kinase PKC1 that may act on the BCK1 kinase that then phosphorylates MKK1 and MKK2 which themselves phosphorylate the MPK1 kinase. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|O54748|STK3_RAT Serine/threonine-protein kinase 3 OS=Rattus norvegicus GN=Stk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 132 bits (333), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 92/266 (34%), Positives = 145/266 (54%), Gaps = 41/266 (15%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIF 121
L+ LG+G+ G+VFK HK++ + A+K + + +E++I++Q +SPY+VK + +
Sbjct: 30 LEKLGEGSYGSVFKAIHKESGQVVAIKQVPVESDVQEIIKEISIMQQCDSPYVVKYYGSY 89
Query: 122 TKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
K + ++ I+MEY AGS+ ++ R + L+ED I TI + LKGL Y+H +HRDIK
Sbjct: 90 FK-NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILKSTLKGLEYLHFMRKIHRDIK 148
Query: 181 PANVLINEKMEHPCGYSCLYESGEA---------RHRKHG-------------GYNGFAA 218
N+L+N + G++ L + G A R+ G GYN A
Sbjct: 149 AGNILLNTE-----GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC-VA 202
Query: 219 DIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIR 274
DIWS G+T +E+ G P+ + P + + I PP+ PE S+ F DF++
Sbjct: 203 DIWSLGITSIEMAEGKPPYADIHP------MRAIFMIPTNPPPTFRKPELWSDDFTDFVK 256
Query: 275 CCLQKGDPSKRWTASQLLSHPFLADA 300
CL K P +R TA+QLL HPF+ +A
Sbjct: 257 KCLVKS-PEQRATATQLLQHPFIKNA 281
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates NKX2-1. Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P33886|WIS1_SCHPO Protein kinase wis1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=wis1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 132 bits (332), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/267 (34%), Positives = 135/267 (50%), Gaps = 29/267 (10%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSP 112
+S++ KL+ LG+GN G V+K H+ T ALK ++ Q EL+IL + SP
Sbjct: 317 MSEIIKLEELGKGNYGVVYKALHQPTGVTMALKEIRLSLEEATFNQIIMELDILHKAVSP 376
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
YIV + F G V I MEYMDAGS++ + + G E ++ + V++GL +
Sbjct: 377 YIVDFYGAFFV-EGSVFICMEYMDAGSMD-KLYAGGIKDEGVLARTAYAVVQGLKTLKEE 434
Query: 173 -NIVHRDIKPANVLINEKME----------------HPCGYSCLYESGEARHRKHGGYNG 215
NI+HRD+KP NVL+N + C R R G NG
Sbjct: 435 HNIIHRDVKPTNVLVNSNGQVKLCDFGVSGNLVASISKTNIGCQSYMAPERIRVGGPTNG 494
Query: 216 F-----AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270
AD+WS G+T++E+ +G YP+ P + + AIC +PPSLP+ S + R
Sbjct: 495 VLTYTVQADVWSLGLTILEMALGAYPY-PPESYTSIFAQLSAICDGDPPSLPDSFSPEAR 553
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFL 297
DF+ CL K +PS R +L +HP+L
Sbjct: 554 DFVNKCLNK-NPSLRPDYHELANHPWL 579
|
Dosage-dependent regulator of mitosis with serine/ threonine protein kinase activity. May play a role in the integration of nutritional sensing with the control over entry into mitosis. It may interact with cdc25, wee1 and win1. May activate sty1. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 300 | ||||||
| 350538357 | 335 | MAPKK [Solanum lycopersicum] gi|51471932 | 0.796 | 0.713 | 0.534 | 8e-72 | |
| 290784293 | 327 | mitogen-activated protein kinase kinase | 0.803 | 0.737 | 0.522 | 1e-71 | |
| 315258235 | 325 | mitogen-activated protein kinase kinase | 0.803 | 0.741 | 0.522 | 3e-71 | |
| 108743310 | 325 | mitogen-activated protein kinase kinase | 0.796 | 0.735 | 0.518 | 9e-70 | |
| 118489678 | 321 | unknown [Populus trichocarpa x Populus d | 0.8 | 0.747 | 0.501 | 2e-68 | |
| 225456228 | 314 | PREDICTED: mitogen-activated protein kin | 0.8 | 0.764 | 0.505 | 9e-68 | |
| 147770515 | 314 | hypothetical protein VITISV_038954 [Viti | 0.8 | 0.764 | 0.505 | 1e-67 | |
| 357595123 | 324 | hematopoietic protein kinase [Medicago t | 0.883 | 0.817 | 0.472 | 2e-67 | |
| 224125868 | 310 | predicted protein [Populus trichocarpa] | 0.8 | 0.774 | 0.501 | 2e-67 | |
| 356520673 | 318 | PREDICTED: mitogen-activated protein kin | 0.93 | 0.877 | 0.450 | 3e-67 |
| >gi|350538357|ref|NP_001234595.1| MAPKK [Solanum lycopersicum] gi|51471932|gb|AAU04436.1| MAPKK [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 276 bits (706), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 141/264 (53%), Positives = 183/264 (69%), Gaps = 25/264 (9%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYI 114
+LEKL+VLG GNGGTV+KVRHK+T A+YALKV+ D Q E++ILR+T SPY+
Sbjct: 65 ELEKLKVLGHGNGGTVYKVRHKRTSAIYALKVVHGDSDPEIRRQILREISILRRTESPYV 124
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+KCH + P G++ ILMEYM+AG+LE +KS+ SE + I++QVL GL Y+HS I
Sbjct: 125 IKCHGVIDMPGGDIGILMEYMNAGTLENLLKSQLTFSELCLARIAKQVLGGLDYLHSHKI 184
Query: 175 VHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARHRKH--GGY 213
+HRD+KP+N+L+N +ME PC +C Y S E G Y
Sbjct: 185 IHRDLKPSNLLVNREMEVKIADFGVSKIMGRTLDPCNSYVGTCAYMSPERFDPDTYGGNY 244
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
NG+AADIWS G+T+MELYMG++PFL PGQ PD+ +LM AICF EPPSLPE +SEKF DF+
Sbjct: 245 NGYAADIWSLGLTLMELYMGHFPFLPPGQRPDWATLMCAICFGEPPSLPENTSEKFNDFM 304
Query: 274 RCCLQKGDPSKRWTASQLLSHPFL 297
+CCLQK + SKRW+A QLL HPF+
Sbjct: 305 KCCLQK-ESSKRWSAHQLLQHPFI 327
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290784293|gb|ADD62693.1| mitogen-activated protein kinase kinase [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 275 bits (704), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 139/266 (52%), Positives = 186/266 (69%), Gaps = 25/266 (9%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSP 112
+S+LEKL+VLG GNGGTV+KVRHK+T A+YALKV+ D Q E++ILR+T+SP
Sbjct: 57 ISELEKLKVLGHGNGGTVYKVRHKRTSAIYALKVVHGDSDPEIRRQILREISILRRTDSP 116
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
Y++KCH + P G++ ILMEYM++G+LE +KS+ SE + I++QVL GL Y+H+
Sbjct: 117 YVIKCHGVIDMPGGDIGILMEYMNSGTLENLLKSQTTFSELCLAKIAKQVLSGLDYLHNH 176
Query: 173 NIVHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARHRKHGG- 212
I+HRD+KP+N+L+N +ME PC +C Y S E G
Sbjct: 177 KIIHRDLKPSNLLVNREMEVKIADFGVSKIMCRTLDPCNSYVGTCAYMSPERFDPDTYGV 236
Query: 213 -YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
YNG+AADIWS G+T+MELYMG++PFL PGQ PD+ +LM AICF EPPSLP+ +SEKF+D
Sbjct: 237 NYNGYAADIWSLGLTLMELYMGHFPFLPPGQRPDWATLMCAICFGEPPSLPKGTSEKFKD 296
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
F+ CCLQK + SKRW+A QLL HPF+
Sbjct: 297 FMECCLQK-ESSKRWSAQQLLQHPFV 321
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|315258235|gb|ADT91696.1| mitogen-activated protein kinase kinase 1 [Nicotiana attenuata] | Back alignment and taxonomy information |
|---|
Score = 274 bits (701), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 139/266 (52%), Positives = 183/266 (68%), Gaps = 25/266 (9%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSP 112
+S+LEKL+VLG GNGGTV+KVRHK+T A+YALKV+ D Q E++ILR+T+SP
Sbjct: 56 ISELEKLKVLGHGNGGTVYKVRHKRTSAIYALKVVHGDSDPEIRRQVLREISILRRTDSP 115
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
YI+KCH + P G++ ILMEYM++G+LE +KS +E + I++QVL GL Y+H+
Sbjct: 116 YIIKCHGVIDMPGGDIGILMEYMNSGTLESLLKSHATFTELSLAKIAKQVLSGLDYLHNH 175
Query: 173 NIVHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARHRKHGG- 212
I+HRD+KP+N+L+N +ME PC +C Y S E G
Sbjct: 176 KIIHRDLKPSNLLVNREMEVKIADFGVSKIMCRTLDPCNSYVGTCAYMSPERFDPDTYGV 235
Query: 213 -YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
YNG+AADIWS G+T+MELYMG++PFL PGQ PD+ +LM AICF EPPSLPE +S F+D
Sbjct: 236 NYNGYAADIWSLGLTLMELYMGHFPFLPPGQRPDWATLMCAICFGEPPSLPEGTSGNFKD 295
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
FI CCLQK + SKRW+A QLL HPF+
Sbjct: 296 FIECCLQK-ESSKRWSAQQLLQHPFI 320
|
Source: Nicotiana attenuata Species: Nicotiana attenuata Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|108743310|dbj|BAE95414.1| mitogen-activated protein kinase kinase [Nicotiana benthamiana] | Back alignment and taxonomy information |
|---|
Score = 269 bits (688), Expect = 9e-70, Method: Compositional matrix adjust.
Identities = 137/264 (51%), Positives = 182/264 (68%), Gaps = 25/264 (9%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYI 114
+LEKL+VLG GNGGTV++VRHK+T A+YALKV+ D Q E++ILR+T+SPY+
Sbjct: 58 ELEKLKVLGHGNGGTVYEVRHKRTSAIYALKVVHGDSDPEIRRQILREISILRRTDSPYV 117
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+KCH + P G++ ILMEYM+ G+LE +KS+ SE + I++QVL GL Y+H+ I
Sbjct: 118 IKCHGVIDMPGGDIGILMEYMNVGTLESLLKSQATFSELSLAKIAKQVLSGLDYLHNHKI 177
Query: 175 VHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARHRKHGG--Y 213
+HRD+KP+N+L+N +ME PC +C Y S E G Y
Sbjct: 178 IHRDLKPSNLLVNREMEVKIADFGVSKIMCRTLDPCNSYVGTCAYMSPERFDPGTYGVNY 237
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
NG+AADIWS G+T+MELY+G++PFL PGQ PD+ +LM AICF EPPSLPE +S FRDFI
Sbjct: 238 NGYAADIWSLGLTLMELYIGHFPFLPPGQRPDWATLMCAICFGEPPSLPEGTSVNFRDFI 297
Query: 274 RCCLQKGDPSKRWTASQLLSHPFL 297
CCLQK + SKRW+A QLL+HPF+
Sbjct: 298 ECCLQK-ESSKRWSAQQLLNHPFI 320
|
Source: Nicotiana benthamiana Species: Nicotiana benthamiana Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118489678|gb|ABK96640.1| unknown [Populus trichocarpa x Populus deltoides] | Back alignment and taxonomy information |
|---|
Score = 265 bits (677), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 133/265 (50%), Positives = 180/265 (67%), Gaps = 25/265 (9%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
+ +EK+ VLG GNGGTV+KVRHK+ +YALKV+ D Q E+ ILR+T+SP
Sbjct: 47 NDIEKIHVLGHGNGGTVYKVRHKRNSQIYALKVVHGDSDPLVRRQIYREIEILRRTDSPN 106
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
IVKCH ++ KPSG+++I MEYMD G+L+ +K G +E + ++ QVL GL Y+H++
Sbjct: 107 IVKCHGVYEKPSGDIAITMEYMDLGTLDSLLKKHGTFNESKLSHVASQVLNGLSYLHAQK 166
Query: 174 IVHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARHRKH--GG 212
I+HRDIKP+N+L+N+ ME C +C Y S E G
Sbjct: 167 IIHRDIKPSNLLVNKDMEVKIADFGVSKIMHRTLDACNSYVGTCAYMSPERFDPDTYGGN 226
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
YNG+AADIWS G+ ++ELYMG++PFL PGQ PD+ +LM AICF +PPSLPE +SE+FRDF
Sbjct: 227 YNGYAADIWSLGLILLELYMGHFPFLPPGQRPDWATLMCAICFGDPPSLPEGASEEFRDF 286
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
I+CCLQK + KRWTA+QLL+HPF+
Sbjct: 287 IQCCLQK-ESGKRWTAAQLLAHPFV 310
|
Source: Populus trichocarpa x Populus deltoides Species: Populus trichocarpa x Populus deltoides Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456228|ref|XP_002283080.1| PREDICTED: mitogen-activated protein kinase kinase 5 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 263 bits (671), Expect = 9e-68, Method: Compositional matrix adjust.
Identities = 134/265 (50%), Positives = 182/265 (68%), Gaps = 25/265 (9%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
+ LEK++V+G GNGGTV+KV+HK+T A YALKV+ D Q E+ ILR T+SP+
Sbjct: 45 ADLEKIEVIGHGNGGTVYKVQHKRTAANYALKVVHGDCDPTVRRQVLREMEILRFTDSPF 104
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
+V+CH IF KPSG+++ILMEYMDAG+L+ ++++G SE + ++ QVL GL Y+HS
Sbjct: 105 VVQCHGIFQKPSGDIAILMEYMDAGTLKTLLETKGTFSEVDLAGVAGQVLNGLSYLHSHK 164
Query: 174 IVHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARH-RKHG-G 212
I+HRDIKPAN+L+N ME C +C Y S E HG
Sbjct: 165 IIHRDIKPANLLVNGNMEVKIADFGVSKIMRRMLDSCNSYVGTCAYMSPERFDPDSHGSN 224
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
Y+G++ DIWS G+T++ELY+G++P L GQ+PD+ +LM AICF E P+LPE SE+FR+F
Sbjct: 225 YDGYSGDIWSLGLTLLELYVGHFPLLPAGQKPDWATLMCAICFGEEPALPEGVSEEFRNF 284
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
I CCLQK D +KRWTA+QLLSHPF+
Sbjct: 285 IECCLQK-DSTKRWTAAQLLSHPFI 308
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147770515|emb|CAN75681.1| hypothetical protein VITISV_038954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 262 bits (670), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 134/265 (50%), Positives = 182/265 (68%), Gaps = 25/265 (9%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
+ LEK++V+G GNGGTV+KV+HK+T A YALKV+ D Q E+ ILR T+SP+
Sbjct: 45 ADLEKIEVIGHGNGGTVYKVQHKRTAANYALKVVHGDCDPTVRRQVLREMEILRFTDSPF 104
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
+V+CH IF KPSG+++ILMEYMDAG+L+ ++++G SE + ++ QVL GL Y+HS
Sbjct: 105 VVQCHGIFQKPSGDIAILMEYMDAGTLKTLLETQGTFSEVDLAGVAGQVLNGLSYLHSHK 164
Query: 174 IVHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARH-RKHG-G 212
I+HRDIKPAN+L+N ME C +C Y S E HG
Sbjct: 165 IIHRDIKPANLLVNGNMEVKIADFGVSKIMRRMLDSCNSYVGTCAYMSPERFDPDSHGSN 224
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
Y+G++ DIWS G+T++ELY+G++P L GQ+PD+ +LM AICF E P+LPE SE+FR+F
Sbjct: 225 YDGYSGDIWSLGLTLLELYVGHFPLLPAGQKPDWATLMCAICFGEEPALPEGVSEEFRNF 284
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
I CCLQK D +KRWTA+QLLSHPF+
Sbjct: 285 IECCLQK-DSTKRWTAAQLLSHPFI 308
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357595123|gb|AET86557.1| hematopoietic protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 262 bits (669), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 139/294 (47%), Positives = 186/294 (63%), Gaps = 29/294 (9%)
Query: 32 IPKPVSC---PNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALK 88
+P P + P+ T A+ G + EKL VLG GNGGTV+KVRHK T +YALK
Sbjct: 26 VPLPANIYKQPSTSATTASVAGGDNISAGDFEKLSVLGHGNGGTVYKVRHKLTSIIYALK 85
Query: 89 VMQCDRGTPPNPQ---ELNILRQ-TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV 144
+ D + E+NILR+ T+ +VK H F KP+G+V ILMEYMD+GSLE +
Sbjct: 86 INHYDSDPTTRRRALTEVNILRRATDCTNVVKYHGSFEKPTGDVCILMEYMDSGSLETAL 145
Query: 145 KSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME------------- 191
K+ G SE + T++R +L GL Y+H+RNI HRDIKP+N+L+N K E
Sbjct: 146 KTTGTFSESKLSTVARDILNGLTYLHARNIAHRDIKPSNILVNIKNEVKIADFGVSKFMG 205
Query: 192 ---HPCGY---SCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE 243
C +C Y S E + G YNGF+ADIWS G+T+ ELY+GY+PFL+ GQ
Sbjct: 206 RTLEACNSYVGTCAYMSPERFDPEVYGGNYNGFSADIWSLGLTLFELYVGYFPFLQSGQR 265
Query: 244 PDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
PD+ SLM AICF +PPSLPE +S +FR+F+ CCL+K + +RW+A+QLL+HPFL
Sbjct: 266 PDWASLMCAICFSDPPSLPETASSEFRNFVECCLKK-ESGERWSAAQLLTHPFL 318
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125868|ref|XP_002329737.1| predicted protein [Populus trichocarpa] gi|222870645|gb|EEF07776.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 262 bits (669), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 133/265 (50%), Positives = 179/265 (67%), Gaps = 25/265 (9%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
+ +EK+ VLG GNGGTV+KVRHK+ +YALKV+ D Q E+ ILR+T+SPY
Sbjct: 47 NDIEKIHVLGHGNGGTVYKVRHKRNSQIYALKVVHGDSDPLVRRQIYREIEILRRTDSPY 106
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
IV+CH + KPSG++ I+MEYM+ G+L+ ++ G E + ++RQVL GL Y+H +
Sbjct: 107 IVQCHGSYEKPSGDIGIVMEYMELGTLDSILQKYGAFDESKLSHVARQVLHGLSYLHGQK 166
Query: 174 IVHRDIKPANVLINEKME----------------HPCGY---SCLYESGEARHRKHGG-- 212
I+HRDIKP+N+L+N+ ME C +C Y S E G
Sbjct: 167 IIHRDIKPSNLLVNKDMEVKIADFGVSKIMQRTLDACNSYVGTCAYMSPERFDPDTYGVN 226
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
Y+G+A DIWS G+T+MELY+G++PFL PGQ PD+ +LM AICF +PPSLPE +SE+FRDF
Sbjct: 227 YDGYAGDIWSLGLTLMELYLGHFPFLPPGQRPDWATLMCAICFGDPPSLPEGASEEFRDF 286
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
I+CCLQK + SKRWT SQLLSHPF+
Sbjct: 287 IQCCLQK-ESSKRWTTSQLLSHPFV 310
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520673|ref|XP_003528985.1| PREDICTED: mitogen-activated protein kinase kinase 4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 261 bits (667), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 140/311 (45%), Positives = 194/311 (62%), Gaps = 32/311 (10%)
Query: 20 VRKPRHLVTQLNIPKPVS------CPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTV 73
VR RH +L +P+P P T A + + LEKL +LG GNGGTV
Sbjct: 4 VRHRRHPNLRLPLPEPSERRLRFPLPLPPTTTAKPASGDAIAAADLEKLAILGHGNGGTV 63
Query: 74 FKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQ-TNSPYIVKCHQIFTKPSGEVS 129
+KVRHK T A YALK++ D + E +ILR+ T+ P++V+ H F KPSG+V+
Sbjct: 64 YKVRHKATSATYALKIIHSDTDATRRRRALSETSILRRVTDCPHVVRFHSSFEKPSGDVA 123
Query: 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK 189
ILMEYMD G+LE + + G SE+ + ++R VL+GL Y+H+RNI HRDIKPAN+L+N +
Sbjct: 124 ILMEYMDGGTLETALAASGTFSEERLAKVARDVLEGLAYLHARNIAHRDIKPANILVNSE 183
Query: 190 -----------------MEHPCGY--SCLYESGEARHRKH--GGYNGFAADIWSFGVTMM 228
+E Y +C Y S + + G YNGFAADIWS G+T+
Sbjct: 184 GDVKIADFGVSKLMCRSLEACNSYVGTCAYMSPDRFDPEAYGGNYNGFAADIWSLGLTLF 243
Query: 229 ELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTA 288
ELY+G++PFL+ GQ PD+ +LM AICF +PPSLPE +S +FRDF+ CCL+K + +RWT
Sbjct: 244 ELYVGHFPFLQAGQRPDWATLMCAICFGDPPSLPETASPEFRDFVECCLKK-ESGERWTT 302
Query: 289 SQLLSHPFLAD 299
+QLL+HPF+ +
Sbjct: 303 AQLLTHPFVCN 313
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 300 | ||||||
| TAIR|locus:2082390 | 293 | MKK8 "MAP kinase kinase 8" [Ar | 0.506 | 0.518 | 0.477 | 6.8e-49 | |
| TAIR|locus:2028301 | 305 | MKK10 "MAP kinase kinase 10" [ | 0.563 | 0.554 | 0.387 | 6.7e-45 | |
| FB|FBgn0010269 | 396 | Dsor1 "Downstream of raf1" [Dr | 0.64 | 0.484 | 0.380 | 3.9e-35 | |
| TAIR|locus:2206885 | 310 | MKK9 "MAP kinase kinase 9" [Ar | 0.56 | 0.541 | 0.486 | 1.1e-34 | |
| UNIPROTKB|Q5ZIF0 | 395 | MAP2K1 "Uncharacterized protei | 0.673 | 0.511 | 0.36 | 2.4e-33 | |
| UNIPROTKB|Q0VD16 | 393 | MAP2K1 "MAP2K1 protein" [Bos t | 0.646 | 0.493 | 0.362 | 3e-33 | |
| UNIPROTKB|F1PJI7 | 380 | MAP2K1 "Uncharacterized protei | 0.646 | 0.510 | 0.362 | 3e-33 | |
| UNIPROTKB|J9P5W6 | 393 | MAP2K1 "Uncharacterized protei | 0.646 | 0.493 | 0.362 | 3e-33 | |
| UNIPROTKB|Q02750 | 393 | MAP2K1 "Dual specificity mitog | 0.646 | 0.493 | 0.362 | 3e-33 | |
| MGI|MGI:1346866 | 393 | Map2k1 "mitogen-activated prot | 0.646 | 0.493 | 0.362 | 3e-33 |
| TAIR|locus:2082390 MKK8 "MAP kinase kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 349 (127.9 bits), Expect = 6.8e-49, Sum P(2) = 6.8e-49
Identities = 75/157 (47%), Positives = 100/157 (63%)
Query: 35 PVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR 94
P+ V +S ++ L+++ VLG GNGGTVFKV+ K T +YALK ++ +
Sbjct: 29 PIIPATKVSATVSSCASNTFSVANLDRISVLGSGNGGTVFKVKDKTTSEIYALKKVK-EN 87
Query: 95 GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDI 154
+ +E+ ILR NSPY+ KCH IF PSGEVSILM+YMD GSLE RG ++E
Sbjct: 88 WDSTSLREIEILRMVNSPYVAKCHDIFQNPSGEVSILMDYMDLGSLE---SLRG-VTEKQ 143
Query: 155 ICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191
+ +SRQVL+G Y+H IVHRDIKPAN+L + K E
Sbjct: 144 LALMSRQVLEGKNYLHEHKIVHRDIKPANLLRSSKEE 180
|
|
| TAIR|locus:2028301 MKK10 "MAP kinase kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 285 (105.4 bits), Expect = 6.7e-45, Sum P(2) = 6.7e-45
Identities = 69/178 (38%), Positives = 108/178 (60%)
Query: 20 VRKPRHLVT-QLNIPKPVSCPNLVHTEAASYGQE-----IDGLSQLEKLQVLGQGNGGTV 73
VR+ RH L+IP P+ + A+S I L+ LEKL VLGQG+GGTV
Sbjct: 4 VRERRHQEPLTLSIP-PLIYHGTAFSVASSSSSSPETSPIQTLNDLEKLSVLGQGSGGTV 62
Query: 74 FKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133
+K RH++T LYALKV++ + T E +IL++ S +I+KC+ +F ++ +ME
Sbjct: 63 YKTRHRRTKTLYALKVLRPNLNTTVTV-EADILKRIESSFIIKCYAVFVSLY-DLCFVME 120
Query: 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191
M+ GSL + ++ SE ++ +++ ++L+GL Y+ IVH DIKP+N+LIN+K E
Sbjct: 121 LMEKGSLHDALLAQQVFSEPMVSSLANRILQGLRYLQKMGIVHGDIKPSNLLINKKGE 178
|
|
| FB|FBgn0010269 Dsor1 "Downstream of raf1" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 309 (113.8 bits), Expect = 3.9e-35, Sum P(2) = 3.9e-35
Identities = 81/213 (38%), Positives = 116/213 (54%)
Query: 48 SYGQEIDGLSQ--LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---E 102
S ++I LS LEKL LG GNGG V KVRH T + A K++ + Q E
Sbjct: 74 SQKEKIGELSDEDLEKLGELGSGNGGVVMKVRHTHTHLIMARKLIHLEVKPAIKKQILRE 133
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQV 162
L +L + N P+IV + F GE+SI MEYMD GSL++ +K GR+ E I+ I+ V
Sbjct: 134 LKVLHECNFPHIVGFYGAFYS-DGEISICMEYMDGGSLDLILKRAGRIPESILGRITLAV 192
Query: 163 LKGLFYMHSRN-IVHRDIKPANVLINEKMEHP-CGYSC---LYES------GEARH---- 207
LKGL Y+ + I+HRD+KP+N+L+N E C + L +S G +
Sbjct: 193 LKGLSYLRDNHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMANSFVGTRSYMSPE 252
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP 240
R G + +DIWS G++++E+ +G YP P
Sbjct: 253 RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 285
|
|
| TAIR|locus:2206885 MKK9 "MAP kinase kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 376 (137.4 bits), Expect = 1.1e-34, P = 1.1e-34
Identities = 88/181 (48%), Positives = 118/181 (65%)
Query: 20 VRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEI---DGLS--QLEKLQVLGQGNGGTVF 74
VR+ R L +L +P P+S + +++ + +G+S LEKL VLG GNGG V+
Sbjct: 4 VRERRQLNLRLPLP-PISDRRFSTSSSSATTTTVAGCNGISACDLEKLNVLGCGNGGIVY 62
Query: 75 KVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPS-GEVSI 130
KVRHK T +YALK + D T +E+ ILR+T+SPY+VKCH IF KP GEVSI
Sbjct: 63 KVRHKTTSEIYALKTVNGDMDPIFTRQLMREMEILRRTDSPYVVKCHGIFEKPVVGEVSI 122
Query: 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190
LMEYMD G+LE RG ++E + ++Q+LKGL Y+H+ IVHRDIKPAN+L+N K
Sbjct: 123 LMEYMDGGTLE---SLRGGVTEQKLAGFAKQILKGLSYLHALKIVHRDIKPANLLLNSKN 179
Query: 191 E 191
E
Sbjct: 180 E 180
|
|
| UNIPROTKB|Q5ZIF0 MAP2K1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 306 (112.8 bits), Expect = 2.4e-33, Sum P(2) = 2.4e-33
Identities = 81/225 (36%), Positives = 123/225 (54%)
Query: 44 TEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNP-- 100
T+ G+ D EK+ LG GNGG VFKV HK + + A K++ + + N
Sbjct: 55 TQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII 112
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
+EL +L + NSPYIV + F GE+SI ME+MD GSL+ +K GR+ E I+ +S
Sbjct: 113 RELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 171
Query: 161 QVLKGLFYMHSRN-IVHRDIKPANVLINEKMEHP-CGYSC---LYES------GEARH-- 207
V+KGL Y+ ++ I+HRD+KP+N+L+N + E C + L +S G +
Sbjct: 172 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 231
Query: 208 --RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250
R G + +DIWS G++++E+ +G YP P + L LM
Sbjct: 232 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDSKE--LELM 274
|
|
| UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 304 (112.1 bits), Expect = 3.0e-33, Sum P(2) = 3.0e-33
Identities = 78/215 (36%), Positives = 119/215 (55%)
Query: 44 TEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNP-- 100
T+ G+ D EK+ LG GNGG VFKV HK + + A K++ + + N
Sbjct: 55 TQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 112
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
+EL +L + NSPYIV + F GE+SI ME+MD GSL+ +K GR+ E I+ +S
Sbjct: 113 RELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 171
Query: 161 QVLKGLFYMHSRN-IVHRDIKPANVLINEKMEHP-CGYSC---LYES------GEARH-- 207
V+KGL Y+ ++ I+HRD+KP+N+L+N + E C + L +S G +
Sbjct: 172 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 231
Query: 208 --RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP 240
R G + +DIWS G++++E+ +G YP P
Sbjct: 232 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 266
|
|
| UNIPROTKB|F1PJI7 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 304 (112.1 bits), Expect = 3.0e-33, Sum P(2) = 3.0e-33
Identities = 78/215 (36%), Positives = 119/215 (55%)
Query: 44 TEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNP-- 100
T+ G+ D EK+ LG GNGG VFKV HK + + A K++ + + N
Sbjct: 55 TQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 112
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
+EL +L + NSPYIV + F GE+SI ME+MD GSL+ +K GR+ E I+ +S
Sbjct: 113 RELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 171
Query: 161 QVLKGLFYMHSRN-IVHRDIKPANVLINEKMEHP-CGYSC---LYES------GEARH-- 207
V+KGL Y+ ++ I+HRD+KP+N+L+N + E C + L +S G +
Sbjct: 172 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 231
Query: 208 --RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP 240
R G + +DIWS G++++E+ +G YP P
Sbjct: 232 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 266
|
|
| UNIPROTKB|J9P5W6 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 304 (112.1 bits), Expect = 3.0e-33, Sum P(2) = 3.0e-33
Identities = 78/215 (36%), Positives = 119/215 (55%)
Query: 44 TEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNP-- 100
T+ G+ D EK+ LG GNGG VFKV HK + + A K++ + + N
Sbjct: 55 TQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 112
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
+EL +L + NSPYIV + F GE+SI ME+MD GSL+ +K GR+ E I+ +S
Sbjct: 113 RELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 171
Query: 161 QVLKGLFYMHSRN-IVHRDIKPANVLINEKMEHP-CGYSC---LYES------GEARH-- 207
V+KGL Y+ ++ I+HRD+KP+N+L+N + E C + L +S G +
Sbjct: 172 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 231
Query: 208 --RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP 240
R G + +DIWS G++++E+ +G YP P
Sbjct: 232 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 266
|
|
| UNIPROTKB|Q02750 MAP2K1 "Dual specificity mitogen-activated protein kinase kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 304 (112.1 bits), Expect = 3.0e-33, Sum P(2) = 3.0e-33
Identities = 78/215 (36%), Positives = 119/215 (55%)
Query: 44 TEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNP-- 100
T+ G+ D EK+ LG GNGG VFKV HK + + A K++ + + N
Sbjct: 55 TQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 112
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
+EL +L + NSPYIV + F GE+SI ME+MD GSL+ +K GR+ E I+ +S
Sbjct: 113 RELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 171
Query: 161 QVLKGLFYMHSRN-IVHRDIKPANVLINEKMEHP-CGYSC---LYES------GEARH-- 207
V+KGL Y+ ++ I+HRD+KP+N+L+N + E C + L +S G +
Sbjct: 172 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 231
Query: 208 --RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP 240
R G + +DIWS G++++E+ +G YP P
Sbjct: 232 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 266
|
|
| MGI|MGI:1346866 Map2k1 "mitogen-activated protein kinase kinase 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 304 (112.1 bits), Expect = 3.0e-33, Sum P(2) = 3.0e-33
Identities = 78/215 (36%), Positives = 119/215 (55%)
Query: 44 TEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNP-- 100
T+ G+ D EK+ LG GNGG VFKV HK + + A K++ + + N
Sbjct: 55 TQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 112
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
+EL +L + NSPYIV + F GE+SI ME+MD GSL+ +K GR+ E I+ +S
Sbjct: 113 RELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 171
Query: 161 QVLKGLFYMHSRN-IVHRDIKPANVLINEKMEHP-CGYSC---LYES------GEARH-- 207
V+KGL Y+ ++ I+HRD+KP+N+L+N + E C + L +S G +
Sbjct: 172 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 231
Query: 208 --RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP 240
R G + +DIWS G++++E+ +G YP P
Sbjct: 232 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 266
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.12 | 0.766 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 300 | |||
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-95 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-73 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-70 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-63 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-63 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-60 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-58 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-57 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-57 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-49 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-46 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-45 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-45 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-45 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-44 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-40 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-40 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-36 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-35 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-34 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-33 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-33 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-32 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-31 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-30 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-28 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-28 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-26 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-26 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 9e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 282 bits (724), Expect = 1e-95
Identities = 127/266 (47%), Positives = 164/266 (61%), Gaps = 32/266 (12%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
S LE+++VLGQG+ G V+KVRHK T +YALK + D Q EL LR SPY
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-R 172
+VKC+ F K GE+SI++EYMD GSL +K G++ E ++ I+RQ+LKGL Y+H+ R
Sbjct: 61 VVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 173 NIVHRDIKPANVLINEKME----------------HPC----GYSCLYESGEARHRKHGG 212
+I+HRDIKP+N+LIN K E C G + Y S E R G
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG-TVTYMSPE---RIQGE 175
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP-ECSSEKFRD 271
+AADIWS G+T++E +G +PFL PGQ P F LM AIC PPSLP E S +FRD
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPPPSLPAEEFSPEFRD 234
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
FI CLQK DP KR +A++LL HPF+
Sbjct: 235 FISACLQK-DPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 1e-73
Identities = 123/301 (40%), Positives = 175/301 (58%), Gaps = 37/301 (12%)
Query: 26 LVTQLNIPKPVSCPNLVHTEAASYGQEID--GLSQLEKLQVLGQGNGGTVFKVRHKQTLA 83
L L +P P S + + +AS LS+LE++ +G G GGTV+KV H+ T
Sbjct: 41 LAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGR 100
Query: 84 LYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSL 140
LYALKV+ + Q E+ ILR N P +VKCH +F +GE+ +L+E+MD GSL
Sbjct: 101 LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFMDGGSL 159
Query: 141 E-IYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK---------- 189
E ++ L++ ++RQ+L G+ Y+H R+IVHRDIKP+N+LIN
Sbjct: 160 EGTHIADEQFLAD-----VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214
Query: 190 -------MEHPCGYSC---LYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPF 237
M+ PC S Y S E + HG Y+G+A DIWS GV+++E Y+G +PF
Sbjct: 215 SRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
Query: 238 LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
G++ D+ SLM AIC +PP P +S +FR FI CCLQ+ +P+KRW+A QLL HPF+
Sbjct: 274 -GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQR-EPAKRWSAMQLLQHPFI 331
Query: 298 A 298
Sbjct: 332 L 332
|
Length = 353 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 8e-70
Identities = 90/258 (34%), Positives = 127/258 (49%), Gaps = 25/258 (9%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVK 116
E L+ LG+G+ G V+ R K+T L A+KV++ + + E+ IL++ P IV+
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ +F ++ ++MEY + G L +K RGRLSED RQ+L L Y+HS+ IVH
Sbjct: 62 LYDVFEDE-DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 177 RDIKPANVLINEKMEHPC----GYSCLYESGEARHR-------------KHGGYNGFAAD 219
RD+KP N+L++E H G + + GE GY G A D
Sbjct: 121 RDLKPENILLDEDG-HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY-GKAVD 178
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQK 279
IWS GV + EL G PF Q + + PP + S E +D IR L K
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPE-AKDLIRKLLVK 237
Query: 280 GDPSKRWTASQLLSHPFL 297
DP KR TA + L HPF
Sbjct: 238 -DPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 3e-63
Identities = 94/258 (36%), Positives = 136/258 (52%), Gaps = 28/258 (10%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM--QCDRGTPPNPQELNILRQTNSPYIVKC 117
E L+ +G+G G V+K RHK+T A+KV+ + E+ IL++ P IVK
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + K E+ I+ME+ GSL+ +KS + L+E I + +++LKGL Y+HS I+H
Sbjct: 63 YGSYLKK-DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 177 RDIKPANVLINEKMEHPC---GYSCLYESGEARHRKHG-------------GYNGFAADI 220
RDIK AN+L+ E G S +AR+ G Y + ADI
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY-DYKADI 180
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRCCLQ 278
WS G+T +EL G P+ E + + I PP L PE S++F+DF++ CLQ
Sbjct: 181 WSLGITAIELAEGKPPYSELP----PMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236
Query: 279 KGDPSKRWTASQLLSHPF 296
K +P KR TA QLL HPF
Sbjct: 237 K-NPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 6e-63
Identities = 85/269 (31%), Positives = 134/269 (49%), Gaps = 38/269 (14%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILRQTNSPY 113
+ + ++LG+G+ G+V+ K T L A+K ++ + +E+ IL P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 114 IVKC--HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
IV+ + + ++I +EY+ GSL +K G+L E +I +RQ+L+GL Y+HS
Sbjct: 61 IVRYYGSER-DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 172 RNIVHRDIKPANVLINEK----------------------MEHPCGYSCLYESGEARHRK 209
IVHRDIK AN+L++ G + + E
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP-YWMAPEV---I 175
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI-CFREPPSLPECSSEK 268
G G AADIWS G T++E+ G P+ + + ++ + I EPP +PE SE+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPW---SELGNPMAALYKIGSSGEPPEIPEHLSEE 232
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+DF+R CL++ DP KR TA +LL HPFL
Sbjct: 233 AKDFLRKCLRR-DPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 7e-60
Identities = 98/265 (36%), Positives = 140/265 (52%), Gaps = 29/265 (10%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
LE L LG GN G V KV H+ T + A+K ++ + Q EL+IL + NSPY
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLE-IYVKSRGRLSEDIICTISRQVLKGLFYMHS- 171
IV + F +G++SI MEYMD GSL+ I + +GR+ E I+ I+ VLKGL Y+H
Sbjct: 61 IVGFYGAFYN-NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 172 RNIVHRDIKPANVLINEKME-HPCGYSCLYESGE----------------ARHRKHGGYN 214
I+HRD+KP+N+L+N + + C + SG+ A R G
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGV---SGQLVNSLAKTFVGTSSYMAPERIQGNDY 176
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPD-FLSLMLAICFREPPSLP-ECSSEKFRDF 272
+DIWS G++++EL G +P+ PD L+ I PP LP S F+DF
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
+ CL K DP +R + +LL HPF+
Sbjct: 237 VNLCLIK-DPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 4e-58
Identities = 86/269 (31%), Positives = 126/269 (46%), Gaps = 39/269 (14%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYI 114
E L+ LG G+ GTV+K +HK T + A+K+++ Q E+ ILR+ + P I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V+ F + ++MEY + G L Y+ G LSED I+ Q+L+GL Y+HS I
Sbjct: 61 VRLIDAFEDKD-HLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 175 VHRDIKPANVLINEK--------------------MEHPCGYSCLYESGEARHRKHGGYN 214
+HRD+KP N+L++E + G + Y + E GY
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVG-TPWYMAPE-VLLGGNGY- 176
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC------FREPPSLPECSSEK 268
G D+WS GV + EL G PF + L + I SE+
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPF----SGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+D I+ CL K DPSKR TA ++L HP+
Sbjct: 233 AKDLIKKCLNK-DPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 2e-57
Identities = 94/263 (35%), Positives = 144/263 (54%), Gaps = 41/263 (15%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIF 121
L+ LG+G+ G+V+K HK+T + A+KV+ + +E++IL+Q +SPYIVK + +
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 122 TKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
K + ++ I+MEY AGS+ +K + L+E+ I I Q LKGL Y+HS +HRDIK
Sbjct: 68 FK-NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126
Query: 181 PANVLINEKMEHPCGYSCLYE---SGEARHR-------------------KHGGYNGFAA 218
N+L+NE+ G + L + SG+ + GYN A
Sbjct: 127 AGNILLNEE-----GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-NKA 180
Query: 219 DIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIR 274
DIWS G+T +E+ G P+ + P + + I + PP+L PE S +F DF++
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDIHP------MRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234
Query: 275 CCLQKGDPSKRWTASQLLSHPFL 297
CL K DP +R +A QLL HPF+
Sbjct: 235 KCLVK-DPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-57
Identities = 98/271 (36%), Positives = 140/271 (51%), Gaps = 36/271 (13%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIV 115
+ +L LG+G GG+V K R K T ++ALK + D Q EL I + SPYIV
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 116 KCHQIFTKP-SGEVSILMEYMDAGSLE-IY--VKSRG-RLSEDIICTISRQVLKGLFYMH 170
K + F S + I MEY + GSL+ IY VK RG R+ E ++ I+ VLKGL Y+H
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 171 SRNIVHRDIKPANVLINEKME-HPCGYSCLYESGE----------------ARHRKHGGY 213
SR I+HRDIKP+N+L+ K + C + SGE A R G
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGV---SGELVNSLAGTFTGTSFYMAPERIQGKP 179
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPG-QEPDFLSLMLAICFREPPSLPECS------S 266
+D+WS G+T++E+ +PF G + L+ I P L + S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
E+F+DFI+ CL+K DP++R T +L HP++
Sbjct: 240 EEFKDFIKQCLEK-DPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-53
Identities = 92/272 (33%), Positives = 131/272 (48%), Gaps = 43/272 (15%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQTNSPY 113
L+ +G+G+ G V+K K+T + A+KV+ + QE+ L Q SPY
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
I K + F K S ++ I+MEY GS +K G+L E I I R+VL GL Y+H
Sbjct: 61 ITKYYGSFLKGS-KLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118
Query: 174 IVHRDIKPANVLINEKMEHPCGYSCLYE---SGEARHR-------------------KHG 211
+HRDIK AN+L++E+ G L + SG+ K
Sbjct: 119 KIHRDIKAANILLSEE-----GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSLPECS-SEK 268
GY+ ADIWS G+T +EL G P L P + ++ I PPSL S+
Sbjct: 174 GYDE-KADIWSLGITAIELAKGEPPLSDLHP------MRVLFLIPKNNPPSLEGNKFSKP 226
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
F+DF+ CL K DP +R +A +LL H F+ A
Sbjct: 227 FKDFVSLCLNK-DPKERPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 5e-52
Identities = 76/253 (30%), Positives = 116/253 (45%), Gaps = 60/253 (23%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVKCHQIF 121
LG+G GTV+ R K+T A+K+++ + + + E+ IL++ N P IVK + +F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 122 TKPSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
+ ++MEY + GSL+ +K G+LSED I I Q+L+GL Y+HS I+HRD+K
Sbjct: 61 EDE-NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 181 PANVLINEKMEHPC----GYSCLYESGEARHRKHGG--------------YNGFAADIWS 222
P N+L++ G S L S ++ + G Y +DIWS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 223 FGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDP 282
GV + EL + +D IR LQK DP
Sbjct: 180 LGVILYEL------------------------------------PELKDLIRKMLQK-DP 202
Query: 283 SKRWTASQLLSHP 295
KR +A ++L H
Sbjct: 203 EKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-49
Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 36/265 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILRQTNSPYIV 115
E ++ +G+G+ G V+ VR K LY LK + + E+ IL++ N P I+
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR----LSEDIICTISRQVLKGLFYMHS 171
K ++ F + G++ I+MEY D G L +K + + E+ I Q+ L Y+HS
Sbjct: 63 KYYESFEEK-GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 172 RNIVHRDIKPANVLINEK-------------MEH--PCGYSC----LYESGEARHRKHGG 212
R I+HRDIKP N+ + + + Y S E K
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK--P 179
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
YN + +DIWS G + EL +PF + + L L L I + P +P S + R+
Sbjct: 180 YN-YKSDIWSLGCVLYELCTLKHPF----EGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
+ LQK DP +R + +Q+L PF+
Sbjct: 235 VSSLLQK-DPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 94/296 (31%), Positives = 143/296 (48%), Gaps = 59/296 (19%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIV 115
EKL LG GNGG V KV H+ + + A K++ + Q EL +L + NSPYIV
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNI 174
+ F GE+SI ME+MD GSL+ +K GR+ E+I+ IS VL+GL Y+ I
Sbjct: 63 GFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121
Query: 175 VHRDIKPANVLINEKME-HPCGYSCLYESGE----------------ARHRKHGGYNGFA 217
+HRD+KP+N+L+N + E C + SG+ + R G +
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQ 178
Query: 218 ADIWSFGVTMMELYMGYYP---------------FLEPGQEPDFLS-------------- 248
+DIWS G++++E+ +G YP + G+ +
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238
Query: 249 ---LMLAICFREPPSLPECS-SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
L+ I PP LP + S++F+DF+ CL+K +P +R +L HPF+ A
Sbjct: 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK-NPKERADLKELTKHPFIKRA 293
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-45
Identities = 90/273 (32%), Positives = 135/273 (49%), Gaps = 34/273 (12%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
LE + LG GNGG+V KV+H T + A KV+ + Q EL I+ + SPY
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
IV + F + + ME+MD GSL+ K G + +I+ I+ V++GL Y+++ +
Sbjct: 65 IVSFYGAFLN-ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 174 -IVHRDIKPANVLINEKME-HPCGYSCLYESGE----------------ARHRKHGGYNG 215
I+HRDIKP+N+L+N + + C + SGE + R GG
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGV---SGELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPD-------FLSLMLAICFREPPSLPECS-SE 267
+D+WS G++++EL +G +PF + D L L+ I PP LP E
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
RDF+ CL K DP++R T QL + P A
Sbjct: 241 DLRDFVDACLLK-DPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-45
Identities = 95/270 (35%), Positives = 143/270 (52%), Gaps = 34/270 (12%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPY 113
++E L LG+GN G+V+KV H+ T A+K ++ + Q EL+IL + SPY
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLE-IYVKSR--GRLSEDIICTISRQVLKGL-FYM 169
IV + F G V + MEYMDAGSL+ +Y + ED++ I+ V+KGL F
Sbjct: 61 IVDFYGAFFI-EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 170 HSRNIVHRDIKPANVLINEKME-HPCGY---------------SCLYESGEARHR-KHGG 212
NI+HRD+KP NVL+N + C + C +S A R K GG
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGC--QSYMAPERIKSGG 177
Query: 213 YNGFA-----ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267
N +D+WS G++++E+ +G YP+ P + + + AI +PP+LP S+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPY-PPETYANIFAQLSAIVDGDPPTLPSGYSD 236
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+DF+ CL K P++R T +QLL HP+L
Sbjct: 237 DAQDFVAKCLNK-IPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-45
Identities = 89/273 (32%), Positives = 130/273 (47%), Gaps = 40/273 (14%)
Query: 57 SQLEKLQVLGQGNGGTVFKVR---HKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY 113
E ++V+G G V+ + + +A+ + + +C +E+ + Q N P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS---RGRLSEDIICTISRQVLKGLFYMH 170
+VK + F E+ ++M Y+ GSL +KS RG L E II T+ ++VLKGL Y+H
Sbjct: 61 VVKYYTSFVVGD-ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 171 SRNIVHRDIKPANVLINEKMEHPCG----YSCLYESGEARHRK----------------- 209
S +HRDIK N+L+ E + L + G+ +
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 210 -HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268
GY+ F ADIWSFG+T +EL G P+ + P LML + +PPSL + K
Sbjct: 180 QVHGYD-FKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTL-QNDPPSLETGADYK 234
Query: 269 -----FRDFIRCCLQKGDPSKRWTASQLLSHPF 296
FR I CLQK DPSKR TA +LL H F
Sbjct: 235 KYSKSFRKMISLCLQK-DPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 7e-45
Identities = 88/273 (32%), Positives = 135/273 (49%), Gaps = 48/273 (17%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYI 114
+ L+ +G+G G V+K + T A+K M R N + E+ I++ P I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNI 77
Query: 115 VK---CHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
V + + E+ ++MEYMD GSL +I ++ R++E I + R+VL+GL Y+H
Sbjct: 78 VDYYDSYLV----GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 171 SRNIVHRDIKPANVLINEKMEHPC-----GYSC-LYESGEARH---------------RK 209
S+N++HRDIK N+L+++ G++ L + R+ RK
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSE 267
Y DIWS G+ +E+ G P+L EP L + I + P L PE S
Sbjct: 192 D--YG-PKVDIWSLGIMCIEMAEGEPPYLR---EPP-LRALFLITTKGIPPLKNPEKWSP 244
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
+F+DF+ CL K DP KR +A +LL HPFL A
Sbjct: 245 EFKDFLNKCLVK-DPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-44
Identities = 93/272 (34%), Positives = 131/272 (48%), Gaps = 42/272 (15%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--PQELNILRQTNSPY 113
E +Q +G G G V+K R T L A+KV++ + G QE+++L++ P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
IV + + ++ I+MEY GSL +IY +RG LSE I + R+ LKGL Y+H
Sbjct: 62 IVAYFGSYLR-RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 173 NIVHRDIKPANVLINEKME---HPCGYSCLYESGEARH-----------------RKHGG 212
+HRDIK AN+L+ E + G S + A+ + GG
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF-LSLMLAICF-----REPPSLPECS- 265
Y+G DIW+ G+T +E L Q P F L M A+ PP L +
Sbjct: 181 YDG-KCDIWALGITAIE--------LAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231
Query: 266 -SEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
S F DFI+ CL K DP KR TA++LL HPF
Sbjct: 232 WSPVFHDFIKKCLTK-DPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 80/258 (31%), Positives = 121/258 (46%), Gaps = 35/258 (13%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQ----CDRGTPPNPQ-ELNILRQTNSPYIVKCHQ 119
LG+G+ G V VR K T LYA+KV++ R + E NIL + N P+IVK H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
F ++ +++EY G L ++ GR SE+ + +++ L Y+HS I++RD+
Sbjct: 61 AFQTEE-KLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 180 KPANVLINEKMEHPC----GYSCLYESGEARHR--------------KHGGYNGFAADIW 221
KP N+L++ H G + S +R GY G A D W
Sbjct: 120 KPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGD 281
S GV + E+ G PF ++ + ++P PE S + RD I LQK D
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRK-----EIYEKILKDPLRFPEFLSPEARDLISGLLQK-D 231
Query: 282 PSKRWT---ASQLLSHPF 296
P+KR A ++ +HPF
Sbjct: 232 PTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-42
Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 40/262 (15%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILRQTNSPYIVKCH 118
++G+G G V+K + +T A+K + ++ QE+++L+ P IVK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+ S + I++EY + GSL +K G E ++ QVL+GL Y+H + ++HRD
Sbjct: 66 G-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRD 124
Query: 179 IKPANVLINEKMEHPCGYSCLYESGEARH--RKHGGYNGF-------------------A 217
IK AN+L + G L + G A A
Sbjct: 125 IKAANILTTKD-----GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 218 ADIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
+DIWS G T++EL G P+ L P ++ + I + P LPE S + +DF+
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQDDHPPLPEGISPELKDFLMQ 233
Query: 276 CLQKGDPSKRWTASQLLSHPFL 297
C QK DP+ R TA QLL HP++
Sbjct: 234 CFQK-DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-40
Identities = 80/268 (29%), Positives = 121/268 (45%), Gaps = 36/268 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
++ +G G G V+ + T L A+K ++ P + E+ +L P +V
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
K + + +V I MEY G+LE ++ L E +I + Q+L+GL Y+HS IV
Sbjct: 63 KYYGVEVHRE-KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 176 HRDIKPANVLI-------------------NEKMEHPCGYSCL----YESGEA-RHRKHG 211
HRDIKPAN+ + N S Y + E K
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE--CSSEKF 269
G+ AADIWS G ++E+ G P+ E E +M + P +P+ S +
Sbjct: 182 GHGR-AADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVGAGHKPPIPDSLQLSPEG 237
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+DF+ CL+ DP KR TAS+LL HPF+
Sbjct: 238 KDFLDRCLES-DPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 9e-40
Identities = 87/266 (32%), Positives = 135/266 (50%), Gaps = 37/266 (13%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYI 114
++ ++LG GNGGTV+K H T + A+KV+ D Q EL IL + +SPYI
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ + F + +SI E+MD GSL++Y ++ E ++ I+ V+KGL Y+ S I
Sbjct: 62 IGFYGAFFVEN-RISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEARH-------------------RKHGGYNG 215
+HRD+KP+N+L+N + G L + G + R G G
Sbjct: 117 LHRDVKPSNMLVNTR-----GQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFL---SLMLAICFREPPSLPECS-SEKFRD 271
+D+WS G++ MEL +G +P+ + + L L+ I +PP LP SEKF
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
FI C++K P +R L+ HPF+
Sbjct: 232 FITQCMRK-QPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 7e-36
Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 68/295 (23%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
EK+ +G+G G V+K R+K+T L ALK ++ + P E+ +L++ P IV
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 116 KCHQIFT-KPSGEVSILMEYMD---AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
+ +I T K G + ++ EYMD G L+ + +E I +Q+L+GL Y+HS
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 172 RNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH---RKHGGYN-------------- 214
I+HRDIK +N+LIN G L + G AR R Y
Sbjct: 119 NGILHRDIKGSNILINND-----GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 215 ------GFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC------------- 254
G D+WS G + EL++G F G E + L + +C
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIF--QGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 255 --FREPPSLPECSSEKFRDFIRCCLQKG-----------DPSKRWTASQLLSHPF 296
+ E + + R+F + + DP KR +A Q L H +
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-36
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 36/264 (13%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQIFT 122
LG G G V+K +HK+T A K++Q + E++IL + P IV ++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 123 KPSGEVSILMEYMDAGSLE-IYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
++ IL+E+ D G+L+ I ++ L+E I + RQ+L+ L ++HS ++HRD+K
Sbjct: 73 Y-ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131
Query: 182 ANVLI----NEKMEHPCGYSCLYESGEARHR-------------------KHGGYNGFAA 218
N+L+ + K+ G S +S + K Y+ + A
Sbjct: 132 GNILLTLDGDVKLAD-FGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD-YKA 189
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRCC 276
DIWS G+T++EL P E + + ++L I EPP+L P S F DF++ C
Sbjct: 190 DIWSLGITLIELAQME----PPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSC 245
Query: 277 LQKGDPSKRWTASQLLSHPFLADA 300
L K DP R TA++LL HPF++D
Sbjct: 246 LVK-DPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 53/280 (18%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTN-SPYIVK 116
+++G+G+ TV + K+T YA+K++ + E +L + N P I+K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ F + ++EY G L Y++ G L E + ++L L Y+HS+ I+H
Sbjct: 67 LYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIH 125
Query: 177 RDIKPANVLINEKM-------------------EHPCGYSCLYESGEARHRKH------- 210
RD+KP N+L+++ M E G + +S ++R+
Sbjct: 126 RDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT 185
Query: 211 ----------GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS 260
G ++D+W+ G + ++ G PF E +L + + PP+
Sbjct: 186 AEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSNEYLTFQKILKLEYSFPPN 244
Query: 261 LPECSSEKFRDFIRCCLQKGDPSKRWTAS----QLLSHPF 296
P +D I L DP R + +L +HPF
Sbjct: 245 FPPD----AKDLIEKLLVL-DPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 74/219 (33%), Positives = 110/219 (50%), Gaps = 33/219 (15%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
QE+ +L + P IV+ + + + I +E + GSL +K G E +I +R
Sbjct: 51 QEIALLSKLQHPNIVQ-YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR 109
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH------------- 207
Q+L GL Y+H RN VHRDIK AN+L++ G L + G A+
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDTN-----GVVKLADFGMAKQVVEFSFAKSFKGS 164
Query: 208 ---------RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP 258
+ GGY G AADIWS G T++E+ G P+ Q ++ +E
Sbjct: 165 PYWMAPEVIAQQGGY-GLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKEL 220
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
P +P+ S++ +DFI CLQ+ DPS R TA++LL HPF+
Sbjct: 221 PPIPDHLSDEAKDFILKCLQR-DPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 84/282 (29%), Positives = 127/282 (45%), Gaps = 59/282 (20%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-------QELNILRQ-TNS 111
E ++V+G+G G V+K RHK+T L A+K+M +E NILR+ +N
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIM------DIIEDEEEEIKEEYNILRKYSNH 62
Query: 112 PYIVKCHQIFTKPS-----GEVSILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQV 162
P I + F K + ++ ++ME GS+ VK RL E+ I I R+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKME-HPCGYSCLYESGEARHRKHGG--------- 212
L+GL Y+H ++HRDIK N+L+ + E + + R++
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 213 ------------YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF--REP 258
Y+ +D+WS G+T +EL G P + P M A+ R P
Sbjct: 183 EVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCD--MHP-----MRALFKIPRNP 234
Query: 259 P---SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
P PE S+KF DFI CL K + +R +LL HPF+
Sbjct: 235 PPTLKSPENWSKKFNDFISECLIK-NYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (321), Expect = 3e-34
Identities = 84/284 (29%), Positives = 118/284 (41%), Gaps = 48/284 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSP-Y 113
L+ LG+G+ G V+ R ++ ALKV+ + +E+ IL N P
Sbjct: 3 RILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR---LSEDIICTISRQVLKGLFYMH 170
IVK + F ++MEY+D GSLE +K GR LSE I Q+L L Y+H
Sbjct: 60 IVKLYDFFQDEGSLY-LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 171 SRNIVHRDIKPANVLINEKMEHPC----GYSCL----------------------YESGE 204
S+ I+HRDIKP N+L++ G + L Y + E
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP----- 259
Y ++DIWS G+T+ EL G PF + I P
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 260 ---SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
S PE S+ D ++ L K DP R ++S LSH LA
Sbjct: 239 LSPSNPELISKAASDLLKKLLAK-DPKNRLSSSSDLSHDLLAHL 281
|
Length = 384 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 94/304 (30%), Positives = 142/304 (46%), Gaps = 67/304 (22%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIV 115
EK+ LG GNGG VFKV HK + + A K++ + Q EL +L + NSPYIV
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN-I 174
+ F GE+SI ME+MD GSL+ +K GR+ E I+ +S V+KGL Y+ ++ I
Sbjct: 67 GFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125
Query: 175 VHRDIKPANVLINEKME-HPCGYSCLYESGE----------------ARHRKHGGYNGFA 217
+HRD+KP+N+L+N + E C + SG+ + R G +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQE---------------------------------- 243
+DIWS G++++E+ +G YP P +
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242
Query: 244 PD------FLSLMLAICFREPPSLPECS-SEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
PD L+ I PP LP +F+DF+ CL K +P++R QL+ H F
Sbjct: 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK-NPAERADLKQLMVHAF 301
Query: 297 LADA 300
+ +
Sbjct: 302 IKRS 305
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-33
Identities = 88/282 (31%), Positives = 138/282 (48%), Gaps = 57/282 (20%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNI-LRQTNSPYI 114
LE ++ LG+G G V K+RH T + A+K ++ + + +L+I +R + PY
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 115 VKCH-QIFTKPSGEVSILMEYMDAGSLEIY--VKSRG-RLSEDIICTISRQVLKGLFYMH 170
V + +F + G+V I ME MD + Y V +G + EDI+ I+ ++K L Y+H
Sbjct: 63 VTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 171 SR-NIVHRDIKPANVLINE----KMEHPCGYSCLYESGE-----ARHRKHG--------- 211
S+ +++HRD+KP+NVLIN K+ C + SG A+ G
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKL---CDFGI---SGYLVDSVAKTIDAGCKPYMAPER 174
Query: 212 --------GYNGFAADIWSFGVTMMELYMGYYPFLE---PGQEPDFLSLMLAICFREP-P 259
GY+ +D+WS G+TM+EL G +P+ P Q+ L EP P
Sbjct: 175 INPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQ-------LKQVVEEPSP 226
Query: 260 SLPECS-SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
LP S +F+DF+ CL+K + +R +LL HPF
Sbjct: 227 QLPAEKFSPEFQDFVNKCLKK-NYKERPNYPELLQHPFFELH 267
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-32
Identities = 88/259 (33%), Positives = 134/259 (51%), Gaps = 32/259 (12%)
Query: 61 KLQVLGQGNGGTVFK---VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKC 117
KL+ +G+G+ G V+K R K+ +A+ + + + + QE+ +L Q +SPYI +
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ + K ++ I+MEY+ GS +K G L E I TI R++LKGL Y+HS +HR
Sbjct: 68 YGSYLK-GTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 178 DIKPANVLINE----KMEHPCGYSCLYESGEARHR-------------KHGGYNGFAADI 220
DIK ANVL++E K+ L ++ R+ K Y+ F ADI
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 221 WSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278
WS G+T +EL G P L P + ++ I PP+L S+ F++F+ CL
Sbjct: 185 WSLGITAIELAKGEPPNSDLHP------MRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238
Query: 279 KGDPSKRWTASQLLSHPFL 297
K DP R TA +LL H F+
Sbjct: 239 K-DPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 83/297 (27%), Positives = 122/297 (41%), Gaps = 75/297 (25%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNP-QELNILRQTNSPYIV 115
EKL+ LG+G G V+K R K+T + ALK ++ D G P +E+++L++ P IV
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIV 61
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNI 174
K + + ++ EY D L+ Y+ R LS ++I +I Q+L+GL Y HS I
Sbjct: 62 KLLDVIHTERK-LYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119
Query: 175 VHRDIKPANVLINEKME-------------HPCGYSCL--------YESGE----ARHRK 209
+HRD+KP N+LIN P Y + E ++H
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAPEILLGSKH-- 175
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE--------------------PDFLSL 249
Y A DIWS G E+ G F PG P L
Sbjct: 176 ---Y-STAVDIWSVGCIFAEMITGKPLF--PGDSEIDQLFKIFQILGTPTEESWPGVTKL 229
Query: 250 MLAICFR-EPPSLPECSSEKF--------RDFIRCCLQKGDPSKRWTASQLLSHPFL 297
++ P P EK D + LQ +P+KR +A + L HP+
Sbjct: 230 ---PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQY-NPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 84/281 (29%), Positives = 134/281 (47%), Gaps = 39/281 (13%)
Query: 52 EIDG------LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELN- 104
IDG L+ LE L +G G G V+K+R K+T + A+K M+ N + L
Sbjct: 4 TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63
Query: 105 ---ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQ 161
+L+ + PYIVKC+ F S +V I ME M ++ + +G + EDI+ ++
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDS-DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVA 122
Query: 162 VLKGLFYMHSR-NIVHRDIKPANVLINEK-----------------MEHPCGYSC-LYES 202
++K L Y+ + ++HRD+KP+N+L++ C Y +
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182
Query: 203 GE--ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS 260
E + Y+ AD+WS G++++EL G +P+ + +F ++ I EPPS
Sbjct: 183 PERIDPPDPNPKYD-IRADVWSLGISLVELATGQFPY--KNCKTEF-EVLTKILQEEPPS 238
Query: 261 LP--ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
LP E S F F+ CL K D KR +LL HPF+
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTK-DHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 82/299 (27%), Positives = 121/299 (40%), Gaps = 73/299 (24%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNP-QELNILRQTNSPY 113
+ + L +G+G G VFK + ++T ALK + R G P +E+ L+ PY
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSR 172
+VK +F SG ++MEYM L ++ R L E + + R +LKG+ YMH+
Sbjct: 61 VVKLLDVFPHGSG-FVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 173 NIVHRDIKPANVLINEKMEH----PCGYSCLYESGEARH-------------------RK 209
I+HRD+KPAN+LI+ G + L+ E R RK
Sbjct: 119 GIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE--------------------PDFLSL 249
+ D+W+ G EL G P PG+ P SL
Sbjct: 178 YDP----GVDLWAVGCIFAELLNG-SPLF-PGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 250 MLA--ICFRE-PPS-----LPECSSEKF---RDFIRCCLQKGDPSKRWTASQLLSHPFL 297
I F E P P+ S E + + DPSKR +A++ L HP+
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVY-----DPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 79/269 (29%), Positives = 131/269 (48%), Gaps = 39/269 (14%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQE--------LNILRQ 108
S ++L+++G+G G V++ +H T + ALK++ D TP + L+ LRQ
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQ 58
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
+ P I K + + K + I+MEY + GS+ +K+ G ++E I I R+VL L Y
Sbjct: 59 SQPPNITKYYGSYLKGP-RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKY 116
Query: 169 MHSRNIVHRDIKPANVLINEKMEHP---C--GYSCLYESGEARHR--------------K 209
+H ++HRDIK AN+L+ C G + L ++
Sbjct: 117 IHKVGVIHRDIKAANILVT--NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-SEK 268
G Y ADIWS G+T+ E+ G P+ F ++ML I +PP L + S+
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMML-IPKSKPPRLEDNGYSKL 230
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
R+F+ CL + +P +R +A +LL ++
Sbjct: 231 LREFVAACLDE-EPKERLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 80/292 (27%), Positives = 119/292 (40%), Gaps = 64/292 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
+KL +G+G G V+K R K T + A+K ++ + P+ E+ +L++ N P I+
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
K +F + ++ E+MD ++ + L E +I + Q+L+GL + HS I+
Sbjct: 62 KLLDVFRHKGD-LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 176 HRDIKPANVLINEKMEHPCGYSCLYESGEAR-----HRKH------------------GG 212
HRD+KP N+LIN + G L + G AR R + G
Sbjct: 121 HRDLKPENLLINTE-----GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPG--------------------QEPDFLSLMLA 252
Y DIWS G EL P PG P F SL
Sbjct: 176 Y-STPVDIWSVGCIFAELLSR-RPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232
Query: 253 ICFR-------EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
F P L +S + D + L DP KR TA Q L+HP+
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY-DPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-30
Identities = 91/306 (29%), Positives = 143/306 (46%), Gaps = 69/306 (22%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIV 115
E++ LG GNGG V KV+HK + + A K++ + Q EL +L + NSPYIV
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN-I 174
+ F GE+SI ME+MD GSL+ +K R+ E+I+ +S VL+GL Y+ ++ I
Sbjct: 67 GFYGAFYS-DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 175 VHRDIKPANVLINEKME-HPCGYSCLYESGE----------------ARHRKHGGYNGFA 217
+HRD+KP+N+L+N + E C + SG+ + R G +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 218 ADIWSFGVTMMELYMGYYPFLEP-----------------GQEPDFLS------------ 248
+DIWS G++++EL +G YP P EP +S
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242
Query: 249 -------------LMLAICFREPPSLPE-CSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
L+ I PP LP + F++F+ CL K +P++R L++H
Sbjct: 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIK-NPAERADLKMLMNH 301
Query: 295 PFLADA 300
F+ +
Sbjct: 302 TFIKRS 307
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQ----CDRGTPPN-PQELNILRQTNSPYIVKCHQ 119
LG G G V V+ K +ALK ++ + G + E IL + N P+IVK ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
F K + +LMEY G L ++ RG E V+ Y+H+R I++RD+
Sbjct: 61 TF-KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 180 KPANVLINEKMEHPCGYSCLYESGEARHRKHG---------------------GYNGFAA 218
KP N+L++ GY L + G A+ K G GY+ F+
Sbjct: 120 KPENLLLDSN-----GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSV 173
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEP 244
D WS G+ + EL G PF E ++P
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDP 199
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 85/257 (33%), Positives = 131/257 (50%), Gaps = 28/257 (10%)
Query: 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQTNSPYIVKC 117
KL+ +G+G+ G VFK +T + A+K++ + QE+ +L Q +SPY+ K
Sbjct: 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ + K + ++ I+MEY+ GS + + G L E I TI R++LKGL Y+HS +HR
Sbjct: 68 YGSYLKDT-KLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 178 DIKPANVLINEKMEHPCG----YSCLYESGEARHR-------------KHGGYNGFAADI 220
DIK ANVL++E E L ++ R+ K Y+ ADI
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-KADI 184
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKG 280
WS G+T +EL G P E + ++ I PP+L S+ ++F+ CL K
Sbjct: 185 WSLGITAIELAKGE----PPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK- 239
Query: 281 DPSKRWTASQLLSHPFL 297
+PS R TA +LL H F+
Sbjct: 240 EPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 75/309 (24%), Positives = 114/309 (36%), Gaps = 90/309 (29%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----------QELNILRQTN 110
L+ +G G G V K+T A+K + N +E+ +LR
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLR 57
Query: 111 SPYIVKCHQIFTKPS----GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
I+ I PS +V I+ E M+ L +KS L++D I Q+L+GL
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------LYESGEARHRKHG------- 211
Y+HS N++HRD+KP+N+L+N +C L + + G
Sbjct: 117 KYLHSANVIHRDLKPSNILVNS--------NCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 212 --------------GYNGFAADIWSFGVTMMELYMG--------YYPFLE--------PG 241
Y A DIWS G EL Y L P
Sbjct: 169 TRWYRAPELLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 242 QE-------PDFLSLMLAICFREPPSL----PECSSEKFRDFIRCCLQKGDPSKRWTASQ 290
+E + + ++ + L P +S + D + L DP KR TA +
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVF-DPKKRITADE 285
Query: 291 LLSHPFLAD 299
L+HP+LA
Sbjct: 286 ALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 36/267 (13%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM---QCDRGTPPNP--QELNILRQTNSP 112
E L+V+G+G G V V+ + T ++A+K M +C E IL++ N P
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
++V F + + ++++ + G L ++ + + SE+ + +++ L Y+HS+
Sbjct: 61 FLVNLWYSF-QDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 173 NIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN------------------ 214
I+HRDIKP N+L++E+ G+ + + A
Sbjct: 120 GIIHRDIKPDNILLDEQ-----GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 215 --GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
A D WS GVT E G P+ G + A P S + D
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232
Query: 273 IRCCLQKGDPSKRW--TASQLLSHPFL 297
I L++ DP KR L +HP+
Sbjct: 233 INKLLER-DPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 86/260 (33%), Positives = 126/260 (48%), Gaps = 32/260 (12%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVM--QCDRGTPPNPQELNILRQTNSPYIVKCHQIF 121
VLG+G G V+ R T A+K + + R P +E+ + IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 122 TKPSGEVSILMEYMDAGSLEIYVKSR-GRLS--EDIICTISRQVLKGLFYMHSRNIVHRD 178
++ +G I ME + GSL ++S+ G L E I ++Q+L+GL Y+H IVHRD
Sbjct: 75 SE-NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 179 IKPANVLINE-----KME-----------HPCGYS----CLYESGEARHRKHGGYNGFAA 218
IK NVL+N K+ +PC + Y + E + GY G A
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPA 192
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI-CFREPPSLPECSSEKFRDFIRCCL 277
DIWS G T++E+ G PF+E G EP + M + F+ P +PE S + ++FI C
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELG-EPQ--AAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249
Query: 278 QKGDPSKRWTASQLLSHPFL 297
+ DP KR +A LL PFL
Sbjct: 250 EP-DPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 74/271 (27%), Positives = 117/271 (43%), Gaps = 41/271 (15%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
E L+ +G+G+ GTV KVR K + K + T Q E+NILR+ P IV
Sbjct: 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 116 K-CHQIFTKPSGEVSILMEYMDAGSL----EIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
+ +I + + + I+MEY + G L + K R + E+ I I Q+L L+ H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 171 SRN-----IVHRDIKPANVLINEKM---------------EHPCGYSC----LYESGEAR 206
+R+ ++HRD+KPAN+ ++ + + Y S E
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 207 HRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
+ H Y+ +DIWS G + EL PF + L L I + +P S
Sbjct: 183 N--HMSYDE-KSDIWSLGCLIYELCALSPPF----TARNQLQLASKIKEGKFRRIPYRYS 235
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ + I+ L DP KR + +LL P +
Sbjct: 236 SELNEVIKSMLNV-DPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 79/265 (29%), Positives = 123/265 (46%), Gaps = 38/265 (14%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC------DRGTPPNPQELNILRQTNSPY 113
E L +G+G+ G VFKV K +YA+K + +R + E +L + +S Y
Sbjct: 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID--EARVLAKLDSSY 60
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGR-LSEDIICTISRQVLKGLFYMHS 171
I++ ++ F G+++I+MEY + G L +K RGR L ED + Q+L GL ++HS
Sbjct: 61 IIRYYESFLD-KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 172 RNIVHRDIKPANVLINEKMEHPCG-------------------YSCLYESGEARHRKHGG 212
+ I+HRDIK N+ ++ G + Y S E K
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK--P 177
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
YN +D+W+ GV + E G +PF Q +L+L I P + + S++
Sbjct: 178 YNE-KSDVWALGVVLYECCTGKHPFDANNQ----GALILKIIRGVFPPVSQMYSQQLAQL 232
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
I CL K D +R QLL +P L
Sbjct: 233 IDQCLTK-DYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-28
Identities = 84/262 (32%), Positives = 132/262 (50%), Gaps = 38/262 (14%)
Query: 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQTNSPYIVKC 117
KL+ +G+G+ G VFK +T + A+K++ + QE+ +L Q +SPY+ K
Sbjct: 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ + K + ++ I+MEY+ GS +++ G E I T+ +++LKGL Y+HS +HR
Sbjct: 68 YGSYLKGT-KLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 178 DIKPANVLINEKMEHPCGYSCLYESGEARHR----------------------KHGGYNG 215
DIK ANVL++E+ G L + G A + Y+
Sbjct: 126 DIKAANVLLSEQ-----GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
ADIWS G+T +EL G P + + ++ I PP+L S+ F++FI
Sbjct: 181 -KADIWSLGITAIELAKGE----PPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 276 CLQKGDPSKRWTASQLLSHPFL 297
CL K DPS R TA +LL H F+
Sbjct: 236 CLNK-DPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 81/292 (27%), Positives = 120/292 (41%), Gaps = 61/292 (20%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIV 115
E L V+G+G G V K R+K T + A+K + +E+ +LRQ IV
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ F + G + ++ EY++ LE+ S G L D + + Q+L+ + Y HS NI+
Sbjct: 64 NLKEAF-RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 176 HRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGG------------YN--------- 214
HRDIKP N+L++E G L + G AR + Y
Sbjct: 123 HRDIKPENILVSES-----GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 215 --GFAADIWSFGVTMMELYMGYYPF------------------LEPGQEPDFLSLMLAIC 254
G D+W+ G M EL G F L P + F S
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 255 FREP-PSLPECSSEKFR--------DFIRCCLQKGDPSKRWTASQLLSHPFL 297
P PS PE ++ DF++ CL + DP +R T +LL HP+
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACL-RMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 37/272 (13%)
Query: 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM----QCDRGTPPNPQELNILRQT 109
D S L+ +G+G+ G V K T A+K M Q R N E+ I+R
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN--EVVIMRDY 73
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
P IV+ + + E+ ++ME+++ G+L V + R++E+ I T+ VLK L ++
Sbjct: 74 QHPNIVEMYSSYLV-GDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLAVLKALSFL 131
Query: 170 HSRNIVHRDIKPANVLI----NEKMEHPCGYSCLYESGEARHRK---------------H 210
H++ ++HRDIK ++L+ K+ G+ C S E RK
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSD-FGF-CAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEK 268
Y G DIWS G+ ++E+ G P+ EP L M I PP L S +
Sbjct: 190 LPY-GTEVDIWSLGIMVIEMVDGEPPYFN---EPP-LQAMKRIRDNLPPKLKNLHKVSPR 244
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
R F+ L + DP++R TA++LL+HPFLA A
Sbjct: 245 LRSFLDRMLVR-DPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 60/281 (21%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ-------------CDRGTPPNPQEL 103
E ++ LG G+ G V VRHK + YALK++ + E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN--------EK 52
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163
IL+ P++V + F + + ++MEY+ G L +++ GR E + + QV+
Sbjct: 53 RILQSIRHPFLVNLYGSF-QDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRK-------------- 209
L Y+HS +IV+RD+KP N+L++ GY + + G A+ K
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDS-----DGYIKITDFGFAKRVKGRTYTLCGTPEYLA 166
Query: 210 -----HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFL-SLMLAICFREPPSLPE 263
GY G A D W+ G+ + E+ GY PF + P + +L R P
Sbjct: 167 PEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFD--DNPIQIYEKILEGKVRFPSFF-- 221
Query: 264 CSSEKFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLAD 299
S +D IR LQ D +KR + + +HP+ A
Sbjct: 222 --SPDAKDLIRNLLQV-DLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 85/261 (32%), Positives = 129/261 (49%), Gaps = 34/261 (13%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ--ELNILRQTNSPYIVKCHQIFT 122
LG G G V+K ++K+T AL A KV++ E+ IL N PYIVK F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 123 KPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
G++ I++E+ G+++ + R L+E I I RQ+L+ L Y+HS I+HRD+K
Sbjct: 80 W-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 182 ANVLIN--------------------EKMEHPCG--YSCLYESGEARHRKHGGYNGFAAD 219
NVL+ ++ + G Y E K Y+ + AD
Sbjct: 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD-YKAD 197
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRCCL 277
IWS G+T++E+ P E + + ++L I EPP+L P S +FRDF++ L
Sbjct: 198 IWSLGITLIEMAQ----IEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTAL 253
Query: 278 QKGDPSKRWTASQLLSHPFLA 298
K P R +A+QLL HPF++
Sbjct: 254 DK-HPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 79/293 (26%), Positives = 123/293 (41%), Gaps = 67/293 (22%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ-CDRGTPP---NP---QELNILRQTNSP 112
EK + LG+G V+K R K+T + A+K ++ +R N +E+ +L++ P
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHS 171
I+ +F S ++++ E+M+ LE +K + L+ I + L+GL Y+HS
Sbjct: 63 NIIGLLDVFGHKS-NINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 172 RNIVHRDIKPANVLINEKME---------HPCGYSCL----------YESGE----ARHR 208
I+HRD+KP N+LI G Y + E ARH
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH- 179
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE--------------------PDFLS 248
Y G D+WS G EL + PFL PG P S
Sbjct: 180 ----Y-GVGVDMWSVGCIFAEL-LLRVPFL-PGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 249 LMLAICFRE--PPSLPEC---SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
L + F+ P L + +S+ D ++ L +P+KR TA Q L HP+
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLL-TLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 73/270 (27%), Positives = 109/270 (40%), Gaps = 43/270 (15%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKCHQ 119
+ +G G VF + K T +YA+KV++ N E +IL Q SPY+VK +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
F + ++MEY+ G L +++ G L ED+ +++ L Y+HS I+HRD+
Sbjct: 61 SFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 180 KPANVLINEKMEH------------PCGYSCLYESGEARHRKHGG---Y----------N 214
KP N+LI+ H E ++ G Y +
Sbjct: 120 KPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR--EPPSLPECSSEKFRDF 272
D WS G + E +G PF E F + I E P E S E D
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN----ILNGKIEWPEDVEVSDE-AIDL 233
Query: 273 IRCCLQKGDPSKR---WTASQLLSHPFLAD 299
I L DP KR + ++ +HPF
Sbjct: 234 ISKLLVP-DPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 65/265 (24%), Positives = 118/265 (44%), Gaps = 37/265 (13%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALY----ALKVMQCDRGTPPNP----QELNILRQTN 110
LE + LG+G G V+K K A+K ++ + +E +I+++ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLS 59
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYM 169
P IV+ + T+ + I+ EYM G L +++ G L+ + ++ Q+ KG+ Y+
Sbjct: 60 HPNIVRLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 170 HSRNIVHRDIKPANVLINEKME------------HPCGYSCLYESGEARHR-------KH 210
S+N VHRD+ N L+ E + + Y G+ + K
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 211 GGYNGFAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
G + +D+WSFGV + E++ +G P+ PG + + +L +R P PE ++
Sbjct: 179 GKFT-SKSDVWSFGVLLWEIFTLGEQPY--PGMSNEEVLELLEDGYRLPR--PENCPDEL 233
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSH 294
+ + C DP R T S+L+
Sbjct: 234 YELMLQCWAY-DPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 81/298 (27%), Positives = 125/298 (41%), Gaps = 80/298 (26%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-------PYI 114
++ LG G G+V+ R+K+T L A+K M + + +E LR+ S P I
Sbjct: 4 IKQLGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRN 173
VK ++F + + E+ + EYM+ ++ +G+ SE +I +I Q+L+GL ++H
Sbjct: 61 VKLKEVF-RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 174 IVHRDIKPANVLINE----KMEHPCGYSCLYESGEARH-------------R-------- 208
HRD+KP N+L++ K+ + AR R
Sbjct: 120 FFHRDLKPENLLVSGPEVVKI---ADFGL------AREIRSRPPYTDYVSTRWYRAPEIL 170
Query: 209 -KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC------------ 254
+ Y+ DIW+ G M ELY F PG E D L + ++
Sbjct: 171 LRSTSYS-SPVDIWALGCIMAELYTLRPLF--PGSSEIDQLYKICSVLGTPTKQDWPEGY 227
Query: 255 -------FREPPS--------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
FR P +P S E D I+ L+ DP KR TASQ L HP+
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPE-AIDLIKDMLRW-DPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 54/283 (19%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELN-ILRQTNSP 112
L+ L +G+G GTV K+ HK + + A+K ++ + +L+ ++R ++ P
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 113 YIVKCH-QIFTKPSGEVSILMEYMDAGSLE-----IYVKSRGRLSEDIICTISRQVLKGL 166
YIVK + +F + G+ I ME MD SL+ +Y + + E+I+ I+ +K L
Sbjct: 64 YIVKFYGALFRE--GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 167 FYMHSR-NIVHRDIKPANVLINEKMEHP------CGYSCLYESGEARHRKHG-------- 211
Y+ I+HRD+KP+N+L++ G L +S A+ R G
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ--LVDS-IAKTRDAGCRPYMAPE 177
Query: 212 --------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPS 260
GY+ +D+WS G+T+ E+ G +P+ P + S+ + +PP
Sbjct: 178 RIDPSARDGYD-VRSDVWSLGITLYEVATGKFPY------PKWNSVFDQLTQVVKGDPPI 230
Query: 261 LPECS----SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
L S F +FI CL K D SKR +LL HPF+ D
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIK-DESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM------QCDRGTPPNPQELNILRQTNS 111
+ L+ LG+G+ G+V+KV+ YALK + Q +R N E+ IL N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN--EIRILASVNH 58
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR----LSEDIICTISRQVLKGLF 167
P I+ + F ++ I+MEY G L + R + + E I I Q+L+GL
Sbjct: 59 PNIISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 168 YMHSRNIVHRDIKPANVLI--NEKME-HPCGYSCLYESGEARHR------------KHGG 212
+H + I+HRD+K AN+L+ N+ ++ G S + + A+ + K
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
Y+ + +DIWS G + E+ PF + L + + P +P S+ ++F
Sbjct: 178 YS-YKSDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPPIYSQDLQNF 232
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
IR LQ P R ++L+ P +
Sbjct: 233 IRSMLQV-KPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 75/269 (27%), Positives = 120/269 (44%), Gaps = 49/269 (18%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-------QELNILRQTNSPYIV 115
++LGQG G V+ T A+K + D +P E+ +L+ IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ + +SI MEYM GS++ +K+ G L+E + +RQ+L+G+ Y+HS IV
Sbjct: 68 QYYGCLRDD-ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 176 HRDIKPANVL-------------INEKMEHPCGYSCLYES--------------GEARHR 208
HRDIK AN+L +++++ C +S GE R
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP-PSLPECSSE 267
K AD+WS G T++E+ P+ E E ++ + I + P LP S
Sbjct: 187 K--------ADVWSVGCTVVEMLTEKPPWAE--FEA--MAAIFKIATQPTNPQLPSHVSP 234
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
R+F+R + + KR +A +LL H F
Sbjct: 235 DARNFLRRTFVE-NAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-26
Identities = 77/261 (29%), Positives = 127/261 (48%), Gaps = 34/261 (13%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVM--QCDRGTPPNPQELNILRQTNSPYIVKCHQIFT 122
LG G G V+K ++K+T L A KV+ + + E++IL + P IVK F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 123 KPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
+ + IL+E+ G+++ + R L+E I + +Q L+ L Y+H I+HRD+K
Sbjct: 73 YEN-NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131
Query: 182 ANVLIN--------------------EKMEHPCG--YSCLYESGEARHRKHGGYNGFAAD 219
N+L ++ + G Y E K Y+ + AD
Sbjct: 132 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKAD 190
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEKFRDFIRCCL 277
+WS G+T++E+ P E + + ++L I EPP+L + S S +F+DF++ CL
Sbjct: 191 VWSLGITLIEMAQ----IEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCL 246
Query: 278 QKGDPSKRWTASQLLSHPFLA 298
+K + RWT +QLL HPF+
Sbjct: 247 EK-NVDARWTTTQLLQHPFVT 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-25
Identities = 87/271 (32%), Positives = 130/271 (47%), Gaps = 38/271 (14%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQ-TNSPYIVK 116
E ++V+G G G V+K RH +T L A+KVM E+N+L++ ++ I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 117 CHQIFTK--PSG---EVSILMEYMDAGSLEIYVK-SRGR-LSEDIICTISRQVLKGLFYM 169
+ F K P G ++ ++ME+ AGS+ VK ++G L ED I I R++L+GL ++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 170 HSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHRKHGG-------------- 212
H+ ++HRDIK NVL+ E E G S + R G
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 213 -----YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-S 266
Y+ + +DIWS G+T +E+ G P + P + + I PP L S
Sbjct: 198 NPDATYD-YRSDIWSLGITAIEMAEGAPPLCD--MHP--MRALFLIPRNPPPKLKSKKWS 252
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+KF DFI CL K S R + QLL HPF+
Sbjct: 253 KKFIDFIEGCLVKNYLS-RPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 84/269 (31%), Positives = 126/269 (46%), Gaps = 43/269 (15%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--PQELNILRQTNSPYIVK 116
E +Q +G G G V+K R+ T L A+KV++ + G QE+ +++ IV
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + ++ I ME+ GSL+ G LSE I +SR+ L+GL+Y+HS+ +H
Sbjct: 71 YFGSYLR-RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEARH-------------------------RKHG 211
RDIK AN+L+ + G+ L + G + + G
Sbjct: 130 RDIKGANILLTDN-----GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSLPECS--SE 267
GYN DIW+ G+T +EL P L P + L LM F +PP L + S
Sbjct: 185 GYNQL-CDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKSNF-QPPKLKDKMKWSN 239
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
F F++ L K +P KR TA +LL HPF
Sbjct: 240 SFHHFVKMALTK-NPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 7e-25
Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 52/271 (19%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALY----ALKVMQCDRGTPPNP----QELNILRQTN 110
L + LG+G G V+K + K A+K ++ D + +E I+R+ +
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYM 169
P +VK + T+ + I+MEYM+ G L Y+ K+R +LS + + + Q+ +G+ Y+
Sbjct: 60 HPNVVKLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 170 HSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGE---ARHRK------------ 209
S+N +HRD+ N L+ E G S + R K
Sbjct: 119 ESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-------DFLSLMLAICFREPPSLP 262
G + +D+WSFGV + E++ G++P + L + P P
Sbjct: 177 EGKFT-SKSDVWSFGVLLWEIFTL-------GEQPYPGMSNEEVLEYLKNGYRLPQP--P 226
Query: 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
C E D + C + DP R T S+L+
Sbjct: 227 NCPPE-LYDLMLQCWAE-DPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-24
Identities = 87/264 (32%), Positives = 128/264 (48%), Gaps = 38/264 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-------QELNILRQTNSPYIV 115
Q LG+G+ GTV+ V+ K+ +A LKV++ NP QE +L + + P IV
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSL----EIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
K H F + I+ EY + L E + LSE+ +C Q+L G+ YMH
Sbjct: 66 KFHASFLE-RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 172 RNIVHRDIKPANVLINEKMEH--PCGYSCL----------------YESGEARHRKHGGY 213
R I+HRD+K N+ + + G S L Y S EA KH GY
Sbjct: 125 RRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA--LKHQGY 182
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
+ +DIWS G + E+ + F GQ +FLS++L I PSLPE S + +
Sbjct: 183 DS-KSDIWSLGCILYEMCCLAHAFE--GQ--NFLSVVLRIVEGPTPSLPETYSRQLNSIM 237
Query: 274 RCCLQKGDPSKRWTASQLLSHPFL 297
+ L K DPS R +A+++L +PF+
Sbjct: 238 QSMLNK-DPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-24
Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 53/274 (19%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----------PQELNILRQTNSP 112
++G G+ G+V+ + + L A+K ++ + + +E+ +L++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
IV+ + + + ++I +EY+ GS+ + + G E ++ RQ+LKGL Y+H+R
Sbjct: 67 NIVQ-YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 173 NIVHRDIKPANVL-------------INEKMEHPCGYSCLYESGEARHRKHGGYNGFA-- 217
I+HRDIK AN+L I++K+E S ++ AR G A
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLE---ANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 218 ----------ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR----EPPSLPE 263
ADIWS G ++E+ G +PF PD + + AI F+ P +P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF------PD-CTQLQAI-FKIGENASPEIPS 234
Query: 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
S + DF+ + D +KR TA++LL HPFL
Sbjct: 235 NISSEAIDFLEKTFEI-DHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 87/298 (29%), Positives = 131/298 (43%), Gaps = 57/298 (19%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD---RGTPPNP-QELNILRQTNS 111
+ + + + +G+G G V+K R K T L ALK ++ D G P +E+ ILRQ N
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 112 PYIVKCHQI---------FTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQV 162
IV +I F K G ++ EYMD + + SED I + +Q+
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHGGYN----- 214
L+GL Y H +N +HRDIK +N+L+N K + G + LY S E+R +
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 215 ----------GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS---- 260
G A D+WS G + EL+ P + QE L L+ +C P+
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISRLCGSPCPAVWPD 244
Query: 261 ---LPECSSEKFRDFIRCCLQKG------------------DPSKRWTASQLLSHPFL 297
LP ++ K + R L++ DPSKR TA + L+ P+L
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 76/294 (25%), Positives = 121/294 (41%), Gaps = 64/294 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALK---VMQCDRGTPPNP-QELNILRQTNS---P 112
E+L +G+G GTV+K R T ALK V + G P + +E+ +L+Q S P
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 113 YIVKCHQIFTKPSGE----VSILMEYMD---AGSLEIYVKSRGRLSEDIICTISRQVLKG 165
IV+ + P + ++++ E++D A L K G L + I + RQ+L+G
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKP-G-LPPETIKDLMRQLLRG 119
Query: 166 LFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR----------------HRK 209
+ ++HS IVHRD+KP N+L+ G + + G AR +R
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSD-----GQVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 210 H----GGYNGFAADIWSFGVTMMELYM------GYYP------FLE----PGQE--PDFL 247
D+WS G EL+ G + P +E P +
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234
Query: 248 SLML-AICFREPPSLPEC---SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
SL + P S E+ D ++ L +P KR +A + L HP+
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTF-NPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-23
Identities = 83/279 (29%), Positives = 117/279 (41%), Gaps = 57/279 (20%)
Query: 60 EKLQVLGQGNGGTVF--KVRHKQTLALYALKVMQCDRGTPPNPQE--------LNILRQT 109
K +VLG+G GTV+ Q +A+ +++ + E L L+
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 110 N-SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
N Y+ C T +SI ME++ GS+ + G L E + C ++Q+L G+ Y
Sbjct: 63 NIVQYLGTCLDDNT-----ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAY 117
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH---------------RKHG-- 211
+H+ +VHRDIK NV M P G L + G AR HG
Sbjct: 118 LHNNCVVHRDIKGNNV-----MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 212 -----------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI-CFREP- 258
GY G +DIWS G T+ E+ G P D L+ M I R
Sbjct: 173 YWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPL----ASMDRLAAMFYIGAHRGLM 227
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
P LP+ S DF+ CL + D +R +A QLL H FL
Sbjct: 228 PRLPDSFSAAAIDFVTSCLTR-DQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-23
Identities = 78/259 (30%), Positives = 116/259 (44%), Gaps = 38/259 (14%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKCHQ 119
+G+G V+K + ALK +Q +E+++L+Q + P ++K
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVK---SRGRL-SEDIICTISRQVLKGLFYMHSRNIV 175
F + + E++I++E DAG L +K + RL E I Q+ L +MHS+ I+
Sbjct: 70 SFIE-NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128
Query: 176 HRDIKPANVLIN------------------EKME-HPCGYSCLYESGEARHRKHG-GYNG 215
HRDIKPANV I + H + Y S E R H GYN
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE---RIHENGYN- 184
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP-ECSSEKFRDFIR 274
F +DIWS G + E+ PF G + + SL I + P LP + SE+ RD +
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 275 CCLQKGDPSKRWTASQLLS 293
C+ DP KR S +L
Sbjct: 243 RCINP-DPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 3e-23
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 59/274 (21%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALY----ALKVMQCDRGTPPNPQ-------ELNILR 107
L + LG+G G V+K K A+K ++ D + Q E I+R
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED----ASEQQIEEFLREARIMR 56
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKG 165
+ + P IVK + T+ + I+MEYM G L Y++ LS + + + Q+ +G
Sbjct: 57 KLDHPNIVKLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 166 LFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGE---ARHRK-------- 209
+ Y+ S+N +HRD+ N L+ E G S + + K
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173
Query: 210 ----HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-------DFLSLMLAICFREP 258
G + +D+WSFGV + E++ G+EP + L +
Sbjct: 174 ESLKEGKFT-SKSDVWSFGVLLWEIFTL-------GEEPYPGMSNAEVLEYLKKGYRLPK 225
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292
P P C E + C + DP R T S+L+
Sbjct: 226 P--PNCPPE-LYKLMLQCWAE-DPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-23
Identities = 69/268 (25%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ--------ELNILRQT 109
+ K Q LG G + ++ R +T L A+K + R T + E+ ++ +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
N P+I++ T ++ +E+M GS+ + G E +I + Q+L+GL Y+
Sbjct: 61 NHPHIIRMLGA-TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 170 HSRNIVHRDIKPANVLINEKMEH----PCGY-----SCLYESGE------------ARHR 208
H I+HRD+K AN+LI+ + G + +GE A
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI-CFREPPSLPECSSE 267
G G + D+WS G ++E+ P+ + + L+L+ I PS+PE S
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHP 295
RD CL+ P R + +LL HP
Sbjct: 239 GLRDVTLRCLE-LQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
E+ L+ + IV+ T +SI +EY+ GS+ +++ GR E ++ +
Sbjct: 57 SEIETLKDLDHLNIVQYLGFETTEE-YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE 115
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLI-------------------------NEKMEHPCG 195
QVL+GL Y+HS+ I+HRD+K N+L+ N M+
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG--- 172
Query: 196 YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF 255
S + + E H GY+ DIWS G ++E++ G P+ E ++
Sbjct: 173 -SVFWMAPEVIHSYSQGYSA-KVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNK 227
Query: 256 REPPSLPECSSEKF----RDFIRCCLQKGDPSKRWTASQLLSHPF 296
R P +P S DF+ C +P R TA +LL HPF
Sbjct: 228 RSAPPIPPDVSMNLSPVALDFLNACFTI-NPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 83/263 (31%), Positives = 126/263 (47%), Gaps = 33/263 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--PQELNILRQTNSPYIVKC 117
E +Q +G G G V+K R+ T L A+K+++ + G + QE+ ++++ IV
Sbjct: 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ ++ I MEY GSL+ G LSE I + R+ L+GL Y+HS+ +HR
Sbjct: 72 FGSYLSRE-KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 178 DIKPANVLINE--------------------KMEHPCGYSCLYESGEARHRKHGGYNGFA 217
DIK AN+L+ + K + G A K+GGYN
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190
Query: 218 ADIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSLPECS--SEKFRDFI 273
DIW+ G+T +EL P L P + L LM F +PP L + + S F +F+
Sbjct: 191 -DIWAVGITAIELAELQPPMFDLHPMRA---LFLMSKSNF-QPPKLKDKTKWSSTFHNFV 245
Query: 274 RCCLQKGDPSKRWTASQLLSHPF 296
+ L K +P KR TA +LL+H F
Sbjct: 246 KISLTK-NPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 80/311 (25%), Positives = 126/311 (40%), Gaps = 76/311 (24%)
Query: 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILRQ 108
D +S+ EKL +GQG G VFK RHK+T + ALK + + P +E+ IL+
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67
Query: 109 TNSPYIVKCHQI-FTKPS------GEVSILMEYMD---AGSLEIYVKSRGRLSEDIICTI 158
+V +I TK + G ++ E+ + AG L + LSE I +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS-NKNVKFTLSE--IKKV 124
Query: 159 SRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR---HRKHGGYN- 214
+ +L GL+Y+H I+HRD+K AN+LI + G L + G AR K+ N
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKD-----GILKLADFGLARAFSLSKNSKPNR 179
Query: 215 ----------------------GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA 252
G D+W G M E++ P ++ E L+L+
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLISQ 238
Query: 253 ICFREPPS---------------LPECSSEKFRDFIRCCLQKG------------DPSKR 285
+C P LP+ K ++ ++ ++ DP+KR
Sbjct: 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKR 298
Query: 286 WTASQLLSHPF 296
A L+H F
Sbjct: 299 IDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 82/302 (27%), Positives = 124/302 (41%), Gaps = 80/302 (26%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----------QELNILRQ 108
+ L +G G G V +T A+K + R P +EL +L+
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL--SR-----PFQSAIHAKRTYRELRLLKH 70
Query: 109 TNSPYIVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163
+ ++ +FT S +V ++ M A L VK + +LS+D I + Q+L
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQ-KLSDDHIQFLVYQIL 128
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKH------------- 210
+GL Y+HS I+HRD+KP+N+ +NE E + + G ARH
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELK-----ILDFGLARHTDDEMTGYVATRWYRA 183
Query: 211 -------GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREPPSL- 261
YN DIWS G M EL G F PG + D L ++ + L
Sbjct: 184 PEIMLNWMHYNQ-TVDIWSVGCIMAELLTGKTLF--PGSDHIDQLKRIMNLVGTPDEELL 240
Query: 262 PECSSEKFRDFIRC----------------------CLQKG---DPSKRWTASQLLSHPF 296
+ SSE R++I+ L+K DP KR TA++ L+HP+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 297 LA 298
LA
Sbjct: 301 LA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 4e-22
Identities = 83/271 (30%), Positives = 131/271 (48%), Gaps = 38/271 (14%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQ-TNSPYIVK 116
E ++++G G G V+K RH +T L A+KVM QE+N+L++ ++ I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 117 CHQIFTK--PSG---EVSILMEYMDAGSLEIYVK-SRGR-LSEDIICTISRQVLKGLFYM 169
+ F K P G ++ ++ME+ AGS+ +K ++G L E+ I I R++L+GL ++
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 170 HSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHRKHGG-------------- 212
H ++HRDIK NVL+ E E G S + R G
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 213 -----YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-S 266
Y+ F +D+WS G+T +E+ G P + P + + I P L S
Sbjct: 188 NPDATYD-FKSDLWSLGITAIEMAEGAPPLCD--MHP--MRALFLIPRNPAPRLKSKKWS 242
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+KF+ FI CL K + S+R T QL+ HPF+
Sbjct: 243 KKFQSFIESCLVK-NHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-22
Identities = 78/265 (29%), Positives = 118/265 (44%), Gaps = 37/265 (13%)
Query: 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVK 116
+ + +GQG GTV+ T A+K M + P + E+ ++R+ P IV
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVN 80
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ E+ ++MEY+ GSL V + + E I + R+ L+ L ++HS ++H
Sbjct: 81 YLDSYLV-GDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 177 RDIKPANVLINEKMEHPCGYS----CLYESGEARHRK---------------HGGYNGFA 217
RDIK N+L+ M+ + C + E R Y G
Sbjct: 139 RDIKSDNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 195
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRC 275
DIWS G+ +E+ G P+L + P L + I P L PE S FRDF+
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLN--ENP--LRALYLIATNGTPELQNPEKLSAIFRDFLNR 251
Query: 276 CLQKGDPSKRWTASQLLSHPFLADA 300
CL+ D KR +A +LL HPFL A
Sbjct: 252 CLEM-DVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 79/312 (25%), Positives = 117/312 (37%), Gaps = 79/312 (25%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALK--VMQCDR-GTPPNPQ-ELNILRQTNS 111
L E L LG+G G V+K R +T + ALK +M ++ G P E+ IL++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 112 PYIVKC-------HQIFTKPSGEVSILMEYMD---AGSLEIYVKSRGRLSEDIICTISRQ 161
P +V + G V ++ YMD +G LE +L+E I Q
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE---NPSVKLTESQIKCYMLQ 123
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEK------------MEHPCGYSCLYESGEARH-- 207
+L+G+ Y+H +I+HRDIK AN+LI+ + + G
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 208 ------------------RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL 249
R++ A DIW G E++ P L+ + D L L
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTT----AVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHL 238
Query: 250 MLAIC-------FREPPSLPECS------------SEKFRDFIRCCLQ------KGDPSK 284
+ +C + SLP C E+F L DP K
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 285 RWTASQLLSHPF 296
R TAS L HP+
Sbjct: 299 RLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-21
Identities = 68/260 (26%), Positives = 113/260 (43%), Gaps = 26/260 (10%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP------QELNILRQTNSPYIV 115
L+ + +G G+V+ + + T +A+KV++ N + ++ Q SPY+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 116 KCHQIFTKPSGE-VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
K + F S + + ++MEY++ G +K+ G L ED +V+ G+ +H R I
Sbjct: 61 KLYYSFQ--SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYNGFA------------ADIWS 222
+HRDIKP N+LI++ L +G + G + A +D WS
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 223 FGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDP 282
G + E GY PF +L+ P + E S + D I L DP
Sbjct: 179 LGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN-RLLCMDP 236
Query: 283 SKRWTAS---QLLSHPFLAD 299
+KR A+ ++ SHPF
Sbjct: 237 AKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 80/303 (26%), Positives = 118/303 (38%), Gaps = 78/303 (25%)
Query: 64 VLGQG--NGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILRQTNSPYIVKC 117
++G+ + V +HK T L A+K + D + + QE+ RQ P I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSR---GRLSEDIICTISRQVLKGLFYMHSRNI 174
F S E+ ++ M GS E +K+ G L E I I + VL L Y+HS+
Sbjct: 65 VTSFIVDS-ELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGF 122
Query: 175 VHRDIKPANVLIN-EKMEHPCG--YSCLYESGEARHRK-HG------------------- 211
+HR +K +++L++ + G YS R R H
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 212 ---GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECS-- 265
GYN +DI+S G+T EL G+ PF + + ML R P L + S
Sbjct: 183 NLQGYNE-KSDIYSVGITACELANGHVPFKDMP-----ATQMLLEKVRGTVPCLLDKSTY 236
Query: 266 -------------------------------SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
SE F F+ CLQ+ DP R +ASQLL+H
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR-DPESRPSASQLLNH 295
Query: 295 PFL 297
F
Sbjct: 296 SFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-21
Identities = 78/264 (29%), Positives = 120/264 (45%), Gaps = 38/264 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQE-------LNILRQTNSPYIV 115
++LGQG G V+ T A K +Q D +P +E + +L+ IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 116 KCHQIFTKPSGE--VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
+ + + E ++I MEYM GS++ +K+ G L+E + +RQ+L+G+ Y+HS
Sbjct: 68 QYYGCL-RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 174 IVHRDIKPANVLINEKMEHPCG-------YSCLYESGEARHRKHG-------------GY 213
IVHRDIK AN+L + G + SG G GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP-PSLPECSSEKFRDF 272
G AD+WS G T++E+ P+ E + ++ + I + P LP SE RDF
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
Query: 273 IRCCLQKGDPSKRWTASQLLSHPF 296
+ C + R +A +LL HPF
Sbjct: 242 LGCIFVEA--RHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 7e-21
Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 58/274 (21%)
Query: 64 VLGQGNGGTVFK--VRHKQ-TLALYALKVMQCDRGTPPNPQ------ELNILRQTNSPYI 114
LG+G G V+K ++ K A+K + + + E ++++ P +
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 115 VK----CHQIFTKPSGEVSILMEYMDAGSLEIYVKSR---------GRLSEDIICTISRQ 161
V+ C + + +++EYM+ G L Y++ LS + + + Q
Sbjct: 59 VRLLGVCTE-----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG---- 212
+ KG+ Y+ S+ VHRD+ N L+ E + G S + +K GG
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 213 ---------YNGF--AADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREPPS 260
F +D+WSFGV + E++ +G P+ PG + + L +R
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEEVLEYLRKGYR--LP 227
Query: 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
PE ++ + + C Q DP R T S+L+
Sbjct: 228 KPEYCPDELYELMLSCWQL-DPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 70/265 (26%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM-----QCDRGTPPNPQELNILRQTNSPYI 114
L+ +G G+ G V+ R +T + A+K M Q + +E+ L+Q P
Sbjct: 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT 77
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
++ + + ++MEY + +I + L E I I L+GL Y+HS
Sbjct: 78 IEYKGCYLREH-TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEAR---------------------HRKHGGY 213
+HRDIK N+L+ E G L + G A G Y
Sbjct: 137 IHRDIKAGNILLTEP-----GTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-SEKFRDF 272
+G D+WS G+T +EL P + +S + I + P+L S+ FR+F
Sbjct: 192 DG-KVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
+ CLQK P R ++ +LL H F+
Sbjct: 247 VDSCLQK-IPQDRPSSEELLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 76/274 (27%), Positives = 123/274 (44%), Gaps = 43/274 (15%)
Query: 60 EKLQVLGQGNGGTVFKVRH---KQTLALYALKVMQCDR---------GTPPNPQELNILR 107
E L+VLG G G VF VR LYA+KV++ T Q L +R
Sbjct: 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR 62
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLF 167
+ P++V H F + ++ ++++Y++ G L ++ R +E + +++ L
Sbjct: 63 RC--PFLVTLHYAF-QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 168 YMHSRNIVHRDIKPANVLIN---------------------EKMEHPCGYSCLYESGEAR 206
++H I++RDIK N+L++ E+ CG + Y + E
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG-TIEYMAPEVI 178
Query: 207 HRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
GG++ A D WS GV EL G PF G++ + I +PP P+ S
Sbjct: 179 RGGSGGHDK-AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-FPKTMS 236
Query: 267 EKFRDFIRCCLQKGDPSKRW---TASQLLSHPFL 297
+ RDFI+ L+K DP KR A ++ +HPF
Sbjct: 237 AEARDFIQKLLEK-DPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-20
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-----RGTPPNPQELNILRQTNS 111
LE+++ +G G G V VR + + YALKVM + E +L++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
P+I++ + +LMEY+ G L Y+++ GR S + +++ L Y+HS
Sbjct: 61 PFIIRLFWT-EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 172 RNIVHRDIKPANVLINE----KMEH-------------PCGYSCLYESGEARHRKHGGYN 214
+ IV+RD+KP N+L+++ K+ CG + Y + E K G+N
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG-TPEYLAPEVIQSK--GHN 176
Query: 215 GFAADIWSFGVTMMELYMGYYPF 237
A D W+ G+ + E+ +GY PF
Sbjct: 177 K-AVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 40/267 (14%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQ 119
LG+G G V + K T +YA K + R G E IL + +S +IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHR 177
F ++ ++M M+ G L+ ++ + G E + Q++ GL ++H R IV+R
Sbjct: 61 AFETKD-DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 178 DIKPANVLINEKMEHPCGYSCLYESGEARHRKHG-------GYNGFAA------------ 218
D+KP NVL+++ G + + G A K G G G+ A
Sbjct: 120 DLKPENVLLDDH-----GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 219 -DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277
D ++ G T+ E+ G PF + ++ + L P+ S + +D L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEALL 233
Query: 278 QKGDPSKR-----WTASQLLSHPFLAD 299
QK DP KR +A ++ HP D
Sbjct: 234 QK-DPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 79/276 (28%), Positives = 122/276 (44%), Gaps = 45/276 (16%)
Query: 59 LEKLQVLGQGNGGTVFKVRH---KQTLALYALKVMQ---------CDRGTPPNPQELNIL 106
E L+VLG G G VF VR + LYA+KV++ T Q L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 107 RQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
RQ SP++V H F + ++ ++++Y++ G L ++ R R E + S +++ L
Sbjct: 62 RQ--SPFLVTLHYAFQTDT-KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 167 FYMHSRNIVHRDIKPANVLI---------------------NEKMEHPCGYSCLYESGEA 205
++H I++RDIK N+L+ E+ CG + Y + +
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG-TIEYMAPDI 177
Query: 206 RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265
GG++ A D WS GV M EL G PF G++ + I EPP P+
Sbjct: 178 VRGGDGGHDK-AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-YPQEM 235
Query: 266 SEKFRDFIRCCLQKGDPSKRW-----TASQLLSHPF 296
S +D I+ L K DP KR A ++ HPF
Sbjct: 236 SALAKDIIQRLLMK-DPKKRLGCGPSDADEIKKHPF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHK----QTLALYALKVMQCDRGTPPNP-----QELNILRQ 108
L+ ++ LG+G+ G V R+ T A+K + +E+ ILR
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEILRT 62
Query: 109 TNSPYIVKCHQIFTKPSG-EVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGL 166
+ IVK + KP G + ++MEY+ +GSL Y+ + R +++ + S Q+ KG+
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 167 FYMHSRNIVHRDIKPANVLI--------------------------NEKMEHPC-GYS-- 197
Y+ S+ +HRD+ N+L+ E E P Y+
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP 244
CL S + A+D+WSFGVT+ EL+ P P E
Sbjct: 183 CLRTS-----KFS-----SASDVWSFGVTLYELFTYGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 74/259 (28%), Positives = 118/259 (45%), Gaps = 36/259 (13%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVR---HKQTLALYALKV--MQCDRGTPPNPQELNILRQTN 110
L+ + + +G+G V++ ++ +AL +++ M + +E+++L+Q N
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLE---IYVKSRGRL-SEDIICTISRQVLKGL 166
P ++K F + E++I++E DAG L Y K + RL E + Q+ +
Sbjct: 61 HPNVIKYLDSFIE-DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 167 FYMHSRNIVHRDIKPANVLINEKME-------------------HPCGYSCLYESGEARH 207
+MHSR ++HRDIKPANV I H + Y S E H
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP-ECSS 266
GYN F +DIWS G + E+ PF G + + SL I + P LP E S
Sbjct: 180 EN--GYN-FKSDIWSLGCLLYEMAALQSPFY--GDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 267 EKFRDFIRCCLQKGDPSKR 285
EK R+ + C+ DP +R
Sbjct: 235 EKLRELVSMCIYP-DPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 82/270 (30%), Positives = 120/270 (44%), Gaps = 48/270 (17%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFT 122
++LGQG G V+ T A+K +Q D +P +E+N L H+
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 123 K--------PSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ +SI ME+M GS++ +KS G L+E++ +RQ+L+G+ Y+HS I
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 175 VHRDIKPANVLINEKMEHPCG---------YSCLYESGEARHRKHG-------------G 212
VHRDIK AN+L + G CL SG G G
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICL--SGTGMKSVTGTPYWMSPEVISGEG 185
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR---EP--PSLPECSSE 267
Y G ADIWS G T++E+ P+ E M AI F+ +P P LP S+
Sbjct: 186 Y-GRKADIWSVGCTVVEMLTEKPPWAE-------FEAMAAI-FKIATQPTNPVLPPHVSD 236
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
RDF++ + R +A +LL H F+
Sbjct: 237 HCRDFLKRIFV--EAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 79/271 (29%), Positives = 122/271 (45%), Gaps = 38/271 (14%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-ELNILRQ-TNSPYIVKC 117
E ++ +G+G G V+KV +K+ +L A+K++ + E NIL+ N P +VK
Sbjct: 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 118 HQIFTKPS----GEVSILMEYMDAGSLEIYVKS---RG-RLSEDIICTISRQVLKGLFYM 169
+ +F K G++ +++E + GS+ VK G RL E +I I L GL ++
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 170 HSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHRKHGGYNGFAA-------- 218
H+ I+HRD+K N+L+ + G S S R G + A
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 219 ----------DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSS 266
D+WS G+T +EL G P + P + + I PP+L PE
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFD--MHP--VKTLFKIPRNPPPTLLHPEKWC 260
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
F FI CL K D R + + LL HPF+
Sbjct: 261 RSFNHFISQCLIK-DFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 82/310 (26%), Positives = 123/310 (39%), Gaps = 86/310 (27%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALK-------VMQCDRGTPPNPQELNILRQT 109
+ + L +G+G G V HK T A+K C R +E+ ILR+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRF 60
Query: 110 NSPYIVKCHQIFTKPS----GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKG 165
I+ I PS +V I+ E M+ L +K++ LS D I Q+L+G
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRG 118
Query: 166 LFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---LYESGEAR-HRKHGGYNGF----- 216
L Y+HS N++HRD+KP+N+L+N +C + + G AR + GF
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLN--------TNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 217 -------------------AADIWSFGVTMMELYMGYYPFLEPGQEPDFLS-LMLAICFR 256
A DIWS G + E+ F PG+ D+L L L +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF--PGK--DYLHQLNLILGVL 226
Query: 257 EPPS---LPECSSEKFRDFIR---CC-------------------LQKG---DPSKRWTA 288
PS L S + R++I+ L K +P KR T
Sbjct: 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV 286
Query: 289 SQLLSHPFLA 298
+ L+HP+L
Sbjct: 287 EEALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 66/292 (22%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD---RGTPPNP-QELNILRQTNSPYIV 115
EKL+ +G+G GTVFK ++++T + ALK ++ D G P + +E+ +L++ IV
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ + + +++++ EY D L+ Y S G + +I+ + Q+LKGL + HS N+
Sbjct: 63 RLYDVLHSDK-KLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEAR-----------------HRK------HG 211
+HRD+KP N+LIN+ G L + G AR +R
Sbjct: 121 LHRDLKPQNLLINKN-----GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-PDFLSLMLAICFREP-----PSLPECS 265
Y+ + D+WS G EL P PG + D L + + P P + +
Sbjct: 176 LYST-SIDMWSAGCIFAELANAGRPLF-PGNDVDDQLKRIFRL-LGTPTEESWPGVSKLP 232
Query: 266 SEKF---------------------RDFIRCCLQKGDPSKRWTASQLLSHPF 296
K RD ++ L +P +R +A + L HP+
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQ-NLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 80/274 (29%), Positives = 126/274 (45%), Gaps = 44/274 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-ELNILRQ-TNSPYIVKC 117
E ++ +G+G G VFKV +K+ + A+K++ + E NIL+ ++ P +VK
Sbjct: 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 118 HQIFTKPS----GEVSILMEYMDAGSLEIYVK---SRG-RLSEDIICTISRQVLKGLFYM 169
+ ++ K ++ +++E + GS+ VK RG R+ E II I + L GL ++
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 170 HSRNIVHRDIKPANVLI-NEKMEHPCGYSCLYESGEARHRKH------------------ 210
H +HRD+K N+L+ E + + R R++
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 211 ---GGYNGFAADIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFREPPSL--PE 263
Y+ D+WS G+T +EL G P L P + + I PP+L PE
Sbjct: 201 QLDSTYDA-RCDVWSLGITAIELGDGDPPLADLHP------MRALFKIPRNPPPTLHQPE 253
Query: 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
S +F DFIR CL K D KR T S LL H F+
Sbjct: 254 LWSNEFNDFIRKCLTK-DYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-18
Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 44/267 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELN-------ILRQTNSPYIV 115
++LG+G G V+ T A+K + D + +E+N +L+ IV
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 116 KCHQIFTKPS-GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ + P ++SI +EYM GS++ +K+ G L+E++ +RQ+L+G+ Y+HS I
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 175 VHRDIKPANVLINEKMEHPCG-------YSCLYESGEARHRKHG-------------GYN 214
VHRDIK AN+L + G + SG G GY
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR---EP--PSLPECSSEKF 269
G AD+WS T++E+ P+ E M AI F+ +P P LP+ S+
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAE-------YEAMAAI-FKIATQPTKPMLPDGVSDAC 238
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSHPF 296
RDF++ + +R TA LL HPF
Sbjct: 239 RDFLKQIFV--EEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 69/294 (23%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD--RGTPPNP-QELNILRQTNSPYI 114
QLEKL G+G TV+K R++ T + ALK + D GTP +E++++++ I
Sbjct: 4 QLEKL---GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS---RGRLSEDIICTISRQVLKGLFYMHS 171
V+ H + + ++ ++ EYMD L+ Y+ + RG L + + + + Q+LKG+ + H
Sbjct: 61 VRLHDVIHTEN-KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 172 RNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG-GYNGFAA------------ 218
++HRD+KP N+LIN++ G L + G A R G N F+
Sbjct: 119 NRVLHRDLKPQNLLINKR-----GELKLADFGLA--RAFGIPVNTFSNEVVTLWYRAPDV 171
Query: 219 -----------DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC------------- 254
DIWS G M E+ G P D L + I
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 255 FRE-PPSLPECSSEKFR-----------DFIRCCLQKGDPSKRWTASQLLSHPF 296
E P+ P + + D + LQ +P R +A L HP+
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQL-NPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 37/269 (13%)
Query: 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQT 109
D + + + +GQG GTV+ T A+K M + P + E+ ++R+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMREN 73
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
+P IV + E+ ++MEY+ GSL V + + E I + R+ L+ L ++
Sbjct: 74 KNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFL 131
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYS----CLYESGEARHRK---------------H 210
HS ++HRDIK N+L+ M+ + C + E R
Sbjct: 132 HSNQVIHRDIKSDNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEK 268
Y G DIWS G+ +E+ G P+L + P L + I P L PE S
Sbjct: 190 KAY-GPKVDIWSLGIMAIEMVEGEPPYLN--ENP--LRALYLIATNGTPELQNPERLSAV 244
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
FRDF+ CL+ D +R +A +LL HPFL
Sbjct: 245 FRDFLNRCLEM-DVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 70/299 (23%), Positives = 109/299 (36%), Gaps = 71/299 (23%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM-----------QCDRGTPPNPQELNI 105
E ++V+G+G G V+ VR K T +YA+KV+ R E +I
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVR------AERDI 54
Query: 106 LRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKG 165
L +SP+IVK + F + ++MEYM G L + + E+ +++
Sbjct: 55 LADADSPWIVKLYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 166 LFYMHSRNIVHRDIKPANVL-----------------INEKMEHPCGYSCLYES-----G 203
L +H +HRDIKP N+L +N+ + + +
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 204 EARHRKHG------------------------GYNGFAADIWSFGVTMMELYMGYYPFLE 239
R R H Y D WS GV + E+ G+ PF
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYS 232
Query: 240 PGQEPDFLSLM-LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWT-ASQLLSHPF 296
+ + ++ R PP P S + D I L DP R ++ SHPF
Sbjct: 233 DTLQETYNKIINWKESLRFPPDPP--VSPEAIDLICRLLC--DPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 79/279 (28%), Positives = 121/279 (43%), Gaps = 46/279 (16%)
Query: 59 LEKLQVLGQGNGGTVFKVRH---KQTLALYALKVMQ---------CDRGTPPNPQELNIL 106
E L+VLG G G VF VR T LYA+KV+Q T L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 107 RQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
RQ SP++V H F + ++ ++++Y+ G + ++ R SED + S +++ L
Sbjct: 62 RQ--SPFLVTLHYAF-QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 167 FYMHSRNIVHRDIKPANVLIN---------------------EKMEHPCGYSCLYESGEA 205
++H IV+RDIK N+L++ E+ CG + Y + E
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG-TIEYMAPEI 177
Query: 206 RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265
K G +G A D WS G+ + EL G PF G+ + I +PP P
Sbjct: 178 IRGKGG--HGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-FPSFI 234
Query: 266 SEKFRDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
+ +D + L+K DP KR AS++ HPF
Sbjct: 235 GPEAQDLLHKLLRK-DPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 72/293 (24%)
Query: 63 QVLGQGNGGT---VFKVRHKQTLALYALKVM-QCDRGTPP--NPQELNILRQTNS-PYIV 115
++LG+ GT V K + ++T YA+K M + + N +E+ LR+ + P I+
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 116 KCHQI-FTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRN 173
+ ++ F + +G ++++ E MD +L +K R R L E + + Q+LK L +MH
Sbjct: 62 RLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 174 IVHRDIKPANVLINEKMEHPCGYSCLYESGEAR--HRKH-------------------GG 212
I HRDIKP N+LI + + L + G R + K G
Sbjct: 121 IFHRDIKPENILIKDDILK------LADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAICFREPPSLPECSSEKFR- 270
Y G DIW+ G E+ + +P L PG E D ++ + + + +KFR
Sbjct: 175 YYGPKMDIWAVGCVFFEI-LSLFP-LFPGTNELDQIAKIHDVLGTPDAEV----LKKFRK 228
Query: 271 ------DF-------IRCCLQKG--------------DPSKRWTASQLLSHPF 296
+F +R L DP +R TA Q L HP+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 75/295 (25%), Positives = 123/295 (41%), Gaps = 71/295 (24%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-------ELNILRQTNSP 112
EKL +G+G+ G VFK R+++T + A+K + +P E+ +L+Q P
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV---ESEDDPVIKKIALREIRMLKQLKHP 60
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
+V ++F + ++ ++ EY D L K+ + E +I I Q L+ + + H
Sbjct: 61 NLVNLIEVFRR-KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 173 NIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN------------------ 214
N +HRD+KP N+LI ++ G L + G AR G +
Sbjct: 120 NCIHRDVKPENILITKQ-----GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 215 ----GFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLML------------------ 251
G D+W+ G EL G L PG+ + D L L+
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQP--LWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232
Query: 252 ---AICFREPPSLPECSSEKFR-------DFIRCCLQKGDPSKRWTASQLLSHPF 296
+ EP + E KF F++ CLQ DP++R + +LL HP+
Sbjct: 233 FFKGLSIPEPETR-EPLESKFPNISSPALSFLKGCLQM-DPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 47/270 (17%)
Query: 62 LQVLGQGNGGTVFKVRH---KQTLALYALKVMQ------CDRGTPPNPQELNILRQTNSP 112
L+VLG+G G VF+VR T ++A+KV++ + T E NIL P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
+IV F + G++ +++EY+ G L ++++ G ED C ++ L ++H +
Sbjct: 61 FIVDLIYAF-QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 173 NIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY------------------- 213
I++RD+KP N+L++ + G+ L + G + H G
Sbjct: 120 GIIYRDLKPENILLDAQ-----GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 214 --NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
+G A D WS G M ++ G PF ++ ++ + +LP + + RD
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-----KGKLNLPPYLTPEARD 229
Query: 272 FIRCCLQKGDPSKRW-----TASQLLSHPF 296
++ L++ +PS R A+++ SHPF
Sbjct: 230 LLKKLLKR-NPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 72/266 (27%), Positives = 115/266 (43%), Gaps = 44/266 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
EK++V+G+G G V R K L +K + ++ T E +L+ + P I+
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRN 173
+ ++ F + + I+MEY G+L Y++ R L ED I Q+L L ++H++
Sbjct: 63 EYYENFLE-DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 174 IVHRDIKPANVLINEK------------------------MEHPCGYSCLYESGEARHRK 209
I+HRD+K N+L+++ + PC Y S E K
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPC-----YISPELCEGK 176
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
YN +DIW+ G + EL F E P +L+L I + + S
Sbjct: 177 --PYNQ-KSDIWALGCVLYELASLKRAF-EAANLP---ALVLKIMSGTFAPISDRYSPDL 229
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSHP 295
R I L DPSKR SQ+++ P
Sbjct: 230 RQLILSML-NLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 43/269 (15%)
Query: 62 LQVLGQGNGGTVF---KVRHKQTLALYALKVMQCD----RGTPPNPQELNILRQTNSPYI 114
L+VLGQG+ G VF K+ LYA+KV++ R E +IL + N P+I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
VK H F G++ ++++++ G L + +E+ + ++ L ++HS I
Sbjct: 61 VKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 175 VHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHRKHGGYN 214
++RD+KP N+L++ E ++H CG + Y + E +R+ G+
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG-TVEYMAPEVVNRR--GHT 176
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
+AD WSFGV M E+ G PF Q D M I + +P+ S + + +R
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPF----QGKDRKETMTMI-LKAKLGMPQFLSPEAQSLLR 230
Query: 275 CCLQKGDPSKRWTAS-----QLLSHPFLA 298
L K +P+ R A ++ HPF +
Sbjct: 231 -ALFKRNPANRLGAGPDGVEEIKRHPFFS 258
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-18
Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 31/259 (11%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYI 114
Q L+V+G+G+ G V+H + YA+K ++ + + +E +L + P I
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGRL-SEDIICTISRQVLKGLFYMHSR 172
V + F + G + I+MEY D G L +K RG+L ED I Q+ G+ ++H +
Sbjct: 61 VAFKESF-EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 173 NIVHRDIKPANVLINEK-------------MEHPCGYSCLYESGEARHR-----KHGGYN 214
++HRDIK N+ + + + P Y+C Y G + ++ YN
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYN 178
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
+DIWS G + EL +PF Q + +L+L +C LP S + R I+
Sbjct: 179 N-KSDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233
Query: 275 CCLQKGDPSKRWTASQLLS 293
++ +P R +A+ +LS
Sbjct: 234 QMFKR-NPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 5e-18
Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 35/265 (13%)
Query: 56 LSQLEKLQVLGQGNG--GTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNI--LRQTNS 111
L E ++ L +G G V ++HK T L+ K N E + L + N
Sbjct: 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQK--IIKAKNF-NAIEPMVHQLMKDN- 68
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
P +K + T G V ++M+Y+ G L +K G+LSE + I RQ+++ L +H
Sbjct: 69 PNFIKLYYSVTTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 172 RNIVHRDIKPANVLINEKMEHP--CGY---------SCL-----YESGE--ARHRKHGGY 213
NI+H DIK NVL + + C Y SC Y S E H
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHN----- 182
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
+ D W+ GV EL G +PF + ++ + L ++ + S+ DF+
Sbjct: 183 YDVSFDWWAVGVLTYELLTGKHPF-KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV 241
Query: 274 RCCLQKGDPSKRWTA-SQLLSHPFL 297
+ L K + + R T ++++ HPFL
Sbjct: 242 QSML-KYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-18
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV----KSRGRLSEDIIC 156
+E+++L+Q N P ++K + F + E++I++E DAG L + K + + E +
Sbjct: 51 KEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 157 TISRQVLKGLFYMHSRNIVHRDIKPANVLIN-------------------EKMEHPCGYS 197
Q+ L +MHSR ++HRDIKPANV I H +
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE 257
Y S E H GYN F +DIWS G + E+ PF G + + SL I +
Sbjct: 170 PYYMSPERIHEN--GYN-FKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCD 224
Query: 258 PPSLP-ECSSEKFRDFIRCCLQKGDPSKR 285
P LP + SE+ R + C+ DP KR
Sbjct: 225 YPPLPSDHYSEELRQLVNMCINP-DPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 79/269 (29%), Positives = 120/269 (44%), Gaps = 37/269 (13%)
Query: 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQT 109
D + + + +GQG GTVF T A+K Q + P + E+ ++++
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIK--QINLQKQPKKELIINEILVMKEL 73
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
+P IV F E+ ++MEY+ GSL V + + E I + R+ L+ L ++
Sbjct: 74 KNPNIVNFLDSFLV-GDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFL 131
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYS----CLYESGEARHRK---------------H 210
H+ ++HRDIK NVL+ M+ + C + E R
Sbjct: 132 HANQVIHRDIKSDNVLLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEK 268
Y G DIWS G+ +E+ G P+L + P L + I P L PE S
Sbjct: 190 KAY-GPKVDIWSLGIMAIEMVEGEPPYLN--ENP--LRALYLIATNGTPELQNPEKLSPI 244
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
FRDF+ CL+ D KR +A +LL HPFL
Sbjct: 245 FRDFLNRCLEM-DVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 78/266 (29%), Positives = 125/266 (46%), Gaps = 31/266 (11%)
Query: 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM----QCDRGTPPNPQELNILRQT 109
D S LE +G+G+ G V R K + A+K+M Q R N E+ I+R
Sbjct: 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN--EVVIMRDY 75
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
+V+ ++ + E+ +LME++ G+L V S+ RL+E+ I T+ VL+ L Y+
Sbjct: 76 QHQNVVEMYKSYLVGE-ELWVLMEFLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYL 133
Query: 170 HSRNIVHRDIKPANVL--INEKMEHPCGYSCLYESGEARHRKH--------------GGY 213
HS+ ++HRDIK ++L ++ +++ C S + RK
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP 193
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEKFRD 271
G DIWS G+ ++E+ G P+ P + M + PP L S RD
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPPYFS--DSP--VQAMKRLRDSPPPKLKNAHKISPVLRD 249
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297
F+ L + +P +R TA +LL HPFL
Sbjct: 250 FLERMLTR-EPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-17
Identities = 77/273 (28%), Positives = 119/273 (43%), Gaps = 39/273 (14%)
Query: 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQT 109
D + + + +GQG GTV+ T A++ M + P + E+ ++R+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMREN 74
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
+P IV + E+ ++MEY+ GSL V + + E I + R+ L+ L ++
Sbjct: 75 KNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFL 132
Query: 170 HSRNIVHRDIKPANVLI--------------------NEKMEHPCGYSCLYESGEARHRK 209
HS ++HRDIK N+L+ K G + + + E RK
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG-TPYWMAPEVVTRK 191
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSE 267
G DIWS G+ +E+ G P+L + P L + I P L PE S
Sbjct: 192 AYGPK---VDIWSLGIMAIEMIEGEPPYLN--ENP--LRALYLIATNGTPELQNPEKLSA 244
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
FRDF+ CL D KR +A +LL H FL A
Sbjct: 245 IFRDFLNRCLDM-DVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 33/265 (12%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQ 119
LG+G G V + + T LYA K + R G E IL + +S +IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYV----KSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
F + ++ ++M M+ G L ++ + E C + Q++ GL ++H R I+
Sbjct: 61 AFQTKT-DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 176 HRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHGGYNGFAA-------------D 219
+RD+KP NVL++ G + + G+++ + + G GF A D
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD 179
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQK 279
++ GVT+ E+ PF G++ + L I + + P+ S + F L K
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKSFCEALLAK 238
Query: 280 GDPSKRW-----TASQLLSHPFLAD 299
DP KR L +HP D
Sbjct: 239 -DPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 55/274 (20%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQ-----CDRGTPPNPQELNILRQT---NSPYIVK 116
+G+G G V++VR K T +YA+KV+ + E NIL +T SP+IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
F S ++ ++ +YM G L +++ GR SED +++ L ++H +IV+
Sbjct: 61 LKFSFQTDS-DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 177 RDIKPANVLI--------------------NEKMEHPCGYS-------CLYESGEARHRK 209
RD+KP N+L+ N+ CG + L E G +H
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH-- 177
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
D WS GV + E+ G+ PF D + I F + S++
Sbjct: 178 --------VDFWSLGVLVFEMCCGWSPFY----AEDTQQMYRNIAFGKVRFPKNVLSDEG 225
Query: 270 RDFIRCCLQKGDPSKRW----TASQLLSHPFLAD 299
R F++ L + +P R A +L HPF AD
Sbjct: 226 RQFVKGLLNR-NPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 44/265 (16%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQEL-----NILRQT-NSPYIVKC 117
VLG+G+ G V K T LYA+KV++ D + E +L P++ +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
H F + +MEY++ G L +++ GR E + +++ GL ++H R I++R
Sbjct: 62 HSCFQTKD-RLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 178 DIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN---------------------GF 216
D+K NVL++ + G+ + + G + GG G
Sbjct: 121 DLKLDNVLLDSE-----GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
A D W+ GV + E+ G PF ++ F S++ + P S++ + ++
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-----EDEVRYPRWLSKEAKSILKSF 230
Query: 277 LQKGDPSKRWTASQ-----LLSHPF 296
L K +P KR + HPF
Sbjct: 231 LTK-NPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 9e-17
Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 10/138 (7%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTNSPY 113
+K+++LG+G+ G VF VR K T L+ALKV+ N E IL + P+
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 114 IVKCHQIFTKPSGEVSIL-MEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMH 170
+ + F + L M+Y G L ++ + LSE++ + +VL L Y+H
Sbjct: 63 LPTLYASFQ--TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 171 SRNIVHRDIKPANVLINE 188
IV+RD+KP N+L++E
Sbjct: 121 LLGIVYRDLKPENILLHE 138
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 72/267 (26%), Positives = 109/267 (40%), Gaps = 43/267 (16%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQ-----CDRGTPPNPQELNILRQTNSPYIVKCH 118
++G+G+ G V VR K T +YA+KVM+ +E +IL +NSP+I +
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 119 QIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
F + + ++MEY G L + + + ED+ +++ + +H VHR
Sbjct: 68 YAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 178 DIKPANVLINEKMEHPCGYSCLYESGEARH---RKH------------------------ 210
DIKP NVLI+ G+ L + G A K
Sbjct: 127 DIKPENVLIDRT-----GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 211 -GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
G G D WS GV E+ G PF E + ++M F + P P+ SS+ F
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD-F 240
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSHPF 296
D I+ L +R L HPF
Sbjct: 241 LDLIQSLLC--GQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 50/137 (36%), Positives = 78/137 (56%), Gaps = 8/137 (5%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQTNSPYIVK 116
+KL LG+G+ TV+K R K T L ALK ++ + G P +E ++L+ IV
Sbjct: 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 117 CHQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNI 174
H I TK + ++++ EY+D L+ Y+ G LS + Q+L+GL Y H R +
Sbjct: 68 LHDIIHTKKT--LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRV 124
Query: 175 VHRDIKPANVLINEKME 191
+HRD+KP N+LI+E+ E
Sbjct: 125 LHRDLKPQNLLISERGE 141
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-16
Identities = 46/146 (31%), Positives = 79/146 (54%), Gaps = 15/146 (10%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC---DRGTPPNP-QELNILRQ-TNSPYI 114
EKL+ +G+G G V+K R K T L ALK + + G PP +E+++L+ + S YI
Sbjct: 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 115 VKC----HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-----LSEDIICTISRQVLKG 165
V+ H + ++ EY+D+ L+ ++ S GR L I + Q+LKG
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 166 LFYMHSRNIVHRDIKPANVLINEKME 191
+ + H ++HRD+KP N+L++++
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKG 148
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 70/303 (23%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSP 112
S+ + ++ +G G G V ++ A+K + P + EL ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 113 YIVKCHQIFTKPSGE---VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
I+ I P + V ++M+ M+ L + S L+E+ I Q+L+GL Y+
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR-----HRKHGGY----------- 213
HS N++HRD+KP+N+L+NE E G + G AR +H +
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIG-----DFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 214 --------NGF--AADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREPPS-- 260
+ A D+WS G E+ +G L PG+ L L+L++ P
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQ-LFPGKNYVHQLKLILSV-LGSPSEEV 235
Query: 261 LPECSSEKFRDFIRCCLQKG-------------------------DPSKRWTASQLLSHP 295
L S++ R +I+ +K DP +R T Q L HP
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295
Query: 296 FLA 298
FLA
Sbjct: 296 FLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-16
Identities = 67/303 (22%), Positives = 107/303 (35%), Gaps = 79/303 (26%)
Query: 65 LGQGNGGTVFK---VRHKQTLALYALKVMQCDRGTPPNPQ-------------ELNILRQ 108
LG+G G V K + +A+ +K+++ + Q EL I+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
I+ ++ + ++++M+ M L+ V + RL+E + I Q+L GL
Sbjct: 77 IKHENIMGLVDVYVE-GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCG-------YSCLYESGEARHRKHG---------- 211
+H +HRD+ PAN+ IN K Y S +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194
Query: 212 ------------GYN--GFAADIWSFGVTMMELYMGYYPFLEPGQE-------------- 243
G FA D+WS G EL G F PG+
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF--PGENEIDQLGRIFELLGT 252
Query: 244 ------PDFLSLMLAICF--REPPSL----PECSSEKFRDFIRCCLQKGDPSKRWTASQL 291
P L L F R+P L P S + D ++ L K +P +R +A +
Sbjct: 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI-DLLQSLL-KLNPLERISAKEA 310
Query: 292 LSH 294
L H
Sbjct: 311 LKH 313
|
Length = 335 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-16
Identities = 67/259 (25%), Positives = 112/259 (43%), Gaps = 47/259 (18%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM---------QCDRGTPPNPQELNIL 106
LS E + LG G+ G V +HK T YA+K + Q QE +IL
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA----QEKSIL 72
Query: 107 RQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
+ + P+IV F + V L+E++ G L +++ GR D+ +++
Sbjct: 73 MELSHPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF 131
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY------------- 213
Y+HS++I++RD+KP N+L++ K G+ + + G A+ +
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNK-----GHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEV 186
Query: 214 -----NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL--MLAICFREPPSLPECSS 266
+G A D W+ GV + E GY PF + + F +LA + P
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLK----FPNWFD 239
Query: 267 EKFRDFIRCCLQKGDPSKR 285
+ RD ++ LQ D +KR
Sbjct: 240 GRARDLVKGLLQT-DHTKR 257
|
Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 29/268 (10%)
Query: 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNS 111
D + L+ +G+G+ G V K + L A+K M + E+ I+R
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
+V+ + + E+ ++ME+++ G+L V + R++E+ I + VLK L +H+
Sbjct: 77 ENVVEMYNSYLV-GDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHA 134
Query: 172 RNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKH---GGY-----------N 214
+ ++HRDIK ++L+ G+ C S E RK Y
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGF-CAQVSKEVPRRKSLVGTPYWMAPELISRLPY 193
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEKFRDF 272
G DIWS G+ ++E+ G P+ EP L M I PP L S + F
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYF---NEPP-LKAMKMIRDNLPPKLKNLHKVSPSLKGF 249
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFLADA 300
+ L + DP++R TA++LL HPFLA A
Sbjct: 250 LDRLLVR-DPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 82/300 (27%), Positives = 124/300 (41%), Gaps = 82/300 (27%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILRQTNSPYIV 115
+K++ +G+G G V+K R+K T + ALK ++ D T P +E+++L++ N P IV
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 116 KCHQIFTKPSGEVSI-------LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
K + + + L ++MDA L + +I + Q+L+GL +
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAF 115
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH-----RKHG------------ 211
HS ++HRD+KP N+LIN + G L + G AR R +
Sbjct: 116 CHSHRVLHRDLKPQNLLINTE-----GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
Query: 212 -----GYNGFAADIWSFGVTMMELYMGYYPFLEPG-QEPDFLSLMLAICFRE-------- 257
Y A DIWS G E M L PG E D L + FR
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAE--MVTRRALFPGDSEIDQLFRI----FRTLGTPDEVV 224
Query: 258 ----------PPSLPECSSEKF-----------RDFIRCCLQKGDPSKRWTASQLLSHPF 296
PS P+ + + F RD + L DP+KR +A L+HPF
Sbjct: 225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHY-DPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 39/263 (14%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVM-----QCDRGTPPNPQELNILRQTNSPYIVK 116
L+ +G G+ G V+ R +T + A+K M Q + +E+ L++ P ++
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + ++MEY + ++ + L E I I+ L+GL Y+HS N++H
Sbjct: 90 YKGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEAR---------------------HRKHGGYNG 215
RDIK N+L+ E G L + G A G Y+G
Sbjct: 149 RDIKAGNILLTEP-----GQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDG 203
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-SEKFRDFIR 274
D+WS G+T +EL P + +S + I E P+L S+ FR+F+
Sbjct: 204 -KVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258
Query: 275 CCLQKGDPSKRWTASQLLSHPFL 297
CLQK P R T+ +LL H F+
Sbjct: 259 SCLQK-IPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 63/291 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKV-MQCDRGTPPNP---QELNILRQTNSPYIV 115
E L ++G+G+ G V K +HK+T + A+K ++ + +E+ +L+Q +V
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
++F + + ++ E++D L+ K L E + Q+L+G+ + HS NI+
Sbjct: 64 NLIEVFRRKK-RLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 176 HRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGG-----------YN---------- 214
HRDIKP N+L++ G L + G AR G Y
Sbjct: 123 HRDIKPENILVS-----QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 215 -GFAADIWSFGVTMMELYMG--YYP-----------------FLEPGQE-----PDFLSL 249
G A DIW+ G + E+ G +P + QE P F +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 250 MLAICFREPPSL----PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
L +E L P+ S D + CL+ DP R ++SQLL H F
Sbjct: 238 RLPEV-KEIEPLEKRFPKLSGLVL-DLAKQCLRI-DPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 62/264 (23%), Positives = 118/264 (44%), Gaps = 41/264 (15%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQ----CDRGTPPNP-QELNILRQTNSPYIVKCHQ 119
+G+G+ G V +VR + T +YALK ++ R + E +L Q N P+IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
F P ++ +++ +++ G L +++ GR + ++L L +H N+++RD+
Sbjct: 61 SFQSP-EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 180 KPANVLINEKMEHPCGYSCLYESG--EARHRKHGGYNGF-------------------AA 218
KP N+L++ + G+ L + G + + N F A
Sbjct: 120 KPENILLDYQ-----GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278
D W+ GV + E+ G PF + + ++ M +EP P+ +D + L
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYD-----ENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLS 229
Query: 279 KGDPSKRW---TASQLLSHPFLAD 299
+ DP++R A ++ +HPF +
Sbjct: 230 R-DPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 84/315 (26%), Positives = 128/315 (40%), Gaps = 83/315 (26%)
Query: 53 IDG--LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALK-VMQCDRGTPPNPQ-------E 102
ID L + E LQ LG+G G V+K ++T + ALK + R N E
Sbjct: 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR----NATDAQRTFRE 56
Query: 103 LNILRQ-TNSPYIVKCHQIFTKPSGEVSILM--EYMDAGSLEIYVKSRGRLSEDI-ICTI 158
+ L++ + P IVK + K + I + EYM+ +++ R + ED+ I
Sbjct: 57 IMFLQELGDHPNIVKLLNVI-KAENDKDIYLVFEYMET---DLHAVIRANILEDVHKRYI 112
Query: 159 SRQVLKGLFYMHSRNIVHRDIKPANVLINEK----------------MEHPCGYSCL--- 199
Q+LK L Y+HS N++HRD+KP+N+L+N +E L
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 200 -----YESGE---ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF--------LE---- 239
Y + E R Y D+WS G + E+ +G F LE
Sbjct: 173 VATRWYRAPEILLGSTR----YT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 240 ----PGQE------PDFLSLMLAICFREPPS-----LPECSSEKFRDFIRCCLQKGDPSK 284
P E F + ML P LP+ S + D ++ L +P+K
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL-DLLKKLLVF-NPNK 285
Query: 285 RWTASQLLSHPFLAD 299
R TA + L HP++A
Sbjct: 286 RLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 46/269 (17%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKCHQ 119
VLG G GTV + +A+KV+ + + + E+ L + IVKCH+
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 120 IFTK--PSGEVSILM-----EYMDAGSLEIYVKSRGRLS----EDIICTISRQVLKGLFY 168
F K P ++LM +Y +AG L +KSR + + E + QVL + +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158
Query: 169 MHSRNIVHRDIKPANVLINE------------KMEHP----------CGYSCLYESGEAR 206
+HS++++HRDIK AN+L+ KM CG + Y + E
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG-TPYYVAPEIW 217
Query: 207 HRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
RK Y+ AD++S GV + EL PF E + + LA + +P LP S
Sbjct: 218 RRK--PYSK-KADMFSLGVLLYELLTLKRPFDGENME-EVMHKTLAGRY-DP--LPPSIS 270
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHP 295
+ ++ + L DP +R ++S+LL+ P
Sbjct: 271 PEMQEIVTALLS-SDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYI 114
+ ++V+G+G G V VRHK + +YA+K++ + +E +I+ NS +I
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V+ H F + ++MEYM G L + + S + E + +V+ L +HS
Sbjct: 106 VQLHYAFQDDK-YLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 175 VHRDIKPANVLINE-------------KMEHPCGYSCL-------YESGEA-RHRKHGGY 213
+HRD+KP N+L+++ KM+ C Y S E + + GY
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 214 NGFAADIWSFGVTMMELYMGYYPFL 238
G D WS GV + E+ +G PF
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 83/312 (26%), Positives = 123/312 (39%), Gaps = 80/312 (25%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALK--VMQCDRGTPPNPQELNILRQTNSPYI 114
S+ L+ LG G+ G VF A+K V+ + +E+ I+R+ + I
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 115 VKCHQIFTKPSGE--------------VSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
VK +++ PSG V I+ EYM+ V +G LSE+
Sbjct: 65 VKVYEVLG-PSGSDLTEDVGSLTELNSVYIVQEYMETDLAN--VLEQGPLSEEHARLFMY 121
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLIN-EKMEHPCGYSCLYESGEAR----HRKHGGY-- 213
Q+L+GL Y+HS N++HRD+KPANV IN E + G + G AR H H GY
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG-----DFGLARIVDPHYSHKGYLS 176
Query: 214 -----------------NGF--AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI- 253
N + A D+W+ G E+ G P E + + L+L
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESV 235
Query: 254 ----------CFREPPS----------------LPECSSEKFRDFIRCCLQKGDPSKRWT 287
PS LP + E DF+ L +P R T
Sbjct: 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL-DFLEQILTF-NPMDRLT 293
Query: 288 ASQLLSHPFLAD 299
A + L HP+++
Sbjct: 294 AEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 49/272 (18%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCD--------RGTPPNPQELNILRQTNSPYI 114
+VLG+G+ G V R K++ LYA+KV++ D T + L++ R N P++
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ + F P + +ME+++ G L +++ R E + ++ L ++H + I
Sbjct: 59 TQLYCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN-------------------- 214
++RD+K NVL++ + G+ L + G + G
Sbjct: 118 IYRDLKLDNVLLDHE-----GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 215 -GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
G + D W+ GV + E+ G+ PF E E D +L P L + + + + F+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFM 231
Query: 274 RCCLQKGDPSKRWTA------SQLLSHPFLAD 299
+P+ R + +L HPF +
Sbjct: 232 -----TKNPTMRLGSLTLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 69/263 (26%), Positives = 114/263 (43%), Gaps = 39/263 (14%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVM-----QCDRGTPPNPQELNILRQTNSPYIVK 116
L+ +G G+ G V+ R + + A+K M Q + +E+ L++ P ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + ++MEY + ++ + L E I ++ L+GL Y+HS N++H
Sbjct: 80 YRGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEAR---------------------HRKHGGYNG 215
RD+K N+L++E G L + G A G Y+G
Sbjct: 139 RDVKAGNILLSEP-----GLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-SEKFRDFIR 274
D+WS G+T +EL P + +S + I E P+L SE FR+F+
Sbjct: 194 -KVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 275 CCLQKGDPSKRWTASQLLSHPFL 297
CLQK P R T+ LL H F+
Sbjct: 249 SCLQK-IPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 39/263 (14%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVM-----QCDRGTPPNPQELNILRQTNSPYIVK 116
L +G G+ G V+ + T + A+K M Q + +E+ L+Q P ++
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ K ++MEY + ++ + L E I I+ L+GL Y+HS N++H
Sbjct: 86 YKGCYLKEH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEAR---------------------HRKHGGYNG 215
RDIK N+L+ E G L + G A G Y+G
Sbjct: 145 RDIKAGNILLTEP-----GQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDG 199
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-SEKFRDFIR 274
D+WS G+T +EL P + +S + I + P+L ++ FR F+
Sbjct: 200 -KVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254
Query: 275 CCLQKGDPSKRWTASQLLSHPFL 297
CLQK P +R +++LL H F+
Sbjct: 255 YCLQK-IPQERPASAELLRHDFV 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 27/253 (10%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQIFT 122
+G+G+ G V K T A+K M + E+ I+R + +V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 123 KPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPA 182
E+ ++ME+++ G+L V + R++E+ I T+ VL+ L Y+H++ ++HRDIK
Sbjct: 90 V-GDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 183 NVLINE--KMEHPCGYSCLYESGEARHRKH---GGY-----------NGFAADIWSFGVT 226
++L+ +++ C S E RK Y G DIWS G+
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 227 MMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEKFRDFIRCCLQKGDPSK 284
++E+ G P+ EP L M I PP + + S R F+ L + +PS+
Sbjct: 208 VIEMIDGEPPYF---NEPP-LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR-EPSQ 262
Query: 285 RWTASQLLSHPFL 297
R TA +LL HPFL
Sbjct: 263 RATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 52/135 (38%), Positives = 76/135 (56%), Gaps = 6/135 (4%)
Query: 61 KLQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQTNSPYIVKC 117
KL LG+G TVFK R K T L ALK ++ + G P +E+++L+ IV
Sbjct: 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRL-SEDIICTISRQVLKGLFYMHSRNIVH 176
H I ++++ EY+D+ L+ Y+ + G L S + Q+L+GL Y H R I+H
Sbjct: 69 HDIIHTERC-LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 177 RDIKPANVLINEKME 191
RD+KP N+LINEK E
Sbjct: 127 RDLKPQNLLINEKGE 141
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-15
Identities = 41/140 (29%), Positives = 81/140 (57%), Gaps = 8/140 (5%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGTPPNP-QELNILRQTNS 111
+ Q EK++ +G+G G V+K R + +T+AL +++ Q D G P +E+++L++
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSED--IICTISRQVLKGLFYM 169
IV+ + + ++ EY+D L+ ++ S +++ +I T Q+L+G+ Y
Sbjct: 61 GNIVRLQDVVHSEK-RLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 170 HSRNIVHRDIKPANVLINEK 189
HS ++HRD+KP N+LI+ +
Sbjct: 119 HSHRVLHRDLKPQNLLIDRR 138
|
Length = 294 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 83/289 (28%), Positives = 119/289 (41%), Gaps = 63/289 (21%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKC 117
LQ +G G G V R + T A+K + TP + EL +L+ I+
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
IF P ++ + E + L + SR L + I Q+L+GL Y+HS +VHR
Sbjct: 75 SDIFISPLEDIYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHR 132
Query: 178 DIKPANVLINEKME-HPCGYSCLYESGEARHRKH--GGY-----------------NGFA 217
D+KP+N+LINE + C + G AR + GY
Sbjct: 133 DLKPSNILINENCDLKICDF------GLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVE 186
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEP--------DFL-----SLMLAIC----FREPPS 260
DIWS G E+ G F PG++ D L ++ IC R S
Sbjct: 187 VDIWSAGCIFAEMLEGKPLF--PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244
Query: 261 LPECS----SEKF-------RDFIRCCLQKGDPSKRWTASQLLSHPFLA 298
LP+ SEKF D + L DP KR +A++ L+HP+LA
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVF-DPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 41/134 (30%), Positives = 76/134 (56%), Gaps = 8/134 (5%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM---QCDRGTPPNP-QELNILRQTNSPYIV 115
+K++ +G+G G V+K R K T + ALK + D G P +E+++L++ N P IV
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLS--EDIICTISRQVLKGLFYMHSRN 173
+ + + ++ ++ E++D L+ Y+ S +I + Q+L+G+ Y HS
Sbjct: 62 RLLDVVHSEN-KLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 174 IVHRDIKPANVLIN 187
++HRD+KP N+LI+
Sbjct: 120 VLHRDLKPQNLLID 133
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 64/263 (24%), Positives = 107/263 (40%), Gaps = 34/263 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
++VLG+G G R + +L K + R + + E+ IL P I+
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRL-SEDIICTISRQVLKGLFYMHSRN 173
+ F + I MEY + G+L + V+ +G+L E+++ Q++ + Y+H
Sbjct: 63 AYYNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 174 IVHRDIKPANVLINEK-------------------MEHPCGYSCLYESGEARHRKHGGYN 214
I+HRDIK N+ + + M + Y S E YN
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK--YN 179
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
F +DIW+ G + EL F + L+L++ I + S + +
Sbjct: 180 -FKSDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234
Query: 275 CCLQKGDPSKRWTASQLLSHPFL 297
LQ+ DP KR TA ++L P L
Sbjct: 235 SLLQQ-DPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 75/268 (27%), Positives = 127/268 (47%), Gaps = 52/268 (19%)
Query: 63 QVLGQGNGGTVF----KVRHKQ--TLALYALKVMQCDRGTPPNPQ-----ELNILRQTNS 111
+V+G G G V K+ K+ +A+ LK G+ + E +I+ Q +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-----GSSDKQRLDFLTEASIMGQFDH 64
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYMH 170
P I++ + TK S V I+ EYM+ GSL+ ++ ++ G+ + + + R + G+ Y+
Sbjct: 65 PNIIRLEGVVTK-SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 171 SRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG------------- 212
N VHRD+ N+L+N C G S E EA + GG
Sbjct: 124 EMNYVHRDLAARNILVN--SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 213 YNGF--AADIWSFGVTMME-LYMGYYPFLE-PGQEPDFLSLMLAI--CFREPPSLPECSS 266
Y F A+D+WSFG+ M E + G P+ + Q+ ++ A+ +R PP + +C S
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-----VIKAVEDGYRLPPPM-DCPS 235
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294
++ + C QK D ++R T SQ++S
Sbjct: 236 ALYQ-LMLDCWQK-DRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 51/144 (35%), Positives = 79/144 (54%), Gaps = 9/144 (6%)
Query: 55 GLSQLE---KLQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQ 108
G ++E KL+ LG+G TVFK R K T L ALK ++ + G P +E+++L+
Sbjct: 1 GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKD 60
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLF 167
IV H I ++++ EY+D L+ Y+ G +S + Q+L+GL
Sbjct: 61 LKHANIVTLHDI-VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 168 YMHSRNIVHRDIKPANVLINEKME 191
Y H R ++HRD+KP N+LINE+ E
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGE 142
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQC-----DRGTPPNPQELNILRQ-TNSPYIVK 116
+V+G+G+ V VR K+T +YA+KV++ D E ++ Q +N P++V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
H F S + ++EY++ G L +++ + +L E+ S ++ L Y+H R I++
Sbjct: 61 LHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN---------------------G 215
RD+K NVL++ + G+ L + G + G G
Sbjct: 120 RDLKLDNVLLDSE-----GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 216 FAADIWSFGVTMMELYMGYYPF--LEPGQEPDFLS--LMLAICFREPPSLPECSSEKFRD 271
F+ D W+ GV M E+ G PF + PD + + + + +P S K
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234
Query: 272 FIRCCLQKGDPSKRWTA------SQLLSHPFL 297
++ L K DP +R + + HPF
Sbjct: 235 VLKSFLNK-DPKERLGCHPQTGFADIQGHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 68/266 (25%), Positives = 115/266 (43%), Gaps = 41/266 (15%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
++LG+G G V VR K T YA+K+++ + + E +L+ T P++
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
F + + +MEY + G L ++ SED +++ L Y+HS ++V+R
Sbjct: 61 KYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 178 DIKPANVLINE--------------------KMEHPCGYSCLYESGEARHRKHGGYNGFA 217
D+K N+++++ M+ CG + Y + E + Y G A
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG-TPEYLAPEV--LEDNDY-GRA 175
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277
D W GV M E+ G PF E F L+L R P +L S + + + L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEEIRFPRTL----SPEAKSLLAGLL 230
Query: 278 QKGDPSKRW-----TASQLLSHPFLA 298
+K DP +R A +++ H F A
Sbjct: 231 KK-DPKQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 71/266 (26%), Positives = 108/266 (40%), Gaps = 55/266 (20%)
Query: 62 LQVLGQGNGGTVFKVRHKQT----LALYALKVMQCDRGTPPNPQ---------ELNILR- 107
L+ LG G G V+KVR K LAL + V G + E+ I++
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVL 163
Q P IV+ ++ F + + + I+M+ ++ L + S + R +E+ I I Q++
Sbjct: 65 QLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 164 KGLFYMH-SRNIVHRDIKPANVLI-------------------NEKMEHPCG---YSCLY 200
L Y+H + IVHRD+ P N+++ K+ G YSC
Sbjct: 124 LALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC-- 181
Query: 201 ESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS 260
K+ Y G AD+W+FG + ++ PF + LSL I
Sbjct: 182 ----PEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFY----STNMLSLATKIVEAVYEP 232
Query: 261 LPECS-SEKFRDFIRCCLQKGDPSKR 285
LPE SE D I CL D R
Sbjct: 233 LPEGMYSEDVTDVITSCLTP-DAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 57/239 (23%)
Query: 54 DGLSQLEKLQVL---GQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNI 105
DG S+L + +V+ G G G VF V+HK+T + K + RG + E+N+
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNV 65
Query: 106 LRQTNSPYIVK-CHQIFTKPSGEVSILMEYMDAGSLEIYV----KSRGRLSEDIICTISR 160
+R+ IV+ + K + ++ ILME+ DAG L + K G++ E I I+R
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 161 QVLKGLFYMHS-------RNIVHRDIKPANVLIN-------------------------- 187
Q+L L Y H+ ++HRD+KP N+ ++
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 188 ---------EKMEHPCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF 237
E M H C + Y S E + Y+ +D+W+ G + EL G PF
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 68/302 (22%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTP-PNPQELNILRQTNS 111
+++ EKL +G+G G V++ R + + ALK ++ D G P + +E+ +L
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 112 PYIVKCHQIFTKPSGE-VSILMEY--MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
P IV+ ++ + + ++MEY D SL + + SE + + Q+L+GL Y
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQY 123
Query: 169 MHSRNIVHRDIKPANVLINEK-------------MEHPCG------YSCLYES-----GE 204
+H I+HRD+K +N+L+ +K P + Y + G
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---------- 254
+ A D+W+ G + EL + + P L E + L L++ +
Sbjct: 184 TTYTT-------AIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 255 FREPP-----SLPE-----------CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298
F + P +LP+ SE + L DP KR TA + L +
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY-DPKKRATAEEALESSYFK 294
Query: 299 DA 300
+
Sbjct: 295 EK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 30/201 (14%)
Query: 57 SQLEKLQVLGQGNGGTVFK---VRHKQTLAL-YALKVMQCDRGTPPNP---QELNILRQT 109
++LEK++VLG G GTV+K + + + + A+KV++ + N E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFY 168
+ P++V+ I S +V ++ + M G L YV++ + + + Q+ KG+ Y
Sbjct: 67 DHPHVVRLLGI--CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 169 MHSRNIVHRDIKPANVLINEKMEH----PCGYSCLYESGEARHRKHGG------------ 212
+ + +VHRD+ NVL+ +H G + L + E + GG
Sbjct: 125 LEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 213 -YNGFA--ADIWSFGVTMMEL 230
+ + +D+WS+GVT+ EL
Sbjct: 184 LHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 49/136 (36%), Positives = 77/136 (56%), Gaps = 6/136 (4%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQTNSPYIVK 116
EKL+ LG+G+ TV+K + K L ALKV +Q + GTP +E ++L+ IV
Sbjct: 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 117 CHQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
H I TK + ++++ EY+ + K G L + + Q+L+GL Y+H R I+
Sbjct: 68 LHDIIHTKET--LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125
Query: 176 HRDIKPANVLINEKME 191
HRD+KP N+LI++ E
Sbjct: 126 HRDLKPQNLLISDTGE 141
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-14
Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 44/264 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ------TNSPYIVK 116
+VLG+G+ G V K T +A+K ++ D + E ++ + P++
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL-- 58
Query: 117 CHQIFTKPSGE-VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
H T + E + +MEY++ G L +++S GR E + +++ GL ++H + I+
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 176 HRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGG----------------------Y 213
+RD+K NVL+++ G+ + + G + +G Y
Sbjct: 119 YRDLKLDNVLLDKD-----GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
N + D WSFGV + E+ +G PF G++ D L +I + P P S++ +D +
Sbjct: 174 N-ESVDWWSFGVLLYEMLIGQSPF--HGEDED--ELFDSIL-NDRPHFPRWISKEAKDCL 227
Query: 274 RCCLQKGDPSKRW-TASQLLSHPF 296
++ DP+KR + HPF
Sbjct: 228 SKLFER-DPTKRLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-14
Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 36/252 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQC-----DRGTPPNPQELNILRQTNS-PYIVK 116
+V+G+G+ V VR K+ +YA+KV++ D E ++ Q +S P++V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
H F S + +++EY++ G L +++ + +L E+ + ++ L ++H R I++
Sbjct: 61 LHSCFQTTS-RLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN---------------------G 215
RD+K NVL++ G+ L + G + G G
Sbjct: 120 RDLKLDNVLLDAD-----GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS--LMLAICFREPPSLPECSSEKFRDFI 273
F+ D W+ GV M E+ G PF PD + + + +P +P S K +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234
Query: 274 RCCLQKGDPSKR 285
+ L K DP +R
Sbjct: 235 KGFLNK-DPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 69/263 (26%), Positives = 111/263 (42%), Gaps = 37/263 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
++LG+G G V VR K T YA+K+++ + + E +L+ T P++
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
F + + +MEY + G L ++ +E+ +++ L Y+HSR++V+R
Sbjct: 61 KYAF-QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 178 DIKPANVLINEKMEHPCGYSCLYESG---EARHRKHGGYN-------------GFAADIW 221
DIK N+++++ L + G A + G G A D W
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDF-LSLMLAICFREPPSL-PECSSEKFRDFIRCCLQK 279
GV M E+ G PF E F L LM I F P +L PE S + L K
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKS------LLAGLLK 231
Query: 280 GDPSKRW-----TASQLLSHPFL 297
DP +R A +++ H F
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT------NSPYIV 115
L VLG+G+ G V K T LYA+K+++ D + E ++ + P++
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ H F + + +MEY++ G L ++ GR E + ++ GLF++HS+ I+
Sbjct: 65 QLHSCF-QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 176 HRDIKPANVLINEK--------------------MEHPCGYSCLYESGEARHRKHGGYNG 215
+RD+K NV+++ + + CG ++ +G
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK--- 180
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250
+ D W+FGV + E+ G PF ++ F S+M
Sbjct: 181 -SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSP 112
++ E L V+G+G G V K RHK+T + A+K + +EL +LR
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
IV+ + F + G++ ++ EY++ LE+ + + + + + Q++K + + H
Sbjct: 61 NIVELKEAFRR-RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 173 NIVHRDIKPANVLIN-EKMEHPCGYSC---LYESGEARHRKH-------------GGYNG 215
+IVHRDIKP N+LI+ + C + L E A + ++ G G
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQ 242
A D+WS G + EL G F PG+
Sbjct: 180 KAVDMWSVGCILGELSDGQPLF--PGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 40/268 (14%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQE---LNILRQTNSPYIV 115
++G+G G V+ R T +YA+K + R G E L+++ + P+IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
F P ++S +++ M+ G L ++ G SE + + +++ GL +MH+R +V
Sbjct: 61 CMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 176 HRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHG--GY-------NGFA----AD 219
+RD+KPAN+L++E G +C + S + H G GY G A AD
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 220 IWSFGVTMMELYMGYYPF----LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
+S G + +L G+ PF + E D ++L +A LP+ S + R +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------VELPDSFSPELRSLLEG 232
Query: 276 CLQKGDPSKRWT----ASQLLSHPFLAD 299
LQ+ + A ++ HPF
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 63/253 (24%), Positives = 118/253 (46%), Gaps = 43/253 (16%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQE---LNILRQTNSPYIV 115
++G+G G V+ R T +YA+K + R G E L+++ + P+IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
F P ++ +++ M+ G L ++ G SE + + +++ GL +MH+R +V
Sbjct: 61 CMTYAFHTPD-KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 176 HRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHG--GYNGF-------------- 216
+RD+KPAN+L++E G +C + ++ + H G +G+
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGTAYDS 175
Query: 217 AADIWSFGVTMMELYMGYYPFLE----PGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
+AD +S G + +L G+ PF + E D ++L + + LP+ S + +
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV------ELPDSFSPELKSL 229
Query: 273 IRCCLQKGDPSKR 285
+ LQ+ D SKR
Sbjct: 230 LEGLLQR-DVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 39/251 (15%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILR------QTNSPYIV 115
L VLG+G+ G V K T LYA+K+++ D + E ++ P++
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ H F + +MEY++ G L +++ G+ E + ++ GLF++HS+ I+
Sbjct: 65 QLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 176 HRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN--------------------- 214
+RD+K NV+++ + G+ + + G + GG
Sbjct: 124 YRDLKLDNVMLDAE-----GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
G + D W+FGV + E+ G PF ++ F S+M S P+ S++ +
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-----EHNVSYPKSLSKEAVSICK 233
Query: 275 CCLQKGDPSKR 285
L K P+KR
Sbjct: 234 GLLTK-HPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 52/145 (35%), Positives = 80/145 (55%), Gaps = 11/145 (7%)
Query: 55 GLSQLE---KLQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQ 108
G +LE KL LG+G TV+K R K T L ALK ++ + G P +E+++L+
Sbjct: 1 GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD 60
Query: 109 TNSPYIVKCHQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGRL-SEDIICTISRQVLKGL 166
IV H I T+ S ++++ EY+D L+ Y+ G + + Q+L+GL
Sbjct: 61 LKHANIVTLHDIIHTEKS--LTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 167 FYMHSRNIVHRDIKPANVLINEKME 191
Y H R ++HRD+KP N+LINE+ E
Sbjct: 118 NYCHRRKVLHRDLKPQNLLINERGE 142
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVK 116
++V+G+G G V VRHK + +YA+K++ + +E +I+ NSP++V+
Sbjct: 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
F + + ++MEYM G L + + S + E + +V+ L +HS ++H
Sbjct: 108 LFCAF-QDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH 165
Query: 177 RDIKPANVLINE-------------KMEHPCGYSC-------LYESGEARHRKHG-GYNG 215
RD+KP N+L+++ KM+ C Y S E + G GY G
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 216 FAADIWSFGVTMMELYMGYYPF 237
D WS GV + E+ +G PF
Sbjct: 226 RECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 44/271 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVM-----QCDRGTPPNPQELNILRQ-TNSPYIVK 116
+V+G+G+ V V K+T +YA+KV+ D E ++ +N P++V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
H F S + ++E++ G L +++ + +L E+ S ++ L ++H R I++
Sbjct: 61 LHSCFQTES-RLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEARH--RK-------------------HGGYNG 215
RD+K NVL++ + G+ L + G + R G G
Sbjct: 120 RDLKLDNVLLDAE-----GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 216 FAADIWSFGVTMMELYMGYYPF----LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
F+ D W+ GV M E+ G PF + + + + + + +P S K
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234
Query: 272 FIRCCLQKGDPSKRWTA------SQLLSHPF 296
++ L K DP +R + SHPF
Sbjct: 235 VLKGFLNK-DPKERLGCHPQTGFRDIKSHPF 264
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 41/260 (15%)
Query: 57 SQLEKLQVLGQGNGGTVFKV------RHKQTLALYALKVMQCDRGTPPNPQELNILRQTN 110
S + K +V+G G G VF+ R + +A+ LK ++ E +I+ Q +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYM 169
I++ + TK I+ EYM+ G+L+ Y++ G S + + R + G+ Y+
Sbjct: 65 HHNIIRLEGVVTKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYS------CLYESGEARHRKHGG----------- 212
N VHRD+ N+L+N +E C S L + E + GG
Sbjct: 124 SDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 213 --YNGF--AADIWSFGVTMME-LYMGYYPFLEPGQEPDFLSLMLAI--CFREPPSLPECS 265
Y F A+D+WSFG+ M E + G P+ + +M AI FR P + +C
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----EVMKAINDGFRLPAPM-DCP 236
Query: 266 SEKFRDFIRCCLQKGDPSKR 285
S ++ ++C Q D ++R
Sbjct: 237 SAVYQLMLQCWQQ--DRARR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 59 LEKLQVLGQGNGGTVFKVRHK----QTLALYALKVMQCDRGTPPNP---QELNILRQTNS 111
L+K++VLG+G+ G V + T + A+K ++ + G +E+NIL+
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 112 PYIVKCHQIFTKPSGE-VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
IVK ++ G+ + ++MEY+ GSL Y+ + +L+ + ++Q+ +G+ Y+H
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 171 SRNIVHRDIKPANVLI-NEKMEH--PCGYSCLYESGEARHR-KHGGYN------------ 214
S++ +HRD+ NVL+ N+++ G + G +R + G +
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 215 ---GFAADIWSFGVTMMELYMGYYPFLEP 240
+A+D+WSFGVT+ EL P
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSP 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 68/250 (27%), Positives = 106/250 (42%), Gaps = 62/250 (24%)
Query: 101 QELNILRQTNSPYIVKCHQIFT-----KPSGEVSILMEYMDAGSLEIYVKSRGRLSEDII 155
+EL +L+ ++ +FT + +V ++ M A L VK + +L++D +
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ-KLTDDHV 122
Query: 156 CTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYNG 215
+ Q+L+GL Y+HS +I+HRD+KP+N+ +NE E + + G ARH G
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK-----ILDFGLARHTDDE-MTG 176
Query: 216 FAA--------------------DIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAIC 254
+ A DIWS G M EL G F PG + D L L+L +
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLV 234
Query: 255 FREPPSL-PECSSEKFRDFIRCCLQKG-------------------------DPSKRWTA 288
L + SSE R++I+ Q D KR TA
Sbjct: 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 294
Query: 289 SQLLSHPFLA 298
+Q L+H + A
Sbjct: 295 AQALAHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 73/296 (24%), Positives = 122/296 (41%), Gaps = 70/296 (23%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNP-QELNILRQTNSPYIV 115
EKL + +G G V++ R K+T + ALK ++ ++ G P +E+NIL + P IV
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 116 KCHQIFT-KPSGEVSILMEYM--DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
++ ++ ++MEY+ D SL +K SE + + Q+L G+ ++H
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLHDN 125
Query: 173 NIVHRDIKPANVLINEK---------MEHPCG-----YSCL-----YES-----GEARHR 208
I+HRD+K +N+L+N + + G Y+ L Y + G +
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY- 184
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC-------FREPPS 260
A D+WS G EL F PG+ E D L+ + + +
Sbjct: 185 ------STAIDMWSVGCIFAELLTKKPLF--PGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 LPECSSEKFRDFIRCCLQKG--------------------DPSKRWTASQLLSHPF 296
LP + F + L+K DP+KR +A L HP+
Sbjct: 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 34/196 (17%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
+ +G+GN G V+K K + V C PP+ QE IL+Q + P IVK
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV---AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + + I+ME + GSL ++ K + RL+ + +S G+ Y+ S+N +H
Sbjct: 58 IGVCVQ-KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 177 RDIKPANVLINEK------------MEHPCGYSCL---------YESGEARHRKHGGYNG 215
RD+ N L+ E E Y+ + + EA + +G Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN--YGRYTS 174
Query: 216 FAADIWSFGVTMMELY 231
+D+WS+G+ + E +
Sbjct: 175 -ESDVWSYGILLWETF 189
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 76/305 (24%), Positives = 118/305 (38%), Gaps = 81/305 (26%)
Query: 62 LQVLGQGNGGTVFKVRHKQT-----LALYAL-----KVMQCDRGTPPNPQELNILR---- 107
++ LGQG G V R+ +T +A+ + K + R +EL +LR
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRHFRG 60
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLF 167
N + +F E+ + E M+A L ++S L++ + Q+L GL
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 168 YMHSRNIVHRDIKPANVLINEKME-HPCGYSCLYESGEAR--HRKHGGYNGF-------- 216
Y+HS N++HRD+KP N+L+N E C + G AR G GF
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDF------GLARGFSENPGENAGFMTEYVATR 173
Query: 217 ----------------AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP- 259
A D+WS G + EL G P + D L+ +L + P
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQV-LGTPDE 231
Query: 260 -SLPECSSEKFRDFIRC-------------------------CLQKGDPSKRWTASQLLS 293
+L S K +++IR L DP+KR + + L
Sbjct: 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291
Query: 294 HPFLA 298
HP+LA
Sbjct: 292 HPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 73/292 (25%), Positives = 115/292 (39%), Gaps = 66/292 (22%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVM----QCDRGTPPNPQELNILRQTNSPYIVKC 117
L+ +G G GTV ++T A A+K + Q + +EL +L+ ++
Sbjct: 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 118 HQIFTKPSG-----EVSILMEYM--DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
+FT + ++M +M D G L +LSED I + Q+LKGL Y+H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKL----MKHEKLSEDRIQFLVYQMLKGLKYIH 135
Query: 171 SRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH--RKHGGY---NGFAA------- 218
+ I+HRD+KP N+ +NE E + + G AR + GY + A
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELK-----ILDFGLARQTDSEMTGYVVTRWYRAPEVILNW 190
Query: 219 -------DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP------------ 259
DIWS G M E+ G P + D L ++ +
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249
Query: 260 ----SLPECSSEKFRDFIRCC-------LQKG---DPSKRWTASQLLSHPFL 297
LP + FR + L+K D R TA++ L+HP+
Sbjct: 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 63/259 (24%), Positives = 119/259 (45%), Gaps = 36/259 (13%)
Query: 57 SQLEKLQVLGQGNGGTVFK---VRHKQTLAL-YALKVMQCDRGTPPNPQELN---ILRQT 109
++L++++VLG G GTV+K V +T+ + A+K++ G N + ++ I+
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFY 168
+ P++V+ + P+ + ++ + M G L YV + + + ++ Q+ KG+ Y
Sbjct: 67 DHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124
Query: 169 MHSRNIVHRDIKPANVLI---NEKMEHPCGYSCLYESGEARHRKHGG------------- 212
+ R +VHRD+ NVL+ N G + L E E + GG
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 213 YNGFA--ADIWSFGVTMMELY-MGYYPF--LEPGQEPDFLSLMLAICFREPPSLPECSSE 267
Y F +D+WS+GVT+ EL G P+ + + PD L + P P C+ +
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL-----PQPPICTID 239
Query: 268 KFRDFIRCCLQKGDPSKRW 286
+ ++C + D ++
Sbjct: 240 VYMVMVKCWMIDADSRPKF 258
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-13
Identities = 68/267 (25%), Positives = 110/267 (41%), Gaps = 43/267 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
++LG+G G V VR K + YA+K+++ + + E +L+ T P++
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
F + + +MEY++ G L ++ SED +++ L Y+HS IV+R
Sbjct: 61 KYSF-QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 178 DIKPANVLINE--------------------KMEHPCGYSCLYESGEARHRKHGGYNGFA 217
D+K N+++++ M+ CG + Y + E G A
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG-TPEYLAPEVLEDNDYGR---A 175
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDF-LSLMLAICFREPPSLPECSSEKFRDFIRCC 276
D W GV M E+ G PF E F L LM I F P S + +
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF------PRTLSADAKSLLSGL 229
Query: 277 LQKGDPSKRW-----TASQLLSHPFLA 298
L K DP+KR A +++ H F
Sbjct: 230 LIK-DPNKRLGGGPDDAKEIMRHSFFT 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILR------QTNSPYIV 115
L VLG+G+ G V K T LYA+K+++ D + E ++ Q P++
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ H F + + +MEY++ G L +++ G+ E + ++ GLF++H R I+
Sbjct: 65 QLHSCF-QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 176 HRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN--------------------- 214
+RD+K NV+++ + G+ + + G + G
Sbjct: 124 YRDLKLDNVMLDSE-----GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250
G + D W++GV + E+ G PF ++ F S+M
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 37/136 (27%), Positives = 76/136 (55%), Gaps = 7/136 (5%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC---DRGTPPNP-QELNILRQTNSPYIV 115
K++ +G+G G V+K R+K+T + A+K ++ + G P +E+++L++ P IV
Sbjct: 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 116 KCHQIFTKPSGEVSILMEY--MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
+ + S + ++ E+ MD + + +++ + Q+L+G+ + HSR
Sbjct: 63 CLQDVLMQES-RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 174 IVHRDIKPANVLINEK 189
++HRD+KP N+LI+ K
Sbjct: 122 VLHRDLKPQNLLIDNK 137
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-13
Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIV 115
+ +L+ LQ +G+G G V ++ A+K ++ D E +++ Q +V
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFLAEASVMTQLRHSNLV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRN 173
+ + + G + I+ EYM GSL Y++SRGR L D + S V + + Y+ + N
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 174 IVHRDIKPANVLINEK----------------MEHPCGYSCLYESGEARHRKHGGYNGFA 217
VHRD+ NVL++E + + + EA K
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK--- 179
Query: 218 ADIWSFGVTMMELY-MGYYPF 237
+D+WSFG+ + E+Y G P+
Sbjct: 180 SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYI 114
E ++V+G+G G V VRHK T +YA+K++ + +E +I+ NSP++
Sbjct: 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V+ F + + ++MEYM G L + + S + E + +V+ L +HS
Sbjct: 106 VQLFYAF-QDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 175 VHRDIKPANVLINE-------------KMEHPCGYSC-------LYESGEARHRKHG-GY 213
+HRD+KP N+L+++ KM C Y S E + G GY
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 214 NGFAADIWSFGVTMMELYMGYYPF 237
G D WS GV + E+ +G PF
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 65 LGQGNGGTVFK--VRHKQTLALYALKVMQCDRGTPPNPQEL----NILRQTNSPYIVKCH 118
LG GN GTV K + K++ A+K+++ D P EL N+++Q ++PYIV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
I S ++ME + G L +++ ++E I + QV G+ Y+ N VHRD
Sbjct: 63 GICEAES--WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 179 IKPANVLINEKMEHPC-----GYSCLYESGEA--RHRKHG------------GYNGFA-- 217
+ NVL+ +H G S + E + + HG Y F+
Sbjct: 121 LAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 218 ADIWSFGVTMMELY-MGYYPFL 238
+D+WSFGV M E + G P+
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 34/263 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQE----LNILRQTNSPYIV 115
K++ +G+G+ G V+ K+ Y +K + + +P +E + +L P IV
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRL-SEDIICTISRQVLKGLFYMHSRN 173
+ + F + +G + I+M+Y + G L + RG L ED I Q+ L ++H R
Sbjct: 63 QYQESFEE-NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 174 IVHRDIKPANV-----------------LINEKME--HPCGYSCLYESGEARHRKHGGYN 214
I+HRDIK N+ ++N +E C + Y S E + YN
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR--PYN 179
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
+DIW+ G + E+ + F E G + +L+L I P + S R+ +
Sbjct: 180 N-KSDIWALGCVLYEMCTLKHAF-EAG---NMKNLVLKIIRGSYPPVSSHYSYDLRNLV- 233
Query: 275 CCLQKGDPSKRWTASQLLSHPFL 297
L K +P R + + +L F+
Sbjct: 234 SQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQ 119
LG+G G V V+ K T +YA K + R G E IL + NSP+IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDI--ICTISRQVLKGLFYMHSRNIVHR 177
F + + ++M M+ G L+ ++ + G ++ + S Q+ G+ ++HS +IV+R
Sbjct: 61 AFESKT-HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 178 DIKPANVLINEKMEHPCGYSCLYESGEARHRKHG-------GYNGFAA------------ 218
D+KP NVL++++ G L + G A K G G NG+ A
Sbjct: 120 DMKPENVLLDDQ-----GNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 219 -DIWSFGVTMMELYMGYYPF 237
D ++ G ++ E+ G PF
Sbjct: 175 VDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 70/247 (28%), Positives = 103/247 (41%), Gaps = 55/247 (22%)
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGE----VSILMEYMDAGSLEIYVKSRGRLSEDIICT 157
E+ +LR + ++ I P E V I+ E MD +I ++S LS+D
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQI-IRSSQTLSDDHCQY 112
Query: 158 ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY---- 213
Q+L+GL Y+HS N++HRD+KP+N+L+N + L + + Y
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172
Query: 214 -------------NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFL-SLMLAICFREPP 259
A D+WS G EL +G P L PG+ D++ L L P
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAEL-LGRKP-LFPGK--DYVHQLKLITELLGSP 228
Query: 260 S---LPECSSEKFRDFIRC----------------------CLQKG---DPSKRWTASQL 291
S L +EK R +IR L+K DPSKR T +
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288
Query: 292 LSHPFLA 298
L+HP+LA
Sbjct: 289 LAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 12/133 (9%)
Query: 66 GQGNGGTVFKVRHK--QTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCH 118
G+G G V+K + K + YA+K + D+ +E+ +LR+ +V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 119 QIF-TKPSGEVSILMEYMDAGSLEI----YVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
++F V +L +Y + +I R + ++ ++ Q+L G+ Y+HS
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 174 IVHRDIKPANVLI 186
++HRD+KPAN+L+
Sbjct: 129 VLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 71/286 (24%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-------PNP---------QE 102
+ ++ LGQG+ G V++ A V++ + T N E
Sbjct: 8 ITLIRELGQGSFGMVYEG--------LAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIIC-----T 157
+++++ N ++V+ + + + ++ME M G L+ Y++SR R + T
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTL-VVMELMAKGDLKSYLRSR-RPEAENNPGLGPPT 117
Query: 158 ISR------QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR----- 206
+ + ++ G+ Y+ ++ VHRD+ N ++ E + G + G R
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG-----DFGMTRDIYET 172
Query: 207 --HRKHG----------------GYNGFAADIWSFGVTMMEL-YMGYYPFLEPGQEPDFL 247
+RK G G +D+WSFGV + E+ + P+ G +
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNE-- 228
Query: 248 SLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
++ + LPE +K + +R C Q +P R T +++S
Sbjct: 229 EVLKFVIDGGHLDLPENCPDKLLELMRMCWQY-NPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 63/253 (24%), Positives = 120/253 (47%), Gaps = 35/253 (13%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKC 117
L+ ++ LG G G V+ + + A+K ++ +P E N+++Q P +V+
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL 66
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIV 175
+ + T+ + I+ EYM+ GSL ++K+ +L+ + + ++ Q+ +G+ ++ +N +
Sbjct: 67 YAVVTQEP--IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 176 HRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG------------GYNGFA- 217
HRD++ AN+L++E + C G + L E E R+ Y F
Sbjct: 125 HRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 218 -ADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPE-CSSEKFRDFIR 274
+D+WSFG+ + E+ G P+ PG + L +R P P+ C E +
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPY--PGMTNPEVIQNLERGYRMP--RPDNCPEELYELMRL 238
Query: 275 CCLQKGDPSKRWT 287
C +K P +R T
Sbjct: 239 CWKEK--PEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 33/261 (12%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQ----CDRGTPPNPQELNILRQTNSPYIVKC 117
++V+G+G+ G V VRH+ Y +K + R QE +L Q P IV
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGRL-SEDIICTISRQVLKGLFYMHSRNIV 175
+ + G + I+M + + G L +K +G+L E+ + Q+ L Y+H ++I+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 176 HRDIKPANVLINEK-------------MEHPCGYSC------LYESGEARHRKHGGYNGF 216
HRD+K NV + +E+ C + Y S E K YN +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK--PYN-Y 181
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
+D+W+ G + E+ + F D SL+ I + P +P+ S + + I
Sbjct: 182 KSDVWALGCCVYEMATLKHAF----NAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237
Query: 277 LQKGDPSKRWTASQLLSHPFL 297
L K P KR + +L P++
Sbjct: 238 LSK-RPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 48/160 (30%), Positives = 68/160 (42%), Gaps = 29/160 (18%)
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQ 161
E +ILR N P I++ FT IL Y L Y+ ++ ++ I I R
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEA------RHRKHGGYNG 215
VL+ + Y+H I+HRDIK N+ IN HP G CL + G A K+ G+ G
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFIN----HP-GDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 216 F----------------AADIWSFGVTMMELYMGYYPFLE 239
A DIWS G+ + E+ + E
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 41/264 (15%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNIL-RQTNSPYIVK 116
+V+G+G+ G V +HK YA+KV+Q Q E N+L + P++V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
H F ++ +++Y++ G L +++ E + ++ L Y+HS NI++
Sbjct: 61 LHYSFQTAD-KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 177 RDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHRKHGGYNGF 216
RD+KP N+L++ E +EH CG + Y + E ++ Y+
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG-TPEYLAPEVLRKQP--YDR- 175
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
D W G + E+ G PF + M +P L S R +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKPLRLKPNISVSARHLLEGL 230
Query: 277 LQKGDPSKRWTAS----QLLSHPF 296
LQK D +KR A ++ +H F
Sbjct: 231 LQK-DRTKRLGAKDDFLEIKNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 57/245 (23%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELN--------ILRQTNSPYI 114
+V+G+G+ G V + K + YA+KV+Q + T +E N +L+ P++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQ--KKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V H F ++ +++Y++ G L +++ E + +V + Y+HS NI
Sbjct: 59 VGLHYSFQTAE-KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNI 117
Query: 175 VHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHRKHGGYN 214
++RD+KP N+L++ E +E CG + Y + E ++ Y+
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG-TPEYLAPEVLRKE--PYD 174
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
D W G + E+ G PF +S M +P LP + D +
Sbjct: 175 R-TVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKPLQLPGGKTVAACDLLV 228
Query: 275 CCLQK 279
L K
Sbjct: 229 GLLHK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 70/292 (23%), Positives = 114/292 (39%), Gaps = 63/292 (21%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQEL------------- 103
E ++++ G G V+ VRHK+T +A+K + N Q L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKI--------NKQNLILRNQIQQVFVER 52
Query: 104 NILRQTNSPYIVKCHQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQV 162
+IL +P++V F TK + ++MEY++ G +K+ G L D+ +
Sbjct: 53 DILTFAENPFVVSMFCSFETKR--HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110
Query: 163 LKGLFYMHSRNIVHRDIKPANVLIN------------EKMEHPCGYSCLYESGEARHRKH 210
+ L Y+H+ IVHRD+KP N+LI K+ + LYE + +
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 211 --------------------GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250
GY G D W+ G+ + E +G PF G P+ L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFF--GDTPEELFGQ 227
Query: 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRW---TASQLLSHPFLAD 299
+ E P E +D I L++ +P +R A ++ H F
Sbjct: 228 VISDDIEWPEGDEALPADAQDLISRLLRQ-NPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 39/249 (15%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKCHQ 119
+G+GN G VF R + A+K C PP+ QE IL+Q + P IV+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+ T+ + I+ME + G ++++ G RL + + G+ Y+ S++ +HRD
Sbjct: 61 VCTQKQ-PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119
Query: 179 IKPANVLINEK---------MEHPCGYSCLYESGEARH----------RKHGGYNGFAAD 219
+ N L+ EK M +G + +G Y+ +D
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS-ESD 178
Query: 220 IWSFGVTMMELY-MGY--YPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
+WSFG+ + E + +G Y L Q + + + + P L C +R RC
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPEL--CPDAVYRLMERC- 232
Query: 277 LQKGDPSKR 285
+ DP +R
Sbjct: 233 -WEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-12
Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 38/268 (14%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIV 115
L+ + LG G G V+ T + A+K ++ +P QE I+++ +V
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 116 KCHQIFTKPSGE-VSILMEYMDAGSLEIYVKS-RGR-LSEDIICTISRQVLKGLFYMHSR 172
+ + + ++ E + I+ EYM GSL ++KS G+ L + ++ Q+ +G+ Y+ SR
Sbjct: 65 QLYAVCSE--EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 173 NIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG-------------YN 214
N +HRD+ N+L+ E C G + L E E R G Y
Sbjct: 123 NYIHRDLAARNILVGEN--LVCKIADFGLARLIEDDEYTAR-EGAKFPIKWTAPEAANYG 179
Query: 215 GFA--ADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
F +D+WSFG+ + E+ G P+ PG + + +R P P C E +
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPY--PGMTNREVLEQVERGYRM-PRPPNCPEELYDL 236
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299
++C DP +R T L FL D
Sbjct: 237 MLQC--WDKDPEERPTFEYL--QSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-12
Identities = 74/265 (27%), Positives = 116/265 (43%), Gaps = 37/265 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIV 115
E ++ +G+G+ G ++ + K +K + + + +E+ +L + P IV
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRL-SEDIICTISRQVLKGLFYMHSRN 173
F + +G + I+MEY D G L + + RG L SED I + Q+ GL ++H R
Sbjct: 63 TFFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 174 IVHRDIKPANVL------------------INEKME--HPCGYSCLYESGEARHRKHGGY 213
I+HRDIK N+ +N+ ME + C + Y S E + Y
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR--PY 179
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPECSSEKFRDF 272
N DIWS G + EL +PF + + L+L IC P P S + R
Sbjct: 180 NN-KTDIWSLGCVLYELCTLKHPF----EGNNLHQLVLKICQGYFAPISPNFSRD-LRSL 233
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
I L K P R + + +L PFL
Sbjct: 234 IS-QLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-12
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 46/276 (16%)
Query: 59 LEKLQVLGQGNGGTVFKVRHK----QTLALYALKVMQCDRGTPPNP---QELNILRQTNS 111
L++++ LG+G+ G V R+ T A+K ++ + G +E+ ILR
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65
Query: 112 PYIVKCHQIFTKPSGE-VSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYM 169
IVK I T+ G + ++ME++ +GSL+ Y+ +++ +++ + Q+ KG+ Y+
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYNGF------------- 216
SR VHRD+ NVL+ + + G L ++ E + +
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 217 ------AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM-----------LAICFREPP 259
A+D+WSFGVT+ EL Y E FL ++ L E
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT--YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 260 SLP---ECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292
LP C E ++ +C + PSKR T L+
Sbjct: 244 RLPRPPNCPEEVYQLMRKCWEFQ--PSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 69/269 (25%), Positives = 105/269 (39%), Gaps = 51/269 (18%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKCHQ 119
+GQG G VF + K T + ALK M+ N E +IL T S ++VK
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSED--------IICTISRQVLKGLFYMHS 171
F + + MEY+ G + + G LSED + + +H
Sbjct: 69 AFQDDE-YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--------LHE 119
Query: 172 RNIVHRDIKPANVLINEK----------------MEHPCGYSCLYESGEARHRKHGGYNG 215
+HRD+KP N LI+ + S Y + E K GY+
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGK--GYD- 176
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPD--FLSLM-LAICFREPP-SLPECS-SEKFR 270
F D WS G + E G+ PF G P+ + +L + P P + S++
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPF--SGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234
Query: 271 DFIRCCLQKGDPSKRWTA-SQLLSHPFLA 298
D I + DPS+R+ + + +HPF
Sbjct: 235 DLITKLIN--DPSRRFGSLEDIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 33/196 (16%)
Query: 59 LEKLQVLGQGNGGTVFK-VRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVK 116
L+ +G+G G V Q +A+ K ++ D E +++ P +V+
Sbjct: 8 LKLGATIGKGEFGDVMLGDYRGQKVAV---KCLKDDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTI--SRQVLKGLFYMHSRNI 174
+ + + + I+ EYM GSL Y++SRGR + + + V +G+ Y+ +N
Sbjct: 65 LLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 175 VHRDIKPANVLINE---------------KMEHPCG-YSCLYESGEA-RHRKHGGYNGFA 217
VHRD+ NVL++E G + + EA R +K F+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKK------FS 177
Query: 218 --ADIWSFGVTMMELY 231
+D+WSFG+ + E+Y
Sbjct: 178 TKSDVWSFGILLWEIY 193
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
QE +L + I+ + + +L YM+ G+L+++++ + +S
Sbjct: 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 161 --------QVLKGLFYMHSRNIVHRDIKPANVLINEKME------------HPCGYSCLY 200
Q+ G+ Y+H R ++H+DI N +I+E+++ P Y CL
Sbjct: 117 QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 201 ESGEARHRK--------HGGYNGFAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLML 251
+ E R K + Y+ A+D+WSFGV + EL +G P++E +P ++ L
Sbjct: 177 D-NENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE--IDPFEMAAYL 232
Query: 252 AICFR--EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
+R +P + P ++ + CC DP +R + SQL+
Sbjct: 233 KDGYRLAQPINCP----DELFAVMACCWAL-DPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 68/279 (24%), Positives = 108/279 (38%), Gaps = 61/279 (21%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILR----------QTNS 111
L VLG+G+ G V +K+T LYA+K ++ +G E+ L
Sbjct: 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALK--KGDIIARDEVESLMCEKRIFETANSERH 61
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
P++V F V +MEY G L +++ SE + V+ GL Y+H
Sbjct: 62 PFLVNLFACFQTED-HVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 172 RNIVHRDIKPANVLIN--------------EKMEHP------CGY------SCLYESGEA 205
IV+RD+K N+L++ E M CG L E+
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 206 RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265
R A D W GV + E+ +G PF PG + + + +I E P
Sbjct: 180 R----------AVDWWGLGVLIYEMLVGESPF--PGDDEE--EVFDSIVNDEVR-YPRFL 224
Query: 266 SEKFRDFIRCCLQKGDPSKRWTASQ-----LLSHPFLAD 299
S + +R L++ +P +R + + + PF D
Sbjct: 225 SREAISIMRRLLRR-NPERRLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 56/258 (21%), Positives = 115/258 (44%), Gaps = 30/258 (11%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT------NSPYIVK 116
+VLG+G+ G V K +A+K ++ D + E ++ + +P++
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ F + + +ME+++ G L +++ +GR + +++ GL ++HS+ I++
Sbjct: 61 LYCTF-QTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 177 RDIKPANVLINEK-----------MEHPCGYS-----CLYESGEARHRKHGGYNGFAADI 220
RD+K NV+++ E+ G + C A G F+ D
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKG 280
WSFGV + E+ +G PF ++ F S+ + + P P +++ +D + ++
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRV-----DTPHYPRWITKESKDILEKLFER- 233
Query: 281 DPSKRW-TASQLLSHPFL 297
DP++R + HPF
Sbjct: 234 DPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 64/266 (24%), Positives = 117/266 (43%), Gaps = 41/266 (15%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN-------SPYIV 115
+V+G+G+ G V RHK YA+KV+Q + +E +I+ + N P++V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQ-KKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
H F + + ++ +++Y++ G L +++ E + ++ L Y+HS NIV
Sbjct: 60 GLHFSF-QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 176 HRDIKPANVLIN--------------EKMEHPCGYSCL-----YESGEARHRKHGGYNGF 216
+RD+KP N+L++ E +EH S Y + E H++ Y+
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ--PYDR- 175
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
D W G + E+ G PF + +++ +P L + R +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-----NKPLQLKPNITNSARHLLEGL 230
Query: 277 LQKGDPSKRWTAS----QLLSHPFLA 298
LQK D +KR A ++ +H F +
Sbjct: 231 LQK-DRTKRLGAKDDFMEIKNHIFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 32/200 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQ------TLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVK 116
+V+G G G V R K +A+ LK ++ E +I+ Q + P I+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ TK S V I+ EYM+ GSL+ ++ K G+ + + + R + G+ Y+ V
Sbjct: 70 LEGVVTK-SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128
Query: 176 HRDIKPANVLINEKMEHPCGYS------CLYESGEARHRKHGG-------------YNGF 216
HRD+ N+L+N + C S L + EA + GG Y F
Sbjct: 129 HRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 217 --AADIWSFGVTMMELYMGY 234
A+D+WS+G+ M E+ M Y
Sbjct: 187 TSASDVWSYGIVMWEV-MSY 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 44/268 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
++LG+G G V V+ K T YA+K+++ + + E +L+ + P++
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVH 176
F + + +MEY + G L ++ SED +++ L Y+HS +N+V+
Sbjct: 61 KYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 177 RDIKPANVLINE--------------------KMEHPCGYSCLYESGEARHRKHGGYNGF 216
RD+K N+++++ M+ CG + Y + E G
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG-TPEYLAPEVLEDNDYGR--- 175
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-PECSSEKFRDFIRC 275
A D W GV M E+ G PF E F L+L R P +L PE S +
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEEIRFPRTLSPEAKS------LLS 228
Query: 276 CLQKGDPSKRW-----TASQLLSHPFLA 298
L K DP +R A +++ H F A
Sbjct: 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFA 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTI 158
+E N+++ +V+ + + TK + I+ EYM GSL ++KS G++ +
Sbjct: 50 EEANLMKTLQHDKLVRLYAVVTKEE-PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108
Query: 159 SRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG-- 211
S Q+ +G+ Y+ +N +HRD++ ANVL++E + C G + + E E R+
Sbjct: 109 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTAREGAKF 166
Query: 212 ----------GYNGFA--ADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREP 258
+ F +D+WSFG+ + E+ G P+ PG + L +R P
Sbjct: 167 PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY--PGMSNSDVMSALQRGYRMP 224
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
E ++ D ++ C K +R T L S
Sbjct: 225 R--MENCPDELYDIMKTCW-KEKAEERPTFDYLQS 256
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 31/202 (15%)
Query: 59 LEKLQVLGQGNGGTVFKVRHK----QTLALYALKVMQCDRGTPPNPQ----ELNILRQTN 110
L+ +Q LG+GN G+V R+ T + A+K +Q T + + E+ IL+
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ--HSTAEHLRDFEREIEILKSLQ 63
Query: 111 SPYIVKCHQI-FTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFY 168
IVK + ++ + ++MEY+ GSL Y+ K R RL + + Q+ KG+ Y
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCG-------------YSCLYESGE------ARHRK 209
+ S+ VHRD+ N+L+ + G Y + E GE A
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 210 HGGYNGFAADIWSFGVTMMELY 231
A+D+WSFGV + EL+
Sbjct: 184 TESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTI 158
E N+++ +VK H + TK + I+ E+M GSL ++KS + +
Sbjct: 50 AEANVMKTLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 159 SRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG-- 211
S Q+ +G+ ++ RN +HRD++ AN+L++ + C G + + E E R+
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAREGAKF 165
Query: 212 ----------GYNGFA--ADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREP 258
+ F +D+WSFG+ +ME+ G P+ PG + L +R P
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY--PGMSNPEVIRALERGYRMP 223
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
C E + +RC K P +R T + S
Sbjct: 224 RP-ENCPEELYNIMMRC--WKNRPEERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 36/248 (14%)
Query: 57 SQLEKLQVLGQGNGGTVFK---VRHKQTLAL-YALKVMQCDRGTPPNPQELN---ILRQT 109
++L+K++VLG G GTV+K + + + + A+KV++ + N + L+ ++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFY 168
SPY+ C + + V ++ + M G L YV+ ++ R+ + Q+ KG+ Y
Sbjct: 67 GSPYV--CRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY 124
Query: 169 MHSRNIVHRDIKPANVLI---NEKMEHPCGYSCLYESGEARHRKHGG------------- 212
+ +VHRD+ NVL+ N G + L + E + GG
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 213 YNGFA--ADIWSFGVTMMELY-MGYYPFLE-PGQE-PDFLSLMLAICFREPPSLPECSSE 267
+ F +D+WS+GVT+ EL G P+ P +E PD L + P P C+ +
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-----PQPPICTID 239
Query: 268 KFRDFIRC 275
+ ++C
Sbjct: 240 VYMIMVKC 247
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 59/216 (27%), Positives = 86/216 (39%), Gaps = 47/216 (21%)
Query: 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186
E+ ++ E M + +I V S LS D + Q+L+GL Y+HS I+HRDIKP N+L+
Sbjct: 78 EIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136
Query: 187 NEKME-HPC--GYSCLYESGEARHRKH---------------GGYNGFAADIWSFGVTMM 228
N C G + + E E++H + A DIWS G
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 229 ELYMGYYPF--LEPGQEPDF---------LSLMLAIC-------FREPPSLPECS----- 265
EL F P Q+ D L M + C R P P
Sbjct: 197 ELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTL 256
Query: 266 ----SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ + + C + DP KR +A+ L+HP+L
Sbjct: 257 SSQATHEAVHLL-CRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 66/297 (22%)
Query: 58 QLEKLQVLGQGNGGTV---FKVRHKQTLALYAL-KVMQCDRGTPPNPQELNILRQTNSPY 113
+ + L +G G G+V + R +Q +A+ L + Q +EL +L+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 114 IVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
++ +FT + EV ++ M A L VK + +LS++ + + Q+L+GL Y
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGA-DLNNIVKCQ-KLSDEHVQFLIYQLLRGLKY 133
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYNGFAA---------- 218
+HS I+HRD+KP+NV +NE E + + G AR + G+ A
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELR-----ILDFGLAR-QADDEMTGYVATRWYRAPEIM 187
Query: 219 ----------DIWSFGVTMMELYMGYYPFLEPGQE--PDFLSLMLAICFREPPSLPECSS 266
DIWS G M EL G F PG + +M + P L + SS
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALF--PGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 267 EKFRDFIRC----------------------CLQKG---DPSKRWTASQLLSHPFLA 298
E R +I+ L+K D KR +AS+ L+HP+ +
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 38/204 (18%)
Query: 63 QVLGQGNGGTVFKVRHKQ------TLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVK 116
+V+G G G V + R K +A+ LK ++ E +I+ Q + P I+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ TK S V I+ E+M+ G+L+ +++ + G+ + + + R + G+ Y+ N V
Sbjct: 70 LEGVVTK-SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 176 HRDIKPANVLIN-----------------EKMEHPCGYSCL-------YESGEA-RHRKH 210
HRD+ N+L+N + P S L + + EA +RK
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 211 GGYNGFAADIWSFGVTMMELYMGY 234
A+D+WS+G+ M E+ M Y
Sbjct: 189 TS----ASDVWSYGIVMWEV-MSY 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 68/275 (24%), Positives = 113/275 (41%), Gaps = 50/275 (18%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKC 117
+VLG+G G V + + T +YA K ++ R G E IL + NS ++V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 118 HQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNI 174
+ TK + + +++ M+ G L+ ++ + G E+ + ++ GL +H I
Sbjct: 66 AYAYETKDA--LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG----------GY----------N 214
V+RD+KP N+L+++ G+ + + G A G GY
Sbjct: 124 VYRDLKPENILLDDY-----GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF----R 270
F+ D W G + E+ G PF + ++ + R E SEKF R
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE-----RRVKEDQEEYSEKFSEAAR 233
Query: 271 DFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300
R L K DP R A ++ +HPF A
Sbjct: 234 SICRQLLTK-DPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 60/264 (22%), Positives = 116/264 (43%), Gaps = 42/264 (15%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT------NSPYIVK 116
++LG+G+ G VF K T +A+K ++ D + E ++ + P++
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ F + + +MEY++ G L +++S + + +++ GL ++HS+ IV+
Sbjct: 61 LYCTF-QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 177 RDIKPANVLIN-EKMEHPCGYSCLYES--GEARHRKHGG--------------YNGFAAD 219
RD+K N+L++ + + E+ G+A+ G YN + D
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN-TSVD 178
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD-----FIR 274
WSFGV + E+ +G PF +E F S+ + + P P + + +D F+R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-----DNPCYPRWLTREAKDILVKLFVR 233
Query: 275 CCLQKGDPSKRW-TASQLLSHPFL 297
+P +R + HPF
Sbjct: 234 ------EPERRLGVKGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 6/130 (4%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQTNSPYIVKCH 118
L+ LG+G+ TV+K + L ALKV M+ + G P +E ++L+ IV H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 119 QIF-TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
I TK + ++ + EYM + ++ G L + Q+L+GL Y+H ++I+HR
Sbjct: 70 DIIHTKET--LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 178 DIKPANVLIN 187
D+KP N+LI+
Sbjct: 128 DLKPQNLLIS 137
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 59/203 (29%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 63 QVLGQGNGGTVFK-VRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVK 116
+ +G+G G V++ V A+ V C T P+ QE I+RQ + P+IVK
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ T+ V I+ME G L Y+ ++ L + S Q+ L Y+ S+ V
Sbjct: 72 LIGVITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV 129
Query: 176 HRDIKPANVLINEKMEHPC------GYSCLYESGEARHRKHG------------GYNGF- 216
HRDI NVL++ C G S E G + F
Sbjct: 130 HRDIAARNVLVSSP---DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 217 -AADIWSFGVTMMELYM-GYYPF 237
A+D+W FGV M E+ M G PF
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 43/214 (20%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ-----------CDRGTPPNPQELNILR 107
E ++V+G+G G V V+ K T +YA+K++ C R +E N+L
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR------EERNVLV 56
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGL 166
+ +I H F + + ++M+Y G L + K RL ED+ +++ +
Sbjct: 57 NGDCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI 115
Query: 167 FYMHSRNIVHRDIKPANVL--INEKMEHPCGYSCL------------------YESGE-- 204
+H + VHRDIKP NVL +N + SCL Y S E
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 205 -ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF 237
A G Y G D WS GV M E+ G PF
Sbjct: 176 QAMEDGMGKY-GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 66/250 (26%), Positives = 99/250 (39%), Gaps = 65/250 (26%)
Query: 101 QELNILRQTNSPYIVKCHQIFT-KPSG----EVSILMEYMDAGSLEIYVKSRG-RLSEDI 154
+EL +L+ ++ +FT SG + ++M YM +I G LSED
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI----MGHPLSEDK 118
Query: 155 ICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH--RKHGG 212
+ + Q+L GL Y+HS I+HRD+KP N+ +NE E + + G ARH + G
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELK-----ILDFGLARHADAEMTG 173
Query: 213 Y-----------------NGFAADIWSFGVTMMELYMGYYPFL----------------E 239
Y DIWS G M E+ G F
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
Query: 240 PGQEPDFLSLMLAICFRE-PPSLPECSSEKFR-----------DFIRCCLQKGDPSKRWT 287
PG P+F+ + + SLP+ + F D + L+ D KR T
Sbjct: 234 PG--PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLEL-DVDKRLT 290
Query: 288 ASQLLSHPFL 297
A++ L HP+
Sbjct: 291 ATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 70/256 (27%), Positives = 107/256 (41%), Gaps = 55/256 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ-----------CDRGTPPNPQELNILRQ 108
E L+V+G+G G V V+ K T +YA+K++ C R +E ++L
Sbjct: 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR------EERDVLVN 57
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGS-LEIYVKSRGRLSEDIICTISRQVLKGLF 167
+ +I H F + + ++M+Y G L + K RL ED+ +++ +
Sbjct: 58 GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPCGY-------SCL------------------YES 202
+H VHRDIKP NVL+++ G+ SCL Y S
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDK-----NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 203 GE---ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM-LAICFREP 258
E A G Y G D WS GV M E+ G PF + +M F+ P
Sbjct: 172 PEILQAMEDGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230
Query: 259 PSLPECSSEKFRDFIR 274
P + + SE+ +D IR
Sbjct: 231 PDVTDV-SEEAKDLIR 245
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 58/250 (23%), Positives = 111/250 (44%), Gaps = 44/250 (17%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--PQELNILRQTNSPYIVKCHQIFT 122
LG G G V++ K + + A+K+++ D +E+ L++ +++ + +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 123 KPSGE-VSILMEYMDAGSLEIYVKS-RGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
GE V I+ E M+ GSL +++S G+ L + ++ QV +G+ Y+ +N +HRD+
Sbjct: 73 --VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDL 130
Query: 180 KPANVLINEKMEHPCGYSC-LYESGEARHRK----------------------HGGYNGF 216
N+L+ E C + + G AR K HG ++
Sbjct: 131 AARNILVGE------DLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST- 183
Query: 217 AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
+D+WSFG+ + E++ G P+ PG + + +R P +C E ++ + C
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY--PGMNNHEVYDQITAGYRM-PCPAKCPQEIYKIMLEC 240
Query: 276 CLQKGDPSKR 285
+P R
Sbjct: 241 --WAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 73/318 (22%), Positives = 117/318 (36%), Gaps = 88/318 (27%)
Query: 46 AASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNI 105
AS G + ++ L G+ G VF LK+ Q E +
Sbjct: 63 VASLGYTV--------IKTLTPGSEGRVFVATKPGQPDPVVLKIGQ----KGTTLIEAML 110
Query: 106 LRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLK 164
L+ N P +++ T SG ++ ++ + L Y+ R L D I +Q+L+
Sbjct: 111 LQNVNHPSVIRMKD--TLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILE 168
Query: 165 GLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHR---------------- 208
GL Y+H++ I+HRD+K N+ IN+ + C+ + G A+
Sbjct: 169 GLRYLHAQRIIHRDVKTENIFINDVDQ-----VCIGDLGAAQFPVVAPAFLGLAGTVETN 223
Query: 209 -----KHGGYNGFAADIWSFGVTMMELYMGYYP---FLEPGQEPD---------FLSLM- 250
YN ADIWS G+ + E M YP F +P P+ L ++
Sbjct: 224 APEVLARDKYNS-KADIWSAGIVLFE--MLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280
Query: 251 -LAICFREPPSLPECSSEKFRDFIR------------CCLQK----------------GD 281
L + E P P S R FI C Q+ D
Sbjct: 281 TLKVHPEEFPRDPG--SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338
Query: 282 PSKRWTASQLLSHPFLAD 299
+ R +A ++L++P A
Sbjct: 339 AAMRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-10
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 57 SQLEKLQVLGQGNGGTVFK---VRHKQTLAL-YALKVMQCDRGTPPNPQELN----ILRQ 108
++L KL++LG G GTV K + ++ + A+K +Q DR QE+ +
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEITDHMLAMGS 65
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLF 167
+ YIV+ I P + ++ + GSL +V + R L + Q+ KG++
Sbjct: 66 LDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 168 YMHSRNIVHRDIKPANVLINEKME------------HPCGYSCLYESGE------ARHRK 209
Y+ +VHR++ N+L+ +P Y + A
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 210 HGGYNGFAADIWSFGVTMMELYMGY----YPFLEPGQEPDFL 247
G +D+WS+GVT+ E+ M Y Y + P + PD L
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEM-MSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 80/319 (25%), Positives = 119/319 (37%), Gaps = 90/319 (28%)
Query: 61 KLQV-LGQG--NGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-------N 110
+LQV +G+G N +V+ RH T L +++ + + L L+
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFR 57
Query: 111 SPYIVKCHQIFTKPS--GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
P I+ +FT S +S M Y A SL G +SE +I I L+GL Y
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNY 116
Query: 169 MHSRNIVHRDIKPANVLINEK-MEHPCGYSCLYE-------------------------S 202
+H +HR+IK +++LI+ + G S LY S
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 203 GEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLE-------------PGQEPDFLSL 249
E + GYN +DI+S G+T EL G PF + P P ++
Sbjct: 177 PELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235
Query: 250 -------------------------------MLAICFREPPSLPECSSEKFRDFIRCCLQ 278
M + R P + S F++ + CLQ
Sbjct: 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS--SKTFSPAFQNLVELCLQ 293
Query: 279 KGDPSKRWTASQLLSHPFL 297
+ DP KR +AS LLSH F
Sbjct: 294 Q-DPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 16/143 (11%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGTP-PNPQELNILR---QTN 110
Q E + +G G GTV+K R + +AL +++V + G P +E+ +L+ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 111 SPYIVK----CHQIFTKPSGEVSILMEYMDAGSLEIY---VKSRGRLSEDIICTISRQVL 163
P IV+ C T +V+++ E++D L Y V G L + I + RQ L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 164 KGLFYMHSRNIVHRDIKPANVLI 186
+GL ++H+ IVHRD+KP N+L+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 24/154 (15%)
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQ 161
E IL N P+ V + F K + +++E++ G +++ R D+ C + Q
Sbjct: 81 ERKILNYINHPFCVNLYGSF-KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY-------- 213
++ Y+ S NIV+RD+KP N+L+++ G+ + + G A+ Y
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKD-----GFIKMTDFGFAKVVDTRTYTLCGTPEY 194
Query: 214 ----------NGFAADIWSFGVTMMELYMGYYPF 237
+G AAD W+ G+ + E+ +G PF
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 65/278 (23%)
Query: 63 QVLGQGNGGTV-----FKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSP 112
+ LG+G G V F+++ + A+K+++ + E N+L+Q N P
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK--ENASSSELRDLLSEFNLLKQVNHP 63
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVK--------------SRGRLSED----- 153
+++K + ++ G + +++EY GSL +++ +R D
Sbjct: 64 HVIKLYGACSQ-DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 154 -----IICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE--KME-HPCGYSC-LYESGE 204
+ + + Q+ +G+ Y+ +VHRD+ NVL+ E KM+ G S +YE
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 205 ARHRKHGG---------------YNGFAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLS 248
R G Y +D+WSFGV + E+ +G P+ PG P+ L
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPY--PGIAPERLF 239
Query: 249 LMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKR 285
+L +R E P CS E + + C Q +P KR
Sbjct: 240 NLLKTGYRMERPE--NCSEEMYNLMLTCWKQ--EPDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 36/145 (24%), Positives = 70/145 (48%), Gaps = 26/145 (17%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM-QCD---RG-TPPNPQELNILRQTNSPYI 114
E ++V+G+G G V V+ K T +YA+K + + + + E +IL + ++P++
Sbjct: 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM----- 169
VK + F + + ++MEY+ G + + + +E+ + FY+
Sbjct: 64 VKLYYSFQDEN-YLYLIMEYLPGGDMMTLLMKKDTFTEE----------ETRFYIAETIL 112
Query: 170 -----HSRNIVHRDIKPANVLINEK 189
H +HRDIKP N+L++ K
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAK 137
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPY 113
+ +VLG+G G V + + T +YA K ++ R G E IL + NS +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHS 171
+V + + +++ M+ G L+ ++ + G E+ + ++L GL +H
Sbjct: 62 VVNLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 172 RNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHG--GY----------NGF 216
N V+RD+KP N+L+++ G + GE+ + G GY
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 217 AADIWSFGVTMMELYMGYYPF 237
+ D W G + E+ G PF
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 67/264 (25%), Positives = 118/264 (44%), Gaps = 35/264 (13%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKC 117
L+ ++ LG G G V+ + A+K ++ +P + +E I+++ +V+
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL 66
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGR-LSEDIICTISRQVLKGLFYMHSRNIV 175
+ + ++ + I+ EYM GSL ++K GR L + ++ QV G+ Y+ N +
Sbjct: 67 YAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 176 HRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG------------YNGFA- 217
HRD++ AN+L+ + + C G + L E E R+ Y F
Sbjct: 125 HRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 218 -ADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
+D+WSFG+ + EL G P+ PG + + +R P P+ + +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPY--PGMNNREVLEQVERGYRMP--CPQDCPISLHELMLQ 238
Query: 276 CLQKGDPSKRWTASQLLSHPFLAD 299
C +K DP +R T L S FL D
Sbjct: 239 CWKK-DPEERPTFEYLQS--FLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 35/196 (17%)
Query: 65 LGQGNGGTVFKVRHKQ------TLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCH 118
LG GN G+V K + +A+ LK G +E +++ Q + P IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+ + ++ME G L Y+K R + + ++ QV G+ Y+ S++ VHRD
Sbjct: 63 GVCKGEP--LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRD 120
Query: 179 IKPANVLINEK---------MEHPCGYSCLYESGEARHRKHG------------GYNGF- 216
+ NVL+ + M G S R G Y F
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALGAG----SDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 217 -AADIWSFGVTMMELY 231
+D+WS+GVT+ E +
Sbjct: 177 SKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 36/263 (13%)
Query: 61 KLQV-LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCH 118
+L+V LGQG G V+ T + A+K ++ +P QE ++++ +V+ +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY 67
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRG----RLSEDIICTISRQVLKGLFYMHSRNI 174
+ ++ + I+ EYM GSL ++K RL + + ++ Q+ G+ Y+ N
Sbjct: 68 AVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQ--LVDMAAQIASGMAYVERMNY 123
Query: 175 VHRDIKPANVLINEKMEHPC---GYSCLYESGEARHRKHG--------------GYNGFA 217
VHRD++ AN+L+ E + G + L E E R+ G
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 218 ADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
+D+WSFG+ + EL G P+ PG + + +R P PEC E D + C
Sbjct: 184 SDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVERGYRMPCP-PEC-PESLHDLMCQC 239
Query: 277 LQKGDPSKRWTASQLLSHPFLAD 299
+K +P +R T L FL D
Sbjct: 240 WRK-EPEERPTFEYL--QAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-09
Identities = 48/192 (25%), Positives = 86/192 (44%), Gaps = 27/192 (14%)
Query: 65 LGQGNGGTV----FKVRHKQT-LALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQ 119
LG GN G V +K+R KQ +A+ LK +E I+ Q ++PYIV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR--M 60
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
I + + ++ME G L ++ + ++ + + QV G+ Y+ +N VHRD
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 179 IKPANVL-INEKMEHPC--GYSCLYESGEARHRKHGG--------------YNGFA--AD 219
+ NVL +N+ G S + ++ ++ + F+ +D
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSD 180
Query: 220 IWSFGVTMMELY 231
+WS+G+TM E +
Sbjct: 181 VWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 47/266 (17%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTN 110
EID S ++ L+ LG G G V++ T + A+K ++ P + E I+++
Sbjct: 2 EIDRTS-IQLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPKDFLAEAQIMKKLR 59
Query: 111 SPYIVKCHQIFTKPSGE-VSILMEYMDAGSLEIYVKSRG----RLSEDIICTISRQVLKG 165
P +++ + + T E + I+ E M GSL Y++ +L + I ++ QV G
Sbjct: 60 HPKLIQLYAVCTL--EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASG 115
Query: 166 LFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-LYESGEAR-------HRKHGG----- 212
+ Y+ ++N +HRD+ NVL+ E C + + G AR + G
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGE------NNICKVADFGLARVIKEDIYEAREGAKFPIK 169
Query: 213 --------YNGFA--ADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSL 261
YN F+ +D+WSFG+ + E+ G P+ PG + + +R P
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY--PGMTNAEVLQQVDQGYRMPC-- 225
Query: 262 PECSSEKFRDFIRCCLQKGDPSKRWT 287
P ++ D + C K DP R T
Sbjct: 226 PPGCPKELYDIMLDCW-KEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 70/316 (22%), Positives = 115/316 (36%), Gaps = 85/316 (26%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNS 111
S K++ +G G G V VR T ALYA+K ++ N E +IL + ++
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
++VK + F + + +M+Y+ G + + G ED+ ++ + +H
Sbjct: 61 EWVVKLYYSF-QDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK 119
Query: 172 RNIVHRDIKPANVLIN---------------------------------EKMEHPCGYS- 197
+HRDIKP N+LI+ + ME +S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 198 ---CLYESGEARH-RKH----------------------GGYNGFAADIWSFGVTMMELY 231
C + E R R+H GY D WS GV + E+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ-LCDWWSVGVILYEML 238
Query: 232 MGYYPFLE--PGQEPDFLSLMLAICFREPPSLPECS--SEKFRDFIR--CCLQKGDPSKR 285
+G PFL P + + + I + +P + S + D I CC R
Sbjct: 239 VGQPPFLADTPAE-----TQLKVINWETTLHIPSQAKLSREASDLILRLCC----GAEDR 289
Query: 286 W---TASQLLSHPFLA 298
A ++ +HPF
Sbjct: 290 LGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 59/253 (23%), Positives = 115/253 (45%), Gaps = 39/253 (15%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIV 115
L +L +++G+G G V + + T A+K ++CD +E ++ + + +V
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDII--CTISRQVLKGLFYMHSRN 173
+ + + I+ME M G+L ++++RGR +I S V +G+ Y+ S+
Sbjct: 63 RLLGVILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 174 IVHRDIKPANVLINEKMEHPCGYSCLYESGEARHR-------------------KHGGYN 214
+VHRD+ N+L++E G + + + G AR KH ++
Sbjct: 121 LVHRDLAARNILVSED-----GVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFS 175
Query: 215 GFAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSEKFRDF 272
+D+WS+GV + E++ G P+ P + + +R EPP C ++ +
Sbjct: 176 S-KSDVWSYGVLLWEVFSYGRAPY--PKMSLKEVKECVEKGYRMEPPE--GCPADVYV-L 229
Query: 273 IRCCLQKGDPSKR 285
+ C + +P KR
Sbjct: 230 MTSCWET-EPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 35/133 (26%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 65 LGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFT 122
+G+G G V+K + K + YALK ++ + +E+ +LR+ P ++ ++F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 123 KPSG-EVSILMEYMDAGSLEIYVKSRG--------RLSEDIICTISRQVLKGLFYMHSRN 173
S +V +L +Y + I R +L ++ ++ Q+L G+ Y+H+
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 174 IVHRDIKPANVLI 186
++HRD+KPAN+L+
Sbjct: 129 VLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 40/163 (24%), Positives = 81/163 (49%), Gaps = 34/163 (20%)
Query: 101 QELNILRQTNSPYIVKCHQIFT--KPSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICT 157
+E ++ + + P +V+ + + T KP + I+ E+M+ G L Y++ R G+LS+D++ +
Sbjct: 48 EEAKVMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLS 104
Query: 158 ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH-------RKH 210
+ + V +G+ Y+ + +HRD+ N L++ G + + G R+
Sbjct: 105 MCQDVCEGMEYLERNSFIHRDLAARNCLVSST-----GVVKVSDFGMTRYVLDDEYTSSS 159
Query: 211 GG-------------YNGFA--ADIWSFGVTMMELYM-GYYPF 237
G ++ ++ +D+WSFGV M E++ G PF
Sbjct: 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 47/207 (22%), Positives = 90/207 (43%), Gaps = 37/207 (17%)
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
P +V H+ V +++++ + G L ++ + E+ + + +++ L +H
Sbjct: 45 PNMVCLHKYIVSEDS-VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR 103
Query: 172 RNIVHRDIKPANVLINE----KMEHPCGYSCLYES--GEARHRKH-----GGYNGF--AA 218
IV RD+ P N+L+++ ++ + +S + +S GEA + GG + A
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEAC 163
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM----LAICFREPPSLPECSSEKFRDFIR 274
D WS G + EL G +L+ I ++PE SE+ R ++
Sbjct: 164 DWWSLGAILFELLTG-------------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQ 210
Query: 275 CCLQKGDPSKRWTA-----SQLLSHPF 296
LQ +P++R A + SHPF
Sbjct: 211 QLLQF-NPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 67 QGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYIVKCHQIF 121
+G G V+ R K LYA+KV++ N E + L + SP+IV H +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIV--HLYY 71
Query: 122 TKPSGE-VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
+ S V ++MEY+ G ++ + G E++ +V L Y+H I+HRD+K
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 181 PANVLINEK 189
P N+LI+ +
Sbjct: 132 PDNMLISNE 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 33/215 (15%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ------TNSPYIVK 116
+VLG+G+ G V K T +YA+KV++ D + + + + P++
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
H F + +MEY++ G L ++ + E + +V L ++H +++
Sbjct: 61 LHCCFQTKD-RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 177 RDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN---------------------G 215
RD+K N+L++ + G+ L + G + G G
Sbjct: 120 RDLKLDNILLDAE-----GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250
+ D W+ GV M E+ G PF ++ F S++
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 35/258 (13%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCHQIFTK 123
LGQG G V+ T + A+K ++ P QE I+++ +V + + ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 124 PSGEVSILMEYMDAGSLEIYVKS-RGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
+ I+ E+M GSL ++K G+ L + ++ Q+ G+ Y+ N +HRD++
Sbjct: 73 EP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 182 ANVLINEKMEHPC-----GYSCLYESGEARHRKHG--------------GYNGFAADIWS 222
AN+L+ + + C G + L E E R+ G +D+WS
Sbjct: 131 ANILVGDNL--VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 223 FGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGD 281
FG+ + EL G P+ PG + + +R P P+ E + ++ C +K D
Sbjct: 189 FGILLTELVTKGRVPY--PGMVNREVLEQVERGYRMP--CPQGCPESLHELMKLCWKK-D 243
Query: 282 PSKRWTASQLLSHPFLAD 299
P +R T + S FL D
Sbjct: 244 PDERPTFEYIQS--FLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 43/214 (20%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ-----------CDRGTPPNPQELNILR 107
E L+V+G+G G V V+ K ++A+K++ C R +E ++L
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR------EERDVLV 56
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGL 166
++ +I H F + + ++M+Y G L + K RL ED+ +++ +
Sbjct: 57 NGDNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 167 FYMHSRNIVHRDIKPANVL--INEKMEHPCGYSC--LYESG------------------- 203
+H + VHRDIKP N+L +N + SC L E G
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 204 EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF 237
+A G Y G D WS GV M E+ G PF
Sbjct: 176 QAMEDGKGKY-GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 38/209 (18%)
Query: 57 SQLEKLQVLGQGNGGTVF--KVRHKQTLALYALK--VMQCDRGTPPNPQELNILRQTNSP 112
S+L L+ LG G G V K R K +A+ ++ M D +E ++ + + P
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFI----EEAKVMMKLSHP 59
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHS 171
+V+ + + TK + I+ EYM G L Y++ R G+L + + + V + + Y+ S
Sbjct: 60 NLVQLYGVCTK-QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 172 RNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR------HRKHGG------------- 212
+HRD+ N L+ E + + G AR + G
Sbjct: 119 NGFIHRDLAARNCLVGED-----NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 213 -YNGFA--ADIWSFGVTMMELY-MGYYPF 237
Y+ F+ +D+WSFGV M E++ G P+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 59/219 (26%)
Query: 62 LQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTNS 111
+ LG+G G VF + + L A+K ++ + + E +L
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELLTNFQH 67
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG--------------RLSEDIICT 157
IVK + + T+ ++ EYM+ G L +++S G L+ +
Sbjct: 68 ENIVKFYGVCTE-GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 158 ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------YSCLYESGEARHRK 209
I+ Q+ G+ Y+ S++ VHRD+ N L+ + G Y+ Y +
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-------YR 179
Query: 210 HGG---------------YNGFA--ADIWSFGVTMMELY 231
GG Y F +D+WSFGV + E++
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 40/208 (19%)
Query: 63 QVLGQGNGGTVFK--VRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIV 115
++LG+GN G VFK ++ K +A V C P E IL+Q + P IV
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVA-----VKTCKEDLPQELKIKFLSEARILKQYDHPNIV 55
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
K + T+ + I+ME + G ++ K + L + + G+ Y+ S+N
Sbjct: 56 KLIGVCTQRQ-PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 175 VHRDIKPANVLINE------------KMEHPCGYSCL--------YESGEARHRKHGGYN 214
+HRD+ N L+ E + E YS + + EA + +G Y+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN--YGRYS 172
Query: 215 GFAADIWSFGVTMMELY-MGYYPFLEPG 241
+D+WS+G+ + E + +G P+ PG
Sbjct: 173 S-ESDVWSYGILLWETFSLGVCPY--PG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 15/143 (10%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQT----LALYALKVMQCDRGTPPNP-QELNILRQTNS- 111
Q E + +G+G G VFK R + +AL ++V + G P + +E+ +LR +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 112 --PYIVK----CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVL 163
P +V+ C T +++++ E++D L Y+ + + I + Q+L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 164 KGLFYMHSRNIVHRDIKPANVLI 186
+GL ++HS +VHRD+KP N+L+
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILV 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 9e-08
Identities = 34/133 (25%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 65 LGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIF- 121
+G+G G V+K + K + YALK ++ + +E+ +LR+ P ++ ++F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 122 TKPSGEVSILMEYMDAGSLEIYVKSRG--------RLSEDIICTISRQVLKGLFYMHSRN 173
+ +V +L +Y + I R +L ++ ++ Q+L G+ Y+H+
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 174 IVHRDIKPANVLI 186
++HRD+KPAN+L+
Sbjct: 129 VLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 34/133 (25%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELN--------ILRQTNSPYI 114
+V+G+G+ G V + K YA+KV+Q + N +E +L+ P++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQ--KKIVLNRKEQKHIMAERNVLLKNVKHPFL 58
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V H F + + ++ ++++++ G L +++ E + ++ L Y+HS NI
Sbjct: 59 VGLHYSF-QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 175 VHRDIKPANVLIN 187
V+RD+KP N+L++
Sbjct: 118 VYRDLKPENILLD 130
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 60/265 (22%), Positives = 108/265 (40%), Gaps = 32/265 (12%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKC 117
+VLG+G G V + + T +YA K ++ R G E IL + NS ++V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 118 HQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNI 174
+ TK + + +++ M+ G L+ ++ + G E + ++ GL + I
Sbjct: 66 AYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 175 VHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHG--GYNG----------FAAD 219
V+RD+KP N+L++++ G + GE + G GY F+ D
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPD 183
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQK 279
W G + E+ G PF + + + + + E SE + R L K
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-EDQEEYSEKFSEDAKSICRMLLTK 242
Query: 280 GDPSKRW-----TASQLLSHPFLAD 299
+P +R A+ + HP +
Sbjct: 243 -NPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPS----GEVSILMEYMDAGSLEIYVKSRGRLSEDIIC 156
+E+ +LR P IV+ I PS ++ ++ E M++ L +K+ L+ +
Sbjct: 48 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQ 106
Query: 157 TISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187
Q+L+ L Y+H+ N+ HRD+KP N+L N
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNILAN 137
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 35/152 (23%), Positives = 72/152 (47%), Gaps = 25/152 (16%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTIS 159
+E ++ + + P +V+ + + T+ S + ++ E+M+ G L Y+++ RG+ S++ + +
Sbjct: 48 EEAQVMMKLSHPKLVQLYGVCTERS-PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 160 RQVLKGLFYMHSRNIVHRDIKPANVLINEKM--------------------EHPCGYSCL 199
V +G+ Y+ S N++HRD+ N L+ E +
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166
Query: 200 YESGEARHRKHGGYNGFAADIWSFGVTMMELY 231
+ S E Y+ +D+WSFGV M E++
Sbjct: 167 WSSPEV--FSFSKYSS-KSDVWSFGVLMWEVF 195
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 53/229 (23%), Positives = 83/229 (36%), Gaps = 52/229 (22%)
Query: 56 LSQLEKLQVLGQGNGGTVFK--------VRHKQTLALYALKVMQCDRGTPPNPQ----EL 103
LS + L+ LG+G G V+K ++A+ LK + P Q E
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK----ENAEPKVQQEFRQEA 59
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG--------------- 148
++ P IV + TK +L EY+ G L ++
Sbjct: 60 ELMSDLQHPNIVCLLGVCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 149 -RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGE 204
L I+ Q+ G+ Y+ S + VHRD+ N L+ E + G S S +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 205 ARHRKHGG-------------YNGFA--ADIWSFGVTMMELY-MGYYPF 237
+ Y F +DIWSFGV + E++ G P+
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKC 117
+VLG+G G V + + T +YA K ++ R G E IL + NS ++V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 118 HQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNI 174
+ TK + + +++ M+ G L+ ++ G E + ++ GL +H I
Sbjct: 66 AYAYETKDA--LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG----------GYNG--------- 215
V+RD+KP N+L+++ G+ + + G A H G GY
Sbjct: 124 VYRDLKPENILLDDH-----GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 216 -FAADIWSFGVTMMELYMGYYPF 237
F+ D W+ G + E+ G PF
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 65/303 (21%), Positives = 112/303 (36%), Gaps = 94/303 (31%)
Query: 56 LSQLEKLQVLGQGNGGTVFKV--------RHKQTLALYALKVMQCDRGTPPNPQEL---- 103
+L + LG+G G V K T+A+ LK ++ E+
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK 70
Query: 104 ------NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR---------- 147
NI+ + C Q G + +++EY G+L ++++R
Sbjct: 71 MIGKHKNIIN-----LLGVCTQ-----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120
Query: 148 ------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---------- 191
L++ + + + QV +G+ ++ S+ +HRD+ NVL+ E
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
Query: 192 --HPCGYSCLYESGEARHRKHGGYNG------------------FAADIWSFGVTMMELY 231
H Y +RK NG +D+WSFGV + E++
Sbjct: 181 DIHHIDY----------YRKTT--NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 232 -MGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTAS 289
+G P+ PG + L +L +R E P C+ E + C PS+R T
Sbjct: 229 TLGGSPY--PGIPVEELFKLLKEGYRMEKPQN--CTQELYHLMRDC--WHEVPSQRPTFK 282
Query: 290 QLL 292
QL+
Sbjct: 283 QLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 6/133 (4%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVK 116
++V+G+G G V V+ K T +YA+K + + E ++L +++SP++V
Sbjct: 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ F + + + ++ME++ G L + SED+ + + + +H +H
Sbjct: 66 LYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH 124
Query: 177 RDIKPANVLINEK 189
RDIKP N+LI+
Sbjct: 125 RDIKPDNILIDRG 137
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 44/220 (20%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTL-----ALYALKVMQCDRGTPPNPQ------ELNI 105
S L+++ LG+G G VF + K L +K +Q T EL++
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ---KTKDENLQSEFRRELDM 61
Query: 106 LRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGR--------LSEDIIC 156
R+ + +V+ + + IL EY D G L+ +++ ++ + LS
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMIL-EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 157 TISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL----YESGEARHRKH-- 210
+ Q+ G+ ++ + VHRD+ N L++ + E L Y S + R
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 211 ------------GGYNGFAADIWSFGVTMMELY-MGYYPF 237
++ +D+WSFGV M E++ G PF
Sbjct: 181 PLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 35/136 (25%), Positives = 67/136 (49%), Gaps = 6/136 (4%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPY 113
E L+V+G+G G V V+ K T +YA+K+++ E +IL + + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
+VK F + + ++ME++ G + + + LSE+ + + + +H
Sbjct: 63 VVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 174 IVHRDIKPANVLINEK 189
+HRDIKP N+L++ K
Sbjct: 122 FIHRDIKPDNLLLDAK 137
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPY 113
E L+V+G+G G V V+ K T +YA+K+++ E +IL + +S +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
+VK F + + ++ME++ G + + + L+E+ + + + +H
Sbjct: 63 VVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 174 IVHRDIKPANVLINEK 189
+HRDIKP N+L++ K
Sbjct: 122 FIHRDIKPDNLLLDSK 137
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 48/202 (23%), Positives = 92/202 (45%), Gaps = 32/202 (15%)
Query: 57 SQLEKLQVLGQGNGGTVFK---VRHKQTLAL-YALKVMQCDRGTPPNPQELN---ILRQT 109
++ +K++VLG G GTV+K + + + + A+K ++ N + L+ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFY 168
++P++ C + + V ++ + M G L YV+ + + + Q+ KG+ Y
Sbjct: 67 DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 169 MHSRNIVHRDIKPANVLINEKMEH----PCGYSCLYESGEARHRKHGG------------ 212
+ R +VHRD+ NVL+ +H G + L + E + GG
Sbjct: 125 LEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 213 ----YNGFAADIWSFGVTMMEL 230
Y +D+WS+GVT+ EL
Sbjct: 184 LHRIYT-HQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 56/248 (22%), Positives = 107/248 (43%), Gaps = 39/248 (15%)
Query: 65 LGQGNGGTVFKV---RHKQTLALYALK--VMQCDRGTPPNPQELNILRQTNSPYIVKCHQ 119
LG G G V++ ++ T+A+ LK M+ + +E ++++ P +V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLLG 69
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSED--IICTISRQVLKGLFYMHSRNIVHR 177
+ T+ I+ E+M G+L Y++ R + ++ ++ Q+ + Y+ +N +HR
Sbjct: 70 VCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 178 DIKPANVLINE-KMEHPCGYSCLYESGEARHRKHGG--------------YNGFA--ADI 220
D+ N L+ E + + + H G YN F+ +D+
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 221 WSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFR--EPPSLPECSSEKFRDFIRCCL 277
W+FGV + E+ G P+ PG + + +L +R P P K + +R C
Sbjct: 189 WAFGVLLWEIATYGMSPY--PGIDLSQVYELLEKGYRMERPEGCP----PKVYELMRACW 242
Query: 278 QKGDPSKR 285
Q +PS R
Sbjct: 243 Q-WNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 36/136 (26%), Positives = 64/136 (47%), Gaps = 6/136 (4%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNS 111
S K++ LG G G V R T ALYA+K ++ N E +IL + ++
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
++V+ + F + + +M+Y+ G + + G ED+ ++ + +H
Sbjct: 61 EWVVRLYYSF-QDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK 119
Query: 172 RNIVHRDIKPANVLIN 187
+HRDIKP N+LI+
Sbjct: 120 MGFIHRDIKPDNILID 135
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 30/165 (18%)
Query: 152 EDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-MEHPCGYSC---LYE------ 201
ED+IC S QV KG+ ++ SR +HRD+ N+L++E + C + +Y+
Sbjct: 179 EDLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237
Query: 202 SGEAR--------HRKHGGYNGFAADIWSFGVTMMELY-MGYYPFLEPGQEPD---FLSL 249
G+AR +D+WSFGV + E++ +G P+ PG + D L
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRL 295
Query: 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
R P + E ++ + C G+PS+R T S+L+ H
Sbjct: 296 KEGTRMRAPDY---TTPEMYQTMLDC--WHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 56/234 (23%)
Query: 101 QELNILRQTNSPYIVKCHQI-FTKPSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICT 157
+E I+ + +++ + + T P V+ E GSL ++ G +C
Sbjct: 45 KEAAIMHSLDHENLIRLYGVVLTHPLMMVT---ELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 158 ISRQVLKGLFYMHSRNIVHRDIKPANVL-------------------INEKM----EH-- 192
+ Q+ G+ Y+ S+ +HRD+ N+L NE EH
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161
Query: 193 -PCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL-- 249
P + C ES R H A+D+W FGVT+ E M Y G+EP + L
Sbjct: 162 VPFAW-CAPESLRTRTFSH------ASDVWMFGVTLWE--MFTY-----GEEP-WAGLSG 206
Query: 250 --MLAICFREPPSL--PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+L +E L PE + + + C +P+ R T + L FL +
Sbjct: 207 SQILKKIDKEGERLERPEACPQDIYNVMLQCWAH-NPADRPTFAAL--REFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 66/265 (24%), Positives = 99/265 (37%), Gaps = 72/265 (27%)
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLE--IYVKSRGRLSEDIICTIS 159
EL++ + N P IV F E+ ++ +M GS + I +SE I I
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYIL 107
Query: 160 RQVLKGLFYMHSRNIVHRDIKPANVLIN----------------------EKMEHPC-GY 196
+ VLK L Y+H VHR +K +++LI+ ++ H Y
Sbjct: 108 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY 167
Query: 197 SCL---YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLE-------------- 239
S + S E + GY+ +DI+S G+T EL G+ PF +
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 226
Query: 240 ----------PGQE----PDFLSLMLAIC-----FREPPSLPECS--------SEKFRDF 272
P +E P + PS E S S F F
Sbjct: 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
+ CLQ+ +P R +AS LL+H F
Sbjct: 287 VEQCLQR-NPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 63/259 (24%), Positives = 104/259 (40%), Gaps = 51/259 (19%)
Query: 59 LEKLQVLGQGNGGTVFK--VRHKQTLALYALKVMQCDRGTPPNPQ-------ELNILRQT 109
+ L+ LG G G V++ R + A+ L+V + Q E I+ +
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAV-ELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGRLSE-------DIICTISRQ 161
N IV+ + + IL+E M G L+ +++ +R R D++ +R
Sbjct: 67 NHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL-FCARD 124
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR-------HRKHG--- 211
V KG Y+ + +HRDI N L+ K P + + + G AR +RK G
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCK--GPGRVAKIADFGMARDIYRASYYRKGGRAM 182
Query: 212 -------------GYNGFAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFR- 256
G D+WSFGV + E++ +GY P+ PG+ + + R
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY--PGRTNQEVMEFVTGGGRL 240
Query: 257 EPPSLPECSSEKFRDFIRC 275
+PP C +R C
Sbjct: 241 DPP--KGCPGPVYRIMTDC 257
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR----LSEDIICT 157
EL+ L + IVK F K ++ ++MEY G L +K R + E +
Sbjct: 115 ELHCLAACDHFGIVKHFDDF-KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 158 ISRQVLKGLFYMHSRNIVHRDIKPANVLIN----------------------EKMEHPCG 195
+ Q++ L +HSR ++HRD+K AN+ + + CG
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 196 YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF 255
+ Y + E RK Y+ AD+WS GV + EL + PF P Q +M + +
Sbjct: 234 -TPYYLAPELWERKR--YSK-KADMWSLGVILYELLTLHRPFKGPSQR----EIMQQVLY 285
Query: 256 REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ P S + + L K +P+ R T QLL FL
Sbjct: 286 GKYDPFPCPVSSGMKALLDPLLSK-NPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 19/36 (52%), Positives = 25/36 (69%)
Query: 154 IICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK 189
II TI RQ+L L +HS IVHRD+KP N++ +E
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291
|
Length = 566 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 57/259 (22%), Positives = 111/259 (42%), Gaps = 58/259 (22%)
Query: 63 QVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGTPPNPQEL----NILRQTNSPYIV 115
++LG+G G+V + + K + A+K+++ D + + +E +++ + P ++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 116 KC--HQIFTKPSGEVSILM---EYMDAGSLEIYVKSRGRLSEDIICTISRQVL------- 163
K + ++ G + I M +M G L ++ R+ E+ T+ Q L
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM-SRIGEEPF-TLPLQTLVRFMIDI 122
Query: 164 -KGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY--NGFA--- 217
G+ Y+ S+N +HRD+ N ++NE M C+ + G ++ G Y G A
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENMT-----VCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 218 ------------------ADIWSFGVTMMELY-MGYYPFLEPGQEPD--FLSLMLAICFR 256
+D+W+FGVTM E+ G P+ G E + L+ +
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY--AGVENSEIYNYLIKGNRLK 235
Query: 257 EPPSLPECSSEKFRDFIRC 275
+P P+C + + +C
Sbjct: 236 QP---PDCLEDVYELMCQC 251
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 28/162 (17%)
Query: 152 EDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-KMEHPCGY---------SCLYE 201
ED++ + S QV KG+ ++ S+N +HRD+ N+L+ ++ C + S
Sbjct: 214 EDLL-SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272
Query: 202 SGEAR-----HRKHGGYN---GFAADIWSFGVTMMELY-MGYYPFLEPGQEPD--FLSLM 250
G AR +N F +D+WS+G+ + E++ +G P+ PG D F M
Sbjct: 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY--PGMPVDSKFYK-M 329
Query: 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292
+ +R PEC+ + D ++ C DP KR T Q++
Sbjct: 330 IKEGYRMLS--PECAPSEMYDIMKSCWD-ADPLKRPTFKQIV 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 3/88 (3%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTIS 159
E +LR+ + P ++ + + G ++ L+ L Y+ +R R L + ++
Sbjct: 209 HEARLLRRLSHPAVLALLDV--RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 160 RQVLKGLFYMHSRNIVHRDIKPANVLIN 187
RQ+L + Y+H I+HRDIK NVL+N
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVN 294
|
Length = 461 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 60/278 (21%)
Query: 63 QVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGTPPNPQEL-------------NIL 106
++LG+G G+V + + Q + A+K M+ D T +E N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 107 RQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSR-GRLSEDI----ICTISR 160
+ + Q KP +++ +M G L ++ SR G L E + +
Sbjct: 65 KLIGVCFEASSLQKIPKPM----VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY--NGFAA 218
+ G+ Y+ +RN +HRD+ N ++ E M C+ + G ++ G Y G A
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMT-----VCVADFGLSKKIYSGDYYRQGRIA 175
Query: 219 ---------------------DIWSFGVTMME-LYMGYYPFLEPGQEPDFLSLMLAICFR 256
D+W+FGVTM E G P+ + L +
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235
Query: 257 EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+P +C E + C + DP R T ++L
Sbjct: 236 QP---EDCLDELYDLMYSC--WRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 57/228 (25%)
Query: 101 QELNILRQTNSPYIVK----CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR------- 149
+E +++ N P IVK C + +P I+ME M+ G L Y++
Sbjct: 48 KEAHLMSNFNHPNIVKLLGVC--LLNEP---QYIIMELMEGGDLLSYLRDARVERFGPPL 102
Query: 150 LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------- 198
L+ + I V KG Y+ + +HRD+ N L++EK GY
Sbjct: 103 LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-----GYDADRVVKIGDFGL 157
Query: 199 ---LYESGEARHRKHG--------------GYNGFAADIWSFGVTMME-LYMGYYPFLEP 240
+Y+S R G G +D+WSFGV M E L +G P+ P
Sbjct: 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--P 215
Query: 241 GQEP-DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWT 287
+ L + A + P C +K + C + DPS+R T
Sbjct: 216 ALNNQEVLQHVTAGGRLQKP--ENC-PDKIYQLMTNCWAQ-DPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 56/209 (26%)
Query: 126 GEVSILMEYMDAGSLEIYVKSR-----------GRLSEDIIC-----TISRQVLKGLFYM 169
G + +++EY G+L ++++R ++ E+ + + + QV +G+ Y+
Sbjct: 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150
Query: 170 HSRNIVHRDIKPANVLINEK--MEHPCGYSCLYESGEARHRKHGGY-----NG------- 215
SR +HRD+ NVL+ E M+ + + G AR Y NG
Sbjct: 151 ESRRCIHRDLAARNVLVTEDNVMK-------IADFGLARGVHDIDYYKKTSNGRLPVKWM 203
Query: 216 -----------FAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFR-EPPSLP 262
+D+WSFG+ M E++ +G P+ PG + L +L R + P
Sbjct: 204 APEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY--PGIPVEELFKLLREGHRMDKP--S 259
Query: 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQL 291
C+ E + +R C P++R T QL
Sbjct: 260 NCTHELYM-LMRECWH-AVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 26/87 (29%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQ 161
E++IL+ + I+ + S ++ +Y L YV G L + TI R+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINE 188
+L+ L Y+H R I+HRD+K N+ ++E
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDE 220
|
Length = 392 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 43/199 (21%)
Query: 125 SGEVSILMEYMDAGSLEIYVKSRGRL---SEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
G + ++ EY G L +++ + ED++ S QV KG+ ++ S+N +HRD+
Sbjct: 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS-FSYQVAKGMAFLASKNCIHRDLAA 169
Query: 182 ANVLINE-KMEHPCGYSCLYESGEARHRKHGG--------------------YNG---FA 217
NVL+ K+ C + G AR + +N F
Sbjct: 170 RNVLLTHGKIVKICDF------GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 223
Query: 218 ADIWSFGVTMMELY-MGYYPFLEPGQEPD--FLSLMLAICFREPPSLPECSSEKFRDFIR 274
+D+WS+G+ + E++ +G P+ PG D F ++ +R + PE + + D ++
Sbjct: 224 SDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYK-LIKEGYRM--AQPEHAPAEIYDIMK 278
Query: 275 CCLQKGDPSKRWTASQLLS 293
C DP KR T Q++
Sbjct: 279 TCWDA-DPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISR 160
E L Q + IV+ + T+ + + I+ EYM G+L+ ++ K G+L + +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGN-TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESG-EARHRKHGG---- 212
+ G+ Y+ VH+ + VL+N + C G+ L E EA + G
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAIYTTMSGKSPV 172
Query: 213 ---------YNGF--AADIWSFGVTMME-LYMGYYPFLEPGQEPDFLSLMLAI--CFREP 258
Y+ F A+D+WSFG+ M E + G P+ + + ++ A+ FR P
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKAVEDGFRLP 228
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
P + C QK + +R SQ+ S
Sbjct: 229 A--PRNCPNLLHQLMLDCWQK-ERGERPRFSQIHS 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 46/205 (22%), Positives = 86/205 (41%), Gaps = 39/205 (19%)
Query: 65 LGQGNGGTVFKVR-----HKQTLALYALKVMQ--CDRGTPPNPQELNILRQTNSPYIVKC 117
LG+G G VF +Q L A+K ++ D +E +L +IVK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-------------RLSEDIICTISRQVLK 164
+ + + + ++ EYM G L ++++ G L++ + I++Q+
Sbjct: 73 YGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 165 GLFYMHSRNIVHRDIKPANVLINEKMEHPCG-YSCLYESGEARHRKHGG----------- 212
G+ Y+ S++ VHRD+ N L+ E + G + + + + GG
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191
Query: 213 ----YNGFA--ADIWSFGVTMMELY 231
Y F +D+WS GV + E++
Sbjct: 192 ESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 32/138 (23%), Positives = 53/138 (38%), Gaps = 41/138 (29%)
Query: 130 ILMEYMDAGSLEIYVKSRGRLSEDIIC---TISRQVLK--------GLFYMHSRNIVHRD 178
++MEYM+ G L +++ + + C ++S L G+ Y+ S N VHRD
Sbjct: 96 MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155
Query: 179 IKPANVLINEKMEHPCGYSC----------LYESGEARHRKH--------------GGYN 214
+ N L+ Y+ LY S R + G
Sbjct: 156 LATRNCLVG------KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF 209
Query: 215 GFAADIWSFGVTMMELYM 232
+D+W+FGVT+ E+
Sbjct: 210 TTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 20/145 (13%)
Query: 56 LSQLEKLQVLGQGNGGTV---FKVRHKQTLALYALK-----VMQCDRGTPPNPQELNILR 107
L + + L+ +G G G V + Q +A+ L V R +EL +++
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY----RELVLMK 70
Query: 108 QTNSPYIVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQV 162
N I+ +FT +V ++ME MDA ++ + L + + + Q+
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYLLYQM 127
Query: 163 LKGLFYMHSRNIVHRDIKPANVLIN 187
L G+ ++HS I+HRD+KP+N+++
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVK 152
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 38/210 (18%)
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQV 162
+++ Q + ++ H + + S E ++ E+++ G L++ + K +GR+ T+++Q+
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGS-ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQL 126
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINE-----------KMEHPCGYSCLYESGEARHRK-- 209
L Y+ +N+VH ++ N+L+ K+ P G S S E R +
Sbjct: 127 ASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDP-GVSFTALSREERVERIP 185
Query: 210 --------HGGYNGFAADIWSFGVTMMEL-YMGYYPFLE--PGQEPDFLSLMLAICFREP 258
G AAD WSFG T++E+ + G P E P ++ F + +
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF--------YEKK 237
Query: 259 PSLPECSSEKFRDFIRCCLQ---KGDPSKR 285
LPE S ++ I CL PS R
Sbjct: 238 HRLPEPSCKELATLISQCLTYEPTQRPSFR 267
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 26/91 (28%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDII 155
+EL +L+ N I+ +FT +V ++ME MDA ++ L + +
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERM 125
Query: 156 CTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186
+ Q+L G+ ++HS I+HRD+KP+N+++
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 156
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 54/227 (23%), Positives = 99/227 (43%), Gaps = 48/227 (21%)
Query: 56 LSQLEKLQVLGQGNGGTVFK-------VRHKQTLALYALKVMQCDRGTPPNPQELNILRQ 108
LS + ++ LG+ G ++K + H Q +A+ LK + + QE +++ +
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICT----------- 157
+ P IV + T+ V +L EY++ G L ++ R S D+ C+
Sbjct: 64 LHHPNIVCLLGVVTQEQ-PVCMLFEYLNQGDLHEFLIMRSPHS-DVGCSSDEDGTVKSSL 121
Query: 158 -------ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSC-LYESGEAR 206
I+ Q+ G+ Y+ S VH+D+ N+LI E++ G S +Y + R
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 207 HRK---------------HGGYNGFAADIWSFGVTMMELY-MGYYPF 237
+ +G ++ +DIWSFGV + E++ G P+
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 52/208 (25%)
Query: 126 GEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYM 169
G + +++EY G+L Y+++R +LS + + + QV +G+ Y+
Sbjct: 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY-----NG--------- 215
S+ +HRD+ NVL+ E + + G AR H Y NG
Sbjct: 157 ASKKCIHRDLAARNVLVTED-----NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 211
Query: 216 ---------FAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPEC 264
+D+WSFGV + E++ +G P+ PG + L +L R + PS C
Sbjct: 212 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEELFKLLKEGHRMDKPS--NC 267
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLL 292
++E + +R C PS+R T QL+
Sbjct: 268 TNELYM-MMRDCWH-AVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 23/58 (39%), Positives = 32/58 (55%)
Query: 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186
L E+M AG + + ++I + RQVL GL +H IVHRDIKP N+L+
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV 342
|
Length = 507 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 26/91 (28%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDII 155
+EL +++ N I+ +FT +V I+ME MDA ++ + L + +
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERM 128
Query: 156 CTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186
+ Q+L G+ ++HS I+HRD+KP+N+++
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTIS 159
+E ++ + + +V+ + + TK + I+ EYM G L Y++ G R + +
Sbjct: 48 EEAKVMMKLSHEKLVQLYGVCTKQR-PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 160 RQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYNGFA-- 217
+ V +G+ Y+ S+ +HRD+ N L++++ G + + G +R+ Y
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQ-----GCVKVSDFGLSRYVLDDEYTSSVGS 161
Query: 218 --------------------ADIWSFGVTMMELY-MGYYPF--LEPGQEPDFLSLMLAIC 254
+D+W+FGV M E+Y +G P+ + + +S L +
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL- 220
Query: 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
+R P +SEK + C + +R T QLLS
Sbjct: 221 YR-----PHLASEKVYAIMYSCWHE-KAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 39/160 (24%)
Query: 65 LGQGNGGTVFKVRH-----KQTLALYALKVMQCDRGTPPNP---QELNILRQTNSPYIVK 116
+GQG G VF+ R + + A+K+++ + +E ++ + + P IVK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 117 ----CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG----------------------RL 150
C KP + +L EYM G L +++ R L
Sbjct: 73 LLGVC--AVGKP---MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 151 SEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190
S I++QV G+ Y+ R VHRD+ N L+ E M
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM 167
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 34/136 (25%), Positives = 64/136 (47%), Gaps = 6/136 (4%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ----CDRGTPPNPQ-ELNILRQTNS 111
S K++ LG G G V T ALYA+K ++ +R + + E +IL + ++
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
++VK + F + + +M+Y+ G + + E + ++ + +H
Sbjct: 61 EWVVKLYYSF-QDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119
Query: 172 RNIVHRDIKPANVLIN 187
+HRDIKP N+LI+
Sbjct: 120 MGFIHRDIKPDNILID 135
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 25/91 (27%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDII 155
+EL +++ N I+ +FT +V ++ME MDA ++ + L + +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMELDHERM 121
Query: 156 CTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186
+ Q+L G+ ++HS I+HRD+KP+N+++
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 17/60 (28%), Positives = 32/60 (53%), Gaps = 4/60 (6%)
Query: 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE 188
I+MEY++ L+ + S G ++ I R V K +HS I+H D+ +N++++
Sbjct: 75 IIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSG 130
|
Length = 211 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 56/210 (26%)
Query: 126 GEVSILMEYMDAGSLEIYVKSR-----------GRLSED-------IICTISRQVLKGLF 167
G + +++EY G+L Y+++R R+ ++ + CT QV +G+
Sbjct: 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY--QVARGME 151
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY-----NG------- 215
Y+ S+ +HRD+ NVL+ E + + G AR + Y NG
Sbjct: 152 YLASQKCIHRDLAARNVLVTEN-----NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWM 206
Query: 216 -----------FAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFR-EPPSLP 262
+D+WSFGV M E++ +G P+ PG + L +L R + P+
Sbjct: 207 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEELFKLLKEGHRMDKPA-- 262
Query: 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292
C++E + +R C PS R T QL+
Sbjct: 263 NCTNELYM-MMRDCWH-AIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 33/162 (20%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIY-----VKSRGRLSEDII 155
+E+ I+ + +P I++ + + ++ EYM+ G L + ++S + +I
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 156 CT-------ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEA 205
++ Q+ G+ Y+ S N VHRD+ N L+ G S SG+
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD- 183
Query: 206 RHRKHG----------------GYNGFAADIWSFGVTMMELY 231
+R G G A+D+W+FGVT+ E++
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 12/90 (13%)
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE--CSSEKFRDF 272
G A D W+ G+ + E+ G PF ++ F +++ ++ + P S RD
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL-----KKEVTFPGSPPVSSSARDL 264
Query: 273 IRCCLQKGDPSKR---WT-ASQLLSHPFLA 298
IR L K DPSKR A+++ HPF
Sbjct: 265 IRKLLVK-DPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 32/164 (19%)
Query: 152 EDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-MEHPCGYSC---LYE------ 201
ED+IC S QV +G+ ++ SR +HRD+ N+L++E + C + +Y+
Sbjct: 174 EDLIC-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232
Query: 202 SGEAR--------HRKHGGYNGFAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLA 252
G AR +D+WSFGV + E++ +G P+ PG + +
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY--PGVQIN-----EE 285
Query: 253 IC--FREPPSL--PECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292
C ++ + PE ++ + + C Q GDP +R T S L+
Sbjct: 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQ-GDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 29/120 (24%), Positives = 52/120 (43%), Gaps = 5/120 (4%)
Query: 80 QTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134
T A+K+++ D + +E + + P IV P G + + EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC 194
+ +L + + G L + QVL L H++ IVHRD+KP N+++++ P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 56/252 (22%), Positives = 104/252 (41%), Gaps = 65/252 (25%)
Query: 63 QVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVK 116
+ LG+G G+V + + Q +A+ +K+ C R + E +++ + P +++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 117 ----CHQIFTKPSGEVS--ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLK------ 164
C Q + G S +++ +M G L ++ RL + ++ ++K
Sbjct: 65 LIGVCLQT-VESEGYPSPVVILPFMKHGDLHSFLLY-SRLGDCPQYLPTQMLVKFMTDIA 122
Query: 165 -GLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY--NGFAA--- 218
G+ Y+ S++ +HRD+ N ++NE M C+ + G ++ +G Y G A
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMN-----VCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 219 ------------------DIWSFGVTMMEL-------YMGY-----YPFLEPG----QEP 244
D+WSFGVTM E+ Y G Y +L G Q P
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237
Query: 245 DFLSLMLAICFR 256
D L + ++
Sbjct: 238 DCLDGLYSLMSS 249
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 68/274 (24%), Positives = 113/274 (41%), Gaps = 71/274 (25%)
Query: 65 LGQGNGGTVFKV--------RHKQTLALYALKVMQCDRGTPPNPQ-ELNILRQTNSPYIV 115
LG+G G VF + K +A+ ALK + + Q E +L +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQREAELLTVLQHQHIV 70
Query: 116 KCHQIFTKPSGEVSILM-EYMDAGSLEIYVKSRG------RLSEDIIC---------TIS 159
+ + + T+ G +++ EYM G L +++S G ED+ I+
Sbjct: 71 RFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 160 RQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR------HRKHGG- 212
Q+ G+ Y+ S + VHRD+ N L+ + + G + G +R + + GG
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIG-----DFGMSRDIYSTDYYRVGGR 183
Query: 213 --------------YNGFA--ADIWSFGVTMMELYMGYYPFLEPGQEPDF-LSLMLAI-C 254
Y F +DIWSFGV + E++ G++P + LS AI C
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT-------YGKQPWYQLSNTEAIEC 236
Query: 255 F---REPPSLPECSSEKFRDFIRCCLQKGDPSKR 285
RE C E + ++ C Q+ +P +R
Sbjct: 237 ITQGRELERPRTCPPEVY-AIMQGCWQR-EPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 45/204 (22%), Positives = 80/204 (39%), Gaps = 52/204 (25%)
Query: 74 FKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQTNSPYIVKCHQIFTKPSGEVSI 130
F VR + L L A+K+++ D +E+ IL + P I++ + + +
Sbjct: 39 FNVRKGRPL-LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDPLCM 96
Query: 131 LMEYMDAGSLEIYVKSRGRL-------------------SEDIICTISRQVLKGLFYMHS 171
+ EYM+ G L ++ S S + ++ Q+ G+ Y+ S
Sbjct: 97 ITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156
Query: 172 RNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYNGF--------------- 216
N VHRD+ N L+ E + + + G +R+ G Y
Sbjct: 157 LNFVHRDLATRNCLVGENLTIK-----IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC 211
Query: 217 --------AADIWSFGVTMMELYM 232
A+D+W+FGVT+ E+ M
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 37/169 (21%), Positives = 68/169 (40%), Gaps = 48/169 (28%)
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDI------ 154
+E+ I+ + P I++ + S + ++ EYM+ G L ++ SR E
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCIT-SDPLCMITEYMENGDLNQFL-SRHEPQEAAEKADVV 125
Query: 155 ------ICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---LYESGEA 205
+ ++ Q+ G+ Y+ S N VHRD+ N L+ G + + + G +
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV--------GKNYTIKIADFGMS 177
Query: 206 RHRKHGGYNGF-----------------------AADIWSFGVTMMELY 231
R+ G Y A+D+W+FGVT+ E+
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 55/214 (25%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALK-VMQCDRGTPPNPQ----ELNILRQTNSPYIVKCH 118
++G G+ G V++ T A+K V+Q +PQ EL I++ N I+
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQ-------DPQYKNRELLIMKNLNHINIIFLK 125
Query: 119 QIFTKPSGE-------VSILMEYMDAGSLEIYVKSRGR----LSEDIICTISRQVLKGLF 167
+ + ++++ME++ ++ Y+K R L ++ S Q+ + L
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 168 YMHSRNIVHRDIKPANVLINEKM-----------------EHPCGYSC--LYES-----G 203
Y+HS+ I HRD+KP N+LI+ + Y C Y + G
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 204 EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF 237
+ H D+WS G + E+ +GY F
Sbjct: 245 ATNYTTH-------IDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 33/153 (21%)
Query: 105 ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQV 162
I++ + P ++ I G +++ YM G L +++S +D+I QV
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-GFGLQV 107
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR----------HRKHGG 212
KG+ Y+ S+ VHRD+ N +++E + G AR H G
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCMLDESFTVKVA-----DFGLARDIYDKEYYSVHNHTGA 162
Query: 213 -------------YNGFA--ADIWSFGVTMMEL 230
F +D+WSFGV + EL
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 32/166 (19%)
Query: 152 EDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-MEHPCGYSC---LYE------ 201
ED+I S QV +G+ ++ SR +HRD+ N+L++E + C + +Y+
Sbjct: 173 EDLIS-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 202 SGEAR--------HRKHGGYNGFAADIWSFGVTMMELY-MGYYPFLEPG--QEPDFLSLM 250
G+AR +D+WSFGV + E++ +G P+ PG + +F
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY--PGVQIDEEFCRR- 288
Query: 251 LAICFREPPSL--PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+E + PE ++ + + C +P R T S+L+
Sbjct: 289 ----LKEGTRMRAPEYATPEIYSIMLDCWH-NNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 37/177 (20%), Positives = 63/177 (35%), Gaps = 20/177 (11%)
Query: 138 GSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY 196
SL ++ RGR L+E+ I + Q L L +H + + + L+ +
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGS--VAF 58
Query: 197 SCLYESGEAR------HRKHGGYNGFAADIWSFGVTMMELYMGYY---PFLEPGQEPDFL 247
+S + Y ADI+S G+T+ E Y E
Sbjct: 59 KTPEQSRPDPYFMAPEVIQGQSY-TEKADIYSLGITLYE--ALDYELPYNEERELSAILE 115
Query: 248 SLMLAICFREPPSLPE----CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
L+ + +P ++ F DF+R C + P +R A+ L+H A
Sbjct: 116 ILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASR-LPQRREAANHYLAHCRALFA 171
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 44/194 (22%), Positives = 79/194 (40%), Gaps = 46/194 (23%)
Query: 130 ILMEYMDAGSLEIYVK----------------SRGRLSEDIICTISRQVLKGLFYMHSRN 173
++ EYM G L +++ ++G L + I+ Q+ G+ Y+ S++
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143
Query: 174 IVHRDIKPANVLINEKMEHPCG-YSCLYESGEARHRKHGG---------------YNGFA 217
VHRD+ N L+ + G + + + + GG Y F
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 203
Query: 218 --ADIWSFGVTMMELYMGYYPFLEPGQEPDF-LSLMLAI-CFREPPSL--PECSSEKFRD 271
+D+WSFGV + E++ G++P F LS I C + L P ++ D
Sbjct: 204 TESDVWSFGVILWEIFT-------YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYD 256
Query: 272 FIRCCLQKGDPSKR 285
+ C Q+ +P +R
Sbjct: 257 IMLGCWQR-EPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 52/208 (25%)
Query: 126 GEVSILMEYMDAGSLEIYVKSRG-----------RLSEDII-----CTISRQVLKGLFYM 169
G + +L+EY G+L Y+++R +L E+ + + + QV +G+ Y+
Sbjct: 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGY-----NG--------- 215
S+ +HRD+ NVL+ E + + G AR + Y NG
Sbjct: 151 ASQKCIHRDLAARNVLVTED-----NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205
Query: 216 ---------FAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPEC 264
+D+WSFGV + E++ +G P+ PG + L +L R + P+ C
Sbjct: 206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY--PGIPVEELFKLLKEGHRMDKPA--NC 261
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLL 292
+ E + +R C PS+R T QL+
Sbjct: 262 THELYM-IMRECWH-AVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 34/134 (25%), Positives = 56/134 (41%), Gaps = 36/134 (26%)
Query: 158 ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEA------RHRKHG 211
I +Q+L + Y+H + ++HRDIK N+ +N G L + G A R
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-----GKIVLGDFGTAMPFEKEREAFDY 326
Query: 212 GYNGFAA----------------DIWSFGVTMMELYMGYYPFL-------EPGQEPDFLS 248
G+ G A DIWS G+ +++ M + F +PG++ +
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLD--MLSHDFCPIGDGGGKPGKQLLKII 384
Query: 249 LMLAICFREPPSLP 262
L++C E P P
Sbjct: 385 DSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 31/115 (26%)
Query: 150 LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-KMEHPCGYSCLYESGEARHR 208
LS + S QV G+ ++ S+N VHRD+ NVLI E K+ C + G AR
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF------GLARDI 289
Query: 209 KHGG--------------------YNGF---AADIWSFGVTMMELY-MGYYPFLE 239
+N +D+WSFG+ + E++ +G P+ E
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 34/149 (22%), Positives = 62/149 (41%), Gaps = 37/149 (24%)
Query: 117 CHQIFTKPSGEVS------ILMEYMDAGSLEIYVKS--------RGRLSEDI--ICTISR 160
CH + + G VS ++ME M G L+ Y++S GR + + ++
Sbjct: 68 CHHV-VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----SCLYESGEARH--------- 207
++ G+ Y++++ VHRD+ N ++ G +YE+ R
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 208 ------RKHGGYNGFAADIWSFGVTMMEL 230
K G + +D+WSFGV + E+
Sbjct: 187 WMAPESLKDGVFTTS-SDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 300 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 98.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.75 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.68 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.51 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.29 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.13 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.0 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.96 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.79 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.75 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.71 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.52 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.65 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.97 | |
| PLN02236 | 344 | choline kinase | 94.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.09 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.01 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.52 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.45 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.37 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.33 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 92.38 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.6 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.48 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 88.8 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 88.63 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.11 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 88.04 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 80.41 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-58 Score=385.18 Aligned_cols=243 Identities=30% Similarity=0.412 Sum_probs=210.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---------CCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---------PNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
.+.|.+.+.||+|+||.|-+|..++|++.||||++++..... ...+|+++|++++|||||+++++|+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d- 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD- 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence 356889999999999999999999999999999997643221 1258999999999999999999999876
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC--------------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-------------- 192 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-------------- 192 (300)
+.||||||++||+|.+.+..++.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+...
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 889999999999999999999999999999999999999999999999999999999999876221
Q ss_pred -------CccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 193 -------PCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 193 -------~~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
.+.++..|-+||......-..+..++||||+||+||-+++|.+||.+....+...+.+........+..+..+
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I 409 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI 409 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence 1234667888888765544445569999999999999999999999887777666666555555566677889
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+++..+||.+||.. ||++|||++|+|+||||+++
T Consensus 410 seea~dlI~~mL~V-dP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 410 SEEALDLINWMLVV-DPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hHHHHHHHHHhhEe-CcccCcCHHHHhcChhhhcc
Confidence 99999999999999 99999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-54 Score=355.90 Aligned_cols=240 Identities=48% Similarity=0.767 Sum_probs=211.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++.+.++.||+|..|+||+++++.|++.+|+|++...... .+..+|+++++..+||+||.+|+.|..+...++|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 45778899999999999999999999999999999543322 233679999999999999999999987642499999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCc-----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPC----------------- 194 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~----------------- 194 (300)
|||++|+|.+++...+++++.....++.++++||.|||+ .+|+||||||+|||++.++..++
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tf 237 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTF 237 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccc
Confidence 999999999999988899999999999999999999995 89999999999999999877532
Q ss_pred cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCCchHHHHHHHHhhCCCCCCCCC-CChHHHHH
Q 040812 195 GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP-GQEPDFLSLMLAICFREPPSLPEC-SSEKFRDF 272 (300)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 272 (300)
.++..|++||-.. |..|+.++||||||++++|+++|+.||... .....+.+.+..+..+.+|.+|.. +++++++|
T Consensus 238 vGT~~YMsPERi~---g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 238 VGTSAYMSPERIS---GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred cccccccChhhhc---CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 2355566666544 778999999999999999999999999765 345677888888999999999997 99999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||++ ||.+|||+.|+++|||+++
T Consensus 315 V~~CL~K-dp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 315 VSCCLRK-DPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred HHHHhcC-CcccCCCHHHHhcCHHHhh
Confidence 9999999 9999999999999999975
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=369.37 Aligned_cols=232 Identities=30% Similarity=0.435 Sum_probs=201.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+|...+.||+|||+.+|.+++..+|+.||+|++.+.... ....+|+++.++|+|||||+++++|++.. ++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-NVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-ceEEE
Confidence 5799999999999999999999999999999999764333 33467999999999999999999999876 99999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL------------ 199 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~------------ 199 (300)
+|+|..++|..+++.+..++|.+++.+++||+.||.|||+++|+|||||..|+|++++...++|++++
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 99999999999999888999999999999999999999999999999999999999998877766555
Q ss_pred -------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 200 -------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 200 -------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
|.+||... ....+..+||||+||+||-||+|++||... ...+.... .......+|..++.++++|
T Consensus 177 TlCGTPNYIAPEVl~---k~gHsfEvDiWSlGcvmYtLL~G~PPFetk----~vkety~~-Ik~~~Y~~P~~ls~~A~dL 248 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLN---KSGHSFEVDIWSLGCVMYTLLVGRPPFETK----TVKETYNK-IKLNEYSMPSHLSAEAKDL 248 (592)
T ss_pred eecCCCcccChhHhc---cCCCCCchhhhhhhhHHHhhhhCCCCcccc----hHHHHHHH-HHhcCcccccccCHHHHHH
Confidence 44444444 334567899999999999999999999542 22233332 2355677888999999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
|.++|+. ||.+|||++++|.|+||.
T Consensus 249 I~~lL~~-~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 249 IRKLLRP-NPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHhcC-CcccCCCHHHHhcCHhhh
Confidence 9999999 999999999999999994
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=362.14 Aligned_cols=238 Identities=28% Similarity=0.402 Sum_probs=204.5
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhc-CCCceeEeceeeeCCCC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQT-NSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 126 (300)
.....+|..++.||+|+|++|++|+++.+++.||||++.+.... +-...|-.+|.+| .||+|++|+..|.++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~- 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE- 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence 55678899999999999999999999999999999998754332 2235699999999 8999999999999876
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG----------- 195 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~----------- 195 (300)
.+|+|+||+++|+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||++.++...+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 899999999999999999999999999999999999999999999999999999999999988765322
Q ss_pred ---------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh
Q 040812 196 ---------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC 254 (300)
Q Consensus 196 ---------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 254 (300)
++..|-+||... .+..++.+|+|+||||+|+|+.|.+||...++...+..++
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~---~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~---- 300 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLN---DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ---- 300 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhc---CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH----
Confidence 233344444443 4456779999999999999999999998766544443333
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.....+|...++.++|||+++|.. ||++|+|+++|.+||||+++
T Consensus 301 -~l~y~fp~~fp~~a~dLv~KLLv~-dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 301 -ALDYEFPEGFPEDARDLIKKLLVR-DPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred -HhcccCCCCCCHHHHHHHHHHHcc-CccccccHHHHhhCcccccC
Confidence 345677888899999999999999 99999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=347.35 Aligned_cols=238 Identities=31% Similarity=0.487 Sum_probs=206.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC-----CHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-----NPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
.+.++|++++.||+|+||+|++++.+++++.||+|++++...... ...|..+|.+++||.||.++..|++.. .+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-kL 100 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-KL 100 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-eE
Confidence 456889999999999999999999999999999999987554332 357999999999999999999999865 99
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP--------------- 193 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~--------------- 193 (300)
|+|+||+.||.|...+++.+.|++..++.++..|+.||.|||++||+||||||+|||++.++...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999886642
Q ss_pred ----ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 194 ----CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 194 ----~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+.++.-|++||... +..++..+|+||||+++|||+||.+||...+.. +.+..+.....+..|..++.+.
T Consensus 181 ~t~tfcGT~eYmAPEil~---~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----~~~~~I~~~k~~~~p~~ls~~a 253 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILL---GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----KMYDKILKGKLPLPPGYLSEEA 253 (357)
T ss_pred ccccccCCccccChHHHh---cCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----HHHHHHhcCcCCCCCccCCHHH
Confidence 23455677777766 557888999999999999999999999765433 4444444444466677799999
Q ss_pred HHHHHHHhccCCCCCCC----CHHHHhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRW----TASQLLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rp----t~~~~l~hpw~~~~ 300 (300)
++++.++|+. ||++|. ++.++.+||||+++
T Consensus 254 rdll~~LL~r-dp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 254 RDLLKKLLKR-DPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHHHHhcc-CHHHhcCCCCChHHhhcCcccccC
Confidence 9999999999 999996 69999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=338.76 Aligned_cols=240 Identities=28% Similarity=0.438 Sum_probs=200.9
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
....++|.+.+.||+|+||+||+|+++.++..||||.+.+...... ...|+++|+.++|||||++++++..++ ++
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-FI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-eE
Confidence 3456789999999999999999999999999999999976653322 246999999999999999999988865 99
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC-CC--------CCcc----
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-ME--------HPCG---- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~-~~--------~~~~---- 195 (300)
|+|||||.||+|.+|++.++.+++..++.++.||+.||++||+++|+||||||+|||++.. .. .++|
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999875 21 1222
Q ss_pred -----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 196 -----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 196 -----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
++.+|++||... ...|+.|+|+||+|+|+|+|++|+.||...+..+-. . .........+..+..
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~---~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~-~-~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIM---SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL-L-YIKKGNEIVPVLPAE 239 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHH---hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH-H-HHhccccccCchhhh
Confidence 466688888765 345788999999999999999999999765443222 1 122233445666777
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+..+.+++...++. ||..|.+..+.+.|+++..
T Consensus 240 ~s~~~~~Ll~~ll~~-~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 240 LSNPLRELLISLLQR-NPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ccCchhhhhhHHHhc-CccccCchHHhhhhhhccc
Confidence 888888999999999 9999999999999998753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=326.91 Aligned_cols=237 Identities=28% Similarity=0.460 Sum_probs=205.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+++|+.++.||.|+||.|.+++.+.+|..+|+|++...... +...+|..+|+.+.||+++++++.+.+.. ++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eE
Confidence 4678999999999999999999999999999999999765433 23467999999999999999999988765 99
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
||||||.+||.|..++++.++|++..++.++.||+.||+|||+.+|++|||||+|||+|.++..++.
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 9999999999999999999999999999999999999999999999999999999999998775332
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++.-|.+||... ...++.++|+|||||++|||+.|.+||...+.. .+...+. .....+|...++++++|
T Consensus 200 TlCGTPeYLAPEii~---sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----~iY~KI~-~~~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQ---SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----QIYEKIL-EGKVKFPSYFSSDAKDL 271 (355)
T ss_pred EecCCccccChHHhh---cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----HHHHHHH-hCcccCCcccCHHHHHH
Confidence 244466666655 556788999999999999999999999876653 3333333 45678899999999999
Q ss_pred HHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 273 IRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 273 i~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
|..+|+. |-.+|. ...++.+||||+++
T Consensus 272 l~~LL~v-D~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 272 LKKLLQV-DLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHhh-hhHhhhcCcCCCccccccCcccccc
Confidence 9999999 999994 58899999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=347.90 Aligned_cols=242 Identities=30% Similarity=0.391 Sum_probs=200.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcC-CCceeEeceeeeCCCCcEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTN-SPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 129 (300)
...++|.++++||.|+||.||+|+.+.++..||||.++...... ..++|+..|++++ ||||+++.+++.+....+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 44678999999999999999999999999999999987654332 2268999999999 9999999999877654899
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 130 ILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
+|||||+. +|.++++.++ .|++..++.|+.||++||+|+|.+|+.|||+||+|||+..+...++++
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99999977 9999998765 599999999999999999999999999999999999999655544443
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC----------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS---------- 260 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------- 260 (300)
+..|.+||...+ .++|+.++||||+|||++|+.+-++.|.+.++.+.+.++...+.......
T Consensus 166 YTeYVSTRWYRAPEvLLr--s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLR--SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred cchhhhcccccchHHhhh--ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 444777777665 45889999999999999999999999977666555554444332111111
Q ss_pred ---------------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 261 ---------------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 261 ---------------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+-..++.++.++|.+||.. ||++||||+++|+||||+.
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~W-DP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAW-DPDKRPTASQALQHPFFQV 296 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcC-CCccCccHHHHhcCccccc
Confidence 1122578899999999999 9999999999999999974
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=343.51 Aligned_cols=238 Identities=32% Similarity=0.486 Sum_probs=200.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-------CCCCCHHHHHHHHhcC-CCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-------GTPPNPQELNILRQTN-SPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 125 (300)
...++|++.+.||+|+||+|++|++..+++.||+|++.... ......+|+.++++++ ||||+++++++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34678999999999999999999999999999999776541 1223357999999999 999999999999876
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC-CCCCc----------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-MEHPC---------- 194 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~-~~~~~---------- 194 (300)
.+|+|||||.||+|.+++...+++.+..++.+++||++|++|+|++||+||||||+|||++.+ +..++
T Consensus 94 -~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 -KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred -eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 699999999999999999998899999999999999999999999999999999999999987 54322
Q ss_pred ---------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 195 ---------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 195 ---------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
-++..|.+||...... .+.+.++||||+||+||.|++|+.||...+. ...... .......+|..+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~-~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~k-i~~~~~~~p~~~ 246 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKG-TYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRK-IRKGEFKIPSYL 246 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHH-HhcCCccCCCCc
Confidence 2344566666655321 1557899999999999999999999976322 222222 445667788888
Q ss_pred -ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 -SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 -~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.++++|+.+||.. ||.+|+++.++++||||+.
T Consensus 247 ~S~~~~~Li~~mL~~-~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVP-DPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCC-CcccCCCHHHHhhChhhcc
Confidence 99999999999999 9999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=324.82 Aligned_cols=239 Identities=26% Similarity=0.444 Sum_probs=189.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+.|+.+.++|+|+||.||+|++++||+.||||.|........ ..+|+++|++++|+|+|.++++|.... .+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-klhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-KLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-eeEEEe
Confidence 578999999999999999999999999999999975544332 268999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---cc-------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---GY------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---~~------------- 196 (300)
|||+..-|.++-.....++...++.++.|++.|+.|+|+++++||||||+|||++.++..+. |+
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 99998444444343446899999999999999999999999999999999999999876543 33
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---------CC-----
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---------PP----- 259 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------~~----- 259 (300)
+..|.+||.... ...|++++||||+||++.||+||.+.|.+..+-.....+......-. .+
T Consensus 161 YVATRWYRaPELLvG--DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 161 YVATRWYRAPELLVG--DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhccChhhhcc--cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 222444444331 25789999999999999999999999977665554444444322110 00
Q ss_pred CCC------------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 260 SLP------------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 260 ~~~------------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+| ...+.-+.||++.||.. ||.+|++.++++.||||.+
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~-dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKM-DPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcC-CccccccHHHHhcChHHHH
Confidence 011 12356789999999999 9999999999999999953
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=340.11 Aligned_cols=240 Identities=27% Similarity=0.380 Sum_probs=199.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
.+.++|++++.||+|+||.||+|+.+.||.++|+|++++..... ....|-.+|....+|+||+++..|.+.. ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-~L 216 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-YL 216 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-ee
Confidence 36788999999999999999999999999999999998754332 2356889999999999999999999876 99
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee----------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------- 198 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------- 198 (300)
||||||++||++.++|...+.|++..++.++.+++.|+..||+.|++||||||+|+|||..|..++.+++
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999987665333222
Q ss_pred --------------------------------------------------------eccccccccccCCCCCCchhhHHH
Q 040812 199 --------------------------------------------------------LYESGEARHRKHGGYNGFAADIWS 222 (300)
Q Consensus 199 --------------------------------------------------------~~~~~~~~~~~~~~~~~~~~DiwS 222 (300)
-|.+||... +..|+..+|+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll---~kgY~~~cDwWS 373 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL---GKGYGKECDWWS 373 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh---cCCCCccccHHH
Confidence 233333332 455677999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCC
Q 040812 223 FGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLAD 299 (300)
Q Consensus 223 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt---~~~~l~hpw~~~ 299 (300)
|||||||||.|.+||...+....+.+++.-.. ..........+++.+|||.+||. ||++|.. ++||.+||||++
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-~l~fP~~~~~s~eA~DLI~rll~--d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-TLKFPEEVDLSDEAKDLITRLLC--DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-hccCCCcCcccHHHHHHHHHHhc--CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999988777666655553221 11122223467999999999996 8999985 999999999987
Q ss_pred C
Q 040812 300 A 300 (300)
Q Consensus 300 ~ 300 (300)
+
T Consensus 451 v 451 (550)
T KOG0605|consen 451 V 451 (550)
T ss_pred C
Confidence 5
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=334.00 Aligned_cols=239 Identities=35% Similarity=0.545 Sum_probs=195.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCC-cEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSG-EVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~ 132 (300)
..+|...+.||+|+||.||++.+.++|...|||.+..... .+...+|+.+|.+++|||||+++|......+ .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4567889999999999999999999999999999865421 1224689999999999999999997544333 689999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-CCCCCc----------------
Q 040812 133 EYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-KMEHPC---------------- 194 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~-~~~~~~---------------- 194 (300)
||+++|+|.+++...+ .+++..++.+++||+.||.|||++|++||||||+|||++. ++..++
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999999999876 7999999999999999999999999999999999999988 443322
Q ss_pred ------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 195 ------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 195 ------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
-++..|++||.... |....+++|||||||++.||+||+.||... ................|.+|..++++
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~--g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRN--GEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccCCccccCchhhcC--CCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCCCcccCHH
Confidence 23455667776553 333446999999999999999999999753 11111222323334466889999999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.++||.+|+.. ||++|||++++|+|||+++
T Consensus 252 a~~Fl~~C~~~-~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 252 AKDFLRKCFKR-DPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHHhhc-CcccCcCHHHHhhChhhhc
Confidence 99999999999 9999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=337.18 Aligned_cols=240 Identities=30% Similarity=0.450 Sum_probs=196.2
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC----HHHHHHHHhcCCCceeEeceeeeCC-CCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILRQTNSPYIVKCHQIFTKP-SGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 128 (300)
...+.|+.+++||+|+||.||+|++..+|+.||+|.+..+.....+ .+||.+|+++.||||+++.+..... .+.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3456799999999999999999999999999999999877655544 6899999999999999999998765 5689
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee--------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL-------- 199 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~-------- 199 (300)
|||+|||++ +|.-++... -+|++.+++.+++||+.||.|+|.+||+|||||.+||||+.++..+++++++
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999998 888888764 4799999999999999999999999999999999999999998876655444
Q ss_pred ------------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC------C
Q 040812 200 ------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS------L 261 (300)
Q Consensus 200 ------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------~ 261 (300)
|.+||.... ...|+.++|+||.||||.||++|++.|.+.++...+..+. ..+...... +
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG--~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf-klcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLG--ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF-KLCGSPTEDYWPVSKL 349 (560)
T ss_pred CcccccceEEeeccChHHhcC--CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH-HHhCCCChhccccccC
Confidence 344444332 2467889999999999999999999997765543333332 222111111 1
Q ss_pred C-------------------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 262 P-------------------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 262 ~-------------------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
| ...++...+|+..+|.. ||.+|.|++++|+|+||.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~l-dP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSL-DPDKRGTASSALQSEYFT 404 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhcc-CccccccHHHHhcCcccc
Confidence 1 12367788999999999 999999999999999994
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=319.03 Aligned_cols=242 Identities=25% Similarity=0.348 Sum_probs=196.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC----HHHHHHHHhcCCCceeEeceeeeCC-CCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILRQTNSPYIVKCHQIFTKP-SGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 128 (300)
..++.|+.+..|++|+||.||+|+++.|++.||+|.++-+....-| ++||.+|.+.+|||||.+-++.... .+.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4567899999999999999999999999999999999876655444 7999999999999999998886533 2469
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee--------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL-------- 199 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~-------- 199 (300)
|+|||||+. +|..++..- .+|...+++.++.|++.|++|||...|+|||||++|+|++..+..+++++++
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999998 999999864 4899999999999999999999999999999999999999987765544433
Q ss_pred -----------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-----------
Q 040812 200 -----------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE----------- 257 (300)
Q Consensus 200 -----------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------- 257 (300)
|.+||.... ...|+.++||||+|||+.||+++++.|.+.........+........
T Consensus 232 k~~T~lVVTLWYRaPELLLG--~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLG--AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred ccCcceEEEeeecCHHHhcC--CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 344443332 34678899999999999999999999977665544444433221110
Q ss_pred ---------------CCCCCCC-CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 258 ---------------PPSLPEC-SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 258 ---------------~~~~~~~-~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...++.. +++...+|+..+|.. ||.+|.|++|.|+|+||.+
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~-dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTY-DPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhcc-CccccccHHHhhccccccc
Confidence 0112222 468899999999999 9999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=307.49 Aligned_cols=237 Identities=30% Similarity=0.446 Sum_probs=190.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+|...+.||+|.||.||+|++.++|+.||||.++.....+ ...+|++.|+.++|+||+.++++|.... .+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-NLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-ceEEEE
Confidence 57889999999999999999999999999999998654332 3478999999999999999999998765 899999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee------------
Q 040812 133 EYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL------------ 199 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~------------ 199 (300)
||++. +|+..++++. .++..+++.++.++++||+|||++.|+||||||.|+|+++++..+++++++
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99987 9999998754 589999999999999999999999999999999999999998765544333
Q ss_pred -------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC------------
Q 040812 200 -------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS------------ 260 (300)
Q Consensus 200 -------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------------ 260 (300)
|.+||.... ...|+..+||||.|||+.||+-|.+-|.+.++- +.+..+-.......+.
T Consensus 160 ~~V~TRWYRAPELLfG--sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFG--SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cceeeeeccChHHhcc--chhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCccccccccHH
Confidence 444444332 245788999999999999999987666554433 3333332221111111
Q ss_pred ------------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 261 ------------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 261 ------------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+-...++++.||+..|+.. ||.+|++++|+++|+||+.
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~y-nP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTY-NPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhcc-CchhcccHHHHhcchhhhc
Confidence 1122367789999999999 9999999999999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=339.67 Aligned_cols=235 Identities=29% Similarity=0.496 Sum_probs=201.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+-|++++.||.|+-|.|-+|++..||+.+|||++.+.... ....+|+-+|+-+.|||+++++++|++.. ++|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-HLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-eEEE
Confidence 45579999999999999999999999999999999765322 23468999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-----------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL----------- 199 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~----------- 199 (300)
|+||++||.|++++..++++++.++.+++.||+.|+.|+|..+|+||||||+|+|++..+..++++++.
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 999999999999999999999999999999999999999999999999999999999987765544333
Q ss_pred -------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 200 -------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 200 -------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
|.+||.... ..+.+.++||||.|||||.||||+.||.+ .+...++..+. .....+|..++.++++|
T Consensus 170 TSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~-~G~f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQ-RGVFEMPSNISSEAQDL 242 (786)
T ss_pred ccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHH-cCcccCCCcCCHHHHHH
Confidence 444444321 23457799999999999999999999963 33444444444 45677889999999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|+|.+||++|||+..
T Consensus 243 Lr~ml~V-Dp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 243 LRRMLDV-DPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHhcc-CccccccHHHHhhCchhhc
Confidence 9999999 9999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=335.33 Aligned_cols=232 Identities=30% Similarity=0.520 Sum_probs=203.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..... ...+|+++++.++||||+.++++|+... .+|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-HLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-eEEEEe
Confidence 67999999999999999999999999999999986544332 2367999999999999999999999876 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC-------------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP------------------- 193 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~------------------- 193 (300)
|||.| +|+.++.+.+.++++.++.++.++++||.|||+.+|+|||+||.|||++.++..+
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 99987 9999999999999999999999999999999999999999999999999876543
Q ss_pred ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 194 CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+-++..|++||..+ +..|+..+|+||+|||+|||++|++||... .+...+.. ....+...|...+..+..|+
T Consensus 160 ikGtPlYmAPElv~---e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~-I~~d~v~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 160 IKGTPLYMAPELVE---EQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKS-ILKDPVKPPSTASSSFVNFL 231 (808)
T ss_pred ccCcccccCHHHHc---CCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHH-HhcCCCCCcccccHHHHHHH
Confidence 23577789988876 778899999999999999999999999642 22233333 33566777888999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.+|.+ ||.+|.+..+++.|||.++
T Consensus 232 ~gLL~k-dP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 232 QGLLIK-DPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHhhc-ChhhcccHHHHhcChHHhh
Confidence 999999 9999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=329.59 Aligned_cols=233 Identities=26% Similarity=0.421 Sum_probs=194.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++++++||||+++++++.+.. ..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-FLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-eEEEE
Confidence 468999999999999999999999999999999865321 123467999999999999999999887654 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++...+.+
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC 159 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCccccc
Confidence 99999999999999888899999999999999999999999999999999999998876543322
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...... .....+. .....++...++.++++|.+
T Consensus 160 gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i~-~~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 160 GTPEYLAPEVIQ---SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKIL-AGKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred CChhhcCHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hCCcCCCccCCHHHHHHHHH
Confidence 23455666543 445678999999999999999999999764332 2222222 23455677789999999999
Q ss_pred HhccCCCCCCCC-----HHHHhcCCCCCC
Q 040812 276 CLQKGDPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 276 ~l~~~dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
||+. ||.+|++ ++++++||||+.
T Consensus 232 ~l~~-dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 232 LLVV-DRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HcCC-CHHHccCCccCCHHHHhcCccccC
Confidence 9999 9999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=336.04 Aligned_cols=236 Identities=31% Similarity=0.481 Sum_probs=200.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+....|...++||+|..|.||.|+...+++.||||.+....... ...+|+.+|+..+|+|||.+++.|...+ .+|+|
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-eLWVV 348 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-ELWVV 348 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-eeEEE
Confidence 45567888999999999999999999999999999987655443 3478999999999999999999988764 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------------- 195 (300)
|||++||+|.+.+... .+++.++..|++.+++||.|||.+||+|||||.+|||++.++..+++
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 9999999999998765 59999999999999999999999999999999999999988765443
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--CCCCCCChHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP--SLPECSSEKFR 270 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 270 (300)
++..|++||... ...|++++||||||++++||+-|++||...+.. ..++.+..+..+ ..++.+++.++
T Consensus 428 TmVGTPYWMAPEVvt---rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----rAlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVT---RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred cccCCCCccchhhhh---hcccCccccchhhhhHHHHHhcCCCCccCCChH----HHHHHHhhcCCCCcCCccccCHHHH
Confidence 344566766655 446889999999999999999999999764332 333333334444 45778999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||+.+||+. |+++|+++.|+|+||||+.
T Consensus 501 dFL~~cL~~-dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 501 DFLDRCLVV-DVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHhhc-chhcCCCHHHHhcChhhhh
Confidence 999999999 9999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=315.21 Aligned_cols=226 Identities=31% Similarity=0.461 Sum_probs=193.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEece-eeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQ-IFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~-~~~~~~~~~~ 129 (300)
.+.+|+++++||+|+||.||++....+|+.+|.|.++-+.... ....|+.+|++++|||||++++ .+..++.-++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3567999999999999999999999999999999987444332 2356999999999999999999 4555443499
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHh--CC--ccccCCCCCceeecCCCCCCccce----
Q 040812 130 ILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHS--RN--IVHRDIKPANVLINEKMEHPCGYS---- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~--~~--i~H~Dlkp~Nill~~~~~~~~~~~---- 197 (300)
||||||.+|+|.++++. +..+++..++.++.|++.||.++|. .. |+||||||.||+++.++..+.|++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999974 4569999999999999999999998 44 999999999999999988766653
Q ss_pred ---------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC
Q 040812 198 ---------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 198 ---------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (300)
..|+.||... +..|+.+|||||+||++|||+.-.+||.+. ++.+....+..+..+.+|
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~---~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIH---ESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHh---cCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCc
Confidence 4455655544 667889999999999999999999999764 666777778878777788
Q ss_pred -CCCChHHHHHHHHHhccCCCCCCCCH
Q 040812 263 -ECSSEKFRDFIRCCLQKGDPSKRWTA 288 (300)
Q Consensus 263 -~~~~~~l~~li~~~l~~~dp~~Rpt~ 288 (300)
+.+|.++.++|..|+.. ||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~v-d~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAV-DPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccC-CcccCCCc
Confidence 78899999999999999 99999985
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=333.69 Aligned_cols=235 Identities=28% Similarity=0.435 Sum_probs=196.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++.+.||+|+||.||+|+++.+++.||+|+++.... .....+|+.++++++||||+++++++..+. ..|
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 94 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-RVY 94 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-EEE
Confidence 35789999999999999999999999999999999875421 123457999999999999999999998765 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 9999999999999999888899999999999999999999999999999999999999876554332
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+..|.+||... +..++.++|||||||++|||+||..||...... .....+. .....+|...+..+++||
T Consensus 175 ~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 175 LCGTPEYLAPEVIQ---SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKIL-AGRLKFPNWFDGRARDLV 246 (329)
T ss_pred ecCChhhcCHHHHc---CCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHHHh-cCCcCCCCCCCHHHHHHH
Confidence 22355565543 455678999999999999999999999654321 2222222 334566777899999999
Q ss_pred HHHhccCCCCCCCC-----HHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
.+||+. ||++|++ ++++++||||++
T Consensus 247 ~~~L~~-dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQT-DHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhc-CHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999 9999997 799999999976
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=335.06 Aligned_cols=237 Identities=26% Similarity=0.358 Sum_probs=201.5
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC-----CHHHHHHHHhc-CCCceeEeceeeeCCCC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-----NPQELNILRQT-NSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 126 (300)
..++++|.++++||+|+||+|+++..+.+++.+|||+++++..... ...|.+++..+ +||.++.++.+|.+..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~- 442 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE- 442 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-
Confidence 4578899999999999999999999999999999999998765432 24577777766 5999999999999875
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
++|+||||+.||++..+ ...+.|++..++.++..++.||.|||++|||+||||.+|||+|.+|..++.+
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999999994433 3446899999999999999999999999999999999999999887754332
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
+.-|.+||... +..|+.++|+|||||+|||||+|+.||.+.+++..+..++ ...+.+|..++.
T Consensus 522 g~~TsTfCGTpey~aPEil~---e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-----~d~~~yP~~ls~ 593 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLT---EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-----NDEVRYPRFLSK 593 (694)
T ss_pred CCccccccCChhhcChhhhc---cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-----cCCCCCCCcccH
Confidence 34456666554 6789999999999999999999999998776654444443 567888999999
Q ss_pred HHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
+..++|+++|.+ ||++|.. +++|.+||||+++
T Consensus 594 ea~~il~~ll~k-~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 594 EAIAIMRRLLRK-NPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHHHHHHhcc-CcccccCCCCCCchhhhhCCccccC
Confidence 999999999999 9999996 5899999999874
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=330.25 Aligned_cols=239 Identities=46% Similarity=0.856 Sum_probs=193.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
..+++|+.++.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++|+||+++++++.... ..|+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-EIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-eEEE
Confidence 3567899999999999999999999999999999998654322 23467999999999999999999987654 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||||+++++|... ...++..+..++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999999998643 2457788899999999999999999999999999999999876543222
Q ss_pred -----eeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 197 -----SCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 197 -----~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+..|.+||.... ..+.+.+.++|||||||++|||++|+.||.... ..++......+.....+..+...+.++
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CccHHHHHHHHhccCCCCCCCccCHHH
Confidence 234566665432 123455679999999999999999999997432 233344444444455566677789999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++||.+||.. ||++|||+.|+++||||.+
T Consensus 305 ~~li~~~l~~-~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 305 RHFISCCLQR-EPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HHHHHHHccC-ChhhCcCHHHHhcCccccc
Confidence 9999999999 9999999999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=316.57 Aligned_cols=239 Identities=31% Similarity=0.445 Sum_probs=196.5
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..-+++.|++++.||.|.-|+||+|+.+.++..+|+|++.+.... ....-|-.||..+.||.++.+|..|+.+.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~- 150 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK- 150 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-
Confidence 344678899999999999999999999999999999999765432 22345999999999999999999999876
Q ss_pred cEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee------
Q 040812 127 EVSILMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------ 198 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------ 198 (300)
+.|+|||||+||+|..++++ ...|++..++.++..++.||+|||-.||++|||||+||||.+++.....++.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999999975 3469999999999999999999999999999999999999877553111000
Q ss_pred ---------------------------------------------------------------------ecccccccccc
Q 040812 199 ---------------------------------------------------------------------LYESGEARHRK 209 (300)
Q Consensus 199 ---------------------------------------------------------------------~~~~~~~~~~~ 209 (300)
-|.+|| ..
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE---vI 307 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE---VI 307 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce---ee
Confidence 011111 11
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC--CCChHHHHHHHHHhccCCCCCCCC
Q 040812 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE--CSSEKFRDFIRCCLQKGDPSKRWT 287 (300)
Q Consensus 210 ~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~dp~~Rpt 287 (300)
.|..-+.++|+|+|||++|||+.|..||.+.+..+.+.+++. .+..+|. ..+..++|||+++|.+ ||++|..
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----~~l~Fp~~~~vs~~akDLIr~LLvK-dP~kRlg 381 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----QPLKFPEEPEVSSAAKDLIRKLLVK-DPSKRLG 381 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----CCCcCCCCCcchhHHHHHHHHHhcc-Chhhhhc
Confidence 133335689999999999999999999999888877766663 3444444 4678999999999999 9999998
Q ss_pred ----HHHHhcCCCCCCC
Q 040812 288 ----ASQLLSHPFLADA 300 (300)
Q Consensus 288 ----~~~~l~hpw~~~~ 300 (300)
++||.+||||+++
T Consensus 382 ~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 382 SKRGAAEIKRHPFFEGV 398 (459)
T ss_pred cccchHHhhcCccccCC
Confidence 9999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=323.82 Aligned_cols=238 Identities=29% Similarity=0.502 Sum_probs=193.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----------------CCCHHHHHHHHhcCCCceeEec
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----------------PPNPQELNILRQTNSPYIVKCH 118 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~E~~~l~~l~h~niv~~~ 118 (300)
.+++|++++.||+|.||.|-+|++..+++.||||++.+.... +...+|+.+|+++.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 578999999999999999999999999999999999643211 1235799999999999999999
Q ss_pred eeeeCCC-CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-
Q 040812 119 QIFTKPS-GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY- 196 (300)
Q Consensus 119 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~- 196 (300)
++..++. ..+|||+|||..|.+...-.....+++.+++.+++.++.||+|||.+||+||||||+|+|+++++..++++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 9987653 46999999999888764433333499999999999999999999999999999999999999887764433
Q ss_pred -----------------------eeeccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 040812 197 -----------------------SCLYESGEARHRKH-GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA 252 (300)
Q Consensus 197 -----------------------~~~~~~~~~~~~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 252 (300)
+..+.+||.-.... ..+.+.+.||||+||+||.|+.|+.||.+.....-+.+++
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv-- 332 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV-- 332 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh--
Confidence 44455666544322 3345778999999999999999999997654433222222
Q ss_pred HhhCCCCCCCCC--CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 253 ICFREPPSLPEC--SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 253 ~~~~~~~~~~~~--~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+.+..+|.. ..+.++|+|.+||.+ ||++|.+..++..|||..
T Consensus 333 ---n~pL~fP~~pe~~e~~kDli~~lL~K-dP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 333 ---NDPLEFPENPEINEDLKDLIKRLLEK-DPEQRITLPDIKLHPWVT 376 (576)
T ss_pred ---cCcccCCCcccccHHHHHHHHHHhhc-Chhheeehhhheecceec
Confidence 455566654 689999999999999 999999999999999985
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=300.92 Aligned_cols=234 Identities=26% Similarity=0.415 Sum_probs=199.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++++.||+|-||.||+|+.++++..||+|++.+.. ......+|+++..+++||||++++++|.++. .+|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riy 98 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIY 98 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeE
Confidence 4678899999999999999999999999999999986543 2334578999999999999999999999876 899
Q ss_pred EEEeccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 130 ILMEYMDAGSLEIYVK--SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
+++||..+|+|...+. ...++++..+..++.|++.||.|+|.++|+||||||+|+|++..+..+++.
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence 9999999999999998 456799999999999999999999999999999999999999876654332
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||..+ +...+..+|+|++|++.||++.|.+||........+.. .......+|..++.+++
T Consensus 179 R~tlcgt~dyl~pEmv~---~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr-----I~k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVE---GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR-----IRKVDLKFPSTISGGAA 250 (281)
T ss_pred ceeeecccccCCHhhcC---CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH-----HHHccccCCcccChhHH
Confidence 34455665544 55567899999999999999999999976553322222 22445677889999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
|+|.+|+.. +|.+|.+..|++.|||+.
T Consensus 251 dlI~~ll~~-~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 251 DLISRLLVK-NPIERLALTEVMDHPWIV 277 (281)
T ss_pred HHHHHHhcc-CccccccHHHHhhhHHHH
Confidence 999999999 999999999999999984
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=328.82 Aligned_cols=233 Identities=24% Similarity=0.371 Sum_probs=199.2
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+....+.+.+++.||+|.||.||+|.++.+ ..||+|.++..... ..+.+|+++|++|+|+|||++++++..+. .+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-pi 276 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PI 276 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ce
Confidence 44445566788899999999999999999863 47899999875544 67789999999999999999999998765 89
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-------
Q 040812 129 SILMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL------- 199 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~------- 199 (300)
||||||++.|+|.++++. +..+.......++.||+.|++||+++++|||||.++|||++++..++++++++
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999999987 45789999999999999999999999999999999999999988776665554
Q ss_pred -------------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 200 -------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 200 -------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
|.+||+.. -+.++.+||||||||+||||+| |+.||.+... .+.+..+..+.....|..+
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~---~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----~ev~~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALN---YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----EEVLELLERGYRLPRPEGC 429 (468)
T ss_pred ceeecCCCCCCceecCHHHHh---hCCcccccceeehhhhHHHHhccCCCCCCCCCH----HHHHHHHhccCcCCCCCCC
Confidence 34444443 3346779999999999999998 8999965433 3566677778899999999
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
++.+.++|..||.. +|++|||++.+.
T Consensus 430 P~~vY~lM~~CW~~-~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHE-DPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhC-CcccCCCHHHHH
Confidence 99999999999999 999999998664
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=319.85 Aligned_cols=241 Identities=27% Similarity=0.372 Sum_probs=185.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
..++|++.+.||+|+||.||+|++..+++.||+|++....... ...+|+.++++++||||+++++++.... ..|+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv 81 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-TLTLV 81 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-eEEEE
Confidence 3578999999999999999999999999999999987543222 3467999999999999999999988765 89999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------- 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------- 197 (300)
|||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++..+++++
T Consensus 82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 999965 77777765 356899999999999999999999999999999999999988765433222
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC-------------
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP------------- 258 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------- 258 (300)
..|.+||.... ...++.++|||||||++|+|+||..||....+.......+........
T Consensus 161 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 161 SNEVVTLWYRPPDVLLG--STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred CCCcccCCCCChHHHcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 23555554321 234677999999999999999999999764332222211111100000
Q ss_pred --CC----CC---------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 259 --PS----LP---------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 259 --~~----~~---------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.. .+ ...++.+.+|+.+||+. ||++|||+.++++||||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~-dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQC-FPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhcc-CchhccCHHHHhcCcccccC
Confidence 00 00 01346789999999999 99999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=317.03 Aligned_cols=240 Identities=34% Similarity=0.491 Sum_probs=199.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+.+.|++...||.|..+.||+|+...++..||||++..+.-.. ...+|+..|+.++||||+.++..|..+. .+|+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-ELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-eeEE
Confidence 35678999999999999999999999999999999997654333 3467999999999999999999999876 8999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 131 LMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
||.||.+|++.++++.. ..+++..+..|+++++.||.|||.+|.+|||||+.||||+.+|..+++
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999999863 248999999999999999999999999999999999999998776443
Q ss_pred ----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC----
Q 040812 196 ----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL---- 261 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 261 (300)
++..|++||..-... ..|+.|+||||||++..||.+|..||..... ++.+.....+.++..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~-~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP----mkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQL-HGYDFKADIWSFGITACELAHGHAPFSKYPP----MKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcc-cCccchhhhhhhhHHHHHHhcCCCCcccCCh----HHHHHHHhcCCCCCccccc
Confidence 345577888754333 3467799999999999999999999965333 344444444555421
Q ss_pred -----CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 262 -----PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 262 -----~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
....+..++++|..||++ ||.+|||++++|+|+||+.+
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~k-DP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVK-DPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhc-CcccCCCHHHHhccHHHhhc
Confidence 123466799999999999 99999999999999999753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=316.70 Aligned_cols=238 Identities=27% Similarity=0.382 Sum_probs=186.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+++|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+|+.++++++||||+++++++.... ..++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv 81 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-CLTLV 81 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-eEEEE
Confidence 467899999999999999999999999999999998754322 23468999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 132 MEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 999976 8998887644 579999999999999999999999999999999999998876543322
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC--------------
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-------------- 257 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------------- 257 (300)
+..|.+||... .+..++.++|||||||++|+|+||+.||...+.......+........
T Consensus 161 ~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 161 SNEVVTLWYRPPDVLL--GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cCceecccccChHHhc--CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 22345555432 124567899999999999999999999976543322221111110000
Q ss_pred ---CC--------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 258 ---PP--------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 258 ---~~--------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.+ ......++++.+||.+||+. ||++|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~-dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLY-ETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCc-CcccCCCHHHHhcCCCC
Confidence 00 00123577899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=305.62 Aligned_cols=238 Identities=27% Similarity=0.380 Sum_probs=198.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++|++-+.||+|.|+.|+++.+..+|+.+|+|++.... ..+...+|+.+.+.++||||+++++.+..+ +..|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-ceeEEE
Confidence 357899999999999999999999999999999885432 223346799999999999999999998765 499999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-------------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH------------------- 192 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~------------------- 192 (300)
+|+++|++|..-+-.+.-+++..+...++||+.||.|+|.+||+|||+||+|+++.+....
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 9999999998777666678999999999999999999999999999999999999764321
Q ss_pred --CccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 193 --PCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 193 --~~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
-..++..|.+||... ...++..+|||+-|||||-|+.|.+||.+.++. ...+.+.......+...++.++++.+
T Consensus 169 ~~G~~GtP~fmaPEvvr---kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred cccccCCCcccCHHHhh---cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhccccCCCCcccCcCCHHHH
Confidence 112344566666554 456888999999999999999999999875554 33344444444556667788999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+|+.+||.. ||++|+|+.|+|+|||+.+
T Consensus 245 ~LvrrML~~-dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 245 SLIRRMLTV-NPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHhcc-ChhhhccHHHHhCCchhcc
Confidence 999999999 9999999999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=326.08 Aligned_cols=227 Identities=27% Similarity=0.431 Sum_probs=188.7
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.||+|+||.||+|+++.+++.||+|+++..... ....+|+.++++++||||+++++++.... ..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-EEEEEEeCCCC
Confidence 4699999999999999999999999998754321 12356999999999999999999988765 89999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------ee
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------SC 198 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~~ 198 (300)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+ +.
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999998888899999999999999999999999999999999999998876543322 23
Q ss_pred eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhc
Q 040812 199 LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278 (300)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 278 (300)
.|.+||... +..++.++|||||||++|||+||..||...+.. ..... .......++...++++.++|.+||.
T Consensus 160 ~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~-~~~~~~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 160 EYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFEL-ILMEEIRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred cccChhhhc---CCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHH-HHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 355555543 456788999999999999999999999654322 22222 2233456777889999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCC
Q 040812 279 KGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 279 ~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
. ||++|| ++.++++||||.+
T Consensus 232 ~-dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 232 K-DPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred C-CHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9 999999 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=316.98 Aligned_cols=236 Identities=27% Similarity=0.416 Sum_probs=185.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||+|+++.+++.||+|+++..... ....+|+.++++++|+||+++++++.... ..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-KLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-EEEEEE
Confidence 4699999999999999999999999999999998754322 23467999999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
||++++++..+......+++..++.++.|++.||.|||+.|++||||||+||+++.++...+++
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9999987776665556799999999999999999999999999999999999998776443222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-----------hC-----
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----------FR----- 256 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------~~----- 256 (300)
+..|.+||... +..++.++|||||||++|||++|+.||...........+..... ..
T Consensus 160 ~~~~~~~y~aPE~~~---~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 160 EYVATRWYRSPELLL---GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred ccccccccCCcHHHc---CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22345555543 44577899999999999999999999975433222211111000 00
Q ss_pred -CCC----------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 257 -EPP----------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 257 -~~~----------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..+ ......+..+.+||.+||+. ||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~-~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKL-NPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccC-CcccCCCHHHHhcCCCC
Confidence 000 01123577899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=317.09 Aligned_cols=237 Identities=22% Similarity=0.332 Sum_probs=192.0
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-eEEEEE
Confidence 478899999999999999999999999999998653321 12457999999999999999999988765 899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 133 EYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 999999999887643 3589999999999999999999999999999999999998765443222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|||++|+.||........... +...........+...++++.+|
T Consensus 160 ~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~l 235 (285)
T cd05631 160 GRVGTVGYMAPEVIN---NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-VDRRVKEDQEEYSEKFSEDAKSI 235 (285)
T ss_pred CCCCCCCccCHhhhc---CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-HHHHhhcccccCCccCCHHHHHH
Confidence 23345555543 45678899999999999999999999976544322222 22222233445667789999999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 273 IRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
|.+||.. ||++||+ ++++++||||+++
T Consensus 236 i~~~l~~-~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 236 CRMLLTK-NPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHHhhc-CHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999 9999997 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=327.08 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=191.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+|+.++.+++||||+++++++.... ..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-YLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-EEEEE
Confidence 4699999999999999999999999999999999754221 22457999999999999999999988755 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~ 159 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV 159 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCcc
Confidence 99999999999998888899999999999999999999999999999999999998876543322
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC---CCCChHHHHH
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP---ECSSEKFRDF 272 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|||++|..||...........+.........+... ..+++++.++
T Consensus 160 gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 160 GSPDYMAPEVLR---GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred cCccccChhHhc---CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 23355666543 4567889999999999999999999997544322222111110001111111 2458899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. +|++||+++++++||||++
T Consensus 237 i~~~l~~-~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 237 ITKLIND-PSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHhhC-hhhhcCCHHHHHhCcccCC
Confidence 9999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=320.16 Aligned_cols=235 Identities=25% Similarity=0.393 Sum_probs=195.9
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
........+.+.||+|+||+||++.++.+ ..||+|.+...... ..+.+|+.+|.+++|||||+++|++..+.+..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 34455667778899999999999999853 23999998754322 25678999999999999999999998765468
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCC-ccccCCCCCceeecCCC-CCC-----------
Q 040812 129 SILMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRN-IVHRDIKPANVLINEKM-EHP----------- 193 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~-i~H~Dlkp~Nill~~~~-~~~----------- 193 (300)
++||||+++|+|..++.. ...++...+..++.||+.||.|||+++ |+||||||+|||++.+. ..+
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999999987 568999999999999999999999999 99999999999999875 322
Q ss_pred --------ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 194 --------CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 194 --------~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
.+++..|++||..... +..++.|+||||||+++|||+||+.||..... ..........+..+.+|..+
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred cccccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCCCCCccC
Confidence 2345568888887754 56788999999999999999999999976543 11222223467778888889
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.+..+|.+||.. ||++||++.+++.
T Consensus 272 ~~~l~~l~~~CW~~-dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLV-DPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCC-CCCcCCCHHHHHH
Confidence 99999999999999 9999999998863
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=326.36 Aligned_cols=235 Identities=23% Similarity=0.345 Sum_probs=193.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCC-eEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTL-ALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+|+.+++.++||||+++++++.... ..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES-YL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-EE
Confidence 4678999999999999999999976654 7899999865322 122357999999999999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
|+||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~ 186 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY 186 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence 9999999999999999988889999999999999999999999999999999999999887654322
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++..|.+||... +..++.++|||||||++|||+||..||...+.. .....+. .....+|...++.+.++
T Consensus 187 ~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 187 TLCGTPEYIAPEILL---NVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LIYQKIL-EGIIYFPKFLDNNCKHL 258 (340)
T ss_pred eecCChhhcCHHHHh---CCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HHHHHHh-cCCCCCCCCCCHHHHHH
Confidence 123356666543 455678999999999999999999999754332 2222222 33445677789999999
Q ss_pred HHHHhccCCCCCCC-----CHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
|.+||+. ||++|+ +++++++||||++
T Consensus 259 i~~~l~~-dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSH-DLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHccc-CHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999 999995 8999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=330.45 Aligned_cols=236 Identities=24% Similarity=0.320 Sum_probs=188.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+.|++++.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++++++|+||+++++++.+.. ..|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-NLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-EEEEE
Confidence 3689999999999999999999999999999999754322 12357999999999999999999998755 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------------- 195 (300)
|||+++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++...+.
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999876543322
Q ss_pred --------------------------------------------------ceeeccccccccccCCCCCCchhhHHHHHH
Q 040812 196 --------------------------------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGV 225 (300)
Q Consensus 196 --------------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~ 225 (300)
++..|.+||... +..++.++|||||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DiwSlG~ 236 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL---RKGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc---CCCCCCccceeehhh
Confidence 223355555543 445678999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC--CCCChHHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCC
Q 040812 226 TMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP--ECSSEKFRDFIRCCLQK-GDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 226 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~-~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++|||+||..||...........+. ........+ ..+++++++||.+|+.. .++..|++++++++||||++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVI---NWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHH---ccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 9999999999997654332222221 111122222 35789999999995543 15666999999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=326.15 Aligned_cols=237 Identities=24% Similarity=0.358 Sum_probs=186.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+|+.++.+++|+||+++++.+.+.. ..|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-NLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-eEEEE
Confidence 4689999999999999999999999999999999753221 12356999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||||++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999998888899999999999999999999999999999999999998776543322
Q ss_pred ---------------------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 040812 197 ---------------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF 237 (300)
Q Consensus 197 ---------------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf 237 (300)
+..|.+||... +..++.++|||||||++|||++|+.||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM---QTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc---CCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 22344555443 455778999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhCCCCCCCC--CCChHHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q 040812 238 LEPGQEPDFLSLMLAICFREPPSLPE--CSSEKFRDFIRCCLQK-GDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~-~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
...........+.. ......+|. ..+++++++|.+++.. .++..||+++|+++||||+++
T Consensus 237 ~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMN---WKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHc---CcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 76443322222211 112222332 3688999999987642 133456899999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=320.23 Aligned_cols=238 Identities=33% Similarity=0.420 Sum_probs=200.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcC-CCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTN-SPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 128 (300)
....|++.+.||+|.||.||+|+.+.+|+.+|+|++.+..... ...+|+.+|+++. |||||.+++.|++.. .+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eE
Confidence 3457999999999999999999999999999999998765432 4478999999998 999999999999876 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC----C---Ccc------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME----H---PCG------ 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~----~---~~~------ 195 (300)
++|||+|+||.|.+.+... .+++..+..++.||+.|++|||+.||+||||||+|+|+..... . ++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999876 4999999999999999999999999999999999999976532 1 122
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
++..|.+||... +..++..+||||+||++|.|++|.+||...........+..... ......+..++
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~---~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-~f~~~~w~~is 266 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLG---GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-DFTSEPWDDIS 266 (382)
T ss_pred CCceEeeecCCccccCchhhc---CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-CCCCCCccccC
Confidence 234455555544 45688899999999999999999999988776655554333222 23444556789
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.+++||..||.. ||.+|+|+.++|+|||+++
T Consensus 267 ~~akd~i~~ll~~-dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 267 ESAKDFIRKLLEF-DPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred HHHHHHHHHhccc-CcccCCCHHHHhcCccccC
Confidence 9999999999999 9999999999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=320.92 Aligned_cols=225 Identities=26% Similarity=0.451 Sum_probs=186.7
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
||+|+||.||+|++..+++.||+|+++..... ..+.+|+.++++++||||+++++++.... ..|+||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-KLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-eEEEEEcCCCCCc
Confidence 79999999999999999999999998753211 22356999999999999999999988754 8999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------------ceeec
Q 040812 140 LEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------------YSCLY 200 (300)
Q Consensus 140 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------------~~~~~ 200 (300)
|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+. ++..|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 99999888889999999999999999999999999999999999999877554322 23335
Q ss_pred cccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccC
Q 040812 201 ESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKG 280 (300)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 280 (300)
.+||... +..++.++|||||||++|||+||..||...... ..... .......++...++.+.++|.+||..
T Consensus 160 ~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~- 230 (312)
T cd05585 160 LAPELLL---GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----EMYRK-ILQEPLRFPDGFDRDAKDLLIGLLSR- 230 (312)
T ss_pred CCHHHHc---CCCCCCccceechhHHHHHHHhCCCCcCCCCHH----HHHHH-HHcCCCCCCCcCCHHHHHHHHHHcCC-
Confidence 5555543 455778999999999999999999999654322 22222 22445667788999999999999999
Q ss_pred CCCCCC---CHHHHhcCCCCCC
Q 040812 281 DPSKRW---TASQLLSHPFLAD 299 (300)
Q Consensus 281 dp~~Rp---t~~~~l~hpw~~~ 299 (300)
||++|| ++.++++||||++
T Consensus 231 dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 231 DPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CHHHcCCCCCHHHHHcCCCcCC
Confidence 999997 5899999999986
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=319.59 Aligned_cols=227 Identities=27% Similarity=0.443 Sum_probs=188.0
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.||+|+||.||++++..+++.||+|+++..... ..+.+|+.++++++||||+++++++.... ..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-EEEEEEeCCCC
Confidence 4699999999999999999999999998754321 12346999999999999999999988764 89999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------ee
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------SC 198 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~~ 198 (300)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+ +.
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99999998887899999999999999999999999999999999999998775543222 23
Q ss_pred eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhc
Q 040812 199 LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278 (300)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 278 (300)
.|.+||... +..++.++|||||||++|||+||+.||...+.. .....+ ......+|..+++++.++|.+||.
T Consensus 160 ~y~aPE~~~---~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~-~~~~~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 160 EYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELI-LMEEIRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred CcCCccccc---CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH-hcCCCCCCCCCCHHHHHHHHHHcc
Confidence 455555543 556788999999999999999999999754332 222222 133445677889999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCC
Q 040812 279 KGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 279 ~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
. ||++|+ ++.++++||||.+
T Consensus 232 ~-dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 232 K-DPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred C-CHHHhCCCCCCCHHHHHcCCCcCC
Confidence 9 999998 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=329.50 Aligned_cols=236 Identities=24% Similarity=0.313 Sum_probs=188.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++++.||+|+||.||+|++..+++.||+|++..... .....+|+.++++++|+||+++++.+.... ..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-NLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-EEEEE
Confidence 479999999999999999999999999999999864321 122457999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999999998888899999999999999999999999999999999999998776543222
Q ss_pred -----------------------------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHH
Q 040812 197 -----------------------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMME 229 (300)
Q Consensus 197 -----------------------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~e 229 (300)
+..|.+||... +..++.++|||||||++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL---RTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc---CCCCCcceeeeeccceeee
Confidence 22345555443 4456789999999999999
Q ss_pred HHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCC
Q 040812 230 LYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRW---TASQLLSHPFLAD 299 (300)
Q Consensus 230 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rp---t~~~~l~hpw~~~ 299 (300)
|+||+.||...........+. .............+++++.++|.+|+ . +|++|+ ++.++++||||++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~s~~~~~li~~l~-~-~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVI-NWETTLHIPSQAKLSREASDLILRLC-C-GAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHh-ccCccccCCCCCCCCHHHHHHHHHHh-c-CHhhcCCCCCHHHHhCCCCcCC
Confidence 999999997654322211111 11111111223357889999999976 6 999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=318.49 Aligned_cols=238 Identities=36% Similarity=0.606 Sum_probs=190.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++.+.||+|+||.||++++..++..+|+|++...... ..+.+|+.++++++||||+++++++.... ..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EEEEEe
Confidence 46899999999999999999999999999999998754321 23567999999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCccc---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++...+.+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 9999999999998877899999999999999999999986 699999999999998876543322
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHH---------------------------
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFL--------------------------- 247 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~--------------------------- 247 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...... ...
T Consensus 163 ~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 163 VGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred CCCcCcCCHhHhc---CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccccccc
Confidence 23355555543 456788999999999999999999999643221 110
Q ss_pred ----------------HHHHHHhhCCCCCCC-CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 248 ----------------SLMLAICFREPPSLP-ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 248 ----------------~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.....+.....+..+ ...++++++||.+||+. ||++|||+.++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~-~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIK-NPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccC-CcccCCCHHHHhcChHHhh
Confidence 011111111122222 24678999999999999 9999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=321.90 Aligned_cols=235 Identities=33% Similarity=0.486 Sum_probs=206.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
-..|...+.||+|+||.||+|.+..+++.||+|++..+.... ...+|+.+|.+.+++||.++|+.|.... .+|++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-KLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-cHHHHH
Confidence 345777899999999999999999999999999998765443 3467999999999999999999998765 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-------------------C
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-------------------P 193 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-------------------~ 193 (300)
|||.||++.+.++....+.+..+..++++++.||.|||.++.+|||||+.|||+...+.. .
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 999999999999988778999999999999999999999999999999999999877443 3
Q ss_pred ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 194 CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+.++.+|++||... +..|+.++||||||++.+||++|.+|+....+ +..+..+....+|.+...+++.+++||
T Consensus 171 fvGTPfwMAPEVI~---~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----mrvlflIpk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIK---QSGYDTKADIWSLGITAIELAKGEPPHSKLHP----MRVLFLIPKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred ccccccccchhhhc---cccccchhhhhhhhHHHHHHhcCCCCCcccCc----ceEEEeccCCCCCccccccCHHHHHHH
Confidence 45677889998876 55688899999999999999999999976555 233444556778888888999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..||.+ ||+.||+|.++|+|+|++.
T Consensus 244 ~~CL~k-~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 244 EACLDK-NPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHhhc-CcccCcCHHHHhhhHHHHh
Confidence 999999 9999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=301.98 Aligned_cols=240 Identities=26% Similarity=0.450 Sum_probs=191.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCc-eeEeceeeeCCC-----
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPY-IVKCHQIFTKPS----- 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 125 (300)
...|+.+++||+|+||+||+|+.+.+|+.||+|.+..+... ....+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 56788899999999999999999999999999999765442 23478999999999999 999999987765
Q ss_pred CcEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRG----RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----- 196 (300)
+.+++||||++. +|..++.... .++...++.+++||+.||+|||+++|+||||||.|||+++.+..++.+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 279999999976 9999998754 478889999999999999999999999999999999999987654433
Q ss_pred --------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC--
Q 040812 197 --------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS-- 260 (300)
Q Consensus 197 --------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 260 (300)
+..|.+||..... ..|+..+||||+|||++||++++..|.+..+......+...........
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs--~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGS--TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCC--CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 3335566654422 2578899999999999999999999976655333333332221111000
Q ss_pred -----------CC------------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 261 -----------LP------------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 261 -----------~~------------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++ ....++..+++.+||+. +|.+|.|+..+++||||.+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y-~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQY-DPAKRISAKGALTHPYFSE 307 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhcc-CcccCcCHHHHhcChhhcc
Confidence 00 11135789999999999 9999999999999999975
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=318.50 Aligned_cols=232 Identities=26% Similarity=0.443 Sum_probs=188.3
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|+++...... ....|..++.++ +||||+++++++.... ..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-RLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-EEEEEEeCCC
Confidence 46999999999999999999999999998643221 234688888888 7999999999998765 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++...+.+ +
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 999999998878899999999999999999999999999999999999998876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----CchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ----EPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
..|.+||... +..++.++|||||||++|+|+||+.||..... ..................+|..++..+.++|
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 160 PNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred ccccCHHHHc---CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 2345555543 45677899999999999999999999963211 1111222233333445567788899999999
Q ss_pred HHHhccCCCCCCCC------HHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWT------ASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt------~~~~l~hpw~~~ 299 (300)
.+||.. ||++|++ ++++++||||++
T Consensus 237 ~~~L~~-dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 237 KGFLNK-DPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHhcc-CHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999 9999997 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=318.72 Aligned_cols=227 Identities=27% Similarity=0.443 Sum_probs=187.8
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.||+|+||.||++++..+++.||+|++...... ..+.+|+.+++.++||||+++++++.... ..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-RLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-EEEEEEeCCCC
Confidence 4699999999999999999999999999754322 12356999999999999999999988754 89999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------ee
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------SC 198 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~~ 198 (300)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+++ +.
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99999998877899999999999999999999999999999999999998775543322 23
Q ss_pred eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhc
Q 040812 199 LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278 (300)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 278 (300)
.|.+||... +..++.++|||||||++|+|+||+.||...+.. .....+ ......+|...++++.++|.+||.
T Consensus 160 ~y~aPE~~~---~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~~-~~~~~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 160 EYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI-LMEDIKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred CccChhhhc---CCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHHHh-ccCCccCCCCCCHHHHHHHHHHcC
Confidence 345555443 455678999999999999999999999654322 222222 234456677889999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCC
Q 040812 279 KGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 279 ~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
. ||++|+ ++.++++||||.+
T Consensus 232 ~-dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 232 K-DPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred C-CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9 999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=326.13 Aligned_cols=234 Identities=24% Similarity=0.408 Sum_probs=188.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|+||+++++++.... ..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-YLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-eEEEE
Confidence 4789999999999999999999999999999999753211 12356999999999999999999998765 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------------- 195 (300)
|||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999877654322
Q ss_pred -----------------------------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 040812 196 -----------------------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGY 234 (300)
Q Consensus 196 -----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~ 234 (300)
++..|.+||... +..++.++|||||||++|||++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL---QTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc---CCCCCCeeeeecchhHHHHhhcCC
Confidence 223355555443 445678999999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhCCCCCCCC--CCChHHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCC
Q 040812 235 YPFLEPGQEPDFLSLMLAICFREPPSLPE--CSSEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLAD 299 (300)
Q Consensus 235 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~dp~~Rpt---~~~~l~hpw~~~ 299 (300)
.||...........+. ........+. .++++++++|.+|+ . +|.+|++ +.++++||||++
T Consensus 237 ~Pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~s~~~~~li~~ll-~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 237 PPFCSDNPQETYRKII---NWKETLQFPDEVPLSPEAKDLIKRLC-C-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCCCHHHHHHHHH---cCCCccCCCCCCCCCHHHHHHHHHHc-c-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9997544322211111 1111222232 46889999999998 5 8999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=329.97 Aligned_cols=239 Identities=24% Similarity=0.371 Sum_probs=183.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCC------CceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNS------PYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~ 127 (300)
..++|++.+.||+|+||.||+|.+..+++.||||+++.... ......|+.+++.++| .+++.+++++..+.+.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 34789999999999999999999999999999999864321 2223558888877755 4588899988876668
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCC---------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKME--------------- 191 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~--------------- 191 (300)
.|+|||++ +++|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 99999999 66899998887889999999999999999999997 59999999999999986542
Q ss_pred -C---Ccc-------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh
Q 040812 192 -H---PCG-------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC 254 (300)
Q Consensus 192 -~---~~~-------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 254 (300)
. ++| ++..|.+||... +..++.++|||||||++|||+||+.||...+.. +....+....
T Consensus 286 ~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL---GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-EHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccCccccccccCCccccCcHHhh---cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHc
Confidence 1 122 234567777654 556788999999999999999999999654432 1111111110
Q ss_pred hCCC-----------------------CC--------------C-CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 040812 255 FREP-----------------------PS--------------L-PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296 (300)
Q Consensus 255 ~~~~-----------------------~~--------------~-~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw 296 (300)
...+ +. . ....++.+.|||.+||+. ||++|||++|+|+|||
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~-dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY-DRQKRLNARQMTTHPY 440 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc-ChhhCCCHHHHhcCcc
Confidence 0000 00 0 001245678999999999 9999999999999999
Q ss_pred CCC
Q 040812 297 LAD 299 (300)
Q Consensus 297 ~~~ 299 (300)
|.+
T Consensus 441 ~~~ 443 (467)
T PTZ00284 441 VLK 443 (467)
T ss_pred ccc
Confidence 975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=306.65 Aligned_cols=246 Identities=27% Similarity=0.370 Sum_probs=190.6
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCC-
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKP- 124 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 124 (300)
+...+.-..|..++.||+|+||.|+.+.++.+|+.||||.+...-. .....+|+++|+.++|+||+.+.+++..+
T Consensus 15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 3344445567778999999999999999999999999998763222 22346899999999999999999998752
Q ss_pred ---CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----
Q 040812 125 ---SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----- 196 (300)
Q Consensus 125 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----- 196 (300)
-..+|+|+|+|+. +|.+.++....++...+..++.||+.||+|+|+.+|+||||||+|+|++.+...++.+
T Consensus 95 ~~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 95 RDKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ccccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 1359999999965 9999999887799999999999999999999999999999999999999875543322
Q ss_pred ----------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh------
Q 040812 197 ----------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC------ 254 (300)
Q Consensus 197 ----------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------ 254 (300)
+..|.+||... ....|+.++||||+|||+.||++|++-|.+.+....+..++....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll--~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLL--NSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHh--ccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 22344554442 245678899999999999999999999965543322211111110
Q ss_pred -------------hCC--CCC-----CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 -------------FRE--PPS-----LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 -------------~~~--~~~-----~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
... .+. .-...++...+|+.+||.. ||.+|+|++|+|.||||+.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~f-dP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVF-DPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhcc-CccccCCHHHHhcChhhhh
Confidence 001 111 1125688999999999999 9999999999999999963
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=327.75 Aligned_cols=234 Identities=24% Similarity=0.351 Sum_probs=188.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++++.||+|+||.||+|++..+++.||+|++..... .....+|+.++++++|+||+++++.+.+.. ..|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-EEEEE
Confidence 368999999999999999999999999999999875322 123457999999999999999999998764 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999999998877899999999999999999999999999999999999998765543322
Q ss_pred ---------------------------------------------------eeeccccccccccCCCCCCchhhHHHHHH
Q 040812 197 ---------------------------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGV 225 (300)
Q Consensus 197 ---------------------------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~ 225 (300)
+..|.+||... +..++.++|||||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DiwSlGv 236 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL---RTGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc---CCCCCCeeeEEechH
Confidence 22355555443 445678999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC--CCCCChHHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCC
Q 040812 226 TMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLAD 299 (300)
Q Consensus 226 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~dp~~Rpt---~~~~l~hpw~~~ 299 (300)
++|||+||+.||...........+. ........ ....++++.++|.+|+ . ||++|++ ++++++||||++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~~p~~~~~s~~~~~li~~l~-~-~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVI---NWQTSLHIPPQAKLSPEASDLIIKLC-R-GPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH---ccCCCcCCCCcccCCHHHHHHHHHHc-c-CHhHcCCCCCHHHHhcCCCcCC
Confidence 9999999999997644322221111 11122222 2457899999999976 6 9999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=317.31 Aligned_cols=232 Identities=26% Similarity=0.422 Sum_probs=190.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCC-ceeEeceeeeCCCCcEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSP-YIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~lv 131 (300)
+|++++.||+|+||.||+|++..+++.||+|++...... .....|..++..++|+ +|+.+++++.... ..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-EEEEE
Confidence 588999999999999999999999999999998754221 1235688888888775 5888888887654 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999998888899999999999999999999999999999999999998876543322
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...... .....+ ......++...++++.++
T Consensus 160 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i-~~~~~~~~~~~~~~~~~l 231 (324)
T cd05587 160 TFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSI-MEHNVSYPKSLSKEAVSI 231 (324)
T ss_pred eecCCccccChhhhc---CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH-HcCCCCCCCCCCHHHHHH
Confidence 23355555543 455778999999999999999999999654332 222222 234456677889999999
Q ss_pred HHHHhccCCCCCCCCH-----HHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTA-----SQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~-----~~~l~hpw~~~ 299 (300)
+.+||.. ||++|++. +++++||||+.
T Consensus 232 i~~~l~~-~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 232 CKGLLTK-HPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHhhc-CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999 99999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=325.47 Aligned_cols=234 Identities=25% Similarity=0.399 Sum_probs=186.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++++.||+|+||.||++.+..+++.||+|++..... ...+.+|+.++++++||||+++++++.+.. ..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-YLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-eeEEE
Confidence 468999999999999999999999999999999865321 122356999999999999999999998765 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------------- 195 (300)
|||+++|+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++...+.
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999876543222
Q ss_pred --------------------------------------------------ceeeccccccccccCCCCCCchhhHHHHHH
Q 040812 196 --------------------------------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGV 225 (300)
Q Consensus 196 --------------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~ 225 (300)
++..|.+||... +..++.++|||||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGv 236 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL---QQGYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc---cCCCCCceeeEecch
Confidence 222355555543 445778999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC--CCChHHHHHHHHHhccCCCCC---CCCHHHHhcCCCCCC
Q 040812 226 TMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE--CSSEKFRDFIRCCLQKGDPSK---RWTASQLLSHPFLAD 299 (300)
Q Consensus 226 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~dp~~---Rpt~~~~l~hpw~~~ 299 (300)
++|||+||..||........+..+. .......+|. .++.++++||.+||. +|.+ |+++.++++||||++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~~p~~~~~s~~~~dli~~lL~--~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKII---NWRETLYFPDDIHLSVEAEDLIRRLIT--NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHH---ccCCccCCCCCCCCCHHHHHHHHHHhc--CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999999999996544322111111 1122233333 468899999999995 4555 569999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=317.88 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=183.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC----CcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----GEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 129 (300)
+|++.+.||+|+||.||+|.++.+++.||+|.+...... ..+.+|+.++++++||||+++++++.... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998643211 23467999999999999999999875432 2489
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
+|||||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++...++++
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999996 589999988778999999999999999999999999999999999999998765433222
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH---------------
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA--------------- 252 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------------- 252 (300)
..|.+||.... ....++.++|||||||++|||+||+.||........ ...+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred cccccCCCCCCCcCCHHHHhc-cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhhh
Confidence 22445554321 114567799999999999999999999965432111 011000
Q ss_pred ---------HhhCCCCCC---CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 253 ---------ICFREPPSL---PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 253 ---------~~~~~~~~~---~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.....+... ....++.+.++|.+||.. ||++|||++|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF-DPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc-CcccCCCHHHHhcCchhhh
Confidence 000011111 123567889999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=317.43 Aligned_cols=227 Identities=26% Similarity=0.450 Sum_probs=186.1
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|+++.+++.||+|+++..... .....|..++..+ +||||+++++++.... ..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-RLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-EEEEEEcCCC
Confidence 4699999999999999999999999998754221 1234577788766 6999999999988764 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++...+.+ +
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 999999998888899999999999999999999999999999999999999876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||+||+.||...+.. .....+ .......+...++++.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i-~~~~~~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 160 PDYIAPEILQ---EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAI-LNDEVVYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCHHHHc---CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHH-hcCCCCCCCCCCHHHHHHHHHHc
Confidence 3345555443 455678999999999999999999999654332 222222 23445567778999999999999
Q ss_pred ccCCCCCCCCH------HHHhcCCCCCC
Q 040812 278 QKGDPSKRWTA------SQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~------~~~l~hpw~~~ 299 (300)
+. ||++|+++ +++++||||++
T Consensus 232 ~~-dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 232 TK-NPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred cc-CHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 99 99999998 99999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=315.31 Aligned_cols=227 Identities=24% Similarity=0.428 Sum_probs=185.1
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHh-cCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQ-TNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|+++.+++.||+|+++.... ......|..++.. .+||||+++++++.... ..|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-HLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-EEEEEECCCC
Confidence 469999999999999999999999999975421 1223457777765 48999999999998754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999999998888899999999999999999999999999999999999999876543222 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||++|..||...+.. ..... .....+..+...+.+++++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 160 PDYIAPEILQ---GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFES-IRVDTPHYPRWITKESKDILEKLF 231 (316)
T ss_pred cCccCHHHHc---CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHH-HHhCCCCCCCCCCHHHHHHHHHHc
Confidence 3355555543 456778999999999999999999999654322 22222 223445667778999999999999
Q ss_pred ccCCCCCCCCH-HHHhcCCCCCC
Q 040812 278 QKGDPSKRWTA-SQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~-~~~l~hpw~~~ 299 (300)
.. ||++|+++ +++++||||++
T Consensus 232 ~~-dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 232 ER-DPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred cC-CHHHcCCChHHHHcCCCcCC
Confidence 99 99999997 58999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.97 Aligned_cols=237 Identities=30% Similarity=0.467 Sum_probs=190.8
Q ss_pred cceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCCCC------CCCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGT------PPNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
+|++.+.||+|+||.||++++. .+++.||+|++...... ....+|+.+++++ +|+||+++++++.... .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-K 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC-E
Confidence 4899999999999999999874 46889999998753211 1235689999999 5899999999988754 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
.|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999999998888899999999999999999999999999999999999998875543222
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
+..|.+||.... ...++.++|||||||++|||+||..||............... .....+.++...++
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRG--KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-ILKCDPPFPSFIGP 236 (332)
T ss_pred CCccccccCCccccCHHHhcC--CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCH
Confidence 233555555431 123567899999999999999999999654333222222222 23445566778899
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
.+.++|.+||.. ||++|| +++++++||||++
T Consensus 237 ~~~~li~~~l~~-dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 237 EAQDLLHKLLRK-DPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHHHHcCC-CHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999 999999 8899999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=323.07 Aligned_cols=234 Identities=29% Similarity=0.450 Sum_probs=189.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+|+.++..++|+||+++++++.+.. ..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-HLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-eEEEE
Confidence 4799999999999999999999999999999999754322 23457999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99999999999998888899999999999999999999999999999999999998876543222
Q ss_pred ---------------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 040812 197 ---------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE 243 (300)
Q Consensus 197 ---------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 243 (300)
+..|.+||... +..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR---GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHc---CCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 22344444433 446778999999999999999999999765432
Q ss_pred chHHHHHHHHhhCCCCCCCC--CCChHHHHHHHHHhccCCCCCCCC-HHHHhcCCCCCC
Q 040812 244 PDFLSLMLAICFREPPSLPE--CSSEKFRDFIRCCLQKGDPSKRWT-ASQLLSHPFLAD 299 (300)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~dp~~Rpt-~~~~l~hpw~~~ 299 (300)
.....+.. .......|. .+++++.++|.+|| . ||.+|++ ++++++||||++
T Consensus 237 ~~~~~i~~---~~~~~~~p~~~~~~~~~~~li~~ll-~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIIN---WKESLRFPPDPPVSPEAIDLICRLL-C-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhc---cCCcccCCCCCCCCHHHHHHHHHHc-c-ChhhcCCCHHHHhcCCCcCC
Confidence 22222211 011222222 35899999999999 5 8999999 999999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=319.38 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=183.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
..+|++++.||+|+||.||+|.+..+++.||+|.... ....+|+.++++++||||+++++++.... ..|+|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----GGTATEAHILRAINHPSIIQLKGTFTYNK-FTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----hhhHHHHHHHHhCCCCCCCCEeEEEEECC-eeEEEEecC
Confidence 4679999999999999999999999999999997542 23578999999999999999999988754 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------- 196 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------- 196 (300)
. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 244 (391)
T PHA03212 166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244 (391)
T ss_pred C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence 6 58999988877899999999999999999999999999999999999998765543322
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC------chHHHHHHHH----------------
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE------PDFLSLMLAI---------------- 253 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~------~~~~~~~~~~---------------- 253 (300)
+..|.+||... +..++.++|||||||++|||+||..||...... ......+...
T Consensus 245 gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 245 GTIATNAPELLA---RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred CccCCCChhhhc---CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 22344555433 456788999999999999999999887643211 0111111000
Q ss_pred -------hhC---CCCCCC-----CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 -------CFR---EPPSLP-----ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 -------~~~---~~~~~~-----~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
... .+...+ ...+.++.++|.+||.. ||++|||++|+++||||.+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~-dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAF-DAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcC-ChhhCCCHHHHhcChhhcc
Confidence 000 000000 12356799999999999 9999999999999999976
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.24 Aligned_cols=232 Identities=28% Similarity=0.465 Sum_probs=187.2
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|+++...... ...+|+.++.++ +||||+++++++.... ..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-EEEEEEeCCC
Confidence 46999999999999999999999999997643221 124577777766 8999999999988765 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++...+.+ +
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 999999998888899999999999999999999999999999999999999876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----CchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ----EPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
..|.+||... +..++.++|||||||++|||+||+.||..... ..................+|...+..+.++|
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 160 PNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred ccccCHHHHc---CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 2345555443 55677899999999999999999999953211 1111222223333455567888899999999
Q ss_pred HHHhccCCCCCCCC------HHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWT------ASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt------~~~~l~hpw~~~ 299 (300)
.+||.. ||++|++ ++++++||||++
T Consensus 237 ~~~L~~-dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 237 KSFLNK-DPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHhcC-CHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999 9999998 589999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=308.16 Aligned_cols=236 Identities=24% Similarity=0.350 Sum_probs=191.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-eEEEEE
Confidence 488999999999999999999999999999998654322 22357999999999999999999987765 899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 133 EYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++...+.+
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 999999999888643 3589999999999999999999999999999999999998765432221
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|||++|+.||........... +...........+...++.+.++
T Consensus 160 ~~~~~~~y~aPE~~~---~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 160 GRVGTVGYMAPEVVK---NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-VERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred cccCCCCccCcHHhc---CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-HHHHhhhcccccCcccCHHHHHH
Confidence 22355565543 45567899999999999999999999976443322222 22222334455666789999999
Q ss_pred HHHHhccCCCCCCC-----CHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|| +++++++||||.+
T Consensus 236 i~~~l~~-~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 236 CRQLLTK-DPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHccC-CHHHhcCCCCCCHHHHhcCcCccC
Confidence 9999999 999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.86 Aligned_cols=231 Identities=26% Similarity=0.384 Sum_probs=185.8
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHH---HHhcCCCceeEeceeeeCCCCcEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNI---LRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
|++.+.||+|+||.||+|.+..+++.||+|+++..... ....+|+.+ +++++||||+++++++.... ..|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-HVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-EEEE
Confidence 67899999999999999999999999999999754211 112345444 45678999999999988754 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||||+++++|..++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++...+++
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 9999999999988864 4799999999999999999999999999999999999999876543332
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+..|.+||... +..++.++|||||||++|||++|+.||...... .....+. ......|..+++.+.+
T Consensus 159 ~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~ 230 (324)
T cd05589 159 STFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFDSIV-NDEVRYPRFLSREAIS 230 (324)
T ss_pred cccccCccccCHhHhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hCCCCCCCCCCHHHHH
Confidence 22345555433 456778999999999999999999999654332 2222222 2344567778999999
Q ss_pred HHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 272 FIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 272 li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
+|.+||.. ||++|| ++.++++||||+++
T Consensus 231 li~~~L~~-dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 231 IMRRLLRR-NPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHhhc-CHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999 999999 69999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=322.81 Aligned_cols=235 Identities=29% Similarity=0.463 Sum_probs=186.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcC-C-----CceeEeceeeeCCCCcEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTN-S-----PYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~l 130 (300)
+|++.+.||+|+||.|-+|.+.+|++.||||++++.... .....|+.+|..++ | -|+|+++++|...+ ++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-ceee
Confidence 689999999999999999999999999999999875533 23356999999997 4 38999999998754 9999
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-----Cccc-------
Q 040812 131 LMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-----PCGY------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-----~~~~------- 196 (300)
|+|.++. +|.++++.+. .|+...++.++.||+.||.+||+.||||+||||+||||...... ++|.
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 9999966 9999999764 58999999999999999999999999999999999999865443 2332
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE------------- 257 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------- 257 (300)
+..|.+||... |..|+.+.||||||||++||+||.+.|.+.+.. +.+..+..+....
T Consensus 345 vytYiQSRfYRAPEVIL---GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~-DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 345 VYTYIQSRFYRAPEVIL---GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY-DQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred ceeeeeccccccchhhc---cCCCCCccceeehhhhHHhHhcCccccCCCCHH-HHHHHHHHHhCCCCHHHHHhccccce
Confidence 33466776665 888999999999999999999997777544332 2222222211000
Q ss_pred -----------------------------------CCCCC-----------CCCChHHHHHHHHHhccCCCCCCCCHHHH
Q 040812 258 -----------------------------------PPSLP-----------ECSSEKFRDFIRCCLQKGDPSKRWTASQL 291 (300)
Q Consensus 258 -----------------------------------~~~~~-----------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~ 291 (300)
....| ......+.|||.+||.. ||.+|+|+.++
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~-dP~~R~tp~qa 499 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW-DPAERITPAQA 499 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc-CchhcCCHHHH
Confidence 00011 01124579999999999 99999999999
Q ss_pred hcCCCCCC
Q 040812 292 LSHPFLAD 299 (300)
Q Consensus 292 l~hpw~~~ 299 (300)
|+||||..
T Consensus 500 l~Hpfl~~ 507 (586)
T KOG0667|consen 500 LNHPFLTG 507 (586)
T ss_pred hcCccccc
Confidence 99999974
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=321.29 Aligned_cols=240 Identities=27% Similarity=0.410 Sum_probs=192.0
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++||||+++++++.+.. ..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~-~~ 118 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK-YL 118 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-EE
Confidence 4567899999999999999999999999999999998643211 12357999999999999999999988755 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999999998754 689999999999999999999999999999999999998876543222
Q ss_pred --------eeecccccccccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC--CC
Q 040812 197 --------SCLYESGEARHRK-HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE--CS 265 (300)
Q Consensus 197 --------~~~~~~~~~~~~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 265 (300)
+..|.+||..... .+..++.++|||||||++|||+||+.||........+..+.. ......++. .+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~ 274 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD---HKNSLTFPDDIEI 274 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc---CCCcCCCCCcCCC
Confidence 2335566654322 133467899999999999999999999976443222222211 112233343 46
Q ss_pred ChHHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSK--RWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~--Rpt~~~~l~hpw~~~ 299 (300)
+.++.++|.+||+. +|.+ |++++++++||||++
T Consensus 275 s~~~~~li~~~L~~-~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTD-REVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccC-hhhccCCCCHHHHhcCcccCC
Confidence 89999999999998 9988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=306.76 Aligned_cols=229 Identities=28% Similarity=0.418 Sum_probs=184.3
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
||+|+||.||++.+..+++.||+|.+...... ..+..|+.++++++|+||+++.+++.... ..|+||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-DLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-eEEEEEeCCCCCC
Confidence 79999999999999999999999998654322 22356999999999999999999887754 8999999999999
Q ss_pred HHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------
Q 040812 140 LEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------- 196 (300)
Q Consensus 140 L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------- 196 (300)
|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++...+.+
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 9988743 34689999999999999999999999999999999999998765543222
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
+..|.+||... +..++.++|||||||++|||+||+.||................ .......+...++.+.+++.+|
T Consensus 160 ~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 160 TPGFMAPELLQ---GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred CcCccCHHHhc---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-cccCCCCcccCCHHHHHHHHHH
Confidence 22345555443 4566789999999999999999999997544332222222222 2334455677899999999999
Q ss_pred hccCCCCCCC-----CHHHHhcCCCCCC
Q 040812 277 LQKGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 277 l~~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
|.. ||++|| +++++++||||++
T Consensus 236 l~~-~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 236 LAK-DPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred hcC-CHHHhcCCCCCCHHHHhcChhhhc
Confidence 999 999999 8899999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=313.60 Aligned_cols=227 Identities=27% Similarity=0.455 Sum_probs=186.9
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+..+++.||+|+++..... ....+|..+++.+ +||||+++++++.... ..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-RLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 4699999999999999999999999999754321 1234688888877 6999999999988754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+++|..++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++...+.+ +
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 999999998888899999999999999999999999999999999999998876543222 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|+|+||+.||...... .....+ .......+...++.+.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~~i-~~~~~~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 160 PDYIAPEILS---YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQSI-LEDEVRYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ccccCHHHhc---CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHHHH-HcCCCCCCCcCCHHHHHHHHHHc
Confidence 3355555543 556788999999999999999999999654321 222222 23445567778999999999999
Q ss_pred ccCCCCCCCCH-----HHHhcCCCCCC
Q 040812 278 QKGDPSKRWTA-----SQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~-----~~~l~hpw~~~ 299 (300)
.. ||++||++ .++++||||++
T Consensus 232 ~~-dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 232 TK-NPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cC-CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99 99999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=306.57 Aligned_cols=236 Identities=25% Similarity=0.408 Sum_probs=180.4
Q ss_pred CcceeeeeecCCcceEEEEEEEcc-CCeEEEEEEeecCCCCC----CCHHHHHHHHhc---CCCceeEeceeeeC----C
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQ-TLALYALKVMQCDRGTP----PNPQELNILRQT---NSPYIVKCHQIFTK----P 124 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l---~h~niv~~~~~~~~----~ 124 (300)
.+|++.+.||+|+||.||+|++.. +++.||+|.++...... ...+|+.+++++ +||||+++++++.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999854 57889999987543322 235677777665 69999999998742 2
Q ss_pred CCcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------ 196 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------ 196 (300)
....++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 346899999997 4999998753 3589999999999999999999999999999999999998776543322
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC----
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS---- 260 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 260 (300)
+..|.+||... +..++.++|||||||++|||++|++||...........+........+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred ccCCcccccccccccccChHHHh---CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 23355555543 44567899999999999999999999976554333333322111000000
Q ss_pred ------------------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 261 ------------------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 261 ------------------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.....++.++++|.+||+. ||++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF-NPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhcc-CchhcCCHHHHhcCCCC
Confidence 1123577889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=317.31 Aligned_cols=227 Identities=26% Similarity=0.443 Sum_probs=187.1
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.||+|+||.||++.+..+++.||+|+++..... ....+|+.+++.++||||+++++++.... ..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-EEEEEEeCCCC
Confidence 4699999999999999999999999999754321 12356889999999999999999988754 89999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
|+|..++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++...+.+ +
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 9999999887789999999999999999999997 7999999999999998876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||+||..||...... .... ........++...++++.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~-~i~~~~~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 160 PEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFE-LILMEEIRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCHHHHc---cCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHH-HHhcCCCCCCCCCCHHHHHHHHHHh
Confidence 2345555443 456778999999999999999999999654332 1222 2223445667788999999999999
Q ss_pred ccCCCCCCC-----CHHHHhcCCCCCC
Q 040812 278 QKGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
.. ||++|+ ++.++++||||.+
T Consensus 232 ~~-dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 232 KK-DPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hc-CHHHhCCCCCCCHHHHhcCCCcCC
Confidence 99 999997 8999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=312.95 Aligned_cols=239 Identities=37% Similarity=0.616 Sum_probs=190.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++.+.||+|+||.||++.+..++..+|+|.+...... ..+.+|++++++++|+||+++++++.... ..|+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-EEEEEE
Confidence 46899999999999999999999999999999998754322 23467999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCccc---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+|||++.++...+.+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 9999999999998877899999999999999999999975 799999999999998876543222
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchH----------------------------
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF---------------------------- 246 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~---------------------------- 246 (300)
+..|.+||... +..++.++|||||||++|+|++|+.||.........
T Consensus 163 ~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 163 VGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred CCCccccCHHHhc---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 22355566543 455778999999999999999999999643221100
Q ss_pred ------------HHHHHHHhhCCCCCCCC-CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 247 ------------LSLMLAICFREPPSLPE-CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 247 ------------~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
......+.....+..+. ..+.++++||.+||+. ||++|||++|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK-NPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccC-CcccCcCHHHHhhCHHHhc
Confidence 00111111122222222 3577899999999999 9999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.42 Aligned_cols=227 Identities=25% Similarity=0.399 Sum_probs=185.8
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|+++..... .....|..++..+ +||||+++++++.... ..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-RLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-eEEEEEeCCC
Confidence 4699999999999999999999999998754321 1234688888765 7999999999998764 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 999999998888899999999999999999999999999999999999999876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||+||+.||...... .....+. ......|...+.++.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 160 PDYIAPEILQ---ELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFESIL-HDDVLYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCHHHHc---CCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHHHHH-cCCCCCCCCCCHHHHHHHHHHh
Confidence 2345555443 455778999999999999999999999754432 2222222 3344566678999999999999
Q ss_pred ccCCCCCCC-------CHHHHhcCCCCCC
Q 040812 278 QKGDPSKRW-------TASQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rp-------t~~~~l~hpw~~~ 299 (300)
.. ||++|+ +++++++||||.+
T Consensus 232 ~~-dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 232 TK-NPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cc-CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99 999999 8999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=305.60 Aligned_cols=232 Identities=28% Similarity=0.424 Sum_probs=194.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC-----HHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+|++.+.||+|+||+|-+|.....|+.||||.++++...+.. .+|+++|..++||||++++++|++.. .+.||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-KIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-KIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-eEEEE
Confidence 5799999999999999999999999999999999877655432 67999999999999999999999865 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------------- 195 (300)
|||..+|.|.+|+..++.+++.+++.+++||.+|+.|+|.++++|||||.+|||+|.+++.++.
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT 211 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT 211 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence 9999999999999999999999999999999999999999999999999999999998776433
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
++.+|..||.... ..+.++.+|-|||||+||.|+.|..||.+.+. ...+.++..+.... | ..+.+..-||
T Consensus 212 FCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrE-P-~~PSdA~gLI 283 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYRE-P-ETPSDASGLI 283 (668)
T ss_pred hcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccC-C-CCCchHHHHH
Confidence 2444555555441 23457899999999999999999999966433 23444443332222 2 2355678999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
..||.. ||++|.|++++..|=|++
T Consensus 284 RwmLmV-NP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 284 RWMLMV-NPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHhc-CcccchhHHHHhhhheee
Confidence 999999 999999999999999975
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=314.19 Aligned_cols=227 Identities=29% Similarity=0.479 Sum_probs=186.2
Q ss_pred eeecCCcceEEEEEEEc---cCCeEEEEEEeecCCC------CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 63 QVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRG------TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+.||+|+||.||++++. .+++.||+|+++.... .....+|+.+++.++||||+++++++..+. ..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-KLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-eEEEEEe
Confidence 67999999999999874 4688999999875321 112356999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999998888899999999999999999999999999999999999998876543322
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...... .....+. .....++...++.+.++|.
T Consensus 161 ~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~li~ 232 (323)
T cd05584 161 CGTIEYMAPEILM---RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----KTIDKIL-KGKLNLPPYLTPEARDLLK 232 (323)
T ss_pred CCCccccChhhcc---CCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----HHHHHHH-cCCCCCCCCCCHHHHHHHH
Confidence 23355555543 445677999999999999999999999754432 2222222 2344567778999999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
+||.. ||++|| +++++++||||..
T Consensus 233 ~~l~~-~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 233 KLLKR-NPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHccc-CHhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999 999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=311.49 Aligned_cols=228 Identities=25% Similarity=0.419 Sum_probs=185.1
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHh-cCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQ-TNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|+++.... ......|..++.. ++||||+++++++.... ..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-NLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-EEEEEEeCCC
Confidence 469999999999999999999999999975421 1123457777765 58999999999988754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999999998877899999999999999999999999999999999999998875543222 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||+||..||...+.. .....+. ...+..+...+.+++++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~-~~~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 160 PDYIAPEILL---GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIR-MDNPCYPRWLTREAKDILVKLF 231 (316)
T ss_pred ccccCHHHHc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hCCCCCCccCCHHHHHHHHHHh
Confidence 2355565543 456788999999999999999999999654322 2222222 2334566678999999999999
Q ss_pred ccCCCCCCCCHH-HHhcCCCCCCC
Q 040812 278 QKGDPSKRWTAS-QLLSHPFLADA 300 (300)
Q Consensus 278 ~~~dp~~Rpt~~-~~l~hpw~~~~ 300 (300)
.. ||++||++. ++++||||+++
T Consensus 232 ~~-~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 232 VR-EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred cc-CHhhcCCChHHHHcCcccCCC
Confidence 99 999999996 99999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=308.13 Aligned_cols=240 Identities=25% Similarity=0.383 Sum_probs=187.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+++|++.+.||+|+||.||+|.++.+++.||+|.++..... ....+|+.++++++|+||+++++++..+. ..|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-SLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-eEEEE
Confidence 457899999999999999999999999999999998754322 23467999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 132 MEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++...+.+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 999986 888887654 3589999999999999999999999999999999999998776543322
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh----------------
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF---------------- 255 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------- 255 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...+..............
T Consensus 162 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 162 SNEVVTLWYRPPDVLLG--SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccCCHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 222445554321 234677999999999999999999999765443222222111000
Q ss_pred --CCCC-------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 --REPP-------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 --~~~~-------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+. .....++++++++|.+||.. ||.+|||+.|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQY-ESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccC-ChhhCCCHHHHhcChhhhh
Confidence 0000 01123578899999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=302.80 Aligned_cols=236 Identities=28% Similarity=0.430 Sum_probs=189.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCC----cEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSG----EVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~lv~e 133 (300)
.|+-.+++|+|+||.||+|...++++.||||.+-.+... ..+|+.+|+.+.|||||++..+|....+ +..+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 477889999999999999999999999999988665543 2569999999999999999888754322 3668999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC----CCccc---------
Q 040812 134 YMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME----HPCGY--------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~----~~~~~--------- 196 (300)
|++. +|...++. +.+++...++.+..||++||.|||+.||+||||||.|+|+|.+.. +++|.
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 9987 99988874 567999999999999999999999999999999999999997632 23332
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-------CC----
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-------PP---- 259 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------~~---- 259 (300)
+..|.+||.... ...|+.+.||||.||++.||+-|++-|.+.........++....... .+
T Consensus 182 niSYicSRyYRaPELifg--a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred ceeEEEeccccCHHHHcC--ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 444666666553 34678899999999999999999999987655444444443321000 00
Q ss_pred -------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 260 -------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 260 -------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+....+++..+|+.++|+. +|.+|.++.|++.||||.+
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y-~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQY-SPSKRLSALEALAHPFFDE 311 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhcc-ChhhcCCHHHHhcchhhHH
Confidence 02334578999999999999 9999999999999999975
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=320.08 Aligned_cols=235 Identities=26% Similarity=0.409 Sum_probs=188.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|.++.+++.||+|+++..... ....+|+.++.+++|+||+++++.+.... ..|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-NLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-EEEEE
Confidence 4689999999999999999999999999999998743211 12356899999999999999999988764 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999998888899999999999999999999999999999999999998775543222
Q ss_pred ---------------------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 040812 197 ---------------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF 237 (300)
Q Consensus 197 ---------------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf 237 (300)
+..|.+||... +..++.++|||||||++|||+||+.||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM---QTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc---CCCCCCcceeccccceeeecccCCCCC
Confidence 23355555543 455778999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhCCCCCCCC--CCChHHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCCC
Q 040812 238 LEPGQEPDFLSLMLAICFREPPSLPE--CSSEKFRDFIRCCLQKGDPSKRW---TASQLLSHPFLADA 300 (300)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~dp~~Rp---t~~~~l~hpw~~~~ 300 (300)
...........+.. ......+|. ..+++++++|.+++ . ||.+|+ +++++++||||+++
T Consensus 237 ~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~~li~~l~-~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMN---WKETLVFPPEVPISEKAKDLILRFC-T-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHc---CCCceecCCCCCCCHHHHHHHHHhc-c-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 76543322222211 111222232 36889999999976 6 899998 48999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=311.29 Aligned_cols=232 Identities=26% Similarity=0.423 Sum_probs=189.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 131 (300)
+|++.+.||+|+||.||+|++..+++.||+|++....... ....|..++..+ .|++|+.+++++.... ..|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-RLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-EEEEE
Confidence 4889999999999999999999999999999987643221 124467777766 5789999999987754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999998888899999999999999999999999999999999999999876543222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...... .....+. .....+|...++++.++
T Consensus 160 ~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~s~~~~~l 231 (323)
T cd05616 160 TFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIM-EHNVAYPKSMSKEAVAI 231 (323)
T ss_pred cCCCChhhcCHHHhc---CCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHH-hCCCCCCCcCCHHHHHH
Confidence 23355555543 456788999999999999999999999654332 2222222 33455677889999999
Q ss_pred HHHHhccCCCCCCCCH-----HHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTA-----SQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~-----~~~l~hpw~~~ 299 (300)
+.+||+. ||++|++. .++++||||+.
T Consensus 232 i~~~l~~-~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 232 CKGLMTK-HPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHccc-CHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999999 99999984 89999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=310.95 Aligned_cols=227 Identities=26% Similarity=0.458 Sum_probs=183.7
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHh-cCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQ-TNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+..+++.||+|+++..... .....|..++.. .+||||+++++++.... ..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-HLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 4699999999999999999999999999754321 112346666654 48999999999988754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999999998888899999999999999999999999999999999999998775543222 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||++|+.||...+.. .....+ ....+.++...+.++.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~i-~~~~~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 160 PDYIAPEILK---GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDSI-LNDRPHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred ccccCHHHHc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HcCCCCCCCCCCHHHHHHHHHHc
Confidence 3345555443 455778999999999999999999999754332 222222 23455677788999999999999
Q ss_pred ccCCCCCCCCH-HHHhcCCCCCC
Q 040812 278 QKGDPSKRWTA-SQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~-~~~l~hpw~~~ 299 (300)
.. ||++||++ .++++||||++
T Consensus 232 ~~-~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 232 ER-DPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred cC-CHHHcCCChHHHHcCcccCC
Confidence 99 99999986 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=322.61 Aligned_cols=239 Identities=23% Similarity=0.364 Sum_probs=183.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCC-------CCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKP-------SGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------~~~ 127 (300)
...+|++.+.||+|+||.||+|.+..+++.||||.+..+. ....+|+.+|++++|+||+++++++... ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 3467999999999999999999999999999999885432 2235799999999999999998876321 124
Q ss_pred EEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-C---Cccc---
Q 040812 128 VSILMEYMDAGSLEIYVK----SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-H---PCGY--- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-~---~~~~--- 196 (300)
+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|.
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 7799999986 7776664 3456999999999999999999999999999999999999986532 2 2221
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC--------
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-------- 256 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------- 256 (300)
+..|.+||.... ...++.++|||||||++|||+||.+||.+.........++......
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLG--ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 233556665321 2357789999999999999999999997654433322222211000
Q ss_pred ----------------CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 ----------------EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 ----------------~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....+|...++++.+||.+||+. ||++|||+.|+++||||.+
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~-dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKY-EPLKRLNPIEALADPFFDD 356 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCC-ChhHCcCHHHHhCChhHHh
Confidence 00113445678999999999999 9999999999999999964
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=297.09 Aligned_cols=233 Identities=30% Similarity=0.426 Sum_probs=192.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++||||+++++++.... ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence 4688999999999999999999999999999998754322 12356999999999999999999988765 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+|+||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++...+.+
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999999998877899999999999999999999999999999999999999875543222
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
...|.+||... +...+.++|||||||++|||++|+.||....... ..............+...+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVIS---GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFKIATQPTNPQLPSHVSP 234 (263)
T ss_pred cccccCCCcCccccCcceec---cCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHHHhccCCCCCCCccCCH
Confidence 12345555543 3446789999999999999999999996543221 22222233344566778899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.+.++|.+||.. +|++|||+.++++||||
T Consensus 235 ~~~~li~~~l~~-~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 235 DARNFLRRTFVE-NAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHHhhc-CcccCCCHHHHhhCCCC
Confidence 999999999999 99999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=309.93 Aligned_cols=232 Identities=26% Similarity=0.436 Sum_probs=188.6
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|+++...... ...+|+.++.++ +|+||+.+++++.... .+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-RLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-EEEEEEeCCC
Confidence 46999999999999999999999999997643221 235688888887 6999999999988754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 999999998877899999999999999999999999999999999999998876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE--PDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
..|.+||... +..++.++|||||||++|||+||..||...... ..............+...|...+..+.++|.+
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 160 PNYIAPEILR---GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred cccCCHHHHC---CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2345555443 556788999999999999999999999643221 12222333333445566788889999999999
Q ss_pred HhccCCCCCCCC------HHHHhcCCCCCC
Q 040812 276 CLQKGDPSKRWT------ASQLLSHPFLAD 299 (300)
Q Consensus 276 ~l~~~dp~~Rpt------~~~~l~hpw~~~ 299 (300)
||.. ||++|++ ++++++||||++
T Consensus 237 ~L~~-dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 237 FLNK-DPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred Hhcc-CHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999 9999998 579999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=302.62 Aligned_cols=235 Identities=25% Similarity=0.395 Sum_probs=180.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhc---CCCceeEeceeeeCC----CC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQT---NSPYIVKCHQIFTKP----SG 126 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l---~h~niv~~~~~~~~~----~~ 126 (300)
+|++.+.||+|+||.||+|.++.+++.||+|.++...... ...+|+.+++.+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999987543222 234577777655 799999999987542 23
Q ss_pred cEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------
Q 040812 127 EVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------- 196 (300)
..++||||+.+ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++...+.+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 58999999985 898888753 3489999999999999999999999999999999999998776543222
Q ss_pred ----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC--------
Q 040812 197 ----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP-------- 258 (300)
Q Consensus 197 ----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 258 (300)
+..|.+||... +..++.++|||||||++|+|++|.+||...........+.........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred CcccCCCccccccccCchHhh---CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 23356666543 455788999999999999999999999655433222222221110000
Q ss_pred --------------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 259 --------------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 259 --------------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
......+++.+.++|.+||+. ||++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTF-NPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhcc-CcccCCCHHHHhcCCCC
Confidence 001124577889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=300.52 Aligned_cols=230 Identities=26% Similarity=0.354 Sum_probs=181.5
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
||+|+||.||+++++.+++.||+|.+...... .....|+.++++++||||+++++++.... ..|+||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-HLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-eEEEEEecCCCCC
Confidence 79999999999999999999999998643221 22346999999999999999999988754 8999999999999
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------eee
Q 040812 140 LEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------SCL 199 (300)
Q Consensus 140 L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------~~~ 199 (300)
|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++...+.+ +..
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 998886533 488999999999999999999999999999999999998775542221 223
Q ss_pred ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhcc
Q 040812 200 YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQK 279 (300)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 279 (300)
|.+||... +..++.++|||||||++|||++|..||............................+++++++|.+||+.
T Consensus 160 y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 160 YMAPEILK---EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred ccCHHHHc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 45555443 445778999999999999999999999754333222222222222222222346789999999999999
Q ss_pred CCCCCCCCH----HHHhcCCCCCC
Q 040812 280 GDPSKRWTA----SQLLSHPFLAD 299 (300)
Q Consensus 280 ~dp~~Rpt~----~~~l~hpw~~~ 299 (300)
||++||++ +++++||||+.
T Consensus 237 -~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 -KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred -CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 77889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=311.43 Aligned_cols=241 Identities=26% Similarity=0.348 Sum_probs=185.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||++++..+++.||+|++...... ..+.+|+.++..++|+||+.+++++.... ..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-NLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-eEEEE
Confidence 4799999999999999999999999999999998642211 22456899999999999999999998764 89999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--------------- 195 (300)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999999976 4579999999999999999999999999999999999999876543221
Q ss_pred -----ceeeccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -----YSCLYESGEARHRKH--GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++..|.+||...... ...++.++|||||||++|||++|+.||...........+.........+......++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 233455666543211 2345678999999999999999999996543322221211110001111222347889
Q ss_pred HHHHHHHHhccCCCC--CCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPS--KRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~--~Rpt~~~~l~hpw~~~ 299 (300)
++++|.+||.. +++ .|++++++++||||++
T Consensus 240 ~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICS-PETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccC-cccccCCCCHHHHhcCCCCCC
Confidence 99999998865 444 3889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=311.60 Aligned_cols=238 Identities=25% Similarity=0.336 Sum_probs=183.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
-.++|++.+.||+|+||.||++.+..+++.||+|.+...... ....+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999999999999998654222 23357999999999999999999886432
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
...|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 247999999976 66666643 488999999999999999999999999999999999999876543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH---------------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA--------------- 252 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------------- 252 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...+....+......
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred CccCCCCcccCCCCCchhcc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 22356666543 556778999999999999999999999765432211111110
Q ss_pred ---HhhCCC-------------------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 253 ---ICFREP-------------------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 253 ---~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.....+ .......++.+++||.+||.. ||++|||+.|+++||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~-dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI-DPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhcc-CcccCCCHHHHhcCchhhh
Confidence 000000 001122357799999999999 9999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=311.89 Aligned_cols=227 Identities=26% Similarity=0.396 Sum_probs=182.8
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHH-HHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELN-ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|++....... ....|.. +++.++||||+++++++.... ..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-KLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-EEEEEEcCCC
Confidence 46999999999999999999999999987532211 1223433 457799999999999988754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 999999998888899999999999999999999999999999999999998876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||++|..||...+.. .....+. ......+...++.+.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~i~-~~~~~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 160 PEYLAPEVLR---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----EMYDNIL-NKPLRLKPNISVSARHLLEGLL 231 (323)
T ss_pred hhhcChhhhc---CCCCCccccccccchhhhhhhcCCCCCCCCCHH----HHHHHHH-cCCCCCCCCCCHHHHHHHHHHh
Confidence 2355555543 456778999999999999999999999654321 2222222 3344555667999999999999
Q ss_pred ccCCCCCCCCH----HHHhcCCCCCC
Q 040812 278 QKGDPSKRWTA----SQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~----~~~l~hpw~~~ 299 (300)
+. ||++||++ .++++||||++
T Consensus 232 ~~-~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 232 QK-DRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred hc-CHHhCCCCCCCHHHHHcCCCcCC
Confidence 99 99999987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=302.35 Aligned_cols=236 Identities=22% Similarity=0.347 Sum_probs=189.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+|+..+.||+|+||.||++.+..+++.||+|.+....... ...+|+.++++++|+|++.+++.+.... ..|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-EEEEEE
Confidence 4788899999999999999999999999999986543221 2356999999999999999999987754 899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 133 EYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++...+.+
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 999999999988643 3589999999999999999999999999999999999998765432222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|+|++|+.||......... ..............+...++++.++
T Consensus 160 ~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 160 GRVGTVGYMAPEVVK---NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred CCCCCccccChHHHc---CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhhhhhcCccCCHHHHHH
Confidence 23455555543 445778999999999999999999999764432211 1122222222334566788999999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
+.+||+. ||++||| ++|+++||||++
T Consensus 236 i~~~l~~-~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 236 CKMLLCK-DPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHhhc-CHHHccCCCCCchHHHHcChhhhc
Confidence 9999999 9999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=310.46 Aligned_cols=232 Identities=24% Similarity=0.355 Sum_probs=183.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKPS 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 125 (300)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++..... ..+.+|+.++.++ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4568999999999999999999852 34578999998753322 2346799999999 8999999999887666
Q ss_pred CcEEEEEeccCCCCHHHHHHhC----------------------------------------------------------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR---------------------------------------------------------- 147 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------- 147 (300)
+.+++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5799999999999999998742
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------------eeccc
Q 040812 148 ----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------------CLYES 202 (300)
Q Consensus 148 ----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------------~~~~~ 202 (300)
..+++..+..++.||+.||.|||++||+||||||+|||++.++...++++ ..|.+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 23677888999999999999999999999999999999987655433221 23555
Q ss_pred cccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCC
Q 040812 203 GEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGD 281 (300)
Q Consensus 203 ~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~d 281 (300)
||... +..++.++|||||||++|||+| |..||........... ..........+...++.+.++|.+||.. |
T Consensus 245 PE~~~---~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~-d 317 (338)
T cd05102 245 PESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---RLKDGTRMRAPENATPEIYRIMLACWQG-D 317 (338)
T ss_pred cHHhh---cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHhcCCCCCCCCCCCHHHHHHHHHHccC-C
Confidence 55443 4557789999999999999997 9999976544332222 2222334455677889999999999999 9
Q ss_pred CCCCCCHHHHhc
Q 040812 282 PSKRWTASQLLS 293 (300)
Q Consensus 282 p~~Rpt~~~~l~ 293 (300)
|++|||+.++++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=315.94 Aligned_cols=240 Identities=26% Similarity=0.396 Sum_probs=190.0
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++.+.||+|+||.||++++..+++.||+|++...... ..+.+|+.+++.++||||+++++++..+. ..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~-~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK-YL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-EE
Confidence 3457899999999999999999999999999999998642211 12357999999999999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++..++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999999999754 68999999999999999999999999999999999999876543222
Q ss_pred -------ceeeccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC--CC
Q 040812 196 -------YSCLYESGEARHRKH-GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE--CS 265 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 265 (300)
++..|.+||...... .+.++.++|||||||++|||+||+.||...........++. ......+|. ..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~---~~~~~~~p~~~~~ 274 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD---HKNSLNFPEDVEI 274 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCcccCCCCcccC
Confidence 233466666654322 23467899999999999999999999976543222222211 112233333 46
Q ss_pred ChHHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSK--RWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~--Rpt~~~~l~hpw~~~ 299 (300)
+..++++|.+||.. ++.+ |++++++++||||++
T Consensus 275 s~~~~~li~~~L~~-~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 275 SKHAKNLICAFLTD-REVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccC-chhccCCCCHHHHhcCcccCC
Confidence 88999999999976 6544 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=313.79 Aligned_cols=237 Identities=28% Similarity=0.398 Sum_probs=189.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|+++.+++.||+|+++.... ...+.+|+.+++.++|+||+++++++.... ..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-NLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-eEEEE
Confidence 468999999999999999999999999999999975432 122356899999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 132 MEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++...+.+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999999875 6799999999999999999999999999999999999999876543222
Q ss_pred ------eeeccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC--CCC
Q 040812 197 ------SCLYESGEARHRKH---GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP--ECS 265 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 265 (300)
+..|.+||...... +..++.++|||||||++|||+||+.||........+..+... .....++ ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 236 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF---QRFLKFPEDPKV 236 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---CCccCCCCCCCC
Confidence 22355666543211 345677999999999999999999999765433222222111 1112223 246
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.+.++|.+|| . ||++|||++++++||||.+
T Consensus 237 ~~~~~~li~~ll-~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 237 SSDFLDLIQSLL-C-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHHHHHHHc-c-ChhhCCCHHHHhCCCCcCC
Confidence 889999999999 5 8999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.24 Aligned_cols=236 Identities=27% Similarity=0.323 Sum_probs=180.4
Q ss_pred eeeeecCC--cceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 61 KLQVLGQG--NGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 61 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
++++||+| +|++||++.++.+++.||+|.+....... ...+|+.+++.++||||+++++++..+. ..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-EEEEEEec
Confidence 56789999 78999999999999999999987543222 2356999999999999999999998765 89999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 135 MDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.....+
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999653 3589999999999999999999999999999999999998764332111
Q ss_pred ----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC----------
Q 040812 197 ----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR---------- 256 (300)
Q Consensus 197 ----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------- 256 (300)
...|.+||..... ...++.++|||||||++|||+||+.||...................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1225566654321 1346789999999999999999999996533222111111000000
Q ss_pred -----------------------C--------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 -----------------------E--------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 -----------------------~--------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
. ........++.+.+||.+||+. ||++|||++++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR-NPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhh-CchhcCCHHHHhcChhhhh
Confidence 0 0001123467899999999999 9999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=308.24 Aligned_cols=232 Identities=26% Similarity=0.418 Sum_probs=188.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCC-CceeEeceeeeCCCCcEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNS-PYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv 131 (300)
+|+..+.||+|+||.||+|+++.+++.||+|++...... .....|..++..+.| ++|+++++++.... ..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-RLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-EEEEE
Confidence 478889999999999999999999999999998754321 123457888887764 67888988887754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------------- 195 (300)
|||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 9999999999999888889999999999999999999999999999999999999987654322
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...... .....+. ......|...+.++.++
T Consensus 160 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~l 231 (323)
T cd05615 160 TFCGTPDYIAPEIIA---YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIM-EHNVSYPKSLSKEAVSI 231 (323)
T ss_pred CccCCccccCHHHHc---CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hCCCCCCccCCHHHHHH
Confidence 223355555443 455778999999999999999999999754332 2222222 33445677789999999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
+.+||.. ||++|++ .+++++||||+.
T Consensus 232 i~~~l~~-~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 232 CKGLMTK-HPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HHHHccc-CHhhCCCCCCCCHHHHhcCcccCC
Confidence 9999999 9999997 579999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=299.30 Aligned_cols=237 Identities=31% Similarity=0.474 Sum_probs=189.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ....+|+.+++.++||||+++++.+.... ..|+|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-KLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-EEEEEEe
Confidence 45789999999999999999999999999999998754322 12357999999999999999999987754 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------------ 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------------ 195 (300)
|+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++...+.
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 99999999999888889999999999999999999999999999999999999876543221
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC--CCCCChHHHHH
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDF 272 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l 272 (300)
++..|.+||.......+.++.++|||||||++|+|++|..||............... ...++.. ...++..+.++
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQPPKLKDKMKWSNSFHHF 244 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCCCcccccCCCCHHHHHH
Confidence 123456666643333445677999999999999999999999654432221111111 1111111 12457889999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPF 296 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw 296 (300)
|.+||.. ||++||+++++++|||
T Consensus 245 i~~~l~~-~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 245 VKMALTK-NPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHccC-CchhCcCHHHHhcCCC
Confidence 9999999 9999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=312.44 Aligned_cols=227 Identities=28% Similarity=0.457 Sum_probs=184.8
Q ss_pred eeecCCcceEEEEEEEc---cCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 63 QVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
+.||+|+||.||++++. .+++.||+|++...... ....+|+.++++++||||+++++++..+. ..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-KLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-EEEEEEcCC
Confidence 67999999999999873 57899999999754321 12356999999999999999999988754 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------- 196 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------- 196 (300)
++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 9999999998877899999999999999999999999999999999999998776543322
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...... .....+. .....++...++.+.++|.+|
T Consensus 161 ~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 161 TVEYMAPEVVN---RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMIL-KAKLGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred ChhhcCHHHHc---CCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHHHHH-cCCCCCCCCCCHHHHHHHHHH
Confidence 22344455433 345677999999999999999999999654322 2222222 334456777899999999999
Q ss_pred hccCCCCCCCC-----HHHHhcCCCCCC
Q 040812 277 LQKGDPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 277 l~~~dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
|+. ||++||+ ++++++||||..
T Consensus 233 l~~-~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 233 FKR-NPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hhc-CHhHcCCCCCCCHHHHhCCCCcCC
Confidence 999 9999999 778999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=301.28 Aligned_cols=240 Identities=25% Similarity=0.368 Sum_probs=186.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+++|++.+.||+|+||.||+|++..+++.||+|.++..... ....+|+.++++++|+||+++++++..+. ..|+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-SLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-eEEEE
Confidence 467899999999999999999999999999999998754322 23467999999999999999999998764 89999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------
Q 040812 132 MEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------- 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------- 197 (300)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++...++++
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 999975 888888753 46899999999999999999999999999999999999998765433222
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----------C----
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF-----------R---- 256 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~---- 256 (300)
..|.+||.... ...++.++|||||||++|||+||++||...+.......+...... .
T Consensus 162 ~~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 162 SNEVVTLWYRPPDILLG--STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccceeecccCcHHHhC--CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 22444554321 234667999999999999999999999754432211111110000 0
Q ss_pred --CCC--------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 --EPP--------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 --~~~--------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+ .....+++.++++|.+||.. ||.+|||++|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~-dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQF-EGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcC-CcccCcCHHHHhcCccccc
Confidence 000 01124678899999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=298.21 Aligned_cols=241 Identities=28% Similarity=0.391 Sum_probs=188.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
...++|++.+.||+|+||.||+|++..+++.||+|++...... ....+|+.++++++|+||+++++++.... ..|+|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-~~~iv 84 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-KLWIC 84 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-EEEEE
Confidence 3456799999999999999999999999999999998654322 12357999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++...+.+
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999998777899999999999999999999999999999999999998775432221
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
...|.+||.........++.++|||||||++|||++|..||...........................++..+.+|
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 1235555554322234456789999999999999999999965432211111111100011111123467899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPF 296 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw 296 (300)
|.+||.. ||++|||++++++|+|
T Consensus 245 i~~~l~~-~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 245 VKISLTK-NPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHhhC-ChhhCcCHHHHhcCCC
Confidence 9999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=313.01 Aligned_cols=238 Identities=27% Similarity=0.347 Sum_probs=184.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC----CcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----GEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 129 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ....+|+.+++.++|+||+++++++.... ...|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999988643221 23467999999999999999999987543 2689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-----------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------- 198 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~----------- 198 (300)
+||||+.+ +|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.++...+.+++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999974 888888877789999999999999999999999999999999999999987654333222
Q ss_pred ---------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH-----------------
Q 040812 199 ---------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA----------------- 252 (300)
Q Consensus 199 ---------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~----------------- 252 (300)
.|.+||.... ...++.++|||||||++|||++|+.||...........+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMG--SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cCCCCCcCCCcCCHHHHcC--CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2344443321 134677999999999999999999999654432211111100
Q ss_pred -HhhCC---CC------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 253 -ICFRE---PP------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 253 -~~~~~---~~------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... ++ ......++++.+||.+||.. ||++|||+.++++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~-dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVF-DPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCC-ChhhCcCHHHHhcCHhhCC
Confidence 00000 11 12234578899999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=296.79 Aligned_cols=236 Identities=27% Similarity=0.452 Sum_probs=190.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
+|+..+.||+|+||.||++.+..+++.||+|++...... ..+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-eEE
Confidence 478889999999999999999999999999998754321 23356999999999999999999987654 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-C---Cccc---------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-H---PCGY--------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-~---~~~~--------- 196 (300)
+||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++. . ++|.
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999999999988778999999999999999999999999999999999999976542 1 1111
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
+..|.+||... +..++.++|||||||++|+|++|..||.....................+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLR---GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred cCCccccccccccceeCHhHhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 12344554432 3456779999999999999999999996543322222222222223455667778
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
++++.+++.+||.. ||++||++.++++||||+
T Consensus 237 ~~~~~~~i~~~l~~-~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 237 SPGLRDVTLRCLEL-QPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CHHHHHHHHHHcCC-CcccCcCHHHHhcCcccC
Confidence 89999999999999 999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=294.41 Aligned_cols=231 Identities=29% Similarity=0.446 Sum_probs=189.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----------CCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----------PNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+....... .+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 4677889999999999999999889999999886543322 2356899999999999999999987754
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++...+.++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 89999999999999999988778999999999999999999999999999999999999987765433222
Q ss_pred ----------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 198 ----------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 198 ----------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
..|.+||... +..++.++|+|||||++|+|+||..||...... ..+........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~ 232 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVK---QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKIGENASPEI 232 (267)
T ss_pred cccCCccccccccCCCcCccChhHhc---cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHHhccCCCcC
Confidence 1233444332 345667899999999999999999999754332 22223333445566
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+...+..+.++|.+||+. ||++||++.++++||||
T Consensus 233 ~~~~~~~~~~li~~~l~~-~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 233 PSNISSEAIDFLEKTFEI-DHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcccCHHHHHHHHHHccC-CchhCcCHHHHhhCCCC
Confidence 777899999999999999 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=288.12 Aligned_cols=241 Identities=32% Similarity=0.478 Sum_probs=194.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----------CHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----------NPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
....|+--+.||.|..+.|-++..+.++..+|+|++........ ..+|+.+|+++ .||+|+.+.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 45667888999999999999999999999999999864332211 14589999997 69999999999998
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---ccc----
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP---CGY---- 196 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~---~~~---- 196 (300)
+. .+++|+|.|+.|.|.+++...-.++++..+.|++|++.|+.|||..+|+||||||+|||++++.+.. +|+
T Consensus 95 ~s-F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 95 DA-FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred cc-hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 75 8999999999999999999988899999999999999999999999999999999999999987653 333
Q ss_pred -----------eeecccccccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC
Q 040812 197 -----------SCLYESGEARHRK---HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (300)
+..|.+||..... ....|+..+|+||.|||||.|+.|.+||....+. -++..+..-........+
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-lMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-LMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-HHHHHHHhcccccCCcch
Confidence 3345555544321 2334677999999999999999999999753221 111222222222333446
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+.++..+|||.+||+. ||.+|.|++|+|.||||.
T Consensus 253 adis~~~KdLIsrlLqV-dp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQV-DPTKRITAKEALAHPFFI 287 (411)
T ss_pred hhccccHHHHHHHHHee-CchhcccHHHHhcChHHH
Confidence 77899999999999999 999999999999999994
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=306.89 Aligned_cols=235 Identities=29% Similarity=0.435 Sum_probs=202.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++|+.++.+|+|+||.+++++.+...+.+++|.+........ ..+|+.++++++|||||.+.+.|..++..+|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 5789999999999999999999999999999999976554433 357999999999999999999999876559999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 132 MEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
|+||+||+|.+.+... ..|+++.+..++.||+.|+.|||+++|+|||||+.|||++.+.....|+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999999753 4699999999999999999999999999999999999999876654443
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|..||... +..|+.|+|||||||++|||++-+++|... ++...+..+....-..+|...+.+++
T Consensus 163 a~tvvGTp~YmcPEil~---d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~----~m~~Li~ki~~~~~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILS---DIPYNEKSDIWSLGCCLYEMCTLKPAFKAS----NMSELILKINRGLYSPLPSMYSSELR 235 (426)
T ss_pred hheecCCCcccCHHHhC---CCCCCccCcchhhcchHHHHHhcccccCcc----chHHHHHHHhhccCCCCCccccHHHH
Confidence 44455555544 677899999999999999999999999653 44455666665666788889999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+|..||.. +|+.||++.++|.+|.+.
T Consensus 236 ~lv~~~l~~-~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 236 SLVKSMLRK-NPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHhhc-CCccCCCHHHHhhChhhh
Confidence 999999999 999999999999998764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=308.84 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=187.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+++++.+++.+|+|++..... ...+.+|+.++..++|+||+++++++.... ..|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-NLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-EEEEE
Confidence 468999999999999999999999999999999864221 112456888999999999999999988765 89999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--------------- 195 (300)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++...+.
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999999976 4578999999999999999999999999999999999999876543222
Q ss_pred -----ceeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -----YSCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++..|.+||..... ....++.++|||||||++|||++|+.||...........+.........+.....++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 23346666654321 12346779999999999999999999997543322222221110001112223457899
Q ss_pred HHHHHHHHhccCCCCC--CCCHHHHhcCCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSK--RWTASQLLSHPFLADA 300 (300)
Q Consensus 269 l~~li~~~l~~~dp~~--Rpt~~~~l~hpw~~~~ 300 (300)
++++|.+||.. ++++ |++++++++||||.++
T Consensus 240 ~~~li~~ll~~-~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 240 AKDLIRRLICS-REHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHHccC-hhhhcCCCCHHHHhCCCCcCCC
Confidence 99999999965 5444 7899999999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.84 Aligned_cols=236 Identities=27% Similarity=0.355 Sum_probs=192.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
..++|++.+.||+|+||.||+|++..+++.||+|++....... .+.+|+..+..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4578999999999999999999999999999999987654322 2356899999999999999888764321
Q ss_pred --CcEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---
Q 040812 126 --GEVSILMEYMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--- 196 (300)
Q Consensus 126 --~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--- 196 (300)
..+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++...+++
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 1378999999999999998652 3689999999999999999999999999999999999999876543322
Q ss_pred ------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 197 ------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 197 ------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
+..|.+||... +..++.++|||||||++|||++|+.||.... ....+........
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----~~~~~~~~~~~~~ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWR---RKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTLAGRY 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHhcCCC
Confidence 22355565543 4567889999999999999999999996532 2233444444445
Q ss_pred CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 259 ~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
..++..+++++.+++.+||.. ||++||++.++++|||++
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~-dP~~RPs~~ell~~p~~~ 301 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSS-DPKRRPSSSKLLNMPICK 301 (496)
T ss_pred CCCCCCCCHHHHHHHHHHccc-ChhhCcCHHHHHhCHHHH
Confidence 556778899999999999999 999999999999999975
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=300.72 Aligned_cols=237 Identities=38% Similarity=0.635 Sum_probs=188.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++.+.||+|+||.||++.+..++..+|+|.++.+... ..+.+|+.++++++||||+++++++..+. ..|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-EISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-EEEEEee
Confidence 3689999999999999999999999999999998754321 22457999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccc----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+|||++.++...+.+
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 99999999999888889999999999999999999997 5999999999999998875443322
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH--------------------------
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL-------------------------- 249 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~-------------------------- 249 (300)
...|.+||... +..++.++|||||||++|+|+||+.||...+.. .....
T Consensus 160 ~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 160 GTRSYMSPERLQ---GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCcCccChhHhc---CCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccc
Confidence 22345555432 455778999999999999999999999543211 11111
Q ss_pred -------HHHHhhCCCCCCCC-CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 250 -------MLAICFREPPSLPE-CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 250 -------~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
........++..+. ..+.+++++|.+||.. ||++|||+.++++||||.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK-NPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccC-ChhhCcCHHHHhcChhhhh
Confidence 11111112222222 3677899999999999 9999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=297.48 Aligned_cols=237 Identities=22% Similarity=0.346 Sum_probs=190.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+|+..+.||+|+||.||++.+..+++.+|+|.+...... ....+|+.++++++|+||+.+++.+.... ..|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-EEEEEE
Confidence 477889999999999999999999999999998654322 12357999999999999999999887754 899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 133 EYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++...+.+
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 999999999888653 3699999999999999999999999999999999999998765433222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|+|||||++|+|+||..||......... ..+...........+...+..+.++
T Consensus 160 ~~~g~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05632 160 GRVGTVGYMAPEVLN---NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEVDRRVLETEEVYSAKFSEEAKSI 235 (285)
T ss_pred CCCCCcCccChHHhc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhhccccccCccCCHHHHHH
Confidence 22344555442 455778999999999999999999999754332222 2222222233345566788899999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 273 IRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
+.+||+. ||++||+ +.++++|+||++.
T Consensus 236 i~~~l~~-~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 236 CKMLLTK-DPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHccC-CHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999 9999999 8899999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.88 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=189.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++.+.||+|+||.||+|+++.+++.||+|++...... ..+.+|+.+++.++||||+++++++.... ..
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~-~~ 118 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-YL 118 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-EE
Confidence 3457899999999999999999999999999999998642211 12356899999999999999999988754 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999999998754 58999999999999999999999999999999999999877543221
Q ss_pred -------ceeeccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-CCCCCC--CC
Q 040812 196 -------YSCLYESGEARHRKH-GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLP--EC 264 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~--~~ 264 (300)
++..|.+||...... ...++.++|||||||++|||++|+.||...+.... ...+... ....++ ..
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----YSKIMNHKNSLTFPDDND 273 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCcccCCCcCC
Confidence 234466777654322 23467899999999999999999999975433222 2222211 122233 35
Q ss_pred CChHHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSK--RWTASQLLSHPFLAD 299 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~--Rpt~~~~l~hpw~~~ 299 (300)
++..++++|.+||.. ++.+ |++++++++||||++
T Consensus 274 ~s~~~~~li~~~L~~-~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 274 ISKEAKNLICAFLTD-REVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CCHHHHHHHHHHcCC-hhhhcCCCCHHHHhcCcccCC
Confidence 789999999999975 5544 889999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=288.99 Aligned_cols=232 Identities=25% Similarity=0.393 Sum_probs=188.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||++.++.+++.||+|.+....... .+.+|+.++++++|+|++++++.+....+..|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4899999999999999999999999999999987543322 245699999999999999999987655557899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++...+.+
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999999763 3589999999999999999999999999999999999998765432221
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
...|.+||... +..++.++|||||||++|+|++|+.||...+. ............+..+...++.+.++
T Consensus 161 ~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd08223 161 TLIGTPYYMSPELFS---NKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----NSLVYRIIEGKLPPMPKDYSPELGEL 233 (257)
T ss_pred cccCCcCccChhHhc---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcCCCCCccccCHHHHHH
Confidence 22345555433 45567799999999999999999999964332 12222233344445667788999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+.+||.. ||++||++.++++||||
T Consensus 234 i~~~l~~-~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSK-RPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhcc-CcccCCCHHHHhcCCCC
Confidence 9999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=295.09 Aligned_cols=234 Identities=35% Similarity=0.519 Sum_probs=192.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++.+.||.|+||.||+|++..+++.||+|.+....... .+.+|+.+++.++|+||+++++++..+. ..|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-KLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-eEEEEEE
Confidence 46899999999999999999999999999999987543221 2467999999999999999999988764 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
|+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||++++++...++.+
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 99999999999865 7899999999999999999999999999999999999998765432221
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC-CChHHHHHH
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC-SSEKFRDFI 273 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li 273 (300)
..|.+||... +..++.++|||||||++|+|+||..||...... .....+.....+..+.. .++.+.+++
T Consensus 159 ~~~~~y~~PE~~~---~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 159 VGTPFWMAPEVIK---QSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cCCccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 1244555443 444778999999999999999999999654322 22223333444555555 788999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.+||.. ||++|||++++++||||.++
T Consensus 232 ~~~l~~-~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 232 SLCLNK-DPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HHHhhC-ChhhCcCHHHHhhChhhcCC
Confidence 999999 99999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=304.70 Aligned_cols=234 Identities=22% Similarity=0.313 Sum_probs=179.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
..+|++++.||+|+||.||+|.+..+++.||+|+... .....|+.++++++|+||+++++++.... ..|+|||++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----cccHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEEEcc
Confidence 3469999999999999999999999999999997532 23467999999999999999999988754 899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------------c
Q 040812 136 DAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------------Y 196 (300)
Q Consensus 136 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------------~ 196 (300)
.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++...+. +
T Consensus 140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~g 218 (357)
T PHA03209 140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG 218 (357)
T ss_pred CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccc
Confidence 65 88887764 4569999999999999999999999999999999999999876543222 2
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc-h---------HHHHHHHHhhCCCCCCC----
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-D---------FLSLMLAICFREPPSLP---- 262 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~---------~~~~~~~~~~~~~~~~~---- 262 (300)
+..|.+||... +..++.++|||||||++|||+++..|+....... . ....+... ...+..++
T Consensus 219 t~~y~aPE~~~---~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~ 294 (357)
T PHA03209 219 TVETNAPEVLA---RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL-KVHPEEFPRDPG 294 (357)
T ss_pred cccccCCeecC---CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh-ccChhhcCCCCc
Confidence 23455666543 4567889999999999999998655553322111 0 00111100 00011111
Q ss_pred --------------------------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 263 --------------------------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 263 --------------------------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
...+.++.++|.+||+. ||++|||+.|+++||||++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~-dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF-DAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC-CcccCcCHHHHhcCchhccC
Confidence 13456778899999999 99999999999999999863
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.65 Aligned_cols=238 Identities=24% Similarity=0.328 Sum_probs=183.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
-.++|++.+.||+|+||.||+|.+..+++.||||.+...... ....+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 467899999999999999999999999999999998653322 22357999999999999999999875432
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++...+.+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 257999999976 77777753 488999999999999999999999999999999999999875543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-------------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC------------- 254 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------- 254 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...+....+..++....
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCcccCCcccCCcCCHHHHh---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 23355555543 45677899999999999999999999975443222222211100
Q ss_pred -----hCCC-------------------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 -----FREP-------------------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 -----~~~~-------------------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+ .......++.+++||.+||+. ||++|||+.++++||||..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~-dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI-DASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc-CcccCCCHHHHhcCccccc
Confidence 0000 001112346789999999999 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=298.93 Aligned_cols=240 Identities=35% Similarity=0.558 Sum_probs=193.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++++.||+|+||.||++.+..+++.||+|.++..... ..+.+|+.++++++|+||+++++.+.... ..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-AVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-eEEEEEe
Confidence 4689999999999999999999999999999988653221 23467999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccce------------
Q 040812 134 YMDAGSLEIYVKSR---GRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
|+++++|..++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++...++++
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999999988763 368999999999999999999996 59999999999999998765433322
Q ss_pred -----eecccccccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 198 -----CLYESGEARHRK---HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 198 -----~~~~~~~~~~~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
..|.+||..... ....++.++|||||||++|+|+||+.||..... .........+.....+..+..+++++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-hhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 234555543211 112346799999999999999999999965432 22223333344455666777789999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.++|.+||.. +|++||+++++++||||..
T Consensus 239 ~~li~~~l~~-~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 239 QDFVAKCLNK-IPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred HHHHHHHccc-CcccCCCHHHHhcChhhhh
Confidence 9999999999 9999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=295.41 Aligned_cols=235 Identities=28% Similarity=0.461 Sum_probs=183.0
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||+|.+..+|+.||+|.++..... ....+|+.++++++|+||+++++++.+.. ..|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-KLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-ceEEEEe
Confidence 588999999999999999999999999999998754322 23467999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 134 YMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+++ +|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++...+.+
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9975 78777764 55799999999999999999999999999999999999998776543322
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC----------------C
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR----------------E 257 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----------------~ 257 (300)
+..|.+||.... ...++.++|||||||++|+|+||..||............+...... .
T Consensus 159 ~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 159 EVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CccccCCcChHHHhC--CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 123455554321 2345779999999999999999999975544332222211111000 0
Q ss_pred CCC---------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 258 PPS---------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 258 ~~~---------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.+. ....++++++++|.+||.. ||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVC-NPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcC-ChhhcCCHHHHhcCCCC
Confidence 000 1124678899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=307.87 Aligned_cols=238 Identities=26% Similarity=0.368 Sum_probs=185.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||++++..+++.||+|++..... ...+.+|+.++..++|+||+++++++.... ..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-YLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-EEEEE
Confidence 479999999999999999999999999999999864221 112356889999999999999999998764 89999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--------------- 195 (300)
|||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++...+.
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999999986 4579999999999999999999999999999999999999877654322
Q ss_pred -----ceeeccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC---CCC
Q 040812 196 -----YSCLYESGEARHRKH--GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP---ECS 265 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 265 (300)
++..|.+||...... .+.++.++|||||||++|||+||+.||...........+.. ......++ ..+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---~~~~~~~p~~~~~~ 236 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---HEERFQFPSHITDV 236 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc---CCCcccCCCccccC
Confidence 223355666543211 13467799999999999999999999965433222211111 11112222 346
Q ss_pred ChHHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSK--RWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~--Rpt~~~~l~hpw~~~ 299 (300)
+++++++|.+||.. ++++ |++++++++||||++
T Consensus 237 ~~~~~~li~~ll~~-~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICS-RERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccC-chhhcCCCCHHHHhcCCCcCC
Confidence 88999999999986 6554 568999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=306.28 Aligned_cols=227 Identities=24% Similarity=0.369 Sum_probs=182.6
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHH-HHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQEL-NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|++....... ....|. .+++.++||||+++++++.... ..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-KLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 46999999999999999999999999987532211 122343 3578899999999999988765 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------------
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------- 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------- 197 (300)
+++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++...++++
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 9999999988778999999999999999999999999999999999999998765443322
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||++|..||...+.. .....+ ...+..++...+..+.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i-~~~~~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 160 PEYLAPEVLR---KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDNI-LHKPLQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCHHHhc---CCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHHH-hcCCCCCCCCCCHHHHHHHHHHc
Confidence 2345555432 445678999999999999999999999654321 222222 23445666778899999999999
Q ss_pred ccCCCCCCCCH----HHHhcCCCCCC
Q 040812 278 QKGDPSKRWTA----SQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~----~~~l~hpw~~~ 299 (300)
+. ||++|+++ .++++|+||..
T Consensus 232 ~~-~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 232 HK-DQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cC-CHhhcCCCCCCHHHHhCCCCcCC
Confidence 99 99999975 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=307.31 Aligned_cols=227 Identities=24% Similarity=0.365 Sum_probs=181.5
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHH-HHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELN-ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|++....... ....|.. +++.++||||+++++++.... ..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-KLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-EEEEEEcCCC
Confidence 46999999999999999999999999987542211 1233443 467799999999999988754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 999999998888899999999999999999999999999999999999998876543222 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|||++|..||...+.. .....+. ......+...+..+.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 160 PEYLAPEVIR---KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMYDNIL-HKPLVLRPGASLTAWSILEELL 231 (325)
T ss_pred hhhCCHHHHc---CCCCCCcCccccccceehhhhcCCCCCCCCCHH----HHHHHHH-cCCccCCCCCCHHHHHHHHHHh
Confidence 3355555543 455678999999999999999999999754322 2222222 2233444567889999999999
Q ss_pred ccCCCCCCCCH----HHHhcCCCCCC
Q 040812 278 QKGDPSKRWTA----SQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~----~~~l~hpw~~~ 299 (300)
.. ||++||++ .++++||||+.
T Consensus 232 ~~-~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 232 EK-DRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cc-CHHhcCCCCCCHHHHhcCCCcCC
Confidence 99 99999976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=301.11 Aligned_cols=233 Identities=31% Similarity=0.488 Sum_probs=188.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+|++.+.||+|+||.||+|.+..+++.||+|.+....... .+.+|+.++++++|+||+++++.+.... ..|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-YLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-EEEEE
Confidence 36899999999999999999999999999999987654332 2456999999999999999999987754 89999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 132 MEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++...++.
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999999998753 4689999999999999999999999999999999999998765432221
Q ss_pred -----------------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 040812 197 -----------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG 241 (300)
Q Consensus 197 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 241 (300)
+..|.+||... +..++.++|||||||++|+|++|..||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS---GDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc---CCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11244444432 4456779999999999999999999997654
Q ss_pred CCchHHHHHHHHhhCCCCCCCC--CCChHHHHHHHHHhccCCCCCCCC----HHHHhcCCCCCC
Q 040812 242 QEPDFLSLMLAICFREPPSLPE--CSSEKFRDFIRCCLQKGDPSKRWT----ASQLLSHPFLAD 299 (300)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~dp~~Rpt----~~~~l~hpw~~~ 299 (300)
....+.... ......+. ..++.+.++|.+||.. ||++||+ ++++++||||++
T Consensus 237 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 RDETFSNIL-----KKEVTFPGSPPVSSSARDLIRKLLVK-DPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred hHHHHHHHh-----cCCccCCCccccCHHHHHHHHHHccC-CHhHCCCchhhHHHHHcCchhhc
Confidence 433322222 11222222 3689999999999999 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.95 Aligned_cols=237 Identities=23% Similarity=0.315 Sum_probs=181.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
-.++|++.+.||+|+||.||++.+..+++.||+|.+...... ....+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 467899999999999999999999999999999998654322 12356999999999999999999875432
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
...|+||||+++ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++...+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 247999999976 67766653 588999999999999999999999999999999999998876543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-------------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC------------- 254 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------- 254 (300)
+..|.+||... +..++.++|||||||++|+|++|+.||...+........+....
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred ccccCCccccCCccCHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 23355555543 45577899999999999999999999965432222111111100
Q ss_pred -----hCC-------------------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 255 -----FRE-------------------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 255 -----~~~-------------------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
... ....+...+..++++|.+||.. ||++|||+.|+++||||.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~-dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI-DPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcC-CchhcCCHHHHhcCcchh
Confidence 000 0011122356789999999999 999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=296.72 Aligned_cols=239 Identities=32% Similarity=0.485 Sum_probs=192.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+.++|++.+.||+|+||.||++.+..++..+|+|++...... ..+.+|+.++++++|+||+++++.+.... ..|+||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-KLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-eEEEEe
Confidence 346799999999999999999999989999999998654322 23467999999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 133 EYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++...+.+
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999999999998764 4699999999999999999999999999999999999998765443322
Q ss_pred ----eeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--CCCCCCChH
Q 040812 197 ----SCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP--SLPECSSEK 268 (300)
Q Consensus 197 ----~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 268 (300)
+..|.+||.... ..+..++.++|||||||++|+|++|+.||...... ..+........+ ..+..++.+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcCCCCCcCCcccCCHH
Confidence 223455554321 12334567899999999999999999999654332 222222222222 235567899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.++|.+||.. ||++||+++++++||||.+
T Consensus 238 ~~~li~~~l~~-~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 238 FNDFLKSCLVK-DPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred HHHHHHHHhcc-ChhhCcCHHHHhcChhhcc
Confidence 99999999999 9999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=311.37 Aligned_cols=234 Identities=21% Similarity=0.362 Sum_probs=195.0
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
..+....++..+...||+|+||+||+|+|-+ .||||++..+... +.|.+|+.++++-+|.||+-++|++..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3445566778899999999999999999986 6999999866544 34678999999999999999999998764
Q ss_pred CcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee------
Q 040812 126 GEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------ 198 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------ 198 (300)
+.||..+|+|.+|..+++. ..+|.....+.|++||++|+.|||.++|+|||||..||++.+++...+|+++
T Consensus 462 --~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 462 --LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred --eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 4999999999999999975 3479999999999999999999999999999999999999998776555443
Q ss_pred ---------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC----CCC
Q 040812 199 ---------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR----EPP 259 (300)
Q Consensus 199 ---------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~~ 259 (300)
.|++||.........+++.+|||||||++|||+||.+||.....+ +++..+..+ ...
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heEEEecccccCccch
Confidence 378888877777888999999999999999999999999743333 333333333 222
Q ss_pred CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 260 SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 260 ~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..-.+++.++++|+..||.. ++++||.+.+||.
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~-~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKF-DREERPLFPQLLS 648 (678)
T ss_pred hhhccCHHHHHHHHHHHHhc-CcccCccHHHHHH
Confidence 33456678999999999999 9999999998875
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=296.31 Aligned_cols=234 Identities=29% Similarity=0.443 Sum_probs=193.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||++.+..+++.||+|+++..... ..+.+|+.++++++||||+++++++.... ..|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-NLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-eEEEE
Confidence 4689999999999999999999999999999998753321 23457999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+..
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC 159 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCC
Confidence 99999999999998888899999999999999999999999999999999999999876543322
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
+..|.+||... +...+.++||||||+++|+|+||..||...... ....... .....++...++.++++|.+
T Consensus 160 ~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 160 GTPEYLAPEIIL---SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKIL-EGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred CCccccChhhhc---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh-cCCccCCccCCHHHHHHHHH
Confidence 22344555432 345667899999999999999999999654421 1222222 33455677789999999999
Q ss_pred HhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 276 CLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 276 ~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
||.. ||.+|+ +++|+++||||+++
T Consensus 232 ~l~~-~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 232 LLQV-DLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HccC-CHHHccCcccCCHHHHHcCcccccC
Confidence 9999 999999 89999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=291.01 Aligned_cols=234 Identities=27% Similarity=0.347 Sum_probs=183.6
Q ss_pred Ccceeeeee--cCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVL--GQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++.+.+ |+|+||.||++..+.+++.+|+|.+....... .|+.....+ +|+||+++++.+.... ..|+|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~-~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLK-GHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCC-eeEEEEE
Confidence 455666665 99999999999999999999999987543221 133333322 7999999999998765 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-CCCcc---------------ce
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-EHPCG---------------YS 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-~~~~~---------------~~ 197 (300)
|+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ ...++ ++
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 169 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence 999999999998877899999999999999999999999999999999999998876 32221 12
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|+|++|..||................. ......+...++.+.++|.+||
T Consensus 170 ~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 245 (267)
T PHA03390 170 LDYFSPEKIK---GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSML 245 (267)
T ss_pred CcccChhhhc---CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHh
Confidence 3355666553 44567899999999999999999999975433221112222222 3333455578999999999999
Q ss_pred ccCCCCCCCC-HHHHhcCCCCCC
Q 040812 278 QKGDPSKRWT-ASQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt-~~~~l~hpw~~~ 299 (300)
+. ||.+|++ ++++++||||++
T Consensus 246 ~~-~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 246 KY-NINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred cc-ChhhCCchHHHHhcCCcccC
Confidence 99 9999996 699999999975
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=292.98 Aligned_cols=229 Identities=21% Similarity=0.315 Sum_probs=184.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..+|++.+.||+|+||.||+|.++ ..+..||+|.++...... .+.+|+.++++++||||+++++++.... ..|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN-TMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-CcE
Confidence 457899999999999999999875 456789999987643222 3467999999999999999999987654 899
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++...+..+
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999999999999764 47899999999999999999999999999999999999988754432221
Q ss_pred ---------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 198 ---------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 198 ---------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
..|.+||... +..++.++|||||||++||+++ |+.||...... .....+........+..++.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQ---YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKAVEDGFRLPAPRNCPN 235 (266)
T ss_pred hcccCCCCceeecCHHHHh---hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCCCCCCCCCCCCH
Confidence 2355555443 4567789999999999999875 99999654332 22222333344456777899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+.+++.+||.. +|++||+++++++
T Consensus 236 ~~~~li~~c~~~-~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQK-ERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCC-CchhCCCHHHHHH
Confidence 999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=285.90 Aligned_cols=238 Identities=29% Similarity=0.472 Sum_probs=188.0
Q ss_pred CCCcceee-eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHh-cCCCceeEeceeeeCC---CCcEE
Q 040812 55 GLSQLEKL-QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIFTKP---SGEVS 129 (300)
Q Consensus 55 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~---~~~~~ 129 (300)
-+++|.+. ++||-|-.|.|-.|..+.|++.+|+|++.. .....+|++..-. -.|||||.++++|++. ...+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 35567664 679999999999999999999999999853 2344678776544 4799999999998753 23578
Q ss_pred EEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC------Cccc-----
Q 040812 130 ILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH------PCGY----- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~------~~~~----- 196 (300)
+|||.++||.|...+++++. |+++++..|++||..|+.|||+.+|.||||||+|+|.+..... ++|+
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999999999999998764 9999999999999999999999999999999999999865321 2222
Q ss_pred ----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---CchHHHHHHHHhhCCCCCCCC
Q 040812 197 ----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ---EPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 197 ----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~ 263 (300)
+..|.+||... ...|+..+|+||+||+||-|++|.+||..... .+.+..-+.......+..-++
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg---~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred CCccccCCcccccccCHHHhC---chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 33455555443 34478899999999999999999999976533 223333332222333444456
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+|+..+|+|+.+|.. +|++|.|+++++.|||++.
T Consensus 293 ~VSe~aKdlIR~LLkt-~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKT-EPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred HHHHHHHHHHHHHhcC-CchhheeHHHhhcCchhcc
Confidence 7899999999999999 9999999999999999974
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=289.98 Aligned_cols=233 Identities=32% Similarity=0.457 Sum_probs=187.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-------CCHHHHHHHHhcCCCceeEeceeeeCC-CCcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-------PNPQELNILRQTNSPYIVKCHQIFTKP-SGEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 129 (300)
+|+..+.||+|+||.||+|.+..+++.||+|.+....... ...+|+.++++++|+||+++++++... .+..+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6889999999999999999999999999999986543221 235699999999999999999987653 34689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-----------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------- 198 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~----------- 198 (300)
++|||+++++|.+++.....+++..++.++.|++.||.|||+.+++|+||||+||+++.++...+.+++
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999887789999999999999999999999999999999999999877554332221
Q ss_pred -----------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 199 -----------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 199 -----------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
.|.+||.. .+..++.++|||||||++|||+||+.||....... ...........+.++...++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVI---SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred CCccccCCccccccCHHHh---CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HHHHHhcCCCCCCCchhcCH
Confidence 23344433 24456779999999999999999999997543322 22222223334566777889
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.++++| +||.. +|++||+++|+++||||+
T Consensus 237 ~~~~li-~~~~~-~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFV-EARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcC-ChhhCcCHHHHhcCcccc
Confidence 999999 67778 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=287.35 Aligned_cols=231 Identities=31% Similarity=0.452 Sum_probs=189.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||+|.+..+++.|++|.+...... ..+.+|+.++++++||||+++++++.... ..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-KLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-EEEEEEE
Confidence 478889999999999999999999999999998654322 23457999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+.++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999764 46899999999999999999999999999999999999998755433221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
..|.+||... +..++.++|+|||||++|+|+||+.||..... ............+..+..++..+.++
T Consensus 160 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08529 160 TIVGTPYYLSPELCE---DKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILKIIRGVFPPVSQMYSQQLAQL 232 (256)
T ss_pred ccccCccccCHHHhc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCccccCHHHHHH
Confidence 2244444433 44567799999999999999999999965442 12233333344555666788999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
|.+||+. +|++||++.++++|||+
T Consensus 233 i~~~l~~-~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTK-DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccC-CcccCcCHHHHhhCCCC
Confidence 9999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=293.22 Aligned_cols=237 Identities=26% Similarity=0.414 Sum_probs=185.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||+|.++.+++.||+|.+...... ..+.+|+.++++++|+|++++++++.... ..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-KLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-EEEEEE
Confidence 4689999999999999999999999999999998654322 23467999999999999999999988755 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------- 197 (300)
||+++++|..++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++...+.++
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 99999999888877667999999999999999999999999999999999999997765432221
Q ss_pred ----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-----------------
Q 040812 198 ----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR----------------- 256 (300)
Q Consensus 198 ----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----------------- 256 (300)
..|.+||.... +..++.++|||||||++|+|+||+.||...................
T Consensus 160 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 160 YVATRWYRAPELLVG--DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cccccccCCHHHHhC--CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 23444444321 2346779999999999999999999997554332222221110000
Q ss_pred CCCC---------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 257 EPPS---------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 257 ~~~~---------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..+. .....+..+.+||.+||.. ||++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQM-DPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcC-CccccCCHHHHhcCCCC
Confidence 0000 0123578899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=290.16 Aligned_cols=232 Identities=29% Similarity=0.419 Sum_probs=186.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
+|++.+.||+|+||.||+|... +++.+|+|.+...... ..+.+|+.++++++|+||+++++++... +..|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEE
Confidence 4788899999999999999874 6789999988754322 1235699999999999999999998875 4899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
+||||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+..+
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999999988778999999999999999999999999999999999999987655433221
Q ss_pred -------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 198 -------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 198 -------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
..|.+||... +..++.++|||||||++|+|+||..||............. ......+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 233 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVIN---ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG--AHRGLMPRLPDS 233 (265)
T ss_pred ccccccccccCCCccccChhhhc---CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh--hccCCCCCCCCC
Confidence 1234444432 3446779999999999999999999996543322211111 111234456677
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.+..+.++|.+||.. +|++||++.++++||||
T Consensus 234 ~~~~~~~~i~~~l~~-~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 234 FSAAAIDFVTSCLTR-DQHERPSALQLLRHDFL 265 (265)
T ss_pred CCHHHHHHHHHHhcC-CcccCCCHHHHhcCCCC
Confidence 899999999999999 99999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=305.20 Aligned_cols=227 Identities=26% Similarity=0.396 Sum_probs=181.2
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHH-HHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQEL-NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|++..+++.||+|++....... ....|. .+++.++|+||+++++++.... ..|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-eEEEEEeCCC
Confidence 46999999999999999999999999987532111 112233 3467789999999999988765 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------e
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------S 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~ 197 (300)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+ +
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 999999998888899999999999999999999999999999999999998775543222 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
..|.+||... +..++.++|||||||++|+|++|..||...... .....+. ..+...+...+..+.++|.+||
T Consensus 160 ~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~-~~~~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 160 PEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNIL-NKPLQLKPNITNSARHLLEGLL 231 (325)
T ss_pred ccccCHHHHc---CCCCCCccccccccHHHHHHhcCCCCCCCCCHH----HHHHHHH-hCCcCCCCCCCHHHHHHHHHHc
Confidence 3355555443 456778999999999999999999999754332 2222222 2334455578899999999999
Q ss_pred ccCCCCCCCCHH----HHhcCCCCCC
Q 040812 278 QKGDPSKRWTAS----QLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~~----~~l~hpw~~~ 299 (300)
+. ||.+|+++. ++++|+||..
T Consensus 232 ~~-~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 232 QK-DRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cc-CHHHCCCCCCCHHHHhcCcccCC
Confidence 99 999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=297.76 Aligned_cols=234 Identities=35% Similarity=0.539 Sum_probs=185.7
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC----HHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
|++.+.||+|+||.||++++..+++.||+|++......... .+|+.++++++|+||+++++++.... ..++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-YLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-EEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-cccccccc
Confidence 78999999999999999999999999999999865433222 34899999999999999999998754 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---c---------------
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---Y--------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---~--------------- 196 (300)
+++++|.+++.....+++..+..++.||+.||.+||++|++|+||||+||+++.++...+. .
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999977789999999999999999999999999999999999999976543222 1
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-C--CCCCCCCCChHHHHH
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-E--PPSLPECSSEKFRDF 272 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~l 272 (300)
+..|.+||... .+...+.++||||||+++|+|++|..||...... +........... . ...........+.++
T Consensus 160 ~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 160 GTPEYMAPEVLQ--QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSGGGSCHHHHT--TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccc--ccccccccccccccccccccccccccccccccch-hhhhhhhhcccccccccccccchhHHHHHHH
Confidence 22344554432 2556788999999999999999999999765111 111222211111 0 111111123889999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
|.+||.. ||++||++.++++||||
T Consensus 237 i~~~l~~-~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSK-DPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSS-SGGGSTTHHHHHTSGGG
T ss_pred HHHHccC-ChhHCcCHHHHhcCCCC
Confidence 9999999 99999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=292.52 Aligned_cols=235 Identities=24% Similarity=0.401 Sum_probs=182.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+|+.++++++||||+++++++..+. ..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-RLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-eEEEEEe
Confidence 488999999999999999999999999999998654322 23467999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------
Q 040812 134 YMDAGSLEIYVKSR---GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------- 197 (300)
|++ ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++...+.++
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 997 5888888642 46899999999999999999999999999999999999988765433222
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-----------------
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC----------------- 254 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------------- 254 (300)
..|.+||.... ...++.++|||||||++|+|+||+.||.................
T Consensus 159 ~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 159 THEVVTLWYRAPEVLLG--SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cCCcccccccChHHhcC--CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 23455554321 22356799999999999999999999975433221111111000
Q ss_pred -------hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 255 -------FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 255 -------~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..........+++++.++|.+||.. ||++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIY-DPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcC-ChhhCCCHHHHhcCCCC
Confidence 0000011234688899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=294.98 Aligned_cols=237 Identities=27% Similarity=0.407 Sum_probs=189.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.+++.+.|+||+++++.+.... ..|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-EEEEee
Confidence 446899999999999999999999999999999998754432 23457999999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------- 197 (300)
||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+.++
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 999999999998653 6899999999999999999999999999999999999987765433222
Q ss_pred ----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 198 ----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 198 ----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
..|.+||... +...+.++|||||||++|+|+||+.||............. .........+...+..+.++|
T Consensus 176 ~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 176 MVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred ccCCccccCHHHHc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh--cCCCCCCCCccccCHHHHHHH
Confidence 2344455433 4456789999999999999999999996544322111111 111112233556788999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||.. ||++||++.++++||||..
T Consensus 251 ~~~l~~-~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 251 NRCLDM-DVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHCcC-CcccCcCHHHHhhChhhhc
Confidence 999999 9999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=294.64 Aligned_cols=237 Identities=28% Similarity=0.419 Sum_probs=190.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
...+|++.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+|+.+++.++|+||+++++++.... ..|+|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 95 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-ELFVVM 95 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-eEEEEE
Confidence 346799999999999999999999999999999998654322 23357999999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
||+++++|..++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+..
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 999999999988754 689999999999999999999999999999999999998765432222
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
...|.+||... +..++.++|||||||++|+|+||..||............. .........+..+++.+.++|
T Consensus 175 ~~~~~~y~aPE~~~---~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 175 MVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred cCCCccccCcchhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCcccCCcccCCHHHHHHH
Confidence 12344555433 4456779999999999999999999997654322221111 111122234566789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||.. ||++||++.++++||||+.
T Consensus 250 ~~~l~~-dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 250 NRCLEM-DVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHhhc-ChhhCCCHHHHhhChHhhh
Confidence 999999 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=294.71 Aligned_cols=242 Identities=33% Similarity=0.479 Sum_probs=191.3
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+..-+.|++++.||+|+||.||+|++..+++.+|+|.+...... ..+.+|+.++++++|+||+++++.+..+. ..|
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 85 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-KLW 85 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-eEE
Confidence 344557899999999999999999999999999999998654321 23456999999999999999999987654 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
+||||+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++...+.+
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999999888764 45689999999999999999999999999999999999998765432221
Q ss_pred -------eeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC--CCCCCCC
Q 040812 197 -------SCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP--PSLPECS 265 (300)
Q Consensus 197 -------~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 265 (300)
+..|.+||..... ....++.++|||||||++|||+||..||...... ........... ...+..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSEPPTLSQPSKW 241 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHHhcCCCccCCCCccc
Confidence 1235566654211 1234567899999999999999999999654322 22222221222 2234567
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.++.++|.+||.. ||++||+++++++||||..
T Consensus 242 ~~~~~~li~~~l~~-~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 242 SMEFRDFLKTALDK-HPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred CHHHHHHHHHHhcC-CcccCcCHHHHhcCccccc
Confidence 88999999999999 9999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=292.35 Aligned_cols=239 Identities=31% Similarity=0.467 Sum_probs=186.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhc-CCCceeEeceeeeCCC-----Cc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQT-NSPYIVKCHQIFTKPS-----GE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----~~ 127 (300)
..+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.+++++ +|+||+++++++.... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 346789999999999999999999999999999998654322 2346789999988 6999999999886431 35
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 128 VSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
.|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++...+.+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 89999999999999999863 3589999999999999999999999999999999999999875443222
Q ss_pred ----------eeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 197 ----------SCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 197 ----------~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
+..|.+||..... .+..++.++|||||||++|||++|..||......... ............+..
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 240 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPAPRLKSKK 240 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---HHHhcCCCCCCCCCC
Confidence 2235566654321 1334677999999999999999999999654322111 111111222223345
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.+.++.+||.+||.. ||++|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~-~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVK-NHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCC-ChhhCCCHHHHhhCCCC
Confidence 788999999999999 99999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=300.82 Aligned_cols=237 Identities=30% Similarity=0.458 Sum_probs=196.9
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..+.++ |.+.+.||+|-|+.|-+|++.-+|+.||||++.+..... ...+|+..|+.++|||||++|++.....
T Consensus 14 gkIAGL--YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT- 90 (864)
T KOG4717|consen 14 GKIAGL--YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT- 90 (864)
T ss_pred cceeee--ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc-
Confidence 334444 888999999999999999999999999999997765443 2357999999999999999999987654
Q ss_pred cEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC----CCccce----
Q 040812 127 EVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME----HPCGYS---- 197 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~----~~~~~~---- 197 (300)
.+|+|+|+-.+|+|++|+-+. ..+++..++.++.||+.|+.|+|+-.++||||||+|+.+.+... .++|+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 899999999999999999754 35999999999999999999999999999999999999875421 233333
Q ss_pred -----------eeccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 198 -----------CLYESGEARHRKHGG-YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
..|.+||... |. +..+++||||||||||-|++|++||...++.+..-.++ ......|..+
T Consensus 171 PG~kL~TsCGSLAYSAPEILL---GDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-----DCKYtvPshv 242 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILL---GDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-----DCKYTVPSHV 242 (864)
T ss_pred CcchhhcccchhhccCchhhh---cCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-----cccccCchhh
Confidence 3344555443 33 34578999999999999999999998776654433333 4567889999
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.+.++||..||+. ||.+|.+.++|..|+|++.
T Consensus 243 S~eCrdLI~sMLvR-dPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 243 SKECRDLIQSMLVR-DPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred hHHHHHHHHHHHhc-CchhhccHHHHhccccccC
Confidence 99999999999999 9999999999999999974
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=296.15 Aligned_cols=237 Identities=28% Similarity=0.418 Sum_probs=189.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
...+|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+|+.+++.++|+||+++++++.... ..|+||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~ 95 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 95 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-EEEEee
Confidence 347899999999999999999999999999999998654332 22356899999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------------- 198 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------------- 198 (300)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++...+.+++
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99999999999865 368999999999999999999999999999999999999877654333222
Q ss_pred -----eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 199 -----LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 199 -----~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
.|.+||... +..++.++|+|||||++|+|+||..||...+......... .........+...+..+.+++
T Consensus 175 ~~~~~~y~aPE~~~---~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 175 MVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred ccCCccccCHHHHc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec--cCCCCCCCCccccCHHHHHHH
Confidence 233344332 4456789999999999999999999996544322111111 111122234566788899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||.. ||++||+++++++||||+.
T Consensus 250 ~~~l~~-~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 250 NRCLEM-DVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred HHHccC-ChhhCcCHHHHhcCchhcc
Confidence 999999 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=295.78 Aligned_cols=238 Identities=26% Similarity=0.389 Sum_probs=185.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.++++++|+||+++++++... ...++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-SNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-CEEEE
Confidence 478899999999999999999999999999999754432 1224699999999999999999999875 48999
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-----------
Q 040812 131 LMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------- 198 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~----------- 198 (300)
||||+ +++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++...+++++
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 99999 889999998765 79999999999999999999999999999999999999987665443322
Q ss_pred --------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC--------------
Q 040812 199 --------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-------------- 256 (300)
Q Consensus 199 --------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------- 256 (300)
.|.+||... ....++.++|||||||++|||++|.+||...................
T Consensus 159 ~~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 159 MTHQVVTRWYRAPELLF--GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccceeeeCHHHHh--CCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 234444331 12345779999999999999999988776543322211111110000
Q ss_pred ----CCC-----CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 257 ----EPP-----SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 257 ----~~~-----~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
..+ ......+..+.++|.+||.. ||++|||+.++++||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTL-NPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcC-CcccCcCHHHHhhCccccCC
Confidence 000 01133467899999999999 99999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=289.74 Aligned_cols=234 Identities=36% Similarity=0.509 Sum_probs=189.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
++|++.+.||+|+||.||+|.+..+++.+++|.+........+.+|+.++++++|+||+++++++.... ..|+++||+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNT-DLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-cEEEEEecCC
Confidence 578999999999999999999998899999999876544445678999999999999999999988764 8999999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------------
Q 040812 137 AGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------ 197 (300)
Q Consensus 137 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------ 197 (300)
+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++...++.+
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 161 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIG 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccC
Confidence 9999999975 446899999999999999999999999999999999999998765433322
Q ss_pred -eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHH
Q 040812 198 -CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 198 -~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
..|.+||... +...+.++|||||||++|+|+||+.||............. .........+...+.++.++|.+|
T Consensus 162 ~~~y~~PE~~~---~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 162 TPFWMAPEVIQ---EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--NKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred CccccCHHHHh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--cCCCCCCCchhhcCHHHHHHHHHH
Confidence 2344444432 4456779999999999999999999997543322211111 011111223445678999999999
Q ss_pred hccCCCCCCCCHHHHhcCCCC
Q 040812 277 LQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 277 l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
|+. ||++|||+.++++||||
T Consensus 237 l~~-~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVK-DPEERPSAIQLLQHPFI 256 (256)
T ss_pred Hhc-ChhhCcCHHHHhcCCCC
Confidence 999 99999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=302.22 Aligned_cols=234 Identities=23% Similarity=0.314 Sum_probs=181.9
Q ss_pred CcceeeeeecCCcceEEEEEEEc--cCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+.++++++|+||+++++++.... ..|+|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKS-TVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCC-EEEEEehh
Confidence 46999999999999999999764 35678999987643 23467999999999999999999988754 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------ 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------ 196 (300)
+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 168 ~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~ 246 (392)
T PHA03207 168 YK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246 (392)
T ss_pred cC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccc
Confidence 96 58989887777899999999999999999999999999999999999998775543322
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch---HHHHHHHH-----------------
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPD---FLSLMLAI----------------- 253 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~---~~~~~~~~----------------- 253 (300)
+..|.+||... +..++.++|||||||++|||++|+.||........ +..++...
T Consensus 247 ~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 247 WSGTLETNSPELLA---LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred cccccCccCHhHhc---CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 22344454432 45577899999999999999999999976433211 11111100
Q ss_pred -----hhCCC--CCCC-----CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 -----CFREP--PSLP-----ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 -----~~~~~--~~~~-----~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... ...+ ...+.++.++|.+||.. ||++|||+.|+++||||.+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~-dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTF-DQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhcc-ChhhCCCHHHHhhCchhhc
Confidence 00000 0111 12456789999999999 9999999999999999975
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=288.23 Aligned_cols=239 Identities=33% Similarity=0.458 Sum_probs=188.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
.++|++.+.||+|+||.||+|.+..+++.+++|++...... ....+|+.++++++||||+++++.+.... ..|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-KLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-EEEEEEe
Confidence 36799999999999999999999988999999998754332 23467999999999999999999987754 8999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 134 YMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++...+.+
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999999775 6899999999999999999999999999999999999999876543322
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
...|.+||.........++.++|||||||++|+|+||..||........................+...+.++.++|
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 12245555543221225677999999999999999999999764432222111111001111122334567899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPF 296 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw 296 (300)
.+||.. ||.+|||++++++|+|
T Consensus 241 ~~~l~~-~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 241 KKCLTK-DPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHcCC-ChhhCCCHHHHhcCCC
Confidence 999999 9999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=286.61 Aligned_cols=234 Identities=32% Similarity=0.421 Sum_probs=187.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-------CCHHHHHHHHhcCCCceeEeceeeeCCC-CcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-------PNPQELNILRQTNSPYIVKCHQIFTKPS-GEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 128 (300)
.+|++.+.||+|+||.||.+.+..+++.||+|.+....... .+.+|+.+++++.|+||+++++++.... ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46899999999999999999999999999999886433221 2346999999999999999999876542 368
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
++||||+++++|.+++.....+++..+..++.|++.||.|||+++++|+||||+||+++.++...+.++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999987777899999999999999999999999999999999999987654432221
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
..|.+||... +...+.++|||||||++|+|++|+.||...... ............+..|...+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVIS---GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTNPVLPPHVS 235 (265)
T ss_pred cccccccCCCCccccChhhhc---CCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHHHhcCCCCCCCchhhC
Confidence 2344555432 445677999999999999999999999654222 12222222233445566778
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
..+.++|.+|| . +|++||+++++++|||++
T Consensus 236 ~~~~~~i~~~l-~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIF-V-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHh-c-ChhhCCCHHHHhcCcccC
Confidence 88999999998 6 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=291.38 Aligned_cols=234 Identities=35% Similarity=0.621 Sum_probs=185.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.+..+... ..+.+|+.++++++||||+++++.+.... ..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-RISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-EEEEEEe
Confidence 3678899999999999999999999999999998654322 23457999999999999999999998765 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+||+++.++...+.+
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCC
Confidence 99999997553 578999999999999999999999999999999999998876543322
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch---HHHHHHHHhhCCCCCC-CCCCChHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPD---FLSLMLAICFREPPSL-PECSSEKFRDF 272 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||........ .............+.. ....++++.++
T Consensus 156 ~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 156 TNAYMAPERIS---GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred ChhhcCceeec---CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 22345555443 44577899999999999999999999965332211 1122222222223333 23467899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++||+++++++||||..
T Consensus 233 i~~~l~~-~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 233 ITQCMRK-QPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHhhC-ChhhCCCHHHHhcCccccc
Confidence 9999999 9999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=306.19 Aligned_cols=234 Identities=21% Similarity=0.279 Sum_probs=180.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
...|.+.+.||+|+||.||+|.+..+++.||+|... .....+|+.++++++|+||+++++++... +..|+|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEEcc
Confidence 347999999999999999999999999999999643 22356899999999999999999988765 4899999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------------
Q 040812 136 DAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------------- 195 (300)
Q Consensus 136 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------------- 195 (300)
. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 6 5888888653 469999999999999999999999999999999999999876543222
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-------chHHHHHHHHhhC---C------
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-------PDFLSLMLAICFR---E------ 257 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-------~~~~~~~~~~~~~---~------ 257 (300)
++..|.+||... +..++.++|||||||++|||++|..|+...... .....++...... .
T Consensus 322 ~~GT~~Y~APE~~~---~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 322 IAGTVDTNAPEVLA---GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cCCCcCCcCHHHHc---CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 223344555442 456788999999999999999988766433211 1111121111000 0
Q ss_pred --------------CCCC----C---CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 258 --------------PPSL----P---ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 258 --------------~~~~----~---~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+.. + ...+..+.+||.+||+. ||++|||+.|+|+||||+.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~-DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF-DGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHccc-ChhhCcCHHHHhhCcccCC
Confidence 0000 0 12356789999999999 9999999999999999975
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=298.48 Aligned_cols=232 Identities=25% Similarity=0.376 Sum_probs=171.7
Q ss_pred eeeecCCcceEEEEEEEc--cCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCC-CCcEEEEEeccCCC
Q 040812 62 LQVLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKP-SGEVSILMEYMDAG 138 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~~ 138 (300)
.++||+|+||.||+|+++ .+++.||+|.+..........+|+.++++++||||+++++++... ....|+||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 467999999999999975 467899999987655444567899999999999999999988543 3368999999965
Q ss_pred CHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC----CCCC---cc-------
Q 040812 139 SLEIYVKSR---------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK----MEHP---CG------- 195 (300)
Q Consensus 139 ~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~----~~~~---~~------- 195 (300)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +..+ +|
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 888877532 248999999999999999999999999999999999999432 2221 11
Q ss_pred ------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc--------hHHHHHHHHhh
Q 040812 196 ------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP--------DFLSLMLAICF 255 (300)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~--------~~~~~~~~~~~ 255 (300)
++..|.+||.... ...++.++|||||||++|||+||++||....... .....+.....
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCccccccCCccccccccCCHHHcC--CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 1233566665431 2346789999999999999999999996433211 00000000000
Q ss_pred -----------CCC-------------C----------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 256 -----------REP-------------P----------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 256 -----------~~~-------------~----------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..+ . ......+..+.++|.+||+. ||++|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~-dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM-DPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhcc-CcccCCCHHHHhcCCCC
Confidence 000 0 00112345688999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=305.51 Aligned_cols=226 Identities=31% Similarity=0.485 Sum_probs=179.5
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhc---CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQT---NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
||+|+||.||+|++..+++.||+|++....... ....|..++... .||||+.+++++.... ..|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-DLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-eEEEEEcCCC
Confidence 799999999999999999999999986432211 123466666655 6999999999988765 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------------ce
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------------YS 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------------~~ 197 (300)
+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+. ++
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 99999999888889999999999999999999999999999999999999877543222 22
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC-CCCChHHHHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP-ECSSEKFRDFIRCC 276 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~ 276 (300)
..|.+||.... ...++.++|||||||++|+|+||..||...... .....+.... ..++ ...+++++++|.+|
T Consensus 160 ~~y~aPE~~~~--~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~-~~~~~~~~~~~~~~li~~~ 232 (330)
T cd05586 160 TEYLAPEVLLD--EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYRNIAFGK-VRFPKNVLSDEGRQFVKGL 232 (330)
T ss_pred ccccCHHHHcC--CCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHHHHHHcCC-CCCCCccCCHHHHHHHHHH
Confidence 34566665431 223677999999999999999999999654322 2222222222 2233 34789999999999
Q ss_pred hccCCCCCCC----CHHHHhcCCCCCC
Q 040812 277 LQKGDPSKRW----TASQLLSHPFLAD 299 (300)
Q Consensus 277 l~~~dp~~Rp----t~~~~l~hpw~~~ 299 (300)
|.. ||++|| +++++++||||.+
T Consensus 233 L~~-~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 233 LNR-NPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred cCC-CHHHCCCCCCCHHHHhcCccccC
Confidence 999 999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=288.47 Aligned_cols=238 Identities=51% Similarity=0.856 Sum_probs=197.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|+..+.+++|+||+++++++.... ..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-EISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-eEEEEEE
Confidence 368899999999999999999999999999999876543 234567999999999999999999988764 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccc----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++...+..
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 99999999999887789999999999999999999999 9999999999999998876533221
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC-CChHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC-SSEKFRDF 272 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 272 (300)
...|.+||... +..++.++|+||||+++|+|+||..||..... .........+.....+..+.. .++.+.++
T Consensus 160 ~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 160 FVGTVTYMSPERIQ---GESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred eeecccccCHhhhC---CCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 22344454432 34567799999999999999999999976543 233344444444555556666 88999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
|.+||.. +|++||++.++++||||+++
T Consensus 236 i~~~l~~-~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 236 ISACLQK-DPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHccC-ChhhCCCHHHHHhCHHHHhc
Confidence 9999999 99999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=313.86 Aligned_cols=233 Identities=24% Similarity=0.295 Sum_probs=189.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccC-CeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQT-LALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..|.+.+.||+|+||.||+|....+ ++.||+|.+...... ..+.+|+.+++.++||||+++++++.... ..|+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-KLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-EEEEEEE
Confidence 4599999999999999999998877 788999976443221 12356999999999999999999998764 8999999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc--------------
Q 040812 134 YMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------- 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------- 195 (300)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999988754 3468999999999999999999999999999999999999977654322
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++..|.+||... +..++.++|||||||++|||+||+.||..... ...+..+........+..++.+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~s~~ 298 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWE---RKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYDPFPCPVSSG 298 (478)
T ss_pred ccccccCCCccccCHhHhC---CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCCccCCHH
Confidence 223355555443 45578899999999999999999999965432 2333333334444566778899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+.++|.+||.. ||++||++++++.|+|++
T Consensus 299 ~~~li~~~L~~-dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 299 MKALLDPLLSK-NPALRPTTQQLLHTEFLK 327 (478)
T ss_pred HHHHHHHHhcc-ChhhCcCHHHHHhCHHHH
Confidence 99999999999 999999999999999985
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=290.12 Aligned_cols=238 Identities=38% Similarity=0.642 Sum_probs=195.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|+..+.||+|+||.||++.++.+++.+|+|.+...... ..+.+|+.++++++||||+++++.+.... ..++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-DISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-EEEEEEE
Confidence 3678889999999999999999999999999998765332 23467999999999999999999988764 8999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccc---------------
Q 040812 134 YMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++...+..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 99999999999875 679999999999999999999999 9999999999999999876543322
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHHHHHhhCCCCCCCCC-CChHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAICFREPPSLPEC-SSEKFRDF 272 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 272 (300)
...|.+||... +..++.++|||||||++|+|++|..||..... .......+........+..+.. .++++.++
T Consensus 160 ~~~~~y~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 160 VGTSSYMAPERIQ---GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cCChhccCHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 22345555443 44677899999999999999999999965432 1223334444444555555554 78899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||+.++++||||+.
T Consensus 237 i~~~l~~-~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 237 VNLCLIK-DPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHcCC-CchhCcCHHHHhhCchhhc
Confidence 9999999 9999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=303.86 Aligned_cols=239 Identities=26% Similarity=0.358 Sum_probs=183.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----C
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS-----G 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 126 (300)
.++|++++.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46799999999999999999999999999999998653221 12357999999999999999999875432 2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|++++++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++...+.+
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 478999998 6699887764 4699999999999999999999999999999999999999876543322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh---------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF--------------- 255 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------- 255 (300)
+..|.+||.... ...++.++|||||||++|+|++|..||...+.......+......
T Consensus 172 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 MTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred cCCccccccccCchHhcC--CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 334566665431 235678999999999999999999999654322111111110000
Q ss_pred ---CCCCCC--------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 ---REPPSL--------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 ---~~~~~~--------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+.. ....++.+.+||.+||.. ||++|||+.++++||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~-dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVL-DSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCC-ChhhCCCHHHHhcCcchhc
Confidence 000001 123466789999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=289.44 Aligned_cols=233 Identities=27% Similarity=0.374 Sum_probs=191.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++.+.... ..|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-NMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-eEEEEE
Confidence 589999999999999999999999999999998754322 23467999999999999999999987654 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------- 197 (300)
||+.+++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++++++...+.++
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99999999999987778999999999999999999999999999999999999998765433221
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
..|.+||... +...+.++|+||||+++|+|++|..||...... ...... ..........+...+..+.++|.
T Consensus 160 ~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 160 SGTPGYMAPEVLC---RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIR-AKQETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred CCChhhcCHHHHc---ccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHH-HHhccccccCcccCcHHHHHHHH
Confidence 1233444332 334677999999999999999999999765432 111222 22222455667778899999999
Q ss_pred HHhccCCCCCCCCH--HHHhcCCCC
Q 040812 275 CCLQKGDPSKRWTA--SQLLSHPFL 297 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~--~~~l~hpw~ 297 (300)
+||.. ||.+||++ .|+++||||
T Consensus 235 ~~l~~-~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLER-DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccC-ChhHcCCccHHHHhcCCCC
Confidence 99999 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=292.15 Aligned_cols=237 Identities=29% Similarity=0.449 Sum_probs=188.3
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
|++.+.||+|+||.||++.+..++..+++|.+..... ...+.+|+.+++.++|+||+++++++.... ..|+||||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-EEEEEEEecC
Confidence 6888999999999999999999999999999864332 123467999999999999999999988754 8999999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------
Q 040812 137 AGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------- 196 (300)
Q Consensus 137 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------- 196 (300)
+++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++...+.+
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 165 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 165 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccc
Confidence 9999988764 45689999999999999999999999999999999999998776543322
Q ss_pred eeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 197 SCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 197 ~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
+..|.+||.... ..+..++.++|||||||++|||++|..||.............. ........+..++..+.++|.
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh--cCCCCCCCccccCHHHHHHHH
Confidence 223556665421 1234567799999999999999999999965433221111111 111122345567889999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. ||++||+++++++||||..
T Consensus 244 ~~l~~-~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 244 KCLEK-NVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHccC-ChhhCcCHHHHhcCCCEec
Confidence 99999 9999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=285.22 Aligned_cols=231 Identities=23% Similarity=0.362 Sum_probs=189.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-NLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-eEEEEEe
Confidence 589999999999999999999999999999998653322 23467999999999999999999987654 8999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++...+.++
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999999998753 25789999999999999999999999999999999999987655433221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
..|.+||... +...+.++|+|||||++|+|+||..||..... .........+..+..+...+.++.++
T Consensus 160 ~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08218 160 TCIGTPYYLSPEICE---NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----KNLVLKIIRGSYPPVSSHYSYDLRNL 232 (256)
T ss_pred hccCCccccCHHHhC---CCCCCCccchhHHHHHHHHHHcCCCCccCCCH----HHHHHHHhcCCCCCCcccCCHHHHHH
Confidence 2244444432 44567799999999999999999999965332 23333334455555677789999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
|.+||.. +|++||++.++++||||
T Consensus 233 i~~~l~~-~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKR-NPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhC-ChhhCcCHHHHhhCcCC
Confidence 9999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=287.25 Aligned_cols=233 Identities=35% Similarity=0.513 Sum_probs=186.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++.+.||.|+||.||+|.+..++..+|+|++...... ....+|+..++.++|+||+++++.+.... ..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-ELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-EEEEEEe
Confidence 4689999999999999999999989999999998654332 23467999999999999999999887755 8999999
Q ss_pred ccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 134 YMDAGSLEIYVKSR---GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
++++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++...+..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999999763 4589999999999999999999999999999999999999875432221
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC-----
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP----- 262 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 262 (300)
+..|.+||.... ....+.++|+|||||++|+|++|+.||............. ....+..+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 233 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQ--VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL----QNDPPSLETGADY 233 (267)
T ss_pred ccccccccCChhhcChHHHcc--ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh----cCCCCCcCCcccc
Confidence 122444544332 1256779999999999999999999997654432222222 22222222
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
...++.+.+++.+||.. ||++||+++++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~-~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 234 KKYSKSFRKMISLCLQK-DPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccHHHHHHHHHHcCC-ChhhCcCHHHHhhCCCC
Confidence 24678899999999999 99999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.28 Aligned_cols=240 Identities=27% Similarity=0.419 Sum_probs=188.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCC-CCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKP-SGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 128 (300)
..+++|++++.||+|+||.||+|.+..+++.||+|++...... ..+..|+.++++++||||++++++|... ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3467899999999999999999999999999999998754322 2345799999999999999999987543 3468
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhC-------CccccCCCCCceeecCCCC------
Q 040812 129 SILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSR-------NIVHRDIKPANVLINEKME------ 191 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-------~i~H~Dlkp~Nill~~~~~------ 191 (300)
||||||+++++|.+++.. .+.+++..++.|+.||+.||.|||.. +|+||||||+||||+....
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999875 24699999999999999999999984 4999999999999964211
Q ss_pred --------------CCcc---------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 040812 192 --------------HPCG---------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ 242 (300)
Q Consensus 192 --------------~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 242 (300)
.++| ++..|.+||..... ...++.++||||||||+|||+||..||.....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-TKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 1122 23446666654321 23467899999999999999999999965433
Q ss_pred CchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 243 EPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.. ..+..+. ..+.......+.++.+||..||.. +|.+||++.++|.||||.+
T Consensus 249 ~~---qli~~lk-~~p~lpi~~~S~eL~dLI~~~L~~-dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FS---QLISELK-RGPDLPIKGKSKELNILIKNLLNL-SAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HH---HHHHHHh-cCCCCCcCCCCHHHHHHHHHHhcC-ChhHCcCHHHHhccHHHhh
Confidence 22 2222222 112222234688999999999999 9999999999999999964
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=285.74 Aligned_cols=235 Identities=33% Similarity=0.523 Sum_probs=190.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||+|.+..+++.||+|.++..... ..+.+|+.++++++|+||+++++.+.... ..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-KVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-EEEEEEe
Confidence 588999999999999999999988999999998765443 23357999999999999999999877654 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999998877789999999999999999999999999999999999999865443222
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC--ChH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEK 268 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 268 (300)
...|.+||..........+.++||||||+++|+|++|..||....... ...........+.+|... ++.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHVGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHHhcCCCCCCCcccccCHH
Confidence 123445555432222236779999999999999999999996543221 222223334444555544 889
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+.++|.+||+. ||++|||+.++++|||+
T Consensus 237 ~~~li~~~l~~-~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 237 GKDFLDRCLES-DPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHccC-CcccCCCHHHHhcCCCC
Confidence 99999999999 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=288.32 Aligned_cols=230 Identities=26% Similarity=0.416 Sum_probs=182.0
Q ss_pred eecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC-----CHHHHHHHH---hcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-----NPQELNILR---QTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.||+|+||.||++.+..+++.+|+|.+........ ..+|..+++ ...|+||+.+++++...+ ..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-KLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-eEEEEEecC
Confidence 48999999999999999999999999875443221 123433333 347999999999988754 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------ee
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-----------------SC 198 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-----------------~~ 198 (300)
++++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++...+.+ +.
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 159 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCc
Confidence 9999999998888899999999999999999999999999999999999998775533222 22
Q ss_pred eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhc
Q 040812 199 LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278 (300)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 278 (300)
.|.+||... .+..++.++|||||||++|+|+||..||........ .............++...++++.++|.+||.
T Consensus 160 ~y~aPE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 160 GYMAPEVLQ--KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CccCHHHhc--CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 345555432 134467799999999999999999999975433211 2222223344556777889999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCC
Q 040812 279 KGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 279 ~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
. ||++|+ +++++++||||++
T Consensus 236 ~-~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 236 R-DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred C-CHHHhcCCCCCCHHHHHhCccccC
Confidence 9 999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=307.21 Aligned_cols=239 Identities=28% Similarity=0.410 Sum_probs=206.5
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
.++-..|+.++.||.|+||.||-|++..+.+.||||.+.-.... .+...|+..|++++|||++.+-++|..+. .
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-T 100 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-T 100 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-h
Confidence 34445688899999999999999999999999999987532211 23367999999999999999999999876 7
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC-------------
Q 040812 128 VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP------------- 193 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~------------- 193 (300)
.|+|||||-| +-.+++.- +.++-+.++..|+.+.+.||.|||+.+.||||||+.|||+++.+..+
T Consensus 101 aWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9999999965 88888864 44789999999999999999999999999999999999999876653
Q ss_pred --ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC-CCChHHH
Q 040812 194 --CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE-CSSEKFR 270 (300)
Q Consensus 194 --~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 270 (300)
+.++..|++||.......|.|+-++||||||+++.||..+++|+++. +.+..+..+..+..|.++. .+++.++
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM----NAMSALYHIAQNesPtLqs~eWS~~F~ 255 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNESPTLQSNEWSDYFR 255 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc----hHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence 34577799999888777788888999999999999999999999753 4457777788888888875 5899999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.|+..||++ =|.+|||++++|+|+|+.
T Consensus 256 ~Fvd~CLqK-ipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 256 NFVDSCLQK-IPQERPTSEELLKHRFVL 282 (948)
T ss_pred HHHHHHHhh-CcccCCcHHHHhhcchhc
Confidence 999999999 999999999999999975
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.58 Aligned_cols=234 Identities=23% Similarity=0.331 Sum_probs=184.0
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEE-----ccCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRH-----KQTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
....++|++.+.||+|+||.||+|.+ ..++..||+|+++..... ..+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34466899999999999999999974 345778999998754322 2346799999999 89999999999877
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhCC-------------------------------------------------------
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSRG------------------------------------------------------- 148 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 148 (300)
.. ..++|||||++|+|.+++....
T Consensus 111 ~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 111 GG-PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred CC-cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 54 8999999999999999986421
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 149 --------------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 149 --------------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
.+++..+..++.||+.||.|||++|++||||||+|||++.+...+++++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 3678889999999999999999999999999999999987654322211
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
..|.+||... +..++.++|||||||++|||+| |..||............+ ........+...+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 343 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI---KEGYRMLSPECAP 343 (375)
T ss_pred ccccCCCCCCcceeChhHhc---CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH---HhCccCCCCCCCC
Confidence 1255555543 4567889999999999999998 899996644333332222 2233444556678
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.++.++|.+||.. ||++|||+.++++.
T Consensus 344 ~~l~~li~~cl~~-dP~~RPs~~eil~~ 370 (375)
T cd05104 344 SEMYDIMKSCWDA-DPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHccC-ChhHCcCHHHHHHH
Confidence 8999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=288.78 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=183.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+++|++.+.||+|+||.||+|.++.+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..|+|
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 81 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-TLTLV 81 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-eEEEE
Confidence 357899999999999999999999989999999998654322 23467999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee------------
Q 040812 132 MEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------ 198 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------ 198 (300)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++...+.+++
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999985 899988754 468999999999999999999999999999999999999987654433222
Q ss_pred -------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC--------------
Q 040812 199 -------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-------------- 257 (300)
Q Consensus 199 -------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------------- 257 (300)
.|.+||.... ...++.++|||||||++|+|++|+.||............+.......
T Consensus 161 ~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 161 SNEVVTLWYRPPDVLLG--STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccCCcHHhhc--CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 2344443321 23356799999999999999999999965442222111111100000
Q ss_pred ---------CCC---CCCCCC--hHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 258 ---------PPS---LPECSS--EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 258 ---------~~~---~~~~~~--~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
... .....+ ..+.+++.+||.. ||++|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY-EPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhcc-CcccccCHHHHhcCCCC
Confidence 000 001123 7789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=292.20 Aligned_cols=234 Identities=26% Similarity=0.396 Sum_probs=188.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+|+.+++.++||||+++++.+.... ..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-HLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-EEEEE
Confidence 4689999999999999999999999999999998754321 12357999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++...+..+
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999999999988888999999999999999999999999999999999999987755322211
Q ss_pred --------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-
Q 040812 198 --------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR- 256 (300)
Q Consensus 198 --------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~- 256 (300)
..|.+||... +..++.++|+|||||++|||+||..||.+.... +........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~~~~~~~ 232 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVIL---RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQVISDD 232 (305)
T ss_pred cccccccchhhccccCCccCccccCchhcc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcc
Confidence 1244455432 345678999999999999999999999754322 222222111
Q ss_pred -CCCCCCCCCChHHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCC
Q 040812 257 -EPPSLPECSSEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLAD 299 (300)
Q Consensus 257 -~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt---~~~~l~hpw~~~ 299 (300)
..+......+..+.++|.+||.. ||++||+ +.++++||||..
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 233 IEWPEGDEALPADAQDLISRLLRQ-NPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cCCCCccccCCHHHHHHHHHHhcc-ChhhccCccCHHHHHhCccccC
Confidence 11222335788999999999999 9999998 789999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=290.35 Aligned_cols=239 Identities=36% Similarity=0.593 Sum_probs=191.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++.+.||+|+||.||++.+..+++.||+|++...... ..+.+|+.+++.++||||+++++.+.... ..|+||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-NICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-EEEEEE
Confidence 46799999999999999999999999999999988654322 23467999999999999999999988764 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccce--------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++...+..+
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~ 162 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence 999999999999887789999999999999999999997 69999999999999987755433222
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-------chHHHHHHHHhhCCCCCCCCC-CC
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-------PDFLSLMLAICFREPPSLPEC-SS 266 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~-~~ 266 (300)
..|.+||... ++.++.++|||||||++|+|+||..||...... ...............+.++.. .+
T Consensus 163 ~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 163 VGTSTYMSPERIQ---GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred ccCcccCCHHHHc---cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 2334444432 446677999999999999999999999754332 111222333333333444333 77
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.++.+++.+||.. ||++|||+.|+++|+||..
T Consensus 240 ~~~~~li~~~l~~-dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 240 EDLRDFVDACLLK-DPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHHhcC-CcccCcCHHHHhcCccccc
Confidence 8899999999999 9999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=284.97 Aligned_cols=233 Identities=33% Similarity=0.495 Sum_probs=188.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+|+..+.||+|+||.||+|.+..+++.|++|.+...... ..+.+|+.+++.++|+||+++++++.... ..|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-NLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-eEEE
Confidence 477889999999999999999988999999998654321 23457999999999999999999887654 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|+||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++...+..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 999999999999998877799999999999999999999999999999999999998775543322
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||.... ...++.++|+|||||++|+|++|..||....... ...........+..+..+++.+.++
T Consensus 160 ~~~~~~~y~~pe~~~~--~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 160 SFKGSPYWMAPEVIAQ--QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVFKIGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred ccCCCcceeCHHHhcC--CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHHHHHhcccCCCcCCCcCHHHHHH
Confidence 222444444321 1136779999999999999999999996544211 1111112134455667788999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+.+||.. ||++||++.++++||||
T Consensus 235 i~~~l~~-~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQR-DPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhc-CcccCcCHHHHhcCCCC
Confidence 9999999 99999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=282.90 Aligned_cols=231 Identities=29% Similarity=0.422 Sum_probs=188.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .+.+|+.++++++|+|++++++.+.... ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-ALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-EEEEEEe
Confidence 5899999999999999999999999999999987543222 3457999999999999999999887654 8999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-C---Ccc------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-H---PCG------------ 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-~---~~~------------ 195 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.+.. . +++
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999763 34899999999999999999999999999999999999985432 1 111
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+...|.+||... +...+.++||||||+++|+|++|..||...+.. ..............+...+.++.++
T Consensus 160 ~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~l 232 (256)
T cd08220 160 TVVGTPCYISPELCE---GKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKIMSGTFAPISDRYSPDLRQL 232 (256)
T ss_pred ccccCCcccCchhcc---CCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHHHhcCCCCCCCCcCHHHHHH
Confidence 122355565543 345677999999999999999999999654332 2222333344455667789999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+.+||.. ||++|||+.++++||||
T Consensus 233 i~~~l~~-~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNL-DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccC-ChhhCCCHHHHhhCCCC
Confidence 9999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=288.43 Aligned_cols=229 Identities=28% Similarity=0.402 Sum_probs=185.1
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
||+|+||.||+|.++.+++.||+|.+..... ...+.+|+.++++++||||+++++++.... ..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-DLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-eEEEEEecCCCCc
Confidence 6999999999999999999999999864321 122357999999999999999999988754 8999999999999
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------------ee
Q 040812 140 LEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------CL 199 (300)
Q Consensus 140 L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------~~ 199 (300)
|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...++.+ ..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 999997655 6899999999999999999999999999999999999998765433222 22
Q ss_pred ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhcc
Q 040812 200 YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQK 279 (300)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 279 (300)
|.+||... ++.++.++|||||||++|+|++|+.||.............. .........+...++.+.++|.+||+.
T Consensus 160 y~~PE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 160 YMAPEVLQ---GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-RTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred cCCHHHhc---CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-ccccccccCCccCCHHHHHHHHHHccC
Confidence 44444432 44477899999999999999999999976544222222222 222334456667899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCCCCCC
Q 040812 280 GDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 280 ~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
||++|| ++.++++||||.+
T Consensus 236 -~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 236 -DPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred -ChhHccCCCcccHHHHHhChhhhc
Confidence 999999 8889999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=288.82 Aligned_cols=240 Identities=30% Similarity=0.437 Sum_probs=187.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhc-CCCceeEeceeeeCCC----Cc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQT-NSPYIVKCHQIFTKPS----GE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~----~~ 127 (300)
...++|++.+.||+|+||.||++.+..+++.+|+|++...... ....+|+.+++++ +|||++++++++.... +.
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 3567899999999999999999999999999999998643222 2335689999998 8999999999886432 35
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------
Q 040812 128 VSILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------- 196 (300)
.|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++...+.+
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 8999999999999998863 34689999999999999999999999999999999999998775443221
Q ss_pred ------------eeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--C
Q 040812 197 ------------SCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP--S 260 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 260 (300)
...|.+||..... .+..++.++|||||||++|||++|+.||......... ........+ .
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~ 254 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPRNPPPTLL 254 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH----HHHhcCCCCCCC
Confidence 2235556653211 1223567999999999999999999999754332222 112112222 2
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+...+..+.++|.+||+. ||++||++.++++||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~-~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIK-DFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhc-ChhhCcCHHHHhcCcccC
Confidence 2445678899999999999 999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=289.31 Aligned_cols=235 Identities=27% Similarity=0.431 Sum_probs=182.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|+..+.||+|+||.||+|++..+++.||+|.+..+... ..+.+|+.++++++||||+++++++.... ..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-KLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-cEEEEee
Confidence 488999999999999999999999999999988654322 23467999999999999999999987654 8999999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+. ++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+.++
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 996 589888865 346899999999999999999999999999999999999998765433221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---------------
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE--------------- 257 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------------- 257 (300)
..|.+||.... ....+.++|||||||++|+|+||+.||....................
T Consensus 159 ~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 159 HEVVTLWYRAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccCCeEEec--CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 22455554421 23357789999999999999999999975443222222111100000
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 258 ---------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 258 ---------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
........+++++++|.+||.. ||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHY-DPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCC-CcccCCCHHHHhcCCCC
Confidence 0001123578899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=292.62 Aligned_cols=234 Identities=34% Similarity=0.505 Sum_probs=200.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
-|.++.+||+|+||.||+|.++++|+.+|||.+..+...+....|+.+|++-..+++|++||.|-... .+|+|||||..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-DLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-DLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCC-ceEeehhhcCC
Confidence 37889999999999999999999999999999988887777788999999999999999999887654 79999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC-------------------ccce
Q 040812 138 GSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP-------------------CGYS 197 (300)
Q Consensus 138 ~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~-------------------~~~~ 197 (300)
|++.+.++. +..+++.++..+++..+.||+|||...-+|||||..|||++.++..+ +-++
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGT 192 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGT 192 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccC
Confidence 999999975 45699999999999999999999999999999999999998776542 2346
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC--CCCCCChHHHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS--LPECSSEKFRDFIRC 275 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 275 (300)
.+|++||..+. ..|..++||||||++..||..|++||.+.... ..+..+..+.++. .|+.+++++.||+++
T Consensus 193 PFWMAPEVI~E---IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 193 PFWMAPEVIEE---IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----RAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred cccccHHHHHH---hccchhhhHhhhcchhhhhhcCCCCccccccc----ceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 67888887763 23566999999999999999999999754332 2222233344444 367889999999999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 276 CLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
||.+ +|++|-|+.++++|||++++
T Consensus 266 CLiK-~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 266 CLIK-KPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HhcC-CHHHHHHHHHHhhhhhhcCC
Confidence 9999 99999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=284.53 Aligned_cols=235 Identities=23% Similarity=0.363 Sum_probs=189.1
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccCCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMDAG 138 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~~ 138 (300)
.+.||+|+|+.|--|....++..||||++.+... .....+|++++.+- .|+||++++++|+++. .+|+|||.+.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~-~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT-RFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc-eEEEEEecccCc
Confidence 3679999999999999999999999999976432 23346799999886 5999999999999876 899999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC--------------------------
Q 040812 139 SLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-------------------------- 192 (300)
Q Consensus 139 ~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-------------------------- 192 (300)
+|...+.++..|++.++..+++.|++||.|||.+||.||||||+|||.......
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 999999999899999999999999999999999999999999999998653221
Q ss_pred ----Cccceeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC----------chHHHHHHHHhhC
Q 040812 193 ----PCGYSCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE----------PDFLSLMLAICFR 256 (300)
Q Consensus 193 ----~~~~~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----------~~~~~~~~~~~~~ 256 (300)
++ ++.-|++||.... ....+|..++|.||||||+|-|++|.+||.+.... ..-.+.+-...+.
T Consensus 242 ~L~tPv-GSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 242 ELLTPV-GSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred cccCcc-cchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence 11 2334667766442 23456888999999999999999999999653221 1112222222223
Q ss_pred CCCCC----CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 EPPSL----PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 ~~~~~----~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....+ +..++.+.+|+|..+|.. |+..|.++.++++|||++.
T Consensus 321 GkYeFPdkdWahIS~eakdlisnLlvr-da~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 321 GKYEFPDKDWAHISSEAKDLISNLLVR-DAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred cCCcCChhhhHHhhHHHHHHHHHHHhc-cHHhhhhhhhccCCccccc
Confidence 33344 446799999999999999 9999999999999999974
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=291.78 Aligned_cols=242 Identities=23% Similarity=0.334 Sum_probs=186.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC-CcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS-GEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 128 (300)
...++|++.+.||+|+||.||+|.+..+++.||+|.++...... ...+|+.++++++|+||+++++++.... +..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 35788999999999999999999999999999999987543322 2357999999999999999999986543 368
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 129 SILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
++||||+++ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++...+.+
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 88888875 35689999999999999999999999999999999999999875543222
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC------------
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR------------ 256 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------ 256 (300)
...|.+||.... ...++.++|||||||++|||++|..||...+.......+.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLG--CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred CCCCcccccccccChhhhcC--CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 122455554321 2346779999999999999999999997544332222222110000
Q ss_pred --CCCCC-----------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 --EPPSL-----------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 --~~~~~-----------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... ....++.+.++|.+||.. ||++|||++++++||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~-dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY-DPKKRATAEEALESSYFKE 295 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcC-ChhhCcCHHHHhcChhhcc
Confidence 00000 012478899999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=288.16 Aligned_cols=237 Identities=26% Similarity=0.344 Sum_probs=180.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
..+|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+|+.+++.++|+||+++++++.... ..|+||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-TLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-eEEEEE
Confidence 467999999999999999999999999999999987543322 2367999999999999999999988654 899999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------
Q 040812 133 EYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------- 198 (300)
Q Consensus 133 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------- 198 (300)
||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++...+++++
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9996 577666654 3467889999999999999999999999999999999999877654333222
Q ss_pred ------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----------CC----
Q 040812 199 ------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF-----------RE---- 257 (300)
Q Consensus 199 ------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~~---- 257 (300)
.|.+||.... ...++.++|||||||++|+|+||..||.................. ..
T Consensus 162 ~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 162 SEVVTLWYRPPDVLLG--ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CccccccccCCceeec--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2445554321 123567899999999999999999999654332111111110000 00
Q ss_pred --------CCCC---C--CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 258 --------PPSL---P--ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 258 --------~~~~---~--~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+... . ...+..+.+++.+|+.. ||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~-dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMM-FPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCc-CcccCcCHHHHhcCCCC
Confidence 0000 0 01256789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=289.78 Aligned_cols=239 Identities=33% Similarity=0.476 Sum_probs=186.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhc-CCCceeEeceeeeCC-----CC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQT-NSPYIVKCHQIFTKP-----SG 126 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~ 126 (300)
+..+.|++.+.||+|+||.||+|.+..+++.+|+|++..... ......|+.+++++ +|+||+++++++... ..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 345789999999999999999999999999999999865432 22345688888888 699999999987531 23
Q ss_pred cEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------
Q 040812 127 EVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------- 196 (300)
..|++|||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++...+.+
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 689999999999999999753 3588999999999999999999999999999999999999776543322
Q ss_pred -----------eeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC-CCC
Q 040812 197 -----------SCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-SLP 262 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 262 (300)
...|.+||..... .+..++.++|||||||++|||+||..||......... ........+ ...
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~ 248 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPPPKLKS 248 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----hhHhhCCCCCCcc
Confidence 2235566654321 1334667899999999999999999999654322111 111112222 223
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..++..+.++|.+||.. ||.+|||+.++++||||
T Consensus 249 ~~~~~~~~~li~~cl~~-~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 249 KKWSKKFIDFIEGCLVK-NYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccCHHHHHHHHHHhCC-ChhhCcCHHHHhcCCCC
Confidence 45788999999999999 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=302.41 Aligned_cols=235 Identities=22% Similarity=0.292 Sum_probs=185.1
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceee
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIF 121 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~ 121 (300)
.+....++|++.+.||+|+||.||+|.+..+ +..||+|.++...... .+.+|+.+++.+ +|+||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 3445667899999999999999999997543 3579999987543322 245799999999 899999999998
Q ss_pred eCCCCcEEEEEeccCCCCHHHHHHhC------------------------------------------------------
Q 040812 122 TKPSGEVSILMEYMDAGSLEIYVKSR------------------------------------------------------ 147 (300)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------ 147 (300)
.... ..|+|||||++|+|.+++...
T Consensus 112 ~~~~-~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 THGG-PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred cCCC-CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 7754 899999999999999988532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 148 ----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 148 ----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
..+++..++.++.||+.||.|||++||+||||||+|||++.+....++++
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 13678889999999999999999999999999999999987654332221
Q ss_pred -------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 198 -------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 198 -------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
..|.+||... +..++.++|||||||++|||++ |+.||............. ........+...++++
T Consensus 271 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 344 (374)
T cd05106 271 KGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---KRGYQMSRPDFAPPEI 344 (374)
T ss_pred ccCCCCccceeCHHHhc---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---HcccCccCCCCCCHHH
Confidence 1255555543 4567889999999999999997 999997654433332222 2233445566678999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhc
Q 040812 270 RDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.++|.+||.. ||++|||+.++++
T Consensus 345 ~~li~~cl~~-dp~~RPs~~~l~~ 367 (374)
T cd05106 345 YSIMKMCWNL-EPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHcCC-ChhhCcCHHHHHH
Confidence 9999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=288.44 Aligned_cols=243 Identities=29% Similarity=0.396 Sum_probs=189.2
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhc-CCCceeEeceeeeC----
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQT-NSPYIVKCHQIFTK---- 123 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~---- 123 (300)
....+..++|++.+.||+|+||.||+|.+..+++.+|+|++...... ..+.+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34456778999999999999999999999999999999987653322 2345799999998 69999999998742
Q ss_pred CCCcEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--- 196 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--- 196 (300)
..+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++...+..
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 23468999999999999988753 34688999999999999999999999999999999999999876443221
Q ss_pred ----------------eeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-
Q 040812 197 ----------------SCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE- 257 (300)
Q Consensus 197 ----------------~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~- 257 (300)
+..|.+||.... ..+..++.++|||||||++|||+||+.||......... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~----~~~~~~~~ 246 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL----FKIPRNPP 246 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH----hhccccCC
Confidence 223555665421 12344677999999999999999999999654332211 1111111
Q ss_pred -CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 258 -PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 258 -~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
....+...+..+.++|.+||.. ||++|||+.|+++|+||
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTK-DYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccC-CcccCCCHHHHhhcccC
Confidence 1223455678899999999999 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=275.16 Aligned_cols=241 Identities=30% Similarity=0.370 Sum_probs=192.8
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCC---
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKP--- 124 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~--- 124 (300)
+....+-++|++.+.||+|||+.||+++...+++.||+|.+...... ....+|+...++++|||+++++++...+
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 45556778999999999999999999999999999999998765532 2346799999999999999999876432
Q ss_pred -CCcEEEEEeccCCCCHHHHHHh---CC-CCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCCCCCCcc--
Q 040812 125 -SGEVSILMEYMDAGSLEIYVKS---RG-RLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKMEHPCG-- 195 (300)
Q Consensus 125 -~~~~~lv~e~~~~~~L~~~l~~---~~-~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~~~~~~~-- 195 (300)
....|++++|...|+|.+.++. .+ .+++.++..|+.+|++||++||+.. ++||||||.|||+++.+.....
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 2249999999999999999875 22 5899999999999999999999998 9999999999999986543211
Q ss_pred --------------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 040812 196 --------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL 249 (300)
Q Consensus 196 --------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 249 (300)
.+..|.+||......+...+.++|||||||++|.|+.|..||....+.......
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 144578888888777788889999999999999999999999543221111110
Q ss_pred HHHHhhCCCCCCC--CCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 250 MLAICFREPPSLP--ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 250 ~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+ .+....+| ...++.+.++|+.||+. ||.+||++.+++.+
T Consensus 254 --Av-~n~q~s~P~~~~yse~l~~lik~mlqv-dP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 --AV-QNAQISIPNSSRYSEALHQLIKSMLQV-DPNQRPTIPELLSK 296 (302)
T ss_pred --ee-eccccccCCCCCccHHHHHHHHHHhcC-CcccCCCHHHHHHH
Confidence 01 11112222 23789999999999999 99999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=290.48 Aligned_cols=237 Identities=27% Similarity=0.387 Sum_probs=184.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.+++.++|+||+++++++.... ..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-RLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-eEEEEE
Confidence 4689999999999999999999988999999987643322 23467999999999999999999987654 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------- 197 (300)
||+++++|..+......+++..++.++.||+.||.|||+.|++|+||+|+||++++++...+..+
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 99999999888776667999999999999999999999999999999999999998765433222
Q ss_pred ----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----------------C
Q 040812 198 ----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF-----------------R 256 (300)
Q Consensus 198 ----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------------~ 256 (300)
..|.+||.... ...++.++|||||||++|||+||++||.................. .
T Consensus 160 ~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 160 YVATRWYRAPELLVG--DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred ccceeeccCcHHhcc--ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 22445554321 133567899999999999999999999644321111111100000 0
Q ss_pred CCC---------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 257 EPP---------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 257 ~~~---------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..+ .....++..+.+++.+||.. ||++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRI-DPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcC-CcccchhHHHHhcCCCC
Confidence 000 01234578899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=307.86 Aligned_cols=242 Identities=32% Similarity=0.483 Sum_probs=204.6
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC--CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR--GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+.+.+-|+++..||.|+||.||+|..+.++-..|.|++.... ....+..||.+|..-.||+||.+++.|..++ .+||
T Consensus 28 lnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwi 106 (1187)
T KOG0579|consen 28 LNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWI 106 (1187)
T ss_pred CCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEE
Confidence 344556889999999999999999999999899999885433 3345677999999999999999999887765 8999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-----------------
Q 040812 131 LMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH----------------- 192 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~----------------- 192 (300)
+.|||.||-....+-. ...+++.++.-+++|++.||.|||+++|+|||||+.|||++.+|..
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 9999999999887765 4469999999999999999999999999999999999999877654
Q ss_pred --Cccceeecccccccc--ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC--CCCCC
Q 040812 193 --PCGYSCLYESGEARH--RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSS 266 (300)
Q Consensus 193 --~~~~~~~~~~~~~~~--~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 266 (300)
.+-++..|++|+..- .....+|.+++||||||++|.||..+.+|.... +.+.++..+....+|.+ |..++
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel----npMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc----chHHHHHHHhhcCCCcccCcchhh
Confidence 234577788988643 334567899999999999999999999998543 33455566666666654 77889
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
..+.||+.+||.+ ||..||+++++++||||.++
T Consensus 263 ~~F~DfLk~cL~K-np~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVK-NPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hHHHHHHHHHHhc-CCccCCCHHHHhhCcccccC
Confidence 9999999999999 99999999999999999864
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=288.03 Aligned_cols=233 Identities=34% Similarity=0.534 Sum_probs=189.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..|+..+.||+|+||.||+|.+..++..||+|++...... ..+.+|+.++++++|+||+++++++.... ..|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-KLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-EEEEEEe
Confidence 3578889999999999999999999999999998754322 23457999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|+++++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++...+.+
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 9999999999875 4789999999999999999999999999999999999999765443222
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
+..|.+||... +...+.++|+|||||++|||+||..||...... ...........+..+...+..+.++|.
T Consensus 162 ~~~~~y~apE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 162 VGTPFWMAPEVIQ---QSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVLFLIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cCcccccCHhHhc---cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHhhhhhcCCCCCCchhhhHHHHHHHH
Confidence 12244555432 455678999999999999999999999654322 122222233445556667889999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. +|++||++.++++||||.+
T Consensus 235 ~~l~~-~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 235 ACLNK-DPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred HHccc-CcccCcCHHHHHhChHhhh
Confidence 99999 9999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=287.63 Aligned_cols=223 Identities=17% Similarity=0.225 Sum_probs=179.3
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeC--C-CCcEEEEEec
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTK--P-SGEVSILMEY 134 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~--~-~~~~~lv~e~ 134 (300)
..||+|++|.||+|.. +|+.||+|.++...... .+.+|+.+|++++||||+++++++.+ + ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999998 47899999987643322 23589999999999999999998865 2 2368999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccc----------------e
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGY----------------S 197 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~----------------~ 197 (300)
+++|+|.+++.....+++.....++.|++.||.|||+ .+++||||||+||+++.++..++.+ +
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 183 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence 9999999999888789999999999999999999998 4999999999999999876543322 2
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH-hhCCCCCCCCCCChHHHHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI-CFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
..|.+||..... ...++.++|||||||++|||+||+.||...... .....+ .....+..+...++.++++|.+|
T Consensus 184 ~~y~aPE~~~~~-~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 184 MVYFSYKMLNDI-FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----EIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred ccccCHHHhhhc-cccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 335566654321 245778999999999999999999999754322 222222 22344556666889999999999
Q ss_pred hccCCCCCCCCHHHHhc
Q 040812 277 LQKGDPSKRWTASQLLS 293 (300)
Q Consensus 277 l~~~dp~~Rpt~~~~l~ 293 (300)
|+. ||++|||++++++
T Consensus 259 l~~-dp~~Rps~~ell~ 274 (283)
T PHA02988 259 TSH-DSIKRPNIKEILY 274 (283)
T ss_pred hcC-CcccCcCHHHHHH
Confidence 999 9999999999985
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=286.43 Aligned_cols=234 Identities=28% Similarity=0.460 Sum_probs=183.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC------------CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT------------PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
+|.+.+.||+|+||.||+|.+..+++.+|+|.++..... ..+.+|+.++++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999989999999988642211 12346899999999999999999887654
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
..++||||+.+++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++...+..
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 -YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred -ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 8999999999999999998877899999999999999999999999999999999999998765433221
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC--
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP-- 262 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 262 (300)
+..|.+||..... ...++.++|+||||+++|+|++|..||............ .........+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~ 236 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSY-SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL---GNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccCCccccCHHHhccc-cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh---hccccCCcCCcc
Confidence 1224445443211 123577899999999999999999999643322111111 1111122222
Q ss_pred --CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 263 --ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 263 --~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..++..+.++|.+||.. +|++||+++++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~-~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNACFTI-NPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHHHhcC-ChhhCCCHHHHhhCCCC
Confidence 24578999999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=287.27 Aligned_cols=237 Identities=21% Similarity=0.354 Sum_probs=186.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..++|++.+.||+|+||.||+|..+. .+..||+|.+...... ..+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 45789999999999999999997652 3568999987643321 12356899999999999999999987654
Q ss_pred cEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc
Q 040812 127 EVSILMEYMDAGSLEIYVKSR----------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~ 196 (300)
..|+||||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++...+.+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 899999999999999999752 2346678899999999999999999999999999999999876543322
Q ss_pred ee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 040812 197 SC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC 254 (300)
Q Consensus 197 ~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 254 (300)
++ .|.+||... ++.++.++|||||||++|||++ |..||...... .....+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----~~~~~~~ 235 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLK---DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----QVLKFVM 235 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhc---cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH
Confidence 21 244444432 4556789999999999999998 78899654322 2222233
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc------CCCCCCC
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS------HPFLADA 300 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~------hpw~~~~ 300 (300)
.......+...++.+.+++.+||.. ||++|||+.++++ ||||+++
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 236 DGGYLDQPDNCPERVTDLMRMCWQF-NPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCC-ChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 3444455667789999999999999 9999999999987 9999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=282.65 Aligned_cols=231 Identities=26% Similarity=0.394 Sum_probs=186.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||++.++.++..+|+|.+..... .....+|+.++++++|+||+++++.+.... ..|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-RLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-eEEEEEe
Confidence 58899999999999999999999999999999875422 223457999999999999999999987754 8999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-Ccc---------------
Q 040812 134 YMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-PCG--------------- 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-~~~--------------- 195 (300)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.. .++
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999997543 47999999999999999999999999999999999999876431 111
Q ss_pred ----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 196 ----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 196 ----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+...|.+||... +...+.++|+|||||++|+|++|..||...... ..............+...+..+.+
T Consensus 160 ~~~~~~~~~~ape~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd08225 160 YTCVGTPYYLSPEICQ---NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----QLVLKICQGYFAPISPNFSRDLRS 232 (257)
T ss_pred cccCCCccccCHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhcccCCCCCCCCCHHHHH
Confidence 112244444332 344677999999999999999999999654322 223333333344445567889999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+|.+||.. +|++|||+.++++||||
T Consensus 233 ~i~~~l~~-~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKV-SPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhcc-ChhhCcCHHHHhhCCCC
Confidence 99999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=291.46 Aligned_cols=232 Identities=24% Similarity=0.370 Sum_probs=170.4
Q ss_pred eeeecCCcceEEEEEEEcc--CCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCC-CCcEEEEEeccCCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQ--TLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKP-SGEVSILMEYMDAG 138 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~~ 138 (300)
..+||+|+||.||+|+.+. +++.||+|.+..........+|+.++++++||||+++++++... ....|+||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 3679999999999999754 56889999987655444567899999999999999999987532 3468999999976
Q ss_pred CHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC----CCCC---cc-------
Q 040812 139 SLEIYVKSR---------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK----MEHP---CG------- 195 (300)
Q Consensus 139 ~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~----~~~~---~~------- 195 (300)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +... +|
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 787776421 247899999999999999999999999999999999999432 2221 11
Q ss_pred ------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch---------HHHHHHHHh
Q 040812 196 ------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPD---------FLSLMLAIC 254 (300)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~---------~~~~~~~~~ 254 (300)
++..|.+||.... ...++.++|||||||++|||+||++||........ .........
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CcccccccCcceecccccCcHHhcC--CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 1223566665431 23467899999999999999999999964332110 000000000
Q ss_pred hC----------C-----------------------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 255 FR----------E-----------------------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 255 ~~----------~-----------------------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.. . ........+..+.++|.+||+. ||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~-dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM-DPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhcc-CcccccCHHHHhcCCCC
Confidence 00 0 0000112345688999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=288.66 Aligned_cols=238 Identities=26% Similarity=0.384 Sum_probs=181.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcC-CCceeEeceeeeCCCC----c
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTN-SPYIVKCHQIFTKPSG----E 127 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----~ 127 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.++..... ..+.+|+.+++++. |+||+++++++..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999999999999999998654322 23467999999995 5999999998765431 3
Q ss_pred EEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-CCCCCcccee---
Q 040812 128 VSILMEYMDAGSLEIYVKSR-----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-KMEHPCGYSC--- 198 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~-~~~~~~~~~~--- 198 (300)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++...+++++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 888887642 34799999999999999999999999999999999999998 5443322211
Q ss_pred ----------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-----
Q 040812 199 ----------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE----- 257 (300)
Q Consensus 199 ----------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----- 257 (300)
.|.+||.... ...++.++|||||||++|+|+||..||...........+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLG--STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhC--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 2444554321 23457799999999999999999999976443332222221110000
Q ss_pred --------------C----CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 258 --------------P----PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 258 --------------~----~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
. .......++.+.+||.+||.. ||++||++.++++||||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY-DPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccC-ChhhcCCHHHHhcCCCcC
Confidence 0 000124678899999999999 999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=279.90 Aligned_cols=231 Identities=26% Similarity=0.352 Sum_probs=188.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||.|+||.||.++...+++.+++|.+...... ..+.+|+.++++++|+||+++++++.... ..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-TLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-eEEEEEE
Confidence 589999999999999999999999999999998654322 23467999999999999999999998754 8999999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++..++.++
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999999764 46899999999999999999999999999999999999998765433221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
..|.+||... +..++.++|||||||++|+|++|..||...... +....+........+...+.++.++
T Consensus 160 ~~~~~~~y~ape~~~---~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08221 160 TVVGTPYYMSPELCQ---GVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----NLVVKIVQGNYTPVVSVYSSELISL 232 (256)
T ss_pred ccCCCccccCHhhcC---CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCCccccCHHHHHH
Confidence 2233344332 344667899999999999999999999654322 2232333333344456678999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
|.+||.. ||++||++.++++|||+
T Consensus 233 i~~~l~~-~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQ-DPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHccc-CcccCCCHHHHhhCcCC
Confidence 9999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=287.62 Aligned_cols=235 Identities=30% Similarity=0.459 Sum_probs=185.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||+|.++.+++.||+|.++..... ..+.+|+.++++++|+||+++++++.... ..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-RLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-EEEEEE
Confidence 4689999999999999999999999999999998653322 23467999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
||++++.+..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+.+
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9999988877776666799999999999999999999999999999999999999875543322
Q ss_pred ----eeeccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC--------------
Q 040812 197 ----SCLYESGEARHRKHGG-YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-------------- 257 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------------- 257 (300)
...|.+||... +. .++.++||||||+++|+|++|..||.............. .....
T Consensus 160 ~~~~~~~~~~PE~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 160 DYVATRWYRAPELLV---GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK-CLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred CcccccCCcCCchhc---CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCCHHHhhhcccCccc
Confidence 22345555543 23 567899999999999999999999965432211111111 00000
Q ss_pred ------C--------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 258 ------P--------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 258 ------~--------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
. ...+..++.++.++|.+||.. ||++||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM-DPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhcc-CchhcccHHHHhcCCCC
Confidence 0 012334578899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=286.98 Aligned_cols=236 Identities=28% Similarity=0.419 Sum_probs=183.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-GFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-eeEEEec
Confidence 589999999999999999999999999999998764422 23467999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 134 YMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++...+.+
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 9999999865 44689999999999999999999999999999999999998765432221
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC----------------
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR---------------- 256 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------------- 256 (300)
+..|.+||.... ...++.++|||||||++|||+||.+||...................
T Consensus 159 ~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 159 HQVATRWYRAPELLYG--ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccCcccccCceeeec--cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 223445554321 2345779999999999999999988885543322221111111000
Q ss_pred ----CCC-----CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 257 ----EPP-----SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 257 ----~~~-----~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
... ......+..+.++|.+||.. ||++|||++++++||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVY-DPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhcc-ChhhCCCHHHHhhCcCcC
Confidence 000 01123568899999999999 999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=284.04 Aligned_cols=228 Identities=26% Similarity=0.367 Sum_probs=186.3
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
||.|+||.||+|.+..+++.+|+|++...... ..+.+|+.++++++|+||+++++.+..+. ..|+||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-YIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-ccEEEEecCCCCc
Confidence 69999999999999999999999998754322 23457999999999999999999987754 8999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------eeecc
Q 040812 140 LEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------SCLYE 201 (300)
Q Consensus 140 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------~~~~~ 201 (300)
|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++...+.+ ...|.
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 999998877899999999999999999999999999999999999998765432221 22345
Q ss_pred ccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-hCCCCCCCCCCChHHHHHHHHHhccC
Q 040812 202 SGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPECSSEKFRDFIRCCLQKG 280 (300)
Q Consensus 202 ~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~ 280 (300)
+||... +..++.++|+||||+++|+|++|..||...... ......... .......|...++++.++|.+||..
T Consensus 160 ~PE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~- 233 (262)
T cd05572 160 APEIIL---NKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR- 233 (262)
T ss_pred ChhHhc---CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC-
Confidence 555433 344677999999999999999999999765431 122222222 2445566666789999999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCC
Q 040812 281 DPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 281 dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
||++||+ +.|+++||||++
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhhC
Confidence 9999999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=288.36 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=185.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC-CcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS-GEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 129 (300)
..++|++.+.||+|+||.||+|.++.+++.+|+|.++...... .+.+|+.++++++||||+++++++.... +..|
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3467999999999999999999999999999999997544332 2357999999999999999999876542 4899
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 130 ILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
+||||+.+ +|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++...+.++
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999975 9998887643 5899999999999999999999999999999999999998765433221
Q ss_pred --------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh---------------
Q 040812 198 --------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC--------------- 254 (300)
Q Consensus 198 --------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------- 254 (300)
..|.+||.... ....+.++|||||||++|+|++|..||...........+.....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLG--AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccCchhhcC--CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 22445554321 12346789999999999999999999975443222211111100
Q ss_pred -----------hCCCCCCCCC-CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 255 -----------FREPPSLPEC-SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 255 -----------~~~~~~~~~~-~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
......++.. .++.+.++|.+||+. ||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTY-DPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhcc-CccccCCHHHHhcCCCC
Confidence 0001122333 578899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=324.72 Aligned_cols=240 Identities=32% Similarity=0.430 Sum_probs=201.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecC-----CCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-----RGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..++|++++.||+|+||.|.+++.+.+++.||+|++.+. ....-|..|-.+|..-+.+=|+.++..|.++. ++|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~-~LY 151 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER-YLY 151 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-ceE
Confidence 457899999999999999999999999999999999763 22334577899999989999999999999876 999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--------------- 194 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~--------------- 194 (300)
+||||++||+|-.++....+++++.++.++..|+.||.-||+.|+|||||||+|||+|..|..+.
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999999999998889999999999999999999999999999999999999998876532
Q ss_pred -----cceeecccccccccc-CC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC--CCC
Q 040812 195 -----GYSCLYESGEARHRK-HG-GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP--ECS 265 (300)
Q Consensus 195 -----~~~~~~~~~~~~~~~-~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 265 (300)
.+++-|.+||..... .+ +.|+..+|+||+||++|||+.|..||....-...+-+++.. .....+| ..+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---k~~l~FP~~~~V 308 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---KESLSFPDETDV 308 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch---hhhcCCCccccc
Confidence 235557777776533 34 67899999999999999999999999765443344444433 2233444 458
Q ss_pred ChHHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt---~~~~l~hpw~~~~ 300 (300)
|+++++||.+++. +|+.|.. ++++.+||||.++
T Consensus 309 SeeakdLI~~ll~--~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC--DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred CHHHHHHHHHHhc--ChhhhcccccHHHHHhCccccCC
Confidence 9999999999986 6999998 9999999999874
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=290.48 Aligned_cols=232 Identities=35% Similarity=0.557 Sum_probs=187.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+.|+..+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-KLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-ceEEEEE
Confidence 3478889999999999999999999999999998644322 23467999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++...+.+
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 9999999998864 4689999999999999999999999999999999999998776543322
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
...|.+||... +..++.++|||||||++|||+||..||....... ..........+..+...+..+.++|.
T Consensus 162 ~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 162 VGTPFWMAPEVIK---QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred cCcccccCHHHhC---cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 22244454432 4456779999999999999999999996543221 12222223344555567889999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+||.. +|++||++.++++||||.
T Consensus 235 ~~l~~-~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 235 ACLNK-DPRFRPTAKELLKHKFIT 257 (277)
T ss_pred HHccC-CcccCcCHHHHHHhHHHH
Confidence 99999 999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=286.11 Aligned_cols=238 Identities=34% Similarity=0.511 Sum_probs=187.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhc-CCCceeEeceeeeCCC-----Cc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQT-NSPYIVKCHQIFTKPS-----GE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----~~ 127 (300)
..++|++.+.||+|+||.||+|.++.+++.+++|++...... ..+.+|+.+++++ +|+||+++++++.... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 457899999999999999999999988999999998754432 3346799999998 6999999999986432 24
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------
Q 040812 128 VSILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------- 196 (300)
.|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++...+..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 8999999999999998865 34789999999999999999999999999999999999999775443221
Q ss_pred ------------eeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC-
Q 040812 197 ------------SCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL- 261 (300)
Q Consensus 197 ------------~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 261 (300)
+..|.+||.... .....++.++|||||||++|+|+||..||.......... .......+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~ 239 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF----KIPRNPPPTLK 239 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH----HhhccCCCCCC
Confidence 223556664322 112345678999999999999999999996543322222 2222222222
Q ss_pred -CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 262 -PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 262 -~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+...++.+.++|.+||.. ||++|||+.++++|||+
T Consensus 240 ~~~~~~~~~~~li~~~l~~-dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIK-NYEQRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhc-ChhhCcCHHHHhcCCCC
Confidence 234678999999999999 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=297.67 Aligned_cols=234 Identities=27% Similarity=0.360 Sum_probs=177.9
Q ss_pred eeecCC--cceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQG--NGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
..||+| +||+||++++..+++.||+|++...... ..+.+|+.+++.++||||+++++++.... ..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-WLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-ceEEEEeccc
Confidence 456666 9999999999999999999998754322 23356888888999999999999998764 8999999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------
Q 040812 137 AGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------ 196 (300)
Q Consensus 137 ~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------ 196 (300)
+++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++...+.+
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998764 3589999999999999999999999999999999999998764332211
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh--------------
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-------------- 254 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------------- 254 (300)
...|.+||..... ...++.++|||||||++|||++|..||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQD-LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred cccccccCccCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1125566654321 12357799999999999999999999965433222111110000
Q ss_pred ----------------------------hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 ----------------------------FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 ----------------------------~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.......+...++.+.+||.+||.. ||++|||++++++||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ-DPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccC-CcccCCCHHHHhhCHHHHH
Confidence 0000111223567899999999999 9999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.02 Aligned_cols=239 Identities=37% Similarity=0.615 Sum_probs=185.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCC-CCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKP-SGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~ 132 (300)
++|+..+.||.|++|.||+|.+..+++.+|+|.+...... ..+.+|++++++++|+||+++++++... .+..|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688999999999999999999999999999998754332 2346799999999999999999987543 34689999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 133 EYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++...+..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999988753 345899999999999999999999999999999999999987754433222
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHHHHhhCCCCCCC------CC
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-PDFLSLMLAICFREPPSLP------EC 264 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~------~~ 264 (300)
..|.+||.. .+..++.++|||||||++|+|+||..||...... ....+..........+.++ ..
T Consensus 161 ~~~~~~~~y~~pE~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 161 GTFTGTSFYMAPERI---QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred ccccCCccccCHHHh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 223344433 2445677999999999999999999999765321 1112222222222222222 12
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.++.+.++|.+||.. ||++|||+.|+++||||.+
T Consensus 238 ~~~~~~~li~~~l~~-~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 238 WSEEFKDFIKQCLEK-DPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred hHHHHHHHHHHHcCC-CcccCCCHHHHHhCccccc
Confidence 357899999999999 9999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=255.31 Aligned_cols=238 Identities=27% Similarity=0.470 Sum_probs=187.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+|..+++||+|+||+||+++++++++.||+|.++.+...+ ...+|+-+++.++|.|||+++++...+. .+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-kltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-eeEEeH
Confidence 35778899999999999999999999999999998765443 3478999999999999999999988765 899999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee------------
Q 040812 133 EYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL------------ 199 (300)
Q Consensus 133 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~------------ 199 (300)
|||.. +|..+... ++.++...++.++.|++.||.|+|++++.|||+||.|.||+.++..+...+++
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99965 99988876 67799999999999999999999999999999999999999998765443333
Q ss_pred -------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCC-----------
Q 040812 200 -------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPS----------- 260 (300)
Q Consensus 200 -------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------- 260 (300)
|.+|..... ...|+.+.|+||-|||+.|+.. |++.|.+.+.......+...........
T Consensus 160 aevvtlwyrppdvlfg--akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred ceeeeeeccCcceeee--eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 233333221 2456789999999999999985 6666765554444444443322111111
Q ss_pred ----CC---------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 261 ----LP---------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 261 ----~~---------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+| ...+..-+|+++++|.- +|.+|++++++++||||.+
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~c-np~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKC-NPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhcc-CcccccCHHHHhcCccccc
Confidence 11 11134578999999999 9999999999999999987
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=285.40 Aligned_cols=232 Identities=35% Similarity=0.539 Sum_probs=188.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
-|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++.+.... ..|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-KLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-eEEEEEEe
Confidence 377889999999999999999989999999987643322 23457999999999999999999988754 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------------
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------------- 197 (300)
+++++|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||||+||+++.++...+.++
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 999999999864 46899999999999999999999999999999999999998765433222
Q ss_pred --eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 198 --CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 198 --~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
..|.+||... +...+.++|+|||||++|+|++|..||...... .....+.....+..+..++.++.+++.+
T Consensus 163 ~~~~y~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 163 GTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KVLFLIPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred CCccccChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 1234444332 345567899999999999999999999653321 2222233344555666788999999999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCCC
Q 040812 276 CLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||.. +|++||++.++++||||.+
T Consensus 236 ~l~~-~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 236 CLNK-EPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HccC-ChhhCcCHHHHHhCHHHhh
Confidence 9999 9999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=287.47 Aligned_cols=230 Identities=24% Similarity=0.357 Sum_probs=185.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC-----eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTL-----ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
.++|++.+.||+|+||.||+|.....+ ..||+|.++..... ..+.+|+.++.+++||||+++++++.... .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ-P 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC-c
Confidence 467899999999999999999986654 68999988644321 22467999999999999999999987654 8
Q ss_pred EEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC
Q 040812 128 VSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~ 191 (300)
.|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999999999999754 35788999999999999999999999999999999999998765
Q ss_pred CCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 040812 192 HPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSL 249 (300)
Q Consensus 192 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~ 249 (300)
..+.++ ..|.+||... ++.++.++|||||||++|||+| |..||...... ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~ 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL---YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EV 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhc---cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 432221 1245555432 4456789999999999999998 99999764432 23
Q ss_pred HHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
...+........+..+++.+.+++.+||+. ||++||++.+++++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~-~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLPCPEDCPARVYALMIECWNE-IPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 333334455566778899999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=285.29 Aligned_cols=237 Identities=32% Similarity=0.496 Sum_probs=182.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHH-HHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNI-LRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||++.++.+++.||+|.++...... ....|+.. ++.++|+||+++++++..+. ..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-DVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEEh
Confidence 46899999999999999999999999999999987543221 12345554 56678999999999988654 899999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCccc-----------
Q 040812 133 EYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
||++ ++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+||+++.++...+.+
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 488877754 23689999999999999999999997 999999999999998775543322
Q ss_pred -------eeeccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC-CCCCh
Q 040812 197 -------SCLYESGEARHRKHG-GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP-ECSSE 267 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 267 (300)
+..|.+||....... ..++.++|+|||||++|+|++|+.||....... +..........+..+ ..+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---QQLKQVVEEPSPQLPAEKFSP 235 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---HHHHHHHhcCCCCCCccccCH
Confidence 222455554432111 345779999999999999999999996533221 222222223333333 35789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.++|.+||.. +|++||++.++++||||..
T Consensus 236 ~l~~li~~~l~~-~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 236 EFQDFVNKCLKK-NYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHHHHHHccC-ChhhCcCHHHHhcCchhhh
Confidence 999999999999 9999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=279.86 Aligned_cols=228 Identities=23% Similarity=0.368 Sum_probs=183.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++.+.||+|+||.||++.++. +..+|+|.+...... ..+.+|+.++++++||||+++++++.... ..|+||||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~e~ 80 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-PLYIVTEF 80 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-CEEEEEEc
Confidence 4678999999999999999998865 457899987644322 34567999999999999999999987654 89999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 135 MDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
+++|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++...++++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 999999999875 346899999999999999999999999999999999999987754332221
Q ss_pred ----eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 198 ----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 198 ----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
..|.+||... +..++.++||||||+++|||+| |+.||..... .+....+........+...+..+.++
T Consensus 161 ~~~~~~y~aPE~~~---~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05114 161 AKFPVKWSPPEVFN---FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISRGFRLYRPKLASMTVYEV 233 (256)
T ss_pred CCCchhhCChhhcc---cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 1244454432 4456789999999999999999 9999965432 23333333344455566778899999
Q ss_pred HHHHhccCCCCCCCCHHHHhc
Q 040812 273 IRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.+||.. ||++||+++++++
T Consensus 234 i~~c~~~-~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHE-KPEGRPTFAELLR 253 (256)
T ss_pred HHHHccC-CcccCcCHHHHHH
Confidence 9999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=284.84 Aligned_cols=233 Identities=30% Similarity=0.514 Sum_probs=185.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcC---CCceeEeceeeeCCCCcEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTN---SPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv 131 (300)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++ |||++++++++.... ..|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-RLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-EEEEE
Confidence 478889999999999999999999999999998654322 22456888998886 999999999987654 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+..+
T Consensus 81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 9999999999998664 7899999999999999999999999999999999999997655432221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC-CCChHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE-CSSEKFRD 271 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~ 271 (300)
..|.+||... .+..++.++|+|||||++|+|++|..||...... ..........++.++. ..+.++.+
T Consensus 160 ~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 160 TFVGTPYWMAPEVIT--EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccCCcceeCHHHhc--cCCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhhhccccCCCCCCCcccCCHHHHH
Confidence 1244555432 1334577999999999999999999999654322 1121122223334443 37789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.+||.. ||++||++.++++|+||++
T Consensus 234 ~i~~~l~~-~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 234 FVAACLDE-EPKERLSAEELLKSKWIKA 260 (277)
T ss_pred HHHHHcCC-CcccCcCHHHHhhChHhhc
Confidence 99999999 9999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=282.31 Aligned_cols=236 Identities=32% Similarity=0.480 Sum_probs=184.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
++......||+|+||.||+|.+..++..||+|.+...... ..+.+|+.++++++|+||+++++++.... ..++|+||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 86 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG-FFKIFMEQ 86 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-EEEEEEec
Confidence 3344456899999999999999999999999987654322 23467999999999999999999987754 89999999
Q ss_pred cCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC-CCCCcc---------------
Q 040812 135 MDAGSLEIYVKSR-GRL--SEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-MEHPCG--------------- 195 (300)
Q Consensus 135 ~~~~~L~~~l~~~-~~l--~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~-~~~~~~--------------- 195 (300)
+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++.. +...+.
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 9999999999764 445 888899999999999999999999999999999999752 222111
Q ss_pred ----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 196 ----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 196 ----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+...|.+||..... ...++.++||||||+++|+|++|..||........ ...........+.++...++++.+
T Consensus 167 ~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKG-PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred ccCCCCccccChhhhccc-cccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhccCCCCCcccCHHHHH
Confidence 12334555554211 12356799999999999999999999965432211 111112223445667778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
++.+||.. +|++|||+.+++.||||
T Consensus 244 li~~~l~~-~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEP-DPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCC-CchhCCCHHHHHhCCCC
Confidence 99999999 99999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.62 Aligned_cols=235 Identities=27% Similarity=0.463 Sum_probs=183.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
+|++.+.||+|++|.||+|.+..+++.||+|.++..... ....+|+.++++++|+||+++++++.... ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-KLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-cEEEEEec
Confidence 589999999999999999999999999999998754322 23357999999999999999999988764 89999999
Q ss_pred cCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 135 MDAGSLEIYVKSR---GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++...+..
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 986 888888653 3589999999999999999999999999999999999998775443222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh----------hC---CCC
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC----------FR---EPP 259 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------~~---~~~ 259 (300)
+..|.+||.... ...++.++|||||||++|+|++|..||...+.......+..... .. ...
T Consensus 159 ~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 159 NEVVTLWYRAPDVLLG--SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccChHHhcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 223455554321 23457799999999999999999999976544322222211100 00 000
Q ss_pred C-----------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 260 S-----------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 260 ~-----------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
. .....+..++++|.+||+. ||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQL-NPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcC-CcccCCCHHHHhcCCCC
Confidence 0 1123467899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=300.82 Aligned_cols=224 Identities=23% Similarity=0.410 Sum_probs=190.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++...-++.||+|+-|.||+|+.. ++.||||.++.-. .-+|+-|++|+|+||+.+.|+|.... .+||||||
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-----ETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEf 193 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-----ETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEF 193 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh-----hhhHHHHHhccCcceeeEeeeecCCc-eeEEeeec
Confidence 3444455788999999999999987 6789999875332 23899999999999999999998876 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC------------------Cccc
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH------------------PCGY 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~------------------~~~~ 196 (300)
|..|.|...++....++......+.++|+.|+.|||.+.|||||||.-||||+.+... .+.+
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhh
Confidence 9999999999999899999999999999999999999999999999999999876443 2345
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-CCCCCCCCCChHHHHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 275 (300)
+..|++||... ....+.|+|||||||+|||||||+.||.+.+.. .++..+..+ .....|..+++.++-||++
T Consensus 274 TVaWMAPEvIr---nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 274 TVAWMAPEVIR---NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hHhhhCHHHhh---cCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHH
Confidence 67788888765 456778999999999999999999999654433 444444333 2456788999999999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 040812 276 CLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~h 294 (300)
||.. .|..||++.+++.|
T Consensus 347 cw~s-KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 347 CWNS-KPRNRPSFRQILLH 364 (904)
T ss_pred HHhc-CCCCCccHHHHHHH
Confidence 9999 99999999999988
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=289.51 Aligned_cols=238 Identities=27% Similarity=0.400 Sum_probs=188.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
....|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.+++.++||||+++++++.... ..|
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEE
Confidence 345699999999999999999999989999999998643322 12457999999999999999999988754 799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...++.
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 99999975 77776653 45689999999999999999999999999999999999999876543322
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC-CCCCChHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-PECSSEKFRDF 272 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l 272 (300)
...|.+||.......+.++.++||||||+++|||+||..||...+.. ...........+.. +..+++.+.++
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 23456666553323445678999999999999999999999654321 22222222233332 34567899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++||++.++++||||..
T Consensus 247 i~~~l~~-~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 247 VDSCLQK-IPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHhcC-ChhhCcCHHHHhcChhhcc
Confidence 9999999 9999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=287.55 Aligned_cols=239 Identities=28% Similarity=0.422 Sum_probs=181.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC----
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS---- 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 125 (300)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 45678999999999999999999999999999999986543222 2356999999999999999999875432
Q ss_pred ---CcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----
Q 040812 126 ---GEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---- 197 (300)
Q Consensus 126 ---~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---- 197 (300)
+..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++...+..+
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 246999999975 788777654 36899999999999999999999999999999999999998765433221
Q ss_pred -------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 198 -------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 198 -------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
..|.+||.... ...++.++||||||+++|||+||..||...... .....+.......+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~~~ 244 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGSIT 244 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcC--CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 12455554321 123567999999999999999999999654322 11112222111100
Q ss_pred CC---------------C-------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 259 PS---------------L-------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 259 ~~---------------~-------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+. . +...+..+.++|.+||.. ||++|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~-~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL-DPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcC-ChhhccCHHHHhcCCCC
Confidence 00 0 112356788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=279.22 Aligned_cols=232 Identities=30% Similarity=0.432 Sum_probs=188.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC-CCcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP-SGEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~ 132 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+....... ...+|+.++++++|+||+++++++... ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4889999999999999999999999999999987543322 234689999999999999999977543 34689999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhH-----hCCccccCCCCCceeecCCCCCCccc-------
Q 040812 133 EYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMH-----SRNIVHRDIKPANVLINEKMEHPCGY------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH-----~~~i~H~Dlkp~Nill~~~~~~~~~~------- 196 (300)
||+++++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++...+..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999875 357899999999999999999999 89999999999999999865543222
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
...|.+||... +...+.++|+||||+++|+|++|..||..... ......+.....+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 233 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLN---HMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASKIKEGKFRRIPYR 233 (265)
T ss_pred cCCcccccccccCCCccChhhhc---CCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHHHHhcCCCCCCccc
Confidence 22234444432 34467789999999999999999999975431 222333334445566777
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.+..+.+++.+||.. +|++||++.++++|||+
T Consensus 234 ~~~~~~~l~~~~l~~-~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 234 YSSELNEVIKSMLNV-DPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHHHccC-CcccCCCHHHHhhCCCC
Confidence 889999999999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=282.14 Aligned_cols=232 Identities=28% Similarity=0.427 Sum_probs=179.9
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHH-HHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNI-LRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+..+++.||+|++....... ....|..+ ....+|+|++++++++.... ..|+||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-YLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-eEEEEEeccC
Confidence 56999999999999999999999999986533211 11234333 34558999999999998754 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------eeecc
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------SCLYE 201 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------~~~~~ 201 (300)
+++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+.. ...|.
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~ 160 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYL 160 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCcc
Confidence 999999998877899999999999999999999999999999999999998875543322 22345
Q ss_pred ccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCC
Q 040812 202 SGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGD 281 (300)
Q Consensus 202 ~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~d 281 (300)
+||... +..++.++||||||+++|+|+||..||...+... ............+......+++.+.++|.+||.. |
T Consensus 161 ~pe~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~ 235 (260)
T cd05611 161 APETIL---GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM-D 235 (260)
T ss_pred Chhhhc---CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcccCCCCcccccCCHHHHHHHHHHccC-C
Confidence 555543 3446789999999999999999999996543321 1111111111223334446789999999999999 9
Q ss_pred CCCCCC---HHHHhcCCCCCCC
Q 040812 282 PSKRWT---ASQLLSHPFLADA 300 (300)
Q Consensus 282 p~~Rpt---~~~~l~hpw~~~~ 300 (300)
|++||+ ++|+++||||++.
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 999995 5799999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=278.36 Aligned_cols=233 Identities=37% Similarity=0.573 Sum_probs=190.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCCC-CcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKPS-GEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~ 132 (300)
+|++.+.||+|++|.||+|.+..+++.|++|++..... ...+.+|+.++++++|+||+++++.+.... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999999999999999876543 233467999999999999999999987651 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------- 197 (300)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+.++
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99999999999988778999999999999999999999999999999999999998654432221
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-hCCCCCCCCCCChHHH
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPECSSEKFR 270 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 270 (300)
..|.+||... +...+.++||||||+++|+|++|..||..... ......... ....+..+...+..+.
T Consensus 161 ~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 161 GSVRGTPYWMAPEVIR---GEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cCCCCCccccCHhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccccCCCcCCCcccCHHHH
Confidence 1233333322 33467799999999999999999999976541 222222222 2344566777899999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
++|.+||.. ||++||++.++++||||
T Consensus 235 ~~i~~~l~~-~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRR-DPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcC-ChhhCCCHHHHhhCCCC
Confidence 999999999 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=293.76 Aligned_cols=234 Identities=24% Similarity=0.338 Sum_probs=184.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
...++|++.+.||+|+||.||+|.+.. +++.||+|+++...... ....|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 345689999999999999999997543 45789999987543222 235699999999 899999999988766
Q ss_pred CCcEEEEEeccCCCCHHHHHHhC---------------------------------------------------------
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSR--------------------------------------------------------- 147 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------- 147 (300)
...++++|||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 66799999999999999998642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee---------------------eccc
Q 040812 148 ----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------------------LYES 202 (300)
Q Consensus 148 ----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------------------~~~~ 202 (300)
..+++..+..++.||+.||.|||++||+||||||+|||++.++...+++++ .|.+
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257889999999999999999999999999999999999976554332221 2445
Q ss_pred cccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCC
Q 040812 203 GEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGD 281 (300)
Q Consensus 203 ~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~d 281 (300)
||... +..++.++|||||||++|||++ |..||............+ ........+...++++.+++.+||+. +
T Consensus 244 PE~~~---~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~cl~~-~ 316 (337)
T cd05054 244 PESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL---KEGTRMRAPEYATPEIYSIMLDCWHN-N 316 (337)
T ss_pred cHHhc---CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH---hccCCCCCCccCCHHHHHHHHHHccC-C
Confidence 55433 4557789999999999999998 999997543333222222 22334455667789999999999999 9
Q ss_pred CCCCCCHHHHhcC
Q 040812 282 PSKRWTASQLLSH 294 (300)
Q Consensus 282 p~~Rpt~~~~l~h 294 (300)
|++||+++++++|
T Consensus 317 p~~RPs~~ell~~ 329 (337)
T cd05054 317 PEDRPTFSELVEI 329 (337)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.65 Aligned_cols=238 Identities=23% Similarity=0.312 Sum_probs=184.7
Q ss_pred Cccee-eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----------------CCHHHHHHHHhcCCCceeEece
Q 040812 57 SQLEK-LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----------------PNPQELNILRQTNSPYIVKCHQ 119 (300)
Q Consensus 57 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~E~~~l~~l~h~niv~~~~ 119 (300)
++|.. .+.||+|+||.||+|.+..+++.||+|.++...... ...+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 577999999999999999999999999986543222 2457999999999999999999
Q ss_pred eeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-
Q 040812 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC- 198 (300)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~- 198 (300)
++.... ..|+||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+.+++
T Consensus 88 ~~~~~~-~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 88 VYVEGD-FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEecCC-cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 988754 8999999997 5999999887789999999999999999999999999999999999999887654332211
Q ss_pred --------------------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchH
Q 040812 199 --------------------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF 246 (300)
Q Consensus 199 --------------------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 246 (300)
.|.+||.... ...++.++|||||||++|+|+||..||...+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG--AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhccc--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2344444321 123577999999999999999999999765443222
Q ss_pred HHHHHHHhhCCCC-----------------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 247 LSLMLAICFREPP-----------------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 247 ~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+.......... ......++.+.++|.+||.. ||++||++++++.||||+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL-NPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC-CchhccCHHHHhcCcccCC
Confidence 2222211100000 01123477899999999999 9999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.32 Aligned_cols=230 Identities=23% Similarity=0.372 Sum_probs=197.0
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
...++.+..+.||+|.||+||+|+... ....||||.++..... .+|.+|+..+..++|||||+++|++...+
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 356777889999999999999998643 3468999999876544 46789999999999999999999998765
Q ss_pred CcEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRG--------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~ 191 (300)
..|+|+|||..|||.+++.... .++..+.+.|+.||+.|+.||-++.++||||..+|+||.++..
T Consensus 563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 8999999999999999997431 2788999999999999999999999999999999999998876
Q ss_pred CCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 040812 192 HPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSL 249 (300)
Q Consensus 192 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~ 249 (300)
.+++++ ..|++||+..+ +.++.+||||||||+|||+++ |+.||.+..++ ++
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly---~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~----EV 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY---GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----EV 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc---CcccchhhhhhhhhhhhhhhccccCcccccchH----HH
Confidence 655543 33677777663 457889999999999999997 99999876554 55
Q ss_pred HHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
+..+..+.....|++++.++.+||..||+. +|++||++.||-
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~-~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNE-NPKRRPSFKEIH 756 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhc-CcccCCCHHHHH
Confidence 666666777888999999999999999999 999999999873
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=287.61 Aligned_cols=236 Identities=28% Similarity=0.421 Sum_probs=187.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
.++|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+|+.++++++|||++++++.+.... ..|+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-ELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-cEEEEEe
Confidence 46899999999999999999999888999999998543222 23467999999999999999999988755 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
|+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++...+..+
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 175 (293)
T cd06647 97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (293)
T ss_pred cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence 99999999998754 5889999999999999999999999999999999999987654332221
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
..|.+||... ++.++.++|||||||++|+|++|+.||............. .........+...+..++++|.
T Consensus 176 ~~~~~y~~PE~~~---~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 176 VGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred cCChhhcCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--cCCCCCCCCccccCHHHHHHHH
Confidence 1245555443 3456779999999999999999999996543321111111 0111112234456788999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. +|++||++.++++|+||+.
T Consensus 251 ~~l~~-~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 251 RCLEM-DVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred HHccC-ChhhCcCHHHHhcCHHHhc
Confidence 99999 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.32 Aligned_cols=231 Identities=23% Similarity=0.313 Sum_probs=176.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc----------------CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ----------------TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVK 116 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~ 116 (300)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678999999999999999998643 3457999998754322 23567999999999999999
Q ss_pred eceeeeCCCCcEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHhHhCCcccc
Q 040812 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-------------------RLSEDIICTISRQVLKGLFYMHSRNIVHR 177 (300)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~ 177 (300)
+++++.... ..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 84 LLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999988764 7999999999999999986431 35778899999999999999999999999
Q ss_pred CCCCCceeecCCCCCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh--CC
Q 040812 178 DIKPANVLINEKMEHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM--GY 234 (300)
Q Consensus 178 Dlkp~Nill~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt--g~ 234 (300)
||||+|||++.++...+++++ .|.+||... ++.++.++|||||||++|||++ +.
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL---MGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh---cCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999987654332221 244444432 4557889999999999999987 56
Q ss_pred CCCCCCCCCchHHHHHHHHh----hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 235 YPFLEPGQEPDFLSLMLAIC----FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 235 ~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
.||......... ....... .......+..+++.+.++|.+||.. ||++|||++++.
T Consensus 240 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~-~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVI-ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR-DCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHH-HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccC-CchhCcCHHHHH
Confidence 788654332221 1111111 1112233456788999999999999 999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=279.88 Aligned_cols=230 Identities=20% Similarity=0.316 Sum_probs=186.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
..+|++.+.||+|+||.||+|.+.++++.||+|.+..+... ..+.+|+.++++++|+||+++++++..+. ..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-CcEEEEEe
Confidence 45688999999999999999999999999999998654321 23467999999999999999999987654 89999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------
Q 040812 135 MDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------- 197 (300)
+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++...+.++
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9999999999753 35899999999999999999999999999999999999987655433221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
..|.+||... +..++.++|||||||++|||+| |..||...... ...........+..+...+..+.+
T Consensus 164 ~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 164 GAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred CCCCccccCCHHHhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1244555432 4566789999999999999998 99999654322 222223334455667778999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+|.+||.. ||++||++.++++.
T Consensus 237 li~~cl~~-~p~~Rp~~~~l~~~ 258 (263)
T cd05052 237 LMRACWQW-NPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHccC-CcccCCCHHHHHHH
Confidence 99999999 99999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=278.50 Aligned_cols=229 Identities=25% Similarity=0.364 Sum_probs=186.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
...+|++.+.||+|+||.||++... +..+|+|.++.+.....+.+|+.++++++|+|++++++++....+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 4567999999999999999999775 67899999876554445678999999999999999999765555579999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------------
Q 040812 135 MDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------------- 198 (300)
Q Consensus 135 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------------- 198 (300)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++...+++++
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 161 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence 99999999997643 47899999999999999999999999999999999999987665433221
Q ss_pred --eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 199 --LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 199 --~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
.|.+||... +..++.++|||||||++|+|++ |+.||.... .......+.....+..+..+++.+.++|.+
T Consensus 162 ~~~y~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 162 PVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred ceeecCHHHHc---cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 355555443 4456779999999999999998 999996432 222333333444556667789999999999
Q ss_pred HhccCCCCCCCCHHHHhc
Q 040812 276 CLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~ 293 (300)
||.. ||++|||+.++++
T Consensus 235 ~l~~-~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHL-DAATRPSFLQLRE 251 (256)
T ss_pred HhcC-ChhhCcCHHHHHH
Confidence 9999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=304.09 Aligned_cols=232 Identities=34% Similarity=0.507 Sum_probs=195.4
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCC--CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCH
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDR--GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSL 140 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L 140 (300)
-+||+|+||+||-|++..|....|||-+.... ..++...|+...++++|.|||+++|.+.. +|++-|.||-++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcH
Confidence 46999999999999999999999999986433 34455789999999999999999999765 4699999999999999
Q ss_pred HHHHHh-CCCC--CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC---------C-----------CCccce
Q 040812 141 EIYVKS-RGRL--SEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM---------E-----------HPCGYS 197 (300)
Q Consensus 141 ~~~l~~-~~~l--~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~---------~-----------~~~~~~ 197 (300)
.++++. -+++ ++..+-.+.+||+.||.|||++.|+|||||.+|+|++... . -.+.++
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 999986 4566 8899999999999999999999999999999999997421 1 134456
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
-.|++||....... .|++++|||||||++.||.||++||.+....... +.+.-.....|.+|+.++.+.+.||.+|.
T Consensus 740 LQYMAPEvIDqG~R-GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPR-GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred hhhhChHhhccCCc-CCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 77899998775433 4678999999999999999999999876544322 22223456678889999999999999999
Q ss_pred ccCCCCCCCCHHHHhcCCCCCC
Q 040812 278 QKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 278 ~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.. ||.+||++.++|++||+..
T Consensus 817 ep-d~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 817 EP-DPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred CC-CcccCccHHHhccCccccc
Confidence 99 9999999999999999863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=283.81 Aligned_cols=239 Identities=26% Similarity=0.420 Sum_probs=183.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-RLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-eEEEEE
Confidence 6799999999999999999999999999999998654322 23467999999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-CC---Cccc----------
Q 040812 133 EYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-EH---PCGY---------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-~~---~~~~---------- 196 (300)
||+++ +|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++ .. ++|.
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 99965 8887776543 357888999999999999999999999999999999998543 21 1111
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE------------- 257 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------- 257 (300)
+..|.+||... ....++.++|||||||++|+|+||..||..........+.........
T Consensus 160 ~~~~~~~~~y~~PE~~~--~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 160 FTHEVVTLWYRAPEILL--GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccCceeecccCHHHHh--CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 12345555432 123467799999999999999999999976443322222211110000
Q ss_pred -------CC----CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 258 -------PP----SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 258 -------~~----~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.. ......++.+.+++.+||.. ||++||++.++++||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRL-DPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccC-ChhhCcCHHHHhcCchHhHH
Confidence 00 01124578899999999999 99999999999999999863
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=278.88 Aligned_cols=222 Identities=24% Similarity=0.361 Sum_probs=178.4
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
+.||+|+||.||+|.+..+++.+|+|.+...... ..+.+|+.++++++|+||+++++++.... ..|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CeEEEEeeccCCc
Confidence 3699999999999999989999999987643221 23567999999999999999999987754 8999999999999
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------------------
Q 040812 140 LEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------------------- 198 (300)
Q Consensus 140 L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------------------- 198 (300)
|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++...+..++
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99999764 358999999999999999999999999999999999999877544322221
Q ss_pred -eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHH
Q 040812 199 -LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 199 -~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
.|.+||.. .++.++.++|||||||++|||++ |..||...... ..............+...+..+.+++.+|
T Consensus 160 ~~y~aPE~~---~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 232 (252)
T cd05084 160 VKWTAPEAL---NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QTREAIEQGVRLPCPELCPDAVYRLMERC 232 (252)
T ss_pred eeecCchhh---cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HHHHHHHcCCCCCCcccCCHHHHHHHHHH
Confidence 24445543 24556789999999999999998 89999643321 22222223344556777889999999999
Q ss_pred hccCCCCCCCCHHHHhc
Q 040812 277 LQKGDPSKRWTASQLLS 293 (300)
Q Consensus 277 l~~~dp~~Rpt~~~~l~ 293 (300)
|.. ||++|||+.++++
T Consensus 233 l~~-~p~~Rps~~~~~~ 248 (252)
T cd05084 233 WEY-DPGQRPSFSTVHQ 248 (252)
T ss_pred cCC-ChhhCcCHHHHHH
Confidence 999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=280.56 Aligned_cols=230 Identities=26% Similarity=0.432 Sum_probs=181.3
Q ss_pred eecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC-----CHHHH---HHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-----NPQEL---NILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.||+|+||.||+|.+..+++.||+|.+........ ...|. ..++...||||+.+++++.... ..|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-EEEEEEecC
Confidence 48999999999999999999999999875432211 12333 3344568999999999988765 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------ee
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-----------------SC 198 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-----------------~~ 198 (300)
.|++|..++...+.+++..++.++.|++.||.|||+.+++||||||+||+++.++...+.+ +.
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCc
Confidence 9999999998877899999999999999999999999999999999999998775532222 23
Q ss_pred eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhc
Q 040812 199 LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278 (300)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 278 (300)
.|.+||.... +..++.++||||+||++|+|++|+.||....... ... ............+...+.++.+++.+||.
T Consensus 160 ~y~aPE~~~~--~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 160 GYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCcCcHHhcC--CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-hHH-HHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 3455555431 2346778999999999999999999997643221 111 12222234456677779999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCCCCCC
Q 040812 279 KGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 279 ~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
. ||++|| ++.++++||||++
T Consensus 236 ~-~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 236 R-DVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred c-CHHhccCCCCCCHHHHHhCccccC
Confidence 9 999999 9999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=283.46 Aligned_cols=232 Identities=29% Similarity=0.444 Sum_probs=185.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.|...+.||+|++|.||++.+..+++.+++|.+...... ..+.+|+.+++.++|+||+++++++.... ..|+|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-ELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-eEEEEEecc
Confidence 455668999999999999999988999999988643222 22467999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------------
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------ 197 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------ 197 (300)
++++|.+++.. .++++..+..++.|++.||+|||++|++||||+|+||+++.++...+.++
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 177 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence 99999999987 57899999999999999999999999999999999999998765433222
Q ss_pred -eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC--CCCCChHHHHHHH
Q 040812 198 -CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIR 274 (300)
Q Consensus 198 -~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 274 (300)
..|.+||.. .+..++.++|||||||++|+|++|+.||...... ...........+.. +...+..+.++|.
T Consensus 178 ~~~y~aPE~~---~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 178 TPYWMAPEVI---SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----QAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred CccccCHHHh---cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence 224444443 2445677999999999999999999999654332 22222222222222 2336789999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. ||++||++.++++||||++
T Consensus 251 ~~l~~-~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 251 RMLVR-DPAQRATAAELLNHPFLAK 274 (285)
T ss_pred HHccc-ChhhCcCHHHHccCccccc
Confidence 99999 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.62 Aligned_cols=231 Identities=26% Similarity=0.419 Sum_probs=188.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~l 130 (300)
++|++.+.||+|+||.||++.+..+++.||+|++...... ....+|+.++++++ |+||+++++++.... ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE-NLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-eEEE
Confidence 4789999999999999999999999999999998653221 22356889999998 999999999987654 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------- 197 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------- 197 (300)
|||++++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++...+.++
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999999999998878999999999999999999999999999999999999987655332221
Q ss_pred --------------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 040812 198 --------------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLML 251 (300)
Q Consensus 198 --------------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 251 (300)
..|.+||... +...+.++||||||++++++++|..||........ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~ 232 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN---EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----FQ 232 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhC---CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----HH
Confidence 1223333222 33466789999999999999999999976543211 11
Q ss_pred HHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCH----HHHhcCCCC
Q 040812 252 AICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTA----SQLLSHPFL 297 (300)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~----~~~l~hpw~ 297 (300)
... ......+...++.+.++|.+||.. ||++||++ +++++||||
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~li~~~l~~-~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 233 KIL-KLEYSFPPNFPPDAKDLIEKLLVL-DPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHH-hcCCCCCCccCHHHHHHHHHHhcC-CHhhCCCcccCHHHHhcCCCC
Confidence 111 334456677789999999999999 99999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=283.57 Aligned_cols=237 Identities=33% Similarity=0.515 Sum_probs=192.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+..+.|++.+.||+|+||.||+|.+..++..|++|++..... ...+.+|+..+++++|+|++++++.+.... ..|+|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGD-ELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-EEEEEE
Confidence 456678999999999999999999998899999999876543 234467999999999999999999988764 899999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 133 EYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++...+...
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 9999999999998876 7999999999999999999999999999999999999997755432221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC--CCCCChHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFR 270 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 270 (300)
..|.+||... +..++.++|+|||||++|+|++|..||....... ..........+.. +..++..+.
T Consensus 175 ~~~~~~~y~~PE~~~---~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 175 SVVGTPYWMAPEVIK---RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----ALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred cccCCcccCCHhHhc---CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCcchhhCCHHHH
Confidence 2244555432 4456789999999999999999999996533221 1122222222222 233788999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++|.+||.. +|.+||++.++++|+||++
T Consensus 248 ~li~~~l~~-~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 248 DFLNKCLVK-DPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHhcc-ChhhCcCHHHHhhChHhhc
Confidence 999999999 9999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.74 Aligned_cols=229 Identities=23% Similarity=0.368 Sum_probs=184.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.++..... ..+.+|++++++++|+||+++++++.... .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-P 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC-C
Confidence 4678999999999999999998753 3678999998754332 24567999999999999999999988764 8
Q ss_pred EEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC
Q 040812 128 VSILMEYMDAGSLEIYVKSRG--------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP 193 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~ 193 (300)
.++||||+++++|.+++...+ .+++..+..++.||+.||.+||++|++||||||+||+++.++...
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 999999999999999997542 378889999999999999999999999999999999998775543
Q ss_pred ccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 040812 194 CGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLML 251 (300)
Q Consensus 194 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 251 (300)
+..+ ..|.+||... +..++.++|||||||++|||++ |..||...... ....
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~ 235 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIE 235 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhc---cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH
Confidence 2221 1245555443 5567889999999999999999 99999765432 2222
Q ss_pred HHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 252 AICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+........+...+..+.+++.+||.. ||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQGRLLQRPRTCPSEVYDIMLGCWKR-DPQQRINIKDIHE 276 (280)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCC-CcccCCCHHHHHH
Confidence 2333444455667889999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.20 Aligned_cols=236 Identities=33% Similarity=0.519 Sum_probs=206.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+++....||.|.||.||-|.+.++|+..|+|-++... ..+...+|..++..++|||+|+++|+-.+. ...+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-ekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-EKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-HHHHHHHH
Confidence 4667789999999999999999999999999876422 223447899999999999999999985554 47999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------------ 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------------ 195 (300)
||++|+|.+.++..+..++...+.+..|++.|+.|||++||+||||||+||+++.++..+.|
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99999999999988888999999999999999999999999999999999999988654332
Q ss_pred -----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 196 -----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
++..|++||......+..-+.+.|||||||++.||+||+.||.+.+.+ ..++..+..+..|.+|+.++++.+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCCCCCchhhhHhHH
Confidence 466688998887666555566999999999999999999999876554 467888889999999999999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
|||.+||+. ||++|.++.|++.|.|-+
T Consensus 1472 dFle~Cl~~-dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1472 DFLEHCLEQ-DPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHHHhc-CchhhhHHHHHHHhhccc
Confidence 999999999 999999999999998854
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=277.05 Aligned_cols=228 Identities=27% Similarity=0.415 Sum_probs=184.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
+|++.+.||+|+||.||++.+..+++.+|+|.++..... ....+|+.++++++|+||+++++.+.... ..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-HLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-EEEEEEee
Confidence 588999999999999999999999999999998643322 23356899999999999999999988754 89999999
Q ss_pred cCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 135 MDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++...+.+
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999999998864 33589999999999999999999999999999999999998765433222
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
...|.+||... +...+.++|+||||+++|+|++|..||...+. ...............+..++..+.++|
T Consensus 160 ~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (255)
T cd08219 160 YVGTPYYVPPEIWE---NMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLILKVCQGSYKPLPSHYSYELRSLI 232 (255)
T ss_pred ccCCccccCHHHHc---cCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHHHHHhcCCCCCCCcccCHHHHHHH
Confidence 12244455432 44567899999999999999999999965322 223333333444456677889999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 040812 274 RCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+||.. ||++||++.+++.-
T Consensus 233 ~~~l~~-~P~~Rp~~~~il~~ 252 (255)
T cd08219 233 KQMFKR-NPRSRPSATTILSR 252 (255)
T ss_pred HHHHhC-CcccCCCHHHHhhc
Confidence 999999 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=286.05 Aligned_cols=237 Identities=27% Similarity=0.369 Sum_probs=180.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS------ 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 125 (300)
+++|++.+.||+|+||.||+|.++.+++.+|+|.+...... ....+|+.++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999999999999998654322 23467999999999999999999875432
Q ss_pred -CcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------
Q 040812 126 -GEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------ 197 (300)
Q Consensus 126 -~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------ 197 (300)
...++||||+.+ +|...+.. ...+++..++.++.|++.||.|||++|++|+||||+||++++++...+.++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 247999999976 67766654 447999999999999999999999999999999999999998765432221
Q ss_pred ------------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 040812 198 ------------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 198 ------------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 253 (300)
..|.+||.... +..++.++|||||||++|||++|++||...........+. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~-~~ 242 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG--ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF-KL 242 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhC--CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HH
Confidence 12445554321 2346779999999999999999999996544322221111 11
Q ss_pred hhCCC-------------------CCC-------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 254 CFREP-------------------PSL-------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 254 ~~~~~-------------------~~~-------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..... ... .....+.+.++|.+||.. ||++|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL-DPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc-CcccCcCHHHHhcCCCC
Confidence 10000 000 012346789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=288.47 Aligned_cols=233 Identities=27% Similarity=0.406 Sum_probs=185.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
+.|.....||+|+||.||++.+..++..||||.+...... ..+.+|+.++++++|+||+++++.+.... ..|+||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-ELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-eEEEEEeC
Confidence 4455567899999999999999989999999998643221 23457999999999999999999987754 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------------
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------------- 197 (300)
+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++...+.++
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 999999998854 46899999999999999999999999999999999999987755433222
Q ss_pred --eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC--CCCCCChHHHHHH
Q 040812 198 --CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS--LPECSSEKFRDFI 273 (300)
Q Consensus 198 --~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 273 (300)
..|.+||... +..++.++|||||||++|||++|+.||....... .+.......... .....+..+.+++
T Consensus 180 ~~~~y~aPE~~~---~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 180 GTPYWMAPEVIS---RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCccccCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCccccccccCHHHHHHH
Confidence 2345555442 3456779999999999999999999997543322 122221122222 2235688899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||.. ||++|||++++++||||+.
T Consensus 253 ~~~l~~-~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 253 DLMLVR-EPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHccC-ChhHCcCHHHHhhChhhhc
Confidence 999999 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=292.83 Aligned_cols=239 Identities=28% Similarity=0.372 Sum_probs=184.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCC---CCcEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKP---SGEVS 129 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~ 129 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.++++++|+||+++++++... ....|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6789999999999999999999999999999998754322 2335799999999999999999987532 23689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
+||||+. ++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++...++++
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999996 589999987778999999999999999999999999999999999999998765433222
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH--------------
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-------------- 252 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-------------- 252 (300)
..|.+||.... ...++.++|||||||++|||++|+.||...+.......+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLS--LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred CCcccccccccccccChHHhcC--CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 12344444321 234677999999999999999999999654322111111100
Q ss_pred -----Hh--hCCCCCC-----CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 253 -----IC--FREPPSL-----PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 253 -----~~--~~~~~~~-----~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.. ....... ....++.+.++|.+||+. ||++||++++++.||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF-DPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccC-ChhhCcCHHHHHhChhhhh
Confidence 00 0001111 134578899999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=282.53 Aligned_cols=226 Identities=31% Similarity=0.456 Sum_probs=181.3
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
||+|+||.||++.+..+++.+++|.+...... ....+|+.++++++|+||+++++.+.... ..|+||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-NLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc-EEEEEEecCCCCc
Confidence 68999999999999999999999998654331 23356899999999999999999887654 8999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee---------------------
Q 040812 140 LEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------------------- 198 (300)
Q Consensus 140 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~--------------------- 198 (300)
|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...++.++
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 99999887789999999999999999999999999999999999999987655433322
Q ss_pred ------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC--ChHHH
Q 040812 199 ------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEKFR 270 (300)
Q Consensus 199 ------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~ 270 (300)
.|.+||... +...+.++||||||+++|+|+||..||...... ........ .....+... +..+.
T Consensus 160 ~~~~~~~~~~Pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (265)
T cd05579 160 RIVGTPDYIAPEVIL---GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQNILN-GKIEWPEDVEVSDEAI 231 (265)
T ss_pred CcccCccccCHHHhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhc-CCcCCCccccCCHHHH
Confidence 123333322 233567899999999999999999999654432 12222211 222333333 89999
Q ss_pred HHHHHHhccCCCCCCCCH---HHHhcCCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTA---SQLLSHPFLADA 300 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~---~~~l~hpw~~~~ 300 (300)
+++.+||.. +|++|||+ .++++||||+++
T Consensus 232 ~~i~~~l~~-~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 232 DLISKLLVP-DPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHhcC-CHhhcCCCccHHHHhcCccccCC
Confidence 999999999 99999999 999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=282.66 Aligned_cols=230 Identities=24% Similarity=0.363 Sum_probs=183.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEc----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHK----QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
+++|++.+.||+|+||.||+|.+. .+++.+|+|.+...... ..+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ-PV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-ce
Confidence 567899999999999999999863 35678999998753322 23467999999999999999999987654 79
Q ss_pred EEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC
Q 040812 129 SILMEYMDAGSLEIYVKSR-----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~ 191 (300)
|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999998532 23788899999999999999999999999999999999998755
Q ss_pred CCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 040812 192 HPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSL 249 (300)
Q Consensus 192 ~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~ 249 (300)
..++.++ .|.+||... ++.++.++|||||||++|||++ |..||..... ...
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~ 235 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM---YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEV 235 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhc---cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 4332211 244555443 4557789999999999999998 9999965432 233
Q ss_pred HHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
............+..+++.+.+++.+||+. ||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQE-GPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHccc-CcccCcCHHHHHHH
Confidence 333333444556777899999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=283.63 Aligned_cols=234 Identities=27% Similarity=0.392 Sum_probs=178.2
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcC-CCceeEeceeeeCCC-CcEEEEEe
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTN-SPYIVKCHQIFTKPS-GEVSILME 133 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~~lv~e 133 (300)
|++.+.||+|+||.||+|.+..+++.||+|.++...... ...+|+.++.++. |+|++++++++.+.. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999999999999999987543221 2246888888885 999999999987641 47999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 134 YMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+++ +|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++. +...++.
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence 9975 77777765 456899999999999999999999999999999999999998 4433222
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-----------h--CCCCCC
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----------F--REPPSL 261 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------~--~~~~~~ 261 (300)
+..|.+||... .++..+.++|||||||++|||++|..||...+............. . ......
T Consensus 159 ~~~~~y~aPE~~~--~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 159 ISTRWYRAPECLL--TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCcccCChhHhh--cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 22345555432 234567799999999999999999999965433211111111000 0 000011
Q ss_pred -----------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 262 -----------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 262 -----------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
....+..+.++|.+||.. ||++||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAY-DPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhcc-CcccccCHHHHhhCCCC
Confidence 124578999999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=277.73 Aligned_cols=232 Identities=29% Similarity=0.405 Sum_probs=183.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+++|++.+.||+|+||.||+|++..+++.||+|.++...... .+.+|+.++++++||||+++++++.... ..++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~ 79 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNI 79 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-eEEE
Confidence 367999999999999999999999999999999876533221 2356999999999999999999988654 8999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 131 LMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++...+.+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999988853 33589999999999999999999999999999999999998775442222
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-CCCCCCCCC
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-PPSLPECSS 266 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 266 (300)
...|.+||... +...+.++||||||+++|||+||..||...... ............ ++..+...+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred hHHHhcCCCCccccChhhhc---cCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcC
Confidence 22344555443 345677999999999999999999999654332 122222222222 223334577
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..+.++|.+||.. +|++||++.++++.
T Consensus 235 ~~~~~li~~cl~~-~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYP-DPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCC-CcccCcCHHHHHHH
Confidence 8999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=278.09 Aligned_cols=229 Identities=23% Similarity=0.319 Sum_probs=182.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++.+.||+|+||.||++.+.. +..+|+|.+..... ...+.+|+.++++++||||+++++++.... ..++||||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-PIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-CcEEEEEc
Confidence 3568999999999999999998865 44699998865432 234578999999999999999999987654 78999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee---------------
Q 040812 135 MDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------------- 198 (300)
Q Consensus 135 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~--------------- 198 (300)
+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++...++.+.
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999999764 368999999999999999999999999999999999999887654332211
Q ss_pred -----eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 199 -----LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 199 -----~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
.|.+||... +..++.++|||||||++|+|+| |..||...... .....+........+...++.+.++
T Consensus 161 ~~~~~~y~~pe~~~---~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05113 161 SKFPVRWSPPEVLL---YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKVSQGLRLYRPHLASEKVYAI 233 (256)
T ss_pred CccChhhCCHHHHh---cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 234444332 3456779999999999999999 99999654332 2222233334444566678999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.+||.. ||++||++.+++++
T Consensus 234 i~~cl~~-~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHE-KAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCC-CcccCCCHHHHHHh
Confidence 9999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=281.24 Aligned_cols=237 Identities=29% Similarity=0.447 Sum_probs=202.9
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC-----CHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-----NPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+++|+.+++||+|.||+|-+|+.+.+++.+|+|+++++..... ..-|-.+|+.-+||.+..+-..|.... .+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-rl 243 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-RL 243 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-eE
Confidence 356789999999999999999999999999999999987654322 245888999999999999988888755 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||..||.|.-.+.....|++..++.+...|++||.|||+++|+.||||.+|.|+|.++..++..
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999999999998888899999999999999999999999999999999999999988764433
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+.-|.+||..+ ...|+.++|+|.+||+||||++|+.||.+.+.+.-+ +.+ ......+|..++++.
T Consensus 324 t~kTFCGTPEYLAPEVle---DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-eLI----l~ed~kFPr~ls~eA 395 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLE---DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-ELI----LMEDLKFPRTLSPEA 395 (516)
T ss_pred eeccccCChhhcCchhhc---cccccceeehhhhhHHHHHHHhccCcccccchhHHH-HHH----HhhhccCCccCCHHH
Confidence 33455666655 566888999999999999999999999876654333 222 234567889999999
Q ss_pred HHHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
+.|+..+|.+ ||.+|. .+.|+.+|+||..+
T Consensus 396 ktLLsGLL~k-dP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 396 KTLLSGLLKK-DPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHHHHhhc-ChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999 999998 48999999999864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=276.55 Aligned_cols=231 Identities=33% Similarity=0.515 Sum_probs=190.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ....+|+++++.++|+|++++++.+... +..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 588999999999999999999999999999998765432 2235799999999999999999998776 48999999
Q ss_pred ccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 134 YMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
|+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++...+.+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999999763 5799999999999999999999999999999999999999865543222
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
...|.+||... +...+.++|+||+|+++|+|++|..||..... ..............++...+..+.
T Consensus 160 ~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd08215 160 AKTVVGTPYYLSPELCQ---NKPYNYKSDIWSLGCVLYELCTLKHPFEGENL----LELALKILKGQYPPIPSQYSSELR 232 (258)
T ss_pred ecceeeeecccChhHhc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCcH----HHHHHHHhcCCCCCCCCCCCHHHH
Confidence 12244444332 34467799999999999999999999965432 233333344445566777889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+++.+||.. +|++|||+.++++||||
T Consensus 233 ~~i~~~l~~-~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQK-DPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCC-ChhhCcCHHHHhcCCCC
Confidence 999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=281.35 Aligned_cols=234 Identities=25% Similarity=0.412 Sum_probs=183.3
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
|++.+.||+|++|.||+|.++.+|+.||+|.+...... ..+.+|+.++++++|+|++++++++... +..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence 67789999999999999999999999999998754322 2346799999999999999999998765 489999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 135 MDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
++ ++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++...+.+
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 96 58999987655 689999999999999999999999999999999999998765442221
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh------------------
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF------------------ 255 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------------ 255 (300)
...|.+||.... +..++.++|||||||++|+|+||..||...........+......
T Consensus 159 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 159 EVVTLWYRAPEILLG--SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred cccccCCCCCceeec--CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 223455554321 234577999999999999999999999765432222222111000
Q ss_pred ------CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 256 ------REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 256 ------~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..........+..+.++|.+||+. ||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVY-DPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcC-ChhhCcCHHHHhcCCCC
Confidence 000111234668899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=281.15 Aligned_cols=230 Identities=23% Similarity=0.321 Sum_probs=183.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+|+.++++++|+||+++++++.... .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-P 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-C
Confidence 4678999999999999999999987 7789999987643322 23567999999999999999999887654 7
Q ss_pred EEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Cc
Q 040812 128 VSILMEYMDAGSLEIYVKSRG-------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PC 194 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~ 194 (300)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+++++||||||+||+++.++. . ++
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 899999999999999997643 4889999999999999999999999999999999999986542 1 22
Q ss_pred cce------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhh
Q 040812 195 GYS------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICF 255 (300)
Q Consensus 195 ~~~------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 255 (300)
|.. ..|.+||... +..++.++|||||||++|||++ |..||...... .....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFL---DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEFVTG 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHh---cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHc
Confidence 211 1244444432 4557889999999999999997 99999654332 22223333
Q ss_pred CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 256 REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
......+...+..+.+++.+||+. ||++||++.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~i~~cl~~-~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGRLDPPKGCPGPVYRIMTDCWQH-TPEDRPNFATILER 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCC-CcccCcCHHHHHHH
Confidence 444555677889999999999999 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.94 Aligned_cols=237 Identities=29% Similarity=0.403 Sum_probs=180.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC----CcEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS----GEVS 129 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 129 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.++++++|+||+++++++.... ...|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 6799999999999999999999999999999998643222 22456999999999999999998765432 2589
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+|+||+.+ +|..++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++...+.+
T Consensus 85 lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 85 IVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 99999975 88877754 4799999999999999999999999999999999999998875543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh------------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF------------ 255 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------ 255 (300)
+..|.+||... ....++.++|||||||++|+|+||+.||...+..... ..+.....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIML--NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL-NLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cCCcCCcCcCCCccChHHhh--CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHHhhc
Confidence 12244555432 1234677999999999999999999999653221111 00000000
Q ss_pred -------C---CCCC-----CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 -------R---EPPS-----LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 -------~---~~~~-----~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
. .... .....++.+.++|.+||.. ||++|||+.++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTF-NPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCC-ChhhCcCHHHHhcCccccc
Confidence 0 0000 1123577899999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.58 Aligned_cols=234 Identities=24% Similarity=0.345 Sum_probs=183.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
...++|++.+.||+|+||.||+|.+. .+++.||||+++...... ...+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 34578999999999999999999853 457899999997543322 235799999999 689999999988766
Q ss_pred CCcEEEEEeccCCCCHHHHHHhC---------------------------------------------------------
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSR--------------------------------------------------------- 147 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------- 147 (300)
.+..++|||||++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 65789999999999999998642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------------
Q 040812 148 ----------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------------- 198 (300)
Q Consensus 148 ----------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------------- 198 (300)
..+++..+..++.||+.||.|||++||+||||||+||+++.++...+..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 135777888999999999999999999999999999999876554333221
Q ss_pred --eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 199 --LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 199 --~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
.|.+||... +..++.++|||||||++|+|++ |..||......... ............+...++.+.+++.+
T Consensus 244 ~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 244 PLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---CRRLKEGTRMRAPDYTTPEMYQTMLD 317 (343)
T ss_pred CcceECcHHhc---CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH---HHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 244555432 4556789999999999999997 99999654333222 22222334445566678899999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 040812 276 CLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~h 294 (300)
||.. ||++|||+.++++|
T Consensus 318 cl~~-~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHG-EPSQRPTFSELVEH 335 (343)
T ss_pred HccC-ChhhCcCHHHHHHH
Confidence 9999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=290.13 Aligned_cols=239 Identities=26% Similarity=0.365 Sum_probs=183.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCCC----CcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKPS----GEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 128 (300)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+|+.+++.++|+||+++++++.... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 579999999999999999999999999999999864321 123356999999999999999999876432 248
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++...+.++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 99999996 589999988788999999999999999999999999999999999999987765433221
Q ss_pred --------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH-------------------
Q 040812 198 --------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM------------------- 250 (300)
Q Consensus 198 --------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~------------------- 250 (300)
..|.+||.... +..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccCccChHHHhc--CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 22444444321 2346779999999999999999999996532211110000
Q ss_pred ----HHHhhCCCC---CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 251 ----LAICFREPP---SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 251 ----~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
......... ......++.+.++|.+||+. ||++|||++++++||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVF-DPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcC-ChhhccCHHHHHcCcchhh
Confidence 000000000 11235688899999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=285.90 Aligned_cols=231 Identities=22% Similarity=0.315 Sum_probs=181.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeE--EEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLAL--YALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 128 (300)
.+++|++.+.||+|+||.||+|.+..++.. +|+|.++..... ..+.+|+.++.++ +|+||+++++++.... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~-~~ 83 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YL 83 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-Cc
Confidence 467899999999999999999999877654 577766532211 1235699999999 8999999999987754 89
Q ss_pred EEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 129 SILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++|++||||||+|||++.++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999997532 47899999999999999999999999999999999999887654
Q ss_pred Ccccee------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH
Q 040812 193 PCGYSC------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 193 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 253 (300)
.+..++ .|.+||.. .+..++.++|||||||++|||+| |..||...... ......
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESL---NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL 236 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHH---hccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHHHH
Confidence 332221 24444433 24456789999999999999998 99999654332 222222
Q ss_pred hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
........+...++.+.++|.+||.. ||++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGYRLEKPLNCDDEVYDLMRQCWRE-KPYERPSFAQILVS 276 (303)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 22333445566788999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=275.04 Aligned_cols=231 Identities=31% Similarity=0.506 Sum_probs=191.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ..+.+|++++++++|+|++++++++.... ..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-SLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-EEEEEEe
Confidence 588899999999999999999999999999998765432 23467999999999999999999987754 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||||+||+++.++...+..
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 999999999998878899999999999999999999999999999999999999865433222
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
...|.+||... +...+.++||||||+++|+|++|..||...... ...........+..+...++.+.+++.
T Consensus 160 ~~~~~y~~pe~~~---~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 160 VGTPYWMAPEVIE---MSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIVQDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred ccchhhcCHhhhc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 12244444432 333677999999999999999999999754422 222223334455667778999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+||.. +|++|||+.++++||||
T Consensus 233 ~~l~~-~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQK-DPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhC-ChhhCcCHHHHhcCCCC
Confidence 99999 99999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=284.90 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=178.4
Q ss_pred cceeeeeecCCcceEEEEEEEcc--CCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCC-CcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQ--TLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPS-GEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 129 (300)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ......+|+.++++++||||+++++++.... ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 89999999997632 2233467999999999999999999988652 3799
Q ss_pred EEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC----CCCCCccce---
Q 040812 130 ILMEYMDAGSLEIYVKSR-----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE----KMEHPCGYS--- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~----~~~~~~~~~--- 197 (300)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+++||||||+||+++. ++...++++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 677666431 26899999999999999999999999999999999999988 443322221
Q ss_pred -------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc---------hHHHH
Q 040812 198 -------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP---------DFLSL 249 (300)
Q Consensus 198 -------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---------~~~~~ 249 (300)
..|.+||... ....++.++|||||||++|+|++|+.||....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHh--CCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 1244555432 12345779999999999999999999997544322 00000
Q ss_pred HHHHh---------------------hCCCCCCC-----------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 250 MLAIC---------------------FREPPSLP-----------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 250 ~~~~~---------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..... .......+ ...+..+.++|.+||.. ||++|||+.++++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY-DPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcC-CcccCcCHHHHhcCCCC
Confidence 00000 00000111 14567899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.67 Aligned_cols=233 Identities=30% Similarity=0.432 Sum_probs=188.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcCCCceeEeceeeeCCC-CcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTNSPYIVKCHQIFTKPS-GEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 128 (300)
.+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.+.. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4689999999999999999999999999999987543211 12356999999999999999999886543 368
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++...+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998777799999999999999999999999999999999999998776543222
Q ss_pred ----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 197 ----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 197 ----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
+..|.+||... +...+.++|+|||||++|+|++|+.||...... ............+.+|...+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVIS---GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKIATQPTKPMLPDGVS 235 (264)
T ss_pred cCccccccCCcccccCHhhhc---CCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHHHcCCCCCCCCcccC
Confidence 12244444432 344677899999999999999999999654322 22222233344566788899
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+.+.++|.+||+. |.+||++.++++|||.
T Consensus 236 ~~~~~~i~~~l~~--~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFVE--EKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhcC--cccCccHHHHhcCCCC
Confidence 9999999999975 6999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=282.85 Aligned_cols=230 Identities=20% Similarity=0.306 Sum_probs=181.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCe--EEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLA--LYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 129 (300)
+++|++.+.||+|+||.||+|.+..++. .+++|.++..... ..+.+|+.++.++ +||||+++++++.... ..|
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-YLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-cce
Confidence 3679999999999999999999877664 4688887632211 2346799999999 7999999999987654 799
Q ss_pred EEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC
Q 040812 130 ILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP 193 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~ 193 (300)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 478899999999999999999999999999999999998765433
Q ss_pred ccce------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 040812 194 CGYS------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC 254 (300)
Q Consensus 194 ~~~~------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 254 (300)
+..+ ..|.+||... +..++.++|||||||++|||+| |..||...... .......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----~~~~~~~ 232 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----ELYEKLP 232 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHh
Confidence 2221 1244555432 4456789999999999999997 99999654332 2223333
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.......+..++..+.+++.+||.. ||.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 QGYRMEKPRNCDDEVYELMRQCWRD-RPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 3444556677889999999999999 99999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=277.13 Aligned_cols=228 Identities=23% Similarity=0.351 Sum_probs=183.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.+|++.+.||+|+||.||++.++. +..+|+|.+..... ...+.+|+.++++++|+||+++++++.... ..|+||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-PIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-ceEEEEecC
Confidence 468899999999999999999864 56899999864332 224567999999999999999999887654 899999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee----------------
Q 040812 136 DAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------------- 198 (300)
Q Consensus 136 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------------- 198 (300)
++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++...+++++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 999999999753 468999999999999999999999999999999999999987654333221
Q ss_pred ----eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 199 ----LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 199 ----~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
.|.+||... +..++.++|||||||++|+|+| |..||...... ..............+...+..+.+++
T Consensus 162 ~~~~~y~~Pe~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05059 162 KFPVKWAPPEVFD---YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVESVSAGYRLYRPKLAPTEVYTIM 234 (256)
T ss_pred CCCccccCHHHhc---cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 244444333 4556779999999999999999 89999654332 22223333344455667899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 040812 274 RCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+||.. +|++|||+.++++.
T Consensus 235 ~~cl~~-~p~~Rpt~~~~l~~ 254 (256)
T cd05059 235 YSCWHE-KPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHhcC-ChhhCcCHHHHHHH
Confidence 999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=279.68 Aligned_cols=231 Identities=21% Similarity=0.330 Sum_probs=182.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..++|++.+.||+|+||.||+|.++. ++..||+|.+...... ..+.+|+.+++.++|+||+++++++... +
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-Q 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence 35679999999999999999998752 3568999987543221 1245799999999999999999998765 4
Q ss_pred cEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc
Q 040812 127 EVSILMEYMDAGSLEIYVKSRG----------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~ 196 (300)
..++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++...+.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 8999999999999999987522 256788899999999999999999999999999999999876543322
Q ss_pred e---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 040812 197 S---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC 254 (300)
Q Consensus 197 ~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 254 (300)
+ ..|.+||... ++.++.++|||||||++|||++ |..||...... .......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~~~ 235 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFVM 235 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhh---cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH
Confidence 1 1245555443 4567889999999999999999 78898654321 2222233
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.......+...++.+.+++.+||+. ||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EGGLLDKPDNCPDMLFELMRMCWQY-NPKMRPSFLEIISS 274 (277)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 3444556677889999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=283.86 Aligned_cols=236 Identities=26% Similarity=0.400 Sum_probs=186.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
..|+..+.||+|+||.||++++..++..+|+|.+....... .+.+|+.++++++|+|++++++++..+. ..|+|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEE
Confidence 44888999999999999999999999999999986543221 2356999999999999999999988765 78999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||+.+ +|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++...+..
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV 182 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCccccc
Confidence 999975 77777654 45689999999999999999999999999999999999998765543322
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
+..|.+||......++..+.++|||||||++|||++|..||............ .............++.++++|.+
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~ 259 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTLQSNEWSDYFRNFVDS 259 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---HhccCCCCCCccccHHHHHHHHH
Confidence 23356666543223445678999999999999999999999754322221111 11122233344678899999999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCC
Q 040812 276 CLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
||+. +|.+||++.++++|+|+.
T Consensus 260 ~l~~-~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 260 CLQK-IPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HccC-CcccCcCHHHHHhChhhh
Confidence 9999 999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=290.85 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=180.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----C
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS-----G 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 126 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.++++++|+||+++++++.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999999999999999998643222 12346999999999999999999876432 2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++|++||||||+||+++.++...+.+
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 47999999965 888887654 89999999999999999999999999999999999999876543222
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH---------------
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI--------------- 253 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--------------- 253 (300)
+..|.+||... +..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCcccccccCHHHHh---CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 22345555443 4567789999999999999999999996543222111111100
Q ss_pred ---hhCCC----C----------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 254 ---CFREP----P----------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 254 ---~~~~~----~----------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
....+ . ..+...++.+.++|.+||+. ||++|||+.|+|+||||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI-DPEKRISVDDALQHPYIN 315 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCC-ChhhCcCHHHHhcChhHh
Confidence 00000 0 00113456789999999999 999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=304.62 Aligned_cols=230 Identities=29% Similarity=0.393 Sum_probs=187.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcC-CCceeEece-eeeCC--C---
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTN-SPYIVKCHQ-IFTKP--S--- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~-h~niv~~~~-~~~~~--~--- 125 (300)
+-.++++.+.|.+|||+.||+|++...+..||+|.+-..... ....+|+.+|++|+ |+|||.+++ ..... +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 456788999999999999999999998899999987654211 23367999999997 999999999 33322 1
Q ss_pred CcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCCCCC---Ccc---
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKMEH---PCG--- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~~~~---~~~--- 195 (300)
-.++|+||||.||.|-+++..+ .+|++.+++.|+.|++.||.+||... |||||||-+||||+.++.. ++|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 1378999999999999999853 46999999999999999999999988 9999999999999988753 222
Q ss_pred ----------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 040812 196 ----------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 196 ----------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 253 (300)
.+..|.+||......|...+.|+|||+|||+||-|+....||.+.... .++
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIl--- 267 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AIL--- 267 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEE---
Confidence 245577888877777888899999999999999999999999765432 222
Q ss_pred hhCCCCCCC--CCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 254 CFREPPSLP--ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 254 ~~~~~~~~~--~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.....+| ..+++.+++||..||+. ||++||++-+++.+
T Consensus 268 --ng~Y~~P~~p~ys~~l~~LI~~mL~~-nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 --NGNYSFPPFPNYSDRLKDLIRTMLQP-NPDERPNIYQVLEE 307 (738)
T ss_pred --eccccCCCCccHHHHHHHHHHHHhcc-CcccCCCHHHHHHH
Confidence 1222233 46889999999999999 99999999998753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=295.53 Aligned_cols=233 Identities=32% Similarity=0.432 Sum_probs=195.9
Q ss_pred cee--eeeecCCcceEEEEEEEccCCeEEEEEEeecCC----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 59 LEK--LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 59 y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
|++ .+.||+|.||+||-|+++++|+.||||++.+.+ ......+|+.+|+++.||+||.+...|+.++ .+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-rvFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-RVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-eEEEEe
Confidence 554 378999999999999999999999999996533 2233468999999999999999999999876 899999
Q ss_pred eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC------Cc-----------
Q 040812 133 EYMDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH------PC----------- 194 (300)
Q Consensus 133 e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~------~~----------- 194 (300)
|.+.|+-|+-.+. ..+++++...+.++.||+.||+|||.++|+|+||||+|||+.+.... ++
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9998766665554 36789999999999999999999999999999999999999875332 22
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.++..|.+||... ...|....||||+|||+|--++|..||.+. +++...+....+..++..+..++++..
T Consensus 723 RrsVVGTPAYLaPEVLr---nkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLR---NKGYNRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhcCCccccCHHHHh---hccccccccceeeeEEEEEEecccccCCCc---cchhHHhhccccccCCCchhhcCHHHH
Confidence 2355566666654 445667899999999999999999999653 344455666667788888999999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|||..+|+. .-++|.|++..|.|||+++
T Consensus 797 dlIn~LLqV-km~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 797 DLINNLLQV-KMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHH-HHHHhcchHhhccchhhhc
Confidence 999999999 9999999999999999976
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=284.56 Aligned_cols=236 Identities=26% Similarity=0.403 Sum_probs=186.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+.|...+.||+|+||.||+|++..+++.|++|.+....... ...+|+.++++++|+|++++++++.... ..|+|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 99 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-TAWLV 99 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-EEEEE
Confidence 34777889999999999999999999999999986543221 2356899999999999999999988765 89999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||+.+ +|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++...+.+
T Consensus 100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~ 178 (313)
T cd06633 100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV 178 (313)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcc
Confidence 999965 77777754 45689999999999999999999999999999999999998765443221
Q ss_pred -eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC-CCCCCCChHHHHHHH
Q 040812 197 -SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-SLPECSSEKFRDFIR 274 (300)
Q Consensus 197 -~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 274 (300)
+..|.+||......++.++.++|||||||++|+|++|..||......... ........+ .....++..+++++.
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhcCCCCCCccccCHHHHHHHH
Confidence 23466676654323455677999999999999999999999765332222 222222222 223456788999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||+. +|.+||++.++++||||+.
T Consensus 255 ~~l~~-~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 255 YCLQK-IPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHccC-ChhhCcCHHHHhcCcccCC
Confidence 99999 9999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=293.44 Aligned_cols=235 Identities=22% Similarity=0.280 Sum_probs=182.9
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCC---CCCHHHHHHHHhcC-CCceeEeceee
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGT---PPNPQELNILRQTN-SPYIVKCHQIF 121 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~-h~niv~~~~~~ 121 (300)
.+....++|++.+.||+|+||.||+|.+... +..||+|+++..... ..+.+|+.+++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 3444567899999999999999999987533 357999998654322 23467999999996 99999999998
Q ss_pred eCCCCcEEEEEeccCCCCHHHHHHhC------------------------------------------------------
Q 040812 122 TKPSGEVSILMEYMDAGSLEIYVKSR------------------------------------------------------ 147 (300)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------ 147 (300)
... +..|+|||||++|+|.+++...
T Consensus 111 ~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 TKS-GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ccC-CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 765 4899999999999999988642
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCcee
Q 040812 148 ------------------------------------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVL 185 (300)
Q Consensus 148 ------------------------------------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nil 185 (300)
..+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 13677888999999999999999999999999999999
Q ss_pred ecCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040812 186 INEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQE 243 (300)
Q Consensus 186 l~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 243 (300)
++.+....+.++ ..|.+||... +..++.++|||||||++|||++ |..||......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF---DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc---CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 987654322111 2245555443 4567889999999999999997 99999654333
Q ss_pred chHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 244 PDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..... .+........+..++.++.++|.+||.. ||++||++.++.+
T Consensus 347 ~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~-dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYN---KIKSGYRMAKPDHATQEVYDIMVKCWNS-EPEKRPSFLHLSD 392 (400)
T ss_pred HHHHH---HHhcCCCCCCCccCCHHHHHHHHHHCcc-CHhHCcCHHHHHH
Confidence 22222 2222334455667889999999999999 9999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=284.27 Aligned_cols=234 Identities=28% Similarity=0.415 Sum_probs=185.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
...|+....||+|+||.||++.+..+++.||+|.+...... ..+.+|+.+++.++||||+++++.+.... ..|+|||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~iv~e 98 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-ELWVLME 98 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-eEEEEEe
Confidence 34455667899999999999999988999999998643322 23457999999999999999999988754 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
|+++++|..++.. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++...+..+
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9999999988765 46899999999999999999999999999999999999997765433322
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC--CCCCCCCCCChHHHHH
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR--EPPSLPECSSEKFRDF 272 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l 272 (300)
..|.+||... +..++.++|||||||++|||++|+.||...... ......... .....+...++.+.++
T Consensus 178 ~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 178 VGTPYWMAPEVIS---RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ecCccccCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhccCCCCccccCCCCHHHHHH
Confidence 2344555443 445678999999999999999999999754322 112221111 1122234567889999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||+. +|++||+++++++||||.+
T Consensus 251 i~~~l~~-~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 251 LERMLTR-EPQERATAQELLDHPFLLQ 276 (297)
T ss_pred HHHHhcC-CcccCcCHHHHhhChhhcc
Confidence 9999999 9999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=294.25 Aligned_cols=236 Identities=29% Similarity=0.440 Sum_probs=197.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
....|.+.+.||+|.|+.|.++++..++..||||.+.+...... ..+|+++|+.++|||||+++.+.+.+. .+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-TLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-eeEE
Confidence 45679999999999999999999999999999999977654433 367999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-----------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL----------- 199 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~----------- 199 (300)
||||+.+|.+++++...+++.+..++.++.|+++|++|||+++|+|||||++|||++.+...+++++.+
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence 999999999999999999999999999999999999999999999999999999999988654443222
Q ss_pred -------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 200 -------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 200 -------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
|.+||..... .+.++.+|+||+|+++|-|+.|.+||.+.+-. ............+|-.++.+..++
T Consensus 213 t~cgsppyAaPEl~~g~--~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGK--KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----ELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred ccCCCCCccChHhhcCc--ccCCcceehhhhhhhheeeeecccccCCcccc-----cccchheeeeecccceeechhHHH
Confidence 3344443321 25678999999999999999999999754321 111122234455667778899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.++|.. +|.+|++.+++.+|.|.+.
T Consensus 286 Lrk~lvl-~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 286 LRKFLVL-NPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred HHHhhcc-CccccCCHHHhhhhcccch
Confidence 9999999 9999999999999999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.40 Aligned_cols=237 Identities=32% Similarity=0.445 Sum_probs=182.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS------ 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 125 (300)
.++|++.+.||+|+||.||+|.++.+++.||+|.++...... ...+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 567999999999999999999999999999999987543222 2357999999999999999999876532
Q ss_pred ---CcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----
Q 040812 126 ---GEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---- 197 (300)
Q Consensus 126 ---~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---- 197 (300)
+..|+|+||+++ ++...+... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++...+..+
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 368999999987 777777653 46899999999999999999999999999999999999998765433221
Q ss_pred ----------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--
Q 040812 198 ----------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-- 259 (300)
Q Consensus 198 ----------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 259 (300)
..|.+||... .....+.++|||||||++|+|++|++||........ ...+........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLL--GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELISRLCGSPCPAV 241 (302)
T ss_pred cccCCcccccccceeccCccChHHhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhh
Confidence 1244444332 122356799999999999999999999975443222 2222222111100
Q ss_pred ------------------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 260 ------------------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 260 ------------------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
......+..+.++|.+||.. ||++||++.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL-DPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccC-ChhhCCCHHHHhcCCCC
Confidence 01123578899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.51 Aligned_cols=230 Identities=26% Similarity=0.374 Sum_probs=183.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.++|++.+.||+|+||.||+|.++.+ ...||+|.++..... ..+.+|+.++++++|+||+++++++.... ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR-PVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC-ceE
Confidence 35789999999999999999998644 458999988654322 23456999999999999999999987654 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee----------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------- 198 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------- 198 (300)
+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+|+|+||||+||+++.++...+.++.
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999976 3478999999999999999999999999999999999999987553322211
Q ss_pred -----------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 199 -----------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 199 -----------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
.|.+||... +..++.++||||||+++|+|++ |..||...... .....+........+...+
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIA---YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAVEDGYRLPPPMDCP 234 (266)
T ss_pred ceeccCCCCCccccChhhhc---cCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCC
Confidence 244444432 4456779999999999999998 99999654322 2233333333445566788
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.+.+++.+||+. +|++||++++++++
T Consensus 235 ~~l~~li~~cl~~-~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQK-DRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCC-CcccCcCHHHHHHH
Confidence 9999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=273.61 Aligned_cols=228 Identities=24% Similarity=0.346 Sum_probs=185.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.+.||+|+||.||+|... ++.||+|.++.... ...+.+|+.++++++|+||+++++++... ...|+|||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 80 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG-NPLYIVTE 80 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-CCeEEEEE
Confidence 3567899999999999999999876 68899999976544 23456799999999999999999998764 48999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++...++++
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~ 160 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK 160 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccccCC
Confidence 999999999998655 6899999999999999999999999999999999999998765433321
Q ss_pred --eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 198 --CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 198 --~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
..|.+||... ++.++.++||||||+++|+|++ |..||..... ...............+...++.+.++|.
T Consensus 161 ~~~~~~ape~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 161 LPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVEKGYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred CcccccCchhhc---CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence 1244555432 4456779999999999999997 9999965432 1222223333344556678899999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 040812 275 CCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~ 293 (300)
+||.. +|++|||+.++++
T Consensus 234 ~~l~~-~p~~Rp~~~~l~~ 251 (256)
T cd05039 234 DCWEL-DPAKRPTFKQLRE 251 (256)
T ss_pred HHhcc-ChhhCcCHHHHHH
Confidence 99999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=281.91 Aligned_cols=237 Identities=30% Similarity=0.482 Sum_probs=181.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|+..+.||+|+||.||++.+..+++.+|+|.+...... ..+.+|+.++.++. |+||+++++++..+. ..+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-DCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-cEEEEE
Confidence 4677888999999999999999999999999998654322 23356889999986 999999999887654 789999
Q ss_pred eccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCccc----------
Q 040812 133 EYMDAGSLEIYVK-----SRGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
||+.. ++.++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++...+..
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 99965 6655432 235799999999999999999999974 999999999999998765432221
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC----CCC
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL----PEC 264 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 264 (300)
+..|.+||......+..++.++|||||||++|+|++|+.||.... ...+.+........+.. +..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCCCCcCCCcCCCc
Confidence 223455555432212357789999999999999999999996543 12222222222222222 234
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+..+.+||.+||.. ||++|||++++++||||++
T Consensus 239 ~~~~l~~li~~~l~~-~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 239 FSPSFVNFINLCLIK-DESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCHHHHHHHHHHccC-ChhhCcCHHHHhcChhhhc
Confidence 788999999999999 9999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.18 Aligned_cols=229 Identities=22% Similarity=0.321 Sum_probs=183.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.+.||+|+||.||+|.+.. ++.||+|.++..... ..+.+|+.++++++|+||+++++++.... ..|+|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-PIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCC-Ceeeeee
Confidence 34679999999999999999999765 568999998754322 23567999999999999999999987754 8999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------
Q 040812 134 YMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------- 198 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------- 198 (300)
|+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++...+.+++
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 999999999997643 68999999999999999999999999999999999999987654332211
Q ss_pred -------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 199 -------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 199 -------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.|.+||... +..++.++|||||||++|||+| |+.||...... .....+........+...++.+.
T Consensus 162 ~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 162 EGAKFPIKWTAPEAAL---YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQVDQGYRMPCPPGCPKELY 234 (261)
T ss_pred CCCcCceeccCccccc---cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCCCcCCHHHH
Confidence 244555432 4456779999999999999999 99999654322 22222223333445567789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+||.. +|++||++.++++
T Consensus 235 ~li~~~l~~-~P~~Rp~~~~l~~ 256 (261)
T cd05068 235 DIMLDCWKE-DPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHhhc-CcccCCCHHHHHH
Confidence 999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=289.52 Aligned_cols=238 Identities=26% Similarity=0.398 Sum_probs=182.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcC-CCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTN-SPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 128 (300)
..-..|++++.||+||.+.||++...+.+ .||+|.+..... ...+.+|+..|.+++ |.+|++++++-.. ++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceE
Confidence 34567999999999999999999987755 555555443222 234578999999995 7999999998655 4599
Q ss_pred EEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC---------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH--------------- 192 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~--------------- 192 (300)
||||||-+. +|..+++++.. ++...++.++.||+.|+.++|++||||.||||.|+|+-.....
T Consensus 436 YmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCcccc
Confidence 999999866 99999988654 4446899999999999999999999999999999998654211
Q ss_pred -----CccceeeccccccccccCCC--------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-CCC
Q 040812 193 -----PCGYSCLYESGEARHRKHGG--------YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF-REP 258 (300)
Q Consensus 193 -----~~~~~~~~~~~~~~~~~~~~--------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~ 258 (300)
...++.-|++||+....... ..+.++||||||||||+|+.|++||... .+...-+..+.. +..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---INQIAKLHAITDPNHE 591 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---HHHHHHHHhhcCCCcc
Confidence 12346678999987532211 2467999999999999999999999542 222222332222 233
Q ss_pred CCCCCCCChH-HHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 259 PSLPECSSEK-FRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 259 ~~~~~~~~~~-l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.++|...+.. +.++++.||.. ||.+||++.++|+|||+.
T Consensus 592 Iefp~~~~~~~li~~mK~CL~r-dPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLAR-DPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhc-CcccCCCcHHHhcCcccc
Confidence 3566555444 99999999999 999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.27 Aligned_cols=237 Identities=29% Similarity=0.377 Sum_probs=185.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC----CCCCCHHHHHHHHhcCCCceeEeceeeeCCC----CcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----GTPPNPQELNILRQTNSPYIVKCHQIFTKPS----GEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 129 (300)
+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+|+.+++.++|+||+++++++.... ...|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999999889999999987533 2234567999999999999999999887643 3689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||+++ +|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++...++.
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999985 8999998877899999999999999999999999999999999999999875543221
Q ss_pred ---------eeeccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----------
Q 040812 197 ---------SCLYESGEARHRKHGG-YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF----------- 255 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------- 255 (300)
+..|.+||... +. ..+.++|+|||||++|+|++|.+||...+.......+......
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLL---SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred cccccccccccCcCCceeee---cccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 12244454433 22 5677999999999999999999999655432211111110000
Q ss_pred ----------CC--CC---CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 ----------RE--PP---SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 ----------~~--~~---~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.. .. ......+..+.++|.+||.. ||++||+++++++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF-DPKKRITADEALAHPYLAQ 294 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccC-ChhhCCCHHHHHhCccHHh
Confidence 00 00 01123578899999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=275.96 Aligned_cols=229 Identities=24% Similarity=0.357 Sum_probs=181.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.++||+|+||.||+|.... +..||+|.+..... ...+.+|+.++++++|+||+++++.+.... ..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-PIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CcEEEEe
Confidence 45789999999999999999999764 56799998765332 234467999999999999999999887654 7999999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++...++++
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 9999999999975 346889999999999999999999999999999999999998765432221
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
..|.+||... ++.++.++|||||||++|+|+| |..||...... ..............+...+.++.
T Consensus 162 ~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 162 EGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSALQRGYRMPRMENCPDELY 234 (261)
T ss_pred CCCccceecCCHHHhc---cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCHHHH
Confidence 1244444432 4556779999999999999998 99999654322 22222222333444556789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+||.. ||++||+++++.+
T Consensus 235 ~li~~~l~~-~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKE-KAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccC-CcccCcCHHHHHH
Confidence 999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=287.61 Aligned_cols=239 Identities=28% Similarity=0.382 Sum_probs=181.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCC--------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPS-------- 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 125 (300)
-++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999999999999999998654332 23467999999999999999998765432
Q ss_pred -----CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-C---Cccc
Q 040812 126 -----GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-H---PCGY 196 (300)
Q Consensus 126 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-~---~~~~ 196 (300)
...|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++.... . ++|.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 247899999975 89888864 46899999999999999999999999999999999999975421 1 1111
Q ss_pred -------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH----
Q 040812 197 -------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI---- 253 (300)
Q Consensus 197 -------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---- 253 (300)
+..|.+||... .+..++.++|||||||++|+|++|+.||................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLL--SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHh--CccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 22345555432 13346779999999999999999999996543322221111100
Q ss_pred --------------h--hCCCCC-----CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 --------------C--FREPPS-----LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 --------------~--~~~~~~-----~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
. ...... .....+.++.+||.+||+. ||++|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTF-NPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCC-CchhccCHHHHhCCCcccc
Confidence 0 000010 1124678899999999999 9999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=272.44 Aligned_cols=230 Identities=31% Similarity=0.416 Sum_probs=183.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+|+.++++++|+|++++++++.... ..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-ELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-eEEEE
Confidence 5799999999999999999999989999999988643221 23467999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee---------
Q 040812 132 MEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------- 198 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~--------- 198 (300)
|||+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+..++
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999998864 3458999999999999999999999999999999999999877654332221
Q ss_pred ----------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC-CCCh
Q 040812 199 ----------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE-CSSE 267 (300)
Q Consensus 199 ----------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 267 (300)
.|.+||... +..++.++|||||||++|+|++|..||..... ..............+..+. ..+.
T Consensus 161 ~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred cccceecCCccccCHHHhc---cCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCH
Confidence 234444332 44567799999999999999999999965432 2222232222233333444 6788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+.++|.+||.. +|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~-~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINP-DPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCC-CcccCCCHHHHHH
Confidence 999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=271.50 Aligned_cols=230 Identities=38% Similarity=0.585 Sum_probs=185.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
+|+..+.||+|++|.||++.+..+++.+++|++..... .....+|+..+++++|+|++++++++.... ..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-ELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecC
Confidence 47888999999999999999998899999999876542 234567999999999999999999988764 899999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------
Q 040812 136 DAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------ 196 (300)
Q Consensus 136 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------ 196 (300)
++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++...+.+
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 999999999775 5789999999999999999999999999999999999999765432221
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC--CChHHHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC--SSEKFRDFIR 274 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~ 274 (300)
...|.+||... +...+.++||||||+++|+|++|+.||......... ........+..+.. ++..+.++|.
T Consensus 160 ~~~~~~PE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 160 TPYWMAPEVIN---GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL----FKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred CCcccCHHHHc---CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH----HHHHhcCCCCcCcccccCHHHHHHHH
Confidence 22234444332 344677999999999999999999999654322211 11111233333333 3789999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPF 296 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw 296 (300)
+||+. ||++|||+.++++|||
T Consensus 233 ~~l~~-~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQK-NPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccC-ChhhCCCHHHHhcCCC
Confidence 99999 9999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.99 Aligned_cols=231 Identities=25% Similarity=0.377 Sum_probs=176.8
Q ss_pred cc-eeeeeecCCcceEEEEEEE----ccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCC-CcE
Q 040812 58 QL-EKLQVLGQGNGGTVFKVRH----KQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPS-GEV 128 (300)
Q Consensus 58 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 128 (300)
+| ++.+.||+|+||.||++.. ..+++.||+|.++.... ...+.+|+.++++++||||+++++++.... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 45 8899999999999988653 35678999999875432 123467999999999999999999876432 358
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee----------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------- 198 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------- 198 (300)
++||||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.++...++.++
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999999764 59999999999999999999999999999999999999887554332221
Q ss_pred ------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch-----------HHHHHHHHhh
Q 040812 199 ------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPD-----------FLSLMLAICF 255 (300)
Q Consensus 199 ------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~-----------~~~~~~~~~~ 255 (300)
.|.+||... +...+.++|||||||++|||+||..||........ ..........
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLK---ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred hhccCCCCCCCceeeCHhHhc---ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 234444332 44567899999999999999999999864322100 0001111111
Q ss_pred CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 256 REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
......+...+..+.+++.+||.. ||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rps~~~i~~ 276 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWET-EAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcc-ChhhCCCHHHHHH
Confidence 222334566789999999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=273.32 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=183.8
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCC----eEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTL----ALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKP 124 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 124 (300)
++.+..|+++..||+|+||.||+|..++++ +.+|||.++.... .....+|+..++.++||||+.+..+|...
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 455678999999999999999999765543 3789999987633 33457899999999999999999999875
Q ss_pred CCcEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC----CCCCc-
Q 040812 125 SGEVSILMEYMDAGSLEIYVKS-----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK----MEHPC- 194 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~----~~~~~- 194 (300)
++.+++++||.+. +|.+.++- ...++...++.|+.||+.|+.|||++-|+||||||.|||+..+ +..++
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 5689999999998 88888863 2358999999999999999999999999999999999999877 33322
Q ss_pred --c-------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC---------c
Q 040812 195 --G-------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE---------P 244 (300)
Q Consensus 195 --~-------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------~ 244 (300)
| .+..|.+||.... ...|+++.||||+|||+.||+|-++.|...... .
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG--a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG--ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcc--cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 2 2344566665542 246788999999999999999988888532111 0
Q ss_pred hHHHHHHHHhhCC---CC---CCC--------------------------CCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 245 DFLSLMLAICFRE---PP---SLP--------------------------ECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 245 ~~~~~~~~~~~~~---~~---~~~--------------------------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
....++.-..... .+ ..| ..-++...+|+.++|+. ||-+|.|+++++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~y-DP~kRIta~qAl 335 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTY-DPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhcc-CchhhccHHHHh
Confidence 1111111111000 00 001 11145588999999999 999999999999
Q ss_pred cCCCCCC
Q 040812 293 SHPFLAD 299 (300)
Q Consensus 293 ~hpw~~~ 299 (300)
+|+||.+
T Consensus 336 eh~yF~~ 342 (438)
T KOG0666|consen 336 EHPYFTE 342 (438)
T ss_pred ccccccc
Confidence 9999975
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.54 Aligned_cols=229 Identities=23% Similarity=0.383 Sum_probs=182.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+|.+.+.||+|+||.||++... .++..+|+|.+..... ...+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-PL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-cc
Confidence 467899999999999999999863 3456799998864322 223567999999999999999999987654 89
Q ss_pred EEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc
Q 040812 129 SILMEYMDAGSLEIYVKSRG-------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~ 195 (300)
++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++...+.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999997532 48999999999999999999999999999999999999887654332
Q ss_pred ce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH
Q 040812 196 YS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 196 ~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 253 (300)
.+ ..|.+||... +..++.++|||||||++|+|+| |..||...... .....+
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~~i 235 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECI 235 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH
Confidence 21 1245555432 4567789999999999999998 99999654332 223333
Q ss_pred hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
........+...+..+.+++.+||+. ||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~l~~li~~~l~~-~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQGRVLQRPRTCPKEVYDLMLGCWQR-EPHMRLNIKEIHS 274 (288)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHccC-ChhhCCCHHHHHH
Confidence 33444455667889999999999999 9999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=280.25 Aligned_cols=229 Identities=22% Similarity=0.371 Sum_probs=182.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+|.+.+.||+|+||.||+|++. .++..+++|.+...... ..+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-PL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC-ce
Confidence 456889999999999999999864 34567899988654322 24567999999999999999999988754 89
Q ss_pred EEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 129 SILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
++||||+++++|.+++... +.+++..++.++.||+.||.|||++|++||||||+||+++.++..
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999999999753 237899999999999999999999999999999999999977654
Q ss_pred Cccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 040812 193 PCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLM 250 (300)
Q Consensus 193 ~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 250 (300)
.+.++ ..|.+||... +..++.++|||||||++|||+| |..||...... +..
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~ 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVI 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence 32221 2245555433 4557789999999999999999 99999654332 222
Q ss_pred HHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
...........+...+..+.+++.+||.. ||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~~v~~ 277 (291)
T cd05094 236 ECITQGRVLERPRVCPKEVYDIMLGCWQR-EPQQRLNIKEIYK 277 (291)
T ss_pred HHHhCCCCCCCCccCCHHHHHHHHHHccc-ChhhCcCHHHHHH
Confidence 33333444455666789999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=272.43 Aligned_cols=213 Identities=23% Similarity=0.311 Sum_probs=173.3
Q ss_pred CcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhC
Q 040812 68 GNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR 147 (300)
Q Consensus 68 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 147 (300)
|.||.||+++++.+++.||+|.+..... ..+|...+....||||+++++++.... ..|+||||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLTIIPHCVPNMVCLHKYIVSED-SVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHHHHhcCCCceeehhhheecCC-eEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999999875432 234666666678999999999988754 899999999999999999877
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------eeccccccccccCC
Q 040812 148 GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------------CLYESGEARHRKHG 211 (300)
Q Consensus 148 ~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------------~~~~~~~~~~~~~~ 211 (300)
..+++..+..++.|++.||.|||+.|++||||||+||+++.++......+ ..|.+||... +
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~---~ 156 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG---I 156 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC---C
Confidence 78999999999999999999999999999999999999998765432221 2355665432 4
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCH---
Q 040812 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTA--- 288 (300)
Q Consensus 212 ~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~--- 288 (300)
..++.++||||+||++|||++|+.||...... .........|...++.++++|.+||+. ||++|+++
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~-dp~~R~~~~~~ 226 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSG---------INTHTTLNIPEWVSEEARSLLQQLLQF-NPTERLGAGVA 226 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------cccccccCCcccCCHHHHHHHHHHccC-CHHHhcCCCcc
Confidence 45677999999999999999999888532111 011122345667889999999999999 99999986
Q ss_pred --HHHhcCCCC
Q 040812 289 --SQLLSHPFL 297 (300)
Q Consensus 289 --~~~l~hpw~ 297 (300)
+++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=277.09 Aligned_cols=229 Identities=21% Similarity=0.334 Sum_probs=185.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+..+|++.+.||+|+||.||+|.+.. ++.+|+|.+..... .....+|+.+++.++|+||+++++++.... ..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-CeEEEE
Confidence 34578999999999999999999988 88999999876543 223467999999999999999999987754 899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------
Q 040812 133 EYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------- 197 (300)
||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++...++++
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 999999999999753 35899999999999999999999999999999999999998765433221
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
..|.+||... +..++.++||||||+++|+|++ |..||...... +.............+...++.+.
T Consensus 162 ~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05148 162 SDKKIPYKWTAPEAAS---HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYDQITAGYRMPCPAKCPQEIY 234 (261)
T ss_pred cCCCCceEecCHHHHc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHHhCCcCCCCCCCCHHHH
Confidence 1244454432 3456779999999999999998 89999654322 22222233444555677889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++|.+||+. ||++|||+.++++
T Consensus 235 ~~i~~~l~~-~p~~Rpt~~~l~~ 256 (261)
T cd05148 235 KIMLECWAA-EPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHcCC-CchhCcCHHHHHH
Confidence 999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.75 Aligned_cols=230 Identities=23% Similarity=0.395 Sum_probs=181.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
.++|++.+.||+|+||.||+|+.+. +.+.+++|.+...... ..+.+|+.++++++|+||+++++++.... .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE-P 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC-c
Confidence 3678999999999999999999764 3568999988654332 24577999999999999999999887654 8
Q ss_pred EEEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-
Q 040812 128 VSILMEYMDAGSLEIYVKSRG---------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~- 197 (300)
.|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++...++..
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998655 6899999999999999999999999999999999999988765433221
Q ss_pred -------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh-hC
Q 040812 198 -------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC-FR 256 (300)
Q Consensus 198 -------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~ 256 (300)
..|.+||... +...+.++|||||||++|+|++ |..||...... . ...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~---~~~~~~~~~ 235 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQ---EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-E---VLNRLQAGK 235 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-H---HHHHHHcCC
Confidence 1244555432 3446778999999999999998 88999654332 1 122211 12
Q ss_pred CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 257 EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.....+...+..+.+++.+||.. ||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~-~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAV-NPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCC-CcccCCCHHHHHHH
Confidence 22334556789999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=276.42 Aligned_cols=230 Identities=23% Similarity=0.375 Sum_probs=183.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..++|++.+.||+|+||.||+|.++.. +..||+|.+...... ..+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ- 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC-
Confidence 356899999999999999999998754 378999998644321 13457999999999999999999988764
Q ss_pred cEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc
Q 040812 127 EVSILMEYMDAGSLEIYVKSR----------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~ 196 (300)
..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++...++.
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 899999999999999999642 2367889999999999999999999999999999999999876654332
Q ss_pred ee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 040812 197 SC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC 254 (300)
Q Consensus 197 ~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 254 (300)
++ .|.+||.. .++.++.++|||||||++|||+| |..||...... .......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~~~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESL---KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVLKFVI 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHH---hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHHHHHh
Confidence 21 24444443 24557789999999999999998 99999654322 2222333
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.......+...+..+.++|.+||.. +|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHLDLPENCPDKLLELMRMCWQY-NPKMRPTFLEIVS 273 (277)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCC-ChhhCCCHHHHHH
Confidence 3445566777899999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=276.86 Aligned_cols=239 Identities=29% Similarity=0.449 Sum_probs=189.4
Q ss_pred cceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCCCC------CCCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGT------PPNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
+|++.+.||+|+||.||+|.+. .+|+.||+|+++..... ..+.+|+.+++++ +|+||+.+++++..+. .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT-K 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC-e
Confidence 4789999999999999999985 47899999998753321 2235699999999 5899999999988754 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
.|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.++...+.++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999999999988778999999999999999999999999999999999999988765433222
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
..|.+||..... ....+.++||||||+++|+|+||..||............... .....+..+...+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGG-DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR-ILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccCCcccCChhhccCC-CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH-hhccCCCCCccCCH
Confidence 223444443211 123466899999999999999999999654333233233222 22334455677889
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
.+.+++.+||.. ||++|| +++++++||||+..
T Consensus 238 ~~~~ll~~~l~~-~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 238 LAKDIIQRLLMK-DPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHHHhcC-CHHHhcCCCCCCHHHHHcCcccccC
Confidence 999999999999 999997 89999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=271.66 Aligned_cols=231 Identities=29% Similarity=0.452 Sum_probs=188.6
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++.+.||+|+||.||++.++.+++.+|+|.+....... .+.+|+.++++++|+||+++++++... ...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence 5889999999999999999999999999999987543222 235689999999999999999998775 48999999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 134 YMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+.+
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 9999999999876 34689999999999999999999999999999999999999865443322
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
...|.+||... +..++.++|+||||+++|+|++|+.||...+. ............+..+...+.+++++
T Consensus 160 ~~~~~~~~~~Pe~~~---~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08530 160 TQIGTPHYMAPEVWK---GRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLRYKVQRGKYPPIPPIYSQDLQNF 232 (256)
T ss_pred cccCCccccCHHHHC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCchhhCHHHHHH
Confidence 12334444432 44567799999999999999999999965432 22233333444555666788999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+.+||.. +|++||++.++++||++
T Consensus 233 i~~~l~~-~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQV-KPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCC-CcccCCCHHHHhcCCCC
Confidence 9999999 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=273.84 Aligned_cols=228 Identities=24% Similarity=0.333 Sum_probs=179.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+.++|++.++||+|+||.||+|.+..++ .||+|.++.... ...+.+|+.++++++|+||+++++.+.. ...|+|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEE
Confidence 4567999999999999999999987664 599999875333 2235679999999999999999998643 36899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++...+..+
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999999753 35889999999999999999999999999999999999988755432211
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
..|.+||.. .+..++.++|||||||++|+|+| |..||...... ..............+...+..+.
T Consensus 161 ~~~~~~~~y~~PE~~---~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 161 QGAKFPIKWTAPEAA---LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPECPESLH 233 (262)
T ss_pred cCCcccceecCHhHh---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHHHhcCCCCCCccccCHHHH
Confidence 124444433 24456789999999999999999 88899654332 22222222333344556789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+||.. ||++||++.++++
T Consensus 234 ~li~~~l~~-~p~~Rp~~~~~~~ 255 (262)
T cd05071 234 DLMCQCWRK-EPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHccC-CcccCCCHHHHHH
Confidence 999999999 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=273.02 Aligned_cols=220 Identities=25% Similarity=0.350 Sum_probs=176.2
Q ss_pred eecCCcceEEEEEEE--ccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 64 VLGQGNGGTVFKVRH--KQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
.||+|+||.||+|.+ ..++..+|+|+++...... .+.+|+.+++.+.|+||+++++++.. . ..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-E-SWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C-CcEEEEecCCC
Confidence 589999999999975 4567899999986544322 34578999999999999999998753 3 67999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------------
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------------- 197 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------------- 197 (300)
++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++...++++
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999987778999999999999999999999999999999999999987654332221
Q ss_pred --eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 198 --CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 198 --~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
..|.+||.. .+..++.++|||||||++|||+| |..||...... .....+.....+..+...++++.++|.
T Consensus 160 ~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~i~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 160 WPVKWYAPECM---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQMIESGERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCccccCHhHh---ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 123344432 23456779999999999999998 99999654321 233333344456677788999999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 040812 275 CCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~ 293 (300)
+||+. ||++||++++|.+
T Consensus 233 ~~~~~-~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTY-GVDERPGFAVVEL 250 (257)
T ss_pred HHhcc-CchhCcCHHHHHH
Confidence 99999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=272.93 Aligned_cols=227 Identities=22% Similarity=0.339 Sum_probs=181.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.+.||+|+||.||+|.+.. +..+|+|.+...... ..+.+|+.++++++|+|++++++++.. ...|+|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEE
Confidence 34679999999999999999998774 557899998754332 345689999999999999999998753 36899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------- 198 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------- 198 (300)
|+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||++++++...++.++
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999999753 358999999999999999999999999999999999999987544322211
Q ss_pred -------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 199 -------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 199 -------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.|.+||... +..++.++||||||+++|+|++ |..||...+.. ..............+...+..+.
T Consensus 161 ~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 161 QGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQVERGYRMPCPQDCPISLH 233 (260)
T ss_pred cCCCCCccccChHHHh---cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCCCcCCHHHH
Confidence 244555432 4456779999999999999999 89999654322 22333333445556677889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHh
Q 040812 271 DFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l 292 (300)
+++.+||.. ||++|||+.++.
T Consensus 234 ~li~~~l~~-~p~~Rpt~~~l~ 254 (260)
T cd05070 234 ELMLQCWKK-DPEERPTFEYLQ 254 (260)
T ss_pred HHHHHHccc-CcccCcCHHHHH
Confidence 999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=280.27 Aligned_cols=244 Identities=27% Similarity=0.358 Sum_probs=186.5
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
......++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 344556789999999999999999999999999999998754322 2234579999999999999999999876555
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|+||||+. ++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+.+
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred cEEEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 7999999994 589888864 3688899999999999999999999999999999999998765443322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH-------------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLML------------------- 251 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~------------------- 251 (300)
...|.+||... .+..++.++|||||||++|+|+||+.||..............
T Consensus 162 ~~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 MTGYVSTRYYRAPEIML--TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred cCCCcccccccCceeee--ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 22355555432 124567899999999999999999999965432111110000
Q ss_pred ----HHhhCCCCC---CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 252 ----AICFREPPS---LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 252 ----~~~~~~~~~---~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
......... .....++.+.++|.+||+. +|++||++++++.||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF-DPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCC-ChhhCCCHHHHhcCCcccc
Confidence 000000000 1124578899999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=284.78 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=204.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecC-----CCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-----RGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..+.|...++||+||||.|+-++.+.||+-||+|.+.+. ......++|-.+|.+++.+.||.+-..|++.. .+|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-ALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-ceE
Confidence 345688899999999999999999999999999987543 33334578999999999999999998888765 899
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------- 194 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------- 194 (300)
+||..|.||+|.-++..-+ .|++..++.++.+|+.||.+||..+|+.|||||+|||+|+.+...+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999998887654 6999999999999999999999999999999999999999876532
Q ss_pred -----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 195 -----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 195 -----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
.++..|++||... ++.|+.+.|+|||||++|||+.|+.||........ .+.+.+.....+..+++..++++
T Consensus 342 ~~~~rvGT~GYMAPEvl~---ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQ---NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-REEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred ccccccCcccccCHHHHc---CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-HHHHHHHHhcchhhcccccCHHH
Confidence 2466688888876 44588999999999999999999999976544332 23444555677788899999999
Q ss_pred HHHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
+++...+|.+ ||++|. +++++.+||||+++
T Consensus 418 kslc~~LL~K-dp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 418 KSLCEGLLTK-DPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHcc-CHHHhccCCCcCcchhhhCcccccC
Confidence 9999999999 999998 48899999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=289.81 Aligned_cols=229 Identities=25% Similarity=0.386 Sum_probs=186.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHh-cCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
....|++...+|.|+|+.|..+.+..+++..++|++.... ....+|+.++.. -+||||+++++.+.+.. ..|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--~~~~~e~~~~~~~~~h~niv~~~~v~~~~~-~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--DDNQDEIPISLLVRDHPNIVKSHDVYEDGK-EIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc--cccccccchhhhhcCCCcceeecceecCCc-eeeeeeh
Confidence 4678999999999999999999999999999999997652 233457755544 48999999999998765 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec-CCCCCCcc----------------c
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN-EKMEHPCG----------------Y 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~-~~~~~~~~----------------~ 196 (300)
++.|+-|.+.+.....+. ..+..|+.+|+.|+.|||++|++||||||+|||++ ..+...+. .
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 999998888887765555 88889999999999999999999999999999994 54433221 1
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
+..|.+||... ...++.++||||||++||+|+||+.||...... .++...+. .+.+...+|+.+++||.+|
T Consensus 476 t~~y~APEvl~---~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~---~~~~s~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 476 TLQYVAPEVLA---IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ---MPKFSECVSDEAKDLLQQL 546 (612)
T ss_pred hhcccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc---CCccccccCHHHHHHHHHh
Confidence 23355665554 556889999999999999999999999765443 23333322 3344488999999999999
Q ss_pred hccCCCCCCCCHHHHhcCCCC
Q 040812 277 LQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 277 l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
|+. ||.+|+++.+++.||||
T Consensus 547 L~~-dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQV-DPALRLGADEIGAHPWF 566 (612)
T ss_pred ccC-ChhhCcChhhhccCcch
Confidence 999 99999999999999999
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.20 Aligned_cols=228 Identities=22% Similarity=0.333 Sum_probs=179.1
Q ss_pred ceeeeeecCCcceEEEEEEEcc---CCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCC-----
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSG----- 126 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 126 (300)
|++.+.||+|+||.||+|.... ++..||+|.++.+.... .+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999999764 34789999987543322 34679999999999999999998754331
Q ss_pred cEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--
Q 040812 127 EVSILMEYMDAGSLEIYVKSR------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-- 198 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-- 198 (300)
..++||||+++++|..++... ..+++..+..++.|++.||.|||+.+++||||||+||++++++...+..++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 379999999999999988542 258999999999999999999999999999999999999887554332221
Q ss_pred -------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 199 -------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 199 -------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
.|.+||.. .+..++.++|||||||++|||++ |..||...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~---~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~~~~~~ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESL---ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYLRHGNR 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCC
Confidence 12333322 24556789999999999999999 89999654322 23333344455
Q ss_pred CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 259 ~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
...+...++.+.+++.+||.. ||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~-~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 LKQPEDCLDELYDLMYSCWRA-DPKDRPTFTKLREV 268 (273)
T ss_pred CCCCcCCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 666778899999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.56 Aligned_cols=231 Identities=23% Similarity=0.323 Sum_probs=183.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
++++|++.+.||+|+||.||+|.+..+ ++.||+|+++..... ..+.+|+.++.+++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~- 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ- 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-
Confidence 346789999999999999999997643 578999998754322 22456899999999999999999987755
Q ss_pred cEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 127 EVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 799999999999999998532 2478888999999999999999999999999999999998775
Q ss_pred CCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 040812 191 EHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLS 248 (300)
Q Consensus 191 ~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 248 (300)
...+++++ .|.+||... ++.++.++|||||||++|||+| |..||...... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~ 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM---YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----D 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHh---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----H
Confidence 54333222 244555432 4556789999999999999998 88888654322 2
Q ss_pred HHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 249 LMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
....+........+..++..+.+++.+||+. +|++||++.+++..
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~-~p~~RP~~~~i~~~ 279 (283)
T cd05091 235 VIEMIRNRQVLPCPDDCPAWVYTLMLECWNE-FPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHhCC-CcccCCCHHHHHHH
Confidence 3333334444556778899999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=278.10 Aligned_cols=225 Identities=26% Similarity=0.446 Sum_probs=175.4
Q ss_pred eeeeeecCCcceEEEEEEEc----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHK----QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+.+.||+|.||.||+|.+. ..+..|+||.++..... ..+.+|++.+++++||||+++++++.... ..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-PLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-SEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-cccccc
Confidence 46789999999999999998 45678999999653322 34567999999999999999999998544 799999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-----------
Q 040812 133 EYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL----------- 199 (300)
Q Consensus 133 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~----------- 199 (300)
||+++|+|.+++... ..+++..+..++.||+.||.|||+++++|+||+++||+++.++..+++.+..
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 6799999999999999999999999999999999999999876654433222
Q ss_pred ----------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 200 ----------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 200 ----------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
|.+||... +..++.++||||||+++|||+| |+.||..... ...............+..++..
T Consensus 161 ~~~~~~~~~~~~aPE~~~---~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 233 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLK---DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKLKQGQRLPIPDNCPKD 233 (259)
T ss_dssp ESTTSESGGGGS-HHHHH---HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHHHTTEETTSBTTSBHH
T ss_pred cccccccccccccccccc---ccccccccccccccccccccccccccccccccc----ccccccccccccceeccchhHH
Confidence 23333322 2336789999999999999999 7899865422 2333444445556667788999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.++|.+||.. ||++|||+.++++
T Consensus 234 ~~~li~~C~~~-~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 234 IYSLIQQCWSH-DPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHT-S-SGGGS--HHHHHH
T ss_pred HHHHHHHHcCC-ChhhCcCHHHHHh
Confidence 99999999999 9999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=281.61 Aligned_cols=229 Identities=21% Similarity=0.295 Sum_probs=179.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeE----EEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLAL----YALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+|++.+.||+|+||.||+|.+..+++. ||+|.++..... ..+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cc
Confidence 45799999999999999999998765553 899998643321 2346789999999999999999988753 57
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
++|+||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++...+.++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 8999999999999999864 36889999999999999999999999999999999999988755433221
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
..|.+||... +..++.++|||||||++|||+| |..||...... . .............+..+
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~---~~~~~~~~~~~~~~~~~ 236 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E---ISSILEKGERLPQPPIC 236 (316)
T ss_pred cceeccCCccceeecChHHhc---cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-H---HHHHHhCCCCCCCCCCC
Confidence 1244444332 4556789999999999999998 99999653221 1 22222223334445667
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.++.+++.+||.. ||++||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~-~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMI-DADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 88999999999999 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.61 Aligned_cols=228 Identities=29% Similarity=0.345 Sum_probs=169.8
Q ss_pred cceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCHHHHH
Q 040812 69 NGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV 144 (300)
Q Consensus 69 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 144 (300)
++|.||.++...+++.||+|+++..... ..+.+|+.+++.++|+||+++++++.... ..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-eEEEEEeccCCCCHHHHH
Confidence 4456677777778999999998765222 23467999999999999999999988765 899999999999999999
Q ss_pred HhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------------------
Q 040812 145 KSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------------- 197 (300)
Q Consensus 145 ~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------------- 197 (300)
... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++...+..+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 753 35899999999999999999999999999999999999987654432221
Q ss_pred -eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh---------------------
Q 040812 198 -CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF--------------------- 255 (300)
Q Consensus 198 -~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------------- 255 (300)
..|.+||..... ...++.++|||||||++|||++|..||..........+.......
T Consensus 171 ~~~y~aPE~~~~~-~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQN-LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 124455543321 123567999999999999999999999754322211111110000
Q ss_pred --------CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 --------REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 --------~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..........+.++.+++.+||.. ||++|||++++++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR-DPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhc-CCCcCcCHHHHhcCchHhh
Confidence 000001112246788999999999 9999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=274.44 Aligned_cols=235 Identities=29% Similarity=0.427 Sum_probs=182.4
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCC-CCcEEEEEe
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKP-SGEVSILME 133 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e 133 (300)
|++.+.||+|+||.||+|.+..+++.+|+|.+...... ..+.+|+.++++++|+|++++++++... .+..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999999999999999999865422 2346799999999999999999998765 258999999
Q ss_pred ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 134 YMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||++++++...+..
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9975 888888765 5799999999999999999999999999999999999999876543322
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC--------------
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP-------------- 258 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 258 (300)
...|.+||.... ...++.++||||||+++|||+||+.||.....................
T Consensus 160 ~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 160 NRVITLWYRPPELLLG--ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccCCceeeEc--cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 122455554321 224577999999999999999999999654432211111111000000
Q ss_pred ------------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 259 ------------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 259 ------------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..+....+..+.+++.+||.. ||++||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL-DPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCC-ChhhCcCHHHHhhCcCC
Confidence 001111378899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=278.65 Aligned_cols=233 Identities=22% Similarity=0.330 Sum_probs=184.4
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
....++|++.+.||+|+||.||++.+... ...+|+|.+....... .+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34567899999999999999999998643 3789999987543221 245799999999 79999999999876
Q ss_pred CCCcEEEEEeccCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKS----------------RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~----------------~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
.. ..+++|||+++|+|..++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 88 ~~-~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 88 EG-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CC-CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 54 89999999999999999964 23588999999999999999999999999999999999999
Q ss_pred CCCCCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040812 188 EKMEHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPD 245 (300)
Q Consensus 188 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 245 (300)
.++...+++++ .|.+||.. .+..++.++|||||||++|||++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL---FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHh---ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 87654332221 24445543 24556789999999999999998 99999654322
Q ss_pred HHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 246 FLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..............+...+..+.+++.+||.. ||++|||+.+++++
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~eil~~ 287 (293)
T cd05053 242 --ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHE-VPSQRPTFKQLVED 287 (293)
T ss_pred --HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccc-CcccCcCHHHHHHH
Confidence 22222333444556667889999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=279.10 Aligned_cols=237 Identities=27% Similarity=0.411 Sum_probs=185.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-CCCCCHHHHHHHHhcCC--C----ceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-GTPPNPQELNILRQTNS--P----YIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~~~ 128 (300)
..+|+++..+|+|.||.|-.+.+.+++..||||+++.-. ......-|+++|+++.+ | -++++.+||.-. |++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-ghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-GHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-Cce
Confidence 578999999999999999999999999999999998643 33344569999999943 2 378888888764 599
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC--------------
Q 040812 129 SILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-------------- 192 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-------------- 192 (300)
|||+|.+ |-++.+++..+. +++...++.+..|++.+++|||+.+++|.||||+|||+.+....
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 9999999 559999998754 68999999999999999999999999999999999999643110
Q ss_pred ---------Ccc-------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH
Q 040812 193 ---------PCG-------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250 (300)
Q Consensus 193 ---------~~~-------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 250 (300)
++| .+..|.+||... |-.+++++||||+||||+|++||...|...++. +.+..+
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViL---gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~-EHLaMM 321 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVIL---GLGWSQPCDVWSIGCILVELYTGETLFQTHENL-EHLAMM 321 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchhee---ccCcCCccCceeeeeEEEEeeccceecccCCcH-HHHHHH
Confidence 111 233456666554 556889999999999999999999999765533 333444
Q ss_pred HHHhhCCCCC-----------------CCCC-------------------------CChHHHHHHHHHhccCCCCCCCCH
Q 040812 251 LAICFREPPS-----------------LPEC-------------------------SSEKFRDFIRCCLQKGDPSKRWTA 288 (300)
Q Consensus 251 ~~~~~~~~~~-----------------~~~~-------------------------~~~~l~~li~~~l~~~dp~~Rpt~ 288 (300)
..+....+.. .++. ....+.|||++||.. ||.+|+|+
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f-DP~~RiTl 400 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF-DPARRITL 400 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc-CccccccH
Confidence 4443222111 0110 023589999999999 99999999
Q ss_pred HHHhcCCCCCC
Q 040812 289 SQLLSHPFLAD 299 (300)
Q Consensus 289 ~~~l~hpw~~~ 299 (300)
.|+|.||||+.
T Consensus 401 ~EAL~HpFF~~ 411 (415)
T KOG0671|consen 401 REALSHPFFAR 411 (415)
T ss_pred HHHhcCHHhhc
Confidence 99999999974
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=271.06 Aligned_cols=229 Identities=24% Similarity=0.356 Sum_probs=184.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.+.||+|+||.||+|.+.+ ++.+|+|.+..... ...+.+|+.++++++|+||+++++++.... ..++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-PIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-ceEEEEe
Confidence 45789999999999999999999865 57799999875433 234567999999999999999999987654 7999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------
Q 040812 134 YMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------- 198 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------- 198 (300)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++...+++++
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 999999999997643 68999999999999999999999999999999999999987665433221
Q ss_pred -------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 199 -------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 199 -------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.|.+||... +...+.++|||||||++|+|+| |+.||...... ..............+...+..+.
T Consensus 162 ~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05034 162 EGAKFPIKWTAPEAAN---YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVERGYRMPRPPNCPEELY 234 (261)
T ss_pred hccCCCccccCHHHhc---cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCHHHH
Confidence 234444332 4556789999999999999999 99999654322 22233333334455666788999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+||.. ||++||+++++++
T Consensus 235 ~~i~~~l~~-~p~~Rp~~~~l~~ 256 (261)
T cd05034 235 DLMLQCWDK-DPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHccc-CcccCCCHHHHHH
Confidence 999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=278.15 Aligned_cols=232 Identities=23% Similarity=0.336 Sum_probs=182.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEE-----ccCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRH-----KQTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
...++|++.+.||+|+||.||++.+ ..++..||+|.++..... ..+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3456899999999999999999985 334668999998754322 2346799999999 799999999998765
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----- 197 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----- 197 (300)
. ..|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.+....+.++
T Consensus 112 ~-~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 112 G-PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred C-ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 4 8999999999999999997543 3899999999999999999999999999999999999987654322211
Q ss_pred ----------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCC
Q 040812 198 ----------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPS 260 (300)
Q Consensus 198 ----------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (300)
..|.+||... +..++.++|||||||++|||+| |..||............. .......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~ 264 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI---KEGYRMA 264 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhc---cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH---HcCCcCC
Confidence 1234444332 4456779999999999999998 999997654433332222 2233344
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+...++.+.+++.+||.. +|++|||+.++++
T Consensus 265 ~~~~~~~~~~~li~~cl~~-~p~~Rpt~~ell~ 296 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDA-DPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCHHHHHHHHHHcCC-CchhCcCHHHHHH
Confidence 5566789999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=277.09 Aligned_cols=239 Identities=29% Similarity=0.455 Sum_probs=186.3
Q ss_pred cceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCCC------CCCCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRG------TPPNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
+|++.+.||+|+||.||++++. .+++.||+|+++.... ...+.+|+.++.++ +|+||+++++.+.... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-K 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC-E
Confidence 4788999999999999999864 4578899999875322 12345799999999 5999999999987754 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
.|+||||+.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++...+..+
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999999999987778999999999999999999999999999999999999987755332221
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
..|.+||..... ....+.++||||||+++|+|+||..||................. ...+..+...+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGG-SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKTMSA 237 (288)
T ss_pred ccccccccCCccccCHHHhcCC-CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcccCH
Confidence 223344433211 11246789999999999999999999965433222222222222 333455667889
Q ss_pred HHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLADA 300 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt---~~~~l~hpw~~~~ 300 (300)
.+.++|.+||+. ||++||| +.++++||||+++
T Consensus 238 ~l~~li~~~l~~-~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 238 EARDFIQKLLEK-DPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHHhcC-CHhhccCcchHHHHhcCcccccC
Confidence 999999999999 9999998 5678999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=273.66 Aligned_cols=230 Identities=33% Similarity=0.492 Sum_probs=182.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .....|+.++++++||||+++++++.... ..++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence 588999999999999999999887777777776542211 11245889999999999999999987655 7999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 131 LMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.+. ..+..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~-~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCC-EeecccCceeecCCC
Confidence 9999999999988863 34689999999999999999999999999999999999997542 21111
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
...|.+||... +..++.++|+||||+++|+|++|..||.... .............+..+...+.
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALK---HQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRIVEGPTPSLPETYSR 231 (260)
T ss_pred cccccCCCCCcCccCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHcCCCCCCcchhcH
Confidence 11234444332 3445678999999999999999999995422 2233334444555666777889
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
++.++|.+||.. ||++||++.++++||||
T Consensus 232 ~~~~li~~~l~~-~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNK-DPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcC-ChhhCcCHHHHhhCCCC
Confidence 999999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.63 Aligned_cols=234 Identities=29% Similarity=0.450 Sum_probs=181.3
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
|++.+.||+|++|.||+|.+..+++.+++|.+...... ....+|+.++++++|+||+++++++.... ..++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-DLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC-CEEEEEec
Confidence 56788999999999999999999999999998654332 23457999999999999999999987654 89999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 135 MDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
+++ +|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++...+..+
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 976 88877765 357899999999999999999999999999999999999998655433221
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC----------------
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP---------------- 258 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 258 (300)
..|.+||.... ....+.++||||||+++|+|+||+.||...+................+
T Consensus 159 ~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 159 VVTRWYRAPELLLG--DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred cCcccccCcHHHhc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 22444554321 225678999999999999999999999654432222111111100000
Q ss_pred ---------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 259 ---------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 259 ---------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
......++.++.++|.+||.. ||.+||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHY-DPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhcc-CcccCcCHHHHhhCCCC
Confidence 011224578899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=276.67 Aligned_cols=230 Identities=23% Similarity=0.361 Sum_probs=182.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
...+|++.++||+|+||.||++... .++..+|+|.+..... ...+.+|+.+++.++|+||+++++++.... .
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 81 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-P 81 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-c
Confidence 3467899999999999999999753 3467899998764322 123567999999999999999999987754 7
Q ss_pred EEEEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 128 VSILMEYMDAGSLEIYVKSRG---------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||+++++..
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 999999999999999997542 47889999999999999999999999999999999999987554
Q ss_pred Ccccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 040812 193 PCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLM 250 (300)
Q Consensus 193 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 250 (300)
.+..++ .|.+||.. .+..++.++|||||||++|||++ |.+||...... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI---LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHh---ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHH
Confidence 332211 24444433 24557789999999999999998 99999654332 223
Q ss_pred HHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
...........+..+++.+.++|.+||+. ||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~-~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGRELERPRTCPPEVYAIMQGCWQR-EPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccC-ChhhCCCHHHHHH
Confidence 33333445556677889999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=299.98 Aligned_cols=238 Identities=20% Similarity=0.240 Sum_probs=167.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-CeEEEEEEe------------------ecCC-CCCCCHHHHHHHHhcCCCcee
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQT-LALYALKVM------------------QCDR-GTPPNPQELNILRQTNSPYIV 115 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~------------------~~~~-~~~~~~~E~~~l~~l~h~niv 115 (300)
.++|++++.||+|+||.||+|..+.. +...+.|.+ .... ....+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 56899999999999999999886532 222222211 1000 011235799999999999999
Q ss_pred EeceeeeCCCCcEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
++++++.... ..|+|++++.+ +|..++... .......++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 227 ~l~~~~~~~~-~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEA-NTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECC-eeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999998765 89999999965 777776532 2244677889999999999999999999999999999998775
Q ss_pred CCCcc--------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc---hHH
Q 040812 191 EHPCG--------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP---DFL 247 (300)
Q Consensus 191 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---~~~ 247 (300)
...+. ++..|.+||... +..++.++|||||||++|||++|..++....... ...
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA---GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhc---CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 44322 223344555443 4557789999999999999999876543322211 111
Q ss_pred HHHHHHh--hC--------------------CCCCC-----CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 248 SLMLAIC--FR--------------------EPPSL-----PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 248 ~~~~~~~--~~--------------------~~~~~-----~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.+.... .. ....+ ....+.++.++|.+||+. ||++|||+.|++.||||.+
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~-DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF-DWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc-CcccCcCHHHHhhChhhhc
Confidence 1111100 00 00000 012456788899999999 9999999999999999975
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=270.81 Aligned_cols=221 Identities=25% Similarity=0.342 Sum_probs=177.9
Q ss_pred eeecCCcceEEEEEEEccCC---eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTL---ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+..++ ..+|+|.+...... ..+.+|+.+++++.|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence 46999999999999876544 78999998755432 234679999999999999999998753 36899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------------
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------- 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------- 197 (300)
+++|.+++.....+++..+..++.|++.||.|||..+++|+||||+||+++.++...+..+
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 9999999988778999999999999999999999999999999999999988765332211
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
..|.+||... +..++.++|||||||++|+|++ |..||..... ......+........+...+..++++|
T Consensus 159 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 159 RWPLKWYAPECIN---YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLESGERLPRPEECPQEIYSIM 231 (257)
T ss_pred cccccccCHHHhc---CCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 1244455432 4556779999999999999998 9999965432 122333333444566677889999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 040812 274 RCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+||.. ||++||++.++++
T Consensus 232 ~~cl~~-~p~~Rp~~~~l~~ 250 (257)
T cd05060 232 LSCWKY-RPEDRPTFSELES 250 (257)
T ss_pred HHHhcC-ChhhCcCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=279.45 Aligned_cols=237 Identities=27% Similarity=0.410 Sum_probs=185.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
...|+..+.||+|+||.||+|++..+++.+|+|.+...... ..+.+|+.+++.++|+|++++++++.... ..++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-eeEE
Confidence 34588889999999999999999999999999998643221 12356999999999999999999988754 7999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 131 LMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++...+..
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccc
Confidence 9999974 77776653 44689999999999999999999999999999999999998876543222
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC-CCCCCChHHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS-LPECSSEKFRDFI 273 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 273 (300)
+..|.+||.......+..+.++|||||||++|+|++|..||...... ...........+. .+...+..+.++|
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----HHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 23455666543222344677999999999999999999999654322 1222222222222 3446788899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||.. +|++||+++++++|||+.+
T Consensus 248 ~~cl~~-~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 248 DSCLQK-IPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHhhC-CcccCCCHHHHhhCccccc
Confidence 999999 9999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=273.67 Aligned_cols=229 Identities=24% Similarity=0.369 Sum_probs=181.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCe---EEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLA---LYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.++|++.+.||+|+||.||+|.++.+++ .||+|.++..... ..+.+|+.++++++||||+++++++.... ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-PVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-ceE
Confidence 4568999999999999999999987654 6999998654221 23467999999999999999999987654 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
+||||+++++|.+++.. .+.+++..++.++.|++.||.|||++|++|+||||+||+++.+....+..+
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999999976 346899999999999999999999999999999999999987654322111
Q ss_pred -------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 198 -------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 198 -------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
..|.+||... +..++.++|||||||++|||++ |..||...... .....+........+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~~~ 234 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIEQDYRLPPPM 234 (269)
T ss_pred ccccccccCCCcceeecCHhHhc---cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHHcCCcCCCcc
Confidence 1244555433 4456779999999999999986 99999654322 2222222233344456
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.++..+.+++.+||.. +|++||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~-~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQK-DRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCC-ChhhCcCHHHHHH
Confidence 6788999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=271.45 Aligned_cols=228 Identities=24% Similarity=0.398 Sum_probs=181.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.++||+|+||.||+|..+. ++.||+|.+...... ..+.+|+.++++++|+||+++++++.. +..|+|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEEE
Confidence 34679999999999999999999764 678999998754432 245679999999999999999998743 36899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+.++
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 99999999998653 36899999999999999999999999999999999999998754432221
Q ss_pred ------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 198 ------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 198 ------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
..|.+||... +..++.++|||||||++|||++ |+.||..... .. .............+...+.++.
T Consensus 161 ~~~~~~~~y~~pe~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 161 EGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PE---VIQNLERGYRMPRPDNCPEELY 233 (260)
T ss_pred cCCcccccccCHHHhc---cCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HH---HHHHHHcCCCCCCCCCCCHHHH
Confidence 1234444332 3456779999999999999999 9999965432 22 2222223334455677889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++|.+||.. ||++||+++++++
T Consensus 234 ~li~~~l~~-~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKE-KPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccC-ChhhCCCHHHHHH
Confidence 999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=272.95 Aligned_cols=230 Identities=28% Similarity=0.384 Sum_probs=181.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||++.+..+++.+|+|.+...... ..+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEEE
Confidence 5789999999999999999999989999999987643221 23457999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 132 MEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++...+..+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998863 345899999999999999999999999999999999999987765432221
Q ss_pred ---------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC-CCCCCCCh
Q 040812 198 ---------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-SLPECSSE 267 (300)
Q Consensus 198 ---------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 267 (300)
..|.+||... +...+.++||||||+++|+|++|..||...... .............+ ..+...++
T Consensus 161 ~~~~~~~~~~~~~ape~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccccccCCcCccCHHHhc---CCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccH
Confidence 1234444432 345677899999999999999999999654322 22222222222222 33346788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+++++.+||.. ||++|||++++++
T Consensus 236 ~~~~li~~~l~~-~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINP-DPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCC-CcccCCCHHHHHH
Confidence 999999999999 9999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=291.38 Aligned_cols=230 Identities=27% Similarity=0.362 Sum_probs=187.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCC----eEEEEEEeecCC-C----CCCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTL----ALYALKVMQCDR-G----TPPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
.-++..+.++||+|+||.||+|+.+..+ ..||+|..+... . ...+.+|+++|++++|||||+++|+.....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3345567799999999999999987532 238999987522 1 123467999999999999999999988765
Q ss_pred CcEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-----
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL----- 199 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~----- 199 (300)
.+|+|||+|.||+|.++++..+ .++..+...++.+.+.||+|||+++++||||..+|+|++.+...++.++++
T Consensus 235 -Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 235 -PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred -ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 8999999999999999999876 499999999999999999999999999999999999999876644443333
Q ss_pred --------------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH-hhCCCCCCCC
Q 040812 200 --------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI-CFREPPSLPE 263 (300)
Q Consensus 200 --------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 263 (300)
|.+||... .+.+++++|||||||++||+++ |..||.+.... .....+ ..+.+...+.
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~---~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLN---TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPS 386 (474)
T ss_pred ceeeccccccCcceecChhhhc---cCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCC
Confidence 44444443 3468889999999999999998 88899765432 333334 4566777788
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+..+..++.+||.. ||++||++.++.+
T Consensus 387 ~~p~~~~~~~~~c~~~-~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 387 KTPKELAKVMKQCWKK-DPEDRPTMSTIKK 415 (474)
T ss_pred CCHHHHHHHHHHhccC-ChhhccCHHHHHH
Confidence 8899999999999999 9999999998764
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=277.30 Aligned_cols=231 Identities=23% Similarity=0.335 Sum_probs=182.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-------CCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ-------TLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
..++|.+.+.||+|+||.||++++.. ++..+|+|.++...... .+.+|+.+++++ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34689999999999999999998743 23579999987543221 245699999999 79999999999877
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
.. ..|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 96 ~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 96 DG-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred CC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 54 899999999999999999753 2478899999999999999999999999999999999998
Q ss_pred CCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040812 188 EKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPD 245 (300)
Q Consensus 188 ~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 245 (300)
.++...++.+ ..|.+||... +..++.++|||||||++|||++ |..||..... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~- 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-E- 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhc---cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-H-
Confidence 7654322211 1345555443 4556789999999999999998 8899854322 1
Q ss_pred HHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 246 FLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..............+...+.++.++|.+||.. +|++|||+.+++++
T Consensus 250 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~evl~~ 295 (307)
T cd05098 250 --ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHA-VPSQRPTFKQLVED 295 (307)
T ss_pred --HHHHHHHcCCCCCCCCcCCHHHHHHHHHHccc-ChhhCcCHHHHHHH
Confidence 22222333444566777889999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=287.08 Aligned_cols=233 Identities=25% Similarity=0.293 Sum_probs=181.2
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCCC---CCHHHHHHHHhcC-CCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGTP---PNPQELNILRQTN-SPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~-h~niv~~~~~~~~~ 124 (300)
...++|.+.+.||+|+||.||+|++. .+++.||+|+++...... .+.+|+.+|.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34567889999999999999999964 345789999997543322 3457999999997 99999999998775
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCC--------------------------------------------------------
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRG-------------------------------------------------------- 148 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 148 (300)
. ..++||||+++|+|.+++...+
T Consensus 114 ~-~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 114 G-PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred C-CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 4 8999999999999999996431
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 149 ------------------------------------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 149 ------------------------------------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
.+++..+..++.||+.||.|||+.+++||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 25667788899999999999999999999999999999
Q ss_pred cCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 187 NEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 187 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
+.+....+.++ ..|.+||... +..++.++|||||||++|||++ |..||.......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF---NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc---CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 87654322211 1234444332 3456789999999999999998 899996544332
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
... ..+.....+..+..++.++.+++.+||.. +|++||++.++++.
T Consensus 350 ~~~---~~~~~~~~~~~p~~~~~~l~~li~~cl~~-~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFY---NAIKRGYRMAKPAHASDEIYEIMQKCWEE-KFEIRPDFSQLVHL 395 (401)
T ss_pred HHH---HHHHcCCCCCCCCCCCHHHHHHHHHHcCC-ChhHCcCHHHHHHH
Confidence 222 22223344556677889999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=276.94 Aligned_cols=231 Identities=27% Similarity=0.404 Sum_probs=181.9
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
|+....||+|+||.||++....+++.||+|.+...... ..+.+|+.+++.++|+|++++++.+.... ..|+||||++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-EEEEEEecCC
Confidence 34457899999999999999999999999987533221 22457999999999999999999988765 8999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------------
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------- 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------- 197 (300)
+++|.+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++...+.++
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 9999998754 46899999999999999999999999999999999999998754433221
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC--CCCCCChHHHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS--LPECSSEKFRDFIRC 275 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 275 (300)
..|.+||... +..++.++|+||||+++|+|++|..||...... ..........+.. .....+..+.+++.+
T Consensus 180 ~~y~~pE~~~---~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 180 PYWMAPELIS---RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred ccccCHHHhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence 1244444332 344577999999999999999999999653322 1111111122222 233568899999999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCCC
Q 040812 276 CLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||.. ||.+||++.++++||||.+
T Consensus 253 ~l~~-~P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 253 LLVR-DPAQRATAAELLKHPFLAK 275 (292)
T ss_pred HHhC-CcccCcCHHHHhcChHHhc
Confidence 9999 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=276.60 Aligned_cols=240 Identities=33% Similarity=0.565 Sum_probs=183.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcC-CCceeEeceeeeCCCCcEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTN-SPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 129 (300)
...++|++.+.||+|+||.||+|.+..+++.||+|.++...... ....|+.++.+.. |+||+++++++.... ..|
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~ 90 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-DVF 90 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-eEE
Confidence 45688999999999999999999999989999999987543221 1244666666654 999999999988755 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccce----------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+ .|++||||+|+||+++.++...+.++
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99999965 77777765 4578999999999999999999997 59999999999999987755433322
Q ss_pred --------eeccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC--CCCC
Q 040812 198 --------CLYESGEARHRKH-GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP--ECSS 266 (300)
Q Consensus 198 --------~~~~~~~~~~~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 266 (300)
..|.+||...... .+.++.++||||||+++|+|++|+.||....... ...........+..+ ...+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEEPPSLPPNEGFS 246 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCCCCCCCCCCCCC
Confidence 2345555543211 2336679999999999999999999996532221 222222222222222 2468
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++.+||.+||.. ||++||+++++++||||..
T Consensus 247 ~~l~~li~~~l~~-~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 247 PDFCSFVDLCLTK-DHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHHHccC-ChhhCCCHHHHhcChhhhc
Confidence 8999999999999 9999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=269.37 Aligned_cols=223 Identities=34% Similarity=0.522 Sum_probs=183.7
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
||+|+||.||++.+..+++.+|+|.+....... .+.+|+.++++++|+||+++++.+.... ..|+||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE-KLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC-eeEEEEecCCCCc
Confidence 699999999999999889999999987654322 3467999999999999999999987654 8999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------eeec
Q 040812 140 LEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------------SCLY 200 (300)
Q Consensus 140 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------------~~~~ 200 (300)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++...++. ...|
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 999998877899999999999999999999999999999999999999875543322 2223
Q ss_pred cccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccC
Q 040812 201 ESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKG 280 (300)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 280 (300)
.+||... +...+.++|+||||+++|+|++|..||...+. ........ .....++...+..+.++|.+||..
T Consensus 160 ~~Pe~~~---~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~- 230 (250)
T cd05123 160 LAPEVLL---GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKIL-KDPLRFPEFLSPEARDLISGLLQK- 230 (250)
T ss_pred cChHHhC---CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHh-cCCCCCCCCCCHHHHHHHHHHhcC-
Confidence 4444332 34466789999999999999999999965433 12222222 245567777899999999999999
Q ss_pred CCCCCCCH---HHHhcCCCC
Q 040812 281 DPSKRWTA---SQLLSHPFL 297 (300)
Q Consensus 281 dp~~Rpt~---~~~l~hpw~ 297 (300)
||++||++ +++++||||
T Consensus 231 ~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 231 DPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CHhhCCCcccHHHHHhCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=276.48 Aligned_cols=230 Identities=24% Similarity=0.391 Sum_probs=181.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..++|++.+.||+|+||.||+|.+.. ++..||+|++...... ..+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~- 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK- 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-
Confidence 34679999999999999999999753 5789999998654321 23567999999999999999999987754
Q ss_pred cEEEEEeccCCCCHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCce
Q 040812 127 EVSILMEYMDAGSLEIYVKSR----------------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANV 184 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~----------------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Ni 184 (300)
..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 799999999999999999742 1367888999999999999999999999999999999
Q ss_pred eecCCCCCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 040812 185 LINEKMEHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQ 242 (300)
Q Consensus 185 ll~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~ 242 (300)
+++.++...++.++ .|.+||.. .+..++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI---FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHH---hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99887654332221 13334432 24557789999999999999998 8889865433
Q ss_pred CchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 243 EPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
. +....+........+...+..+.++|.+||+. ||++|||+.|+++
T Consensus 239 ~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-~p~~Rpt~~el~~ 284 (288)
T cd05050 239 E----EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSK-LPSDRPSFASINR 284 (288)
T ss_pred H----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccc-CcccCCCHHHHHH
Confidence 2 22233333333445667789999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=273.66 Aligned_cols=234 Identities=26% Similarity=0.414 Sum_probs=178.0
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhc---CCCceeEeceeeeCCCC----c
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQT---NSPYIVKCHQIFTKPSG----E 127 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----~ 127 (300)
|++.+.||+|+||.||+|.++.+++.||+|.++...... ...+|+.+++++ +|+|++++++++..... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999999889999999997543322 234677777665 69999999999876541 2
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------
Q 040812 128 VSILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------- 197 (300)
.+++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++...++++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 8999999975 8988887643 5899999999999999999999999999999999999998865433322
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC---------
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP--------- 258 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 258 (300)
..|.+||... +..++.++|||||||++|+|+||.+||...........+.........
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLL---QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CcccccccccccccChHHhc---cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 1234444432 455677999999999999999999999764433222222211100000
Q ss_pred -------------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 259 -------------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 259 -------------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.......++.+.++|.+||.. ||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTF-NPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhcc-CCccCCCHHHHhcCcCC
Confidence 000112357789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=272.15 Aligned_cols=229 Identities=25% Similarity=0.361 Sum_probs=180.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC---eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTL---ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.++|++.+.||+|+||.||+|.+..++ ..+|+|.++..... ..+.+|+.++++++||||+++++++.... ..|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-PVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-ccE
Confidence 357899999999999999999986444 37999988653322 23467999999999999999999987654 899
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
+||||+++++|.+++... +.+++..+..++.|++.||.+||+.|++||||||+||+++.++...+.++
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999999764 46899999999999999999999999999999999999987654322221
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
..|.+||.. .+..++.++|+|||||++||+++ |..||....... ....+........+...
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~---~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 234 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAI---AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAIEEGYRLPAPMDC 234 (267)
T ss_pred eeeecCCCccceeecCHhHh---ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHHhCCCcCCCCCCC
Confidence 123344433 24456789999999999999886 999996543321 22222223334445567
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.+.+++.+||+. +|++||++.++++
T Consensus 235 ~~~~~~li~~~l~~-~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQK-DRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHccc-CchhCCCHHHHHH
Confidence 88999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=270.87 Aligned_cols=229 Identities=25% Similarity=0.360 Sum_probs=181.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCe---EEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLA---LYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.++|+..+.||+|+||.||+|....++. .+|+|.++..... ..+.+|+.++++++|+||+++++++.... ..|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-PAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-CcE
Confidence 3578889999999999999999876554 7999988654322 23457999999999999999999987654 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee----------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------- 198 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------- 198 (300)
+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+..++
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 99999999999999975 3578999999999999999999999999999999999999877543222111
Q ss_pred ------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 199 ------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 199 ------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
.|.+||... +..++.++|||||||++|||+| |..||...... .....+........+...
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----~~~~~i~~~~~~~~~~~~ 235 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIA---YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----EVMKAINDGFRLPAPMDC 235 (268)
T ss_pred cceeccCCCcCceecCHHHhh---cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHHHhcCCCCCCCCCC
Confidence 244454432 3456779999999999999998 99999654332 222223333344445567
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+..+.+++.+||+. +|++||++.++++
T Consensus 236 ~~~~~~li~~c~~~-~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQ-DRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCC-CcccCcCHHHHHH
Confidence 89999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=273.12 Aligned_cols=229 Identities=22% Similarity=0.279 Sum_probs=177.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCe----EEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLA----LYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|++.+.||+|+||.||+|.+..+++ .+++|.+....... .+..|+..+.++.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--AS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--Cc
Confidence 34678999999999999999999977666 46777764332221 22456778889999999999998753 36
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 128 VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
.++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++...+..+
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999976 446899999999999999999999999999999999999998765432221
Q ss_pred ------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 198 ------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 198 ------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
..|.+||.. .++.++.++|||||||++|||+| |..||...... ........+..+..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~---~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESI---LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERLAQPQI 235 (279)
T ss_pred CcccccCCCCCcccccCHHHh---ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCCCCCC
Confidence 123344433 24557789999999999999998 99999654321 11222233444455666
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++..+.+++.+||.. ||++|||+.++++
T Consensus 236 ~~~~~~~li~~c~~~-~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMI-DENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCC-CcccCcCHHHHHH
Confidence 788999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=282.53 Aligned_cols=238 Identities=26% Similarity=0.360 Sum_probs=181.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----C
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS-----G 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 126 (300)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++|+||+++++++.... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 35799999999999999999999999999999998653322 23467999999999999999999876432 2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|+|+||+.. +|..++. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++...+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 46999999965 7776653 3689999999999999999999999999999999999999876543322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH-----------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI----------------- 253 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----------------- 253 (300)
+..|.+||.... +..++.++|||||||++|||++|+.||............+...
T Consensus 171 ~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 171 MTGYVVTRWYRAPEVILN--WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCceeeecccChhhhcC--ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 223455655431 2346779999999999999999999997543222111111100
Q ss_pred -hhCCCCCC--------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 -CFREPPSL--------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 -~~~~~~~~--------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.....+.. ....+..+.++|.+||+. ||++||++++++.||||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLEL-DVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCC-ChhhCcCHHHHhcCcchhh
Confidence 00000000 123567899999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=276.00 Aligned_cols=233 Identities=22% Similarity=0.299 Sum_probs=179.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC----------------eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTL----------------ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVK 116 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~ 116 (300)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...... ..+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 467999999999999999999876533 56899998754322 23457999999999999999
Q ss_pred eceeeeCCCCcEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCcee
Q 040812 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-----------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVL 185 (300)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nil 185 (300)
+++++..+ +..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99998875 48999999999999999997654 6899999999999999999999999999999999999
Q ss_pred ecCCCCCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 040812 186 INEKMEHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM--GYYPFLEPGQ 242 (300)
Q Consensus 186 l~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~ 242 (300)
++.++...++.++ .|.+||... ++.++.++|||||||++|||++ |..||.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL---LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh---cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9887544322211 244555433 4457789999999999999998 7888865433
Q ss_pred CchHHHHHHHH---hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 243 EPDFLSLMLAI---CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 243 ~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
........... ........+...+.++.+++.+||+. ||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR-DEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhcc-ChhcCCCHHHHHH
Confidence 22211111100 01111223445678999999999999 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=273.02 Aligned_cols=229 Identities=23% Similarity=0.293 Sum_probs=180.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCe----EEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLA----LYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
...+|++.+.||+|+||.||+|.+..+++ .||+|+++..... ..+.+|+.+++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--T 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--C
Confidence 45678999999999999999999876665 4899998654322 2335689999999999999999988653 5
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------
Q 040812 128 VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------- 198 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------- 198 (300)
.++++||+++|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+|||++.++...+.+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999999999999976 3468999999999999999999999999999999999999876554332221
Q ss_pred -------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 199 -------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
.|.+||.. .+..++.++|||||||++|||+| |..||...... .....+........+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~---~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESI---LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLEKGERLPQPPI 235 (279)
T ss_pred cceeecCCCccchhhCCHHHh---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCCCCcc
Confidence 23444443 24456789999999999999998 89999643321 12222223334445567
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+.++.+++.+||.. ||++||++.++++
T Consensus 236 ~~~~~~~li~~~l~~-dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMI-DSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCC-ChhhCcCHHHHHH
Confidence 889999999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=268.86 Aligned_cols=227 Identities=23% Similarity=0.341 Sum_probs=178.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++.+.||+|+||.||+|.+..+. .+|+|.+...... ..+.+|+.++++++|+|++++++++.. +..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEc
Confidence 356899999999999999999987654 5899987654322 234679999999999999999998753 368999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------------
Q 040812 135 MDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------------- 198 (300)
Q Consensus 135 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------------- 198 (300)
+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||++++++...+++++
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 99999999997532 47899999999999999999999999999999999999987654332211
Q ss_pred ------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 199 ------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 199 ------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
.|.+||.. .+...+.++|||||||++|||+| |..||...... ..............+...+..+.+
T Consensus 162 ~~~~~~~y~~Pe~~---~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 162 GAKFPIKWTAPEAA---LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred CCccchhhCCHHHh---ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCCCCCCcccCHHHHH
Confidence 13333332 23456779999999999999999 99999654322 222222233344556678899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 040812 272 FIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.+||.. ||++||+++++++
T Consensus 235 li~~~l~~-~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKK-DPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccC-CcccCcCHHHHHH
Confidence 99999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=269.42 Aligned_cols=220 Identities=22% Similarity=0.317 Sum_probs=175.0
Q ss_pred eecCCcceEEEEEEEc--cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCC
Q 040812 64 VLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAG 138 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~ 138 (300)
.||+|+||.||+|.+. +++..||+|++...... ..+.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence 4899999999999875 45667999998654322 224679999999999999999998754 3689999999999
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------------
Q 040812 139 SLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------------- 197 (300)
Q Consensus 139 ~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------------- 197 (300)
+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.+....+..+
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999975 446899999999999999999999999999999999999987654322211
Q ss_pred --eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 198 --CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 198 --~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
..|.+||... +..++.++|||||||++|||++ |..||...... .....+........+...++++.++|.
T Consensus 160 ~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05115 160 WPLKWYAPECIN---FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMSFIEQGKRLDCPAECPPEMYALMK 232 (257)
T ss_pred CCcccCCHHHHc---cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1244444432 3456779999999999999996 99999654322 233334445556677788999999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 040812 275 CCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~ 293 (300)
+||.. ||++||++.++.+
T Consensus 233 ~c~~~-~~~~Rp~~~~i~~ 250 (257)
T cd05115 233 DCWIY-KWEDRPNFAKVEE 250 (257)
T ss_pred HHcCC-ChhhCcCHHHHHH
Confidence 99999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=282.77 Aligned_cols=239 Identities=27% Similarity=0.356 Sum_probs=183.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC-----C
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS-----G 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 126 (300)
.++|++.+.||+|+||.||++.+..+++.||+|.+....... ...+|+.++++++|+||+++++++..+. .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 467999999999999999999999999999999986432221 2357999999999999999999886543 1
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
..++||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++...+.++
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 368999999 6699888864 47899999999999999999999999999999999999998765433222
Q ss_pred -------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH-----------------
Q 040812 198 -------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI----------------- 253 (300)
Q Consensus 198 -------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----------------- 253 (300)
..|.+||.... ....+.++|+|||||++|+|++|..||............+...
T Consensus 172 ~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 172 MTGYVVTRWYRAPEVILN--WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred ccccccCCcccCHHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 22344444321 1246779999999999999999999997543321111111100
Q ss_pred --hhCCC-------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 --CFREP-------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 --~~~~~-------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....+ .......+..+.++|.+||.. ||++|||+.++++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVL-DAESRITAAEALAHPYFEE 303 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCC-ChhhCCCHHHHhcCccHhh
Confidence 00000 011235677899999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=272.16 Aligned_cols=227 Identities=19% Similarity=0.299 Sum_probs=173.7
Q ss_pred eeeeeecCCcceEEEEEEEccCCe--EEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCC-----CCcE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLA--LYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKP-----SGEV 128 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 128 (300)
.+.+.||+|+||.||+|.+..++. .+|+|.++..... ..+.+|+.+++.++|+||+++++++... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999987765 6899988654322 2345689999999999999999875321 1247
Q ss_pred EEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee---
Q 040812 129 SILMEYMDAGSLEIYVKS------RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL--- 199 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~--- 199 (300)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999999988742 12478999999999999999999999999999999999998776543333222
Q ss_pred ------------------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCC
Q 040812 200 ------------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPS 260 (300)
Q Consensus 200 ------------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (300)
|.+||. ..+..++.++|||||||++|||++ |+.||..... . .....+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~---~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~---~~~~~~~~~~~~~ 234 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIES---LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-S---EIYDYLRQGNRLK 234 (272)
T ss_pred cCcccceecCCcccCCcccCCHHH---ccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-H---HHHHHHHcCCCCC
Confidence 122222 224456779999999999999999 8999965332 1 2222233333444
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+...++.+.++|.+||.. ||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~-~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLL-NPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCC-CcccCcCHHHHHHH
Confidence 5667889999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=283.00 Aligned_cols=239 Identities=28% Similarity=0.394 Sum_probs=183.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC----CCCCCHHHHHHHHhc-CCCceeEeceeeeCCC-CcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----GTPPNPQELNILRQT-NSPYIVKCHQIFTKPS-GEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~~ 129 (300)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ......+|+.+++++ +|+||+++++++.... ...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467899999999999999999999889999999875422 122345699999999 9999999999876433 3589
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
+||||+.+ +|..++... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++...++.+
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999975 999988765 7889999999999999999999999999999999999998765433321
Q ss_pred ------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH------------
Q 040812 198 ------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI------------ 253 (300)
Q Consensus 198 ------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------------ 253 (300)
..|.+||.... ....+.++|||||||++|+|+||+.||................
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLG--STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccCcchhcccccccccCceeeec--cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 12445554321 2345678999999999999999999996543221111111000
Q ss_pred -----------hhCC---CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 -----------CFRE---PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 -----------~~~~---~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.... ........+.++.++|.+||+. ||++|||+.++++||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVF-NPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccC-CcccccCHHHHhhChhhhh
Confidence 0000 0111123678899999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=281.94 Aligned_cols=240 Identities=25% Similarity=0.324 Sum_probs=182.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
..++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+|+.++++++|+||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 457899999999999999999999999999999998653221 22356999999999999999999875422
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------- 197 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------- 197 (300)
...|++++++ +++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||+++.++...+.++
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 2478899887 67998887654 6899999999999999999999999999999999999998765543322
Q ss_pred --------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH----------------
Q 040812 198 --------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI---------------- 253 (300)
Q Consensus 198 --------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---------------- 253 (300)
..|.+||.... ...++.++|||||||++|+|++|+.||...........+....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 173 EMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred cccccccCCCccCHHHHhC--ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 23455554321 1346679999999999999999999996543322111111100
Q ss_pred -------hhCCCC---CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 -------CFREPP---SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 -------~~~~~~---~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...... ......++++.++|.+||.. ||.+||++.+++.||||.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL-DSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCC-ChhhcCCHHHHhcChhhhh
Confidence 000000 11123577899999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=275.52 Aligned_cols=234 Identities=31% Similarity=0.467 Sum_probs=181.6
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
|+..+.||+|+||.||+|+...+++.||+|.+....... .+.+|+.++++++|+|++++++++... +..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence 567789999999999999999999999999987653222 235699999999999999999998875 489999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 135 MDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++...+.++
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 985 999999875 57999999999999999999999999999999999999998655433221
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh----------------hCCC
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC----------------FREP 258 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------------~~~~ 258 (300)
..|.+||.... ....+.++|||||||++|||++|..||...........+..... ....
T Consensus 159 ~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 159 VVTLWYRAPEILLG--SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccCcCcCChHHhcC--CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 12444554321 22567799999999999999999999966443222211111000 0000
Q ss_pred C--------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 259 P--------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 259 ~--------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+ ......+..+.++|.+||.. ||++||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQY-NPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhcc-CcccCCCHHHHhhCcCC
Confidence 0 00112367899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=274.65 Aligned_cols=227 Identities=23% Similarity=0.357 Sum_probs=178.2
Q ss_pred cceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...... ..+.+|+.+++.++||||+++++.+.... ..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-PLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-CcE
Confidence 47889999999999999998753 2357899988654322 23467999999999999999999987654 799
Q ss_pred EEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCcee
Q 040812 130 ILMEYMDAGSLEIYVKSR------------------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVL 185 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nil 185 (300)
+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999999999998642 24788899999999999999999999999999999999
Q ss_pred ecCCCCCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040812 186 INEKMEHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQE 243 (300)
Q Consensus 186 l~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 243 (300)
+++++...+.+++ .|.+||.. .+..++.++|||||||++|||+| |..||.....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~---~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL---FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH---ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 9987654333222 23334332 24456779999999999999999 9999964332
Q ss_pred chHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 244 PDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.. .............+...+.++.+++.+||.. ||++||++.++++
T Consensus 236 ~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~-~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ER---LFNLLKTGYRMERPENCSEEMYNLMLTCWKQ-EPDKRPTFADISK 281 (290)
T ss_pred HH---HHHHHhCCCCCCCCCCCCHHHHHHHHHHccC-CcccCCCHHHHHH
Confidence 22 2222223334455677889999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=258.03 Aligned_cols=237 Identities=32% Similarity=0.583 Sum_probs=189.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC---HHHHHHHHhc-CCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN---PQELNILRQT-NSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++.+.+..||+|+.|.||+++.+.+|...|||.+......... +..+.++.+- ..|.||+.+|+|..+. .+++.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~Ic 169 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFIC 169 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHHH
Confidence 45567788899999999999999999999999998765433222 2233333332 3699999999999865 78999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCc---------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPC--------------- 194 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~--------------- 194 (300)
||.|.. .+..+++. .+++++..+-.+...++.||.||-+ +||+|||+||+|||+|+.+..++
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 999954 66666654 5579999999999999999999975 68999999999999999877532
Q ss_pred ---cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC--CChHH
Q 040812 195 ---GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC--SSEKF 269 (300)
Q Consensus 195 ---~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l 269 (300)
.+...|++||-..-.....|...+||||||++++||.||+.||...+.+- +.+..+....++.++.. .++.+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---e~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---EVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---HHHHHHHhcCCCCCCcccCcCHHH
Confidence 23445777776655555667889999999999999999999998766553 34444555677777653 69999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+|+..||++ |+.+||...++|+|||+.
T Consensus 326 ~~fv~~CL~k-d~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 326 QSFVKDCLTK-DHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred HHHHHHHhhc-CcccCcchHHHhcCccee
Confidence 9999999999 999999999999999985
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=273.28 Aligned_cols=222 Identities=23% Similarity=0.326 Sum_probs=174.6
Q ss_pred eeecCCcceEEEEEEEccCCe--EEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLA--LYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+..++. .+++|.++..... ..+.+|+.++.++ +||||+++++++.... ..|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeCC
Confidence 358999999999999987775 4688887643221 2345799999999 7999999999987754 8999999999
Q ss_pred CCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--
Q 040812 137 AGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-- 198 (300)
Q Consensus 137 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-- 198 (300)
+++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.++...+++++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997532 37889999999999999999999999999999999999887654333222
Q ss_pred ----------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 199 ----------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 199 ----------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
.|.+||... +..++.++|||||||++|||+| |..||...... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~~~~ 232 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKLPQGYRLEK 232 (270)
T ss_pred cccchhhhccCCCCccccCChHHHc---cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHHHHhCCCCCCC
Confidence 244454432 4456789999999999999997 99999653322 22222333344455
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+...+.++.+++.+||.. ||.+|||+.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~-~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWRE-KPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHccc-ChhhCCCHHHHHH
Confidence 666788999999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=266.79 Aligned_cols=229 Identities=23% Similarity=0.376 Sum_probs=182.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++.+.||+|+||.||++.+.. +..+|+|.+...... ..+.+|+.++++++|||++++++++.... ..++||||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~ 80 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-PICLVFEF 80 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-ceEEEEEc
Confidence 3578999999999999999998864 668999988654322 34577999999999999999999987654 89999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 135 MDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
+++++|.+++... +.+++..++.++.|++.||.+||+.|++|+||||+||+++.++...+.++
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999999999753 46899999999999999999999999999999999999987654322221
Q ss_pred ----eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 198 ----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 198 ----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
..|.+||... ++.++.++|||||||++|||++ |..||...... ..............+...++.+.++
T Consensus 161 ~~~~~~~~aPe~~~---~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05112 161 TKFPVKWSSPEVFS---FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVETINAGFRLYKPRLASQSVYEL 233 (256)
T ss_pred CccchhhcCHhHhc---cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 1244444332 4567789999999999999998 99999643321 2222222233444456678999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.+||.. +|++|||+.+++++
T Consensus 234 ~~~~l~~-~p~~Rp~~~~~l~~ 254 (256)
T cd05112 234 MQHCWKE-RPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHccc-ChhhCCCHHHHHHh
Confidence 9999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.28 Aligned_cols=233 Identities=26% Similarity=0.366 Sum_probs=177.9
Q ss_pred CcceeeeeecCCcceEEEEEEE----ccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCC-CCcEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRH----KQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKP-SGEVS 129 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 129 (300)
.+|++.+.||+|+||.||++.. ..+++.||+|.+...... ..+.+|+.++++++||||+++++++... ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4689999999999999999984 457889999998654321 2346799999999999999999976432 33689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee----------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------- 198 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------- 198 (300)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++...++.++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999999999764 468999999999999999999999999999999999999876544322211
Q ss_pred ------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc------------hHHHHHHHHh
Q 040812 199 ------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP------------DFLSLMLAIC 254 (300)
Q Consensus 199 ------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~------------~~~~~~~~~~ 254 (300)
.|.+||.. .+..++.++|||||||++|||++|..|+....... ..........
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 164 YYKVREPGESPIFWYAPESL---TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred ceeecCCCCCceEeeCHHHh---ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 23444433 24557789999999999999999877764322110 0001111112
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.......+...+..+.+++.+||.. +|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNN-DPSQRPSFSELAL 278 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccC-ChhhCCCHHHHHH
Confidence 2223344566788999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=268.96 Aligned_cols=227 Identities=22% Similarity=0.354 Sum_probs=182.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
..++|++.+.||+|+||.||++.. +++.||+|.++.+.....+.+|+.++++++|+|++++++++... ..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEEC
Confidence 456799999999999999999875 57789999987654444567899999999999999999988653 47999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------
Q 040812 135 MDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------- 197 (300)
Q Consensus 135 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------- 197 (300)
+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++...+.++
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCC
Confidence 99999999997643 5889999999999999999999999999999999999988765433222
Q ss_pred -eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 198 -CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 198 -~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
..|.+||.. .++.++.++|||||||++|||++ |..||...... ..............+...++.+.+++.+
T Consensus 160 ~~~y~~pe~~---~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 160 PVKWTAPEAL---KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----EVKECVEKGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CceecCHHHh---ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----HHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 124444433 24567789999999999999998 99999654322 2222223333444556778999999999
Q ss_pred HhccCCCCCCCCHHHHhc
Q 040812 276 CLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~ 293 (300)
||.. +|++||++.++++
T Consensus 233 ~l~~-~p~~Rp~~~~l~~ 249 (254)
T cd05083 233 CWET-EPKKRPSFHKLRE 249 (254)
T ss_pred HcCC-ChhhCcCHHHHHH
Confidence 9999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=303.55 Aligned_cols=229 Identities=24% Similarity=0.376 Sum_probs=192.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-C----eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQT-L----ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~----~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..+.++.+.||+|.||.||.|....- + ..||+|.++..... ..|.+|..+|++++|||||+++|++.+ .+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCC
Confidence 55678899999999999999997642 2 34899988765433 356789999999999999999999987 458
Q ss_pred EEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--
Q 040812 128 VSILMEYMDAGSLEIYVKSR-------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-- 198 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-- 198 (300)
.+|++|||+||+|..++++. ..++..+...++.||+.|+.||++++++||||..+|+|++.....++++++
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999875 248999999999999999999999999999999999999988666555433
Q ss_pred -------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 199 -------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 199 -------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
.|++||+.. .+.++.|+|||||||++||++| |..||.+..+. +++..+..+..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~---d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~~~~~ggR 922 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLK---DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLLDVLEGGR 922 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHh---hcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHHHHHhCCc
Confidence 366777765 3567789999999999999998 89999765443 34443444557
Q ss_pred CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 259 ~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
...|..+++.+.++|.+||+. +|++||++..+++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~-~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKH-DPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccC-ChhhCccHHHHHh
Confidence 888999999999999999999 9999999999885
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.99 Aligned_cols=233 Identities=27% Similarity=0.371 Sum_probs=178.8
Q ss_pred cceeeeeecCCcceEEEEEEE----ccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCC-CCcEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRH----KQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKP-SGEVS 129 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 129 (300)
.|++++.||+|+||.||+++. ..+++.||+|.++..... ..+.+|+.++++++|+||+++++++... ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478999999999999999984 456889999998644322 2346799999999999999999988765 23689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++...+..+
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 999999999999999764 35899999999999999999999999999999999999987755332221
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----------CchHHHHHHHHhh
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-----------EPDFLSLMLAICF 255 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-----------~~~~~~~~~~~~~ 255 (300)
..|.+||... +..++.++|||||||++|||+|+..|+..... .............
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLI---QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ceeecCCCCCCccccCHHHhc---cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 1234444332 44567799999999999999998776532211 0111111222222
Q ss_pred CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 256 REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
......+...+..+.+|+.+||+. ||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEF-QPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccC-CcccCcCHHHHHHH
Confidence 333445667889999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.47 Aligned_cols=231 Identities=23% Similarity=0.335 Sum_probs=181.2
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEcc-------CCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeee
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQ-------TLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFT 122 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~ 122 (300)
...++|.+.+.||+|+||.||+|++.. ....+|+|.++...... .+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345789999999999999999998642 34579999987543221 245799999999 6999999999987
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 123 KPSGEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
.. +..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 89 ~~-~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 89 QE-GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred cC-CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 65 4899999999999999999753 247889999999999999999999999999999999999
Q ss_pred cCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 187 NEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 187 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
+.++...++.+ ..|.+||... +..++.++|||||||++|+|++ |..||..... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF---DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-E 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc---cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-H
Confidence 87765432221 1245555443 4556789999999999999999 8999954322 1
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..............+...+.++.+++.+||.. ||++|||+.++++
T Consensus 244 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-~p~~Rps~~~ll~ 288 (314)
T cd05099 244 ---ELFKLLREGHRMDKPSNCTHELYMLMRECWHA-VPTQRPTFKQLVE 288 (314)
T ss_pred ---HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC-CcccCcCHHHHHH
Confidence 22222333444455677888999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.86 Aligned_cols=223 Identities=25% Similarity=0.406 Sum_probs=182.3
Q ss_pred eeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+... +..||+|.++..... ....+|+..++.++|+||+++++++... +..++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-EPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-CceEEEEEecc
Confidence 4699999999999999866 889999999765543 2345799999999999999999998874 48999999999
Q ss_pred CCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 137 AGSLEIYVKSR---------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 137 ~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
+++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++...++++
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999875 67999999999999999999999999999999999999998755433221
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
..|.+||... +..++.++|||||||++|+|++ |..||..... ...............+..+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLK---DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYLRKGYRLPKPEYC 232 (262)
T ss_pred ccccccCCCcCccccCHHHhc---cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCCccC
Confidence 2244444432 3356789999999999999999 6999966522 1223333334555667778
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.++.+++.+||.. ||++|||+++++++
T Consensus 233 ~~~~~~li~~~l~~-~p~~Rps~~~l~~~ 260 (262)
T cd00192 233 PDELYELMLSCWQL-DPEDRPTFSELVER 260 (262)
T ss_pred ChHHHHHHHHHccC-CcccCcCHHHHHHh
Confidence 99999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=282.94 Aligned_cols=240 Identities=28% Similarity=0.366 Sum_probs=183.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCC----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSG---- 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 126 (300)
..++|++.+.||+|+||.||+|++..+++.||+|.+...... ....+|+.++++++|+|++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 356799999999999999999999999999999998643221 223569999999999999999988765431
Q ss_pred -cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 127 -EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 127 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
..++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++...+.+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 389999999 5699998875 4699999999999999999999999999999999999999876543322
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh---------------
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC--------------- 254 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------- 254 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...........+.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 171 EMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred cccCCcccccccCHHHHhC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 223455554321 12467799999999999999999999965433211111111000
Q ss_pred --------hCCCC---CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 --------FREPP---SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 --------~~~~~---~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... ......++.+.++|.+||.. ||++|||+.++++||||.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~-~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVL-DPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCC-ChhhCCCHHHHhcCCCccc
Confidence 00000 01123578899999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.08 Aligned_cols=228 Identities=21% Similarity=0.261 Sum_probs=176.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+++|++.+.||+|+||.||+|.+..+++.||+|++..+... ..+.+|+.++++++||||+++++++.+.. ..|+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-PVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-EEEE
Confidence 36899999999999999999999999999999998754322 23467999999999999999999987754 8999
Q ss_pred EEeccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----
Q 040812 131 LMEYMDAGSLEIYVKSR-----------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---- 195 (300)
||||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.++...+.
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999999988641 235667788999999999999999999999999999999876543221
Q ss_pred ---------------------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 040812 196 ---------------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ 242 (300)
Q Consensus 196 ---------------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 242 (300)
++..|.+||.. .+..++.++|||||||++|||+||+.||.....
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l---~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL---LGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh---cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 22334555543 255678899999999999999999999965332
Q ss_pred CchHHHHHHHHhhCCCCC--CCCCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 243 EPDFLSLMLAICFREPPS--LPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
.. .........+.. ....+++.+.+++.+||.. ||++|++..+.+
T Consensus 237 ~k----i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~-DP~kR~ss~eeL 283 (932)
T PRK13184 237 RK----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAV-DPAERYSSVQEL 283 (932)
T ss_pred hh----hhhhhhccChhhccccccCCHHHHHHHHHHccC-ChhhCcCHHHHH
Confidence 21 111111111111 1235788899999999999 999998765544
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.86 Aligned_cols=231 Identities=21% Similarity=0.319 Sum_probs=182.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+...... ..+.+|+.++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999999876 3578999988643221 2235799999999999999999987765557
Q ss_pred EEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--
Q 040812 128 VSILMEYMDAGSLEIYVKSR--------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-- 197 (300)
.+++++|+.+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++...+..+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998753 35889999999999999999999999999999999999987655433221
Q ss_pred -------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCC
Q 040812 198 -------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFRE 257 (300)
Q Consensus 198 -------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (300)
..|.+||... +..++.++|||||||++||+++ |+.||..... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~ 236 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLV---NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKDGY 236 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHh---cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHcCC
Confidence 1244444432 4456789999999999999999 9999965432 12222222333
Q ss_pred CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 258 PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 258 ~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
....+..+++++.+++.+||.. ||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~~~~~ 271 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWAL-DPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCC-ChhhCCCHHHHHH
Confidence 4445566789999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.01 Aligned_cols=234 Identities=32% Similarity=0.433 Sum_probs=180.4
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEEEEec
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
|++.+.||+|+||.||+|....+++.||+|.+....... ...+|+..+++++ |+||+++++++... +..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-DELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-CcEEEEEec
Confidence 678899999999999999999999999999986543221 1246889999999 99999999998875 489999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 135 MDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
+ +++|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++...+..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 779998887654 789999999999999999999999999999999999999865443221
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh--------------CCC--
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF--------------REP-- 258 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------~~~-- 258 (300)
+..|.+||.... +...+.++|+||||+++|||++|+.||.................. ...
T Consensus 159 ~~~~~~~aPE~~~~--~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 159 VSTRWYRAPEILLR--STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCcccccCceeeec--CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 223455655432 234577999999999999999999999654332222111110000 000
Q ss_pred ---------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 259 ---------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 259 ---------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.......+..+.++|.+||+. ||++|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRW-DPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhccc-CcccCCCHHHHhhCCCC
Confidence 001112367899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.33 Aligned_cols=233 Identities=21% Similarity=0.289 Sum_probs=177.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC--------------CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQT--------------LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCH 118 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~ 118 (300)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++..... ..+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 45899999999999999999987543 235899998754322 2346799999999999999999
Q ss_pred eeeeCCCCcEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRG------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
+++.... ..|+||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 84 GVCVSDD-PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEcCCC-ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 9987654 8999999999999999986532 36788899999999999999999999999999999999
Q ss_pred cCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 040812 187 NEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM--GYYPFLEPGQE 243 (300)
Q Consensus 187 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~ 243 (300)
+.++...+.++ ..|.+||... ++.++.++|||||||++|+|+| |..||......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc---cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 87754433221 1234444332 4556889999999999999998 67888654332
Q ss_pred chHHHHHHHH---hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 244 PDFLSLMLAI---CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 244 ~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.......... ........+...++.+.+++.+||.. ||++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSR-DIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCC-CchhCcCHHHHHH
Confidence 2111111111 11112233455788999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=276.45 Aligned_cols=230 Identities=23% Similarity=0.327 Sum_probs=181.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-------CeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQT-------LALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
..+|++.+.||+|+||.||+|.+... ...||+|.++..... ..+.+|+.+++++ +|+||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35799999999999999999986432 236899988754322 2346799999999 899999999998765
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE 188 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~ 188 (300)
. ..++||||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+||+++.
T Consensus 91 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 91 G-PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 4 8999999999999999997532 3678889999999999999999999999999999999987
Q ss_pred CCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchH
Q 040812 189 KMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDF 246 (300)
Q Consensus 189 ~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~ 246 (300)
++...++.+ ..|.+||... +..++.++|||||||++|||++ |..||.....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhc---cCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 654332221 1245555443 4456779999999999999998 8899965332
Q ss_pred HHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 247 LSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
......+........+...+..+.+++.+||.. +|++||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHA-VPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccc-ChhhCcCHHHHHHH
Confidence 223333333445556677889999999999999 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=272.81 Aligned_cols=231 Identities=23% Similarity=0.329 Sum_probs=181.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-------cCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK-------QTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
..++|++.+.||+|+||.||+|++. ..+..||+|.+...... ....+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4577899999999999999999753 23457999988643222 2345799999999 89999999999887
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
.. ..|+||||+.+++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+++
T Consensus 93 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 93 DG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred CC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 54 899999999999999999753 2367888999999999999999999999999999999998
Q ss_pred CCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040812 188 EKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPD 245 (300)
Q Consensus 188 ~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 245 (300)
.++...++++ ..|.+||... +..++.++|||||||++|+|+| |..||.....
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 7654332221 1245555442 4556789999999999999998 7888854322
Q ss_pred HHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 246 FLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
...............+..++..+.+++.+||.. +|++|||+.++++.
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 -EELFKLLKEGHRMDKPANCTNELYMMMRDCWHA-IPSHRPTFKQLVED 292 (304)
T ss_pred -HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccc-ChhhCCCHHHHHHH
Confidence 223333333444455677889999999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=268.48 Aligned_cols=229 Identities=23% Similarity=0.319 Sum_probs=182.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCe----EEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLA----LYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
...+|++.+.||+|+||.||+|.++.+++ .+|+|........ ..+.+|+.++++++|+||+++++++.. +.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 82 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQ 82 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--Cc
Confidence 34678999999999999999999876654 5899987655432 234579999999999999999999876 47
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 128 VSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++...+.++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999999764 46899999999999999999999999999999999999987654332221
Q ss_pred ------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 198 ------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 198 ------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
..|.+||... +..++.++|+|||||++||++| |+.||..... ......+........+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDLLEKGERLPQPPI 235 (279)
T ss_pred ccceecCCCcccccccCHHHhh---cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHhCCCCCCCCCC
Confidence 1244444332 3456779999999999999999 9999965432 122233333445556667
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+..+.+++.+||.. ||++||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~-~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMI-DAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCC-ChhhCCCHHHHHH
Confidence 888999999999999 9999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=276.16 Aligned_cols=238 Identities=26% Similarity=0.297 Sum_probs=179.6
Q ss_pred cceeeeeecCCcceEEEEEEEccC--CeEEEEEEeecCCCC----CCCHHHHHHHHhc-CCCceeEeceeeeCC---CCc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQT--LALYALKVMQCDRGT----PPNPQELNILRQT-NSPYIVKCHQIFTKP---SGE 127 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~---~~~ 127 (300)
+|++.+.||+|+||.||++.+..+ +..||+|.+...... ....+|+.+++++ +|+||+++++..... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999887 889999998643222 2235699999998 599999999864321 235
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
.|++++|+. ++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++...+..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 889999996 59999998777899999999999999999999999999999999999998775543222
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH------------
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA------------ 252 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~------------ 252 (300)
+..|.+||.... ...++.++|||||||++|+|++|..||...+........+..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLS--FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccCcccCccccCcHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 223455554321 234677999999999999999999999654321111100000
Q ss_pred -----------HhhCCCC---CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 253 -----------ICFREPP---SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 253 -----------~~~~~~~---~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....... ......+..+.+++.+||.. ||++|||+.++++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAF-DPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccC-CcccCCCHHHHhcChhhhh
Confidence 0000001 11123578899999999999 9999999999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=264.46 Aligned_cols=221 Identities=25% Similarity=0.355 Sum_probs=177.5
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
+.||+|+||.||++.+.. ++.||+|.+...... ..+.+|+.++++++|+||+++++++.... ..++||||+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-PIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-CeEEEEEcCCCCc
Confidence 469999999999999988 899999988754432 23467999999999999999999988764 8999999999999
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------------------
Q 040812 140 LEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------------- 197 (300)
Q Consensus 140 L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------------- 197 (300)
|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++...+.++
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 9999965 346899999999999999999999999999999999999987654332221
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
..|.+||... ++.++.++|||||||++|||+| |..||...... ..............+...+..+.+++.+|
T Consensus 159 ~~y~~PE~~~---~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 159 IKWTAPEALN---YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRERIESGYRMPAPQLCPEEIYRLMLQC 231 (251)
T ss_pred eccCChHhhc---cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHHHhcCCCCCCCccCCHHHHHHHHHH
Confidence 1244555432 4567789999999999999999 89999654332 11122222334455677889999999999
Q ss_pred hccCCCCCCCCHHHHhc
Q 040812 277 LQKGDPSKRWTASQLLS 293 (300)
Q Consensus 277 l~~~dp~~Rpt~~~~l~ 293 (300)
|.. +|++|||+.++++
T Consensus 232 l~~-~p~~Rp~~~ell~ 247 (251)
T cd05041 232 WAY-DPENRPSFSEIYN 247 (251)
T ss_pred hcc-ChhhCcCHHHHHH
Confidence 999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=272.05 Aligned_cols=233 Identities=20% Similarity=0.313 Sum_probs=176.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc----------------CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ----------------TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVK 116 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~ 116 (300)
.++|++.+.||+|+||.||++.+.. +...+|+|++...... ..+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986542 3457999998754322 23467999999999999999
Q ss_pred eceeeeCCCCcEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCcee
Q 040812 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-----------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVL 185 (300)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nil 185 (300)
+++++.... ..|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 84 LLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999987755 7999999999999999997532 3667889999999999999999999999999999999
Q ss_pred ecCCCCCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 040812 186 INEKMEHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM--GYYPFLEPGQ 242 (300)
Q Consensus 186 l~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~ 242 (300)
++.++...+++++ .|.+||. ..++.++.++|||||||++|||+| |..||.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~---~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWES---ILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHH---HhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9876554322211 1222322 224557789999999999999998 7889965433
Q ss_pred CchHHHHHH---HHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 243 EPDFLSLML---AICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 243 ~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
......... ..........+..+++.+.+++.+||+. ||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR-NAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCC-CcccCCCHHHHHH
Confidence 222111111 0011112233456778999999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=270.98 Aligned_cols=222 Identities=20% Similarity=0.318 Sum_probs=169.9
Q ss_pred eeecCCcceEEEEEEEccCCe-------EEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 63 QVLGQGNGGTVFKVRHKQTLA-------LYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+.||+|+||.||+|.+..++. .+|+|.+...... ..+.+|+.+++.+.||||+++++++..+. ..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEEEe
Confidence 369999999999999865543 3888887543221 23466899999999999999999988754 7899999
Q ss_pred ccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-----------Ccc------
Q 040812 134 YMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-----------PCG------ 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-----------~~~------ 195 (300)
|+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.. ++|
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999997644 58999999999999999999999999999999999999876432 111
Q ss_pred ------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 ------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGY-YPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 ------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
....|.+||.... +..++.++|||||||++|||++|. .||..... ...... ......++...+.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~ 231 (258)
T cd05078 160 PKEILLERIPWVPPECIEN--PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF-----YEDRHQLPAPKWTE 231 (258)
T ss_pred CchhccccCCccCchhccC--CCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH-----HHccccCCCCCcHH
Confidence 1123455554431 234577999999999999999984 66643222 111111 12234556666789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.++|.+||+. ||++|||++++++.
T Consensus 232 ~~~li~~~l~~-~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDY-EPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhcc-ChhhCCCHHHHHHh
Confidence 99999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=267.75 Aligned_cols=228 Identities=27% Similarity=0.326 Sum_probs=180.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+|.+.+.||+|+||.||+|.+... ...||+|........ ..+.+|+.++++++|+||+++++++.. ...|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence 5688999999999999999997643 457899987654321 235679999999999999999998865 36789
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 131 LMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+..+
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 999999999999997644 5899999999999999999999999999999999999988655433221
Q ss_pred --------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 198 --------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 198 --------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
..|.+||.. .+..++.++|||||||++|||++ |..||...... ..............+..++..
T Consensus 164 ~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05056 164 KASKGKLPIKWMAPESI---NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRIENGERLPMPPNCPPT 236 (270)
T ss_pred ecCCCCccccccChhhh---ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCcCCCCCCCCHH
Confidence 124455543 24456789999999999999986 99999655432 222223334444566778899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.++|.+||.. +|++|||+.+++..
T Consensus 237 ~~~li~~~l~~-~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAY-DPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 99999999999 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=265.00 Aligned_cols=224 Identities=21% Similarity=0.322 Sum_probs=171.9
Q ss_pred eeecCCcceEEEEEEEcc---CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+.. ....+|+|.+...... ..+.+|+.+++.++||||+++++++...++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999999753 3467999987543221 2345689999999999999999977655557899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-----------------
Q 040812 137 AGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------------- 198 (300)
Q Consensus 137 ~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~----------------- 198 (300)
+++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++...+++++
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999999764 356788889999999999999999999999999999999987654332221
Q ss_pred ------eccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 199 ------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMG-YYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 199 ------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
.|.+||... +..++.++|||||||++|||++| .+||.... . ............+..+...++.+.+
T Consensus 161 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 161 GAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-S---FDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred cCcCCccccChhHhc---cCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-H---HHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 234444332 34567799999999999999995 55664322 1 2233333334445556667889999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
++.+||.. +|++||++.++++.
T Consensus 234 li~~cl~~-~p~~Rp~~~~il~~ 255 (262)
T cd05058 234 VMLSCWHP-KPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHcCC-ChhhCCCHHHHHHH
Confidence 99999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=271.86 Aligned_cols=237 Identities=27% Similarity=0.432 Sum_probs=200.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC-----HHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
....+|..+.+||+|+||+|-++..+.+.+.+|||+++++...+.. ..|-++|... +-|.+++++.+|..-. .
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-R 424 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-R 424 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-h
Confidence 3456789999999999999999999999999999999876544322 4566666654 4578999999998755 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------ 195 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------ 195 (300)
+|+||||+.||+|.-.+++-++|.+..+..++..|+.||-|||++||+.||||.+|||++.++..++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999988765332
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++.-|.+||.... ..|+.++|+||+||+||||+.|++||.+.+++.-+..++ .....+|..+|.+
T Consensus 505 ~TTkTFCGTPdYiAPEIi~Y---qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-----ehnvsyPKslSkE 576 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-----EHNVSYPKSLSKE 576 (683)
T ss_pred cceeeecCCCcccccceEEe---cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----HccCcCcccccHH
Confidence 3445677776653 358889999999999999999999998876655444444 3456788899999
Q ss_pred HHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
..+++...|.+ .|.+|.. -.++-.||||+.+
T Consensus 577 Av~ickg~ltK-~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 577 AVAICKGLLTK-HPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHHHHhhc-CCccccCCCCccccchhhCcchhhc
Confidence 99999999999 9999985 4689999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=275.98 Aligned_cols=240 Identities=26% Similarity=0.367 Sum_probs=182.7
Q ss_pred cCCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 49 YGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 49 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
+......+++|.-...||+|+||.||+|...++ ..||||.+..... ...|.+|+.++.+++|||+|+++|+|.+..+
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 334445667888889999999999999999874 8999998876554 3568999999999999999999999987542
Q ss_pred cEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCC---ccccCCCCCceeecCCCCCCccceee--
Q 040812 127 EVSILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRN---IVHRDIKPANVLINEKMEHPCGYSCL-- 199 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---i~H~Dlkp~Nill~~~~~~~~~~~~~-- 199 (300)
..+||+||+++|+|.+++.... .++|.....|+.+++.||.|||... |+|||||++|||+|++...++.++++
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 4899999999999999998654 7899999999999999999999753 99999999999999887765544332
Q ss_pred ------------------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCchHHHHHHHHhhC---
Q 040812 200 ------------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG--QEPDFLSLMLAICFR--- 256 (300)
Q Consensus 200 ------------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~--- 256 (300)
|.+||... .+..+.++|||||||+|.|++||+.+..... ...............
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~---~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYAS---TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhc---cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 33333322 2456779999999999999999998886432 222222221111111
Q ss_pred ---CCCCCC-CCCC-----hHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 257 ---EPPSLP-ECSS-----EKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 257 ---~~~~~~-~~~~-----~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+.+. .... ..+..+..+|++. +|.+||++.++++
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~-~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRP-DPKERPTMSQVVK 347 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCc-CCCcCcCHHHHHH
Confidence 112222 2222 2366778899999 9999999999764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=264.61 Aligned_cols=228 Identities=25% Similarity=0.366 Sum_probs=179.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.+.||+|+||.||++.+.. +..+|+|.+..... ...+.+|+.++++++|+||+++++.+.. +..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEE
Confidence 34679999999999999999998764 45689998865432 2345679999999999999999998876 47899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------
Q 040812 134 YMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------- 198 (300)
Q Consensus 134 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------- 198 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++...++++.
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 99999999999753 357888999999999999999999999999999999999887655433221
Q ss_pred -------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 199 -------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 199 -------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.|.+||... ++.++.++|+|||||++|+++| |..||...... ..............+...+.++.
T Consensus 161 ~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 161 EGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred cCCcccccccCHhHhc---cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHhCCCCCCCcccCCHHHH
Confidence 234444332 3456778999999999999999 99999654322 12222223334445567788999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+||.. ||++||++.++++
T Consensus 234 ~~i~~~l~~-~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKN-RPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHccc-CcccCcCHHHHHH
Confidence 999999999 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.56 Aligned_cols=222 Identities=20% Similarity=0.316 Sum_probs=174.4
Q ss_pred eeecCCcceEEEEEEEcc-CC--eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHKQ-TL--ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+.. ++ ..||+|.+...... ..+.+|+.++++++|+||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999999865 33 36999998765442 234679999999999999999999876 48999999999
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------------
Q 040812 137 AGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------------- 197 (300)
Q Consensus 137 ~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------------- 197 (300)
+++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++...+.++
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999998754 6899999999999999999999999999999999999988755433221
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
..|.+||... +..++.++|||||||++|||+| |..||....... ....... .......+...+..+.+
T Consensus 159 ~~~~~~~y~~pE~~~---~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 159 HLKVPFAWCAPESLR---TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDK--EGERLERPEACPQDIYN 232 (257)
T ss_pred CCCCCceecCHHHhc---ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh--cCCcCCCCccCCHHHHH
Confidence 1234444332 3456778999999999999999 999996543321 1111111 22333445667899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 040812 272 FIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.+||.. +|++||++.++++
T Consensus 233 li~~~l~~-~p~~Rps~~~~~~ 253 (257)
T cd05040 233 VMLQCWAH-NPADRPTFAALRE 253 (257)
T ss_pred HHHHHCCC-CcccCCCHHHHHH
Confidence 99999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=262.10 Aligned_cols=222 Identities=24% Similarity=0.352 Sum_probs=176.4
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
+.||+|+||.||+|... +++.+|+|.+...... ..+.+|+.++++++||||+++++++.... ..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCCc
Confidence 36899999999999865 5788999987654321 13467999999999999999999987754 8999999999999
Q ss_pred HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------------e
Q 040812 140 LEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------------------C 198 (300)
Q Consensus 140 L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------------------~ 198 (300)
|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++...+..+ .
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 99998753 45899999999999999999999999999999999999987764322221 1
Q ss_pred eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHh
Q 040812 199 LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277 (300)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 277 (300)
.|.+||... ++.++.++||||||+++|+|++ |..||...... .....+........+...+..+.+++.+||
T Consensus 159 ~y~aPE~~~---~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 159 KWTAPEALN---YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQVEKGYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred cccCHHHhc---cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 244555432 4456779999999999999998 99999654322 222223334444556678899999999999
Q ss_pred ccCCCCCCCCHHHHhcC
Q 040812 278 QKGDPSKRWTASQLLSH 294 (300)
Q Consensus 278 ~~~dp~~Rpt~~~~l~h 294 (300)
.. +|++||++.++++.
T Consensus 232 ~~-~p~~Rp~~~~l~~~ 247 (250)
T cd05085 232 DY-KPENRPKFSELQKE 247 (250)
T ss_pred cc-CcccCCCHHHHHHH
Confidence 99 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=268.63 Aligned_cols=221 Identities=23% Similarity=0.370 Sum_probs=167.8
Q ss_pred eecCCcceEEEEEEEccC------------------------CeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEe
Q 040812 64 VLGQGNGGTVFKVRHKQT------------------------LALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKC 117 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~ 117 (300)
.||+|+||.||+|....+ ...|++|++..... ...+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999985321 23588888754322 1234568889999999999999
Q ss_pred ceeeeCCCCcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC----
Q 040812 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH---- 192 (300)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~---- 192 (300)
++++.... ..++||||+++|+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++..+..
T Consensus 82 ~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 82 HGVCVRGS-ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEeCC-ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99988754 89999999999999999865 4578999999999999999999999999999999999999764321
Q ss_pred ------Cccc------------eeeccccccccccCCCCCCchhhHHHHHHHHHHH-HhCCCCCCCCCCCchHHHHHHHH
Q 040812 193 ------PCGY------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMEL-YMGYYPFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 193 ------~~~~------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~el-ltg~~pf~~~~~~~~~~~~~~~~ 253 (300)
++|. ...|.+||.... +..++.++|||||||++||| ++|..||....... .....
T Consensus 161 ~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~~--- 234 (274)
T cd05076 161 PFIKLSDPGVSFTALSREERVERIPWIAPECVPG--GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-KERFY--- 234 (274)
T ss_pred ceeeecCCccccccccccccccCCcccCchhhcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-HHHHH---
Confidence 1111 122445554321 24567899999999999999 47999996543321 11111
Q ss_pred hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
......+...++.+.++|.+||.. +|++|||+.+++++
T Consensus 235 --~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rps~~~il~~ 272 (274)
T cd05076 235 --EKKHRLPEPSCKELATLISQCLTY-EPTQRPSFRTILRD 272 (274)
T ss_pred --HhccCCCCCCChHHHHHHHHHccc-ChhhCcCHHHHHHh
Confidence 122334445567899999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=267.19 Aligned_cols=222 Identities=25% Similarity=0.383 Sum_probs=174.1
Q ss_pred eeecCCcceEEEEEEEccCC------eEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 63 QVLGQGNGGTVFKVRHKQTL------ALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+.||+|+||.||+|.+.... +.+|+|.+..... ...+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEEe
Confidence 36999999999999986543 7899998865432 223467999999999999999999987654 8999999
Q ss_pred ccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-----CCCc---cce-
Q 040812 134 YMDAGSLEIYVKSR-------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-----EHPC---GYS- 197 (300)
Q Consensus 134 ~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-----~~~~---~~~- 197 (300)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+. ...+ |..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999642 2478899999999999999999999999999999999998765 2222 211
Q ss_pred -----------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCC
Q 040812 198 -----------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPP 259 (300)
Q Consensus 198 -----------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (300)
..|.+||... ++..+.++|||||||++|||+| |..||...... +....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~~~~~ 232 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLL---DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVLQHVTAGGRL 232 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHc---cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHHHHHhcCCcc
Confidence 1234444432 4556789999999999999998 99999643321 222222333444
Q ss_pred CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 260 SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 260 ~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+...++.+.++|.+||.. +|++||++.++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~-~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 QKPENCPDKIYQLMTNCWAQ-DPSERPTFDRIQE 265 (269)
T ss_pred CCcccchHHHHHHHHHHcCC-CcccCCCHHHHHH
Confidence 55667889999999999999 9999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=263.92 Aligned_cols=226 Identities=27% Similarity=0.386 Sum_probs=181.9
Q ss_pred ceeeeeecCCcceEEEEEEEccCC----eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTL----ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++.+.||.|+||.||++++..++ ..||+|.++..... ..+.+|+.+++.++|+||+++++++... +..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEE
Confidence 356788999999999999998766 89999998755432 2446799999999999999999998876 489999
Q ss_pred EeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 132 MEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
|||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||||+||+++.++...+.++
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999999976543 899999999999999999999999999999999999998764322211
Q ss_pred --------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 198 --------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 198 --------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
..|.+||.. .+..++.++|||||||++|+|++ |..||..... ...............+...+.+
T Consensus 160 ~~~~~~~~~~y~~Pe~~---~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T smart00219 160 KKKGGKLPIRWMAPESL---KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYLKKGYRLPKPENCPPE 232 (258)
T ss_pred ccccCCCcccccChHHh---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHhcCCCCCCCCcCCHH
Confidence 223444433 24456789999999999999998 7888865322 2223333334455566678999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.+++.+||.. ||++|||+.++++
T Consensus 233 ~~~~i~~~l~~-~p~~Rpt~~~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAE-DPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHCcC-ChhhCcCHHHHHh
Confidence 99999999999 9999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=266.74 Aligned_cols=228 Identities=21% Similarity=0.325 Sum_probs=168.6
Q ss_pred eeecCCcceEEEEEEEcc--CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQ--TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.||+|+||.||+|.... ....+|+|.+...... ..+.+|+..++.++|+||+++++.+.... ..|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-ceEEEEEeCCC
Confidence 369999999999997543 3457888877543322 12457999999999999999999987654 89999999999
Q ss_pred CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------------
Q 040812 138 GSLEIYVKSRG-----RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------------- 198 (300)
Q Consensus 138 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------------- 198 (300)
|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++...+..++
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999997632 24678889999999999999999999999999999999987654332211
Q ss_pred -------ecccccccccc----CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh-hCCCCCCCCCC
Q 040812 199 -------LYESGEARHRK----HGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC-FREPPSLPECS 265 (300)
Q Consensus 199 -------~~~~~~~~~~~----~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 265 (300)
.|.+||..... .+..++.++|||||||++|||++ |..||................. ....+..+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 24555553321 12345779999999999999999 7888865433221111111111 11122344567
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+..+.+++..|| . ||++|||++++++
T Consensus 240 ~~~~~~~~~~~~-~-dp~~Rpt~~~v~~ 265 (269)
T cd05042 240 SDRWYEVMQFCW-L-DPETRPTAEEVHE 265 (269)
T ss_pred CHHHHHHHHHHh-c-CcccccCHHHHHH
Confidence 888999999998 6 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=261.53 Aligned_cols=242 Identities=27% Similarity=0.370 Sum_probs=187.2
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeC-----
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTK----- 123 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~----- 123 (300)
.+..+.|+...+||+|.||.||+|+.+++++.||+|.+--+.... ...+|+.+|..++|+|++.+++++..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 455678999999999999999999999999999998764333222 33789999999999999999887632
Q ss_pred --CCCcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-
Q 040812 124 --PSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL- 199 (300)
Q Consensus 124 --~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~- 199 (300)
+.+.+|+||++|+. +|..++... .+|+..+++.+++++..||.|+|...|+|||+||+|+||+.++...+.+++.
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 12359999999998 899888765 5899999999999999999999999999999999999999986543333222
Q ss_pred ----------------------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC
Q 040812 200 ----------------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE 257 (300)
Q Consensus 200 ----------------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 257 (300)
|.+||.... ...++++.|||.-||||.||+||.+.|.+..+ ......+...+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG--~r~yg~~iDiWgAgCimaeMwtrspimqgnte-qqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLG--DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-QQQLHLISQLCGSI 248 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhc--ccccCCcchhHhHHHHHHHHHccCccccCChH-HHHHHHHHHHhccC
Confidence 223332221 23568899999999999999999888865543 33333444444333
Q ss_pred CCCCCCCC-------------------------------ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 258 PPSLPECS-------------------------------SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 258 ~~~~~~~~-------------------------------~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.++.+.++ .++..+|+.++|.. ||.+|++++++++|.||..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~-DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL-DPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc-CcccCcchHhhhchhhhhc
Confidence 32222111 35788999999999 9999999999999999953
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=264.15 Aligned_cols=221 Identities=21% Similarity=0.314 Sum_probs=170.5
Q ss_pred eeecCCcceEEEEEEEccCC----------eEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 63 QVLGQGNGGTVFKVRHKQTL----------ALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+.||+|+||.||+|.+..++ ..+++|.+..... ...+.+|+.++++++|+||+++++++.. . ..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-ENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-CcEEE
Confidence 46999999999999998766 4588888765443 3445679999999999999999998876 3 68999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-------CCCccc-------
Q 040812 132 MEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-------EHPCGY------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-------~~~~~~------- 196 (300)
|||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ ...+++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 99999999999998765 789999999999999999999999999999999999998765 122211
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
...|.+||..... ...++.++|||||||++|+|++ |..||...... ....... .....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~-----~~~~~~~~~~~ 231 (259)
T cd05037 159 LSREERVERIPWIAPECIRNG-QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ-----DQHRLPMPDCA 231 (259)
T ss_pred ccccccccCCCccChhhhcCC-CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh-----cCCCCCCCCch
Confidence 1224455543321 1256789999999999999999 58888654322 1111111 11222222347
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+.++|.+||.. +|++|||+.++++
T Consensus 232 ~~~~li~~~l~~-~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTY-DPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhcc-ChhhCCCHHHHHH
Confidence 899999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=265.01 Aligned_cols=228 Identities=20% Similarity=0.301 Sum_probs=169.0
Q ss_pred eeecCCcceEEEEEEEc--cCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.||+|+||.||+|.+. .++..+|+|.++...... .+.+|+.++++++||||+++++++.... ..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-PYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-CcEEEEECCCC
Confidence 36999999999999865 345679999886544321 3456999999999999999999987654 78999999999
Q ss_pred CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 138 GSLEIYVKSRG-----RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 138 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+.+
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999997522 356778889999999999999999999999999999998765432221
Q ss_pred -----eeeccccccccccCC----CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH-hhCCCCCCCCCC
Q 040812 197 -----SCLYESGEARHRKHG----GYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI-CFREPPSLPECS 265 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~----~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 265 (300)
...|.+||......+ ..++.++|||||||++|||++ |..||................ .....+......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 123556665542211 134679999999999999996 999996544332211111111 111112223346
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.+.++|.+|+ . +|++|||+++++.
T Consensus 240 ~~~~~~l~~~c~-~-~P~~Rpt~~~l~~ 265 (269)
T cd05087 240 SDRWYEVMQFCW-L-QPEQRPSAEEVHL 265 (269)
T ss_pred ChHHHHHHHHHh-c-CcccCCCHHHHHH
Confidence 788999999998 7 8999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=267.46 Aligned_cols=233 Identities=25% Similarity=0.376 Sum_probs=180.5
Q ss_pred CcceeeeeecCCcceEEEEEEEc----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCC-CCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHK----QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKP-SGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 128 (300)
..|++.+.||+|+||.||++.+. .+++.+|+|.++..... ..+.+|+.+++.++|+||+++++++... ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999965 34789999998765442 3457799999999999999999987652 2368
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee---------
Q 040812 129 SILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------- 198 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~--------- 198 (300)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++...+++++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999999999997654 58999999999999999999999999999999999999987554333221
Q ss_pred -------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc-----------hHHHHHHHHh
Q 040812 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-----------DFLSLMLAIC 254 (300)
Q Consensus 199 -------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-----------~~~~~~~~~~ 254 (300)
.|.+||... +..++.++|||||||++|||+||..||....... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLR---TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cceeccCCCCCcccccCcHHHc---cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 133343332 3456778999999999999999999986532211 0111111122
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.......+..++.++.+++.+||.. ||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~-~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEA-EPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhcc-ChhhCCCHHHHHH
Confidence 2233344556778999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.14 Aligned_cols=133 Identities=27% Similarity=0.454 Sum_probs=119.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+++|++++.||+|+||.||+|.+..+++.||+|+++..... ..+..|+.++..++|+||+++++++.... ..|+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-NVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-EEEE
Confidence 57899999999999999999999999999999999754322 23456899999999999999999887654 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK 189 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~ 189 (300)
||||+.+++|.+++...+.+++..++.++.||+.||.|||.+||+||||||+|||++.+
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~ 140 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE 140 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC
Confidence 99999999999999887789999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.93 Aligned_cols=236 Identities=25% Similarity=0.414 Sum_probs=193.0
Q ss_pred CCCcce-eeeeecCCcceEEEEEEEccCCeEEEEEEeecCC------CCCCCHHHHHHHHhcCCCceeEeceeeeCCC-C
Q 040812 55 GLSQLE-KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR------GTPPNPQELNILRQTNSPYIVKCHQIFTKPS-G 126 (300)
Q Consensus 55 ~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~ 126 (300)
+.++|- ....||+|+|-+||+|.+..+|..||--.++.+. ....+..|+.+|+.|+|+||++++++|.+.. .
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 344443 3467999999999999999999998865544322 2234567999999999999999999998764 2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCC-CCCCcc--------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEK-MEHPCG-------- 195 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~-~~~~~~-------- 195 (300)
.+-+|+|++..|+|..|+++.++++.+.++.|++||+.||.|||++. |+|||||.+||+|+.+ |..++|
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 47899999999999999999999999999999999999999999985 9999999999999865 333333
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC-CCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS-LPECS 265 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 265 (300)
++.-+++||..+ ..|...+||||||+.|.||+|+..||.+.... .++++.+..+..|. +...-
T Consensus 197 r~s~aksvIGTPEFMAPEmYE----E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~---AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 197 RKSHAKSVIGTPEFMAPEMYE----ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP---AQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred hccccceeccCccccChHHHh----hhcchhhhhhhhhHHHHHHHhccCChhhhCCH---HHHHHHHHcCCCHHHhhccC
Confidence 456678888776 34677999999999999999999999876544 35566666666553 44445
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+++++||.+||.. .++|+|+.|+|+||||..
T Consensus 270 dPevr~fIekCl~~--~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT--KSERLSAKELLKDPFFDE 301 (632)
T ss_pred CHHHHHHHHHHhcC--chhccCHHHHhhChhhcc
Confidence 78999999999976 789999999999999975
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=273.52 Aligned_cols=233 Identities=21% Similarity=0.300 Sum_probs=184.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+.+...+.++||+|.||.|.+|.-.. +..||+|.++.+... ..|..|+++|.+++||||++++++|..++ .+|++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI 613 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMI 613 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHH
Confidence 34567788999999999999999875 689999999865433 45678999999999999999999999876 89999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-----------
Q 040812 132 MEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------- 198 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~----------- 198 (300)
+||+++|+|.+++.... .........|+.||++|++||.+.+++||||.+.|+|++.+...++..++
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999999998763 23445566799999999999999999999999999999998776554432
Q ss_pred ----------eccccccccccCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCCchHHHHHHHH---hhCCCCCCCC
Q 040812 199 ----------LYESGEARHRKHGGYNGFAADIWSFGVTMMELY--MGYYPFLEPGQEPDFLSLMLAI---CFREPPSLPE 263 (300)
Q Consensus 199 ----------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ell--tg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~ 263 (300)
.|+++|+.. -+.++.++|+|+||+++||++ +.+.||....+++...+.-.-. ....-+..|.
T Consensus 694 ~vqgr~vlpiRwmawEsil---lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred eeecceeeeeeehhHHHHH---hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 233444333 345678999999999999996 5899997765543332221111 1112345677
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.++.++.++|.+||.. |-++||+++++..
T Consensus 771 ~cp~~lyelml~Cw~~-es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRR-ESEQRPSFEQLHL 799 (807)
T ss_pred cCcHHHHHHHHHHhch-hhhcCCCHHHHHH
Confidence 8899999999999999 9999999999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.68 Aligned_cols=236 Identities=28% Similarity=0.432 Sum_probs=181.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeC---------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTK--------- 123 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~--------- 123 (300)
+.+|+.++.||+||||.||+++++-+|+.||||.+....... ...+|+..+.+++|||||+++..|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456788899999999999999999999999999987654222 23579999999999999998763200
Q ss_pred ----------------------------------------------C---------------------------------
Q 040812 124 ----------------------------------------------P--------------------------------- 124 (300)
Q Consensus 124 ----------------------------------------------~--------------------------------- 124 (300)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ----------------------C--------CcEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHhHhCC
Q 040812 125 ----------------------S--------GEVSILMEYMDAGSLEIYVKSRGRL-SEDIICTISRQVLKGLFYMHSRN 173 (300)
Q Consensus 125 ----------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~qi~~~l~~lH~~~ 173 (300)
. -.+||=||||+..+|.+++.++... ....++.++++|+.||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1268899999997777777665433 47889999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCcc-------------------------------------ceeeccccccccccCCCCCCc
Q 040812 174 IVHRDIKPANVLINEKMEHPCG-------------------------------------YSCLYESGEARHRKHGGYNGF 216 (300)
Q Consensus 174 i~H~Dlkp~Nill~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~~~ 216 (300)
|+||||||.||+++++...++| ++.+|.+||.........|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999976544333 356677777776655556888
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC---CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS---LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 217 ~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
|+||||||||++||+ .||.- ..+...++.....+..|. +....-+.-+.+|.+|++. ||++||||.|+|+
T Consensus 798 KiDmYSLGIVlFEM~---yPF~T---sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~h-dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEML---YPFGT---SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSH-DPSKRPTATELLN 870 (1351)
T ss_pred hhhhHHHHHHHHHHh---ccCCc---hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcC-CCccCCCHHHHhh
Confidence 999999999999999 45742 333344444433222222 2333445678999999999 9999999999999
Q ss_pred CCCCC
Q 040812 294 HPFLA 298 (300)
Q Consensus 294 hpw~~ 298 (300)
+.||-
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99985
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.12 Aligned_cols=230 Identities=23% Similarity=0.311 Sum_probs=178.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCe----EEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLA----LYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|+..+.||+|+||.||+|.+..++. .+|+|.+....... .+.+|+.+++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--C
Confidence 34678899999999999999999987765 46888876543321 345789999999999999999988653 5
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------
Q 040812 128 VSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------- 198 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------- 198 (300)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++..++.+++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 679999999999999987643 58999999999999999999999999999999999999876554332221
Q ss_pred -------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 199 -------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
.|.+||.. .+..++.++|||||||++|||+| |..||..... . ..............+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~---~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~---~~~~~~~~~~~~~~~~~ 235 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECI---HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-R---EIPDLLEKGERLPQPPI 235 (303)
T ss_pred ccccccCCCccccccCCHHHh---ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-H---HHHHHHHCCCCCCCCCC
Confidence 23333332 24556779999999999999997 8999965322 1 11122222333444566
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+..+.+++..||.. +|++||++.++++.
T Consensus 236 ~~~~~~~li~~c~~~-~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMI-DADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 788999999999999 99999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=275.10 Aligned_cols=229 Identities=20% Similarity=0.299 Sum_probs=190.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
...+...-.+||-|.||.||.|.|++..-.||||.++.+... ..|+.|+.+|+.++|||+|+++|+|..+. .+|||.|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-PFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-PFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-CeEEEEe
Confidence 344566778999999999999999999999999999876543 56788999999999999999999999876 8999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------
Q 040812 134 YMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------- 198 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------- 198 (300)
||..|+|.+|++... .++....+.++.||.+|+.||..+++|||||..+|+|+.++...++.+++
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999999999998754 47777888999999999999999999999999999999988655433222
Q ss_pred -------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 199 -------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 199 -------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.|.+||.... +.++.|+|||+|||+|||+.| |..||.+.+- -+++.-...+....-|+.+++.+.
T Consensus 424 AGAKFPIKWTAPEsLAy---NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqVY~LLEkgyRM~~PeGCPpkVY 496 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAY---NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYGLLEKGYRMDGPEGCPPKVY 496 (1157)
T ss_pred cCccCcccccCcccccc---cccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHhccccccCCCCCCHHHH
Confidence 2455555442 346779999999999999987 8999965432 223333345677788999999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHh
Q 040812 271 DFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l 292 (300)
+||..||+. +|++||++.|+-
T Consensus 497 eLMraCW~W-sPsDRPsFaeiH 517 (1157)
T KOG4278|consen 497 ELMRACWNW-SPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHhcC-CcccCccHHHHH
Confidence 999999999 999999999874
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=258.86 Aligned_cols=228 Identities=28% Similarity=0.401 Sum_probs=174.9
Q ss_pred cceeeeeecCCcceEEEEEEEcc-CCeEEEEEEeecCCCCC------------CCHHHHHHHHh-cCCCceeEeceeeeC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQ-TLALYALKVMQCDRGTP------------PNPQELNILRQ-TNSPYIVKCHQIFTK 123 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~------------~~~~E~~~l~~-l~h~niv~~~~~~~~ 123 (300)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+....... ...+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 78899999886432111 12457777764 799999999999877
Q ss_pred CCCcEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccce-
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGYS- 197 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~~- 197 (300)
.. ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++...+..+
T Consensus 81 ~~-~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 ND-RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CC-eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 54 89999999999999988743 3468999999999999999999996 78999999999999988765433222
Q ss_pred -----------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC
Q 040812 198 -----------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS 260 (300)
Q Consensus 198 -----------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (300)
..|.+||... ++.++.++||||||+++|+|++|+.||...... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~ 232 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVK---NEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----SLATKIVEAVYEP 232 (269)
T ss_pred ceeecccccccccccCcccCcChhhhc---CCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----HHHHHHhhccCCc
Confidence 2234444432 445678999999999999999999999643221 2222222222222
Q ss_pred C-CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 261 L-PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 261 ~-~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
. ....++.+.++|.+||+. ||++||++.|+..+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~-~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTP-DAEARPDIIQVSAM 266 (269)
T ss_pred CCcccCCHHHHHHHHHHCCC-CCccCCCHHHHHHH
Confidence 2 235788999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=259.32 Aligned_cols=222 Identities=19% Similarity=0.299 Sum_probs=166.9
Q ss_pred eeecCCcceEEEEEEEcc------------CCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 63 QVLGQGNGGTVFKVRHKQ------------TLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
+.||+|+||.||+|.... ....+++|++...... ..+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~-~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV-EN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-CC
Confidence 368999999999998542 2336888987543322 13456889999999999999999987654 78
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC----------Ccc--
Q 040812 129 SILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH----------PCG-- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~----------~~~-- 195 (300)
++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.. ++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 999999999999998875 3568999999999999999999999999999999999999765421 111
Q ss_pred ----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 196 ----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
++..|.+||... .+..++.++|||||||++|||+ +|..||...... ..... . .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~----~-~~~~~~~~~ 231 (262)
T cd05077 160 ITVLSRQECVERIPWIAPECVE--DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-EKERF----Y-EGQCMLVTP 231 (262)
T ss_pred ccccCcccccccccccChhhhc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-HHHHH----H-hcCccCCCC
Confidence 122355565432 1345677999999999999997 588888643221 11111 1 111122233
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.++++.++|.+||+. ||++||++.+++++
T Consensus 232 ~~~~~~~li~~cl~~-dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNY-DPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCC-ChhhCcCHHHHHHh
Confidence 467899999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=256.05 Aligned_cols=242 Identities=27% Similarity=0.438 Sum_probs=198.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
.++.+|.++++||+|+|++|-+++.++|.+.||+|+++++-..+ ...-|-.+..+. +||.+|-++.+|..+. .
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes-r 325 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES-R 325 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-e
Confidence 46789999999999999999999999999999999998654332 224466666554 7999999999999876 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC--------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP-------------- 193 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~-------------- 193 (300)
+++|.||++||+|.-.+++.+++++..++.+...|..||.|||++||+.||||.+|+|++..+..+
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999999999999998898888999999999999999999999999999999999999999876542
Q ss_pred -----ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 194 -----CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLE---PGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 194 -----~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
+.++..|.+||... |..|+.++|+|+|||+|+||+.|+.||.- .+.+.+....+.++.......+|...
T Consensus 406 d~tstfcgtpnyiapeilr---geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILR---GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred cccccccCCCcccchhhhc---ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 22345566666654 77899999999999999999999999952 22233333333444445556667777
Q ss_pred ChHHHHHHHHHhccCCCCCCCC------HHHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWT------ASQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt------~~~~l~hpw~~~~ 300 (300)
+-....+++..|.+ ||.+|.. ..++..|+||+.+
T Consensus 483 svkas~vlkgflnk-dp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 483 SVKASHVLKGFLNK-DPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred ehhhHHHHHHhhcC-CcHHhcCCCcccchhhhhcchhhhhC
Confidence 77888899999999 9999974 7899999999853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=271.55 Aligned_cols=240 Identities=25% Similarity=0.358 Sum_probs=193.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---------CCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---------PNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
++|-++..||+|||+.||+|.+....++||+|+...+.... ...+|..+.+.+.||.||++|++|.-+...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45778899999999999999999999999999976543322 235799999999999999999999877778
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC--CccccCCCCCceeecCCCCC-------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR--NIVHRDIKPANVLINEKMEH------------- 192 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~--~i~H~Dlkp~Nill~~~~~~------------- 192 (300)
+|.|+|||+|.+|.-|++....+++.+++.|+.||+.||.||.+. -|+|-||||.|||+.....+
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999998999999999999999999999976 49999999999999654221
Q ss_pred ----------------CccceeeccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh
Q 040812 193 ----------------PCGYSCLYESGEARHRKH-GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF 255 (300)
Q Consensus 193 ----------------~~~~~~~~~~~~~~~~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 255 (300)
...++..|.+||...... ....+.++||||+|||+|..+.|+.||.......++++.-. +..
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT-Ilk 701 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT-ILK 701 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc-hhc
Confidence 223455566777655431 22356799999999999999999999987655444433221 222
Q ss_pred CCCCCCC--CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 256 REPPSLP--ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 256 ~~~~~~~--~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.....+| ..++.+.++||.+||.+ --++|..+.++.+||||.
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaY-RKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAY-RKEDRIDVQQLACDPYLL 745 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHh-hhhhhhhHHHHccCcccc
Confidence 2222233 24788999999999999 889999999999999984
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=280.74 Aligned_cols=233 Identities=21% Similarity=0.311 Sum_probs=193.8
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEcc---CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
+...++..+.++||+|.||.|++|.|.. +...||||+++.+... ++|++|+.+|.+|+|+|++++||+..+ .
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q- 183 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q- 183 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c-
Confidence 3455667888999999999999999974 3357999999876544 567899999999999999999999876 3
Q ss_pred cEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-----
Q 040812 127 EVSILMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL----- 199 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~----- 199 (300)
...+|||+++.|+|.+.+.+ ...|.......++.||+.|+.||..+++|||||..+|+|+......+++++++
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 68899999999999999987 34588899999999999999999999999999999999998766555544443
Q ss_pred -----------------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 200 -----------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 200 -----------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
|.+||+.. ...++.++|||+|||++|||+| |+.||.+... ..+++.+..+.....
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLr---h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLR---HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKNIDAGERLPR 336 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhc---cccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHhccccccCCC
Confidence 44444443 4456779999999999999998 8999976443 355555666777888
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hp 295 (300)
|..+++++.+++..||.. +|.+|||+..|...-
T Consensus 337 Pk~csedIY~imk~cWah-~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAH-NPADRPTFSAIREDL 369 (1039)
T ss_pred CCCChHHHHHHHHHhccC-CccccccHHHHHHhH
Confidence 999999999999999999 999999999986443
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=260.81 Aligned_cols=228 Identities=20% Similarity=0.324 Sum_probs=173.6
Q ss_pred ceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC--C---
Q 040812 59 LEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS--G--- 126 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~--~--- 126 (300)
|.+.+.||+|+||.||+|.+. .+++.||+|++..+.... .+.+|+.++++++||||+++++++.... +
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999865 357899999987543322 2457999999999999999999875432 1
Q ss_pred cEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-
Q 040812 127 EVSILMEYMDAGSLEIYVKSR------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL- 199 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~- 199 (300)
..+++++|+.+|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++...+.+++.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247899999999999887532 2478899999999999999999999999999999999998776544333221
Q ss_pred --------------------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 200 --------------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 200 --------------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
|.+||. ..+..++.++|||||||++|+|++ |..||..... .+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~---~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~ 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALES---LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIKGNR 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhH---HhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHcCCc
Confidence 112222 123445678999999999999999 8899864432 122222223333
Q ss_pred CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 259 ~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
...+...++.+.+++.+||.. +|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~l~~~~l~~-~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 LKQPPDCLEDVYELMCQCWSP-EPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 444556788999999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=258.71 Aligned_cols=228 Identities=19% Similarity=0.288 Sum_probs=166.2
Q ss_pred eeecCCcceEEEEEEEccC--CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQT--LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.||+|+||.||++....+ ...+++|.+...... ..+.+|+.+++.++||||+++++.+.... ..|+||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-PYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-ccEEEEecCCC
Confidence 3599999999999976433 345667776543322 23467889999999999999999988754 89999999999
Q ss_pred CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------------
Q 040812 138 GSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------------- 197 (300)
Q Consensus 138 ~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------------- 197 (300)
|+|.+++... ..+++..++.++.||+.||.|||+++++||||||+|||++.++...+.++
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 9999999753 24677788899999999999999999999999999999987654432221
Q ss_pred -----eeccccccccccC----CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh-hCCCCCCCCCCC
Q 040812 198 -----CLYESGEARHRKH----GGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC-FREPPSLPECSS 266 (300)
Q Consensus 198 -----~~~~~~~~~~~~~----~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 266 (300)
..|.+||...... ...++.++|||||||++|||++ |..||................. ....+..+...+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 2345565543211 1234678999999999999997 5778854333221211111111 111233445578
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.+.+++..|| . +|++||+++++++
T Consensus 240 ~~~~~l~~~c~-~-~P~~Rp~~~~i~~ 264 (268)
T cd05086 240 ERWYEVLQFCW-L-SPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHHh-h-CcccCCCHHHHHH
Confidence 89999999999 6 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=245.46 Aligned_cols=238 Identities=23% Similarity=0.369 Sum_probs=184.9
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC-CCceeEeceeeeCCC-CcEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN-SPYIVKCHQIFTKPS-GEVSIL 131 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~~lv 131 (300)
...++|++.+++|+|-|+.||.|....+++.++||+++.-.. ....+|+.+|+.+. ||||+.++++..++. ....++
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 367889999999999999999999999999999999975432 34578999999997 999999999987653 347899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC----Cccceee--------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH----PCGYSCL-------- 199 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~----~~~~~~~-------- 199 (300)
+||+++.+...+.. .++...++.++.+++.||.|+|+.||+|||+||.|++|+..... +-|..-.
T Consensus 114 FE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 99999877776654 58889999999999999999999999999999999999865321 1222222
Q ss_pred -------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----------------
Q 040812 200 -------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF----------------- 255 (300)
Q Consensus 200 -------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------- 255 (300)
+..||..-. -..+.++.|+|||||++..|+..+-||+...+..+.+.-+..+..
T Consensus 191 VRVASRyfKGPELLVd--y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeehhhcCCchheee--chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 233333322 134678999999999999999999999876655444332222110
Q ss_pred -------CC---------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 256 -------RE---------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 256 -------~~---------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.. ...-....++++.||+.++|.. |-.+|+|+.|++.||||.
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrY-DHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRY-DHQERLTAKEAMAHPYFA 326 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhh-ccccccchHHHhcCchHH
Confidence 00 1111223468999999999999 999999999999999995
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=259.01 Aligned_cols=132 Identities=29% Similarity=0.403 Sum_probs=112.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcC-----C---CceeEeceeeeCC-
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTN-----S---PYIVKCHQIFTKP- 124 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~- 124 (300)
.-++|.+.++||=|-|++||+|.+..+.+.||+|+.+.... ......||.+|++++ | ..||+|++.|...
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 44789999999999999999999999999999999986443 344578999999983 3 3699999998643
Q ss_pred --CCcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeec
Q 040812 125 --SGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLIN 187 (300)
Q Consensus 125 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~ 187 (300)
..++|||+|++ |.+|-.++... +.++...++.|++||+.||.|||. .||+|.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 23699999999 55888888753 359999999999999999999995 6999999999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.14 Aligned_cols=230 Identities=26% Similarity=0.376 Sum_probs=194.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC---eEEEEEEeecCC---CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTL---ALYALKVMQCDR---GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+...+.++||.|.||.|++|+.+..+ ..||||.++... ....|+.|+.||-++.||||++|.|+....+ .++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-PvM 706 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-PVM 706 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-eeE
Confidence 345678899999999999999988655 479999998643 3456788999999999999999999988765 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee---------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL--------- 199 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~--------- 199 (300)
||.|||++|+|..+++. .+.|+.-+..-+++.|++|++||-+.|++||||.++|||++.+..+++.++++
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999999986 46799999999999999999999999999999999999999887665544433
Q ss_pred -------------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 200 -------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 200 -------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
|.+||+... ..++.+|||||+|++|||.++ |+.||.+..+. ..++.+..+.....|-.+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~---RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----dVIkaIe~gyRLPpPmDC 859 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVIKAIEQGYRLPPPMDC 859 (996)
T ss_pred ccccccCCccceeecChhHhhh---cccCchhhccccceEEEEecccCCCcccccchH----HHHHHHHhccCCCCCCCC
Confidence 344444331 235679999999999999986 99999876543 556666677778888889
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+..+.+||..||++ |-.+||.+.+|+.+
T Consensus 860 P~aL~qLMldCWqk-dR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQK-DRNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHH-HhhcCCCHHHHHHH
Confidence 99999999999999 99999999998753
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=257.70 Aligned_cols=230 Identities=17% Similarity=0.163 Sum_probs=166.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCCCC-------------CHHHHHHHHhcCCCceeEecee
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGTPP-------------NPQELNILRQTNSPYIVKCHQI 120 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~-------------~~~E~~~l~~l~h~niv~~~~~ 120 (300)
++|++.+.||+|+||.||+|.+..+ +..+|+|+......... ...+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999999877 67788886543221110 0112334556789999999987
Q ss_pred eeCCCC---cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce
Q 040812 121 FTKPSG---EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS 197 (300)
Q Consensus 121 ~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~ 197 (300)
...... ..+++++++.. ++.+.+......++..++.++.|++.||.|||+++|+||||||+|||++.++...+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 654332 35788888854 77777766555788999999999999999999999999999999999987654422221
Q ss_pred --------------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH-
Q 040812 198 --------------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM- 250 (300)
Q Consensus 198 --------------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~- 250 (300)
..|.+|+. ..+..++.++|||||||++|||+||..||.............
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~---~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDA---HNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHH---hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 22333332 224557889999999999999999999997664433322211
Q ss_pred ----HHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 251 ----LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 251 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+. ... ......++.+.++++.|+.. +|++||+++++++
T Consensus 248 ~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~-~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 CDFIKRLH-EGK-IKIKNANKFIYDFIECVTKL-SYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhh-hhh-hccCCCCHHHHHHHHHHHhC-CCCCCCCHHHHHH
Confidence 1111 111 12334678899999999999 9999999999875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=277.17 Aligned_cols=225 Identities=28% Similarity=0.384 Sum_probs=169.5
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC---CHHHHHHHHhcCCCceeEeceeeeCCC-----CcEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP---NPQELNILRQTNSPYIVKCHQIFTKPS-----GEVSI 130 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~~l 130 (300)
+..-+.||+|+||.||+++++++|+.||||.++....... ..+|+++|++++|+|||+++++-++.. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556779999999999999999999999999987543332 256999999999999999999744322 13579
Q ss_pred EEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-------CCc------
Q 040812 131 LMEYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-------HPC------ 194 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-------~~~------ 194 (300)
|||||.||+|...+++.. .+++.+.+.++..+..||.|||++||+||||||+||++..... +++
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999999998643 4999999999999999999999999999999999999865431 111
Q ss_pred ---------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC--------
Q 040812 195 ---------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-------- 257 (300)
Q Consensus 195 ---------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------- 257 (300)
.++.-|-.|+..+. .++++..+|.|||||++|+++||..||..........+++..+..+.
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~--q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYER--QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhh--ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 22333455555443 35788899999999999999999999976544433333333322111
Q ss_pred ------------CCCCCCCCCh----HHHHHHHHHhccCCCCCCC
Q 040812 258 ------------PPSLPECSSE----KFRDFIRCCLQKGDPSKRW 286 (300)
Q Consensus 258 ------------~~~~~~~~~~----~l~~li~~~l~~~dp~~Rp 286 (300)
..++|...+. .+-.|+..+|.. +|.+|.
T Consensus 253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~-~~~~~~ 296 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEW-NPRKRG 296 (732)
T ss_pred ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhh-hHHHhC
Confidence 1112333333 356788889988 999998
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.06 Aligned_cols=242 Identities=32% Similarity=0.516 Sum_probs=199.3
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC-HHHHHHHHhc-CCCceeEeceeeeCC----CC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQT-NSPYIVKCHQIFTKP----SG 126 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 126 (300)
-+..+.|++.+.||.|.||.||+++.+++++.+|+|+...+...+.. ..|.++++.+ .|||++.++++|... .+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34566789999999999999999999999999999998766554433 4578888877 589999999987422 24
Q ss_pred cEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC------------
Q 040812 127 EVSILMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH------------ 192 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~------------ 192 (300)
.+|||||||.||+..++++. ..++.+..+..|++.++.|+.+||...++|||||-.|||++.++..
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 69999999999999999985 4579999999999999999999999999999999999999987653
Q ss_pred -------Cccceeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC--
Q 040812 193 -------PCGYSCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-- 261 (300)
Q Consensus 193 -------~~~~~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 261 (300)
.+-++..|++||+.... ....|+..+|+||||++..||..|.+|+.+... +..+-.+..+.++.+
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----mraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIPRNPPPKLKR 250 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----hhhhccCCCCCCccccc
Confidence 23457778999875432 234566789999999999999999999965433 233333444445543
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|..+++++.+||..||.+ |.++||+..++|+|||+.+
T Consensus 251 p~kWs~~FndFIs~cL~K-d~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVK-DYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhhHHHHHHHHHHHHHhh-ccccCcchhhhccCCcccc
Confidence 678899999999999999 9999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=270.26 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=198.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC-----HHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++++++..||-|+||.|-+++.+.....+|+|++++.+..+.- ..|-++|...+.|.||++|..|.++. ++|
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-yvY 496 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-YVY 496 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-hhh
Confidence 467788899999999999999998876667999999876654332 45889999999999999999998865 999
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---c-----------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---G----------- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---~----------- 195 (300)
++||-|-||.|++.+.+++.|+...++.++..++.|+.|||++||++|||||+|++++.++..++ |
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 99999999999999999999999999999999999999999999999999999999999876532 2
Q ss_pred ----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 196 ----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 196 ----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
++.-|-+||... ...-..++|.||||+++|||+||.+||...++...+..++..+ ....+|..++....+
T Consensus 577 wTFcGTpEYVAPEIIL---nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi---d~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIIL---NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI---DKIEFPRRITKTATD 650 (732)
T ss_pred eeecCCcccccchhhh---ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh---hhhhcccccchhHHH
Confidence 234455555543 2334568999999999999999999998877655544444332 234567788899999
Q ss_pred HHHHHhccCCCCCCCC-----HHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
+|.+++.. +|.+|.. +.+|.+|.||.+
T Consensus 651 Lik~LCr~-~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 651 LIKKLCRD-NPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHHhc-CcHhhhccccCChHHHHhhhhhhc
Confidence 99999999 9999986 899999999975
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=295.88 Aligned_cols=227 Identities=20% Similarity=0.269 Sum_probs=174.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
.+...+.||+|+||.||+|++..+++.||+|.+.... .....|+..+++++||||+++++++..+. ..|+||||+++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN--SIPSSEIADMGKLQHPNIVKLIGLCRSEK-GAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc--cccHHHHHHHhhCCCCCcceEEEEEEcCC-CCEEEEeCCCC
Confidence 3556678999999999999999889999999886432 23356899999999999999999998765 78999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH---hCCccccCCCCCceeecCCCCCCc--------------cceeec
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH---SRNIVHRDIKPANVLINEKMEHPC--------------GYSCLY 200 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~i~H~Dlkp~Nill~~~~~~~~--------------~~~~~~ 200 (300)
|+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+||+++.+....+ .++..|
T Consensus 768 g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~~y 844 (968)
T PLN00113 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAY 844 (968)
T ss_pred CcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCccccccc
Confidence 99999996 4889999999999999999999 669999999999999987654321 112567
Q ss_pred cccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHHHHhhC------CCCCC------CCCCCh
Q 040812 201 ESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-PDFLSLMLAICFR------EPPSL------PECSSE 267 (300)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~------~~~~~------~~~~~~ 267 (300)
.+||... +..++.++|||||||++|||+||+.||...... ............. ..+.. +.....
T Consensus 845 ~aPE~~~---~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (968)
T PLN00113 845 VAPETRE---TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921 (968)
T ss_pred cCccccc---CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence 8888654 556788999999999999999999999543211 1111111110000 00111 111123
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
++.+++.+||+. ||++|||+.|+++.
T Consensus 922 ~~~~l~~~Cl~~-~P~~RPt~~evl~~ 947 (968)
T PLN00113 922 EVMNLALHCTAT-DPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHhhCcC-CchhCcCHHHHHHH
Confidence 577899999999 99999999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=277.53 Aligned_cols=237 Identities=21% Similarity=0.218 Sum_probs=156.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC----CeEEEEEEeecCCCCCCCHHHHHHHHhc---CCCceeEeceeee-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT----LALYALKVMQCDRGTPPNPQELNILRQT---NSPYIVKCHQIFT----- 122 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~----- 122 (300)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .|..+..++ .+.++..++..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNERVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHHHHHhhchhhHHHHHHhhhccccc
Confidence 567899999999999999999999988 89999998753221 233333332 2333333222211
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCC
Q 040812 123 KPSGEVSILMEYMDAGSLEIYVKSRGR--------------------LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPA 182 (300)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~ 182 (300)
......++||||+.+++|.+++..... .....+..++.||+.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 223479999999999999999875421 123456789999999999999999999999999
Q ss_pred ceeecCC-CCCC---ccc-----------------eeeccccccccccCC-------------------CCCCchhhHHH
Q 040812 183 NVLINEK-MEHP---CGY-----------------SCLYESGEARHRKHG-------------------GYNGFAADIWS 222 (300)
Q Consensus 183 Nill~~~-~~~~---~~~-----------------~~~~~~~~~~~~~~~-------------------~~~~~~~DiwS 222 (300)
|||++.+ +..+ +|. +..|.+||....... ..++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 9999853 3322 222 224566664321111 11334679999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCchHHHHHHH-----------HhhCCCC------CCCCCCChHHHHHHHHHhccCCCCCC
Q 040812 223 FGVTMMELYMGYYPFLEPGQEPDFLSLMLA-----------ICFREPP------SLPECSSEKFRDFIRCCLQKGDPSKR 285 (300)
Q Consensus 223 lG~il~elltg~~pf~~~~~~~~~~~~~~~-----------~~~~~~~------~~~~~~~~~l~~li~~~l~~~dp~~R 285 (300)
|||++|||+++..++... ...+...+.. ....... ...+.......+||.+||+. ||++|
T Consensus 365 lGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~-dP~kR 441 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF-KGRQR 441 (566)
T ss_pred HHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC-CcccC
Confidence 999999999977665321 1111111100 0000000 01111233456899999999 99999
Q ss_pred CCHHHHhcCCCCCC
Q 040812 286 WTASQLLSHPFLAD 299 (300)
Q Consensus 286 pt~~~~l~hpw~~~ 299 (300)
||+.++|+||||++
T Consensus 442 ~ta~e~L~Hpff~~ 455 (566)
T PLN03225 442 ISAKAALAHPYFDR 455 (566)
T ss_pred CCHHHHhCCcCcCC
Confidence 99999999999975
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=265.29 Aligned_cols=223 Identities=24% Similarity=0.324 Sum_probs=183.2
Q ss_pred eeeeeecCCcceEEEEEEEccC----CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQT----LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+.++||.|.||.||.|....- .--||||..+.+... ..|..|..+|+++.||||++++|++... ..||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~--P~Wivm 469 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--PMWIVM 469 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc--ceeEEE
Confidence 4468899999999999986532 235899998775433 3457899999999999999999998753 699999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee------------
Q 040812 133 EYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL------------ 199 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~------------ 199 (300)
|+++-|.|..|++.+. .++......++.||+.||.|||++.++||||..+|||+.+..-.+.+++++
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 9999999999998754 589999999999999999999999999999999999998765444443333
Q ss_pred --------ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 200 --------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 200 --------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
|++||..... .++.+||||-|||.|||++. |..||.+-.+.. .+..+-.+.....|.++++.+.
T Consensus 550 S~~kLPIKWmaPESINfR---rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----VI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFR---RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----VIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred cccccceeecCccccchh---cccchhhHHHHHHHHHHHHHhcCCccccccccc----eEEEecCCCCCCCCCCCChHHH
Confidence 5566655432 35679999999999999975 999998765542 2333455778888999999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHh
Q 040812 271 DFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l 292 (300)
.++.+||.+ ||.+||++.++.
T Consensus 623 slmskcWay-eP~kRPrftei~ 643 (974)
T KOG4257|consen 623 SLMSKCWAY-EPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHhcc-CcccCCcHHHHH
Confidence 999999999 999999988764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=267.10 Aligned_cols=235 Identities=24% Similarity=0.303 Sum_probs=187.2
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
|..++.||-|+||.|.+++..+|...||+|.+.+..... ....|-.||.....+=||+|+..|.+.. .+|+|||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFVMd 709 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVMD 709 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEEEe
Confidence 667899999999999999999999999999987543222 2245889999999999999999998865 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee--------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL-------------- 199 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~-------------- 199 (300)
|++||++..+|-+-+.|++..++.++..+..|+++.|..|+|||||||+|||||.++..++.++++
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 999999999999989999999999999999999999999999999999999999987764443333
Q ss_pred -----------------------------------------------ccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 040812 200 -----------------------------------------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYM 232 (300)
Q Consensus 200 -----------------------------------------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt 232 (300)
|.+||... ...++..+|+||.|||||||+.
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~---r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA---RTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc---ccCccccchhhHhhHHHHHHhh
Confidence 22222222 1224568999999999999999
Q ss_pred CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCCC
Q 040812 233 GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLADA 300 (300)
Q Consensus 233 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt---~~~~l~hpw~~~~ 300 (300)
|++||...........+++- ..........+++.+..++|.+++. ++++|.. ++++..||||+.+
T Consensus 867 g~~pf~~~tp~~tq~kv~nw-~~~l~~~~~~~ls~e~~~li~kLc~--sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINW-RNFLHIPYQGNLSKEALDLIQKLCC--SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeeh-hhccccccccccCHHHHHHHHHHhc--ChhhhhcccchhhhhcCcccccc
Confidence 99999776554433332211 1112223345789999999998875 6888884 7789999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=263.33 Aligned_cols=244 Identities=22% Similarity=0.196 Sum_probs=169.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc----------------cCCeEEEEEEeecCCC----------------CCCCHHH
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK----------------QTLALYALKVMQCDRG----------------TPPNPQE 102 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~----------------~~~~~~E 102 (300)
..++|++.++||+|+||.||+|... ..++.||||.+..... ......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 2356899999864321 1122457
Q ss_pred HHHHHhcCCCce-----eEeceeeeCC-------CCcEEEEEeccCCCCHHHHHHhCC----------------------
Q 040812 103 LNILRQTNSPYI-----VKCHQIFTKP-------SGEVSILMEYMDAGSLEIYVKSRG---------------------- 148 (300)
Q Consensus 103 ~~~l~~l~h~ni-----v~~~~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~---------------------- 148 (300)
+.++.+++|.++ +++++++... .+..|+||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 5667766431 246899999999999999886321
Q ss_pred --CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------------eeeccccccc
Q 040812 149 --RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------------SCLYESGEAR 206 (300)
Q Consensus 149 --~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------------~~~~~~~~~~ 206 (300)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++...+.+ +..|.+||..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 235677889999999999999999999999999999998765432221 2346666654
Q ss_pred cccCCC-------------------CCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCchHHH----HH----HHHhhCCC
Q 040812 207 HRKHGG-------------------YNGFAADIWSFGVTMMELYMGYY-PFLEPGQEPDFLS----LM----LAICFREP 258 (300)
Q Consensus 207 ~~~~~~-------------------~~~~~~DiwSlG~il~elltg~~-pf~~~~~~~~~~~----~~----~~~~~~~~ 258 (300)
...... ....+.||||+||++|+|++|.. ||........... .. ........
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 321100 01125799999999999999976 7743211110000 00 00111122
Q ss_pred CCCCCCCChHHHHHHHHHhccCCC---CCCCCHHHHhcCCCCCC
Q 040812 259 PSLPECSSEKFRDFIRCCLQKGDP---SKRWTASQLLSHPFLAD 299 (300)
Q Consensus 259 ~~~~~~~~~~l~~li~~~l~~~dp---~~Rpt~~~~l~hpw~~~ 299 (300)
....+..++..+||+.+||.. +| .+|+|++|+|+||||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~-~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITK-RDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhcc-CCCCcccCCCHHHHhCCCCcCC
Confidence 233456788999999999997 55 78999999999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=244.80 Aligned_cols=236 Identities=28% Similarity=0.426 Sum_probs=184.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHh-cCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQ-TNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++.+-+..||.|+||+|++..++.+|+..|||.++...... .++.|.....+ -+.||||+++|..-.+ |..|+.
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-GdcWiC 141 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-GDCWIC 141 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-Cceeee
Confidence 345677889999999999999999999999999998765432 22446655444 4679999999987664 589999
Q ss_pred EeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccc---------
Q 040812 132 MEYMDAGSLEIYVK-----SRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
||+|.- +|..+-+ +..++++..+-.|.-..+.||.||-+ ..|+|||+||+|||++..+..+.-.
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 999965 7765543 34579999999999999999999975 5899999999999999887653221
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC--C--
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP--E-- 263 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~-- 263 (300)
..-|++||-..... ..|..+|||||||++|||+.||..||...+. .++.+.++..+.++.+- .
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~-~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSD-KGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKEC 296 (361)
T ss_pred HHHhhhccCCccccChhccCCcc-CCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcccc
Confidence 23366666554332 3467799999999999999999999976543 34455555666666542 2
Q ss_pred -CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 264 -CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 264 -~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
..+..+..||..||.+ |.+.||...+++++||.+
T Consensus 297 ~~~s~~~~~fintCl~K-d~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIK-DRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred cccCHHHHHHHHHHhhc-ccccCcchhhhhcCchhh
Confidence 3678899999999999 999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=239.85 Aligned_cols=220 Identities=37% Similarity=0.554 Sum_probs=175.6
Q ss_pred cceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCHHHHHH
Q 040812 69 NGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVK 145 (300)
Q Consensus 69 ~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 145 (300)
+||.||+|.+..+++.+|+|++..... ...+.+|+..+++++|+|++++++.+.... ..++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-KLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-EEEEEEeCCCCCCHHHHHH
Confidence 589999999999899999999876544 235578999999999999999999987654 8999999999999999998
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------eeecccccccc
Q 040812 146 SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------SCLYESGEARH 207 (300)
Q Consensus 146 ~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------~~~~~~~~~~~ 207 (300)
....++...+..++.+++.++.+||+.+++|+||+|+||+++.++...+.+ ...|.+||...
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence 766689999999999999999999999999999999999999875443222 11233444332
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC---CChHHHHHHHHHhccCCCCC
Q 040812 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC---SSEKFRDFIRCCLQKGDPSK 284 (300)
Q Consensus 208 ~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~dp~~ 284 (300)
+...+.++||||||+++|+|++|..||........... ... ......... .+.++.+++.+||.. +|++
T Consensus 160 ---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~-~p~~ 231 (244)
T smart00220 160 ---GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK---KIG-KPKPPFPPPEWKISPEAKDLIRKLLVK-DPEK 231 (244)
T ss_pred ---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHh-ccCCCCccccccCCHHHHHHHHHHccC-Cchh
Confidence 44567799999999999999999999965332222222 111 222222221 788999999999999 9999
Q ss_pred CCCHHHHhcCCCC
Q 040812 285 RWTASQLLSHPFL 297 (300)
Q Consensus 285 Rpt~~~~l~hpw~ 297 (300)
||++.++++||||
T Consensus 232 Rp~~~~~~~~~~~ 244 (244)
T smart00220 232 RLTAEEALQHPFF 244 (244)
T ss_pred ccCHHHHhhCCCC
Confidence 9999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=260.52 Aligned_cols=236 Identities=28% Similarity=0.430 Sum_probs=185.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCC------CceeEeceeeeCCCCcEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNS------PYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~~~ 129 (300)
++|.+....|+|-|++|..|.+..-|..||||++.++..- ..-+.|+++|++|+. -++++++-.|...+ ++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn-HLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN-HLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc-eeE
Confidence 4688999999999999999999998999999999875533 344789999999963 47899988887755 999
Q ss_pred EEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC----CCccc------
Q 040812 130 ILMEYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME----HPCGY------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~----~~~~~------ 196 (300)
||||.+.- +|.+.++..+ .|....++.++.|+..||..|-..||+|.||||+|||+++... +++|.
T Consensus 511 lVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 511 LVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred EEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence 99999954 9999999755 3888999999999999999999999999999999999987643 23332
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC----------
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP---------- 258 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 258 (300)
+.+|.+||... |-.|++..|+||+||+||||.||+..|.+.... .++.....+-...+
T Consensus 590 neitPYLVSRFYRaPEIiL---G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 590 NEITPYLVSRFYRAPEIIL---GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN-QMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccccHHHHHHhccCcceee---cCcccCCccceeeceeeEEeeccceecCCCCcH-HHHHHHHHhcCCCcHHHhhhcchh
Confidence 23355555544 888999999999999999999999999765443 22222222110000
Q ss_pred -------------------------------C------------CCCCC---CChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 259 -------------------------------P------------SLPEC---SSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 259 -------------------------------~------------~~~~~---~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
| .+|.. .-.++++|+..||.. ||++|.|..++|
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L-dP~KRit~nqAL 744 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL-DPEKRITVNQAL 744 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc-ChhhcCCHHHHh
Confidence 0 01110 124689999999999 999999999999
Q ss_pred cCCCCCC
Q 040812 293 SHPFLAD 299 (300)
Q Consensus 293 ~hpw~~~ 299 (300)
+||||.+
T Consensus 745 ~HpFi~~ 751 (752)
T KOG0670|consen 745 KHPFITE 751 (752)
T ss_pred cCCcccC
Confidence 9999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=236.90 Aligned_cols=235 Identities=26% Similarity=0.351 Sum_probs=181.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCCC-----C
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKPS-----G 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 126 (300)
..+|.-++.+|.|.- .|-.+.+.-.++.||+|....... .+...+|...+..++|+||++++.+|.... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356888899999998 788899988899999998754322 233467999999999999999999987543 2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC-------------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP------------- 193 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~------------- 193 (300)
..|+|||++.. +|.+.+. -.++-..++.|+.|++.|++|||+.||+||||||+||++..+...+
T Consensus 95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 48999999965 9998887 3578889999999999999999999999999999999998664332
Q ss_pred -----ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-----------
Q 040812 194 -----CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE----------- 257 (300)
Q Consensus 194 -----~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------- 257 (300)
.-.+..|.+||+.. |..+...+||||+||++.||++|..-|.+.+....+.+++.......
T Consensus 172 ~~mtpyVvtRyyrapevil---~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cccCchhheeeccCchhee---ccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 22355577777765 44478899999999999999999999975544333322222111000
Q ss_pred ---------------CCCCCC-----------CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 258 ---------------PPSLPE-----------CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 258 ---------------~~~~~~-----------~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
...+|+ .-+..+++++.+||.. ||++|.+++++|+||||+
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi-~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVI-DPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhcc-ChhhcccHHHHhcCCeee
Confidence 000111 1135689999999999 999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=241.28 Aligned_cols=232 Identities=19% Similarity=0.288 Sum_probs=176.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC-HHHHHHHHhcCCCceeEeceeeeCCCC---cEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCHQIFTKPSG---EVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~ 132 (300)
.+.++.+.||+|.||.||+|+|+ |+.||||+|........+ ..|+.....++|+||+.+++.=..+++ .+|||.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 45788999999999999999998 789999999866555444 235555566899999999987433333 499999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC--------CccccCCCCCceeecCCCCCC-----------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR--------NIVHRDIKPANVLINEKMEHP----------- 193 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~i~H~Dlkp~Nill~~~~~~~----------- 193 (300)
+|.+.|+|.+|+.. ..++......++..+++||.|||.. .|.|||||..|||+..++.+-
T Consensus 289 dYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred ecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 99999999999987 4799999999999999999999953 399999999999998876541
Q ss_pred ------------ccceeeccccccccccCC--CCCC-chhhHHHHHHHHHHHHhC----------CCCCCCCCCCchHHH
Q 040812 194 ------------CGYSCLYESGEARHRKHG--GYNG-FAADIWSFGVTMMELYMG----------YYPFLEPGQEPDFLS 248 (300)
Q Consensus 194 ------------~~~~~~~~~~~~~~~~~~--~~~~-~~~DiwSlG~il~elltg----------~~pf~~~~~~~~~~~ 248 (300)
--+++.|++||....... .+.+ ..+||||||.++||++.+ .+||.+.-+.....+
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 135788999998764332 1112 368999999999999863 688876544444444
Q ss_pred HHHHH--hhCCCCCCCCCCC-----hHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 249 LMLAI--CFREPPSLPECSS-----EKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 249 ~~~~~--~~~~~~~~~~~~~-----~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
.+..+ ..+..|..|..+. ..+..+|+.||-. ||..|.|+--+.
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~-Np~aRltALriK 497 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYA-NPAARLTALRIK 497 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcC-CchhhhHHHHHH
Confidence 44432 2334445444332 2477899999999 999999976543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=259.25 Aligned_cols=231 Identities=23% Similarity=0.363 Sum_probs=187.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-------CCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ-------TLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
..++..+.+.||+|.||.|++|.... ....||||.++..... ..+..|+++|+.+ .|+||+.+++++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34445677799999999999997441 1457999998865544 2346799999987 59999999999887
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
.+..++|+||+..|+|..+++..+ .++......++.||+.|++||++..++||||.++|||++
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 568999999999999999998764 388899999999999999999999999999999999999
Q ss_pred CCCCCCccc----------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 188 EKMEHPCGY----------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 188 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
.+...++++ ...|++||+.. ...++.++|||||||+|||++| |..||.+.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~---~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF---DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc---cCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 875443222 22355555554 3567889999999999999998 899996633233
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+. ...+..+.....|..+++++.++|..||.. +|++||++.++.+
T Consensus 530 ~l---~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~-~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 EL---LEFLKEGNRMEQPEHCSDEIYDLMKSCWNA-DPEDRPTFSECVE 574 (609)
T ss_pred HH---HHHHhcCCCCCCCCCCCHHHHHHHHHHhCC-CcccCCCHHHHHH
Confidence 33 334556778889999999999999999999 9999999998763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=257.32 Aligned_cols=241 Identities=33% Similarity=0.462 Sum_probs=201.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+..++|+++..+|+|+||.||+++++.+++..|+|+++..... ....+|+-+++.-+|+||+.+++.+.... .+|+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwic 90 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWIC 90 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEE
Confidence 4567899999999999999999999999999999999865433 33467999999999999999999998755 79999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-------------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH------------------- 192 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~------------------- 192 (300)
||||.||+|.+.-.-.+.+++.++....+..+.||+|||++|-+|||||-.||++++.+..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 9999999999998888899999999999999999999999999999999999999987653
Q ss_pred CccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--CCCCCCChHHH
Q 040812 193 PCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP--SLPECSSEKFR 270 (300)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 270 (300)
.+-++..|++||.......+.|...+|||++|++..|+---++|.+...+.... ..+... ...++ .-+..+++.+-
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-~LmTkS-~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-FLMTKS-GFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-HHhhcc-CCCCCcccCCccchHHHH
Confidence 233567788998877777777888999999999999999888887654332221 122221 12223 33456789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+|++.+|.+ +|++||+++.+|+|||..
T Consensus 249 ~fvK~altk-npKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 249 NFVKGALTK-NPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred HHHHHHhcC-CCccCCChhhheeceeec
Confidence 999999999 999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=233.62 Aligned_cols=231 Identities=18% Similarity=0.254 Sum_probs=183.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
...++++.-.+-+|+||.||.|.|++. .+.|-+|.++.....- .+..|--.+..+.|||+.++.++...+..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 445678888999999999999987642 3345567665433221 22457777888899999999999877766
Q ss_pred cEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--
Q 040812 127 EVSILMEYMDAGSLEIYVKSR--------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-- 196 (300)
..++++.+..-|+|..++... +.++..+...++.|++.|+.|||.+|++|.||..+|++|++....++.+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 789999999999999999821 2477888899999999999999999999999999999999875543322
Q ss_pred -------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhC
Q 040812 197 -------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFR 256 (300)
Q Consensus 197 -------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 256 (300)
...|+++|+.. ...++.++|+|||||+||||+| |+.||.+.+. .+....+..+
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~---n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----fEm~~ylkdG 514 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQ---NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----FEMEHYLKDG 514 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHh---hhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----HHHHHHHhcc
Confidence 22345555544 4457789999999999999998 9999976543 3555556667
Q ss_pred CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 257 EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.....|-++++++...|..||.. .|++||+++++..
T Consensus 515 yRlaQP~NCPDeLf~vMacCWal-lpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWAL-LPEERPSFSQLVI 550 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhc-CcccCCCHHHHHH
Confidence 88888999999999999999999 9999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=251.17 Aligned_cols=227 Identities=23% Similarity=0.266 Sum_probs=180.9
Q ss_pred ceeeeeecCCcceEEEEEEEccCC----eEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTL----ALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
....++||+|+||+||+|.|--.+ .+||+|++......+ .+.+|+.+|.++.|||++++++++..+ .+.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHH
Confidence 456789999999999999985333 378999987655443 346799999999999999999998764 58899
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceeec--cccccc--
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLY--ESGEAR-- 206 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~~--~~~~~~-- 206 (300)
++|+++|+|.++++. +.++.....+.|..||++|+.|||+++++||||..+|||+..-...++..+++. .++...
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999986 457899999999999999999999999999999999999987665544333221 111111
Q ss_pred --------------cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 207 --------------HRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 207 --------------~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+......++.++|||||||++||++| |..||.+...+ ++-.-...+.....|..++-++.-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----eI~dlle~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----EIPDLLEKGERLSQPPICTIDVYM 931 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----HhhHHHhccccCCCCCCccHHHHH
Confidence 11223456789999999999999998 99999765432 333333345667888899999999
Q ss_pred HHHHHhccCCCCCCCCHHHHh
Q 040812 272 FIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l 292 (300)
++.+||.. |+..||+++++.
T Consensus 932 ~mvkCwmi-d~~~rp~fkel~ 951 (1177)
T KOG1025|consen 932 VMVKCWMI-DADSRPTFKELA 951 (1177)
T ss_pred HHHHHhcc-CcccCccHHHHH
Confidence 99999999 999999998875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=233.65 Aligned_cols=236 Identities=27% Similarity=0.397 Sum_probs=179.4
Q ss_pred CcceeeeeecCCcceEEEEEEEcc---CCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
..|.++.+||+|+|+.||++.+.. ..+.||+|.+..........+|+++|..+ .+.||+.+.+++...+ ..++||
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd-~v~ivl 114 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNND-QVAIVL 114 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCC-eeEEEe
Confidence 458889999999999999999887 78899999998777777778999999998 4789999999987754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC----Cc--------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH----PC-------------- 194 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~----~~-------------- 194 (300)
||+++....++.. .++...++.+++.++.||.++|.+||+||||||+|+|.+..... ++
T Consensus 115 p~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 115 PYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred cccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 9999988888886 47899999999999999999999999999999999999743110 00
Q ss_pred ----------------------------------------------cceeeccccccccccCCCCCCchhhHHHHHHHHH
Q 040812 195 ----------------------------------------------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMM 228 (300)
Q Consensus 195 ----------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ 228 (300)
.++..+.+||+... ....++++||||.|||+.
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k--~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR--CPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh--ccCcCCccceeeccceee
Confidence 11122233333221 122356899999999999
Q ss_pred HHHhCCCCCCCCCCCchHH-HHHHHHh----------hCC------------------------------------CCCC
Q 040812 229 ELYMGYYPFLEPGQEPDFL-SLMLAIC----------FRE------------------------------------PPSL 261 (300)
Q Consensus 229 elltg~~pf~~~~~~~~~~-~~~~~~~----------~~~------------------------------------~~~~ 261 (300)
-+++++.||.....+.+.. ++..... .+. ....
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 9999999997554332211 1111000 000 0000
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+..+..+.+|+.+||.. ||.+|.|++++|+||||.+
T Consensus 350 ~d~~~~~~~dlLdk~le~-np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLEL-NPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccHHHHHHHHHHccC-ChhhcccHHHHhcCcCCcc
Confidence 112244789999999999 9999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=229.73 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=179.0
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCC----cEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSG----EVSI 130 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~l 130 (300)
.+--+.||.|+||.||.+.+..+|+.||+|.+.+-. ....+-+|+++|..++|.|++..+++...+.- .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 355688999999999999999999999999875422 22334579999999999999999998765431 3788
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee-----------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL----------- 199 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~----------- 199 (300)
+.|++.. +|...+.....++.+.++-+++||+.||+|||+.+|.||||||.|.|++++-..++.++++
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 9999966 9999998888999999999999999999999999999999999999999985543333222
Q ss_pred ---------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH------------h----
Q 040812 200 ---------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI------------C---- 254 (300)
Q Consensus 200 ---------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------------~---- 254 (300)
|.+||..-. ...|+.++||||+|||+.|++.++..|...+..+.. +.+... .
T Consensus 214 MTqEVVTQYYRAPEiLMG--aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMG--ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hHHHHHHHHhccHHHhhc--chhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHhhhhH
Confidence 333333221 234677999999999999999999999654433221 111111 1
Q ss_pred ---hCC---CCCCC--------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 ---FRE---PPSLP--------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 ---~~~---~~~~~--------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+. .++++ ..-..+..+++..++.. ||.+|.+.++++.|+++.+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~-d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHF-DPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCC-CCcccccHhhhcccccccc
Confidence 111 12221 12234677889999999 9999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=252.07 Aligned_cols=225 Identities=24% Similarity=0.298 Sum_probs=165.7
Q ss_pred eeeeecCCcceE-EEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccCCC
Q 040812 61 KLQVLGQGNGGT-VFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMDAG 138 (300)
Q Consensus 61 ~~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~~ 138 (300)
--+.+|.|+-|+ ||+|... ++.||||.+-.+.. .-..+|+..|+.- .|||||++++.-. +....||..|+|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~-~~A~rEi~lL~eSD~H~NviRyyc~E~-d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF-DFAQREIQLLQESDEHPNVIRYYCSEQ-DRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH-HHHHHHHHHHHhccCCCceEEEEeecc-CCceEEEEehHhhh-
Confidence 346789999886 5999987 68999998754332 1236799999876 7999999999744 45589999999976
Q ss_pred CHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC---CCC-------------------
Q 040812 139 SLEIYVKSRG-R---LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK---MEH------------------- 192 (300)
Q Consensus 139 ~L~~~l~~~~-~---l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~---~~~------------------- 192 (300)
+|.++++..+ . ......+.++.|+++||++||+.+|+||||||.||||+.. +..
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 9999998741 1 1224568899999999999999999999999999999862 211
Q ss_pred -----CccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 193 -----PCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMG-YYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 193 -----~~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
.+.++..|.+||..... ....++||+||||++|+.++| ..||......+ .+++.... .-..+.....
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~---~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~--~L~~L~~~~d 740 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLRED---RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNY--TLVHLEPLPD 740 (903)
T ss_pred hhcccCCCCcccccCHHHHhcc---ccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcc--ceeeeccCch
Confidence 12345557777766533 345589999999999999996 99997543221 12221110 0001111111
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+..|||.+|+.. +|..||++.++|.||+|=
T Consensus 741 ~eA~dLI~~ml~~-dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 741 CEAKDLISRMLNP-DPQLRPSATDVLNHPLFW 771 (903)
T ss_pred HHHHHHHHHhcCC-CcccCCCHHHHhCCCccC
Confidence 2899999999999 999999999999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=234.29 Aligned_cols=186 Identities=26% Similarity=0.334 Sum_probs=156.8
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----------CCCHHHHHHHHhcC---CCceeEe
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----------PPNPQELNILRQTN---SPYIVKC 117 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~---h~niv~~ 117 (300)
.......+|..++.+|+|+||.|++|.++++...|+||.+.+++.. ....-|+++|..++ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 3445678899999999999999999999999999999999765422 12345999999997 9999999
Q ss_pred ceeeeCCCCcEEEEEecc-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---
Q 040812 118 HQIFTKPSGEVSILMEYM-DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP--- 193 (300)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~--- 193 (300)
+++|+++. +.||+||-. +|.+|+++++...++++.+++.|++|++.|+++||++||+|||||-+|+.++.++-.+
T Consensus 635 LdfFEddd-~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 635 LDFFEDDD-YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred hheeecCC-eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 99999865 999999975 5689999999999999999999999999999999999999999999999999875431
Q ss_pred --------------ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 040812 194 --------------CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLE 239 (300)
Q Consensus 194 --------------~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 239 (300)
+.++.-|.+||.... ..+-+..-|||++|++||.++..+.||.+
T Consensus 714 fgsaa~~ksgpfd~f~gtv~~aapevl~g--~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGPFDVFVGTVDYAAPEVLGG--EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCCcceeeeeccccchhhhCC--CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 223444666666542 23457789999999999999999999964
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=224.55 Aligned_cols=232 Identities=23% Similarity=0.325 Sum_probs=170.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHH--HhcCCCceeEeceeeeCC---CCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNIL--RQTNSPYIVKCHQIFTKP---SGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l--~~l~h~niv~~~~~~~~~---~~~~~ 129 (300)
++...++.+.||+|+||.||+|+.. ++.||||++.... ...+.+|-++. -.++|+||+++++.-... ....+
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~-kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE-KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH-HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4556788999999999999999987 5899999986433 23445555554 467999999999974321 12589
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC---------CccccCCCCCceeecCCCCCC---cc--
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR---------NIVHRDIKPANVLINEKMEHP---CG-- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~---------~i~H~Dlkp~Nill~~~~~~~---~~-- 195 (300)
||++|.+.|+|.+|++.+ .+++....+++..|++||+|||+. .|+|||||..|||+..++.+- +|
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999875 689999999999999999999964 499999999999999886542 22
Q ss_pred ----------------ceeeccccccccccCCCC---CCchhhHHHHHHHHHHHHhCCCCC------------C-CCCCC
Q 040812 196 ----------------YSCLYESGEARHRKHGGY---NGFAADIWSFGVTMMELYMGYYPF------------L-EPGQE 243 (300)
Q Consensus 196 ----------------~~~~~~~~~~~~~~~~~~---~~~~~DiwSlG~il~elltg~~pf------------~-~~~~~ 243 (300)
++..|++||..+....-. .-.+.||||+|.+||||+++..-+ . .....
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 356688888776432111 124789999999999999864333 2 11112
Q ss_pred chHHHHHH-HHhhCCCCCCCCCC-----ChHHHHHHHHHhccCCCCCCCCHHHH
Q 040812 244 PDFLSLML-AICFREPPSLPECS-----SEKFRDFIRCCLQKGDPSKRWTASQL 291 (300)
Q Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~dp~~Rpt~~~~ 291 (300)
+...+... .+..+.+|.+|+.+ ...+++.+..||.. ||+.|.|+.-+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDh-DaeARLTA~Cv 496 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDH-DAEARLTAGCV 496 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCC-chhhhhhhHHH
Confidence 22211111 13345556666543 35689999999999 99999997644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=199.42 Aligned_cols=203 Identities=28% Similarity=0.486 Sum_probs=154.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC---CHHHHHHHHh-cCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP---NPQELNILRQ-TNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.+....+..||+|+||.|-+.++..+|...|+|.+......+. ..+|+.+..+ ...|.+|.++|.+-.+ +.+|+.
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-gdvwIc 123 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-GDVWIC 123 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-ccEEEe
Confidence 3456677899999999999999999999999999876544322 1345555433 4679999999987765 589999
Q ss_pred EeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCc---c--------
Q 040812 132 MEYMDAGSLEIYVK----SRGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPC---G-------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~---~-------- 195 (300)
||.|.. +|..+-. .++.+++..+-+|+..++.||.|||++ .++|||+||+|||++..+..++ |
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 999965 8876554 466899999999999999999999976 8999999999999999877532 2
Q ss_pred -------ceeeccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 196 -------YSCLYESGEARHRKHG-GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
+..-|++||-...... ..|+-++||||||++++||.+++.||...... .+.+.++.....|.+|.
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp---F~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP---FQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH---HHHHHHHhcCCCCCCcc
Confidence 2333677776543322 25778999999999999999999999766543 23444445455555553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=203.80 Aligned_cols=190 Identities=39% Similarity=0.608 Sum_probs=160.1
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCHH
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLE 141 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~ 141 (300)
||+|++|.||++....+++.+++|++...... ..+.+|+..++.++|++++++++++... ...+++||++.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence 68999999999999988999999998766543 4567899999999999999999998875 4899999999989999
Q ss_pred HHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-CCCCCccce-------------------eec
Q 040812 142 IYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-KMEHPCGYS-------------------CLY 200 (300)
Q Consensus 142 ~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~-~~~~~~~~~-------------------~~~ 200 (300)
+++... ..++...+..++.+++.++.+||+.|++|+||+|.||+++. +....+.++ ..|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999875 46899999999999999999999999999999999999998 544322221 112
Q ss_pred cccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhcc
Q 040812 201 ESGEARHRKHGG-YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQK 279 (300)
Q Consensus 201 ~~~~~~~~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 279 (300)
.+|+... .. ..+.++|+|++|+++++| ..+.+++..|+..
T Consensus 160 ~~pe~~~---~~~~~~~~~D~~~lg~~~~~l------------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 160 MAPEVLL---GKGYYSEKSDIWSLGVILYEL------------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred cChhHhc---ccCCCCchhhhHHHHHHHHHH------------------------------------HHHHHHHHHHhhC
Confidence 2233222 22 556789999999999999 6788999999999
Q ss_pred CCCCCCCCHHHHhcCC
Q 040812 280 GDPSKRWTASQLLSHP 295 (300)
Q Consensus 280 ~dp~~Rpt~~~~l~hp 295 (300)
||++||++.++++|+
T Consensus 201 -~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 -DPEKRPSAKEILEHL 215 (215)
T ss_pred -CcccCcCHHHHhhCC
Confidence 999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=206.46 Aligned_cols=242 Identities=22% Similarity=0.278 Sum_probs=172.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 131 (300)
+-.+.|.+.+.||+|.||.+-+|.++.+...+++|.+...... .+|.+|...--.| -|.||+.-+++.-...+...++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3456799999999999999999999999999999998764432 3445565544444 4789998887644444588899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-----Cccc------e---
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-----PCGY------S--- 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-----~~~~------~--- 197 (300)
+||++.|+|..-+... .+.+...+.++.|+++|+.|+|+++++|||||.+||||-..... ++|. +
T Consensus 101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999999999888764 47889999999999999999999999999999999998643211 1221 1
Q ss_pred ----eeccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC---CCChH
Q 040812 198 ----CLYESGEARHRKHGGY--NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE---CSSEK 268 (300)
Q Consensus 198 ----~~~~~~~~~~~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 268 (300)
..|.+|+.......+. ..+.+|+|.||+++|.++||.+||..........-...+...+..+..|. ..++.
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~ 259 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEK 259 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHH
Confidence 1133343332221111 24578999999999999999999975433322222222333344444444 45788
Q ss_pred HHHHHHHHhccCCCCCC---CCHHHHhcCCCC
Q 040812 269 FRDFIRCCLQKGDPSKR---WTASQLLSHPFL 297 (300)
Q Consensus 269 l~~li~~~l~~~dp~~R---pt~~~~l~hpw~ 297 (300)
+..+.++-|.. ++++| -++..-.+..|.
T Consensus 260 a~r~Fkk~lt~-~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 260 ALRLFKKSLTP-RFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHHHhcCC-cccccchhHHHHHHHHHHHH
Confidence 99999999999 99999 344444444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=243.62 Aligned_cols=182 Identities=20% Similarity=0.259 Sum_probs=130.9
Q ss_pred HhcCC-CceeEeceeeeCC------CCcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccC
Q 040812 107 RQTNS-PYIVKCHQIFTKP------SGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178 (300)
Q Consensus 107 ~~l~h-~niv~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~D 178 (300)
+.++| .||++++++|... ...++++||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34555 5788888876211 125778899884 599999975 34599999999999999999999999999999
Q ss_pred CCCCceeecCCC-------------------CC---Ccc--------------------------------ceeeccccc
Q 040812 179 IKPANVLINEKM-------------------EH---PCG--------------------------------YSCLYESGE 204 (300)
Q Consensus 179 lkp~Nill~~~~-------------------~~---~~~--------------------------------~~~~~~~~~ 204 (300)
|||+||||+..+ .. ++| ++..|++||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999995311 11 111 122367777
Q ss_pred cccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCC
Q 040812 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSK 284 (300)
Q Consensus 205 ~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~ 284 (300)
... +..++.++|||||||+||||++|.+|+..... ..... .....+...........+++.+||.. ||.+
T Consensus 186 ~~~---~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~~~~L~~-~P~~ 255 (793)
T PLN00181 186 EDN---GSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSL---RHRVLPPQILLNWPKEASFCLWLLHP-EPSC 255 (793)
T ss_pred hhc---cCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHH---HHhhcChhhhhcCHHHHHHHHHhCCC-Chhh
Confidence 654 55678899999999999999999888743211 11111 11111111112245677899999999 9999
Q ss_pred CCCHHHHhcCCCCCC
Q 040812 285 RWTASQLLSHPFLAD 299 (300)
Q Consensus 285 Rpt~~~~l~hpw~~~ 299 (300)
||++.|+++||||.+
T Consensus 256 Rps~~eil~h~~~~~ 270 (793)
T PLN00181 256 RPSMSELLQSEFINE 270 (793)
T ss_pred CcChHHHhhchhhhh
Confidence 999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=197.82 Aligned_cols=178 Identities=36% Similarity=0.518 Sum_probs=147.1
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
|.+.+.||+|++|.||++....+++.+|+|.+..... ...+.+|+..+++++|+|++++++.+.... ..++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-PLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-ceEEEEecc
Confidence 5678899999999999999998899999999876542 234467999999999999999999987654 899999999
Q ss_pred CCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------
Q 040812 136 DAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------ 196 (300)
Q Consensus 136 ~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------ 196 (300)
++++|.+++..... +++..+..++.+++.++.+||+++++|+||+|+||+++.+....+.+
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 99999999987666 89999999999999999999999999999999999999764432211
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLE 239 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 239 (300)
...|.+|+... .....+.++|+||||+++++|++|+.||..
T Consensus 160 ~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11233444332 234556699999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=184.50 Aligned_cols=151 Identities=27% Similarity=0.332 Sum_probs=112.3
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-c-----------ceeeccccc
Q 040812 138 GSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-G-----------YSCLYESGE 204 (300)
Q Consensus 138 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~-~-----------~~~~~~~~~ 204 (300)
|+|.+++..+ ..+++..++.++.||+.||.|||+++ ||+|||++.++.... | ++..|.+||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~fG~~~~~~~~~~~g~~~y~aPE 74 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKLDGSVAFKTPEQSRVDPYFMAPE 74 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceeeccceEeeccccCCCcccccChH
Confidence 6899999874 45999999999999999999999998 999999987654321 1 234567777
Q ss_pred cccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-CC--CCCCCCCh--HHHHHHHHHhcc
Q 040812 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-PP--SLPECSSE--KFRDFIRCCLQK 279 (300)
Q Consensus 205 ~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~--~l~~li~~~l~~ 279 (300)
... +..++.++|||||||++|||+||+.||.................... +. ..+...++ .+.++|.+||..
T Consensus 75 ~~~---~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~ 151 (176)
T smart00750 75 VIQ---GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR 151 (176)
T ss_pred Hhc---CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence 654 55678899999999999999999999965443322222221111111 10 11122333 699999999999
Q ss_pred CCCCCCCCHHHHhcCCCCC
Q 040812 280 GDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 280 ~dp~~Rpt~~~~l~hpw~~ 298 (300)
||++||++.++++|+|+.
T Consensus 152 -~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 152 -LPQRREAANHYLAHCRAL 169 (176)
T ss_pred -ccccccCHHHHHHHHHHH
Confidence 999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-23 Score=183.02 Aligned_cols=233 Identities=21% Similarity=0.211 Sum_probs=167.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCC-eEEEEEEeecCCCCC--CCHHHHHHHHhcCC----CceeEeceeeeCCCCcEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTL-ALYALKVMQCDRGTP--PNPQELNILRQTNS----PYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~--~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~l 130 (300)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+........ ....|+.++..++. .++..+++.......+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998764 689999987654332 45679999998873 5788888877423448999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC--------CCccceeec
Q 040812 131 LMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME--------HPCGYSCLY 200 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~--------~~~~~~~~~ 200 (300)
||+.+ |.+|.++.... +.|+..++..|+.|++.+|++||+.|++||||||+|+++..... .++|....+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99999 67999988653 57999999999999999999999999999999999999986531 133333311
Q ss_pred c----------cccc---cc----------ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC
Q 040812 201 E----------SGEA---RH----------RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE 257 (300)
Q Consensus 201 ~----------~~~~---~~----------~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 257 (300)
. .+.. .. ...+...+.+.|+||++.++.|++.|..||....................
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~ 257 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL 257 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence 1 0000 00 01123345688999999999999999999976554333222222111111
Q ss_pred CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 258 PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 258 ~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
........+..+.++...+-.. +...+|....+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 258 TDRFGDLKPEEFAKILEYIDSL-DYEDKPDYEKLA 291 (322)
T ss_pred cccccCCChHHHHHHHHHhhcc-CCcCCCCHHHHH
Confidence 1113444567778887777777 889999877664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=172.32 Aligned_cols=186 Identities=21% Similarity=0.235 Sum_probs=147.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC-CceeEeceeeeCCCCcEEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-PYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~ 132 (300)
.-.+.|.++++||+|+||.+|+|....+|+.||||+..+........-|..+.+.+++ .+|..+..+..+ ..+..+||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE-KDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc-cccceeee
Confidence 3457899999999999999999999999999999998877777777789999999987 566666665544 44889999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC------Cccceeecccccc
Q 040812 133 EYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH------PCGYSCLYESGEA 205 (300)
Q Consensus 133 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~------~~~~~~~~~~~~~ 205 (300)
|++ |-+|+++..- ..+|+..+++.++-|++.-++|+|.++++||||||+|+|+.-+..+ ++|.++.|.....
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 999 6799998874 4479999999999999999999999999999999999999755332 3444444333221
Q ss_pred cc--------------------ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 040812 206 RH--------------------RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG 241 (300)
Q Consensus 206 ~~--------------------~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 241 (300)
.. ...|...+..-|+-|+|.+|.++.-|..||.+..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 11 0011223446799999999999999999997654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-26 Score=214.17 Aligned_cols=235 Identities=26% Similarity=0.346 Sum_probs=171.3
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecC----CCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD----RGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
..+.+|.|.+|.|+.+......+.++.|.+... ..... ...|+.+-..+.|+|++..+..+.+-.+ ..-+|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhhh
Confidence 467899999999999888777777777765421 10000 1235555567899999887777655443 33449
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---c--------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---G-------------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---~-------------- 195 (300)
|||++ +|..++...+.++..++..+++|++.||+|+|+.||.|||+|++|++++.++..++ |
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 99999998888999999999999999999999999999999999999998754321 1
Q ss_pred ------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH----HhhCCCCCCCCCC
Q 040812 196 ------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA----ICFREPPSLPECS 265 (300)
Q Consensus 196 ------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 265 (300)
+..-|.+||.... ..+....+||||.|++++.|.+|+.||.......+....... .....+..+...+
T Consensus 480 ~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 1222334443321 223455799999999999999999999766554433211111 0111122334456
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+...+.+|.+||+. ||.+|.|+++|++.+||+.+
T Consensus 558 p~~~~~~~~~~l~~-~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 558 PRETRIIIYRMLQL-DPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hhhHHHHHHHHccC-ChhheecHHHHhhChHhhhc
Confidence 78889999999999 99999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=178.19 Aligned_cols=230 Identities=23% Similarity=0.332 Sum_probs=185.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecC----CCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD----RGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++..++-+|.+.-.|..|+|+|.++ .++.|++... +....|..|.-.|+.+.||||+.+++.+..+. ++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEe
Confidence 44566778899999999999999864 4566777543 34456778999999999999999999998876 78999
Q ss_pred EeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCCCCCCcc------------
Q 040812 132 MEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKMEHPCG------------ 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~~~~~~~------------ 195 (300)
..|++.|+|...++.... .+..++..++..|+.|+.|||+-. |.---|....+++|++....+.
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~g 345 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVG 345 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccc
Confidence 999999999999987543 678899999999999999999864 4555788899999987554221
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
....|.+||+.........-.++|+|||.+++||+.|++.||.+....+-- ++....+....+|...+..+..+|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---mkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---MKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---hhhhhccccccCCCCccHHHHHHH
Confidence 245577888877655555556899999999999999999999765544332 233345777888999999999999
Q ss_pred HHHhccCCCCCCCCHHHHh
Q 040812 274 RCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l 292 (300)
.-|+.. ||.+||.+..++
T Consensus 423 ~icmne-dpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNE-DPGKRPKFDMIV 440 (448)
T ss_pred HHHhcC-CCCcCCCcceeh
Confidence 999999 999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=179.20 Aligned_cols=174 Identities=24% Similarity=0.331 Sum_probs=130.1
Q ss_pred CCCceeEeceeeeCC--------------------------CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 040812 110 NSPYIVKCHQIFTKP--------------------------SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163 (300)
Q Consensus 110 ~h~niv~~~~~~~~~--------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~ 163 (300)
+|||||++.+.|.++ ...+|+||.-... +|++++..+ ..+......++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 599999998876321 1258999999976 999999765 467788889999999
Q ss_pred HHHHHhHhCCccccCCCCCceeecCCCC-----------------------------CCccceeeccccccccccCCCC-
Q 040812 164 KGLFYMHSRNIVHRDIKPANVLINEKME-----------------------------HPCGYSCLYESGEARHRKHGGY- 213 (300)
Q Consensus 164 ~~l~~lH~~~i~H~Dlkp~Nill~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~- 213 (300)
+|+.|||.+||.|||+|.+|||+.-+.. .+.|+....++||......|..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999854311 1334444455555544333321
Q ss_pred --CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHH
Q 040812 214 --NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTAS 289 (300)
Q Consensus 214 --~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~ 289 (300)
.-.++|.|+.|.+.||+++...||....+.- .+ ........-+.+|+.+++.+++++..+|+. ||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~-~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r-~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LD-TRTYQESQLPALPSRVPPVARQLVFDLLKR-DPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchhe--ec-hhhhhhhhCCCCcccCChHHHHHHHHHhcC-CccccCCcc
Confidence 1138999999999999999999997633211 01 111223456778899999999999999999 999999854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-23 Score=170.62 Aligned_cols=182 Identities=19% Similarity=0.256 Sum_probs=150.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC-CceeEeceeeeCCCCcEEEEEeccC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-PYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
.|+++++||+|+||.++.|.+.-++++||||.............|....+.|.+ ++|...+.+.. +..+..||||++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGq-eG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ-EGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeecc-ccchhhhhhhhh-
Confidence 689999999999999999999999999999998776666667789999988864 88888877544 444788999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC--------Cccceeecccccccc
Q 040812 137 AGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH--------PCGYSCLYESGEARH 207 (300)
Q Consensus 137 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~--------~~~~~~~~~~~~~~~ 207 (300)
|-+|+++..- .++|+.+.+..++.|++.-++++|++.+|.|||||+|+||...+.. ++|..+.|..|+...
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 6799999875 4479999999999999999999999999999999999999875443 566666666665321
Q ss_pred --------------------ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 040812 208 --------------------RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG 241 (300)
Q Consensus 208 --------------------~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 241 (300)
...|..-+..-|+=|||-++++.|-|.+||.+..
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 0113334557899999999999999999997654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=205.85 Aligned_cols=220 Identities=23% Similarity=0.246 Sum_probs=163.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCH---HHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNP---QELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+|...+.||++.|=+|.+|++.+ | .|+||++-+.... .++. .|++ ...+++||++.+..+...++ ..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k-AAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK-AAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH-HHHHH
Confidence 67888999999999999999987 4 4889998765432 2233 3444 55579999999988866654 78999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------- 197 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------- 197 (300)
-+|..+ +|.+.+..+.-+..-+.+.|+.|++.||.-+|..||+|+|||.+||||++.....+.++
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999977 99999998877889999999999999999999999999999999999997654322221
Q ss_pred ------------eeccccccccccC--------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCC-------CCCchHHHH
Q 040812 198 ------------CLYESGEARHRKH--------GGYNGFAADIWSFGVTMMELYM-GYYPFLEP-------GQEPDFLSL 249 (300)
Q Consensus 198 ------------~~~~~~~~~~~~~--------~~~~~~~~DiwSlG~il~ellt-g~~pf~~~-------~~~~~~~~~ 249 (300)
..|.+||-..... ....+++-||||+||+++||++ |++||.-. ....+....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 1244444332211 1113568899999999999987 78888310 000011111
Q ss_pred HHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+ ....+..++++|..|++. ||++|.++++.|+-
T Consensus 259 L-----------e~Ied~~~Rnlil~Mi~r-dPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 L-----------EKIEDVSLRNLILSMIQR-DPSKRLSAEDYLQK 291 (1431)
T ss_pred H-----------HhCcCccHHHHHHHHHcc-CchhccCHHHHHHh
Confidence 1 111244789999999999 99999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-22 Score=172.82 Aligned_cols=235 Identities=34% Similarity=0.500 Sum_probs=174.6
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCC-ceeEeceeeeCCCCcEEEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSP-YIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~ 132 (300)
|.+.+.||.|+||.||++.+. ..+++|.+....... .+.+|+.++..+.|+ +++++.+.+.... ..++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-SLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-EEEEEE
Confidence 678899999999999999998 688999987655443 246799999999988 7999999985543 689999
Q ss_pred eccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-C---Ccccee-------
Q 040812 133 EYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-H---PCGYSC------- 198 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-~---~~~~~~------- 198 (300)
+++.++++.+++.... .++...+..++.|++.++.++|+.+++|||+||+||+++.... . ++|...
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999999998877664 7899999999999999999999999999999999999997652 2 233221
Q ss_pred ---------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---CchHHHHHHHHhhC-CCC
Q 040812 199 ---------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ---EPDFLSLMLAICFR-EPP 259 (300)
Q Consensus 199 ---------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~-~~~ 259 (300)
.|.+|+..........+...|+||+|++++++++|..||..... .......+...... ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 12222222110004667799999999999999999999765443 12222222221111 111
Q ss_pred CCCCCC----ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 260 SLPECS----SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 260 ~~~~~~----~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
...... ...+.+++..++.. +|..|.+..+...++|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAK-DPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhc-CchhcCCHHHHhhchHhh
Confidence 111111 25789999999999 999999999888776553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=168.98 Aligned_cols=166 Identities=13% Similarity=0.154 Sum_probs=119.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC-----------CHHHHHHHHhcCCCceeEeceeeeCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-----------NPQELNILRQTNSPYIVKCHQIFTKP 124 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~E~~~l~~l~h~niv~~~~~~~~~ 124 (300)
-++|++.+.+|.|+||.||++.. ++..+|+|++........ +.+|+..+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 36799999999999999999755 356899999975433222 35788899999999999988876533
Q ss_pred -------CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC--Ccc
Q 040812 125 -------SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH--PCG 195 (300)
Q Consensus 125 -------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~--~~~ 195 (300)
.+..++||||++|.+|.++.. +++ ....+++.+|..+|+.|++|||+||+||+++.++.. ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg 179 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLS 179 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECC
Confidence 135899999999999988742 333 346699999999999999999999999999876511 112
Q ss_pred ceeecccccccc-ccCCCCCCchhhHHHHHHHHHHHH
Q 040812 196 YSCLYESGEARH-RKHGGYNGFAADIWSFGVTMMELY 231 (300)
Q Consensus 196 ~~~~~~~~~~~~-~~~~~~~~~~~DiwSlG~il~ell 231 (300)
....+....+.. ......+..++|+||||+++..+.
T Consensus 180 ~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence 111111111100 001122346899999999987554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=163.09 Aligned_cols=123 Identities=16% Similarity=0.158 Sum_probs=97.9
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----------CCC-----------------HHHHHHHHhcCCCc
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----------PPN-----------------PQELNILRQTNSPY 113 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~-----------------~~E~~~l~~l~h~n 113 (300)
...||+|+||.||+|.+. +|+.||+|+++..... ..+ .+|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 7999999999764321 111 13899999998877
Q ss_pred eeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-HhCCccccCCCCCceeecC
Q 040812 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM-HSRNIVHRDIKPANVLINE 188 (300)
Q Consensus 114 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~i~H~Dlkp~Nill~~ 188 (300)
+.....+ ... ..++||||++|+++.......+.++...+..++.|++.+|.++ |+.||+||||||+|||++.
T Consensus 81 v~~p~~~-~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~ 153 (190)
T cd05147 81 IPCPEPI-LLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD 153 (190)
T ss_pred CCCCcEE-Eec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC
Confidence 6443332 222 2389999999988766544456799999999999999999999 7999999999999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-23 Score=177.55 Aligned_cols=124 Identities=17% Similarity=0.159 Sum_probs=98.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-CCeEEEEEEeecCCC-------CCCCHHHHHHHHhcCCCceeE-eceeeeCCCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ-TLALYALKVMQCDRG-------TPPNPQELNILRQTNSPYIVK-CHQIFTKPSG 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~ 126 (300)
.++|++.+.||+|+||+||+|.+.. +++.+|||.+..... ...+.+|+.+|++++|+|++. +++. +
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-----~ 91 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-----G 91 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----C
Confidence 4669999999999999999999876 678889998653211 112468999999999999985 4432 3
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCC-CCCceeecCCCC
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI-KPANVLINEKME 191 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dl-kp~Nill~~~~~ 191 (300)
..|+||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC
Confidence 5799999999999973 211 11 1467899999999999999999999 999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=186.75 Aligned_cols=220 Identities=27% Similarity=0.374 Sum_probs=179.1
Q ss_pred eecCCcceEEEEEEE---ccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEEEEecc
Q 040812 64 VLGQGNGGTVFKVRH---KQTLALYALKVMQCDRGT----PPNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.+|+|+||.|++++. ...+..+|+|+.+..... .....|..++...+ ||.+++++..+..+. ..++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-KLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-chhHhhhhc
Confidence 379999999999764 345778999988654322 13345888888887 999999999998765 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------------ceeec
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------------YSCLY 200 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------------~~~~~ 200 (300)
.||+|...+.....+.+...+.+...++.+++++|+.+++|||+|++||+++.+|..... ++..|
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ey 159 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEY 159 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchhh
Confidence 999999999888889999999999999999999999999999999999999998754322 24456
Q ss_pred cccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccC
Q 040812 201 ESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKG 280 (300)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 280 (300)
++||... ....++|.||||++++||+||..||.. +.+.. ........|...+..+++++..++..
T Consensus 160 mApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~-Il~~~~~~p~~l~~~a~~~~~~l~~r- 224 (612)
T KOG0603|consen 160 RAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKR-ILKAELEMPRELSAEARSLFRQLFKR- 224 (612)
T ss_pred hhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHH-HhhhccCCchhhhHHHHHHHHHHHhh-
Confidence 6666654 234589999999999999999999965 22222 22445667888899999999999999
Q ss_pred CCCCCCC-----HHHHhcCCCCCC
Q 040812 281 DPSKRWT-----ASQLLSHPFLAD 299 (300)
Q Consensus 281 dp~~Rpt-----~~~~l~hpw~~~ 299 (300)
+|..|.- +.++++|+||..
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred CHHHHhccCcchhHHHhccchhee
Confidence 9999985 579999999964
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=165.73 Aligned_cols=215 Identities=23% Similarity=0.308 Sum_probs=129.6
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHH-------hcC----------CCceeEecee
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILR-------QTN----------SPYIVKCHQI 120 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~-------~l~----------h~niv~~~~~ 120 (300)
++...+.||.|+++.||.+.+.+|++.+|+|++...... ..++++.++ .+. |-.++..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~--~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA--SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT--HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccccc--chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 467789999999999999999999999999998765522 111222221 111 1112222222
Q ss_pred ee---------CCC--C-----cEEEEEeccCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHhHhCCcccc
Q 040812 121 FT---------KPS--G-----EVSILMEYMDAGSLEIYVKS---RGR----LSEDIICTISRQVLKGLFYMHSRNIVHR 177 (300)
Q Consensus 121 ~~---------~~~--~-----~~~lv~e~~~~~~L~~~l~~---~~~----l~~~~~~~i~~qi~~~l~~lH~~~i~H~ 177 (300)
.. ... . +.+++|+-+.+ +|.+++.. ... +.......+..|++..+++||..|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 11 000 0 24678888865 88887652 211 2223334666899999999999999999
Q ss_pred CCCCCceeecCCCCCCcccee----------------ecccccccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCC
Q 040812 178 DIKPANVLINEKMEHPCGYSC----------------LYESGEARHRK-----HGGYNGFAADIWSFGVTMMELYMGYYP 236 (300)
Q Consensus 178 Dlkp~Nill~~~~~~~~~~~~----------------~~~~~~~~~~~-----~~~~~~~~~DiwSlG~il~elltg~~p 236 (300)
||||+|++++.++....|++. .+.+||..... ..-.++.+.|.|+||+++|.|++|..|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999998876554421 13333332221 112356789999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCC
Q 040812 237 FLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKR 285 (300)
Q Consensus 237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~R 285 (300)
|........... . ...-. ..++.+++||..+|+. ||++|
T Consensus 250 f~~~~~~~~~~~-----~---f~~C~-~~Pe~v~~LI~~lL~~-~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW-----D---FSRCR-DMPEPVQFLIRGLLQR-NPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG-----G---GTTSS----HHHHHHHHHHT-S-SGGGS
T ss_pred CCCCCccccccc-----c---chhcC-CcCHHHHHHHHHHccC-CcccC
Confidence 975432211100 0 01112 5788999999999999 99988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=156.78 Aligned_cols=122 Identities=16% Similarity=0.179 Sum_probs=96.8
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----------------------------CCHHHHHHHHhcCCCc
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----------------------------PNPQELNILRQTNSPY 113 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~~~E~~~l~~l~h~n 113 (300)
.+.||+|+||.||+|.+. +|+.||||+++...... ...+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 89999999987643210 0135788899999988
Q ss_pred eeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeec
Q 040812 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLIN 187 (300)
Q Consensus 114 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~ 187 (300)
+.....+... ..|+||||++|+++.........++...+..++.|++.+|.++|+ .||+||||||+||+++
T Consensus 81 i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 81 VPVPEPILLK---KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCceEEEec---CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 7544433322 248999999987654443334568889999999999999999999 9999999999999998
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=154.01 Aligned_cols=123 Identities=21% Similarity=0.309 Sum_probs=98.0
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhc-----CCCceeEeceeeeCCCC--cEE-E
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQT-----NSPYIVKCHQIFTKPSG--EVS-I 130 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~--~~~-l 130 (300)
-.+.||+|+||.||. ++.++.. +||++..... .....+|+.+++++ .||||++++++++++.| .++ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 346799999999995 6666655 6898865322 22357899999999 57999999999988643 434 7
Q ss_pred EEec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHhHhCCccccCCCCCceeecCC
Q 040812 131 LMEY--MDAGSLEIYVKSRGRLSEDIICTISRQVLKGL-FYMHSRNIVHRDIKPANVLINEK 189 (300)
Q Consensus 131 v~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l-~~lH~~~i~H~Dlkp~Nill~~~ 189 (300)
|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++..
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~ 141 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRI 141 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEecc
Confidence 8999 5579999999764 56666 35678888887 99999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=179.66 Aligned_cols=202 Identities=29% Similarity=0.439 Sum_probs=146.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
-++|..++.|..|+||.||+++++.+.+.+|+|+-+.+. +++. |.. +. +..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l----------ilRn-----ilt----~a---~npfvv---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL----------ILRN-----ILT----FA---GNPFVV---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch----------hhhc-----ccc----cc---CCccee----
Confidence 356889999999999999999999999999996643221 1111 111 11 123344
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---------------------
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--------------------- 194 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~--------------------- 194 (300)
|+-...++.-+.++... +.+++|||+.||+|||+||+|.+|+.-+..+.
T Consensus 136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 56666676655665444 77899999999999999999999986554422
Q ss_pred -------------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 195 -------------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 195 -------------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
.++..|.+|+.... ..|++.+|+|++|+|+||.+-|+.||++...+.-+-.++.... .++..
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilr---qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-~wpE~- 280 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-EWPEE- 280 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhh---hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-ccccc-
Confidence 23445566665543 3478899999999999999999999988766544444443322 22222
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRW---TASQLLSHPFLAD 299 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rp---t~~~~l~hpw~~~ 299 (300)
.+.+.++++++|.++|+. +|..|. .+-++.+|+||..
T Consensus 281 dea~p~Ea~dli~~LL~q-np~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQ-NPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred CcCCCHHHHHHHHHHHHh-ChHhhcccchhhhhhhccceee
Confidence 556788999999999999 999997 4678899999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-19 Score=142.01 Aligned_cols=168 Identities=15% Similarity=0.063 Sum_probs=117.6
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC------CCHHHHHHHHhcCC-CceeEeceeeeCCCCcEEEEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP------PNPQELNILRQTNS-PYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+...|++|+||+|+++.. .+..++.+.+....... .+.+|+++|++++| +++++++++ . ..|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-GRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-CEEEEE
Confidence 3457899999999997776 46778877765433321 24679999999965 789999886 2 469999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCC-CCCceeecCCCCCCccceeecc--ccccc---
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI-KPANVLINEKMEHPCGYSCLYE--SGEAR--- 206 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dl-kp~Nill~~~~~~~~~~~~~~~--~~~~~--- 206 (300)
||+.|.+|.+.... . ...++.|++.+|.++|++||+|||| ||+|||++.++...+-+++... .+...
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999998754321 1 2357889999999999999999999 7999999876543322221111 00110
Q ss_pred --cc------------cCCCCC-----------C-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 040812 207 --HR------------KHGGYN-----------G-FAADIWSFGVTMMELYMGYYPFLEPG 241 (300)
Q Consensus 207 --~~------------~~~~~~-----------~-~~~DiwSlG~il~elltg~~pf~~~~ 241 (300)
.. ....+. + ...++++.|+-+|.++||..++...+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 001111 1 35799999999999999999986544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.8e-20 Score=172.41 Aligned_cols=179 Identities=21% Similarity=0.286 Sum_probs=135.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC---CCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN---SPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv 131 (300)
+...|.+-+.||+|+||.||+|...+ |+.||+|+-+..... .+.--.+++.+|+ -+.|..+...+.-.+ ..++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~-~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-EFYICLQVMERLKPQMLPSIMHISSAHVFQN-ASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-eeeehHHHHHhhchhhhcchHHHHHHHccCC-cceee
Confidence 44678999999999999999999988 999999997654433 2222344555565 234444444444444 56799
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc--ceeecccc------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--YSCLYESG------ 203 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--~~~~~~~~------ 203 (300)
+||.+.|+|.+++...+.+++..+..+..||+..+++||..+|||+||||+|+||......+-+ +..+.+++
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 9999999999999988889999999999999999999999999999999999999754222111 11111121
Q ss_pred -----------------ccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 040812 204 -----------------EARHRKHGGYNGFAADIWSFGVTMMELYMGYYP 236 (300)
Q Consensus 204 -----------------~~~~~~~~~~~~~~~DiwSlG~il~elltg~~p 236 (300)
...+...|..+++.+|.|.|..+++-||.|+.-
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 223344588899999999999999999998543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=148.38 Aligned_cols=125 Identities=14% Similarity=0.124 Sum_probs=98.9
Q ss_pred cceeeeeecCCcceEEEEEE-EccCCeEEEEEEeecCCCC-----------C---------------CCHHHHHHHHhcC
Q 040812 58 QLEKLQVLGQGNGGTVFKVR-HKQTLALYALKVMQCDRGT-----------P---------------PNPQELNILRQTN 110 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-----------~---------------~~~~E~~~l~~l~ 110 (300)
-|++.+.||+|+||.||+|. +..+|+.||+|+++..... . ...+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999999 6678999999998754210 0 0236899999987
Q ss_pred CCc--eeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC-ccccCCCCCceeec
Q 040812 111 SPY--IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN-IVHRDIKPANVLIN 187 (300)
Q Consensus 111 h~n--iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-i~H~Dlkp~Nill~ 187 (300)
+.+ +..+++. . ..++||||++|++|.........+....+..++.||+.+|.+||++| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 533 3344432 2 35899999999888776544455677778899999999999999999 99999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.3e-18 Score=138.69 Aligned_cols=118 Identities=19% Similarity=0.271 Sum_probs=96.6
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----------CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----------PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+.||+|++|.||+|.+ .+..+++|......... ...+|+.++..+.|+++.....++.... ..++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-NFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-CCEEEE
Confidence 5799999999999988 46788999865433211 2346899999999998876666555443 678999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
||++|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|+|||++
T Consensus 79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS 129 (211)
T ss_pred EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE
Confidence 9999999999987532 2 7889999999999999999999999999999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=153.31 Aligned_cols=185 Identities=23% Similarity=0.274 Sum_probs=140.9
Q ss_pred HHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCc-cccCCCCCc
Q 040812 106 LRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNI-VHRDIKPAN 183 (300)
Q Consensus 106 l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i-~H~Dlkp~N 183 (300)
|+.+.|.|+.+++|.+.+. +..++|.+||..|+|.+.+.. ...++......+++.|+.||.|||...| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4678999999999999886 489999999999999999987 4468889999999999999999998765 999999999
Q ss_pred eeecCCCCCCccc---------------------eeeccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 040812 184 VLINEKMEHPCGY---------------------SCLYESGEARHRKHG----GYNGFAADIWSFGVTMMELYMGYYPFL 238 (300)
Q Consensus 184 ill~~~~~~~~~~---------------------~~~~~~~~~~~~~~~----~~~~~~~DiwSlG~il~elltg~~pf~ 238 (300)
++++.....+..+ ..+|.+||....... ...+.+.||||||++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 9999764433222 223455554432211 124678999999999999999999998
Q ss_pred CCCCCchHHHHHHHHhh-CCCCCCCC-----CCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 239 EPGQEPDFLSLMLAICF-REPPSLPE-----CSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
.........+++..+.. ...+..|. ...+++..++..||.. +|++||+++++-
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e-~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEE-IPEKRPSIEQIR 218 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhccc-ChhhCccHHHHH
Confidence 75544443445444333 22222222 3455799999999999 999999998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-19 Score=164.56 Aligned_cols=240 Identities=23% Similarity=0.287 Sum_probs=178.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-CCeEEEEEEeecCCCCCC----CHHHHHHHHhcC-CCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ-TLALYALKVMQCDRGTPP----NPQELNILRQTN-SPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 129 (300)
...|.+.+.||+|+|+.|-+..... +...+|.|.+........ ...|..+-+.+. |.|++.+++...... ..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-ccc
Confidence 3457888889999999999988743 445677776654331111 133777777776 999999999987765 789
Q ss_pred EEEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHhH-hCCccccCCCCCceeecCCC-CC---Ccc-------
Q 040812 130 ILMEYMDAGSLEIYV-KSRG-RLSEDIICTISRQVLKGLFYMH-SRNIVHRDIKPANVLINEKM-EH---PCG------- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~qi~~~l~~lH-~~~i~H~Dlkp~Nill~~~~-~~---~~~------- 195 (300)
++++|..|+++...+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .. +++
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999988 5544 5778889999999999999999 99999999999999999876 32 111
Q ss_pred -------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC
Q 040812 196 -------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 196 -------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (300)
.+.-|.+||..... .+.++..|+||.|+++.-+++|..|+........................+
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~--~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGK--AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccch--hhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 12233333333321 345678999999999999999999997654443322222111112124455
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+....+++.+++.. +|+.|.+.+++..++|+..
T Consensus 256 ~~~~~~~~~~l~k~l~~-~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKE-NPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccC-Cchhccccccccccccccc
Confidence 67788899999999998 9999999999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=133.84 Aligned_cols=123 Identities=17% Similarity=0.179 Sum_probs=94.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC------------------------CCCHHHHHHHHhcCCCc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT------------------------PPNPQELNILRQTNSPY 113 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~E~~~l~~l~h~n 113 (300)
.|.+.+.||+|+||.||++... +|+.||||++...... ....+|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3777899999999999999885 6899999987643210 01245788888887774
Q ss_pred --eeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC
Q 040812 114 --IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191 (300)
Q Consensus 114 --iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~ 191 (300)
+...++ . +..++||||++|++|...... .....++.+++.++.++|+.|++|+||||+||+++.++.
T Consensus 95 i~v~~~~~---~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 95 FPVPKPID---W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCceee---c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 333333 1 246899999999998765431 345678899999999999999999999999999987644
Q ss_pred C
Q 040812 192 H 192 (300)
Q Consensus 192 ~ 192 (300)
.
T Consensus 164 ~ 164 (198)
T cd05144 164 I 164 (198)
T ss_pred E
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=151.69 Aligned_cols=121 Identities=17% Similarity=0.164 Sum_probs=94.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-CC---------CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-GT---------PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
...|...+.||+|+||.||++.+.... +++|...... .. ..+.+|+.+++.++|++++....+.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344567899999999999999886543 3444322111 10 12357999999999999887766555443
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
..++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||++
T Consensus 410 -~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~ 462 (535)
T PRK09605 410 -EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462 (535)
T ss_pred -CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE
Confidence 6789999999999999885 3467899999999999999999999999999994
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-17 Score=131.87 Aligned_cols=114 Identities=15% Similarity=0.220 Sum_probs=88.7
Q ss_pred eecCCcceEEEEEEEccCCeEEEEEEeecCCCC----------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
.||+|+||.||++.+ ++..+++|........ ....+|+.++..+.|+++.....++..+. ..++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-NKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-CCEEEEE
Confidence 389999999999985 4678999986543211 11246999999998876544333333333 5789999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
|++|++|.+++..... .++.|++.+|.+||+.|++|+|++|+||+++
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~ 124 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR 124 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE
Confidence 9999999988765321 7899999999999999999999999999998
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.4e-16 Score=124.87 Aligned_cols=118 Identities=18% Similarity=0.245 Sum_probs=82.3
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC--------------------------HHHHHHHHhcCCCc--
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--------------------------PQELNILRQTNSPY-- 113 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--------------------------~~E~~~l~~l~h~n-- 113 (300)
.+.||+|+||.||+|.+. +++.||||++......... ..|...+.++.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 7889999998754321100 13444454443332
Q ss_pred eeEeceeeeCCCCcEEEEEeccCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeec
Q 040812 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEI-YVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLIN 187 (300)
Q Consensus 114 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~ 187 (300)
+.+.++. ...++||||++++.+.. .+... ... ..+..++.+++.++.++|. .||+|+||||+||+++
T Consensus 81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec-----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333332 14589999999854321 11111 111 6678999999999999999 9999999999999998
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=125.25 Aligned_cols=121 Identities=18% Similarity=0.219 Sum_probs=91.2
Q ss_pred eeec-CCcceEEEEEEEccCCeEEEEEEeecCCC---------------CCCCHHHHHHHHhcCCCce--eEeceeeeCC
Q 040812 63 QVLG-QGNGGTVFKVRHKQTLALYALKVMQCDRG---------------TPPNPQELNILRQTNSPYI--VKCHQIFTKP 124 (300)
Q Consensus 63 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 124 (300)
..|| .||.|+||.+... +..+++|.+..... .....+|+.++.+++|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 8999999998875 66889998753210 1123569999999998875 6666654333
Q ss_pred CCc---EEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 125 SGE---VSILMEYMDA-GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 125 ~~~---~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
.+. .++|||+++| .+|.+++... .+++. .+.||+.+|.+||++||+||||||+|||++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC
Confidence 322 3599999997 6999888653 45544 367899999999999999999999999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.2e-15 Score=114.43 Aligned_cols=119 Identities=23% Similarity=0.317 Sum_probs=97.8
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC--CceeEeceeeeCCCCcEEEEEeccCCC
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS--PYIVKCHQIFTKPSGEVSILMEYMDAG 138 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~~ 138 (300)
+++.||+|.++.||++...+ ..+++|..........+.+|+..++.++| .++++++.+.... +..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecCCe
Confidence 45789999999999999865 67899998654433356789999999977 4888888877654 4799999999988
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC---CccccCCCCCceeecCC
Q 040812 139 SLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR---NIVHRDIKPANVLINEK 189 (300)
Q Consensus 139 ~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~i~H~Dlkp~Nill~~~ 189 (300)
.+..+ +......++.+++.+|..+|.. +++|+|++|+||+++..
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 77654 5566778899999999999985 79999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-16 Score=136.05 Aligned_cols=157 Identities=23% Similarity=0.342 Sum_probs=115.8
Q ss_pred cEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------- 196 (300)
++||.|++|.-.+|.+++..+. ..+......+++|+..|+.| +|.+|+|+||.||++..+...++|.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999997543 36778889999999999999 9999999999999998765443332
Q ss_pred ------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCC
Q 040812 197 ------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFRE 257 (300)
Q Consensus 197 ------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (300)
+..|+.||... |..|+.++||||||+|++|+++ -...|.- ......+..+.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~---g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~ 476 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIR---GQQYSEKVDIYALGLILAELLIQFSTQFER-------IATLTDIRDGI 476 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHh---hhhhhhhcchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCC
Confidence 44455555544 6778999999999999999997 3333311 11122222222
Q ss_pred CC-CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 258 PP-SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 258 ~~-~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+ .+..+. +.-.+|+.+++.. .|.+||++.+.--|+|+.
T Consensus 477 ip~~~~~d~-p~e~~ll~~lls~-~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 477 IPPEFLQDY-PEEYTLLQQLLSP-SPEERPSAIEVALHEFLQ 516 (516)
T ss_pred CChHHhhcC-cHHHHHHHHhcCC-CcccCchHHHHhhhhhcC
Confidence 22 233333 3446899999999 999999988888888863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-14 Score=126.71 Aligned_cols=230 Identities=24% Similarity=0.318 Sum_probs=168.6
Q ss_pred cceeeeeecC--CcceEEEEEEE--ccCCeEEEEEEeecCC----CCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcE
Q 040812 58 QLEKLQVLGQ--GNGGTVFKVRH--KQTLALYALKVMQCDR----GTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 58 ~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 128 (300)
.+.+.+.+|+ |++|.||.+.. ..++..+|+|.-+... ....-.+|+...+++ .|+|.++.+..++.. +..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~-~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS-GIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC-Ccc
Confidence 3667888999 99999999998 8889999999743221 222235677777766 589999988887764 489
Q ss_pred EEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHhHhCCccccCCCCCceeecCC-CCCCccc------
Q 040812 129 SILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLK----GLFYMHSRNIVHRDIKPANVLINEK-MEHPCGY------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~----~l~~lH~~~i~H~Dlkp~Nill~~~-~~~~~~~------ 196 (300)
|+-+|+|. .+|..+...... ++...++..+.+..+ ||.++|..+++|-|+||+||++..+ .....+.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999996 589888887555 889999999999999 9999999999999999999999887 3322221
Q ss_pred ------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 197 ------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 197 ------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
.+.|..++.. .+.++.+.|++|+|.++.+..+|..+...... ..+...-. ...+
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~----~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~---~~ip 344 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELL----NGLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQ---GYIP 344 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhh----ccccchHhhhcchhhhhHhhHhhcccccCCCC-CCcccccc---ccCc
Confidence 1223333332 23457799999999999999998766643211 11111110 0122
Q ss_pred CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 259 ~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.++-+..+..+...+..+++. +|-.|++++.+++|+++.
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~-~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDE-DPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCc-chhhhhHHHHHhcccccc
Confidence 223334466677799999999 999999999999999874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.7e-14 Score=119.75 Aligned_cols=187 Identities=23% Similarity=0.292 Sum_probs=130.3
Q ss_pred HHHhcCCCceeEeceeeeCCC----CcEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCC--c
Q 040812 105 ILRQTNSPYIVKCHQIFTKPS----GEVSILMEYMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRN--I 174 (300)
Q Consensus 105 ~l~~l~h~niv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~--i 174 (300)
.+-++-|.|||+++.++.+.. ....++.||++.|++.+++++. ..+.....++|+.||++||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344567999999999986532 2478999999999999999853 24788889999999999999999875 9
Q ss_pred cccCCCCCceeecCCCCCCccceeec-ccccc-------------------ccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 040812 175 VHRDIKPANVLINEKMEHPCGYSCLY-ESGEA-------------------RHRKHGGYNGFAADIWSFGVTMMELYMGY 234 (300)
Q Consensus 175 ~H~Dlkp~Nill~~~~~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~DiwSlG~il~elltg~ 234 (300)
+|+++..+-|++..++..++|....- ..+.+ +........+.++|||+||....+|..++
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999998876655532110 00100 00001112234899999999999998887
Q ss_pred CCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 235 YPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 235 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.--.+........+.+....... ....-++++..|++. .|..||++.+++.||-+=+
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~l-------en~lqr~~i~kcl~~-eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGL-------ENGLQRGSITKCLEG-EPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eccCCCcceeehhhhhhhheeec-------cCccccCcCcccccC-CCCCCcchhhhhcCceeee
Confidence 65433322222222222211111 122346789999999 9999999999999997643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=136.63 Aligned_cols=238 Identities=25% Similarity=0.300 Sum_probs=172.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+.+.+++.+-+|.++.++.+.-..++...+.|+........ ....+-.++....+|-+++....+.. ....++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~-rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC-RSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC-CCCcch
Confidence 345678889999999999999999888888888765322111 11223333333445767766554333 347899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------ 198 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------ 198 (300)
|++|+.+++|...++..+..+..-++..+..+..++++||...+.|+|++|.|++....+..+...+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99999999999999988778888889999999999999999999999999999998765443222111
Q ss_pred --------------------------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 040812 199 --------------------------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP 240 (300)
Q Consensus 199 --------------------------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 240 (300)
-|.+|+.. .|...+..+|+|++|++++|.++|.+||...
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~---lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL---LGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCccc---ccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 01111111 1333456899999999999999999999776
Q ss_pred CCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHH---HHhcCCCCCCC
Q 040812 241 GQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTAS---QLLSHPFLADA 300 (300)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~---~~l~hpw~~~~ 300 (300)
.....+.++... ....+.-+...++...+++...+.. +|.+|..+. ++-.|+||.++
T Consensus 1039 tpq~~f~ni~~~--~~~~p~g~~~~s~~aq~~~~~ll~~-~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNR--DIPWPEGPEEGSYEAQDLINRLLTE-EPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccC--CCCCCCCccccChhhhhhhhhhhcc-CchhccCcccccccccCCccCCC
Confidence 655444333221 1123344567788999999999999 999999987 99999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.8e-13 Score=121.52 Aligned_cols=153 Identities=20% Similarity=0.280 Sum_probs=116.3
Q ss_pred EEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCH
Q 040812 75 KVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSE 152 (300)
Q Consensus 75 ~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 152 (300)
-|..+.++.+|.|...+.... .....+-++.|+.++||||+++++.++.+. .+|+|+|.+. .|..+++.. +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~--Pl~~~lk~l---~~ 103 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERVR--PLETVLKEL---GK 103 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeeccc--cHHHHHHHh---HH
Confidence 356666788888888876655 222356788899999999999999988765 8999999984 888888754 47
Q ss_pred HHHHHHHHHHHHHHHHhH-hCCccccCCCCCceeecCCCCCCccceeecccccccc------ccCCCCCCc--------h
Q 040812 153 DIICTISRQVLKGLFYMH-SRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARH------RKHGGYNGF--------A 217 (300)
Q Consensus 153 ~~~~~i~~qi~~~l~~lH-~~~i~H~Dlkp~Nill~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~--------~ 217 (300)
..+...++||+.||.||| +++++|++|..+.|+++..+...+|+.-......... .....+..+ .
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s 183 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWS 183 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccc
Confidence 778889999999999998 6789999999999999999998887654432111110 000111111 3
Q ss_pred hhHHHHHHHHHHHHhC
Q 040812 218 ADIWSFGVTMMELYMG 233 (300)
Q Consensus 218 ~DiwSlG~il~elltg 233 (300)
.|.|-|||+++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 5999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=7e-13 Score=120.98 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=90.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----------------------C------------------
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----------------------T------------------ 96 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------~------------------ 96 (300)
..|+. +.||+|++|+||+|+.+.+|+.||||+.+.... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 789999999999999998899999999864310 0
Q ss_pred --CCCHHHHHHHHhc----CCCceeEeceeeeCCCCcEEEEEeccCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHH
Q 040812 97 --PPNPQELNILRQT----NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIY--VKSRG----RLSEDIICTISRQVLK 164 (300)
Q Consensus 97 --~~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~----~l~~~~~~~i~~qi~~ 164 (300)
-++.+|+..+.++ .+.+.+.+-.++.+-.+..++||||++|+.+.++ +...+ .+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 0112344444443 2444444444443323467899999999999874 23322 234444445555554
Q ss_pred HHHHhHhCCccccCCCCCceeecCCCCCCccceeecccccc
Q 040812 165 GLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEA 205 (300)
Q Consensus 165 ~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~~~~~~~ 205 (300)
..|++|+|+||+||+++.++.. .+.....+++..
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~-~~~i~llDFGiv 311 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPE-NPRYIALDFGIV 311 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCC-CCeEEEEecceE
Confidence 5899999999999999887521 123444555544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.7e-14 Score=124.23 Aligned_cols=232 Identities=22% Similarity=0.235 Sum_probs=167.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-cCCeEEEEEEeecCCCCC----CCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-QTLALYALKVMQCDRGTP----PNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
..+.+|..+..||.|.|+.|+.+..+ .++..|++|.+.+..... ....|+.+...+ .|.+++.....|...+ .
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-Q 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-c
Confidence 34667899999999999999998866 678899999876543221 124566666655 5788888777666544 6
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC-CCCCccceeecc-----
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-MEHPCGYSCLYE----- 201 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~-~~~~~~~~~~~~----- 201 (300)
.|+-.|||+++++.........+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +....+....+.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 77999999999998777655578899999999999999999999999999999999999885 333333322221
Q ss_pred -------------ccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 202 -------------SGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 202 -------------~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++...+ ......+.|++|||..+.+..+|.+--..... ...+..+..+..+... ..
T Consensus 421 ~~~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~~i~~~~~p~~~~~~-~~ 489 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLE---DYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SLTIRSGDTPNLPGLK-LQ 489 (524)
T ss_pred cccccccccccccchhhcc---ccccccccccccccccccccccCcccCccccc-------ceeeecccccCCCchH-Hh
Confidence 111111 22345689999999999999998544322111 1112223334444433 77
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+..+.+.++.. ++..|+.+.++..|.=|.
T Consensus 490 ~q~~~kv~~~~-~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINP-DRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCC-ccccchhhhhhcccchhh
Confidence 88888899988 999999999999887554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-12 Score=115.83 Aligned_cols=125 Identities=15% Similarity=0.136 Sum_probs=84.0
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC------------------------------------------CCCH
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT------------------------------------------PPNP 100 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------------------~~~~ 100 (300)
+.||+|++|.||+|+.+ +|+.||||+.+..... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999976 5899999997543100 0123
Q ss_pred HHHHHHHhc----CCCceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHhHhCCc
Q 040812 101 QELNILRQT----NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLK-GLFYMHSRNI 174 (300)
Q Consensus 101 ~E~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~-~l~~lH~~~i 174 (300)
+|+..+.++ +|.+-+.+-.++..-.+..++||||++|++|.++.... ...+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 355555544 23333333333332233578999999999998876532 1222 3345555555 4678899999
Q ss_pred cccCCCCCceeecCCCC
Q 040812 175 VHRDIKPANVLINEKME 191 (300)
Q Consensus 175 ~H~Dlkp~Nill~~~~~ 191 (300)
+|+|++|+||+++.++.
T Consensus 279 ~H~D~hPgNilv~~~g~ 295 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK 295 (437)
T ss_pred eeCCCCcccEEECCCCc
Confidence 99999999999987743
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.4e-12 Score=99.36 Aligned_cols=114 Identities=16% Similarity=0.144 Sum_probs=84.8
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCcee-EeceeeeCCCCcEEEEEeccCCCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIV-KCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
++.|+.|.++.||++... ++.|++|+...... ......|+.+++.+.+.+++ +++... . . ..++|||+++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~-~-~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-P-E-TGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-C-C-CCeEEEEecCCCc
Confidence 467899999999999875 67899999765432 22346799999988765544 454443 2 2 3479999999988
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCc-----cccCCCCCceeecC
Q 040812 140 LEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI-----VHRDIKPANVLINE 188 (300)
Q Consensus 140 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i-----~H~Dlkp~Nill~~ 188 (300)
+... . .....++.+++.+|..||..++ +|+|++|+||+++.
T Consensus 78 l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~ 123 (170)
T cd05151 78 LLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD 123 (170)
T ss_pred cccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC
Confidence 7643 0 1123467899999999999885 99999999999983
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.3e-11 Score=96.11 Aligned_cols=134 Identities=14% Similarity=0.199 Sum_probs=94.0
Q ss_pred eeecCCcceEEEEEEEcc------CCeEEEEEEeecCC-----------CC--------CCC---------HHHHHHHHh
Q 040812 63 QVLGQGNGGTVFKVRHKQ------TLALYALKVMQCDR-----------GT--------PPN---------PQELNILRQ 108 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~-----------~~--------~~~---------~~E~~~l~~ 108 (300)
..||.|-=+.||.|.... .+..+|||+.+... .. ... .+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 35789999985211 00 000 258888888
Q ss_pred cCC--CceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-HhCCccccCCCCCcee
Q 040812 109 TNS--PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM-HSRNIVHRDIKPANVL 185 (300)
Q Consensus 109 l~h--~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~i~H~Dlkp~Nil 185 (300)
+.. -++..++++ . ..++||||+.++.+..-.-....++...+..+..+++.+|..| |..|++|+||++.||+
T Consensus 83 l~~~Gv~vP~pi~~----~-~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 83 MQKAGIPCPEVVVL----K-KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHcCCCCCeEEEe----c-CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 754 456666664 2 4579999997754432222223456667788899999999998 8999999999999999
Q ss_pred ecCCCCCCccceeecccccccc
Q 040812 186 INEKMEHPCGYSCLYESGEARH 207 (300)
Q Consensus 186 l~~~~~~~~~~~~~~~~~~~~~ 207 (300)
++.+ ...+.+++.+..
T Consensus 158 ~~~~------~v~iIDF~qav~ 173 (197)
T cd05146 158 WHDG------KVWFIDVSQSVE 173 (197)
T ss_pred EECC------cEEEEECCCcee
Confidence 9753 344556665544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-10 Score=101.26 Aligned_cols=214 Identities=14% Similarity=0.188 Sum_probs=149.1
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC--CHHHHHHHHhcCCCceeEeceeeeCC---CCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP--NPQELNILRQTNSPYIVKCHQIFTKP---SGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~lv~e~~~~ 137 (300)
+..+.-.-.+.|++....+|..|++|.++.++.... .-.-+++++++.|.|+|++.++|... ...+++|++|.++
T Consensus 282 ~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 282 ELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ccccccccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 334433456789999999999999999954443222 23467889999999999999988632 2358999999886
Q ss_pred -CCHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceeecc
Q 040812 138 -GSLEIYVKS---------------RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYE 201 (300)
Q Consensus 138 -~~L~~~l~~---------------~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~~~ 201 (300)
++|.++--. +...++..+|.++.|+..||.++|+.|+.-+-|.+.+|+++.+....+.+.+.++
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccccee
Confidence 566554421 1246789999999999999999999999999999999999988665544433332
Q ss_pred ----cc-ccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHH
Q 040812 202 ----SG-EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276 (300)
Q Consensus 202 ----~~-~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (300)
.+ +..+. -.+-|.=.||.++..|.||..--...+..+ +.. ...+-..++.+++++|.-+
T Consensus 442 vl~~d~~~~le~------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~---~s~-------~~~I~~~yS~D~rn~v~yl 505 (655)
T KOG3741|consen 442 VLQEDPTEPLES------QQQNDLRDLGLLLLALATGTENSNRTDSTQ---SSH-------LTRITTTYSTDLRNVVEYL 505 (655)
T ss_pred eecCCCCcchhH------HhhhhHHHHHHHHHHHhhcccccccccchH---HHH-------HHHhhhhhhHHHHHHHHHH
Confidence 11 11111 237899999999999999954422211111 110 0112244678888999888
Q ss_pred hccCCCCCCCCHHHHhcC
Q 040812 277 LQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 277 l~~~dp~~Rpt~~~~l~h 294 (300)
... ++++ -++++++.|
T Consensus 506 ~s~-~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 506 ESL-NFRE-KSIQDLLPM 521 (655)
T ss_pred Hhc-Cccc-ccHHHHHHH
Confidence 877 7775 677777643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.3e-10 Score=92.37 Aligned_cols=106 Identities=18% Similarity=0.167 Sum_probs=75.2
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCC--ceeEeceeeeCCC--CcEEEEEecc
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSP--YIVKCHQIFTKPS--GEVSILMEYM 135 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~--~~~~lv~e~~ 135 (300)
+.|+.|.++.||++...+ |+.+++|+...... .....+|..+++.+.+. ++.+++.+..... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998754 57899999765432 33457899999998763 3566666544321 3568999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH 170 (300)
+|.++.+.+.. ..++......++.+++.+|..||
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALH 116 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHh
Confidence 99888765432 24566666666777777777766
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.7e-09 Score=83.79 Aligned_cols=116 Identities=18% Similarity=0.220 Sum_probs=83.1
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----------CCHHHHHHHHhcCCCce--eEeceeeeCCCCcEEE
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----------PNPQELNILRQTNSPYI--VKCHQIFTKPSGEVSI 130 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~l 130 (300)
..+++|+=+.++.+.+. |..+++|.=.+..... ...+|+.++.++.--.| ..++++ ++. ...|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~-~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD-NGLI 76 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC-CCEE
Confidence 35788999999999775 4456666522222111 12469999988765444 344444 333 5679
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
+|||++|-.|.+.+... ...++..+=.-+.-||..||+|+||.++||++....
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~ 129 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR 129 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc
Confidence 99999999999898765 145666666777889999999999999999998864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.8e-09 Score=80.32 Aligned_cols=129 Identities=19% Similarity=0.254 Sum_probs=91.0
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----------CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----------PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+..+-+|+-+.|+++.+. |+.++||.=....... ...+|++.|.+..--+|.-..-++.+.. .-+|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-GGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-CCeE
Confidence 4577889999999999987 6777777532222221 2246888888876544443333343433 4579
Q ss_pred EEeccCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 131 LMEYMDA-GSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 131 v~e~~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
+|||++| .++.+++.... .........++++|-+.+.-||..+|+|+||..+||++.+++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCc
Confidence 9999977 47788886532 12223336889999999999999999999999999999877543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.9e-09 Score=86.37 Aligned_cols=116 Identities=16% Similarity=0.138 Sum_probs=81.6
Q ss_pred eEEEEEEEccCCeEEEEEEeecCCC-----------CC--CCHHHHHHHHhcCCCce--eEeceeeeCC----CCcEEEE
Q 040812 71 GTVFKVRHKQTLALYALKVMQCDRG-----------TP--PNPQELNILRQTNSPYI--VKCHQIFTKP----SGEVSIL 131 (300)
Q Consensus 71 g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~--~~~~E~~~l~~l~h~ni--v~~~~~~~~~----~~~~~lv 131 (300)
..|.++.. .|+.|.||....... .. .+.+|...+.++..-+| +.++.+.+.. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555544 366788886532220 11 24679888888754433 2334444321 1247899
Q ss_pred EeccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC
Q 040812 132 MEYMDAG-SLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE 188 (300)
Q Consensus 132 ~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~ 188 (300)
||++++. +|.+++.. ....+......++.+++..+.-||+.||+|+|+++.|||++.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHL 173 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEec
Confidence 9999885 89998864 234567788899999999999999999999999999999985
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6e-10 Score=101.57 Aligned_cols=135 Identities=23% Similarity=0.328 Sum_probs=92.9
Q ss_pred HHHHHhHh-CCccccCCCCCceeecCCCCCCccceee--------------ccccccc-----------cccCCCCCCch
Q 040812 164 KGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGYSCL--------------YESGEAR-----------HRKHGGYNGFA 217 (300)
Q Consensus 164 ~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~~~~--------------~~~~~~~-----------~~~~~~~~~~~ 217 (300)
.|+.|+|. .+++|++|.|++|.++.++..+.+++.. |+++... +...+...+.+
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~ 189 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPA 189 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccc
Confidence 89999995 5899999999999999987655443222 2222111 11112334568
Q ss_pred hhHHHHHHHHHHHH-hCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 040812 218 ADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296 (300)
Q Consensus 218 ~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw 296 (300)
+|++|+||++|-+. .|+.-+...+.... .........-........+++++++-+.+++.. ++..||++..++..||
T Consensus 190 sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~-~~~~rp~~~~l~~~~f 267 (700)
T KOG2137|consen 190 SDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNG-DSAVRPTLDLLLSIPF 267 (700)
T ss_pred ccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcccccccccccccCcHHHHHHHHHHhcC-CcccCcchhhhhcccc
Confidence 99999999999998 56666654433221 121111111222334567889999999999999 9999999999999999
Q ss_pred CCCC
Q 040812 297 LADA 300 (300)
Q Consensus 297 ~~~~ 300 (300)
|.|.
T Consensus 268 f~D~ 271 (700)
T KOG2137|consen 268 FSDP 271 (700)
T ss_pred cCCc
Confidence 9873
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.2e-09 Score=85.12 Aligned_cols=147 Identities=20% Similarity=0.205 Sum_probs=104.0
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----------------C-------CCCHHHHHHHHhcCCC--c
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----------------T-------PPNPQELNILRQTNSP--Y 113 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------~-------~~~~~E~~~l~~l~h~--n 113 (300)
.++..||-|-=+.||.|.+.+ |..+|+|.-+.... . ....+|..+|.++... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456889999999999999985 78999998642110 0 0124699999998765 6
Q ss_pred eeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC
Q 040812 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP 193 (300)
Q Consensus 114 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~ 193 (300)
+.+.+++ + ..++|||+++|-.|... +++......++..|+.-+.-+-..|++|+|+.+-||+++++
T Consensus 173 VP~P~~~----n-RHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d---- 238 (304)
T COG0478 173 VPKPIAW----N-RHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED---- 238 (304)
T ss_pred CCCcccc----c-cceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC----
Confidence 7777775 2 56899999999665432 23456667777788877777778999999999999999998
Q ss_pred ccceeeccccccccccCCCC-CCchhhHHH
Q 040812 194 CGYSCLYESGEARHRKHGGY-NGFAADIWS 222 (300)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~-~~~~~DiwS 222 (300)
|+....+.|.+........ .--.-||+.
T Consensus 239 -g~~~vIDwPQ~v~~~hp~a~e~l~RDv~n 267 (304)
T COG0478 239 -GDIVVIDWPQAVPISHPDAEELLERDVEN 267 (304)
T ss_pred -CCEEEEeCcccccCCCCCHHHHHHhHHHH
Confidence 4555666766644322110 112457776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.1e-08 Score=78.73 Aligned_cols=122 Identities=20% Similarity=0.253 Sum_probs=76.4
Q ss_pred EEEEEEEccCCeEEEEEEeecCC-----------CCCC-----------------CHHHHHHHHhcCCC--ceeEeceee
Q 040812 72 TVFKVRHKQTLALYALKVMQCDR-----------GTPP-----------------NPQELNILRQTNSP--YIVKCHQIF 121 (300)
Q Consensus 72 ~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~-----------------~~~E~~~l~~l~h~--niv~~~~~~ 121 (300)
.||.|...+ +..+|+|+.+... .... ..+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998865 6799999985321 0001 13599999999876 466676552
Q ss_pred eCCCCcEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-hHhCCccccCCCCCceeecCCCCCCcccee
Q 040812 122 TKPSGEVSILMEYMD--AGSLEIYVKSRGRLSEDIICTISRQVLKGLFY-MHSRNIVHRDIKPANVLINEKMEHPCGYSC 198 (300)
Q Consensus 122 ~~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~-lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~ 198 (300)
..++||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.||+++.+. ..
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~------~~ 146 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGK------VY 146 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTC------EE
T ss_pred -----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecce------EE
Confidence 2369999998 65555444321 2245567788888885555 5799999999999999998862 33
Q ss_pred ecccccccc
Q 040812 199 LYESGEARH 207 (300)
Q Consensus 199 ~~~~~~~~~ 207 (300)
..+++.+..
T Consensus 147 iIDf~qav~ 155 (188)
T PF01163_consen 147 IIDFGQAVD 155 (188)
T ss_dssp E--GTTEEE
T ss_pred EEecCccee
Confidence 445554443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.2e-07 Score=77.08 Aligned_cols=92 Identities=14% Similarity=0.168 Sum_probs=71.6
Q ss_pred CHHHHHHHHhcCCCc--eeEeceeeeCCC---CcEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC
Q 040812 99 NPQELNILRQTNSPY--IVKCHQIFTKPS---GEVSILMEYMDA-GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172 (300)
Q Consensus 99 ~~~E~~~l~~l~h~n--iv~~~~~~~~~~---~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 172 (300)
..+|...+..+..-+ +...+++.+... ...++|+|++++ .+|.+++.....++......++.+++..+.-||+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~ 137 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDA 137 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHC
Confidence 356888877775433 334444443322 136899999988 48999998755577788899999999999999999
Q ss_pred CccccCCCCCceeecCCC
Q 040812 173 NIVHRDIKPANVLINEKM 190 (300)
Q Consensus 173 ~i~H~Dlkp~Nill~~~~ 190 (300)
||+|+|+++.|||++.+.
T Consensus 138 gi~H~Dl~~~NILv~~~~ 155 (206)
T PF06293_consen 138 GIYHGDLNPSNILVDPDD 155 (206)
T ss_pred cCCCCCCCcccEEEeCCC
Confidence 999999999999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.7e-06 Score=69.41 Aligned_cols=124 Identities=15% Similarity=0.082 Sum_probs=87.0
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeec--------CCCCCCCHHHHHHHHhcCCCc--eeEeceee-e-CC-CCcEEEE
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQC--------DRGTPPNPQELNILRQTNSPY--IVKCHQIF-T-KP-SGEVSIL 131 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~-~-~~-~~~~~lv 131 (300)
-|+||-+-|+.....+. .+=+|.-.+ ......+.+|+..+.++..-+ +.+....- . .+ .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 45688888888765532 455665431 113344578999999886533 33443211 1 11 1136799
Q ss_pred EeccCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 132 MEYMDA-GSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 132 ~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
+|-++| .+|.+++.+. .+.+......++.+++..++-||+.|+.|+|+.+.||+++.++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g 165 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG 165 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC
Confidence 997764 6898888653 3467788889999999999999999999999999999998654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.6e-06 Score=72.74 Aligned_cols=227 Identities=14% Similarity=0.188 Sum_probs=135.9
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEecee-----e-eCCCCcEEEEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQI-----F-TKPSGEVSILM 132 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-----~-~~~~~~~~lv~ 132 (300)
...+.||+|+-+.+|-.-...+ . +.|+......... .+.+..|.+. .||-+-.-+.| + .+....+-++|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~-VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--Q-VAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhc--h-hheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3457899999999996544322 3 4477654332211 2233333332 45533321111 1 12122367888
Q ss_pred eccCCC-CHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------
Q 040812 133 EYMDAG-SLEIYVKS------RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------- 195 (300)
Q Consensus 133 e~~~~~-~L~~~l~~------~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------- 195 (300)
..+.+. -+..+... .....+..+....+.++.+..-||+.|..-+|+.++|+|++++.....-
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccC
Confidence 888774 23333321 2246789999999999999999999999999999999999876442110
Q ss_pred --------ceeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC---CCchHHH-HHHHH-------
Q 040812 196 --------YSCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMG-YYPFLEPG---QEPDFLS-LMLAI------- 253 (300)
Q Consensus 196 --------~~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~---~~~~~~~-~~~~~------- 253 (300)
+..-|.+||.... ..|-..+...|-|.||+++++++.| +.||.+.. ....-.+ .+...
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~ 249 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD 249 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence 1233556655431 2233445689999999999999876 99996532 1111111 11110
Q ss_pred ---hhCC-CCCCC-CCCChHHHHHHHHHhccC-CCCCCCCHHH
Q 040812 254 ---CFRE-PPSLP-ECSSEKFRDFIRCCLQKG-DPSKRWTASQ 290 (300)
Q Consensus 254 ---~~~~-~~~~~-~~~~~~l~~li~~~l~~~-dp~~Rpt~~~ 290 (300)
.... +...| +.+++.+..+..+|.... ++.-|||++.
T Consensus 250 ~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 250 QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0001 11122 345788999999999763 4668999764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.5e-06 Score=70.06 Aligned_cols=124 Identities=16% Similarity=0.235 Sum_probs=78.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----------CCHHHHHHHHhcCCCcee---Eeceeee
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----------PNPQELNILRQTNSPYIV---KCHQIFT 122 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~E~~~l~~l~h~niv---~~~~~~~ 122 (300)
.+|...+.+-......|.+-.-. |+.+++|..+...... ...+++..+.+++..++. .++-+.+
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46777888888887777766554 6788999876533211 012334444444332222 2222211
Q ss_pred CC----CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 123 KP----SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 123 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
.. ....++||||++|..|.++.. +++ .+...+.+++.-||+.|+.|+|..|+|++++.++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence 11 114568999999988876543 232 2456677889999999999999999999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.7e-05 Score=71.36 Aligned_cols=132 Identities=15% Similarity=0.180 Sum_probs=81.6
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCC---------------------CC---------------------CCH
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---------------------TP---------------------PNP 100 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~---------------------~~~ 100 (300)
..|+.++-|+||.|+.++ |+.||||+.+.+-. .. +..
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999987 89999999753210 00 012
Q ss_pred HHHHHHHhcC-----CCceeEeceeeeCCCCcEEEEEeccCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHH-HHHhHhC
Q 040812 101 QELNILRQTN-----SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV--KSRGRLSEDIICTISRQVLKG-LFYMHSR 172 (300)
Q Consensus 101 ~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~qi~~~-l~~lH~~ 172 (300)
+|...+.+++ .+++. +=.++.+-.+.-.++|||++|-.+.+.. +. ..++.+.+ +..++.+ +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhc
Confidence 3555554442 23332 2222222123567999999998888774 33 33453333 2222222 2333358
Q ss_pred CccccCCCCCceeecCCCCCCccceeecccccc
Q 040812 173 NIVHRDIKPANVLINEKMEHPCGYSCLYESGEA 205 (300)
Q Consensus 173 ~i~H~Dlkp~Nill~~~~~~~~~~~~~~~~~~~ 205 (300)
|++|.|..|.||+++.++ ....++++..
T Consensus 285 gffHaDpHpGNi~v~~~g-----~i~~lDfGi~ 312 (517)
T COG0661 285 GFFHADPHPGNILVRSDG-----RIVLLDFGIV 312 (517)
T ss_pred CccccCCCccceEEecCC-----cEEEEcCcce
Confidence 999999999999999984 3444455443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.8e-05 Score=65.23 Aligned_cols=72 Identities=15% Similarity=0.229 Sum_probs=51.0
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCce--eEeceeeeCCCCcEEEEEeccCCCC
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYI--VKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
..||+|..+.||+.. +..+++|............+|.++++.+..-++ .+.+++.... +...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDG-GRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-CeeeeeeeecCCcc
Confidence 568999999999842 446778987654433345779999988865443 5566665444 36789999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=0.0001 Score=58.93 Aligned_cols=114 Identities=29% Similarity=0.384 Sum_probs=81.0
Q ss_pred CcceeeeeecCCcc-eEEEEEEEccCCeEEEEEEeecC-----------------------CCCCCCHHHHHHHHhcC--
Q 040812 57 SQLEKLQVLGQGNG-GTVFKVRHKQTLALYALKVMQCD-----------------------RGTPPNPQELNILRQTN-- 110 (300)
Q Consensus 57 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-----------------------~~~~~~~~E~~~l~~l~-- 110 (300)
.+++.++.||.|.- |.||+++-. |+.||+|+++.- ....++..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 999999987 679999994320 01123456777776664
Q ss_pred -CCce--eEeceeeeCC-----------------CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH
Q 040812 111 -SPYI--VKCHQIFTKP-----------------SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170 (300)
Q Consensus 111 -h~ni--v~~~~~~~~~-----------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH 170 (300)
+.++ |+.+||..-. .....||.||.+... .++. .-+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 8888886321 012457888876643 1222 33567777888999
Q ss_pred hCCccccCCCCCcee
Q 040812 171 SRNIVHRDIKPANVL 185 (300)
Q Consensus 171 ~~~i~H~Dlkp~Nil 185 (300)
..||+-+|+++.|..
T Consensus 182 k~gI~~~Dv~~~ny~ 196 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR 196 (207)
T ss_pred HCCeeeccCcccccc
Confidence 999999999999975
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.8e-05 Score=64.69 Aligned_cols=121 Identities=15% Similarity=0.223 Sum_probs=81.0
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----------CCC---------------HHHHHHHHhcCC--Cc
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----------PPN---------------PQELNILRQTNS--PY 113 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~---------------~~E~~~l~~l~h--~n 113 (300)
...|.+|--+.||+|... ++..+|+|+++..... ..| ..|...|+++.. -.
T Consensus 53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 457888999999999874 4789999998643211 000 236666666643 34
Q ss_pred eeEeceeeeCCCCcEEEEEeccCCCCH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCC
Q 040812 114 IVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEK 189 (300)
Q Consensus 114 iv~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~ 189 (300)
+.+.+.+. ...|||||+....+ .=.|++ ..+...++..+..+++..+.-|-. .+++|+||..-|||+.++
T Consensus 132 vP~Pi~~~-----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~ 203 (268)
T COG1718 132 VPEPIAFR-----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG 203 (268)
T ss_pred CCCceeec-----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC
Confidence 44555542 34699999965311 111111 123344788899999999998876 999999999999999853
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.6e-05 Score=61.61 Aligned_cols=116 Identities=24% Similarity=0.230 Sum_probs=83.6
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeE-eceeeeCCCCcEEEEEeccCC
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVK-CHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~lv~e~~~~ 137 (300)
.++.+.||+|++|.||++.+. |..+|+|+-+.+........|+++|..++-.++.. ++.+ . ..++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g----~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c----hhhhhhhhhcC
Confidence 456788999999999999998 45899999887777777788999999998777654 4443 2 23466999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCC-CC-ceeecC
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIK-PA-NVLINE 188 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlk-p~-Nill~~ 188 (300)
-.|.+.-... + +.-+..++.+-.-|-..||-|..|. |. ||++.+
T Consensus 97 ~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~ 142 (201)
T COG2112 97 RPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND 142 (201)
T ss_pred cchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC
Confidence 8887655421 2 2233445555445567899999987 33 555554
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.2e-06 Score=75.63 Aligned_cols=162 Identities=20% Similarity=0.317 Sum_probs=97.7
Q ss_pred HHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCC
Q 040812 100 PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179 (300)
Q Consensus 100 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dl 179 (300)
.....+++.++|+|+..++++.........+|||++. .+|++++..+. +-.. +++ .+++.|-
T Consensus 30 lgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~-------s~~-------~~~~~~~-- 91 (725)
T KOG1093|consen 30 LGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDE-------SLL-------AHGVLHL-- 91 (725)
T ss_pred hhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchh-------hhc-------cccccee--
Confidence 3466778888999999999987655556889999995 49999987653 1110 000 2222222
Q ss_pred CCCceeecCCCCCCccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC
Q 040812 180 KPANVLINEKMEHPCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP 259 (300)
Q Consensus 180 kp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (300)
|++...+ .....+.. ..++|+||||+|.|+.|+.-|..-+...... +....+.........
T Consensus 92 ---~~~~~td-----~~~t~~~~----------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s-~~l~~i~k~~~~d~~ 152 (725)
T KOG1093|consen 92 ---NIIYITD-----HFLTKYPS----------PIGPKSDVWSLGFIILELYLGISLEAELTES-EYLEILLKYYTDDQE 152 (725)
T ss_pred ---hhhhccc-----cccccCCC----------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHH-HHHHHHHHhccCchh
Confidence 2222111 00001111 1225999999999999999987776432221 111222111100000
Q ss_pred --------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 260 --------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 260 --------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+...++....++...|+.. .|..||...++.+++-|.+
T Consensus 153 ~~~~a~e~~~~~~~d~~~~~~~~~c~~~-~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 153 LLSTAMEHLIQLLADKKRLPLLKKCLWL-EPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHHhhhHhHHHHhccCCcc-ccccccchhHHhcCccHHH
Confidence 11223466778899999999 9999999999999887654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.3e-05 Score=77.85 Aligned_cols=181 Identities=20% Similarity=0.301 Sum_probs=114.7
Q ss_pred HHHHHHhcCCCceeEeceeeeCCC--C-cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccC
Q 040812 102 ELNILRQTNSPYIVKCHQIFTKPS--G-EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178 (300)
Q Consensus 102 E~~~l~~l~h~niv~~~~~~~~~~--~-~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~D 178 (300)
|+..+.++.|+|++.++.+..... + ...+.-++|..-++...+..-+..+...++.+..+++.||.++|+....|.-
T Consensus 232 e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~ 311 (1351)
T KOG1035|consen 232 ELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVV 311 (1351)
T ss_pred HHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeE
Confidence 677788899999999988865433 1 1234567899999999998888899999999999999999999988444433
Q ss_pred CCCC---ceeecCCCCCCccc-----e---------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 040812 179 IKPA---NVLINEKMEHPCGY-----S---------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYY 235 (300)
Q Consensus 179 lkp~---Nill~~~~~~~~~~-----~---------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~ 235 (300)
+..+ +--.+..+....+. . ..+.+++..... ....+...|+|.+|.....+..|..
T Consensus 312 L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~~~~~~~~ 390 (1351)
T KOG1035|consen 312 LSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLLQLSQGED 390 (1351)
T ss_pred EecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc-cchhhhhhHHHHHHHHHhhhhhcCc
Confidence 3222 11111111111110 0 000011110000 0111224699999999999988755
Q ss_pred CCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 236 PFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 236 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+-..... . ...++......+.+...+|+.. ++++|+++.+++.|+|.+
T Consensus 391 i~~~~~~-------~-------~~~l~~~~~~~~~d~~~~~~~~-~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 391 ISEKSAV-------P-------VSLLDVLSTSELLDALPKCLDE-DSEERLSALELLTHPFLR 438 (1351)
T ss_pred ccccccc-------h-------hhhhccccchhhhhhhhhhcch-hhhhccchhhhhhchhcc
Confidence 5321111 0 0111222222678899999998 999999999999999975
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.3e-05 Score=59.72 Aligned_cols=121 Identities=21% Similarity=0.325 Sum_probs=84.2
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCC------------------CCCCCHHHHHHHHhcC------CCceeEe
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR------------------GTPPNPQELNILRQTN------SPYIVKC 117 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~E~~~l~~l~------h~niv~~ 117 (300)
...||+|+.-.||.--+. ....||+..... ......+|+.....+. +..|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356999999999954433 235789887655 1223356777666665 6789999
Q ss_pred ceeeeCCCCcEEEEEeccCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC
Q 040812 118 HQIFTKPSGEVSILMEYMDA------GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191 (300)
Q Consensus 118 ~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~ 191 (300)
+|+.+++. -.-+|+|.+.+ -+|.+++... .++. .. ...+-.-..+|-+.+|+.+|++|.||++.....
T Consensus 83 ~G~veT~~-G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNL-GLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCC-ceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99988876 46788888643 3678888554 4554 33 333334456778899999999999999987644
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=65.46 Aligned_cols=120 Identities=18% Similarity=0.181 Sum_probs=75.8
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCC---------------------------------------CCCCHHHH
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---------------------------------------TPPNPQEL 103 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------------------~~~~~~E~ 103 (300)
+.||.-+.|.||+|+.+. |+.||||+-+..-. .-++.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999987 99999998643210 00122344
Q ss_pred HHHHh----cCCCc------eeEeceeeeCCCCcEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHH-hH
Q 040812 104 NILRQ----TNSPY------IVKCHQIFTKPSGEVSILMEYMDAGSLEIY--VKSRGRLSEDIICTISRQVLKGLFY-MH 170 (300)
Q Consensus 104 ~~l~~----l~h~n------iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~l~~~~~~~i~~qi~~~l~~-lH 170 (300)
+...+ +.|-+ |.+++-.+ .+...|+||||+|..+.+. +.+. .++...+ +..+.++... |=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i---~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDKR-GISPHDI---LNKLVEAYLEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHHc-CCCHHHH---HHHHHHHHHHHHH
Confidence 43332 34544 33443332 3356899999999777544 3333 3554433 3333333222 23
Q ss_pred hCCccccCCCCCceeecCCC
Q 040812 171 SRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 171 ~~~i~H~Dlkp~Nill~~~~ 190 (300)
..|++|+|=.|.||++..+.
T Consensus 319 ~~GffHaDPHPGNilv~~~~ 338 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNP 338 (538)
T ss_pred hcCCccCCCCCCcEEEecCC
Confidence 57899999999999999643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=1.5e-06 Score=79.35 Aligned_cols=221 Identities=19% Similarity=0.122 Sum_probs=138.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc-eeEeceeeeCCCCcEEEEEeccC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY-IVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
-++.....++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.+. +.+++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~-~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGED-YLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCccc-ccchhhhhhc
Confidence 3556677899999999999887655444 6665443 23345899999999999 666666665544 8999999998
Q ss_pred CC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC--cc---------------ce
Q 040812 137 AG-SLEIYV-KSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP--CG---------------YS 197 (300)
Q Consensus 137 ~~-~L~~~l-~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~--~~---------------~~ 197 (300)
++ +-...+ ...-.+.......+.+.-..+++++|+.-=+|+| ||+..+..... .+ ++
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~ 393 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAIGT 393 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCCCC
Confidence 87 222111 1111344555666777778899999988778998 78776542211 11 11
Q ss_pred eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC-----CCCC-hHHHH
Q 040812 198 CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP-----ECSS-EKFRD 271 (300)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~~l~~ 271 (300)
..+.+| +....+.+..+.|.||+|+--.+|.-|.+|-..+..... . + +..+..+ ...+ ..-.+
T Consensus 394 ~~~~~p---ev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~----~--~--g~~p~s~~L~~~~aw~~~~~~~ 462 (829)
T KOG0576|consen 394 PEPLAP---EVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLP----M--I--GNGPNSPMLTDKSAWSPVFHRD 462 (829)
T ss_pred CCCCCc---hhhcccccccCCCccCCCcchhhcCCCCCCCCCCccccC----C--C--CCCCCccccchhhhcCcccccC
Confidence 112222 222344555688999999888888888777643211100 0 0 0000000 0011 11124
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+...|+.. .|..|+...+++.|.+|+.
T Consensus 463 ~~~~~~~g-~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 463 FPAPCLNG-LPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CcccccCC-CCCCCcchhhHHHHHHhcc
Confidence 77788888 8999999999998888764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00047 Score=57.51 Aligned_cols=76 Identities=16% Similarity=0.103 Sum_probs=51.4
Q ss_pred eecCCcc-eEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEEEEeccCCCCHH
Q 040812 64 VLGQGNG-GTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSILMEYMDAGSLE 141 (300)
Q Consensus 64 ~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~ 141 (300)
.|..|.+ +.||+.... +..+.+|...... .....+|+.+++.+. +--+.+++++.... +..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCccHh
Confidence 3455555 788998764 3577889876543 334567999988874 33355677765543 4678999999998776
Q ss_pred HH
Q 040812 142 IY 143 (300)
Q Consensus 142 ~~ 143 (300)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 43
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00015 Score=60.20 Aligned_cols=73 Identities=5% Similarity=-0.008 Sum_probs=44.8
Q ss_pred eeecCCcceE-EEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCC---ceeEeceeeeCCC--CcEEEEEeccC
Q 040812 63 QVLGQGNGGT-VFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSP---YIVKCHQIFTKPS--GEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~--~~~~lv~e~~~ 136 (300)
+.|+.|+... ||+.. ..+++|+.+.........+|..++..+... -+.++++...... +..|++|++++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 5677777774 88762 246788765433333456799999887532 2334444332221 24589999999
Q ss_pred CCCH
Q 040812 137 AGSL 140 (300)
Q Consensus 137 ~~~L 140 (300)
|.++
T Consensus 78 G~~l 81 (235)
T cd05155 78 GETA 81 (235)
T ss_pred CCCC
Confidence 8766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00085 Score=57.75 Aligned_cols=105 Identities=13% Similarity=0.102 Sum_probs=68.3
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC---CceeEeceeeeCC--CCcEEEEEec
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS---PYIVKCHQIFTKP--SGEVSILMEY 134 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~--~~~~~lv~e~ 134 (300)
.-.+.||.|..+.||.....+ + .+.+|..+.......+..|...|+.+.. -.+.++++++... .+..++|||+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 445789999999999986543 3 4667875432234466889999988853 3567777765432 3468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~ 171 (300)
++|.++.+. ..+......+..+++.+|..||+
T Consensus 95 i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 95 LRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred cCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence 999876541 12223334445555556665654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0014 Score=56.89 Aligned_cols=125 Identities=15% Similarity=0.214 Sum_probs=85.8
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCC--------C-CCC-------------------CHHHHHHHHhcCCC
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR--------G-TPP-------------------NPQELNILRQTNSP 112 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~-~~~-------------------~~~E~~~l~~l~h~ 112 (300)
+-.+|..|--+.||.|.... |..+|||+++..- . ... ...|+..|.+++..
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44678899999999987765 6779999986211 0 000 12377778887766
Q ss_pred ceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-HhCCccccCCCCCceeecCC
Q 040812 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM-HSRNIVHRDIKPANVLINEK 189 (300)
Q Consensus 113 niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~i~H~Dlkp~Nill~~~ 189 (300)
+|.-.--+.. . ...|||+|+.......=.-....++...+..+-.|++.-++-| |.++++|.||.--|+|+.++
T Consensus 227 GIP~PePIlL--k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG 301 (520)
T KOG2270|consen 227 GIPCPEPILL--K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG 301 (520)
T ss_pred CCCCCCceee--e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC
Confidence 6543322222 1 3569999996432221112234578888999999999888888 57899999999999999775
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0014 Score=64.35 Aligned_cols=108 Identities=19% Similarity=0.199 Sum_probs=68.4
Q ss_pred eeeecCCcceEEEEEEEccCC--eEEEEEEeecCCCC---CCCHHHHHHHHhcC-CCce--eEeceeeeCCC--CcEEEE
Q 040812 62 LQVLGQGNGGTVFKVRHKQTL--ALYALKVMQCDRGT---PPNPQELNILRQTN-SPYI--VKCHQIFTKPS--GEVSIL 131 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~---~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~--~~~~lv 131 (300)
++.++.|.++.+|+......+ ..+++|........ ....+|..+|+.+. |.++ .+++.++.+.. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998775432 46777775433211 23468999999985 6664 66777665431 468999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~ 171 (300)
|||++|..+.+.. -..++......+..+++.+|..||.
T Consensus 123 ME~v~G~~~~~~~--~~~~~~~~r~~l~~~l~~~La~LH~ 160 (822)
T PLN02876 123 MEYLEGRIFVDPK--LPGVAPERRRAIYRATAKVLAALHS 160 (822)
T ss_pred EEecCCcccCCcc--CCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 9999986443210 0123444555556666666655553
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00018 Score=61.33 Aligned_cols=132 Identities=12% Similarity=0.164 Sum_probs=87.5
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----------------CC-------CCCHHHHHHHHhcCCC--
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----------------GT-------PPNPQELNILRQTNSP-- 112 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~-------~~~~~E~~~l~~l~h~-- 112 (300)
+.+++.||-|--+.||.+-+.+ |.+.++|+....+ .. -...+|...|+.+...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4568899999999999999876 7788999753211 00 0113577788777532
Q ss_pred ceeEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 113 niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
-+.+.+++ ...|+|||++.|-.|.+.-+- -+ +..+...+..-+--|-.+|+||+|..-=||+++++
T Consensus 173 pVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd--- 238 (465)
T KOG2268|consen 173 PVPKPIDH-----NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD--- 238 (465)
T ss_pred CCCCcccc-----cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecC---
Confidence 24455553 267899999999887654421 12 23334444444556778999999999999999976
Q ss_pred Cccceeecccccccc
Q 040812 193 PCGYSCLYESGEARH 207 (300)
Q Consensus 193 ~~~~~~~~~~~~~~~ 207 (300)
+.....+||....
T Consensus 239 --~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 --DKIVVIDFPQMVS 251 (465)
T ss_pred --CCEEEeechHhhc
Confidence 3344556665433
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0039 Score=52.39 Aligned_cols=70 Identities=13% Similarity=0.170 Sum_probs=44.8
Q ss_pred eecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCce-eEeceeeeCCCCcEEEEEeccCCCCH
Q 040812 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYI-VKCHQIFTKPSGEVSILMEYMDAGSL 140 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~~~L 140 (300)
.+..|-.+.+|+... +++.+++|........ -...+|..+++.+...++ .+++.. .+ -++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~---~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV--NE---HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE--eC---CEEEEEeccCccc
Confidence 355677888998873 4667888976543222 134679999998865444 333333 22 2589999998665
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0016 Score=53.58 Aligned_cols=79 Identities=23% Similarity=0.267 Sum_probs=53.5
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEeceeeeC--CCCcEEEEEeccCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQIFTK--PSGEVSILMEYMDA 137 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~--~~~~~~lv~e~~~~ 137 (300)
++.|+.|..+.||++.... + .+++|............+|..+++.+...+ +.+++..... ..+..+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4679999999999999876 3 788998654411223356888888775433 4555553222 12357999999999
Q ss_pred CCHHH
Q 040812 138 GSLEI 142 (300)
Q Consensus 138 ~~L~~ 142 (300)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 88776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0022 Score=51.21 Aligned_cols=89 Identities=19% Similarity=0.094 Sum_probs=68.1
Q ss_pred HHHHHHHHhcCC-CceeEeceeeeCCCCcEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHhHh---C
Q 040812 100 PQELNILRQTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIY---VKSRGRLSEDIICTISRQVLKGLFYMHS---R 172 (300)
Q Consensus 100 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~qi~~~l~~lH~---~ 172 (300)
.+|.-+++.+++ +++++++|++. . ++|.||...+++... +.+....++..+..|+.+++..+.+|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888877 68999999862 2 578999987655421 1111235899999999999999999986 3
Q ss_pred CccccCCCCCceeecCCCCCC
Q 040812 173 NIVHRDIKPANVLINEKMEHP 193 (300)
Q Consensus 173 ~i~H~Dlkp~Nill~~~~~~~ 193 (300)
.+.-+|++++|+-+++++..+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk 102 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLK 102 (188)
T ss_pred cEEEeecchHHeEEeCCCcEE
Confidence 477799999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0094 Score=51.56 Aligned_cols=80 Identities=15% Similarity=0.157 Sum_probs=49.0
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEeceee-----eCCCCcEEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQIF-----TKPSGEVSIL 131 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~-----~~~~~~~~lv 131 (300)
...++.++.|.-..+|++... ++ .+++|+............|..++..+...+ +.+++... ....+..++|
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 345677888888899988753 34 577898755332333356777777774322 33443321 1123467899
Q ss_pred EeccCCCCH
Q 040812 132 MEYMDAGSL 140 (300)
Q Consensus 132 ~e~~~~~~L 140 (300)
++|++|..+
T Consensus 102 ~e~i~G~~~ 110 (307)
T TIGR00938 102 VEFLQGLSV 110 (307)
T ss_pred EEeCCCCCC
Confidence 999988543
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.026 Score=49.08 Aligned_cols=76 Identities=12% Similarity=0.179 Sum_probs=45.7
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEecee-----eeCCCCcEEEEEe
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQI-----FTKPSGEVSILME 133 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~~lv~e 133 (300)
-.+.|+.|....+|+..... | .+++|++. .........|+..+..+...+ +.+.+.. +..-.+..+++++
T Consensus 26 ~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTTQ-G-EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred ccchhccccccceEEEEeCC-C-cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34667888888999987653 3 67889875 222233345667776664322 3333321 1111346789999
Q ss_pred ccCCCC
Q 040812 134 YMDAGS 139 (300)
Q Consensus 134 ~~~~~~ 139 (300)
+++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.013 Score=50.25 Aligned_cols=77 Identities=16% Similarity=0.191 Sum_probs=49.6
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEeceee-----eCCCCcEEEEEe
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQIF-----TKPSGEVSILME 133 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~-----~~~~~~~~lv~e 133 (300)
-.+.|..|....+|+.... +..+++|+... ........|+.++..+.+.+ +.+++... ....+..++|++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred heecccCccccceEEEEeC--CCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3567888888899998654 34688898764 22334456888888875433 34443321 111235789999
Q ss_pred ccCCCCH
Q 040812 134 YMDAGSL 140 (300)
Q Consensus 134 ~~~~~~L 140 (300)
+++|..+
T Consensus 95 ~i~G~~~ 101 (296)
T cd05153 95 FLAGEHL 101 (296)
T ss_pred eCCCCCC
Confidence 9998664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.031 Score=49.92 Aligned_cols=72 Identities=18% Similarity=0.167 Sum_probs=48.3
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCC---------CCCCCHHHHHHHHhcC---CCceeEeceeeeCCCCcE
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---------GTPPNPQELNILRQTN---SPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 128 (300)
..+.||-|....||+..+. +..++||.-.... .......|...|+.+. ...+.+++.+..+ ..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded---~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT---MA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---CC
Confidence 3678999999999998874 3468899754211 1112244777776553 2467778877542 45
Q ss_pred EEEEeccCC
Q 040812 129 SILMEYMDA 137 (300)
Q Consensus 129 ~lv~e~~~~ 137 (300)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.031 Score=49.09 Aligned_cols=71 Identities=17% Similarity=0.138 Sum_probs=45.4
Q ss_pred eecCCcceEEEEEEEccCCeEEEEEEeecCC-------C--CCCCHHHHHHHHhcCC--C-ceeEeceeeeCCCCcEEEE
Q 040812 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDR-------G--TPPNPQELNILRQTNS--P-YIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~--~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~lv 131 (300)
.||.|....||++.....++.++||.-.... . .....-|...|+...- | .+++++.+ . .....+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D--~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-D--TEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-c--cccceeh
Confidence 5799999999999987545789999753211 0 1112347777766532 4 45555553 3 2256799
Q ss_pred EeccCC
Q 040812 132 MEYMDA 137 (300)
Q Consensus 132 ~e~~~~ 137 (300)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.046 Score=46.72 Aligned_cols=75 Identities=15% Similarity=0.211 Sum_probs=46.4
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC---CCceeEeceeeeCCCCcEEEEEeccC
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN---SPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+..+.++-|.-..+|+.. .+++.+-+|+-. ......+..|..-|+.|. --.+.+++++..... ..++||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-DAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-CCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-CceEEEEeec
Confidence 456789999999999887 456788899866 334445677888888773 345777888766544 5699999998
Q ss_pred CC
Q 040812 137 AG 138 (300)
Q Consensus 137 ~~ 138 (300)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.099 Score=43.12 Aligned_cols=99 Identities=18% Similarity=0.187 Sum_probs=61.5
Q ss_pred eeeecCCcceEEEEEEEcc-CCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCce-eEeceeeeCCCCcEEEEEeccCCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQ-TLALYALKVMQCDRGT-PPNPQELNILRQTNSPYI-VKCHQIFTKPSGEVSILMEYMDAG 138 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~~ 138 (300)
++.|..|-...+|++.... .++.|++|+....... -...+|+.+++.+...++ +++++.. .. .+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~---~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--QN---GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC---cEEEEeeCCC
Confidence 4668888888999997653 3467889976543221 122468999988854443 3444432 22 3799999997
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC
Q 040812 139 SLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173 (300)
Q Consensus 139 ~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 173 (300)
++...... ...++.+++..|..||...
T Consensus 78 ~l~~~~~~--------~~~~~~~la~~l~~lH~~~ 104 (235)
T cd05157 78 TLEPEDLR--------NPKIYRLIARELAKLHSIK 104 (235)
T ss_pred cCCHHHcc--------ChHHHHHHHHHHHHHhccc
Confidence 66432110 1235667777777788653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.09 Score=44.75 Aligned_cols=45 Identities=11% Similarity=0.042 Sum_probs=27.4
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN 110 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~ 110 (300)
.++|-...|+...+. .|+.+++|.-+.........+|..+|..+.
T Consensus 19 ~~~g~~~~v~~i~~~-~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 19 NESGLDFQVVFAKDT-DGVPWVLRIPRRPDVSERAAAEKRVLALVR 63 (276)
T ss_pred cCCcceeEEEEEEcC-CCCeEEEEecCCHHHHHHHHHHHHHHHHHH
Confidence 344544556655332 367888888654333334567999988875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.4 Score=42.20 Aligned_cols=75 Identities=12% Similarity=0.096 Sum_probs=48.1
Q ss_pred eeeecCCcceEEEEEEEcc----CCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCcee-EeceeeeCCCCcEEEEEecc
Q 040812 62 LQVLGQGNGGTVFKVRHKQ----TLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIV-KCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~ 135 (300)
++.+-.|-...+|++.... .++.|++|+....... -...+|..+++.+..-++. ++++.+. ++ .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~--~g---~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFP--NG---RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEEC--Cc---eEEEee
Confidence 4556668888999987542 2468899987643311 1225699999888654443 4555542 33 579999
Q ss_pred CCCCHH
Q 040812 136 DAGSLE 141 (300)
Q Consensus 136 ~~~~L~ 141 (300)
++.+|.
T Consensus 116 ~g~~l~ 121 (344)
T PLN02236 116 HARTLS 121 (344)
T ss_pred CCCCCC
Confidence 876663
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.93 Score=40.70 Aligned_cols=81 Identities=16% Similarity=0.084 Sum_probs=53.4
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCC----C-----CCCCHHHHHHHHhcC---CCceeEeceeeeCCCCcEE
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----G-----TPPNPQELNILRQTN---SPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~-----~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 129 (300)
.+.||.|.+..||++.....++.++||.-.... . ......|...|+.+. -..+++++.+ ++ ...+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~-~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE-ELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC-CCCE
Confidence 467999999999999997654689999853211 0 111245777777753 2456777765 22 3568
Q ss_pred EEEeccCCCC-HHHHHH
Q 040812 130 ILMEYMDAGS-LEIYVK 145 (300)
Q Consensus 130 lv~e~~~~~~-L~~~l~ 145 (300)
+|||++++.. +.+.+.
T Consensus 108 lVME~L~~~~~lr~~Ll 124 (401)
T PRK09550 108 TVMEDLSDHKILRKGLI 124 (401)
T ss_pred EEEecCCCccHHHHHHh
Confidence 9999998744 444443
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.21 Score=44.44 Aligned_cols=62 Identities=26% Similarity=0.402 Sum_probs=45.2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-HhCCccccCCCCCceeecCC
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM-HSRNIVHRDIKPANVLINEK 189 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~i~H~Dlkp~Nill~~~ 189 (300)
...+|-+|..|-++..+++.. ..++...+.++.-...|+--+ --.+++|.|+.|.||++.-+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 345777889998998888754 345556666666666666544 35789999999999999644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.021 Score=58.35 Aligned_cols=136 Identities=16% Similarity=0.014 Sum_probs=88.2
Q ss_pred HHHHHHhcCCCceeEeceeeeCC-CCcEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhHhC-C--
Q 040812 102 ELNILRQTNSPYIVKCHQIFTKP-SGEVSILMEYMDAGSLEIYVKSRG----RLSEDIICTISRQVLKGLFYMHSR-N-- 173 (300)
Q Consensus 102 E~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~lH~~-~-- 173 (300)
|...++...|+++.....-.... ....|.+++|+.+|.+.+.+-++- .+...-+....++.+.+..-+|+. +
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 44455667899888766654332 234789999999999999986532 233344444444447777777754 2
Q ss_pred --ccccCCCCCceeecCCCCCCccceeecc--ccc--------------cccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 040812 174 --IVHRDIKPANVLINEKMEHPCGYSCLYE--SGE--------------ARHRKHGGYNGFAADIWSFGVTMMELYMGYY 235 (300)
Q Consensus 174 --i~H~Dlkp~Nill~~~~~~~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~DiwSlG~il~elltg~~ 235 (300)
.+|++||+-|.+|..+.....|...+-. .|. .+.....-.++.++|+|+.|+-+|+...|..
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccH
Confidence 6899999999999887755444333322 110 0001111224556999999999999998887
Q ss_pred CC
Q 040812 236 PF 237 (300)
Q Consensus 236 pf 237 (300)
+|
T Consensus 1439 ~f 1440 (2724)
T KOG1826|consen 1439 YF 1440 (2724)
T ss_pred HH
Confidence 77
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.81 Score=39.96 Aligned_cols=75 Identities=20% Similarity=0.250 Sum_probs=45.8
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCce------eEe----ceeeeCCCCcEEEEE
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYI------VKC----HQIFTKPSGEVSILM 132 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~ni------v~~----~~~~~~~~~~~~lv~ 132 (300)
..|.+ .-..+|+....+ |+. ++|+............|+..|..+.-.+| ..+ +...... .+.+-|+
T Consensus 32 ~~l~s-~eN~~f~~~~~~-g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTED-GRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecC-CCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeEEEE
Confidence 44555 556789888775 334 89998776333344567888877632221 111 1122222 2788999
Q ss_pred eccCCCCHH
Q 040812 133 EYMDAGSLE 141 (300)
Q Consensus 133 e~~~~~~L~ 141 (300)
+|++|..+.
T Consensus 108 ~~l~G~~~~ 116 (331)
T COG2334 108 EYLPGRPLE 116 (331)
T ss_pred EecCCcCcC
Confidence 999997776
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.38 Score=41.33 Aligned_cols=98 Identities=17% Similarity=0.173 Sum_probs=62.7
Q ss_pred eeecCCcceEEEEEEEcc------CCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCcee-EeceeeeCCCCcEEEEEec
Q 040812 63 QVLGQGNGGTVFKVRHKQ------TLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIV-KCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~ 134 (300)
+.+..|-...+|++.... +++.+++|+....... ....+|..++..+...++. ++++.+. . .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C---Cchhhe
Confidence 556667777889887643 2578899997654322 2346798888888654433 4444432 2 268999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 173 (300)
++|..+...... + ..++.+++..|..||+..
T Consensus 79 i~G~~l~~~~~~----~----~~~~~~ia~~L~~lH~~~ 109 (302)
T cd05156 79 IPSRTLTTEELR----D----PDISAEIARRMAKLHSIV 109 (302)
T ss_pred eCCCcCCHhHcC----C----cHHHHHHHHHHHHhhCCC
Confidence 998776542111 1 235678888888888754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.52 E-value=0.0086 Score=53.97 Aligned_cols=69 Identities=23% Similarity=0.319 Sum_probs=55.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC---CCCCCHHHHHHHHhcCCCceeEeceeeeC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNPQELNILRQTNSPYIVKCHQIFTK 123 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 123 (300)
..++++....+|.|+||+|+.+..+.++..+|||.+.... ......+|...+..+.|++++++...|..
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence 3567889999999999999999999888889999875332 22334568888899999999998777654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.43 Score=39.21 Aligned_cols=73 Identities=16% Similarity=0.225 Sum_probs=41.4
Q ss_pred ecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc---CCCceeEeceeeeCCCCcEEEEEeccCCCCHH
Q 040812 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT---NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLE 141 (300)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~ 141 (300)
+.-|---..|...+- ...+-+|+-.. .....+..|+.-|..+ +.-.+.+++.+-.. .++.|+||||++-+.+.
T Consensus 24 v~gG~inea~~v~dg--~~~~FvK~n~~-~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~-~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRDG--TDPFFVKCNQR-EQLSMFTAEADGLELLARSNTITVPKVIAVGAS-RDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeecC--CcceEEEecch-hhHHHHHHHHHHHHHHHhcCCccccceEEecCC-CCeeEEEEeeccCCCCC
Confidence 333333344444332 34677786432 2223445566655554 44456677776544 45899999999876553
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.37 E-value=3 Score=42.36 Aligned_cols=79 Identities=15% Similarity=0.208 Sum_probs=44.7
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC--C-----CceeEec-----eeeeCCCC--c
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN--S-----PYIVKCH-----QIFTKPSG--E 127 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~--h-----~niv~~~-----~~~~~~~~--~ 127 (300)
++.|+. ..-.+|+.... +++.+++|+............|...|..+. + |.+++-. .....+.+ .
T Consensus 30 ~~~L~s-~~d~nf~v~~~-~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 30 ATPLDG-ERDLNFRLTTD-DGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred EeecCC-cCCceEEEEeC-CCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 356754 56788888754 466789999876433323334555665552 1 2233211 11122222 4
Q ss_pred EEEEEeccCCCCHHH
Q 040812 128 VSILMEYMDAGSLEI 142 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~ 142 (300)
.+-+++|++|..+.+
T Consensus 108 ~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 108 LLRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEEeccCCCcHHh
Confidence 677899999977654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.33 E-value=1 Score=39.47 Aligned_cols=73 Identities=15% Similarity=0.255 Sum_probs=46.1
Q ss_pred eeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCcee-EeceeeeCCCCcEEEEEeccCC
Q 040812 63 QVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT-PPNPQELNILRQTNSPYIV-KCHQIFTKPSGEVSILMEYMDA 137 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~ 137 (300)
+.|..|=...+|++..... +..|++|+....... -...+|..+++.+..-++- ++++++ .+| +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc---EeehhhcC
Confidence 4555577788898875432 347889987543321 1225799999988765553 455554 233 58899877
Q ss_pred CCH
Q 040812 138 GSL 140 (300)
Q Consensus 138 ~~L 140 (300)
..|
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 655
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=92.38 E-value=0.62 Score=39.04 Aligned_cols=79 Identities=19% Similarity=0.105 Sum_probs=55.2
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc-CCCCH
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM-DAGSL 140 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~-~~~~L 140 (300)
...+..|..+.|+.++... |..+++|+................|+..+-.+.|++++.- .. .-.|++|.+ ++.+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~d-G~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d--~~-~~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRAD-GTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAAD--PE-RGALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcCC-CCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccc--cc-cchhhhhhccCCCch
Confidence 3457789999999998654 7899999976544332222233668888888899999863 22 456899998 45577
Q ss_pred HHHH
Q 040812 141 EIYV 144 (300)
Q Consensus 141 ~~~l 144 (300)
.+..
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 6554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.60 E-value=2.3 Score=38.09 Aligned_cols=75 Identities=12% Similarity=0.118 Sum_probs=45.0
Q ss_pred eeeecCCcceEEEEEEEccCC-eE-----EEEEEeecCC-CCCCCHHHHHHHHhcCCCce-eEeceeeeCCCCcEEEEEe
Q 040812 62 LQVLGQGNGGTVFKVRHKQTL-AL-----YALKVMQCDR-GTPPNPQELNILRQTNSPYI-VKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~-~~-----vaiK~~~~~~-~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e 133 (300)
++.|..|-...+|++...... .. |.++...... ..-...+|+.+++.+...++ .++++.+. + ++|.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--~---g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--D---FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC--C---EEEEE
Confidence 456666888999999754321 22 4444321111 11122569999999876554 45666542 2 58999
Q ss_pred ccCCCCHH
Q 040812 134 YMDAGSLE 141 (300)
Q Consensus 134 ~~~~~~L~ 141 (300)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987663
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.48 E-value=0.48 Score=41.07 Aligned_cols=63 Identities=21% Similarity=0.179 Sum_probs=38.7
Q ss_pred EEEEEeccCC--CCHHH-HHHhCCC-CCHHHHHHHHHHHHHHHHHhH----hCCccccCCCCCceeecCCC
Q 040812 128 VSILMEYMDA--GSLEI-YVKSRGR-LSEDIICTISRQVLKGLFYMH----SRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 128 ~~lv~e~~~~--~~L~~-~l~~~~~-l~~~~~~~i~~qi~~~l~~lH----~~~i~H~Dlkp~Nill~~~~ 190 (300)
..+|+.++.+ ..+.. ...+.|- --...++.++.||+.-.-.+- ..+.+|-||||+|||+-+..
T Consensus 250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 3477776533 22222 1122222 234678889999887553442 23689999999999997653
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=88.80 E-value=0.1 Score=38.23 Aligned_cols=44 Identities=25% Similarity=0.225 Sum_probs=31.9
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHh
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ 108 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~ 108 (300)
+.||+|+.|.||+|+.+. |+.||||+.+... .......+.+|+.
T Consensus 17 ~PlasASiaQVh~a~l~~-g~~VaVKV~rP~i-~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKD-GEEVAVKVQRPGI-EEQIEADLRILRR 60 (119)
T ss_pred chhhheehhhheeeeecc-cchhhhhhcchHH-HHHHHHHHHHHHH
Confidence 679999999999999876 8999999975432 1222335555554
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.63 E-value=4.7 Score=35.18 Aligned_cols=69 Identities=10% Similarity=0.010 Sum_probs=38.3
Q ss_pred cceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCc--eeEec---e--eeeCCCCcEEEEEeccCCCC
Q 040812 69 NGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPY--IVKCH---Q--IFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 69 ~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~n--iv~~~---~--~~~~~~~~~~lv~e~~~~~~ 139 (300)
.-..||+....+ +..+++|+...... ......|+..+..+.... ++... + .... ++..+.|+++++|..
T Consensus 37 ~eN~vy~v~~~~-~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~-~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDED-GRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEH-QGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCC-CCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEE-CCEEEEEEeeeCCCC
Confidence 345789887643 55788998754331 222245777776663221 22221 1 1111 346788999998754
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.11 E-value=0.56 Score=40.87 Aligned_cols=40 Identities=28% Similarity=0.342 Sum_probs=28.4
Q ss_pred HHHHHHHHHHHHHHHHHh---H-hCCccccCCCCCceeecCCCC
Q 040812 152 EDIICTISRQVLKGLFYM---H-SRNIVHRDIKPANVLINEKME 191 (300)
Q Consensus 152 ~~~~~~i~~qi~~~l~~l---H-~~~i~H~Dlkp~Nill~~~~~ 191 (300)
...++.++.||+.-.--+ - ..+.+|-||||+|||+-+...
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~ 317 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKE 317 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCC
Confidence 456788888887644222 2 346899999999999976533
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=88.04 E-value=1.8 Score=38.71 Aligned_cols=102 Identities=16% Similarity=0.151 Sum_probs=60.9
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--------CCCHHHHHHHHhcC--CC-ceeEeceeeeCCCCcEEE
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--------PPNPQELNILRQTN--SP-YIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~l 130 (300)
.+.||-|.-..||++.+...++.|+||.-...... ....-|...|+... -| .+++++.+ . + ....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D-~-e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-D-S-VMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-C-c-HHhhH
Confidence 57899999999999998544567899975321111 11234888887653 24 45556554 2 2 25679
Q ss_pred EEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 040812 131 LMEYMDA-GSLEIYVKSRGRLSEDIICTISRQVLKGLF 167 (300)
Q Consensus 131 v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~ 167 (300)
|||+++. ..|.+.+..+..++ ..+..+..-++..+.
T Consensus 111 vMEdL~~~~ilR~~Li~G~~~p-~~A~~ig~fla~tlf 147 (409)
T PRK12396 111 VMEDLSDHTILRTALINHEIFP-RLADDLTTFLVNTLL 147 (409)
T ss_pred HHHhCcccHHHHHHHHcCCcCh-hHHHHHHHHHHHHHh
Confidence 9999964 34555555544343 344444444444433
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=80.41 E-value=7.4 Score=33.85 Aligned_cols=84 Identities=12% Similarity=0.175 Sum_probs=48.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeec-CCCC---CCCHHHHHHHHhcCCC--ceeEeceeeeCCC-Cc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-DRGT---PPNPQELNILRQTNSP--YIVKCHQIFTKPS-GE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~---~~~~~E~~~l~~l~h~--niv~~~~~~~~~~-~~ 127 (300)
+.....+++.+-.|....+|..... ++.+++. ... .... ....+|..+++.+.-- -+...++++..+. +.
T Consensus 23 ~~~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~ 99 (321)
T COG3173 23 GYAGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGT 99 (321)
T ss_pred CcCCCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCC
Confidence 3344455566655555555666554 6677887 221 1111 2235688888876532 2334555555544 57
Q ss_pred EEEEEeccCCCCHH
Q 040812 128 VSILMEYMDAGSLE 141 (300)
Q Consensus 128 ~~lv~e~~~~~~L~ 141 (300)
.|.||++++|..+.
T Consensus 100 pf~v~~~veGe~~~ 113 (321)
T COG3173 100 PFYVMEWVEGEVVW 113 (321)
T ss_pred ceEEEEEecceecc
Confidence 89999999986443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 300 | ||||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-34 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-34 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-33 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-30 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-30 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-30 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-30 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-30 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-30 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-30 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-27 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-27 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-27 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-26 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-22 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-22 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-22 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-21 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-19 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-18 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-18 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-18 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-18 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-18 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-04 |
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 5e-81
Identities = 74/273 (27%), Positives = 136/273 (49%), Gaps = 34/273 (12%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNIL-RQTNS 111
++ LE L +G G G V+K+R ++T + A+K M+ N + +L+++ + +
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
PYIV+C F + +V I ME M + ++ + +G + E I+ ++ ++K L+Y+
Sbjct: 84 PYIVQCFGTFIT-NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 172 -RNIVHRDIKPANVLINEKME-HPC--GYS-CLYESG-----------------EARHRK 209
++HRD+KP+N+L++E+ + C G S L + +
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SE 267
Y+ AD+WS G++++EL G +P+ + DF ++ + EPP LP S
Sbjct: 203 KPDYD-IRADVWSLGISLVELATGQFPY--KNCKTDF-EVLTKVLQEEPPLLPGHMGFSG 258
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
F+ F++ CL K D KR ++LL H F+
Sbjct: 259 DFQSFVKDCLTK-DHRKRPKYNKLLEHSFIKRY 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 5e-80
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 41/277 (14%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNI-LRQTNS 111
LE + LG+G G V K+RH + + A+K ++ + + +L+I +R +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIY---VKSRGRLSEDIICTISRQVLKGLFY 168
P+ V + + G+V I ME MD + Y + + EDI+ I+ ++K L +
Sbjct: 66 PFTVTFYGALFRE-GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 169 MHS-RNIVHRDIKPANVLINE----KMEHPC--GYS---------------CLYESGE-- 204
+HS +++HRD+KP+NVLIN KM C G S Y + E
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKM---CDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264
GY+ +DIWS G+TM+EL + +P+ G + + P LP
Sbjct: 182 NPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQ---QLKQVVEEPSPQLPAD 237
Query: 265 S-SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
S +F DF CL+K + +R T +L+ HPF
Sbjct: 238 KFSAEFVDFTSQCLKK-NSKERPTYPELMQHPFFTLH 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 5e-78
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 45/281 (16%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNI-LRQTNS 111
L+ L +G+G G+V K+ HK + + A+K ++ Q +L++ +R ++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLF 167
PYIV+ + + G+ I ME M + Y + E+I+ I+ +K L
Sbjct: 81 PYIVQFYGALFRE-GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 168 YMHS-RNIVHRDIKPANVLINE----KMEHPC--GYS-CLYESGEARH------------ 207
++ I+HRDIKP+N+L++ K+ C G S L +S
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKL---CDFGISGQLVDSIAKTRDAGCRPYMAPER 196
Query: 208 ----RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263
GY+ +D+WS G+T+ EL G +P+ P F + + +PP L
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPY--PKWNSVF-DQLTQVVKGDPPQLSN 252
Query: 264 CS----SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
S F +F+ CL K D SKR +LL HPF+
Sbjct: 253 SEEREFSPSFINFVNLCLTK-DESKRPKYKELLKHPFILMY 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 1e-76
Identities = 96/302 (31%), Positives = 138/302 (45%), Gaps = 65/302 (21%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSP 112
EK+ LG GNGG VFKV HK + + A K++ + Q EL +L + NSP
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS- 171
YIV + F GE+SI ME+MD GSL+ +K GR+ E I+ +S V+KGL Y+
Sbjct: 92 YIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 172 RNIVHRDIKPANVLINEKME-HPC--GYS--------------CLYESGEARHRKHGGYN 214
I+HRD+KP+N+L+N + E C G S Y S E R G +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE---RLQGTHY 207
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPD----------------------------- 245
+DIWS G++++E+ +G YP P +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 246 ---------FLSLMLAICFREPPSLPECS-SEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295
L+ I PP LP S +F+DF+ CL K +P++R QL+ H
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHA 326
Query: 296 FL 297
F+
Sbjct: 327 FI 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-62
Identities = 87/261 (33%), Positives = 134/261 (51%), Gaps = 34/261 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN---PQELNILRQTNSPYIVK 116
KL+ +G+G+ G VFK +T + A+K++ + QE+ +L Q +SPY+ K
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + K ++ I+MEY+ GS ++ G L E I TI R++LKGL Y+HS +H
Sbjct: 85 YYGSYLK-DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIH 142
Query: 177 RDIKPANVLINE----KMEHPC--GYS-CLYESGEARHR-------------KHGGYNGF 216
RDIK ANVL++E K+ G + L ++ R+ K Y+
Sbjct: 143 RDIKAANVLLSEHGEVKL---ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-S 198
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
ADIWS G+T +EL G P E P + ++ I PP+L S+ ++F+ C
Sbjct: 199 KADIWSLGITAIELARGEPPHSE--LHP--MKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
Query: 277 LQKGDPSKRWTASQLLSHPFL 297
L K +PS R TA +LL H F+
Sbjct: 255 LNK-EPSFRPTAKELLKHKFI 274
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-61
Identities = 81/268 (30%), Positives = 132/268 (49%), Gaps = 34/268 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKC 117
E + LG G G V+K ++K+T AL A KV++ E+ IL + PYIVK
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 118 HQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ G++ I++E+ G++ I ++ L+E I + RQ+L+ L ++HS+ I+H
Sbjct: 82 LGAYYH-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 177 RDIKPANVLINEKMEHPC---GYSCLYESGEARH-------------------RKHGGYN 214
RD+K NVL+ + + G S + K Y+
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEKFRDF 272
+ ADIWS G+T++E+ P E P + ++L I +PP+L S S +FRDF
Sbjct: 201 -YKADIWSLGITLIEMAQIEPPHHE--LNP--MRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFLADA 300
++ L K +P R +A+QLL HPF++
Sbjct: 256 LKIALDK-NPETRPSAAQLLEHPFVSSI 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-61
Identities = 73/320 (22%), Positives = 122/320 (38%), Gaps = 48/320 (15%)
Query: 9 GLSQPASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQG 68
S + +S K + L + + V + Y +E+ ++ ++ G+G
Sbjct: 13 LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV---GRG 69
Query: 69 NGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128
+ G V +++ KQT A+K ++ + +EL +SP IV + + V
Sbjct: 70 SFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPRIVPLYGAVREGP-WV 125
Query: 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE 188
+I ME ++ GSL +K G L ED Q L+GL Y+H+R I+H D+K NVL++
Sbjct: 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185
Query: 189 KMEHPCGYSC----------LYESGEARHRKHG------------------GYNGFAADI 220
G L G + G DI
Sbjct: 186 D-----GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDI 239
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRCCLQ 278
WS M+ + G +P+ + + L L I PP P + I+ L+
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFR----GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295
Query: 279 KGDPSKRWTASQLLSHPFLA 298
K +P R +A +L A
Sbjct: 296 K-EPVHRASAMELRRKVGKA 314
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-61
Identities = 84/287 (29%), Positives = 121/287 (42%), Gaps = 56/287 (19%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN---PQELNILRQTNSPYIVK 116
E +V+G G V A+K + ++ +E+ + Q + P IV
Sbjct: 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--------GRLSEDIICTISRQVLKGLFY 168
+ F E+ ++M+ + GS+ +K G L E I TI R+VL+GL Y
Sbjct: 78 YYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 169 MHSRNIVHRDIKPANVLINE----KMEHPC--GYS-CLYESGEARHRK------------ 209
+H +HRD+K N+L+ E ++ G S L G+ K
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQI---ADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 210 -------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262
GY+ F ADIWSFG+T +EL G P+ + P LML +PPSL
Sbjct: 194 APEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHK---YPPMKVLML-TLQNDPPSLE 248
Query: 263 ECS---------SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
+ FR I CLQK DP KR TA++LL H F A
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQK-DPEKRPTAAELLRHKFFQKA 294
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 33/288 (11%)
Query: 38 CPNLVHTEAASYGQEIDGLSQLEK---LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR 94
+ H+ G E +EK LQ +G+G+ G V+ + Y +K + R
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61
Query: 95 GTPPN----PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--G 148
+ +E+ +L P IV+ + F + +G + I+M+Y + G L + ++
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVMDYCEGGDLFKRINAQKGV 120
Query: 149 RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-HPC--GYSCLYESGEA 205
ED I Q+ L ++H R I+HRDIK N+ + + G + + S
Sbjct: 121 LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 206 RHR--------------KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLML 251
R ++ YN +DIW+ G + EL + F + +L+L
Sbjct: 181 LARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAF----EAGSMKNLVL 235
Query: 252 AICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
I P + S R + ++ +P R + + +L F+A
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQLFKR-NPRDRPSVNSILEKGFIAK 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-60
Identities = 87/261 (33%), Positives = 138/261 (52%), Gaps = 27/261 (10%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQ 119
+ L+ LG+G+ G+V+K HK+T + A+K + + +E++I++Q +SP++VK +
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 120 IFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+ K + ++ I+MEY AGS+ +I L+ED I TI + LKGL Y+H +HRD
Sbjct: 92 SYFK-NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRD 150
Query: 179 IKPANVLINEKMEHPC---GYSCLYESGEARHR--------------KHGGYNGFAADIW 221
IK N+L+N + G + A+ + GYN ADIW
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-CVADIW 209
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRCCLQK 279
S G+T +E+ G P+ + P + + I PP+ PE S+ F DF++ CL K
Sbjct: 210 SLGITAIEMAEGKPPYAD--IHP--MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265
Query: 280 GDPSKRWTASQLLSHPFLADA 300
P +R TA+QLL HPF+ A
Sbjct: 266 -SPEQRATATQLLQHPFVRSA 285
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-60
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 39/296 (13%)
Query: 32 IPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ 91
+P +L + A + D L+ +G G+ G V+ R + + A+K M
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 92 CDRGTPPNP-----QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS 146
+E+ L++ P ++ + + ++MEY + ++
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVH 147
Query: 147 RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEA- 205
+ L E I ++ L+GL Y+HS N++HRD+K N+L++E G L + G A
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-----GLVKLGDFGSAS 202
Query: 206 --------------------RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPD 245
G Y+ D+WS G+T +EL P
Sbjct: 203 IMAPANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFN--MNA- 258
Query: 246 FLSLMLAICFREPPSLPECS-SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
+S + I E P+L SE FR+F+ CLQK P R T+ LL H F+
Sbjct: 259 -MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK-IPQDRPTSEVLLKHRFVLRE 312
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-60
Identities = 55/287 (19%), Positives = 104/287 (36%), Gaps = 52/287 (18%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQ-TN 110
++ +L+ +G G G+VFK + +YA+K + + Q E+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSL----EIYVKSRGRLSEDIICTISRQVLKGL 166
++V+ + + + I EY + GSL + E + + QV +GL
Sbjct: 70 HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYES--------------GEARH----- 207
Y+HS ++VH DIKP+N+ I+ E G
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 208 --------------RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI 253
+++ + ADI++ +T++ P I
Sbjct: 189 VEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPL-------PRNGDQWHEI 240
Query: 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
P +P+ S++F + ++ + DP +R +A L+ H L A
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHP-DPERRPSAMALVKHSVLLSA 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-59
Identities = 72/265 (27%), Positives = 114/265 (43%), Gaps = 29/265 (10%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYI 114
+ + + +GQG GTV+ T A++ M + E+ ++R+ +P I
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V + E+ ++MEY+ GSL V + E I + R+ L+ L ++HS +
Sbjct: 80 VNYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 175 VHRDIKPANVLINEKMEHPC---GYSCLYESGEARHR--------------KHGGYNGFA 217
+HRDIK N+L+ G+ +++ Y G
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPK 196
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRC 275
DIWS G+ +E+ G P+L + P L + I P L PE S FRDF+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLN--ENP--LRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 276 CLQKGDPSKRWTASQLLSHPFLADA 300
CL+ D KR +A +LL H FL A
Sbjct: 253 CLEM-DVEKRGSAKELLQHQFLKIA 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-59
Identities = 80/271 (29%), Positives = 121/271 (44%), Gaps = 32/271 (11%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPY 113
+ VLG+G G V+ R A+K + P +E+ + +
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMH 170
IV+ F++ + I ME + GSL ++S+ + +E I ++Q+L+GL Y+H
Sbjct: 81 IVQYLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 171 SRNIVHRDIKPANVLINEKM----------------EHPCGYSC----LYESGEARHRKH 210
IVHRDIK NVLIN +PC + Y + E +
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI-CFREPPSLPECSSEKF 269
GY G AADIWS G T++E+ G PF E G+ + M + F+ P +PE S +
Sbjct: 200 RGY-GKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMFKVHPEIPESMSAEA 255
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
+ FI C + DP KR A+ LL FL +
Sbjct: 256 KAFILKCFEP-DPDKRACANDLLVDEFLKVS 285
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-58
Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQT-NSPYIVKC 117
E ++++G G G V+K RH +T L A+KVM QE+N+L++ + I
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 118 HQIFTKPSGEVS-----ILMEYMDAGSLE--IYVKSRGRLSEDIICTISRQVLKGLFYMH 170
+ F K + ++ME+ AGS+ I L E+ I I R++L+GL ++H
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 171 SRNIVHRDIKPANVLINEKME-HPC--GYSCLYESGEARH-------------------R 208
++HRDIK NVL+ E E G S + R
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 206
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-PECSSE 267
Y+ F +D+WS G+T +E+ G P + P + + I P L + S+
Sbjct: 207 PDATYD-FKSDLWSLGITAIEMAEGAPPLCD--MHP--MRALFLIPRNPAPRLKSKKWSK 261
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
KF+ FI CL K + S+R QL+ HPF+ D
Sbjct: 262 KFQSFIESCLVK-NHSQRPATEQLMKHPFIRDQ 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-58
Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVK 116
L+ +G+G+ G V R K + A+K+M + E+ I+R +V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
++ + E+ +LME++ G+L V RL+E+ I T+ VL+ L Y+H++ ++H
Sbjct: 107 MYKSYLV-GEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIH 164
Query: 177 RDIKPANVLINEKMEHPC---GYSCLYESGEARHR--------------KHGGYNGFAAD 219
RDIK ++L+ G+ + + Y D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-ATEVD 223
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--PECSSEKFRDFIRCCL 277
IWS G+ ++E+ G P+ P + M + PP L S RDF+ L
Sbjct: 224 IWSLGIMVIEMVDGEPPYFS--DSP--VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 278 QKGDPSKRWTASQLLSHPFLADA 300
+ DP +R TA +LL HPFL
Sbjct: 280 VR-DPQERATAQELLDHPFLLQT 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-58
Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 49/287 (17%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-QELNILRQTNSPYI 114
S E++ VLGQG G V K R+ YA+K ++ E+ +L N Y+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 115 VKCHQIFTKPSGEVS------------ILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQ 161
V+ + + + V I MEY + G+L + S D + RQ
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEK------------------MEHPCGYSCLYESG 203
+L+ L Y+HS+ I+HRD+KP N+ I+E L S
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 204 EARHRKHG-------------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250
+ G G+ D++S G+ E+ YPF + + L +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL 241
Query: 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
++ PP + + + IR + DP+KR A LL+ +L
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDH-DPNKRPGARTLLNSGWL 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-58
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 39/297 (13%)
Query: 33 PKPVSCPNLVHTEAASYGQEIDGLSQL---EKLQVLGQGNGGTVFKVRHKQTLALYALKV 89
+ + P + + + G + L + +G+G V++ ALK
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64
Query: 90 MQCDRGTPPNP-----QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV 144
+Q +E+++L+Q N P ++K + F + E++I++E DAG L +
Sbjct: 65 VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMI 123
Query: 145 KSRGR----LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK----------- 189
K + + E + Q+ L +MHSR ++HRDIKPANV I
Sbjct: 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 190 --MEHPCG--YSC----LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG 241
+S Y S E H GYN F +DIWS G + E+ PF G
Sbjct: 184 RFFSSKTTAAHSLVGTPYYMSPERIHEN--GYN-FKSDIWSLGCLLYEMAALQSPFY--G 238
Query: 242 QEPDFLSLMLAICFREPPSLP-ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ + SL I + P LP + SE+ R + C+ DP KR + +
Sbjct: 239 DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP-DPEKRPDVTYVYDVAKR 294
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-57
Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 41/273 (15%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILRQTNSPYIV 115
E L +G G+ G K+R K + K + T E+N+LR+ P IV
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 116 KCHQIFT-KPSGEVSILMEYMDAGSLEIYVKSRGR----LSEDIICTISRQVLKGLFYMH 170
+ + + + + I+MEY + G L + + L E+ + + Q+ L H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 171 SRN-----IVHRDIKPANVLINEK-------------MEHPCGYSC------LYESGEAR 206
R+ ++HRD+KPANV ++ K + H ++ Y S E
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 207 HRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
+R YN +DIWS G + EL PF L I + +P S
Sbjct: 189 NRM--SYN-EKSDIWSLGCLLYELCALMPPF----TAFSQKELAGKIREGKFRRIPYRYS 241
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
++ + I L R + ++L +P + +
Sbjct: 242 DELNEIITRMLNL-KDYHRPSVEEILENPLILE 273
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 8e-57
Identities = 58/267 (21%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
+G+G+ TV+K +T A +Q DR + +E +L+ P IV+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 118 H---QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN- 173
+ + K + ++ E M +G+L+ Y+K + ++ + RQ+LKGL ++H+R
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 174 -IVHRDIKPANVLINEKMEHPCGY-------SCLYESGEARHRKHG------------GY 213
I+HRD+K N+ I P G + G Y
Sbjct: 151 PIIHRDLKCDNIFIT----GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKY 206
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-SLPECSSEKFRDF 272
+ + D+++FG+ M+E+ YP+ E + + + P S + + + ++
Sbjct: 207 D-ESVDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299
I C+++ + +R++ LL+H F +
Sbjct: 263 IEGCIRQ-NKDERYSIKDLLNHAFFQE 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-56
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 40/304 (13%)
Query: 17 ASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKV 76
+ +PR + + + + P + S+ Q+ ++L LG G+ G VFKV
Sbjct: 22 SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ-----SFQRLSRLGHGSYGEVFKV 76
Query: 77 RHKQTLALYALKVMQCDRGTPPNP----QELNILRQ-TNSPYIVKCHQIFTKPSGEVSIL 131
R K+ LYA+K P + E+ + P V+ Q + + G + +
Sbjct: 77 RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQ 135
Query: 132 MEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190
E SL+ + ++ G L E + R L L ++HS+ +VH D+KPAN+ + +
Sbjct: 136 TELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG 194
Query: 191 EHPC-----GYSCLYESGEARHRKHG------------GYNGFAADIWSFGVTMMELYMG 233
C G + A + G Y AAD++S G+T++E+
Sbjct: 195 R--CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG-TAADVFSLGLTILEVACN 251
Query: 234 YYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
P + L PP S + R + L+ DP R TA LL+
Sbjct: 252 MEL---PHGGEGWQQLRQGYL---PPEFTAGLSSELRSVLVMMLEP-DPKLRATAEALLA 304
Query: 294 HPFL 297
P L
Sbjct: 305 LPVL 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-56
Identities = 50/278 (17%), Positives = 108/278 (38%), Gaps = 52/278 (18%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIV 115
++++++G G G VFK +H+ Y +K ++ + E+ L + + IV
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER--EVKALAKLDHVNIV 67
Query: 116 KCHQIF---------------TKPSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTI 158
+ + + + I ME+ D G+LE +++ R +L + + +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 159 SRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-------------------HPCGYSCL 199
Q+ KG+ Y+HS+ +++RD+KP+N+ + + + G +
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG-TLR 186
Query: 200 YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP 259
Y S E + Y D+++ G+ + EL E +
Sbjct: 187 YMSPEQISSQ--DYG-KEVDLYALGLILAELLHVCDTAFETS------KFFTDLR---DG 234
Query: 260 SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ + +K + ++ L K P R S++L +
Sbjct: 235 IISDIFDKKEKTLLQKLLSK-KPEDRPNTSEILRTLTV 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-55
Identities = 57/274 (20%), Positives = 111/274 (40%), Gaps = 44/274 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILR--QTNSPY 113
L+ +G G VF+V +++ +YA+K + + E+ L Q +S
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
I++ + + ++ME + L ++K + + + + +L+ + +H
Sbjct: 90 IIRLYDYEITDQ-YIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 174 IVHRDIKPANVLI---------------------NEKMEHPCGYSCLY--------ESGE 204
IVH D+KPAN LI + + G + Y S
Sbjct: 148 IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG-TVNYMPPEAIKDMSSS 206
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPE 263
+ K +D+WS G + + G PF Q + +S + AI P+
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNHEIEFPD 263
Query: 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ +D ++CCL++ DP +R + +LL+HP++
Sbjct: 264 IPEKDLQDVLKCCLKR-DPKQRISIPELLAHPYV 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-54
Identities = 57/274 (20%), Positives = 111/274 (40%), Gaps = 44/274 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN----PQELNILR--QTNSPY 113
L+ +G G VF+V +++ +YA+K + + E+ L Q +S
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
I++ + + ++ME + L ++K + + + + +L+ + +H
Sbjct: 71 IIRLYDYEITDQ-YIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 174 IVHRDIKPANVLI---------------------NEKMEHPCGYSCLY--------ESGE 204
IVH D+KPAN LI + + G + Y S
Sbjct: 129 IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG-TVNYMPPEAIKDMSSS 187
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPE 263
+ K +D+WS G + + G PF Q + +S + AI P+
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNHEIEFPD 244
Query: 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ +D ++CCL++ DP +R + +LL+HP++
Sbjct: 245 IPEKDLQDVLKCCLKR-DPKQRISIPELLAHPYV 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-54
Identities = 68/325 (20%), Positives = 114/325 (35%), Gaps = 90/325 (27%)
Query: 54 DGLSQLEKLQVLGQGNG--GTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
E L V+G+G TV R+K T ++ + + + EL++ +
Sbjct: 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK 81
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKG 165
N P IV F + E+ ++ +M GS + + + ++E I I + VLK
Sbjct: 82 LFNHPNIVPYRATFIADN-ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 166 LFYMHSRNIVHRDIKPANVLINEKME------HPCGYSCLYESGEAR------------- 206
L Y+H VHR +K +++LI+ + + G+ +
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL--SMISHGQRQRVVHDFPKYSVKV 198
Query: 207 ---------HRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE 257
+ GY+ +DI+S G+T EL G+ PF + P L+
Sbjct: 199 LPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD---MPATQMLLE-KLNGT 253
Query: 258 PPSLPECS---------------------------------------------SEKFRDF 272
P L + S S F F
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
+ CLQ+ +P R +AS LL+H F
Sbjct: 314 VEQCLQR-NPDARPSASTLLNHSFF 337
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-54
Identities = 57/274 (20%), Positives = 110/274 (40%), Gaps = 44/274 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILR--QTNSPY 113
L+ +G G VF+V ++ +YA+K + + E+ L Q +S
Sbjct: 59 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
I++ + + ++ME + L ++K + + + + +L+ + +H
Sbjct: 118 IIRLYDYEITDQ-YIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 174 IVHRDIKPANVLI---------------------NEKMEHPCGYSCLY--------ESGE 204
IVH D+KPAN LI + + G + Y S
Sbjct: 176 IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG-AVNYMPPEAIKDMSSS 234
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPE 263
+ K +D+WS G + + G PF Q + +S + AI P+
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---QQIINQISKLHAIIDPNHEIEFPD 291
Query: 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ +D ++CCL++ DP +R + +LL+HP++
Sbjct: 292 IPEKDLQDVLKCCLKR-DPKQRISIPELLAHPYV 324
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-52
Identities = 57/289 (19%), Positives = 98/289 (33%), Gaps = 51/289 (17%)
Query: 50 GQEID-GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELN---- 104
G + +Q LG+G V V YALK + C Q+
Sbjct: 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQR 75
Query: 105 ---ILRQTNSPYIVKCHQIFTKPSG---EVSILMEYMDAGSLEIYVKSR----GRLSEDI 154
+ R N P I++ + G E +L+ + G+L ++ L+ED
Sbjct: 76 EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135
Query: 155 ICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM------------------------ 190
I + + +GL +H++ HRD+KP N+L+ ++
Sbjct: 136 ILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 191 --EHPCGYSC--LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF 246
+ C Y + E + D+WS G + + G P+ Q+ D
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 247 LSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295
++L + P S S + + DP +R LLS
Sbjct: 256 VALAVQNQLSIPQSPRH--SSALWQLLNSMMTV-DPHQRPHIPLLLSQL 301
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 9e-51
Identities = 64/294 (21%), Positives = 95/294 (32%), Gaps = 59/294 (20%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM---QCDRGTPPNPQELNILRQTNSPYIVK 116
+LGQG VF+ RHK+T L+A+KV R +E +L++ N IVK
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 117 CHQIFTKPSGEVSIL-MEYMDAGSLEIYVKSRGR---LSEDIICTISRQVLKGLFYMHSR 172
I + + +L ME+ GSL ++ L E + R V+ G+ ++
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 173 NIVHRDIKPANVLINEKMEHPC-------GYSCLYESGE--------------------A 205
IVHR+IKP N++ + G + E E
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 206 RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI------------ 253
+ H G D+WS GVT G PF +M I
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251
Query: 254 ------------CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295
SL + L+ D K W Q +
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA-DQEKCWGFDQFFAET 304
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-50
Identities = 54/290 (18%), Positives = 105/290 (36%), Gaps = 54/290 (18%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQTNSP 112
L+ E +Q LG+G G VF+ ++K YA+K ++ +E+ L + P
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 113 YIVKCHQIF-----------TKPSGEVSILMEYMDAGSLEIYVKSRGRLS---EDIICTI 158
IV+ + + P + I M+ +L+ ++ R + + I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 159 SRQVLKGLFYMHSRNIVHRDIKPANVLINEKM---------------EHPCGYSCLYESG 203
Q+ + + ++HS+ ++HRD+KP+N+ +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 204 EARHRKHGG--------------YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL 249
ARH G Y+ DI+S G+ + EL YPF + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFEL---LYPF---STQMERVRT 236
Query: 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+ + + P L ++ L P +R A ++ + D
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSP-SPMERPEAINIIENAVFED 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-47
Identities = 57/285 (20%), Positives = 95/285 (33%), Gaps = 40/285 (14%)
Query: 50 GQEIDGLSQLEKLQ-----VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELN 104
G E + + K+ VLG G GT+ R A+K + + + + +E+
Sbjct: 12 GDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFAD-REVQ 69
Query: 105 ILRQTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163
+LR+++ P +++ I +E A E + T+ +Q
Sbjct: 70 LLRESDEHPNVIRYFCTEKDRQ-FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTT 128
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKMEHPC--------GYSCLYESGEA---------- 205
GL ++HS NIVHRD+KP N+LI+ H G G
Sbjct: 129 SGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 206 ----------RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF 255
+ DI+S G + + L+ A
Sbjct: 189 TEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247
Query: 256 REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
+ + R+ I + DP KR +A +L HPF
Sbjct: 248 -DCLHPEKHEDVIARELIEKMIAM-DPQKRPSAKHVLKHPFFWSL 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-47
Identities = 63/293 (21%), Positives = 94/293 (32%), Gaps = 59/293 (20%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM---QCDRGTPPNPQELNILRQTNSPYIVK 116
+LGQG VF+ RHK+T L+A+KV R +E +L++ N IVK
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 117 CHQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGR---LSEDIICTISRQVLKGLFYMHSR 172
I + ++ME+ GSL ++ L E + R V+ G+ ++
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 173 NIVHRDIKPANVLINEKMEHPC-------GYSCLYESGE--------------------A 205
IVHR+IKP N++ + G + E E
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 206 RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI------------ 253
+ H G D+WS GVT G PF +M I
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251
Query: 254 ------------CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
SL + L+ D K W Q +
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA-DQEKCWGFDQFFAE 303
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 40/270 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--------QELNILRQTNSPYI 114
+ LG G V K R K T YA K ++ + +E++ILRQ +
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ H ++ + +V +++E + G L ++ + LSE+ + +Q+L G+ Y+H++ I
Sbjct: 78 ITLHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 175 VHRDIKPANVLINEKMEHPC-------GYSCLYESGEARHRKHG-------------GYN 214
H D+KP N+++ +K G + E G G
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL- 195
Query: 215 GFAADIWSFGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFR 270
G AD+WS GV Y+ G PFL ++ ++ F E S +
Sbjct: 196 GLEADMWSIGVI---TYILLSGASPFLGDTKQETLANITSVSYDFDEEF-FSHTSELA-K 250
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
DFIR L K + KR T + L HP++
Sbjct: 251 DFIRKLLVK-ETRKRLTIQEALRHPWITPV 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKCH 118
+ LG G G V R K T A+K+++ + + E+ +L+ + P I+K +
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
F ++ME G L + R + +E I +QVL G+ Y+H NIVHRD
Sbjct: 103 DFFEDKR-NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 179 IKPANVLINEKMEHPC------GYSCLYESGEARHRKHG-----------GYNGFAADIW 221
+KP N+L+ K + G S ++E+ + + G D+W
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVW 221
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQKG 280
S GV + L GY PF + + F P S +D I+ LQ
Sbjct: 222 SIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-WKNVSEGA-KDLIKQMLQF- 278
Query: 281 DPSKRWTASQLLSHPFLAD 299
D +R +A Q L HP++ +
Sbjct: 279 DSQRRISAQQALEHPWIKE 297
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 68/269 (25%), Positives = 105/269 (39%), Gaps = 36/269 (13%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----------QELNILRQTNSP 112
+ LG G G V ++T A++++ + + E+ IL++ N P
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
I+K F I++E M+ G L V RL E Q+L + Y+H
Sbjct: 201 CIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 173 NIVHRDIKPANVLINEKMEHPC------GYSCLYESGEA----------------RHRKH 210
I+HRD+KP NVL++ + E G+S +
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270
GY A D WS GV + GY PF E + + + + P + SEK
Sbjct: 319 AGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
D ++ L DP R+T + L HP+L D
Sbjct: 378 DLVKKLLVV-DPKARFTTEEALRHPWLQD 405
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-45
Identities = 74/270 (27%), Positives = 115/270 (42%), Gaps = 40/270 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--------QELNILRQTNSPYI 114
+ LG G V K R K T YA K ++ R + +E+NILR+ P I
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ H IF + +V +++E + G L ++ + L+ED +Q+L G+ Y+HS+ I
Sbjct: 71 ITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129
Query: 175 VHRDIKPANVLINEKMEHPC-------GYSCLYESGEARHRKHG-------------GYN 214
H D+KP N+++ +K G + E+G G
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL- 188
Query: 215 GFAADIWSFGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFR 270
G AD+WS GV Y+ G PFL ++ ++ F E S +
Sbjct: 189 GLEADMWSIGVI---TYILLSGASPFLGETKQETLTNISAVNYDFDEEY-FSNTSELA-K 243
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
DFIR L K DP +R T +Q L H ++
Sbjct: 244 DFIRRLLVK-DPKRRMTIAQSLEHSWIKAI 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 73/261 (27%), Positives = 108/261 (41%), Gaps = 27/261 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
+VLG+G+ G V + K T A+KV+ + +E+ +L+Q + P I+K
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
++ F ++ E G L + SR R SE I RQVL G+ YMH IVHR
Sbjct: 92 YEFFEDKG-YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR 150
Query: 178 DIKPANVLINEKMEHPC------GYSCLYESGEARHRKHG-----------GYNGFAADI 220
D+KP N+L+ K + G S +E+ + K G G D+
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDV 210
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQK 279
WS GV + L G PF + + F P + S +D IR L
Sbjct: 211 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ-WKKVSESA-KDLIRKMLTY 268
Query: 280 GDPSKRWTASQLLSHPFLADA 300
PS R +A L H ++
Sbjct: 269 -VPSMRISARDALDHEWIQTY 288
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 69/270 (25%), Positives = 114/270 (42%), Gaps = 40/270 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--------QELNILRQTNSPYI 114
+ LG G V K R K T YA K ++ + +E++ILRQ P I
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ H ++ + +V +++E + G L ++ + LSE+ + +Q+L G+ Y+H++ I
Sbjct: 78 ITLHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 175 VHRDIKPANVLINEKMEHPC-------GYSCLYESGEARHRKHG-------------GYN 214
H D+KP N+++ +K G + E G G
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL- 195
Query: 215 GFAADIWSFGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFR 270
G AD+WS GV Y+ G PFL ++ ++ F E + S +
Sbjct: 196 GLEADMWSIGVI---TYILLSGASPFLGDTKQETLANITAVSYDFDEEF-FSQTSELA-K 250
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
DFIR L K + KR T + L HP++
Sbjct: 251 DFIRKLLVK-ETRKRLTIQEALRHPWITPV 279
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 31/320 (9%)
Query: 4 QGKIPGLSQPASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQ 63
+ + A + + + L + P H + ++ + K +
Sbjct: 36 HNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTE 95
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQIF 121
+LG G G V K T A K+++ E++++ Q + +++ + F
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 122 TKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
+ ++ ++MEY+D G L + + L+E +Q+ +G+ +MH I+H D+K
Sbjct: 156 ESKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 181 PANVLINEKMEHPC-----GYSCLYESGEARHRKHG------------GYNGFAADIWSF 223
P N+L + G + Y+ E G + F D+WS
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 224 GVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQK 279
GV YM G PFL +++ + + S E ++FI L K
Sbjct: 275 GVI---AYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE-FQDISEEA-KEFISKLLIK 329
Query: 280 GDPSKRWTASQLLSHPFLAD 299
+ S R +AS+ L HP+L+D
Sbjct: 330 -EKSWRISASEALKHPWLSD 348
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-45
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 38/268 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNS-PYIVKC 117
+ LG+G V + K T YA K ++ R E+ +L S P ++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 118 HQIFTKPSGEVSILMEYMDAGSL--EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
H+++ S E+ +++EY G + + +SE+ + + +Q+L+G++Y+H NIV
Sbjct: 95 HEVYENTS-EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 176 HRDIKPANVLINEKMEHPC------GYSCLYESGEARHRKHG-------------GYNGF 216
H D+KP N+L++ G S G
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI-TT 212
Query: 217 AADIWSFGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDF 272
A D+W+ G+ YM PF+ + +L++ + + E S DF
Sbjct: 213 ATDMWNIGII---AYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET-FSSVSQLA-TDF 267
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFLADA 300
I+ L K +P KR TA LSH +L
Sbjct: 268 IQSLLVK-NPEKRPTAEICLSHSWLQQW 294
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 73/260 (28%), Positives = 108/260 (41%), Gaps = 28/260 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKCH 118
+LG+G+ G V K + + T YA+KV+ + E+ +L++ + P I+K
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+I S I+ E G L + R R SE I +QV G+ YMH NIVHRD
Sbjct: 88 EILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 179 IKPANVLINEKMEHPC------GYSCLYESGEARHRKHG------------GYNGFAADI 220
+KP N+L+ K + G S ++ + G Y D+
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY-DEKCDV 205
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQK 279
WS GV + L G PF + + F P S + +D IR L
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-WRTISDDA-KDLIRKMLTF 263
Query: 280 GDPSKRWTASQLLSHPFLAD 299
PS R TA+Q L HP++
Sbjct: 264 -HPSLRITATQCLEHPWIQK 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 7e-45
Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 40/270 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--------QELNILRQTNSPYI 114
+ LG G V K R K T YA K ++ R +E++IL++ P +
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ H+++ + +V +++E + G L ++ + L+E+ +Q+L G++Y+HS I
Sbjct: 77 ITLHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 175 VHRDIKPANVL-INEKMEHPC------GYSCLYESGEARHRKHG-------------GYN 214
H D+KP N++ ++ + P G + + G G
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL- 194
Query: 215 GFAADIWSFGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFR 270
G AD+WS GV Y+ G PFL ++ ++ F + S+ +
Sbjct: 195 GLEADMWSIGVI---TYILLSGASPFLGDTKQETLANVSAVNYEFEDEY-FSNTSALA-K 249
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
DFIR L K DP KR T L HP++
Sbjct: 250 DFIRRLLVK-DPKKRMTIQDSLQHPWIKPK 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-45
Identities = 66/262 (25%), Positives = 102/262 (38%), Gaps = 33/262 (12%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQIF 121
LG G G V +V + T +A K + + +E+ + P +V H F
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 122 TKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
+ E+ ++ E+M G L E ++SED RQV KGL +MH N VH D+K
Sbjct: 224 EDDN-EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 181 PANVLINEKMEHPC-----GYSCLYESGEARHRKHG-------------GYNGFAADIWS 222
P N++ K + G + + ++ G G+ D+WS
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWS 341
Query: 223 FGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQ 278
GV Y+ G PF + ++ + S + +DFIR L
Sbjct: 342 VGVL---SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA-FSGISEDG-KDFIRKLLL 396
Query: 279 KGDPSKRWTASQLLSHPFLADA 300
DP+ R T Q L HP+L
Sbjct: 397 A-DPNTRMTIHQALEHPWLTPG 417
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 36/262 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYI 114
+ + LG+G F++ T ++A K++ P+ E++I R ++
Sbjct: 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V H F V +++E SL K R L+E RQ++ G Y+H +
Sbjct: 78 VGFHGFFEDND-FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 175 VHRDIKPANVLINEKMEHPC---GYSCLYESGEARHR--------------KHGGYNGFA 217
+HRD+K N+ +NE +E G + E R + G+ F
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFE 195
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLPECSSEKFRDFIR 274
D+WS G M L +G PF + L I + P + + I+
Sbjct: 196 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPKHI----NPVAASLIQ 247
Query: 275 CCLQKGDPSKRWTASQLLSHPF 296
LQ DP+ R T ++LL+ F
Sbjct: 248 KMLQT-DPTARPTINELLNDEF 268
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 64/269 (23%), Positives = 104/269 (38%), Gaps = 39/269 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---------------QELNILR 107
+ LG G G V + K + A+KV++ + E+++L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLF 167
+ P I+K +F ++ E+ + G L + +R + E I +Q+L G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPC------GYSCLYESGEARHRKHG---------- 211
Y+H NIVHRDIKP N+L+ K G S + + G
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220
Query: 212 --GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEK 268
Y D+WS GV M L GY PF + + F S E
Sbjct: 221 KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND-WKNISDEA 278
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
++ I+ L D +KR TA + L+ ++
Sbjct: 279 -KELIKLMLTY-DYNKRCTAEEALNSRWI 305
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-44
Identities = 42/290 (14%), Positives = 86/290 (29%), Gaps = 58/290 (20%)
Query: 64 VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-------------------PNPQEL- 103
L G+ VF VR + L +ALKV +P+E
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 104 ---------NILRQTNSPYIVKCHQIFTKPS-GEVSILMEYMDA------GSLEIYVKSR 147
+ + + P + + +LM +L+ R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 148 GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---------------- 191
G + ++ Q+++ + S+ +VH P N+ I
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG 248
Query: 192 HPCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF--LEPGQEPDFLSL 249
Y E + + A + W G+++ ++ + PF + PG + +
Sbjct: 249 PASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307
Query: 250 MLAICFREPPSLPECS--SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
L + + + C+ + + I L D +R + + P
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF-DRRRRLLPLEAMETPEF 356
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 69/269 (25%), Positives = 105/269 (39%), Gaps = 36/269 (13%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----------QELNILRQTNSP 112
+ LG G G V ++T A+K++ + + E+ IL++ N P
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
I+K F I++E M+ G L V RL E Q+L + Y+H
Sbjct: 76 CIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 173 NIVHRDIKPANVLINEKMEHPC------GYSCLYESGEA----------------RHRKH 210
I+HRD+KP NVL++ + E G+S +
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 193
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270
GY A D WS GV + GY PF E + + + + P + SEK
Sbjct: 194 AGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
D ++ L DP R+T + L HP+L D
Sbjct: 253 DLVKKLLVV-DPKARFTTEEALRHPWLQD 280
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 36/262 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYI 114
+ + LG+G F++ T ++A K++ P+ E++I R ++
Sbjct: 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
V H F V +++E SL K R L+E RQ++ G Y+H +
Sbjct: 104 VGFHGFFEDND-FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 175 VHRDIKPANVLINEKMEHPC---GYSCLYESGEARHR--------------KHGGYNGFA 217
+HRD+K N+ +NE +E G + E R + G+ F
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFE 221
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLPECSSEKFRDFIR 274
D+WS G M L +G PF + L I + P + + I+
Sbjct: 222 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPKHI----NPVAASLIQ 273
Query: 275 CCLQKGDPSKRWTASQLLSHPF 296
LQ DP+ R T ++LL+ F
Sbjct: 274 KMLQT-DPTARPTINELLNDEF 294
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 67/266 (25%), Positives = 106/266 (39%), Gaps = 37/266 (13%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKCH 118
+ LG+G V + HK T +A K++ + + + Q E I R+ P IV+ H
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+ ++ + + G L + +R SE +Q+L+ + Y HS IVHR+
Sbjct: 72 DSIQEE-SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 179 IKPANVLINEKMEHPC------GYSCLYESGEARHRKHG-------------GYNGFAAD 219
+KP N+L+ K + G + EA H G Y D
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVD 189
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----FREPPSLPECSSEKFRDFIR 274
IW+ GV + L +GY PF + Q L I + P + E + I
Sbjct: 190 IWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPE-WDTVTPEA-KSLID 243
Query: 275 CCLQKGDPSKRWTASQLLSHPFLADA 300
L +P KR TA Q L P++ +
Sbjct: 244 SMLTV-NPKKRITADQALKVPWICNR 268
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 65/262 (24%), Positives = 101/262 (38%), Gaps = 33/262 (12%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQI 120
+ LG G G V + K T ++ K + E++I+ Q + P ++ H
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 121 FTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
F E+ +++E++ G L + ++SE + RQ +GL +MH +IVH DI
Sbjct: 117 FEDKY-EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 180 KPANVLINEKMEHPC-----GYSCLYESGEARHRKHG-------------GYNGFAADIW 221
KP N++ K G + E GF D+W
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMW 234
Query: 222 SFGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCL 277
+ GV Y+ G PF ++ F E S E +DFI+ L
Sbjct: 235 AIGVL---GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA-FSSVSPEA-KDFIKNLL 289
Query: 278 QKGDPSKRWTASQLLSHPFLAD 299
QK +P KR T L HP+L
Sbjct: 290 QK-EPRKRLTVHDALEHPWLKG 310
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-43
Identities = 73/260 (28%), Positives = 108/260 (41%), Gaps = 28/260 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKCH 118
+LG+G+ G V K + + T YA+KV+ + E+ +L++ + P I+K
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+I S I+ E G L + R R SE I +QV G+ YMH NIVHRD
Sbjct: 88 EILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 179 IKPANVLINEKMEHPC------GYSCLYESGEARHRK------------HGGYNGFAADI 220
+KP N+L+ K + G S ++ + G Y D+
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY-DEKCDV 205
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQK 279
WS GV + L G PF + + F P S + +D IR L
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-WRTISDDA-KDLIRKMLTF 263
Query: 280 GDPSKRWTASQLLSHPFLAD 299
PS R TA+Q L HP++
Sbjct: 264 -HPSLRITATQCLEHPWIQK 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 6e-43
Identities = 63/263 (23%), Positives = 102/263 (38%), Gaps = 34/263 (12%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCHQIF 121
+ LG+G G V + + Y K ++ +E++IL I+ H+ F
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 122 TKPSGEVSILMEYMDAGSL--EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
E+ ++ E++ + I S L+E I + QV + L ++HS NI H DI
Sbjct: 71 ESME-ELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 180 KPANVLINEKMEHPC-----GYSCLYESGEARHRKHG-------------GYNGFAADIW 221
+P N++ + G + + G+ A D+W
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMW 187
Query: 222 SFGVTMMELYM---GYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCL 277
S G +Y+ G PFL + ++M A F E E S E DF+ L
Sbjct: 188 SLGTL---VYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-FKEISIEA-MDFVDRLL 242
Query: 278 QKGDPSKRWTASQLLSHPFLADA 300
K + R TAS+ L HP+L
Sbjct: 243 VK-ERKSRMTASEALQHPWLKQK 264
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-43
Identities = 67/265 (25%), Positives = 106/265 (40%), Gaps = 37/265 (13%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKCH 118
+ LG+G V + HK T +A K++ + + + Q E I R+ P IV+ H
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+ ++ + + G L + +R SE +Q+L+ + Y HS IVHR+
Sbjct: 95 DSIQEE-SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 179 IKPANVLINEKMEHPC------GYSCLYESGEARHRKHG-------------GYNGFAAD 219
+KP N+L+ K + G + EA H G Y D
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVD 212
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----FREPPSLPECSSEKFRDFIR 274
IW+ GV + L +GY PF + Q L I + P + E + I
Sbjct: 213 IWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPE-WDTVTPEA-KSLID 266
Query: 275 CCLQKGDPSKRWTASQLLSHPFLAD 299
L +P KR TA Q L P++ +
Sbjct: 267 SMLTV-NPKKRITADQALKVPWICN 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 71/258 (27%), Positives = 111/258 (43%), Gaps = 26/258 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQI 120
+VLG G VF V+ + T L+ALK ++ + E+ +L++ IV I
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 121 FTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
+ + ++M+ + G L + RG +E + +QVL + Y+H IVHRD+K
Sbjct: 75 YESTT-HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 181 PANVLINEKMEHPC------GYSCLYESGEARHR------------KHGGYNGFAADIWS 222
P N+L E+ G S + ++G Y A D WS
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWS 192
Query: 223 FGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQKGD 281
GV L GY PF E + F + F P + S +DFI L+K D
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF-WDDISESA-KDFICHLLEK-D 249
Query: 282 PSKRWTASQLLSHPFLAD 299
P++R+T + LSHP++
Sbjct: 250 PNERYTCEKALSHPWIDG 267
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-42
Identities = 65/259 (25%), Positives = 97/259 (37%), Gaps = 26/259 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQI 120
+G+G+ G V K T A K + + QE+ I++ + P I++ ++
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 121 FTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIK 180
F + ++ ++ME G L V + E I + VL + Y H N+ HRD+K
Sbjct: 75 FEDNT-DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 181 PANVLINEKMEHPC------GYSCLYESGEARHRK------------HGGYNGFAADIWS 222
P N L G + ++ G+ K G Y G D WS
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY-GPECDEWS 192
Query: 223 FGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQKGD 281
GV M L GY PF P L + F E S + IR L K
Sbjct: 193 AGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-WLNVSPQA-ESLIRRLLTK-S 249
Query: 282 PSKRWTASQLLSHPFLADA 300
P +R T+ Q L H +
Sbjct: 250 PKQRITSLQALEHEWFEKQ 268
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 70/258 (27%), Positives = 109/258 (42%), Gaps = 26/258 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFT 122
LG+G V++ + K T YALKV++ E+ +L + + P I+K +IF
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 123 KPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPA 182
P+ E+S+++E + G L + +G SE +Q+L+ + Y+H IVHRD+KP
Sbjct: 119 TPT-EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 183 NVLINEKMEHPC------GYSCLYESGEARHRKHG-------------GYNGFAADIWSF 223
N+L G S + E G Y G D+WS
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSV 236
Query: 224 GVTMMELYMGYYPFLEPGQEPDFLSLMLA--ICFREPPSLPECSSEKFRDFIRCCLQKGD 281
G+ L G+ PF + + +L F P E S +D +R + D
Sbjct: 237 GIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW-WDEVSLNA-KDLVRKLIVL-D 293
Query: 282 PSKRWTASQLLSHPFLAD 299
P KR T Q L HP++
Sbjct: 294 PKKRLTTFQALQHPWVTG 311
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 46/275 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----------QELNILRQTNS 111
++LG+G V + HK T YA+K++ G + +E++ILR+ +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 112 -PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
P I++ + + ++ + M G L Y+ + LSE I R +L+ + +H
Sbjct: 83 HPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 171 SRNIVHRDIKPANVLI-------------------NEKMEHPCGYSCLYESGE----ARH 207
NIVHRD+KP N+L+ EK+ CG + Y + E + +
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG-TPSYLAPEIIECSMN 200
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPP--SLPEC 264
H GY G D+WS GV M L G PF Q +M F P
Sbjct: 201 DNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY--- 256
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
S+ +D + L P KR+TA + L+HPF
Sbjct: 257 -SDTVKDLVSRFLVV-QPQKRYTAEEALAHPFFQQ 289
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 61/320 (19%), Positives = 110/320 (34%), Gaps = 71/320 (22%)
Query: 32 IPKPVSCPNLVHTEAASY-GQEID-GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKV 89
+ P S + + + GQ ++ G +L +VL +G V++ + + YALK
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR 60
Query: 90 MQCDRGTPPNPQELNILRQ--------TNSPYIVKCH-------QIFTKPSGEVSILMEY 134
+ ++ + Q + P IV+ + E +L E
Sbjct: 61 LLS-----NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL 115
Query: 135 MDAGSLEIYVK--SRGRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKM 190
+E K SRG LS D + I Q + + +MH + I+HRD+K N+L++ +
Sbjct: 116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175
Query: 191 --------------EHPCGYSCLYESG--EARHRKHG---------------GYNGFAAD 219
+P E ++ G D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLPECSSEKFRDFIRCC 276
IW+ G + L +PF + L I + PP + F IR
Sbjct: 236 IWALGCILYLLCFRQHPFED--------GAKLRIVNGKYSIPPHDTQ--YTVFHSLIRAM 285
Query: 277 LQKGDPSKRWTASQLLSHPF 296
LQ +P +R + ++++
Sbjct: 286 LQV-NPEERLSIAEVVHQLQ 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 62/266 (23%), Positives = 107/266 (40%), Gaps = 38/266 (14%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKCH 118
+ LG+G V + YA ++ + + + Q E I R P IV+ H
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
++ G ++ + + G L + +R SE +Q+L+ + + H +VHR+
Sbjct: 77 DSISEE-GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRN 135
Query: 179 IKPANVLINEKMEHPC------GYSCLYESGEARHR--------------KHGGYNGFAA 218
+KP N+L+ K++ G + E + + Y G
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPV 194
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----FREPPSLPECSSEKFRDFI 273
D+W+ GV + L +GY PF + Q L I F P + E +D I
Sbjct: 195 DLWACGVILYILLVGYPPFWDEDQH----RLYQQIKAGAYDFPSPE-WDTVTPEA-KDLI 248
Query: 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299
L +PSKR TA++ L HP+++
Sbjct: 249 NKMLTI-NPSKRITAAEALKHPWISH 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-41
Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 34/265 (12%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQTNSPYIVKCHQ 119
+ LG G G V V + + +K + DR P E+ +L+ + P I+K +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 120 IFTKPSGEVSILMEYMDAGSL----EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+F + I+ME + G L LSE + + +Q++ L Y HS+++V
Sbjct: 88 VFEDYH-NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVV 146
Query: 176 HRDIKPANVLINEKMEHPC------GYSCLYESGEARHRK------------HGGYNGFA 217
H+D+KP N+L + H G + L++S E F
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV-TFK 205
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP--PSLPECSSEKFRDFIRC 275
DIWS GV M L G PF E + ++EP + + D ++
Sbjct: 206 CDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 276 CLQKGDPSKRWTASQLLSHPFLADA 300
L K DP +R +A+Q+L H + A
Sbjct: 262 MLTK-DPERRPSAAQVLHHEWFKQA 285
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-41
Identities = 64/311 (20%), Positives = 110/311 (35%), Gaps = 80/311 (25%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-------QELNILRQTNSPYIV 115
+GQG+ G V QT A+ A+K+M ++ NP E+ ++++ + P I
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-------------------------- 149
+ ++++ + ++ME G L +
Sbjct: 92 RLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 150 --------------LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK------ 189
E +I I RQ+ L Y+H++ I HRDIKP N L +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 190 --------------------MEHPCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMME 229
M G + + + E + + Y G D WS GV +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAG-TPYFVAPEVLNTTNESY-GPKCDAWSAGVLLHL 268
Query: 230 LYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTA 288
L MG PF ++ +CF P S RD + L + + +R+ A
Sbjct: 269 LLMGAVPFPGVNDADTISQVLNKKLCFENPN-YNVLSPLA-RDLLSNLLNR-NVDERFDA 325
Query: 289 SQLLSHPFLAD 299
+ L HP+++
Sbjct: 326 MRALQHPWISQ 336
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 72/271 (26%), Positives = 114/271 (42%), Gaps = 44/271 (16%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIF 121
QVLG G G V + H++T ALK++ D P QE++ Q + P+IV ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY-DS--PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 122 ---TKPSGEVSILMEYMDAGSL--EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ I+ME M+ G L I + +E I R + + ++HS NI H
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH 151
Query: 177 RDIKPANVLI---------------------NEKMEHPCGYSCLYESGEARHRKHGGYNG 215
RD+KP N+L ++ PC + Y + E + Y
Sbjct: 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYVAPEVLGPE--KY-D 207
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----FREPPSLPECSSE-KF 269
+ D+WS GV M L G+ PF + + I F P E S + K
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE-WSEVSEDAK- 265
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
IR L+ DP++R T +Q ++HP++ +
Sbjct: 266 -QLIRLLLKT-DPTERLTITQFMNHPWINQS 294
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 3e-40
Identities = 45/301 (14%), Positives = 88/301 (29%), Gaps = 72/301 (23%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQE--------LNILRQT 109
L + VLGQ + + ++T + + V P N + L +LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 110 NSPYIVKCHQIFTKPSGEVS-----------------------ILMEYMDA------GSL 140
+ K H F P V L M + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 141 EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME--------- 191
+ + L ++ QV++ L +H +VH ++P +++++++
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 192 -------HPCGYSCLY--------ESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYP 236
S + + + HR F+ D W+ G+ + ++ P
Sbjct: 254 VRDGARVVSSV-SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 237 FLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
D FR ++P + R + L+ R Q + P
Sbjct: 313 I-----TKDAALGGSEWIFRSCKNIP----QPVRALLEGFLRY-PKEDRLLPLQAMETPE 362
Query: 297 L 297
Sbjct: 363 Y 363
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 59/265 (22%), Positives = 106/265 (40%), Gaps = 35/265 (13%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNIL-RQTNSPYIVKCHQIF 121
+ +G G+ + HK T +A+K++ D+ +E+ IL R P I+ ++
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKII--DKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 122 TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
V ++ E M G L + + SE + + K + Y+H++ +VHRD+KP
Sbjct: 86 DDGK-YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144
Query: 182 ANVLINEKMEHPC-------GYSCLYESGEARHR--------------KHGGYNGFAADI 220
+N+L ++ +P G++ + + GY A DI
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY-DAACDI 203
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI-----CFREPPSLPECSSEKFRDFIRC 275
WS GV + + GY PF + ++ I S +D +
Sbjct: 204 WSLGVLLYTMLTGYTPFANGPDDTPE-EILARIGSGKFSLSGGY-WNSVSDTA-KDLVSK 260
Query: 276 CLQKGDPSKRWTASQLLSHPFLADA 300
L DP +R TA+ +L HP++
Sbjct: 261 MLHV-DPHQRLTAALVLRHPWIVHW 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 48/274 (17%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-------QELNILRQTNSPYIV 115
+V+G+G V + +++T +A+K++ + T +E +I P+IV
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSL--EIYVK--SRGRLSEDIICTISRQVLKGLFYMHS 171
+ + ++ G + ++ E+MD L EI + + SE + RQ+L+ L Y H
Sbjct: 90 ELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 172 RNIVHRDIKPANVLINEKMEHPC------GYSC-LYESGEARHRKHG------------- 211
NI+HRD+KP VL+ K G + L ESG + G
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE 208
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----FREPPSLPECSS 266
Y G D+W GV + L G PF + L I S
Sbjct: 209 PY-GKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGKYKMNPRQ-WSHISE 261
Query: 267 E-KFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
K D +R L DP++R T + L+HP+L +
Sbjct: 262 SAK--DLVRRMLML-DPAERITVYEALNHPWLKE 292
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-40
Identities = 68/274 (24%), Positives = 109/274 (39%), Gaps = 54/274 (19%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM------------QCDRGTPPNPQEL 103
L E + LG+G G V+ R KQ+ + ALKV+ Q R E+
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR-------EV 60
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163
I P I++ + F + V +++EY G++ ++ + E T ++
Sbjct: 61 EIQSHLRHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKME----------HP--------CGYSCLYESGEA 205
L Y HS+ ++HRDIKP N+L+ E H CG + Y E
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-TLDYLPPEM 178
Query: 206 RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLP 262
+ + D+WS GV E +G PF + + I F P +
Sbjct: 179 IEGR--MH-DEKVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFV- 230
Query: 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
+E RD I L+ +PS+R ++L HP+
Sbjct: 231 ---TEGARDLISRLLKH-NPSQRPMLREVLEHPW 260
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 76/273 (27%), Positives = 114/273 (41%), Gaps = 47/273 (17%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----------QELNILRQ-TNS 111
V+G+G V + H+ T +A+K+M+ +E +ILRQ
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
P+I+ + S + ++ + M G L Y+ + LSE +I R +L+ + ++H+
Sbjct: 160 PHIITLIDSYESSS-FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 172 RNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGE-------------------ARH 207
NIVHRD+KP N+L+++ M G+SC E GE +
Sbjct: 219 NNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD 276
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPP--SLPEC 264
H GY G D+W+ GV + L G PF Q +M F P
Sbjct: 277 ETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR--- 332
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
S +D I LQ DP R TA Q L HPF
Sbjct: 333 -SSTVKDLISRLLQV-DPEARLTAEQALQHPFF 363
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-40
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 58/300 (19%)
Query: 48 SYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILR 107
++ Q + L EK +LG G+ GTV + A+K M D E+ +L
Sbjct: 8 NFEQSLKNLVVSEK--ILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIAL-MEIKLLT 63
Query: 108 QT-NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDI-------ICTIS 159
++ + P +++ + T + I +E + +L+ V+S+ E++ ++
Sbjct: 64 ESDDHPNVIRYYCSETTDR-FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 160 RQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC----------------GYSCLYESG 203
RQ+ G+ ++HS I+HRD+KP N+L++ G +SG
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 204 EARHRKHG-------GYN-----------------GFAADIWSFGVTMMELY-MGYYPFL 238
++ R + G+ + DI+S G + G +PF
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 239 EPGQEPDFLSLMLAICFREPPSLPECS-SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ + + E L + S + D I + DP KR TA ++L HP
Sbjct: 242 DK-YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH-DPLKRPTAMKVLRHPLF 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 54/263 (20%), Positives = 101/263 (38%), Gaps = 37/263 (14%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYI 114
+ +LG+G+ V++ T A+K++ E+ I Q P I
Sbjct: 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
++ + F + V +++E G + SE+ Q++ G+ Y+HS
Sbjct: 74 LELYNYFEDSN-YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 174 IVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHR--------------KHGGYNGF 216
I+HRD+ +N+L+ M G + + +H + G
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GL 191
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLPECSSEKFRDFI 273
+D+WS G L +G PF + + + + P L S + +D I
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLADYEMPSFL----SIEAKDLI 243
Query: 274 RCCLQKGDPSKRWTASQLLSHPF 296
L++ +P+ R + S +L HPF
Sbjct: 244 HQLLRR-NPADRLSLSSVLDHPF 265
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-39
Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 26/252 (10%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-PYIVKCHQIF 121
QVLG G G V ++ +K+T +ALK++Q D E+ + + + P+IV+ ++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR--EVELHWRASQCPHIVRIVDVY 80
Query: 122 ---TKPSGEVSILMEYMDAGSL--EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ I+ME +D G L I + +E I + + + + Y+HS NI H
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 140
Query: 177 RDIKPANVLINEKMEHPCGYSCLYES--GEARHRKHGGYNGFAADIWSFGVTMMELYMGY 234
RD+KP N+L K + + L + G A+ Y + D+WS GV M L GY
Sbjct: 141 RDVKPENLLYTSKRPN----AILKLTDFGFAKETTGEKY-DKSCDMWSLGVIMYILLCGY 195
Query: 235 YPFLEPGQEPDFLSLMLAIC-----FREPPSLPECSSE-KFRDFIRCCLQKGDPSKRWTA 288
PF + I F P E S E K IR L+ +P++R T
Sbjct: 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPE-WSEVSEEVK--MLIRNLLKT-EPTQRMTI 251
Query: 289 SQLLSHPFLADA 300
++ ++HP++ +
Sbjct: 252 TEFMNHPWIMQS 263
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-39
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 59/284 (20%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVM---------QCDRGTPPNP--------------- 100
+G+G+ G V ++ YA+KV+ R PP
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 101 ----QELNILRQTNSPYIVKCHQIFTKPS-GEVSILMEYMDAGSLEIYVKSRGRLSEDII 155
QE+ IL++ + P +VK ++ P+ + ++ E ++ G + + LSED
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQA 139
Query: 156 CTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-------------MEHP-------CG 195
+ ++KG+ Y+H + I+HRDIKP+N+L+ E + G
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 196 YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF 255
+ + + E+ ++G A D+W+ GVT+ G PF + + L I
Sbjct: 200 -TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF----MDERIMCLHSKI-K 253
Query: 256 REPPSLPECS--SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ P+ +E +D I L K +P R ++ HP++
Sbjct: 254 SQALEFPDQPDIAEDLKDLITRMLDK-NPESRIVVPEIKLHPWV 296
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 62/315 (19%), Positives = 119/315 (37%), Gaps = 50/315 (15%)
Query: 14 ASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTV 73
S LV + + P + + + ++ Q+ L LG G G+V
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPL--LGSGGFGSV 59
Query: 74 FKVRHKQTLALYALKVM--------QCDRGTPPNPQELNILRQTNS--PYIVKCHQIFTK 123
+ A+K + P E+ +L++ +S +++ F +
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119
Query: 124 PSGEVSILMEYMD-AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPA 182
P V +++E + L ++ RG L E++ + QVL+ + + H+ ++HRDIK
Sbjct: 120 PDSFV-LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178
Query: 183 NVLINEK-------------------MEHPCGYSCLYESGEARHRKHGGYNGFAADIWSF 223
N+LI+ G + +Y E Y+G +A +WS
Sbjct: 179 NILIDLNRGELKLIDFGSGALLKDTVYTDFDG-TRVYSPPEWIRYH--RYHGRSAAVWSL 235
Query: 224 GVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-PECSSEKFRDFIRCCLQKGDP 282
G+ + ++ G PF + ++ + EC + IR CL P
Sbjct: 236 GILLYDMVCGDIPF-------EHDEEIIRGQVFFRQRVSSEC-----QHLIRWCLAL-RP 282
Query: 283 SKRWTASQLLSHPFL 297
S R T ++ +HP++
Sbjct: 283 SDRPTFEEIQNHPWM 297
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-39
Identities = 63/264 (23%), Positives = 101/264 (38%), Gaps = 34/264 (12%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTN 110
+ + + LG+G G V+ R KQ + ALKV+ + + E+ I
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
P I++ + F + +++E+ G L ++ GR E T ++ L Y H
Sbjct: 73 HPNILRMYNYFHDRK-RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 171 SRNIVHRDIKPANVLINEKME----------HP--------CGYSCLYESGEARHRKHGG 212
R ++HRDIKP N+L+ K E H CG + Y E K
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG-TLDYLPPEMIEGK--T 188
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
++ D+W GV E +G PF P I P S+ +D
Sbjct: 189 HDE-KVDLWCAGVLCYEFLVGMPPF----DSPSHTETHRRI-VNVDLKFPPFLSDGSKDL 242
Query: 273 IRCCLQKGDPSKRWTASQLLSHPF 296
I L+ P +R ++ HP+
Sbjct: 243 ISKLLRY-HPPQRLPLKGVMEHPW 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-39
Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 41/270 (15%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIF 121
+ LG+G+ K HK++ +A+K++ R +E+ L+ P IVK H++F
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 122 TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
++ME ++ G L +K + SE I R+++ + +MH +VHRD+KP
Sbjct: 76 HDQL-HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 182 ANVL-----------------------INEKMEHPCGYSCLYESGEARHRKHGGYNGFAA 218
N+L N+ ++ PC + Y + E ++ GY +
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQN--GY-DESC 190
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLS---LMLAI-----CFREPPSLPECSSEKFR 270
D+WS GV + + G PF + S +M I F + S++ +
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA--WKNVSQEAK 248
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
D I+ L DP+KR S L + +L D
Sbjct: 249 DLIQGLLTV-DPNKRLKMSGLRYNEWLQDG 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 61/290 (21%), Positives = 96/290 (33%), Gaps = 55/290 (18%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYI 114
E + LG G G V + H+ T A+K C + P E+ I+++ N P +
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQ--CRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 115 VKCHQIFTKPSGEVS-----ILMEYMDAGSLEIYVKSRGR---LSEDIICTISRQVLKGL 166
V ++ + MEY + G L Y+ L E I T+ + L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPC------GYSCLYESGEARHRKHG--------- 211
Y+H I+HRD+KP N+++ + GY+ + GE G
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 212 ----GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-------- 259
Y D WSFG E G+ PFL Q + +
Sbjct: 195 LEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 260 -----------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298
L + K +++C L +R T Q +
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMW-HQRQRGTDPQNPNVGCFQ 302
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-ELNILRQTNSPYIVKCH 118
+ ++ +G GN G +R K T L A+K ++ N Q E+ R P IV+
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
++ P+ ++I+MEY G L + + GR SED +Q+L G+ Y HS I HRD
Sbjct: 83 EVILTPT-HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRD 141
Query: 179 IKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG-------------GYNGFAADI 220
+K N L++ GYS G Y+G AD+
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADV 201
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSL---PECSSEKFRDFIR 274
WS GVT+ + +G YPF +P + D+ + I + P + PEC I
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC-----CHLIS 256
Query: 275 CCLQKGDPSKRWTASQLLSHP-FLAD 299
DP+ R + ++ +H FL +
Sbjct: 257 RIFVA-DPATRISIPEIKTHSWFLKN 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-38
Identities = 65/257 (25%), Positives = 112/257 (43%), Gaps = 29/257 (11%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKC 117
L+ +G+GN V RH T A+K++ + P + Q E+ I++ N P IVK
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
++ + ++MEY G + Y+ + GR+ E + RQ++ + Y H + IVHR
Sbjct: 80 FEVIETEK-TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 138
Query: 178 DIKPANVLINEKMEHPC---GYSCLYESGEARHRKHG-------------GYNGFAADIW 221
D+K N+L++ M G+S + G G Y+G D+W
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVW 198
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-PECSSEKFRDFIRCCLQKG 280
S GV + L G PF + +L +R P + +C + ++ L
Sbjct: 199 SLGVILYTLVSGSLPFDGQNL-KELRERVLRGKYRIPFYMSTDC-----ENLLKRFLVL- 251
Query: 281 DPSKRWTASQLLSHPFL 297
+P KR T Q++ ++
Sbjct: 252 NPIKRGTLEQIMKDRWI 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 1e-37
Identities = 57/361 (15%), Positives = 103/361 (28%), Gaps = 78/361 (21%)
Query: 5 GKIPGLSQPASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLS------- 57
G PG + + + + T + +LV T + GQ S
Sbjct: 21 GTDPGDVVIEELFNRIPQANVRTTSEYMQSAAD--SLVSTSLWNTGQPFRVESELGERPR 78
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQE--------LNILRQT 109
L + VLGQ + + ++T + + V P N + L +LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 110 NSPYIVKCHQIFTKPSGEVSI-----------------------LMEYMDA------GSL 140
+ K H F P V L M + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 141 EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI-------------- 186
+ + L ++ QV++ L +H +VH ++P ++++
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 187 ---NEKMEHPCGYSCL---YESGE--ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFL 238
P G + + H FA D W+ G+ + ++ P
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN- 317
Query: 239 EPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298
+ L I FR ++P + R + L+ R Q + P
Sbjct: 318 ---TDDAALGGSEWI-FRSCKNIP----QPVRALLEGFLRY-PKEDRLLPLQAMETPEYE 368
Query: 299 D 299
Sbjct: 369 Q 369
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 62/269 (23%), Positives = 103/269 (38%), Gaps = 50/269 (18%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM--------QCDRGTPPNPQELNILRQTNS 111
+LG+G GTVF A+KV+ + P E+ +L + +
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 112 ----PYIVKCHQIFTKPSGEVSILMEY-MDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
P +++ F G + +++E + A L Y+ +G L E QV+ +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 167 FYMHSRNIVHRDIKPANVLINEKM-------------------EHPCGYSCLYESGEARH 207
+ HSR +VHRDIK N+LI+ + G + +Y E
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDG-TRVYSPPEWIS 211
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-PECSS 266
R Y+ A +WS G+ + ++ G PF + +L P + P+C
Sbjct: 212 RH--QYHALPATVWSLGILLYDMVCGDIPF-------ERDQEILEAELHFPAHVSPDC-- 260
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHP 295
IR CL PS R + ++L P
Sbjct: 261 ---CALIRRCLAP-KPSSRPSLEEILLDP 285
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-37
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 36/261 (13%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTNSPYIVKC 117
Q LG+G G V ++ T A+K++ D + E+ I + N +VK
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ + + + +EY G L ++ + E Q++ G+ Y+H I HR
Sbjct: 71 YGHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 178 DIKPANVLINEKMEHPC---GYSCLYESGEARHRKH----------------GGYNGFAA 218
DIKP N+L++E+ G + ++ + ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL---PECSSEKFRDFIRC 275
D+WS G+ + + G P+ +P S P +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-----LALLHK 244
Query: 276 CLQKGDPSKRWTASQLLSHPF 296
L + +PS R T + +
Sbjct: 245 ILVE-NPSARITIPDIKKDRW 264
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 47/273 (17%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQ-CDRGTPPNPQELNILRQTNS-PYIVKCHQI 120
QVLG G G V ++ +K+T +ALK++Q C + +E+ + + + P+IV+ +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR----REVELHWRASQCPHIVRIVDV 123
Query: 121 F---TKPSGEVSILMEYMDAGSL--EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ + I+ME +D G L I + +E I + + + + Y+HS NI
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 183
Query: 176 HRDIKPANVLI----------------------NEKMEHPCGYSCLYESGEARHRKHGGY 213
HRD+KP N+L + + PC + Y + E + Y
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPE--KY 240
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-----FREPPSLPECSSE- 267
+ D+WS GV M L GY PF + I F P E S E
Sbjct: 241 -DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE-WSEVSEEV 298
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
K IR L+ +P++R T ++ ++HP++ +
Sbjct: 299 K--MLIRNLLKT-EPTQRMTITEFMNHPWIMQS 328
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 48/270 (17%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ--------ELNILRQTNSPYI 114
+LG+G+ G V +V +TL A+K++ + E+ +LR+ +
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKIL--KKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 115 VKCHQIFTKPS-GEVSILMEYMDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFYMHSR 172
++ + ++ ++MEY G E+ R Q++ GL Y+HS+
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 173 NIVHRDIKPANVLINEKM------------------EHPCGYSC---LYESGE-ARHRKH 210
IVH+DIKP N+L+ + C S ++ E A
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD- 187
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLPECSSE 267
++GF DIWS GVT+ + G YPF + + L I + P
Sbjct: 188 -TFSGFKVDIWSAGVTLYNITTGLYPF----EGDNIYKLFENIGKGSYAIPGDC----GP 238
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
D ++ L+ +P+KR++ Q+ H +
Sbjct: 239 PLSDLLKGMLEY-EPAKRFSIRQIRQHSWF 267
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 65/291 (22%), Positives = 108/291 (37%), Gaps = 60/291 (20%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQ-TNSPYIVKCHQ 119
VLG+G V + T YA+K+++ G + +E+ +L Q +++ +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
F + ++ E M GS+ ++ R +E + + V L ++H++ I HRD+
Sbjct: 79 FFEEED-RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 180 KPANVL------------------------------INEKMEHPCGYSCLY---ESGEAR 206
KP N+L ++ PCG S Y E EA
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG-SAEYMAPEVVEAF 196
Query: 207 HRKHGGYNGFAADIWSFGVTMMELYMGYYPF-----------LEPGQEPDFLSLMLAIC- 254
+ Y D+WS GV + L GY PF L +I
Sbjct: 197 SEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 255 ----FREPPSLPECSSE-KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
F + S K D I L + D +R +A+Q+L HP++
Sbjct: 256 GKYEFPDKD-WAHISCAAK--DLISKLLVR-DAKQRLSAAQVLQHPWVQGC 302
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-36
Identities = 57/275 (20%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQT 109
E L+ +G+G+ G V V+ T +YA+K M + N +EL I++
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
P++V F ++ ++++ + G L +++ E+ + +++ L Y+
Sbjct: 73 EHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG------------------ 211
++ I+HRD+KP N+L++E G+ + + A
Sbjct: 132 QNQRIIHRDMKPDNILLDEH-----GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186
Query: 212 ------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265
GY FA D WS GVT EL G P+ ++ + P
Sbjct: 187 SSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFE-TTVVTYPSAW 243
Query: 266 SEKFRDFIRCCLQKGDPSKRW-TASQLLSHPFLAD 299
S++ ++ L+ +P +R+ S + + P++ D
Sbjct: 244 SQEMVSLLKKLLEP-NPDQRFSQLSDVQNFPYMND 277
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-36
Identities = 69/261 (26%), Positives = 106/261 (40%), Gaps = 42/261 (16%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYIVKCHQ 119
LG G G V H+ T A+K++ + + +E+ L+ P+I+K +Q
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
+ + P+ + ++MEY+ G L Y+ GR+ E + +Q+L + Y H +VHRD+
Sbjct: 79 VISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 180 KPANVLINEKM-------------------EHPCGYSCLYESGEARHRKHGGYNGFAADI 220
KP NVL++ M CG S Y + E + Y G DI
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG-SPNYAAPEVISGR--LYAGPEVDI 194
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSL-PECSSEKFRDFIRCC 276
WS GV + L G PF + +L I F P L +
Sbjct: 195 WSCGVILYALLCGTLPF----DDEHVPTLFKKIRGGVFYIPEYLNRSV-----ATLLMHM 245
Query: 277 LQKGDPSKRWTASQLLSHPFL 297
LQ DP KR T + H +
Sbjct: 246 LQV-DPLKRATIKDIREHEWF 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-36
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 36/261 (13%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTNSPYIVKC 117
Q LG+G G V ++ T A+K++ D + E+ I + N +VK
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ + + + +EY G L ++ + E Q++ G+ Y+H I HR
Sbjct: 71 YGHRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 178 DIKPANVLINEKMEHPC---GYSCLYESGEARHRKH----------------GGYNGFAA 218
DIKP N+L++E+ G + ++ + ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL---PECSSEKFRDFIRC 275
D+WS G+ + + G P+ +P S P +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-----LALLHK 244
Query: 276 CLQKGDPSKRWTASQLLSHPF 296
L + +PS R T + +
Sbjct: 245 ILVE-NPSARITIPDIKKDRW 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 44/288 (15%), Positives = 95/288 (32%), Gaps = 48/288 (16%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-------QEL 103
+E+ L++LE ++ N Q + +P ++
Sbjct: 53 REVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLS---EDIICTISR 160
+ ++ V Q P + I M+ +L+ ++ R L + I
Sbjct: 113 RRMDPFSTKNTVGQLQPS-SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINE-------------KMEHPCGYSCLYESGEARH 207
Q+ + + ++HS+ ++HRD+KP+N+ M+ + A
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 208 RKHGG----------------YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLML 251
G Y+ DI+S G+ + EL Y F E ++
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELL---YSF-STQMERV--RIIT 284
Query: 252 AICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+ + P L + ++ L P++R A+ ++ + +
Sbjct: 285 DVRNLKFPLLFTQKYPQEHMMVQDMLSP-SPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-09
Identities = 24/149 (16%), Positives = 51/149 (34%), Gaps = 6/149 (4%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN---PQELNILRQTNSP 112
L+ E +Q +G+G G VF+ ++K YA+K ++ +E+ L + P
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
IV+ + + E E S ++ + + ++
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 173 NIVHRDIKPANVLINEKMEHPCGYSCLYE 201
+ + I +M+ C L +
Sbjct: 125 GQLQPSSPKVYLYI--QMQL-CRKENLKD 150
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-35
Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 42/278 (15%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---------Q 101
+ +++E + +G+G G V K R + ++ A+K + +
Sbjct: 14 PTLA-DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISR 160
E+ I+ N P IVK + + P ++ME++ G L + + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 161 QVLKGLFYMHSRN--IVHRDIKPANVLINEKMEHPC--------GYSCLYESG------- 203
+ G+ YM ++N IVHRD++ N+ + E+ G S
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGN 189
Query: 204 ------EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR- 256
E + Y AD +SF + + + G PF + + I
Sbjct: 190 FQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPF--DEYSYGKIKFINMIREEG 246
Query: 257 EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
P++PE + R+ I C DP KR S ++
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSG-DPKKRPHFSYIVKE 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 31/256 (12%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN 110
ID ++E +V+G+G G V K + + A+K ++ + EL L + N
Sbjct: 3 HMID-YKEIEVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESESERKAFIVELRQLSRVN 59
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR---LSEDIICTISRQVLKGLF 167
P IVK + P V ++MEY + GSL + + + Q +G+
Sbjct: 60 HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 168 YMHSRN---IVHRDIKPANVLINEKMEHP--C--GYSCLYESGEARHR-----------K 209
Y+HS ++HRD+KP N+L+ C G +C ++ ++ +
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 176
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
Y+ D++S+G+ + E+ PF E G + + R P L + +
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--PPLIKNLPKPI 233
Query: 270 RDFIRCCLQKGDPSKR 285
+ C K DPS+R
Sbjct: 234 ESLMTRCWSK-DPSQR 248
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 59/267 (22%), Positives = 99/267 (37%), Gaps = 48/267 (17%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKV----------MQCDRGTPPNPQELNILRQTNS 111
+ LG G G V+ K+ +K D E+ IL +
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEI--YVKSRGRLSEDIICTISRQVLKGLFYM 169
I+K IF ++ME +G L++ ++ RL E + I RQ++ + Y+
Sbjct: 89 ANIIKVLDIFENQG-FFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 170 HSRNIVHRDIKPANVLINEKM-------------------EHPCGYSCLYESGEARHRKH 210
++I+HRDIK N++I E CG + Y + E
Sbjct: 147 RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCG-TIEYCAPEVLMGN- 204
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270
Y G ++WS GVT+ L PF L + P + S++
Sbjct: 205 -PYRGPELEMWSLGVTLYTLVFEENPF-------CELEETVEAAIHPPYLV----SKELM 252
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ LQ P +R T +L++ P++
Sbjct: 253 SLVSGLLQP-VPERRTTLEKLVTDPWV 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 67/296 (22%), Positives = 112/296 (37%), Gaps = 67/296 (22%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM---QCDRGTPPNPQ-ELNILRQTNSPYIV 115
EK+ +G+G+ G VFK R++ T + A+K + D E+ +L+Q P +V
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNI 174
++F + + ++ EY D ++ + R + E ++ +I+ Q L+ + + H N
Sbjct: 66 NLLEVF-RRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 175 VHRDIKPANVLINEKME-------------HPCG-YSCL-----YESGE----ARHRKHG 211
+HRD+KP N+LI + P Y Y S E
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ---- 179
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPG--------------------QEPDFLSLML 251
Y G D+W+ G EL G P PG + F +
Sbjct: 180 -Y-GPPVDVWAIGCVFAELLSG-VPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 252 AICFREPPSLPECS--------SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+ P S ++ CL DP++R T QLL HP+ +
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHM-DPTERLTCEQLLHHPYFEN 290
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 43/261 (16%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTNSPYIVKCHQ 119
LG+G+ G V H +T ALK + + E++ L+ P+I+K +
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
+ T P+ ++ +++EY G L Y+ + R++ED +Q++ + Y H IVHRD+
Sbjct: 77 VITTPT-DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134
Query: 180 KPANVLINEKM-------------------EHPCGYSCLYESGEARHRKHGGYNGFAADI 220
KP N+L+++ + + CG S Y + E + K Y G D+
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG-SPNYAAPEVINGK--LYAGPEVDV 191
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSL-PECSSEKFRDFIRCC 276
WS G+ + + +G PF + +L + + P L P + IR
Sbjct: 192 WSCGIVLYVMLVGRLPF----DDEFIPNLFKKVNSCVYVMPDFLSPGA-----QSLIRRM 242
Query: 277 LQKGDPSKRWTASQLLSHPFL 297
+ DP +R T ++ P+
Sbjct: 243 IVA-DPMQRITIQEIRRDPWF 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 66/302 (21%), Positives = 111/302 (36%), Gaps = 73/302 (24%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVM--------------QCDRGTPPNPQ-----E 102
++ L QG + YALK D+ + + E
Sbjct: 36 IRTLNQGKFNKIILCEKDNKF--YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSL--------EIYVKSRGRLSEDI 154
L I+ + Y + C I T EV I+ EYM+ S+ + + +
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 155 ICTISRQVLKGLFYMHS-RNIVHRDIKPANVLI------------------NEKMEHPCG 195
I I + VL Y+H+ +NI HRD+KP+N+L+ ++K++ G
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212
Query: 196 YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC- 254
+ + E + YNG DIWS G+ + ++ PF + + L I
Sbjct: 213 -TYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSL---KISLVELFNNIRT 267
Query: 255 --FREPPSLPECS---------------SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
P S + DF++ L+K +P++R T+ L H +L
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK-NPAERITSEDALKHEWL 326
Query: 298 AD 299
AD
Sbjct: 327 AD 328
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-34
Identities = 58/274 (21%), Positives = 120/274 (43%), Gaps = 42/274 (15%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
EI Q+ Q +G G+ GTV+K + +A+ K++ TP E+ +LR
Sbjct: 20 EIP-DGQITVGQRIGSGSFGTVYKGKWHGDVAV---KMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGL 166
+T I+ T P +++I+ ++ + SL ++ + + + I+RQ +G+
Sbjct: 76 KTRHVNILLFMGYSTAP--QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 167 FYMHSRNIVHRDIKPANVLINE------------KMEHPCGYSCLYESG---------EA 205
Y+H+++I+HRD+K N+ ++E + S +E E
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 206 -RHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-PPSLPE 263
R + Y+ F +D+++FG+ + EL G P+ ++ + P L +
Sbjct: 194 IRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPY--SNINN-RDQIIEMVGRGSLSPDLSK 249
Query: 264 CSS---EKFRDFIRCCLQKGDPSKRWTASQLLSH 294
S ++ + + CL+K +R + ++L+
Sbjct: 250 VRSNCPKRMKRLMAECLKK-KRDERPSFPRILAE 282
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 74/261 (28%), Positives = 111/261 (42%), Gaps = 42/261 (16%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTNSPYIVKCHQ 119
LG G G V +H+ T A+K++ + + E+ L+ P+I+K +Q
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
+ + PS ++ ++MEY+ G L Y+ GRL E + +Q+L G+ Y H +VHRD+
Sbjct: 84 VISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 180 KPANVLINEKM-------------------EHPCGYSCLYESGEARHRKHGGYNGFAADI 220
KP NVL++ M CG S Y + E + Y G DI
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG-SPNYAAPEVISGR--LYAGPEVDI 199
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSL-PECSSEKFRDFIRCC 276
WS GV + L G PF + +L IC F P L P ++
Sbjct: 200 WSSGVILYALLCGTLPF----DDDHVPTLFKKICDGIFYTPQYLNPSV-----ISLLKHM 250
Query: 277 LQKGDPSKRWTASQLLSHPFL 297
LQ DP KR T + H +
Sbjct: 251 LQV-DPMKRATIKDIREHEWF 270
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-33
Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 64/294 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNP-QELNILRQTNSPYIV 115
EKL+ +G+G GTVFK ++++T + ALK ++ D G P + +E+ +L++ IV
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNI 174
+ H + ++++ E+ D L+ Y S L +I+ + Q+LKGL + HSRN+
Sbjct: 65 RLHDVLHSDKK-LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 175 VHRDIKPANVLINEKME-------------HPCG-YSCL-----YESGE----ARHRKHG 211
+HRD+KP N+LIN E P YS Y + A+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL---- 178
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC---------------- 254
Y + D+WS G EL P PG D L + +
Sbjct: 179 -Y-STSIDMWSAGCIFAELANAGRPLF-PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 255 FREPPSLPECS---------SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
++ P P + + RD ++ L+ +P +R +A + L HP+ +D
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK-CNPVQRISAEEALQHPYFSD 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 55/277 (19%), Positives = 98/277 (35%), Gaps = 42/277 (15%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKV-MQCDRGTPPN-PQELNILRQT 109
S L +VLG+G G KV H++T + +K ++ D T +E+ ++R
Sbjct: 6 IFR-PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFY 168
P ++K + K ++ + EY+ G+L +KS + ++ + G+ Y
Sbjct: 65 EHPNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG----------- 212
+HS NI+HRD+ N L+ E G + L + +
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 213 --------------YNGF--AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR 256
+ D++SFG+ + E+ P P + L +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMDFGLNVRGF 239
Query: 257 EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
P F C DP KR + +L
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDL-DPEKRPSFVKLEH 275
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 67/293 (22%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVM---QCDRGTPPNPQ-ELNILRQTNSPYIV 115
E L ++G+G+ G V K R+K T + A+K D+ E+ +L+Q +V
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNI 174
++ K ++ E++D ++ ++ L ++ Q++ G+ + HS NI
Sbjct: 88 NLLEVC-KKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145
Query: 175 VHRDIKPANVLINEKME--------------HPCGYSCL-----YESGE----ARHRKHG 211
+HRDIKP N+L+++ Y Y + E
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK---- 201
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC----------FREPP- 259
Y G A D+W+ G + E++MG P PG + D L ++ F + P
Sbjct: 202 -Y-GKAVDVWAIGCLVTEMFMG-EPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 260 ----SLPECS------------SEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
LPE SE D + CL DP KR ++LL H F
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI-DPDKRPFCAELLHHDF 309
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 43/291 (14%), Positives = 87/291 (29%), Gaps = 68/291 (23%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGTPPNP-------QE 102
G + +LG+G V++ + + LKV + P NP Q
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-----PANPWEFYIGTQL 117
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-----LSEDIICT 157
+ L+ + +K + + ++ E G+L + + + ++ +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 158 ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--------------GYSC----- 198
+ ++L + +H I+H DIKP N ++ G S
Sbjct: 177 FAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPD 245
++ E K +N + D + T+ + G Y + + +
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNK--PWN-YQIDYFGVAATVYCMLFGTYMKV----KNE 289
Query: 246 FLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296
FR P L + +F L + LL
Sbjct: 290 GGECKPEGLFRRLPHLDMWN-----EFFHVMLNI-PDCHHLPSLDLLRQKL 334
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 48/278 (17%), Positives = 104/278 (37%), Gaps = 45/278 (16%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
+I QLE +++G+G G V+ R +A+ +++ +R +E+ R
Sbjct: 29 DIP-FEQLEIGELIGKGRFGQVYHGRWHGEVAI---RLIDIERDNEDQLKAFKREVMAYR 84
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGL 166
QT +V P ++I+ +L V+ L + I+++++KG+
Sbjct: 85 QTRHENVVLFMGACMSP-PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 167 FYMHSRNIVHRDIKPANVLINEK------------------------MEHPCGYSC---- 198
Y+H++ I+H+D+K NV + + G+ C
Sbjct: 144 GYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 199 --LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR 256
+ + ++ +D+++ G EL+ +PF Q + + + +
Sbjct: 204 EIIRQLSPDTEEDKLPFS-KHSDVFALGTIWYELHAREWPF--KTQPAEAIIWQMGTGMK 260
Query: 257 EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
S E D + C + +R T ++L+
Sbjct: 261 PNLSQIGMGKE-ISDILLFCWAF-EQEERPTFTKLMDM 296
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 70/299 (23%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNP-QELNILRQTNSPYIV 115
++ LG+G G V+K T A+K ++ + G P +E+++L++ I+
Sbjct: 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ + + + ++ EY + L+ Y+ +S +I + Q++ G+ + HSR +
Sbjct: 97 ELKSVIHH-NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL 154
Query: 176 HRDIKPANVLINEKMEHPCG-------------------YSCL-----YESGE----ARH 207
HRD+KP N+L++ ++ Y E +RH
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC------------ 254
Y + DIWS E+ M P PG E D L + +
Sbjct: 215 -----Y-STSVDIWSIACIWAEMLMK-TPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGVT 266
Query: 255 --------FREPPS------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
F + L ++ D + L+ DP KR +A L HP+ +
Sbjct: 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLE-MDPVKRISAKNALEHPYFSH 324
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 42/278 (15%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQT 109
+ + +VLG+G G V + + T +YA K ++ R G E IL +
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSL--EIYVKSRGRLSEDIICTISRQVLKGLF 167
NS ++V + + +++ M+ G L IY + E + ++ GL
Sbjct: 242 NSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG---------------- 211
+H IV+RD+KP N+L+++ G+ + + G A H G
Sbjct: 301 DLHRERIVYRDLKPENILLDDH-----GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355
Query: 212 -----GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
Y F+ D W+ G + E+ G PF + ++ + + P E S
Sbjct: 356 VVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSERFS 413
Query: 267 EKFRDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
+ R L K DP++R +A ++ HP
Sbjct: 414 PQARSLCSQLLCK-DPAERLGCRGGSAREVKEHPLFKK 450
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 42/274 (15%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQT 109
L Q ++++ LG G+ G V V+HK++ YA+K++ + E IL+
Sbjct: 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
N P++VK F K + + ++MEY+ G + +++ GR SE + Q++ Y+
Sbjct: 99 NFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG------------------ 211
HS ++++RD+KP N+LI+++ GY + + G A+ K
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ-----GYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILS 212
Query: 212 -GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270
GY A D W+ GV + E+ GY PF + + I P S +
Sbjct: 213 KGY-NKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIV-SGKVRFPSHFSSDLK 266
Query: 271 DFIRCCLQKGDPSKRW-----TASQLLSHPFLAD 299
D +R LQ D +KR+ + + +H + A
Sbjct: 267 DLLRNLLQV-DLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-31
Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 44/276 (15%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP------QELNI 105
EID ++L +++G G G V++ A+K + D + QE +
Sbjct: 3 EID-FAELTLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKL 59
Query: 106 LRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKG 165
P I+ + K + ++ME+ G L + + R+ DI+ + Q+ +G
Sbjct: 60 FAMLKHPNIIALRGVCLKEP-NLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARG 117
Query: 166 LFYMHSRN---IVHRDIKPANVLINEKMEHPC-----------GYSCLYESGEARHR--- 208
+ Y+H I+HRD+K +N+LI +K+E+ G + +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA 177
Query: 209 ---------KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EP 258
+ ++ +D+WS+GV + EL G PF + D L++ +
Sbjct: 178 YAWMAPEVIRASMFSK-GSDVWSYGVLLWELLTGEVPF----RGIDGLAVAYGVAMNKLA 232
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+P E F + C DP R + + +L
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNP-DPHSRPSFTNILDQ 267
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 66/294 (22%), Positives = 119/294 (40%), Gaps = 65/294 (22%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNP-QELNILRQTNSPYIV 115
+KL+ +G+G G V+K + + ALK ++ D G P +E+++L++ + P IV
Sbjct: 24 QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ ++++ E+M+ L+ + + L + I Q+L+G+ + H I
Sbjct: 83 SLIDVIHSER-CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 175 VHRDIKPANVLINEKME-------------HPCG-YSCL-----YESGE----ARHRKHG 211
+HRD+KP N+LIN P Y+ Y + + ++
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK---- 196
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC-------FREPPSLPE 263
Y + DIWS G E+ G P PG + D L + +I + + LP
Sbjct: 197 -Y-STSVDIWSIGCIFAEMITG-KPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 264 CSSEKFRDFIRCCLQKG------------------DPSKRWTASQLLSHPFLAD 299
F+ F + DP+KR +A ++HP+ D
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 50/258 (19%), Positives = 102/258 (39%), Gaps = 32/258 (12%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
ID QL L L + + G ++K R + +KV++ + +E LR
Sbjct: 6 GID-FKQLNFLTKLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 108 QTNSPYIVKCHQIFTK-PSGEVSILMEYMDAGSLE--IYVKSRGRLSEDIICTISRQVLK 164
+ P ++ P+ +++ +M GSL ++ + + + + + +
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 165 GLFYMHSRN--IVHRDIKPANVLINEKMEHPC---GYSCLYESG-----------EARHR 208
G+ ++H+ I + +V+I+E M ++S EA +
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQK 182
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSE 267
K N +AD+WSF V + EL PF + + + + + P++P S
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPF----ADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 268 KFRDFIRCCLQKGDPSKR 285
++ C+ + DP+KR
Sbjct: 239 HVSKLMKICMNE-DPAKR 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 69/309 (22%), Positives = 112/309 (36%), Gaps = 80/309 (25%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNPQ-ELNILRQTNSPYIV 115
EKL +GQG G VFK RH++T ALK + + G P E+ IL+ +V
Sbjct: 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 116 KCHQIFT-------KPSGEVSILMEYMD---AGSLEIYVKSRGRLSEDIICTISRQVLKG 165
+I + G + ++ ++ + AG L + + I + + +L G
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNG 136
Query: 166 LFYMHSRNIVHRDIKPANVLINEK------------------MEHPCGYSCL-----YES 202
L+Y+H I+HRD+K ANVLI P Y+ Y
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196
Query: 203 GE----ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG-QEPDFLSLMLAIC--- 254
E R Y G D+W G M E++ P + G E L+L+ +C
Sbjct: 197 PELLLGERD-----Y-GPPIDLWGAGCIMAEMWTR-SPIM-QGNTEQHQLALISQLCGSI 248
Query: 255 ----------------FREPPSLPECSSEKFRDFIRCC-----LQKG---DPSKRWTASQ 290
++ + ++R + K DP++R +
Sbjct: 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308
Query: 291 LLSHPFLAD 299
L+H F
Sbjct: 309 ALNHDFFWS 317
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 40/276 (14%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQT 109
+ ++LG+G+ TV R T YA+K+++ N E +++ +
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
+ P+ VK + F + ++ + Y G L Y++ G E + +++ L Y+
Sbjct: 88 DHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 170 HSRNIVHRDIKPANVLINEKMEHPC----GYSCLYESGEARHRKH--------------- 210
H + I+HRD+KP N+L+NE M H G + + + R +
Sbjct: 147 HGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 211 -GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
++D+W+ G + +L G PF + F ++ + PE K
Sbjct: 206 EKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-----KLEYDFPEKFFPKA 259
Query: 270 RDFIRCCLQKGDPSKRWT------ASQLLSHPFLAD 299
RD + L D +KR L +HPF
Sbjct: 260 RDLVEKLLVL-DATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 36/275 (13%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQT 109
++ +++G+G G V+ R T +YA+K + R G E +L
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 110 NS---PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
++ P+IV F P ++S +++ M+ G L ++ G SE + + +++ GL
Sbjct: 247 STGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPC----GYSCLYESGEARHR-------------K 209
+MH+R +V+RD+KPAN+L++E H G +C + + K
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
Y +AD +S G + +L G+ PF + D + LP+ S +
Sbjct: 365 GVAY-DSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTL-TMAVELPDSFSPEL 421
Query: 270 RDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
R + LQ+ D ++R A ++ PF
Sbjct: 422 RSLLEGLLQR-DVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 45/297 (15%)
Query: 20 VRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHK 79
++ H + P + +I L + +G G+ GTV +
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIP-WCDLNIKEKIGAGSFGTVHRAEWH 59
Query: 80 QTLALYALKVMQCDRGTPPNP----QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135
+ A+K++ +E+ I+++ P IV T+P +SI+ EY+
Sbjct: 60 GSDV--AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLSIVTEYL 116
Query: 136 DAGSLEIYV---KSRGRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKM 190
GSL + +R +L E +++ V KG+ Y+H+RN IVHR++K N+L+++K
Sbjct: 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY 176
Query: 191 EHPC-----GYSCLYESGEARHR--------------KHGGYNGFAADIWSFGVTMMELY 231
G S L S + + N +D++SFGV + EL
Sbjct: 177 T--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELA 233
Query: 232 MGYYPF--LEPGQEPDFLSLMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKR 285
P+ L P Q ++ A+ F+ + +P + + I C +P KR
Sbjct: 234 TLQQPWGNLNPAQ------VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN-EPWKR 283
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 63/302 (20%), Positives = 108/302 (35%), Gaps = 73/302 (24%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNPQ----ELNILRQTNS- 111
E + +G G GTV+K R + ALK ++ G P E+ +LR+ +
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 112 --PYIVKCHQIFTKPSGE----VSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVL 163
P +V+ + + V+++ E++D L Y+ L + I + RQ L
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKME-------------HPCGYSCL-----YESGE- 204
+GL ++H+ IVHRD+KP N+L+ + + + Y + E
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190
Query: 205 ---ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC------ 254
+ + D+WS G E++ P G E D L + +
Sbjct: 191 LLQSTY-------ATPVDMWSVGCIFAEMFRR-KPLF-CGNSEADQLGKIFDLIGLPPED 241
Query: 255 ----------FREPPSLPECSSEKFR-------DFIRCCLQKGDPSKRWTASQLLSHPFL 297
PP P + L +P KR +A + L H +L
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLT-FNPHKRISAFRALQHSYL 300
Query: 298 AD 299
Sbjct: 301 HK 302
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 67/293 (22%), Positives = 109/293 (37%), Gaps = 63/293 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQTNSPYIVK 116
KL LG+G TV+K + K T L ALK ++ + G P +E+++L+ IV
Sbjct: 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIV 175
H I ++++ EY+D L+ Y+ G ++ + Q+L+GL Y H + ++
Sbjct: 65 LHDIIHTEKS-LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 176 HRDIKPANVLINEKME-------------HPCG-YSCL-----YESGE----ARHRKHGG 212
HRD+KP N+LINE+ E P Y Y + +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD----- 177
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC-------FREPPSLPEC 264
Y D+W G E+ G P PG + L + I + S E
Sbjct: 178 Y-STQIDMWGVGCIFYEMATG-RPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 265 SSEKFRDFIRCCLQKG------------------DPSKRWTASQLLSHPFLAD 299
+ + + L + R +A + HPF
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 45/274 (16%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQEL-----NILRQTNSPYIVK 116
+VLG+G G VF + K T LYA K + R + IL + +S +IV
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 117 CHQIFTKPSGEVSILMEYMDAGSL----EIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
F + ++ ++M M+ G + + E + Q++ GL ++H R
Sbjct: 250 LAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 173 NIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG--------------------- 211
NI++RD+KP NVL+++ G + + G A K G
Sbjct: 309 NIIYRDLKPENVLLDDD-----GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 212 -GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270
Y F+ D ++ GVT+ E+ PF G++ + L + + + P+ S +
Sbjct: 364 EEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFSPASK 421
Query: 271 DFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
DF LQK DP KR + L +HP D
Sbjct: 422 DFCEALLQK-DPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 5e-30
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 67/296 (22%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALK------VMQCDRGTPPNP-QELNILRQTNSP 112
EKL LG+G TV+K R K T + A+K + G +E+ +L++ + P
Sbjct: 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHS 171
I+ F S +S++ ++M+ LE+ +K L+ I L+GL Y+H
Sbjct: 73 NIIGLLDAFGHKSN-ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 172 RNIVHRDIKPANVLINEKME-------------HPCG-YSCL-----YESGE----ARHR 208
I+HRD+KP N+L++E P Y+ Y + E AR
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM- 189
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE--------------------PDFLS 248
Y G D+W+ G + EL + PFL PG PD S
Sbjct: 190 ----Y-GVGVDMWAVGCILAELLLR-VPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS 242
Query: 249 LMLAICFREPPSLP-----ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
L + F+ P +P + + D I+ +P R TA+Q L + ++
Sbjct: 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF-NPCARITATQALKMKYFSN 297
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 63/300 (21%), Positives = 109/300 (36%), Gaps = 74/300 (24%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALK-VMQ----CDRGTPPNPQELNILRQTNSPYI 114
+V+G G+ G V++ + + L A+K V+Q +R EL I+R+ + I
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNI 109
Query: 115 VKCHQIFTKPS---GEVSI--LMEYMDA---GSLEIYVKSRGRLSEDIICTISRQVLKGL 166
V+ F EV + +++Y+ Y +++ L + Q+ + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN------------ 214
Y+HS I HRDIKP N+L++ L + G A+ G N
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPD----TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 225
Query: 215 ---------GFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC---------- 254
+ D+WS G + EL +G F PG D L ++ +
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKVLGTPTREQIRE 283
Query: 255 ---FREPPSLPECS----SEKFR--------DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
P+ ++ FR L+ P+ R T + +H F +
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY-TPTARLTPLEACAHSFFDE 342
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 70/319 (21%), Positives = 114/319 (35%), Gaps = 84/319 (26%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNPQELNILRQ-----------T 109
++ LG G+ TV+ + A+K+++ D T E+ +L++
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 110 NSPYIVKCHQIFT--KPSGE-VSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKG 165
+ +I+K F P+G V ++ E + L + K R + + IS+Q+L G
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 166 LFYMHSR-NIVHRDIKPANVLINEKMEHPCGYSC-LYESGEARHRKHGGYN--------- 214
L YMH R I+H DIKP NVL+ + + G A N
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 203
Query: 215 ---------GFAADIWSFGVTMMELYMGYYPFLEPGQEP-------DFLSLMLAI----- 253
G ADIWS + EL G + F E D ++ ++ +
Sbjct: 204 PEVLLGAPWGCGADIWSTACLIFELITGDFLF--EPDEGHSYTKDDDHIAQIIELLGELP 261
Query: 254 ---------------------------------CFREPPSLPECSSEKFRDFIRCCLQKG 280
E + +++ DF+ LQ
Sbjct: 262 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL- 320
Query: 281 DPSKRWTASQLLSHPFLAD 299
DP KR A L++HP+L D
Sbjct: 321 DPRKRADAGGLVNHPWLKD 339
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 73/281 (25%), Positives = 118/281 (41%), Gaps = 41/281 (14%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRH---KQTLALYALKVMQCDRGTPPNPQ------ELNI 105
G+ E L+VLG G G VF VR T LYA+KV++ E +
Sbjct: 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 106 LRQTN-SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLK 164
L SP++V H F + ++ ++++Y++ G L ++ R R +E + +++
Sbjct: 112 LEHIRQSPFLVTLHYAFQTET-KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 165 GLFYMHSRNIVHRDIKPANVLIN--------------EKMEHP-------CGYSCLYESG 203
L ++H I++RDIK N+L++ E + CG + Y +
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG-TIEYMAP 229
Query: 204 EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263
+ G+ A D WS GV M EL G PF G++ + I + P P+
Sbjct: 230 DIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQ 287
Query: 264 CSSEKFRDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
S +D I+ L K DP KR A ++ H F
Sbjct: 288 EMSALAKDLIQRLLMK-DPKKRLGCGPRDADEIKEHLFFQK 327
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 41/275 (14%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQT 109
++ + L++LG+G G V VR K T YA+K+++ + + E +L+ T
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
P++ F + +MEY + G L ++ +E+ +++ L Y+
Sbjct: 63 RHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 170 HSRNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHRK 209
HSR++V+RDIK N++++ E + CG + Y + E
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG-TPEYLAPEVLEDN 180
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
Y G A D W GV M E+ G PF Q+ + L I E P S +
Sbjct: 181 --DY-GRAVDWWGLGVVMYEMMCGRLPF--YNQDHE--RLFELIL-MEEIRFPRTLSPEA 232
Query: 270 RDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
+ + L+K DP +R A +++ H F
Sbjct: 233 KSLLAGLLKK-DPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 74/310 (23%)
Query: 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKV--MQCDRGTPPNP-QELNILRQT 109
+ SQ ++L+ LG G TV+K +K T ALK + + GTP +E++++++
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR------GRLSEDIICTISRQVL 163
IV+ + + +++++ E+MD L+ Y+ SR L +++ Q+L
Sbjct: 61 KHENIVRLYDVIHT-ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKME-------------HPCG-YSCL-----YESGE 204
+GL + H I+HRD+KP N+LIN++ + P +S Y + +
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 205 ----ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC----- 254
+R Y + DIWS G + E+ G P PG + + L L+ I
Sbjct: 179 VLMGSRT-----Y-STSIDIWSCGCILAEMITG-KPLF-PGTNDEEQLKLIFDIMGTPNE 230
Query: 255 ---------------FREPP----------SLPECSSEKFRDFIRCCLQKGDPSKRWTAS 289
++ P E DF+ LQ +P R +A
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ-LNPDMRLSAK 289
Query: 290 QLLSHPFLAD 299
Q L HP+ A+
Sbjct: 290 QALHHPWFAE 299
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 64/293 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNP-QELNILRQTNSPYIV 115
L+ +G+G G V+K ++ +ALK ++ ++ G P +E++IL++ IV
Sbjct: 5 HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNI 174
K + + + ++ E++D L+ + G L + Q+L G+ Y H R +
Sbjct: 64 KLYDVIHTKK-RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 175 VHRDIKPANVLINEKME-------------HPCG-YSCL-----YESGE----ARHRKHG 211
+HRD+KP N+LIN + E P Y+ Y + + ++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK---- 177
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC----------FREPP- 259
Y DIWS G E+ G P PG E D L + I E P
Sbjct: 178 -Y-STTIDIWSVGCIFAEMVNG-TPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 260 ---SLPECSSEKFRDFIRCCLQKG----------DPSKRWTASQLLSHPFLAD 299
+ + F++ + G DP++R TA Q L H + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 73/277 (26%), Positives = 128/277 (46%), Gaps = 43/277 (15%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRH---KQTLALYALKVMQ----CDRGTPPNPQELNILR 107
SQ E L+VLGQG+ G VF V+ LYA+KV++ R E +IL
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLF 167
+ N P+IVK H F G++ ++++++ G L + +E+ + ++ L
Sbjct: 82 EVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 168 YMHSRNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARH 207
++HS I++RD+KP N+L++ E ++H CG + Y + E +
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG-TVEYMAPEVVN 199
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267
R+ G+ +AD WSFGV M E+ G PF G++ M I + +P+ S
Sbjct: 200 RR--GH-TQSADWWSFGVLMFEMLTGTLPF--QGKDRK--ETMTMIL-KAKLGMPQFLSP 251
Query: 268 KFRDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
+ + +R ++ +P+ R ++ H F +
Sbjct: 252 EAQSLLRMLFKR-NPANRLGAGPDGVEEIKRHSFFST 287
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 73/326 (22%), Positives = 120/326 (36%), Gaps = 69/326 (21%)
Query: 18 SSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVR 77
S +R+ ++++ L KP + + Q E L+V+G+G G V V+
Sbjct: 44 SPLRREKNILEYLEWAKPFT---------SKVKQMRLHREDFEILKVIGRGAFGEVAVVK 94
Query: 78 HKQTLALYALKVMQ-----------CDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSG 126
K ++A+K++ C R E ++L +S +I H F
Sbjct: 95 LKNADKVFAMKILNKWEMLKRAETACFRE------ERDVLVNGDSKWITTLHYAFQDD-N 147
Query: 127 EVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVL 185
+ ++M+Y G L + K RL E++ +++ + +H + VHRDIKP N+L
Sbjct: 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207
Query: 186 INEKMEHPCGYSCL-------------------------YESGE---ARHRKHGGYNGFA 217
++ G+ L Y S E A G Y G
Sbjct: 208 MDMN-----GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPE 261
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPECSSEKFRDFIRCC 276
D WS GV M E+ G PF + +M F+ P + + S +D IR
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN-AKDLIRRL 320
Query: 277 LQKGDPSKRWT---ASQLLSHPFLAD 299
+ R HPF +
Sbjct: 321 IC--SREHRLGQNGIEDFKKHPFFSG 344
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-29
Identities = 58/282 (20%), Positives = 114/282 (40%), Gaps = 58/282 (20%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM-----------QCDRGTPPNPQEL 103
L + L+ LG G+ G V +R + YA+KV+ + E
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND------ER 57
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163
+L P+I++ F + + ++ ++M+Y++ G L ++ R + + +V
Sbjct: 58 LMLSIVTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL---------------------YES 202
L Y+HS++I++RD+KP N+L+++ G+ + Y +
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKN-----GHIKITDFGFAKYVPDVTYTLCGTPDYIA 171
Query: 203 GEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262
E K Y + D WSFG+ + E+ GY PF + + + I P
Sbjct: 172 PEVVSTK--PY-NKSIDWWSFGILIYEMLAGYTPF----YDSNTMKTYEKIL-NAELRFP 223
Query: 263 ECSSEKFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLAD 299
+E +D + + + D S+R + +HP+ +
Sbjct: 224 PFFNEDVKDLLSRLITR-DLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 44/282 (15%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQ- 108
GL + L+V+G+G+ V VR K+T +YA+KV++ + E ++ Q
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
+N P++V H F S + ++EY++ G L +++ + +L E+ S ++ L Y
Sbjct: 67 SNHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 169 MHSRNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHR 208
+H R I++RD+K NVL++ E + CG + Y + E
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG-TPNYIAPEILRG 184
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS-----LMLAICFREPPSLPE 263
+ Y GF+ D W+ GV M E+ G PF G + L I + +P
Sbjct: 185 E--DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPR 240
Query: 264 CSSEKFRDFIRCCLQKGDPSKR------WTASQLLSHPFLAD 299
S K ++ L K DP +R + + HPF +
Sbjct: 241 SLSVKAASVLKSFLNK-DPKERLGCHPQTGFADIQGHPFFRN 281
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 69/299 (23%)
Query: 60 EKLQVLGQGNGGTVFKVRH-KQTLALYALKVMQCDR---GTPPNP-QELNILRQTNS--- 111
E + +G+G G VFK R K ALK ++ G P + +E+ +LR +
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 112 PYIVKCHQIFTKPSGE----VSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKG 165
P +V+ + T + ++++ E++D L Y+ + + I + Q+L+G
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 166 LFYMHSRNIVHRDIKPANVLINEKME-------------HPCGYSCL-----YESGE--- 204
L ++HS +VHRD+KP N+L+ + + + Y + E
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 205 -ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC-------- 254
+ + D+WS G E++ P G + D L +L +
Sbjct: 193 QSSY-------ATPVDLWSVGCIFAEMFRR-KPLF-RGSSDVDQLGKILDVIGLPGEEDW 243
Query: 255 --FREPP--SLPECSSEKFRDFIRCCLQKG----------DPSKRWTASQLLSHPFLAD 299
P + S++ F+ + G +P+KR +A LSHP+ D
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 73/310 (23%), Positives = 123/310 (39%), Gaps = 42/310 (13%)
Query: 20 VRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHK 79
+ +P+ P P P+ S S L+V+G+G+ G V RHK
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHA-KPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 80 QTLALYALKVMQCDRGTPPNPQ-----ELNILRQ-TNSPYIVKCHQIFTKPSGEVSILME 133
YA+KV+Q + E N+L + P++V H F ++ +++
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KLYFVLD 119
Query: 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN------ 187
Y++ G L +++ E + ++ L Y+HS NIV+RD+KP N+L++
Sbjct: 120 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179
Query: 188 --------EKMEHP------CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMG 233
E +EH CG + Y + E H++ Y D W G + E+ G
Sbjct: 180 LTDFGLCKENIEHNSTTSTFCG-TPEYLAPEVLHKQ--PY-DRTVDWWCLGAVLYEMLYG 235
Query: 234 YYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKR----WTAS 289
PF + + I +P L + R + LQK D +KR
Sbjct: 236 LPPF--YSRNTA--EMYDNILN-KPLQLKPNITNSARHLLEGLLQK-DRTKRLGAKDDFM 289
Query: 290 QLLSHPFLAD 299
++ SH F +
Sbjct: 290 EIKSHVFFSL 299
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 44/282 (15%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQ- 108
GL + L+V+G+G+ V VR K+T +YA++V++ + E ++ Q
Sbjct: 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
+N P++V H F S + ++EY++ G L +++ + +L E+ S ++ L Y
Sbjct: 110 SNHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 169 MHSRNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHR 208
+H R I++RD+K NVL++ E + CG + Y + E
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG-TPNYIAPEILRG 227
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS-----LMLAICFREPPSLPE 263
+ Y GF+ D W+ GV M E+ G PF G + L I + +P
Sbjct: 228 E--DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPR 283
Query: 264 CSSEKFRDFIRCCLQKGDPSKR------WTASQLLSHPFLAD 299
S K ++ L K DP +R + + HPF +
Sbjct: 284 SLSVKAASVLKSFLNK-DPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-28
Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 47/280 (16%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRH---KQTLALYALKVMQCDRGTPPNPQ------ELNI 105
E L+VLG+G G VF+VR T ++A+KV++ E NI
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 106 LRQTNSPYIVKCHQIF-TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLK 164
L + P+IV F T G++ +++EY+ G L + ++ G ED C ++
Sbjct: 75 LEEVKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 165 GLFYMHSRNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGE 204
L ++H + I++RD+KP N+++N E + CG + Y + E
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG-TIEYMAPE 191
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264
R G+ A D WS G M ++ G PF G+ + I + +LP
Sbjct: 192 ILMRS--GH-NRAVDWWSLGALMYDMLTGAPPF--TGENRK--KTIDKIL-KCKLNLPPY 243
Query: 265 SSEKFRDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
+++ RD ++ L++ + + R A ++ +HPF
Sbjct: 244 LTQEARDLLKKLLKR-NAASRLGAGPGDAGEVQAHPFFRH 282
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 81/323 (25%), Positives = 124/323 (38%), Gaps = 68/323 (21%)
Query: 34 KPVSCPNLVHTEAASYGQEIDGLS-QLEKLQVLGQGNGGTVFKVRHKQTLALYALK-VMQ 91
P+ PN V AS G+ + +V+G G+ G VF+ + ++ A+K V+Q
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES-DEVAIKKVLQ 74
Query: 92 CDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGE-----VSILMEYMDA---GSLEIY 143
R +EL I+R P +V F + +++++EY+ + Y
Sbjct: 75 DKRFKN---RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY 131
Query: 144 VKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESG 203
K + + +I Q+L+ L Y+HS I HRDIKP N+L++ G L + G
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP----SGVLKLIDFG 187
Query: 204 EARHRKHGGYN---------------------GFAADIWSFGVTMMELYMGYYPFLEPGQ 242
A+ G N DIWS G M EL G F PG+
Sbjct: 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF--PGE 245
Query: 243 -EPDFLSLMLAI-------------CFREPPSLPECS----SEKFR--------DFIRCC 276
D L ++ + P+ S+ FR D I
Sbjct: 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL 305
Query: 277 LQKGDPSKRWTASQLLSHPFLAD 299
L+ PS R TA + L HPF +
Sbjct: 306 LEY-TPSARLTAIEALCHPFFDE 327
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 61/272 (22%), Positives = 114/272 (41%), Gaps = 38/272 (13%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNIL-RQ 108
+ ++LG+G+ G VF K+T +A+K ++ D + E +L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
P++ F + +MEY++ G L +++S + + +++ GL +
Sbjct: 75 WEHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 169 MHSRNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHR 208
+HS+ IV+RD+K N+L++ E M CG + Y + E
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG-TPDYIAPEILLG 192
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268
+ Y + D WSFGV + E+ +G PF GQ+ + L +I + P P ++
Sbjct: 193 Q--KY-NHSVDWWSFGVLLYEMLIGQSPF--HGQDEE--ELFHSIR-MDNPFYPRWLEKE 244
Query: 269 FRDFIRCCLQKGDPSKRWTA-SQLLSHPFLAD 299
+D + + +P KR + HP +
Sbjct: 245 AKDLLVKLFVR-EPEKRLGVRGDIRQHPLFRE 275
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 42/276 (15%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQT 109
+++ E L++LG+G G V V+ K T YA+K+++ + + E +L+ +
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
P++ F + +MEY + G L ++ SED +++ L Y+
Sbjct: 206 RHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 170 HS-RNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHR 208
HS +N+V+RD+K N++++ E ++ CG + Y + E
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG-TPEYLAPEVLED 323
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268
Y G A D W GV M E+ G PF Q+ + L I E P +
Sbjct: 324 N--DY-GRAVDWWGLGVVMYEMMCGRLPF--YNQDHE--KLFELIL-MEEIRFPRTLGPE 375
Query: 269 FRDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
+ + L+K DP +R A +++ H F A
Sbjct: 376 AKSLLSGLLKK-DPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 42/276 (15%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQT 109
L+ L VLG+G+ G V K T LYA+K+++ D + E +L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 110 NS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
P++ + H F + +MEY++ G L +++ GR E + ++ GLF+
Sbjct: 78 GKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 169 MHSRNIVHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHR 208
+ S+ I++RD+K NV+++ E + CG + Y + E
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG-TPDYIAPEIIAY 195
Query: 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268
+ Y G + D W+FGV + E+ G PF G++ D L +I + P+ S++
Sbjct: 196 Q--PY-GKSVDWWAFGVLLYEMLAGQAPF--EGEDED--ELFQSIM-EHNVAYPKSMSKE 247
Query: 269 FRDFIRCCLQKGDPSKR-----WTASQLLSHPFLAD 299
+ + K P KR + H F
Sbjct: 248 AVAICKGLMTK-HPGKRLGCGPEGERDIKEHAFFRY 282
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 73/309 (23%), Positives = 114/309 (36%), Gaps = 84/309 (27%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK-------VMQCDRGTPPNPQELNILRQTNSPYI 114
+LG+G G V HK T + A+K + R +E+ IL+ I
Sbjct: 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENI 71
Query: 115 VKCHQIFTKPSGE----VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
+ I S E V I+ E M L + ++ LS+D I Q L+ + +H
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLH 129
Query: 171 SRNIVHRDIKPANVLINEKMEHPC-------GYSCLYESGEARHRKHGGYNGF------- 216
N++HRD+KP+N+LIN C G + + + A + + G
Sbjct: 130 GSNVIHRDLKPSNLLINSN----CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 217 -----------------AADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREP 258
A D+WS G + EL++ F PG++ L L+ I P
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF--PGRDYRHQLLLIFGIIGT-P 242
Query: 259 PS---LPECSSEKFRDFIRCCLQKG-------------------------DPSKRWTASQ 290
S L S + R++I+ DP+KR TA +
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 291 LLSHPFLAD 299
L HP+L
Sbjct: 303 ALEHPYLQT 311
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 66/288 (22%), Positives = 102/288 (35%), Gaps = 56/288 (19%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM-----------QCDRGTPPNPQEL 103
E L+V+G+G V V+ KQT +YA+K+M C R E
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE------ER 112
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQV 162
++L + +I + H F + + ++MEY G L + G R+ ++ ++
Sbjct: 113 DVLVNGDRRWITQLHFAFQDEN-YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 163 LKGLFYMHSRNIVHRDIKPANVLI---------------------NEKMEHPCG---YSC 198
+ + +H VHRDIKP N+L+ + G Y
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 199 ---LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-IC 254
L G G Y G D W+ GV E++ G PF + ++
Sbjct: 232 PEILQAVGGG--PGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
Query: 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLAD 299
P E RDFI+ L P R A +HPF
Sbjct: 289 LSLPLVDEGVPEE-ARDFIQRLLC--PPETRLGRGGAGDFRTHPFFFG 333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 58/286 (20%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM-----------QCDRGTPPNPQEL 103
E ++V+G+G G V VRHK T +YA+K++ E
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE------ER 120
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163
+I+ NSP++V+ F + ++MEYM G L + + S + E + +V+
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVV 178
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------SCLYESGEARHR-------- 208
L +HS +HRD+KP N+L+++ G+ +C+ + E R
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKS-----GHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 209 ------------KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR 256
G Y G D WS GV + E+ +G PF + +M
Sbjct: 234 DYISPEVLKSQGGDGYY-GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292
Query: 257 EPPSLPECSSEKFRDFIRCCLQKGDPSKRWT---ASQLLSHPFLAD 299
P + S E ++ I L D R ++ H F +
Sbjct: 293 TFPDDNDISKE-AKNLICAFLT--DREVRLGRNGVEEIKRHLFFKN 335
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 70/330 (21%), Positives = 128/330 (38%), Gaps = 42/330 (12%)
Query: 1 DAIQGKIPGLSQPASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLE 60
+ +P + + R + Q N + + ++ L+
Sbjct: 285 EYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFN 344
Query: 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQTNS-PYI 114
L VLG+G+ G V K T LYA+K+++ D + E +L P++
Sbjct: 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ H F + +MEY++ G L +++ GR E + ++ GLF++ S+ I
Sbjct: 405 TQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 175 VHRDIKPANVLIN--------------EKMEHP------CGYSCLYESGEARHRKHGGYN 214
++RD+K NV+++ E + CG + Y + E + Y
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG-TPDYIAPEIIAYQ--PY- 519
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
G + D W+FGV + E+ G PF G++ D L +I + P+ S++ +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPF--EGEDED--ELFQSIM-EHNVAYPKSMSKEAVAICK 574
Query: 275 CCLQKGDPSKR-----WTASQLLSHPFLAD 299
+ K P KR + H F
Sbjct: 575 GLMTK-HPGKRLGCGPEGERDIKEHAFFRY 603
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 47/279 (16%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----ELNILRQ- 108
G+ E ++VLG+G+ G V R K+T LYA+KV++ D + E IL
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
N P++ + F P + +ME+++ G L +++ R E + +++ L +
Sbjct: 81 RNHPFLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHR-------------------- 208
+H + I++RD+K NVL++ + G+ L + G +
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHE-----GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 209 --KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
+ Y G A D W+ GV + E+ G+ PF + D L AI + P
Sbjct: 195 ILQEMLY-GPAVDWWAMGVLLYEMLCGHAPF--EAENED--DLFEAIL-NDEVVYPTWLH 248
Query: 267 EKFRDFIRCCLQKGDPSKR------WTASQLLSHPFLAD 299
E ++ + K +P+ R +L HPF +
Sbjct: 249 EDATGILKSFMTK-NPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 52/312 (16%), Positives = 96/312 (30%), Gaps = 86/312 (27%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-------------ELNIL 106
+ + G+ G V + + + A+K + E+ +L
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 107 RQTNSPYIVKCHQIFTKPS----GEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQ 161
+ P I+ IF ++ ++ E M L + + +S I
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINE----KMEHPCGYSCLYESGEARHRK-------- 209
+L GL +H +VHRD+ P N+L+ + + C + AR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITI---CDF------NLAREDTADANKTHY 193
Query: 210 --------------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAIC 254
G+ D+WS G M E++ F G + L+ ++ +
Sbjct: 194 VTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALF--RGSTFYNQLNKIVEVV 250
Query: 255 FREPPS-LPECSSEKFRDFIRCCLQKG--------------------------DPSKRWT 287
+ SS RD++R L +P +R +
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 288 ASQLLSHPFLAD 299
Q L HP+
Sbjct: 311 TEQALRHPYFES 322
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 67/342 (19%), Positives = 109/342 (31%), Gaps = 109/342 (31%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK--------VMQCDRGTPPNPQELNILRQTNSPY 113
++G+G+ G V+ K T A+K ++ C R +E+ IL + S Y
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILNRLKSDY 86
Query: 114 IVKCHQIFTKPSG----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
I++ + + E+ I++E D+ L+ K+ L+E+ I TI +L G ++
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 170 HSRNIVHRDIKPANVLINEK---------------MEHPCGYSCLYESGEARHRKHGGYN 214
H I+HRD+KPAN L+N+ E E E +
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 215 GF------------------------AADIWSFGVTMMELYMGYYPFLE---------PG 241
+ DIWS G EL + PG
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265
Query: 242 QEPDFLSLMLAICFREP----------------PS---LPECSSEKFRDFIRCCLQKG-- 280
LS P+ L + + +I+ +
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI 325
Query: 281 -----------------------DPSKRWTASQLLSHPFLAD 299
+P+KR T Q L HP+L D
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 69/302 (22%), Positives = 113/302 (37%), Gaps = 83/302 (27%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK--------VMQCDRGTPPNPQELNILRQTNSPY 113
+G G G+V K++ A+K + R +EL +L+
Sbjct: 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHEN 84
Query: 114 IVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
++ +FT S + ++M +M L+ + + SE+ I + Q+LKGL Y
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 169 MHSRNIVHRDIKPANVLINE----KMEHPCGYSCLYESGEARHR---------------- 208
+HS +VHRD+KP N+ +NE K+ + G ARH
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKI---LDF------GLARHADAEMTGYVVTRWYRAP 192
Query: 209 ----KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREPPS-LP 262
YN DIWS G M E+ G F G++ D L+ +L + +
Sbjct: 193 EVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLF--KGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 263 ECSSEKFRDFIRCCLQKG-------------------------DPSKRWTASQLLSHPFL 297
+ + + + +I+ Q D KR TA+Q L+HPF
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
Query: 298 AD 299
Sbjct: 310 EP 311
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 61/348 (17%), Positives = 104/348 (29%), Gaps = 109/348 (31%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
E ++G G+ G V + K + A+K + + + E+ IL + N ++V
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 116 KCHQIFTKPSGE----VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
K I E + +++E D+ + ++ L+E I T+ +L G+ Y+HS
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS 174
Query: 172 RNIVHRDIKPANVLIN--------------------EKMEHPCGYSCLYESGEARHRKHG 211
I+HRD+KPAN L+N +
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 212 GYNGF------------------------AADIWSFGVTMMELYMGYYPFLE-------- 239
A D+WS G EL +
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294
Query: 240 -PGQEPDFLSLMLAICFREP-------------------PS---LPECSSEKFRDFIRCC 276
PG LS PS + E + +IR
Sbjct: 295 FPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF 354
Query: 277 LQKG-------------------------DPSKRWTASQLLSHPFLAD 299
++ +P+KR T ++ L+HPF +
Sbjct: 355 PKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 78/303 (25%), Positives = 120/303 (39%), Gaps = 84/303 (27%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK--------VMQCDRGTPPNPQELNILRQTNSPY 113
L +G G G+V +T A+K ++ R +EL +L+
Sbjct: 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHEN 89
Query: 114 IVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
++ +FT +V ++ M A L VK + +L++D + + Q+L+GL Y
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ-KLTDDHVQFLIYQILRGLKY 147
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSC---LYESGEARHR----------------- 208
+HS +I+HRD+KP+N+ +NE C + + G ARH
Sbjct: 148 IHSADIIHRDLKPSNLAVNE--------DCELKILDFGLARHTADEMTGYVATRWYRAPE 199
Query: 209 ---KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREPPS---L 261
YN DIWS G M EL G F PG + D L L+L + P L
Sbjct: 200 IMLNWMHYN-QTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLV--GTPGAELL 254
Query: 262 PECSSEKFRDFIRCCLQKG-------------------------DPSKRWTASQLLSHPF 296
+ SSE R++I+ Q D KR TA+Q L+H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 297 LAD 299
A
Sbjct: 315 FAQ 317
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 72/302 (23%), Positives = 112/302 (37%), Gaps = 78/302 (25%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK-------VMQCDRGTPPNPQELNILRQTNSPYI 114
L +G+G G V A+K C R +E+ IL + I
Sbjct: 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENI 87
Query: 115 VKCHQIFTKPSGE----VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
+ + I P+ E V I+ + M+ L +K++ LS D IC Q+L+GL Y+H
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIH 145
Query: 171 SRNIVHRDIKPANVLINEKMEHPC-------GYSCLYESGEARHRKHGGY---------- 213
S N++HRD+KP+N+L+N C G + + + Y
Sbjct: 146 SANVLHRDLKPSNLLLNTT----CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 214 -------NGFAADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREPPS---LP 262
+ DIWS G + E+ F PG+ D L+ +L I PS L
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIF--PGKHYLDQLNHILGIL--GSPSQEDLN 257
Query: 263 ECSSEKFRDFIRCCLQKG-------------------------DPSKRWTASQLLSHPFL 297
+ K R+++ K +P KR Q L+HP+L
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 298 AD 299
Sbjct: 318 EQ 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 62/328 (18%), Positives = 108/328 (32%), Gaps = 98/328 (29%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALK-VMQCDRGTPPNPQELNILRQTNSPYIVKCH 118
+ LG G+ G V +V ++ +ALK V+Q R +EL+I++ + I+K
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---RELDIMKVLDHVNIIKLV 66
Query: 119 QIFTKPSGEVS-------------------------------------ILMEYMDA---G 138
F E ++MEY+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 139 SLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC 198
L+ +++S + ++I Q+ + + ++HS I HRDIKP N+L+N K
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK----DNTLK 182
Query: 199 LYESGEARHRKHGGYN---------------------GFAADIWSFGVTMMELYMGYYPF 237
L + G A+ + + D+WS G EL +G F
Sbjct: 183 LCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
Query: 238 LEPGQEP-DFLSLMLAIC-------------FREPPSLPECS----SEKFR--------D 271
G+ D L ++ I P + D
Sbjct: 243 --SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+ L+ +P R + ++HPF
Sbjct: 301 LLEQILRY-EPDLRINPYEAMAHPFFDH 327
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 36/211 (17%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK----VRHKQTLALYALKVMQCDRGTPPNP----QEL 103
+ + L+ LQ LG+GN G+V T + A+K +Q T + +E+
Sbjct: 6 QFE-ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREI 62
Query: 104 NILRQTNSPYIVKCHQIFTKPSGE-VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQ 161
IL+ IVK + + ++MEY+ GSL Y++ + R+ + + Q
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG---- 212
+ KG+ Y+ ++ +HRD+ N+L+ E+ G + + + +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 213 ----------YNGF--AADIWSFGVTMMELY 231
+ F A+D+WSFGV + EL+
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 58/300 (19%), Positives = 107/300 (35%), Gaps = 73/300 (24%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQ-TNSPYI 114
+ ++ LG+G VF+ + +K++ P + E+ IL P I
Sbjct: 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNI 93
Query: 115 VKCHQIFTKP-SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173
+ I P S +++ E+++ + ++ L++ I ++LK L Y HS
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG 150
Query: 174 IVHRDIKPANVLINEKMEHPC-------GYSCLYESGEA-------RHRK-------HGG 212
I+HRD+KP NV+I+ + G + Y G+ R+ K +
Sbjct: 151 IMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQE--------------PDFLSLMLAICFREP 258
Y+ ++ D+WS G + + PF G + D +
Sbjct: 208 YD-YSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 259 P----SLPECSSEKFRDFIRCCLQKG---------------DPSKRWTASQLLSHPFLAD 299
P L S +++ F+ Q D R TA + + HP+
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-25
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 57 SQLEKLQVLGQGNGGTVFK----VRHKQTLALYALKVMQCDRGTPPNP---QELNILRQT 109
L++++ LG+G+ G V T A+K ++ + G +E+ ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 110 NSPYIVKCHQIFTKPSGE-VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLF 167
IVK I T+ G + ++ME++ +GSL+ Y+ + +++ + Q+ KG+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG---------- 212
Y+ SR VHRD+ NVL+ EH G + E+ + +
Sbjct: 141 YLGSRQYVHRDLAARNVLVES--EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 213 ----YNGF--AADIWSFGVTMMELYM 232
+ F A+D+WSFGVT+ EL
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 82/302 (27%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK--------VMQCDRGTPPNPQELNILRQTNSPY 113
LQ +G G G V +T A A+K + R +EL +L+
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHEN 85
Query: 114 IVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
++ +FT + ++M +M L +K +L ED I + Q+LKGL Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRY 143
Query: 169 MHSRNIVHRDIKPANVLINE----KMEHPCGYSCLYESGEARHRK--------------- 209
+H+ I+HRD+KP N+ +NE K+ + G AR
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKI---LDF------GLARQADSEMTGYVVTRWYRAP 194
Query: 210 -----HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREPPS-LP 262
Y DIWS G M E+ G F G + D L ++ + P +
Sbjct: 195 EVILNWMRYT-QTVDIWSVGCIMAEMITGKTLF--KGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 263 ECSSEKFRDFIRCC----------------------LQK---GDPSKRWTASQLLSHPFL 297
S++ +++++ L+K D +R TA + L+HP+
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 298 AD 299
Sbjct: 312 ES 313
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 67/311 (21%), Positives = 105/311 (33%), Gaps = 88/311 (28%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK------VMQCDRGTPPNPQELNILRQTNSPYIV 115
L+ LG G G VF A+K +E+ I+R+ + IV
Sbjct: 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDHDNIV 71
Query: 116 KCHQIFTKPSG-------------EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQV 162
K +I V I+ EYM+ L ++ G L E+ Q+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQL 129
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---LYESGEARH-RKHGGYNGF-- 216
L+GL Y+HS N++HRD+KPAN+ IN + + + G AR H + G
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTE-------DLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 217 ----------------------AADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAI 253
A D+W+ G E+ G F G + + L+L
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF--AGAHELEQMQLILES 240
Query: 254 CFREPPSLPECSSEKFRDFIRCCLQKG-------------------------DPSKRWTA 288
+ +IR + + P R TA
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 289 SQLLSHPFLAD 299
+ LSHP+++
Sbjct: 301 EEALSHPYMSI 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 55/259 (21%), Positives = 99/259 (38%), Gaps = 38/259 (14%)
Query: 19 SVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQ--EIDGLSQLEKLQVLGQGNGGTVFKV 76
S H A + + L+ LQ LG+GN G+V
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFE-ERHLKFLQQLGKGNFGSVEMC 60
Query: 77 RHK----QTLALYALKVMQCDRGTPPNP----QELNILRQTNSPYIVKCHQIFTKPSGE- 127
R+ T + A+K +Q T + +E+ IL+ IVK +
Sbjct: 61 RYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118
Query: 128 VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186
+ ++MEY+ GSL Y++ + R+ + + Q+ KG+ Y+ ++ +HRD+ N+L+
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178
Query: 187 NEKMEHPC-----GYSCLYESGEARHRKHGG--------------YNGF--AADIWSFGV 225
E+ G + + + ++ + F A+D+WSFGV
Sbjct: 179 EN--ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 226 TMMELYMGYYPFLEPGQEP 244
+ EL+ P E
Sbjct: 237 VLYELFTYIEKSKSPPAEF 255
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 68/319 (21%), Positives = 109/319 (34%), Gaps = 75/319 (23%)
Query: 46 AASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALK-VMQCDRGTPPNPQELN 104
AA+ + + + + ++ GQG GTV + K T A+K V+Q R Q +
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ 71
Query: 105 ILRQTNSPYIVKCHQIFTKPSGE------VSILMEYMDA---GSLEIYVKSRGRLSEDII 155
L + P IV+ F ++++MEY+ Y + + +I
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 156 CTISRQVLKGLFYMH--SRNIVHRDIKPANVLINEKMEHPCGYSC---LYESGEARHRKH 210
Q+++ + +H S N+ HRDIKP NVL+NE L + G A+
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA-------DGTLKLCDFGSAKKLSP 184
Query: 211 GGYN----------------GF-----AADIWSFGVTMMELYMGYYPFLEPGQEP-DFLS 248
N G A DIWS G E+ +G F G L
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF--RGDNSAGQLH 242
Query: 249 LMLA---------ICFREP-------PSLPECS-SEKFR-----------DFIRCCLQKG 280
++ + P + S F D + LQ
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY- 301
Query: 281 DPSKRWTASQLLSHPFLAD 299
P +R + L HP+ +
Sbjct: 302 LPEERMKPYEALCHPYFDE 320
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 37/212 (17%)
Query: 57 SQLEKLQVLGQGNGGTVFK----VRHKQTLALYALKVMQCDRGTPPNP-----QELNILR 107
++ +K++VLG G GTV+K ++ A+K ++ T P E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMA 72
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGL 166
++P++ + I + V ++ + M G L YV + + + + Q+ KG+
Sbjct: 73 SVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG--------- 212
Y+ R +VHRD+ NVL+ G + L + E + GG
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 213 ----YNGF--AADIWSFGVTMMELYM-GYYPF 237
+ + +D+WS+GVT+ EL G P+
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 43/218 (19%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK----VRHKQTLALYALKVMQCDRGTPPNP-----QE 102
I L L+ LG G+ G V + +T+++ A+K ++ D + P +E
Sbjct: 14 LIG-EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIRE 71
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQ 161
+N + + +++ + + P + ++ E GSL ++ +G + + Q
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG---- 212
V +G+ Y+ S+ +HRD+ N+L+ + G + +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 213 ----------YNGF--AADIWSFGVTMMELYM-GYYPF 237
F A+D W FGVT+ E++ G P+
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 64/298 (21%), Positives = 125/298 (41%), Gaps = 33/298 (11%)
Query: 21 RKPRHLVTQLNIPKPVSCPNLVHTEAASYGQ-EIDGLSQLEKLQVLGQGNGGTVFKVRHK 79
L+T L+ P P ++ + +Y + E++ + + LG G G V++ K
Sbjct: 184 TVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEME-RTDITMKHKLGGGQYGEVYEGVWK 242
Query: 80 QTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAG 138
+ A+K ++ D +E ++++ P +V+ + T+ I+ E+M G
Sbjct: 243 KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYG 301
Query: 139 SLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-- 194
+L Y++ R +S ++ ++ Q+ + Y+ +N +HR++ N L+ E
Sbjct: 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKV 359
Query: 195 ---GYSCLYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELYM-GYYP 236
G S L YN F +D+W+FGV + E+ G P
Sbjct: 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
Query: 237 FLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ PG + + +L +R PE EK + +R C Q +PS R + +++
Sbjct: 420 Y--PGIDLSQVYELLEKDYRMER--PEGCPEKVYELMRACWQW-NPSDRPSFAEIHQA 472
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 57 SQLEKLQVLGQGNGGTVFK----VRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTN 110
L+ + LG+GN G+V T AL A+K +Q +E+ IL+ +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 111 SPYIVK----CHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKG 165
S +IVK + + + ++MEY+ +G L +++ R RL + S Q+ KG
Sbjct: 83 SDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 166 LFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG-------- 212
+ Y+ SR VHRD+ N+L+ E G + L + +
Sbjct: 140 MEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 213 ------YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQ 242
N F +D+WSFGV + EL+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 34/219 (15%), Positives = 81/219 (36%), Gaps = 34/219 (15%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ-----CDRGTPPNP----Q 101
+I L + LGQG +FK ++ L + D+ +
Sbjct: 3 HKIR-NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISR 160
+++ + + ++V + + E ++ E++ GSL+ Y+K + ++ +++
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVC-GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------LYESGEARHR 208
Q+ + ++ ++H ++ N+L+ + + G + + R
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 209 ---------KHGGYNGFAADIWSFGVTMMELYM-GYYPF 237
++ A D WSFG T+ E+ G P
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-23
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 32/205 (15%)
Query: 57 SQLEKLQVLGQGNGGTVFK----VRHKQTLALYALKVMQCDRGTPPNP---QELNILRQT 109
L+K++ LG+G+ G V + T + A+K ++ D G QE++ILR
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 110 NSPYIVKCHQIFTKPSGE-VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
+I+K + ++MEY+ GSL Y+ + + ++Q+ +G+ Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAY 149
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG----------- 212
+H+++ +HRD+ NVL++ + G + G +R
Sbjct: 150 LHAQHYIHRDLAARNVLLDN--DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 213 ---YNGF--AADIWSFGVTMMELYM 232
F A+D+WSFGVT+ EL
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-23
Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 44/294 (14%)
Query: 26 LVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALY 85
L T+L PK + E G ++ + +L+ LQ +G+G G V ++
Sbjct: 163 LCTRLIKPKVMEGTVAAQDEFYRSGWALN-MKELKLLQTIGKGEFGDVMLGDYRGNKV-- 219
Query: 86 ALKVMQCDRGTPPNP--QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIY 143
A+K ++ D E +++ Q +V+ + + G + I+ EYM GSL Y
Sbjct: 220 AVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277
Query: 144 VKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GY 196
++SRGR L D + S V + + Y+ N VHRD+ NVL++E G
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGL 335
Query: 197 SC-LYESGEARHRKHGG-------------YNGF--AADIWSFGVTMMELYM-GYYPFLE 239
+ + + G F +D+WSFG+ + E+Y G P+
Sbjct: 336 TKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-- 387
Query: 240 PGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
P + + ++ P+ D ++ C D + R T QL
Sbjct: 388 PRIPLKDVVPRVEKGYKMDA--PDGCPPAVYDVMKNCWHL-DAATRPTFLQLRE 438
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 35/242 (14%)
Query: 26 LVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALY 85
T+ + + + EI S + + +V+G G G V+K K +
Sbjct: 15 PTTENLYFQGAMGSDPN-QAVLKFTTEIH-PSCVTRQKVIGAGEFGEVYKGMLKTSSGKK 72
Query: 86 ALKVM--QCDRGTPPNP-----QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAG 138
+ V G E I+ Q + I++ + +K + I+ EYM+ G
Sbjct: 73 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEYMENG 131
Query: 139 SLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--- 194
+L+ +++ G S + + R + G+ Y+ + N VHRD+ N+L+N + C
Sbjct: 132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVS 189
Query: 195 --GYS-CLYESGEARHRKHGG-------------YNGF--AADIWSFGVTMMELYM-GYY 235
G S L + EA + GG Y F A+D+WSFG+ M E+ G
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
Query: 236 PF 237
P+
Sbjct: 250 PY 251
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 58/324 (17%), Positives = 103/324 (31%), Gaps = 100/324 (30%)
Query: 65 LGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTPPNPQ-ELNILRQTNSPYIVKCHQIF 121
+G+G G V+K + K + YALK ++ G + E+ +LR+ P ++ ++F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVF 87
Query: 122 T-KPSGEVSILMEY--------MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
+V +L +Y + K +L ++ ++ Q+L G+ Y+H+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 173 NIVHRDIKPANVLINEKMEHPCGYSCLYESGE--------AR-----HRKHGGYN----- 214
++HRD+KPAN+L+ + E G AR + +
Sbjct: 148 WVLHRDLKPANILVMGEGP---------ERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 215 ---------------GFAADIWSFGVTMMELYMGYYPFLEPGQE---------------- 243
A DIW+ G EL P ++
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIF-HCRQEDIKTSNPYHHDQLDR 256
Query: 244 -------------PDFLSL----MLAICFREPPSLPECSSEKFRDFIRCCLQKG------ 280
D + L FR + K
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316
Query: 281 ----DPSKRWTASQLLSHPFLADA 300
DP KR T+ Q + P+ +
Sbjct: 317 LLTMDPIKRITSEQAMQDPYFLED 340
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 62/310 (20%), Positives = 101/310 (32%), Gaps = 83/310 (26%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALK--------VMQCDRGTPPNPQELNILRQTNS 111
+ L+ +G G G V A+K R +EL +++ N
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNH 83
Query: 112 PYIVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
I+ +FT +V I+ME MDA +L ++ L + + + Q+L G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGI 140
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN------------ 214
++HS I+HRD+KP+N+++ C L + G AR
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD----CTLKIL-DFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 215 --------GFAADIWSFGVTMMELYMGYYPF----------------------------- 237
DIWS G M E+ G F
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 238 --------LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTAS 289
F L + F + + + RD + L D SKR +
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI-DASKRISVD 314
Query: 290 QLLSHPFLAD 299
+ L HP++
Sbjct: 315 EALQHPYINV 324
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-22
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 32/203 (15%)
Query: 63 QVLGQGNGGTVFK--VRHKQTLALYALKVMQCDRGTPPNP----QELNILRQTNSPYIVK 116
+ LG GN GTV K + K+ + A+K+++ + P E N+++Q ++PYIV+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
I S ++ME + G L Y++ + + I + QV G+ Y+ N VH
Sbjct: 83 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 177 RDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG--------------YNGF- 216
RD+ NVL+ + G S + E ++ Y F
Sbjct: 141 RDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 217 -AADIWSFGVTMMELYM-GYYPF 237
+D+WSFGV M E + G P+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPY 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 54/301 (17%), Positives = 107/301 (35%), Gaps = 66/301 (21%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-DRGTPPNPQELNILRQT 109
Q Q++ ++ +G+G G V+ + + A+KV + + E+
Sbjct: 32 QRTI-AKQIQMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASWFRETEIYQTVLM 88
Query: 110 NSPYIVKCHQIFTKPSG---EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
I+ K +G ++ ++ +Y + GSL Y+KS L + ++ + GL
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGL 147
Query: 167 FYMHSRN--------IVHRDIKPANVLINEKMEHPC-----GYSCLYESG---------- 203
++H+ I HRD+K N+L+ + C G + + S
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNT 205
Query: 204 --------------EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFL----------- 238
E+ +R H AD++SFG+ + E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 239 EPGQEPDFLSLMLAICF-REPPSLPECSSE-----KFRDFIRCCLQKGDPSKRWTASQLL 292
+P + + +C + PS P S + + C +P+ R TA ++
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH-NPASRLTALRVK 323
Query: 293 S 293
Sbjct: 324 K 324
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 57/267 (21%), Positives = 99/267 (37%), Gaps = 34/267 (12%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQ 108
++ L + +G+GN G VF R + L A+K + QE IL+Q
Sbjct: 110 VLN-HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQ 168
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLF 167
+ P IV+ + T+ + I+ME + G ++++ G L + + G+
Sbjct: 169 YSHPNIVRLIGVCTQ-KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG---------- 212
Y+ S+ +HRD+ N L+ EK G S G
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 213 ---YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
Y + +D+WSFG+ + E + G P+ P + R P PE
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPY--PNLSNQQTREFVEKGGRLPC--PELCP 341
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLS 293
+ + C +P +R + S +
Sbjct: 342 DAVFRLMEQCWAY-EPGQRPSFSTIYQ 367
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-22
Identities = 52/215 (24%), Positives = 81/215 (37%), Gaps = 36/215 (16%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK---VRHKQTLALYALKVMQCDRGTPPNP-----QEL 103
I + ++LG+G G V++ HK A+K C + + E
Sbjct: 8 GIA-REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEA 64
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQV 162
I++ + P+IVK I + I+ME G L Y++ + L + S Q+
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG------ 211
K + Y+ S N VHRDI N+L+ G S E +
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASP--ECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 212 ------GYNGF--AADIWSFGVTMMELYM-GYYPF 237
+ F A+D+W F V M E+ G PF
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-22
Identities = 47/215 (21%), Positives = 92/215 (42%), Gaps = 34/215 (15%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK---VRHKQTLALY-ALKVMQCDRGTPPNP---QELN 104
++L KL+VLG G GTV K + +++ + +KV++ G +
Sbjct: 9 IFK-ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 105 ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVL 163
+ + +IV+ + S + ++ +Y+ GSL +V+ RG L ++ Q+
Sbjct: 68 AIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG------ 212
KG++Y+ +VHR++ NVL+ + G + L + +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 213 -------YNGF--AADIWSFGVTMMELYM-GYYPF 237
+ + +D+WS+GVT+ EL G P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-22
Identities = 64/329 (19%), Positives = 109/329 (33%), Gaps = 102/329 (31%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQ-----TNSP 112
++ +G G G V +H YA+KV+ R + E +IL++ N+
Sbjct: 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVV---RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMH 170
IVK H F + ++ E + SL + + I ++LK L Y+
Sbjct: 97 NIVKYHGKFMY-YDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 171 SRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR----------------------HR 208
++ H D+KP N+L+++ + + +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 209 KHG-----------------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLM 250
HG G+ ++D+WSFG + ELY G F + L++M
Sbjct: 215 YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLF--RTHEHMEHLAMM 271
Query: 251 LAIC------------------------------------------FREPPSLPECSSEK 268
+I + P E
Sbjct: 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
F DF+ LQ DP+ R + ++LL H FL
Sbjct: 332 FCDFLYSILQI-DPTLRPSPAELLKHKFL 359
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-22
Identities = 52/328 (15%), Positives = 107/328 (32%), Gaps = 97/328 (29%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK--------VMQCDRGTPPNPQELNILRQTNS-P 112
++ LG+G G V+K ++T + A+K R +E+ IL + +
Sbjct: 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHE 69
Query: 113 YIVKCHQIFTKPS-GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
IV + + +V ++ +YM+ L +++ L + Q++K + Y+HS
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHS 127
Query: 172 RNIVHRDIKPANVLINEK--------------MEHPCGYSCLYESGEARHRKHGGYNGF- 216
++HRD+KP+N+L+N + + + + S
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 217 -----------------------AADIWSFGVTMMEL----------------------- 230
D+WS G + E+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 231 ------------------YMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-SEKFRD 271
+ ++ + + P+ +E+ D
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+ LQ +P+KR +A+ L HPF++
Sbjct: 308 LLDKLLQF-NPNKRISANDALKHPFVSI 334
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 33/210 (15%)
Query: 57 SQLEKLQVLGQGNGGTVFK-------VRHKQTLALYALKVMQCDRGTPPNPQELNILRQT 109
++ +K++VLG G GTV+K + K +A+ L+ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV-KSRGRLSEDIICTISRQVLKGLFY 168
++P++ + I + V ++ + M G L YV + + + + Q+ KG+ Y
Sbjct: 75 DNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG----------- 212
+ R +VHRD+ NVL+ G + L + E + GG
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 213 --YNGF--AADIWSFGVTMMELYM-GYYPF 237
+ + +D+WS+GVT+ EL G P+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 43/220 (19%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK------VRHKQTLALYALKVMQCDRGTPPNP----- 100
E+D + + +V+G G G V + + ++A+ LKV G
Sbjct: 41 ELD-ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-----GYTEKQRRDFL 94
Query: 101 QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTIS 159
E +I+ Q + P I++ + TK S V I+ EYM+ GSL+ +++ + + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 160 RQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYS-CLYESGEARHRKHGG- 212
R + G+ Y+ VHRD+ N+LIN + C G L + EA + GG
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 213 ------------YNGF--AADIWSFGVTMMELYM-GYYPF 237
Y F A+D+WS+G+ + E+ G P+
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 48 SYGQEIDGLSQLEKLQVLGQGNGGTVFK------VRHKQTLALYALKVMQCDRGTPPNPQ 101
S+ +EI+ S++ +++G G+ G V + +A+ ALK +R
Sbjct: 41 SFTREIE-ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS 99
Query: 102 ELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISR 160
E +I+ Q + P I++ + T+ I+ EYM+ GSL+ ++++ G+ + + + R
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTR-GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYS-CLYESGEARHRKHGG-- 212
V G+ Y+ VHRD+ NVL++ + C G S L + +A + GG
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 213 -----------YNGF--AADIWSFGVTMMELYM-GYYPF 237
+ F A+D+WSFGV M E+ G P+
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 36/215 (16%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK---VRHKQTLALYALKVMQCDRGTPPNP-----QEL 103
EI ++E + +G+G G V + + + A+K + T + QE
Sbjct: 11 EIQ-RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--NCTSDSVREKFLQEA 67
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQV 162
+RQ + P+IVK + T+ V I+ME G L +++ + L + + Q+
Sbjct: 68 LTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG------ 211
L Y+ S+ VHRDI NVL++ G S E G
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 212 ------GYNGF--AADIWSFGVTMMELYM-GYYPF 237
+ F A+D+W FGV M E+ M G PF
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-21
Identities = 60/310 (19%), Positives = 103/310 (33%), Gaps = 87/310 (28%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALK--------VMQCDRGTPPNPQELNILRQTNSPY 113
L+ +G G G V A+K R +EL +++ N
Sbjct: 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKN 122
Query: 114 IVKCHQIFTKPSG-----EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFY 168
I+ +FT +V ++ME MDA + + L + + + Q+L G+ +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG----------------- 211
+HS I+HRD+KP+N+++ C L + G AR
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSD----CTLKIL-DFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 212 ----GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-DFLSLMLAICFREPPSLPECSS 266
GY DIWS G M E+ F PG++ D + ++ P +
Sbjct: 235 ILGMGYK-ENVDIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 267 EKFRDFIRCCLQK-------------------------------------GDPSKRWTAS 289
R+++ + DP+KR +
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 290 QLLSHPFLAD 299
L HP++
Sbjct: 352 DALQHPYINV 361
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 36/296 (12%)
Query: 21 RKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQ 80
+ L +L P S P A EI L LGQG G V+
Sbjct: 151 KHADGLCHRLTTVCPTSKP--QTQGLAKDAWEIP-RESLRLEVKLGQGCFGEVWMGTWNG 207
Query: 81 TLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139
T + A+K ++ +P QE ++++ +V+ + + ++ + I+ EYM GS
Sbjct: 208 TTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGS 264
Query: 140 LEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--- 194
L ++K L + ++ Q+ G+ Y+ N VHRD++ AN+L+ E + C
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVA 322
Query: 195 --GYSCLYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELYM-GYYPF 237
G + L E E R+ Y F +D+WSFG+ + EL G P+
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 238 LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
PG + + +R P P E D + C +K +P +R T L +
Sbjct: 383 --PGMVNREVLDQVERGYRMPC--PPECPESLHDLMCQCWRK-EPEERPTFEYLQA 433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-21
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 37/296 (12%)
Query: 21 RKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQ 80
+ L +L++P S P + A EI L+ + LG G G V+ + +
Sbjct: 156 KGNDGLCQKLSVPCMSSKPQKPWEKDAW---EIP-RESLKLEKKLGAGQFGEVWMATYNK 211
Query: 81 TLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS 139
+ A+K M+ + E N+++ +VK H + TK + I+ E+M GS
Sbjct: 212 HTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP--IYIITEFMAKGS 268
Query: 140 LEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--- 194
L ++KS + S Q+ +G+ ++ RN +HRD++ AN+L++ C
Sbjct: 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIA 326
Query: 195 --GYSCLYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELYM-GYYPF 237
G + + E E R+ + F +D+WSFG+ +ME+ G P+
Sbjct: 327 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
Query: 238 LEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
PG + L +R P PE E+ + + C + P +R T + S
Sbjct: 387 --PGMSNPEVIRALERGYRMPR--PENCPEELYNIMMRCWKN-RPEERPTFEYIQS 437
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 43/300 (14%), Positives = 98/300 (32%), Gaps = 66/300 (22%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-DRGTPPNPQELNILRQT 109
Q + + +G+G G V++ + + A+K+ + + E+
Sbjct: 37 QRTI-ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVML 93
Query: 110 NSPYIVKCH---QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
I+ ++ ++ +Y + GSL Y+ ++ + + ++ GL
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGL 152
Query: 167 FYMHSR--------NIVHRDIKPANVLINEKMEHPC-----GYSCLYESG---------- 203
++H I HRD+K N+L+ + C G + ++S
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNH 210
Query: 204 --------------EARHRKHGGYNGFAADIWSFGVTMMELYMGYYP-----------FL 238
++ + KH ADI++ G+ E+ +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 239 EPGQEPDFLSLMLAICFRE-----PPSLPECSS-EKFRDFIRCCLQKGDPSKRWTASQLL 292
+P + +C ++ P C + +R C + + R TA ++
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA-NGAARLTALRIK 328
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 36/291 (12%)
Query: 26 LVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALY 85
L +L P S P ++ EI L LGQG G V+ T +
Sbjct: 239 LCHRLTTVCPTSKPQTQGLAKDAW--EIP-RESLRLEVKLGQGCFGEVWMGTWNGTTRV- 294
Query: 86 ALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYV 144
A+K ++ +P QE ++++ +V+ + + ++ + I+ EYM GSL ++
Sbjct: 295 AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFL 352
Query: 145 KSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYS 197
K L + ++ Q+ G+ Y+ N VHRD++ AN+L+ E + C G +
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLA 410
Query: 198 CLYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELYM-GYYPFLEPGQ 242
L E E R+ Y F +D+WSFG+ + EL G P+ PG
Sbjct: 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY--PGM 468
Query: 243 EPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
+ + +R P P E D + C +K +P +R T L +
Sbjct: 469 VNREVLDQVERGYRMPC--PPECPESLHDLMCQCWRK-EPEERPTFEYLQA 516
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 32/247 (12%)
Query: 18 SSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFK-- 75
VR V++ + + +T ++ EI ++E + +G+G G V +
Sbjct: 352 QGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQ-RERIELGRCIGEGQFGDVHQGI 410
Query: 76 ----VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131
+A+ K D QE +RQ + P+IVK + T+ V I+
Sbjct: 411 YMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP--VWII 468
Query: 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190
ME G L +++ + L + + Q+ L Y+ S+ VHRDI NVL++
Sbjct: 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS-- 526
Query: 191 EHPC-----GYSCLYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELY 231
G S E G + F A+D+W FGV M E+
Sbjct: 527 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586
Query: 232 M-GYYPF 237
M G PF
Sbjct: 587 MHGVKPF 593
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 58/325 (17%), Positives = 101/325 (31%), Gaps = 96/325 (29%)
Query: 62 LQVLGQGNGGTVFKVR-HKQTLALYALKVMQCDRGTPPNPQ----ELNILRQ------TN 110
+ LG+G G V + H + + ALK++ R + E+N+L++ N
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFY 168
V F G + I E + + ++K + ++ Q+ L +
Sbjct: 81 KFLCVLMSDWFNF-HGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR----------------HRKHG- 211
+H + H D+KP N+L ++ H H
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT 198
Query: 212 ----------------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC 254
G+ D+WS G + E Y G+ F + L +M I
Sbjct: 199 IVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF--QTHENREHLVMMEKIL 255
Query: 255 -----------------FREPPSLPECSSEK-----------------------FRDFIR 274
++ E SS+ D +R
Sbjct: 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315
Query: 275 CCLQKGDPSKRWTASQLLSHPFLAD 299
L+ DP++R T ++ L HPF A
Sbjct: 316 RMLEF-DPAQRITLAEALLHPFFAG 339
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 57/292 (19%), Positives = 107/292 (36%), Gaps = 61/292 (20%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-DRGTPPNPQELNILRQTNSPYIV 115
L+ L+V +G G V+K + A+K+ D+ + N E+ L I+
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLLNEYV--AVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 116 KCHQIFTKPSG---EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
+ + + ++ ++ + + GSL ++K +S + +C I+ + +GL Y+H
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHED 140
Query: 173 ----------NIVHRDIKPANVLINEKMEHPC----GYSCLYESGEARHRKHG-----GY 213
I HRDIK NVL+ + C G + +E+G++ HG Y
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 214 ------------NGFA---ADIWSFGVTMMELYMGYYPFLEP------------GQEPDF 246
A D+++ G+ + EL P GQ P
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259
Query: 247 LSLMLAICFREP-PSLPECSSE-----KFRDFIRCCLQKGDPSKRWTASQLL 292
+ + ++ P L + + + I C D R +A +
Sbjct: 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH-DAEARLSAGCVG 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 47/293 (16%), Positives = 93/293 (31%), Gaps = 63/293 (21%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-DRGTPPNPQELNILRQTNSPYIVK 116
+ L+ +G+G G V++ + A+K+ D + EL I+
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENV--AVKIFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 117 CHQIFTKPSG---EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR- 172
++ ++ Y + GSL Y++ L I + GL ++H
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 173 -------NIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEA--------------- 205
I HRD+K N+L+ + + C G + ++
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 206 ------RHRKHGGYNGF--AADIWSFGVTMMELYMGYYPFL-----------EPGQEPDF 246
DIW+FG+ + E+ +P F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 247 LSLMLAICF-REPPSLPECSSE-----KFRDFIRCCLQKGDPSKRWTASQLLS 293
+ +C ++ P++P ++ C + +PS R TA ++
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ-NPSARLTALRIKK 295
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-20
Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 45/272 (16%)
Query: 57 SQLEKLQVLGQGNGGTVFK------VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN 110
+V+G+G+ G V+ +++ A+ +L + + +E ++R N
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYM 169
P ++ I P G +L+ YM G L +++S + + + + QV +G+ Y+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEARHRKHGG------- 212
+ VHRD+ N +++E ++ + + ++H
Sbjct: 141 AEQKFVHRDLAARNCMLDE------SFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 213 -------YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLP 262
F +D+WSFGV + EL G P+ +P L+ LA R P P
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--RHIDPFDLTHFLAQGRRLPQ--P 250
Query: 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
E + ++ C + DP+ R T L+
Sbjct: 251 EYCPDSLYQVMQQCWEA-DPAVRPTFRVLVGE 281
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-20
Identities = 44/210 (20%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQT 109
E+ ++ L+ LG G G V + K + A+K+++ + QE + +
Sbjct: 4 ELK-REEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEG-SMSEDEFFQEAQTMMKL 60
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFY 168
+ P +VK + + +K + I+ EY+ G L Y++S G+ L + + V +G+ +
Sbjct: 61 SHPKLVKFYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG----------- 212
+ S +HRD+ N L++ + G + + G
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEV 176
Query: 213 --YNGF--AADIWSFGVTMMELYM-GYYPF 237
Y + +D+W+FG+ M E++ G P+
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-20
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 65 LGQGNGGTVFK--VRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYIVKC 117
LG GN G+V + R ++ A+KV++ +GT +E I+ Q ++PYIV+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK--QGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + + ++ME G L ++ R + + + QV G+ Y+ +N VH
Sbjct: 76 IGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 177 RDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG--------------YNGF- 216
RD+ NVL+ + G S + ++ + + F
Sbjct: 134 RDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 217 -AADIWSFGVTMMELYM-GYYPF 237
+D+WS+GVTM E G P+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPY 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-20
Identities = 57/273 (20%), Positives = 105/273 (38%), Gaps = 52/273 (19%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQT 109
++ + +L+ LQ +G+G G V ++ A+K ++ E +++ Q
Sbjct: 17 ALN-MKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKN--DATAQAFLAEASVMTQL 71
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLF 167
+V+ + + G + I+ EYM GSL Y++SRGR L D + S V + +
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEARHRKHGG----- 212
Y+ N VHRD+ NVL++E + + G
Sbjct: 132 YLEGNNFVHRDLAARNVLVSE------DNVAKVSDFGLTKEASST------QDTGKLPVK 179
Query: 213 --------YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSL 261
F +D+WSFG+ + E+Y G P+ P + + ++
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEKGYKMDA-- 235
Query: 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
P+ + ++ C D + R + QL
Sbjct: 236 PDGCPPAVYEVMKNCWHL-DAAMRPSFLQLREQ 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-19
Identities = 43/212 (20%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILR 107
ID S+L +Q +G G G V + A+K + R + + E ++
Sbjct: 4 VID-PSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMM 58
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGL 166
+ + P +V+ + + + + ++ E+M+ G L Y+++ RG + + + + V +G+
Sbjct: 59 KLSHPKLVQLYGVCLE-QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGG--------- 212
Y+ ++HRD+ N L+ E G + + G
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASP 174
Query: 213 ----YNGF--AADIWSFGVTMMELYM-GYYPF 237
++ + +D+WSFGV M E++ G P+
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 45/209 (21%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTN 110
E++ + + LG G G V++ K+ A+K ++ D +E ++++
Sbjct: 9 EME-RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 67
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFY 168
P +V+ + T+ I+ E+M G+L Y++ R +S ++ ++ Q+ + Y
Sbjct: 68 HPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG------------ 211
+ +N +HRD+ N L+ E G S L
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 212 GYNGF--AADIWSFGVTMMELYM-GYYPF 237
YN F +D+W+FGV + E+ G P+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 35 PVSCPNLVHTEAASYGQ-EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD 93
P+ N T YG EID L L+ LG G G V + + + A+K+++
Sbjct: 2 PLGSKNAPSTAGLGYGSWEID-PKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEG 59
Query: 94 RGTPPN-PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLS 151
+ +E ++ + +V+ + + TK + I+ EYM G L Y++ R R
Sbjct: 60 SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 152 EDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEAR 206
+ + + V + + Y+ S+ +HRD+ N L+N++ G S E
Sbjct: 119 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYT 176
Query: 207 HRKHGG-------------YNGF--AADIWSFGVTMMELYM-GYYPF 237
G Y+ F +DIW+FGV M E+Y G P+
Sbjct: 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 45 EAASYGQEIDGLSQLEKLQVLGQGNGGTVFK---VRHKQTLALYALKVMQCDRGTPPNP- 100
E + + L LG GN G+V + K+ + + A+KV++ +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGT-EKADTE 381
Query: 101 ---QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIIC 156
+E I+ Q ++PYIV+ + + + ++ME G L ++ R + +
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVA 439
Query: 157 TISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG 211
+ QV G+ Y+ +N VHR++ NVL+ + H G S + ++ +
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARS 497
Query: 212 G--------------YNGF--AADIWSFGVTMMELYM-GYYPF 237
+ F +D+WS+GVTM E G P+
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 61/323 (18%), Positives = 106/323 (32%), Gaps = 96/323 (29%)
Query: 62 LQVLGQGNGGTVFKVR-HKQTLALYALKVMQCDRGTPPNPQ----ELNILRQ------TN 110
+ LG+G G V + HK A+K++ + + E+ +L +
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFY 168
+ V+ + F G + I+ E + S ++K G D I ++ Q+ K + +
Sbjct: 76 TFRCVQMLEWFEH-HGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 169 MHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEAR----------------HRKHG- 211
+HS + H D+KP N+L + + H
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 212 ----------------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQ-EPDFLSLMLAIC 254
G+ D+WS G ++E Y+G+ F P + L++M I
Sbjct: 194 LVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVF--PTHDSKEHLAMMERIL 250
Query: 255 -----------------FREPPSLPECSS-----------------------EKFRDFIR 274
+ E SS E+ D I+
Sbjct: 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310
Query: 275 CCLQKGDPSKRWTASQLLSHPFL 297
L+ DP+KR T + L HPF
Sbjct: 311 KMLEY-DPAKRITLREALKHPFF 332
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 54/270 (20%), Positives = 96/270 (35%), Gaps = 57/270 (21%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYIVK 116
+++G+G G V++ + ALK+M + P +E + P++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 117 CHQIFTKPSGEVS----ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
H GE+ + M ++ L ++ +G L+ I RQ+ L H+
Sbjct: 99 IHDF-----GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 173 NIVHRDIKPANVLINEKMEHPCGY-------------------------SCLYESGEARH 207
HRD+KP N+L++ + + Y + E
Sbjct: 154 GATHRDVKPENILVSAD-----DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE--- 205
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267
R + + ADI++ + E G P+ G D LS+M A + P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPY--QG---DQLSVMGAHINQAIPRPSTVRPG 260
Query: 268 ---KFRDFIRCCLQKGDPSKRW-TASQLLS 293
F I + K +P R+ T L +
Sbjct: 261 IPVAFDAVIARGMAK-NPEDRYVTCGDLSA 289
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-19
Identities = 53/268 (19%), Positives = 101/268 (37%), Gaps = 37/268 (13%)
Query: 57 SQLEKLQVLGQGNGGTVFK------VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN 110
+ +V+G+G+ G V+ K A+ +L + E I++ +
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYM 169
P ++ I + G +++ YM G L ++++ + + QV KG+ ++
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 170 HSRNIVHRDIKPANVLINEKMEHPC-----GYS-CLYESGEARHRKHGG----------- 212
S+ VHRD+ N +++EK G + +Y+ G
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 213 ---YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
F +D+WSFGV + EL G P+ P +++ L R PE
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRRLLQ--PEYCP 322
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ + + C R + S+L+S
Sbjct: 323 DPLYEVMLKCWHP-KAEMRPSFSELVSR 349
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 60/284 (21%), Positives = 105/284 (36%), Gaps = 61/284 (21%)
Query: 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELN 104
G+ I+ ++ LG G TV+ A+K + +E++
Sbjct: 6 GKIINERYKIVDK--LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 105 ILRQTNSPYIVKCHQIFTKPSGEVS----ILMEYMDAGSLEIYVKSRGRLSEDIICTISR 160
Q + IV + E ++MEY++ +L Y++S G LS D +
Sbjct: 64 NSSQLSHQNIV---SMID--VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 161 QVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------------ 196
Q+L G+ + H IVHRDIKP N+LI+
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSN-----KTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 197 -SCLYESGE-ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC 254
+ Y S E A+ G DI+S G+ + E+ +G PF G+ +S+ +
Sbjct: 174 GTVQYFSPEQAK----GEATDECTDIYSIGIVLYEMLVGEPPF--NGETA--VSIAIKHI 225
Query: 255 FREPPSLPECS----SEKFRDFIRCCLQKGDPSKRW-TASQLLS 293
P++ + + I +K D + R+ T ++
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEK-DKANRYKTIQEMKD 268
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 38/180 (21%), Positives = 73/180 (40%), Gaps = 37/180 (20%)
Query: 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE- 188
I+MEY+ SL+ +L ++L L Y+HS +V+ D+KP N+++ E
Sbjct: 161 IVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE 218
Query: 189 -----------KMEHPCGY---SCLYESGE-ARHRKHGGYNGFAADIWSFGVTMMELYMG 233
++ GY + +++ E R A DI++ G T+ L +
Sbjct: 219 QLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTGP-----TVATDIYTVGRTLAALTLD 272
Query: 234 YYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRW-TASQLL 292
G+ D L E + + + + + +R + DP +R+ TA ++
Sbjct: 273 LPTR--NGRYVDGL--------PEDDPVLK-TYDSYGRLLRRAIDP-DPRQRFTTAEEMS 320
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 42/200 (21%), Positives = 75/200 (37%), Gaps = 54/200 (27%)
Query: 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK 189
I+MEY+D +L V + G ++ + + L + H I+HRD+KPAN++I+
Sbjct: 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 152
Query: 190 MEHPCGY---------------------------SCLYESGE-ARHRKHGGYNGFAADIW 221
+ Y S E AR G +D++
Sbjct: 153 -----NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR----GDSVDARSDVY 203
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR----EPPSLPECS---SEKFRDFIR 274
S G + E+ G PF G P +++ ++ +P S +
Sbjct: 204 SLGCVLYEVLTGEPPFT--GDSP------VSVAYQHVREDPIPPSARHEGLSADLDAVVL 255
Query: 275 CCLQKGDPSKRW-TASQLLS 293
L K +P R+ TA+++ +
Sbjct: 256 KALAK-NPENRYQTAAEMRA 274
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-18
Identities = 57/309 (18%), Positives = 99/309 (32%), Gaps = 73/309 (23%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM-QCDRGTPPNPQELNILRQTN 110
+D L L+ L+++G+G G V+K + A+KV +R N + + +
Sbjct: 9 SLD-LDNLKLLELIGRGRYGAVYKGSLDERPV--AVKVFSFANRQNFINEKNIYRVPLME 65
Query: 111 SPYIVK----CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
I + ++ E ++MEY GSL Y+ C ++ V +GL
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGL 124
Query: 167 FYMHS---------RNIVHRDIKPANVLINEKMEHPC----GYSCLYESG---------- 203
Y+H+ I HRD+ NVL+ G S
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 204 ------------------EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFL------- 238
A + + D+++ G+ E++M
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 239 -------EPGQEPDFLSLMLAICF-REPPSLPECSSE------KFRDFIRCCLQKGDPSK 284
E G P F + + + ++ P PE E ++ I C + D
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ-DAEA 302
Query: 285 RWTASQLLS 293
R TA
Sbjct: 303 RLTAQXAEE 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-18
Identities = 33/244 (13%), Positives = 65/244 (26%), Gaps = 35/244 (14%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT------NSPYIV 115
L G ++ AL + P + + L +T + P +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ-ETLSRTLRLSRIDKPGVA 94
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ ++ E++ GSL+ S + + H +
Sbjct: 95 RVLD-VVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGVA 151
Query: 176 HRDIKPANVLINE----KMEHPCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELY 231
P+ V ++ + +P DI G ++ L
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYP-AT--------------MPDANPQDDIRGIGASLYALL 196
Query: 232 MGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS---SEKFRDFIRCCLQKGDPSKRWTA 288
+ +P E G L+ +P + + +Q D R +A
Sbjct: 197 VNRWPLPEAG-VRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQG-DGGIR-SA 253
Query: 289 SQLL 292
S LL
Sbjct: 254 STLL 257
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 52/272 (19%), Positives = 100/272 (36%), Gaps = 45/272 (16%)
Query: 57 SQLEKLQVLGQGNGGTVFK------VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN 110
+ +V+G+G+ G V+ K A+ +L + E I++ +
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYM 169
P ++ I + G +++ YM G L ++++ + + QV KG+ Y+
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 170 HSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEARHRKHGG------- 212
S+ VHRD+ N +++E ++ +Y+ G
Sbjct: 145 ASKKFVHRDLAARNCMLDE------KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 213 -------YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLP 262
F +D+WSFGV + EL G P+ P +++ L R P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRRLLQ--P 254
Query: 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
E + + + C R + S+L+S
Sbjct: 255 EYCPDPLYEVMLKCWHP-KAEMRPSFSELVSR 285
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 64/322 (19%), Positives = 107/322 (33%), Gaps = 97/322 (30%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-NPQ---ELNILRQ------TNS 111
L+V+G+G+ G V K + ALK++ R + Q E+ IL N+
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMH 170
++ + FT + + E + E+ K++ + S ++ + +L+ L +H
Sbjct: 159 MNVIHMLENFTF-RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 171 SRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGGY------------ 213
I+H D+KP N+L+ ++ G SC YE H++ Y
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YE-----HQRVYTYIQSRFYRAPEVI 271
Query: 214 ----NGFAADIWSFGVT---------------------MMELYMGYYP------------ 236
G D+WS G M +G
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331
Query: 237 ---------------------FLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
L G+ +L C F DF++
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391
Query: 276 CLQKGDPSKRWTASQLLSHPFL 297
CL+ DP+ R T Q L HP+L
Sbjct: 392 CLEW-DPAVRMTPGQALRHPWL 412
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 53/282 (18%), Positives = 104/282 (36%), Gaps = 56/282 (19%)
Query: 57 SQLEKLQVLGQGNGGTVFK---VRHKQTLALYALKVMQCDRGTPPNP----QELNILRQT 109
Q ++LG+G G+V + + + A+K+++ D + +E +++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 110 NSPYIVKCHQIFTKPSGEVS-----ILMEYMDAGSLEIYVKSRGRLSEDIICT------I 158
+ P++ K + + + +++ +M G L ++ +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 159 SRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEARHR 208
+ G+ Y+ SRN +HRD+ N ++ E + +Y R
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAE------DMTVCVADFGLSRKIYSGDYYRQG 196
Query: 209 KHG------------GYNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI 253
N + +D+W+FGVTM E+ G P+ G E + L
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY--AGIENAEIYNYLIG 254
Query: 254 CFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
R + P PEC E + D + C DP +R + + L
Sbjct: 255 GNRLKQP--PECMEEVY-DLMYQCWSA-DPKQRPSFTCLRME 292
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 64/267 (23%), Positives = 122/267 (45%), Gaps = 36/267 (13%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTN 110
E+ L+ ++ LG G G V+ + + A+K ++ +P E N+++Q
Sbjct: 9 EVP-RETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 111 SPYIVKCHQIFTK-PSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLF 167
+V+ + + T+ P + I+ EYM+ GSL ++K+ L+ + + ++ Q+ +G+
Sbjct: 67 HQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG----------- 211
++ RN +HRD++ AN+L+++ + C G + L E E R+
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 212 -GYNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267
Y F +D+WSFG+ + E+ G P+ PG + L +R P+ E
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNLERGYRMVR--PDNCPE 237
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ +R C ++ P R T L S
Sbjct: 238 ELYQLMRLCWKE-RPEDRPTFDYLRSV 263
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 54/288 (18%), Positives = 109/288 (37%), Gaps = 60/288 (20%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK---VRHKQTLALYALKVMQCDRGTPPNP----QELN 104
ID + L ++LG+G G+V + + T A+K M+ D + E
Sbjct: 30 VIDR-NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA 88
Query: 105 ILRQTNSPYIVK----CHQIFTKPSGEVSILMEYMDAGSLEIYVKSR------GRLSEDI 154
++ + P +++ C ++ ++ + +++ +M G L Y+ +
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 155 ICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGE 204
+ + G+ Y+ +RN +HRD+ N ++ + + +Y
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD------DMTVCVADFGLSKKIYSGDY 202
Query: 205 ARHRKHGG--------------YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPDFL 247
+R+ + +D+W+FGVTM E+ G P+ PG + +
Sbjct: 203 --YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY--PGVQNHEM 258
Query: 248 SLMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
L R + P +C E + + + C + DP R T S L
Sbjct: 259 YDYLLHGHRLKQP--EDCLDELY-EIMYSCWRT-DPLDRPTFSVLRLQ 302
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 53/290 (18%), Positives = 114/290 (39%), Gaps = 64/290 (22%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QE 102
E+ ++ + LGQG+ G V++ V + A+K + + + E
Sbjct: 21 EVA-REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNE 78
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR----------GRLSE 152
+++++ N ++V+ + ++ ++ME M G L+ Y++S S
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 153 DIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYES 202
+ ++ ++ G+ Y+++ VHRD+ N ++ E ++ +YE+
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE------DFTVKIGDFGMTRDIYET 191
Query: 203 GEARHRKHGG--------------YNGF--AADIWSFGVTMMELYM-GYYPFLEPGQEPD 245
+RK G F +D+WSFGV + E+ P+ G +
Sbjct: 192 DY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNE 247
Query: 246 FLSLMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ + + P C F + +R C Q +P R + +++S
Sbjct: 248 QVLRFVMEGGLLDKP--DNCPDMLF-ELMRMCWQY-NPKMRPSFLEIISS 293
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 58/287 (20%), Positives = 106/287 (36%), Gaps = 58/287 (20%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QE 102
E+ + ++ LG G G V++ + + + A+K + + + + E
Sbjct: 26 EVP-RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLME 83
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-------GRLSEDII 155
I+ + N IV+C + + S ILME M G L+ +++ L+ +
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 156 CTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEA 205
++R + G Y+ + +HRDI N L+ G +Y +
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP---GRVAKIGDFGMARDIYRASY- 198
Query: 206 RHRKHGG--------------YNGF--AADIWSFGVTMMELY-MGYYPFLEPGQEPDFLS 248
+RK G F D WSFGV + E++ +GY P+ P + +
Sbjct: 199 -YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEVL 255
Query: 249 LMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ R +PP C + + C Q P R + +L
Sbjct: 256 EFVTSGGRMDPP--KNCPGPVY-RIMTQCWQH-QPEDRPNFAIILER 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 63/330 (19%), Positives = 123/330 (37%), Gaps = 63/330 (19%)
Query: 14 ASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQ-----EIDGLSQLEKLQVLGQG 68
++ S ++ P + +++L ++ N + A E+ + ++ LG G
Sbjct: 24 GAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVP-RKNITLIRGLGHG 82
Query: 69 NGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QELNILRQTNSPYIVKCHQ 119
G V++ + + + A+K + + + + E I+ + N IV+C
Sbjct: 83 AFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSR-------GRLSEDIICTISRQVLKGLFYMHSR 172
+ + S IL+E M G L+ +++ L+ + ++R + G Y+
Sbjct: 142 VSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 173 NIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEARHRKHGG---------- 212
+ +HRDI N L+ G +Y +G +RK G
Sbjct: 201 HFIHRDIAARNCLLTCPGP---GRVAKIGDFGMARDIYRAGY--YRKGGCAMLPVKWMPP 255
Query: 213 ----YNGF--AADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPEC 264
F D WSFGV + E++ +GY P+ P + + + R +PP C
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEVLEFVTSGGRMDPP--KNC 311
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ + C Q P R + +L
Sbjct: 312 PGPVY-RIMTQCWQH-QPEDRPNFAIILER 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 58/353 (16%), Positives = 96/353 (27%), Gaps = 122/353 (34%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNPQELNILRQ--------TNSPYIV 115
LG G+ TV+ Q A+KV++ T E+ +L+ N +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 116 KCHQIFT--KPSGE-VSILMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYM- 169
+ F +G + ++ E + L ++ L + I +QVL+GL Y+
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 170 ----------HSRNI--VHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN--- 214
NI + + G S + G
Sbjct: 164 TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVN 223
Query: 215 -----------------------------------------------GFAADIWSFGVTM 227
ADIWS
Sbjct: 224 PLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMA 283
Query: 228 MELYMGYYPF-----LEPGQEPDFLSLMLAIC-----------------------FREPP 259
EL G Y F E ++ D ++L++ + +
Sbjct: 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343
Query: 260 SLPECSSEK---------------FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
L + F DF+ L+ P KR TA++ L HP+L
Sbjct: 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL-IPEKRATAAECLRHPWL 395
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 46/235 (19%), Positives = 83/235 (35%), Gaps = 57/235 (24%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK--------VRHKQTLALYALKVMQCDRGTPPNPQEL 103
EI LS + ++ LG+ G V+K Q +A+ LK E
Sbjct: 5 EIS-LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR---------------- 147
+ + P +V + TK +S++ Y G L ++ R
Sbjct: 64 MLRARLQHPNVVCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 148 GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------- 198
L + Q+ G+ Y+ S ++VH+D+ NVL+ + +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD------KLNVKISDLGLFR 176
Query: 199 -LYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELYM-GYYPF 237
+Y + + + Y F +DIWS+GV + E++ G P+
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 46/231 (19%), Positives = 83/231 (35%), Gaps = 63/231 (27%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QE 102
I + + LG+G G VF + + L A+K ++ T +E
Sbjct: 11 HIK-RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQRE 67
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--------------- 147
+L +IVK + + + ++ EYM G L ++++
Sbjct: 68 AELLTNLQHEHIVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 148 -GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------- 198
G L + I+ Q+ G+ Y+ S++ VHRD+ N L+
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA------NLLVKIGDFGMS 180
Query: 199 --LYESGEARHRKHGG--------------YNGF--AADIWSFGVTMMELY 231
+Y + +R G Y F +D+WSFGV + E++
Sbjct: 181 RDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 51/330 (15%), Positives = 95/330 (28%), Gaps = 106/330 (32%)
Query: 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQ------TNS 111
++G+G+ G V K + A+K++ + E+ +L
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYM 169
YIV + F + ++ E + +L +++ +S ++ ++Q+ L ++
Sbjct: 116 YYIVHLKRHFMF-RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 170 HSR--NIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHGGYN-------- 214
+ +I+H D+KP N+L+ G SC ++ Y
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ------LGQRIYQYIQSRFYRSP 227
Query: 215 --------GFAADIWSFG---------------------VTMMELYMGYYP--FLEPGQ- 242
A D+WS G + + +G P L+
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287
Query: 243 --------------------------EPDFLSLMLAICFREPPSLPECSSE--------- 267
P L + + E
Sbjct: 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYL 347
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
KF+D I L DP R L H F
Sbjct: 348 KFKDLILRMLDY-DPKTRIQPYYALQHSFF 376
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 64/336 (19%), Positives = 120/336 (35%), Gaps = 67/336 (19%)
Query: 11 SQPASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNG 70
S S VR L + + P E + E +L + LG+G
Sbjct: 38 SSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW--EFP-RDKLTLGKPLGEGCF 94
Query: 71 GTVFK----------VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-PYIVKCHQ 119
G V + T+A+ LK ++ E+ +++ I+
Sbjct: 95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVL 163
T+ G + +++EY G+L Y+++R +++ + + + Q+
Sbjct: 155 ACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 213
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEARHRKHG-- 211
+G+ Y+ S+ +HRD+ NVL+ E + + +G
Sbjct: 214 RGMEYLASQKCIHRDLAARNVLVTE------NNVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 212 ----------GYNGF--AADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREP 258
+ +D+WSFGV M E++ +G P+ PG + L +L R
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEELFKLLKEGHRMD 325
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
P + + +R C PS+R T QL+
Sbjct: 326 K--PANCTNELYMMMRDCWHA-VPSQRPTFKQLVED 358
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 61/291 (20%), Positives = 116/291 (39%), Gaps = 66/291 (22%)
Query: 57 SQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
+L+ + LG+G G V + + T A+K+++ + T EL IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILI 85
Query: 108 QTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR----------------GRL 150
+V TKP G + +++E+ G+L Y++S+ L
Sbjct: 86 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 151 SEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LY 200
+ + + S QV KG+ ++ SR +HRD+ N+L++E +Y
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE------KNVVKICDFGLARDIY 199
Query: 201 ESGEARHRKHG------------GYNGF--AADIWSFGVTMMELY-MGY--YPFLEPGQE 243
+ + + + +D+WSFGV + E++ +G YP ++ +E
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 244 PDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
L R P+ ++ + + C +PS+R T S+L+ H
Sbjct: 260 ---FCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHG-EPSQRPTFSELVEH 304
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 29/125 (23%), Positives = 53/125 (42%), Gaps = 6/125 (4%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIFTK 123
+G G+ G ++ A+K+ P E I + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIR--WCG 74
Query: 124 PSGEVSIL-MEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
G+ +++ ME + SLE R S + ++ Q++ + Y+HS+N +HRD+KP
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 133
Query: 182 ANVLI 186
N L+
Sbjct: 134 DNFLM 138
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIF 121
+ +G GN G + ++ T A+K+ P E +Q + I + + +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY--Y 72
Query: 122 TKPSGEVSIL-MEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
P G+ + + +E + SLE R S + I+ Q++ + Y+HS+N+++RD+
Sbjct: 73 FGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDV 131
Query: 180 KPANVLI 186
KP N LI
Sbjct: 132 KPENFLI 138
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 57/295 (19%), Positives = 110/295 (37%), Gaps = 65/295 (22%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK----------VRHKQTLALYALKVMQCDRGTPPNPQ 101
E +L + LG+G G V + T+A+ LK ++
Sbjct: 31 EFP-RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 89
Query: 102 ELNILRQTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR------------- 147
E+ +++ I+ T+ G + +++EY G+L Y+++R
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 148 ---GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------ 198
+++ + + + Q+ +G+ Y+ S+ +HRD+ NVL+ E
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE------NNVMKIADFG 202
Query: 199 ----LYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELY-MGYYPFLE 239
+ + +G + +D+WSFGV M E++ +G P+
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-- 260
Query: 240 PGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
PG + L +L R P + + +R C PS+R T QL+
Sbjct: 261 PGIPVEELFKLLKEGHRMDK--PANCTNELYMMMRDCWHA-VPSQRPTFKQLVED 312
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-13
Identities = 29/127 (22%), Positives = 56/127 (44%), Gaps = 6/127 (4%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIF 121
+ +G+G+ G +F+ + A+K P E + I + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY--Y 73
Query: 122 TKPSGEVSIL-MEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
G ++L ++ + SLE + GR S + ++Q+L + +H +++V+RDI
Sbjct: 74 FGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 132
Query: 180 KPANVLI 186
KP N LI
Sbjct: 133 KPDNFLI 139
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 55/293 (18%), Positives = 103/293 (35%), Gaps = 69/293 (23%)
Query: 57 SQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
++L + LG G G V + + A+K+++ EL +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLS 81
Query: 108 QTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR------------------G 148
+ IV T G ++ EY G L +++ +
Sbjct: 82 YLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 149 RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------- 198
L + + + S QV KG+ ++ S+N +HRD+ N+L+ G
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH------GRITKICDFGLARD 194
Query: 199 LYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELY-MGY--YPFLEPG 241
+ + + + +D+WS+G+ + EL+ +G YP +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 242 QEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ M+ FR PE + + D ++ C DP KR T Q++
Sbjct: 255 SK---FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDA-DPLKRPTFKQIVQL 301
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-13
Identities = 61/296 (20%), Positives = 118/296 (39%), Gaps = 71/296 (23%)
Query: 57 SQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
L + LG+G G V K ++ + A+K+++ + +P E N+L+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLK 81
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-------------------- 147
Q N P+++K + ++ G + +++EY GSL +++
Sbjct: 82 QVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 148 ----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----- 198
L+ + + + Q+ +G+ Y+ +VHRD+ N+L+ E G
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE------GRKMKISDF 194
Query: 199 -----LYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELY-MGYYPFL 238
+YE R G + + +D+WSFGV + E+ +G P+
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY- 253
Query: 239 EPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
PG P+ L +L R P+ SE+ + C ++ +P KR + +
Sbjct: 254 -PGIPPERLFNLLKTGHRMER--PDNCSEEMYRLMLQCWKQ-EPDKRPVFADISKD 305
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-13
Identities = 59/298 (19%), Positives = 104/298 (34%), Gaps = 76/298 (25%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFK--------VRHKQTLALYALKVMQCDRGTPPNP--- 100
I + LG+G G VF + K +A+ ALK +
Sbjct: 37 HIK-RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDF 90
Query: 101 -QELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR------------ 147
+E +L +IV+ + T+ + ++ EYM G L +++S
Sbjct: 91 QREAELLTMLQHQHIVRFFGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 148 ---GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------ 198
G L + ++ QV G+ Y+ + VHRD+ N L+ + G
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ------GLVVKIGDFG 203
Query: 199 ----LYESGEARHRKHGG--------------YNGF--AADIWSFGVTMMELY-MGYYPF 237
+Y + +R G Y F +D+WSFGV + E++ G P+
Sbjct: 204 MSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261
Query: 238 LEPGQEPDFLSLMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ E P C E + +R C Q+ +P +R + + +
Sbjct: 262 --YQLSNTEAIDCITQGRELERP--RACPPEVY-AIMRGCWQR-EPQQRHSIKDVHAR 313
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 53/290 (18%), Positives = 105/290 (36%), Gaps = 67/290 (23%)
Query: 57 SQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
+ L+ + LG G G V + + + + A+K M EL I+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELKIMS 104
Query: 108 QTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSE-------------- 152
IV T G V ++ EY G L +++ + R+ E
Sbjct: 105 HLGQHENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 153 -DIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------LYE 201
D++ S QV +G+ ++ S+N +HRD+ NVL+ G+ +
Sbjct: 164 RDLLH-FSSQVAQGMAFLASKNCIHRDVAARNVLLTN------GHVAKIGDFGLARDIMN 216
Query: 202 SGEARHRKHG------------GYNGF--AADIWSFGVTMMELY-MGY--YPFLEPGQEP 244
+ + + +D+WS+G+ + E++ +G YP + +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275
Query: 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
F ++ ++ P + + ++ C +P+ R T Q+ S
Sbjct: 276 -FYK-LVKDGYQMAQ--PAFAPKNIYSIMQACWAL-EPTHRPTFQQICSF 320
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 29/148 (19%), Positives = 52/148 (35%), Gaps = 22/148 (14%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCD-RGTPPNPQELNILRQTNSPYIVKCHQIFTK 123
+G G G ++ A V++ + + P EL ++ +K +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 124 P----------SGEVS--------ILMEYMDAG-SLEIYVKSRGRLSEDIICTISRQVLK 164
SG ++ME + G L+ G + + + ++L
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 165 GLFYMHSRNIVHRDIKPANVLINEKMEH 192
L Y+H VH DIK AN+L+ K
Sbjct: 163 VLEYIHENEYVHGDIKAANLLLGYKNPD 190
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 59/321 (18%), Positives = 115/321 (35%), Gaps = 65/321 (20%)
Query: 26 LVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFK---------- 75
T+ + + + E+ +L + LG+G G V
Sbjct: 39 PTTENLYFQGMLAGVSEYELPEDPRWELP-RDRLVLGKPLGEGAFGQVVLAEAIGLDKDK 97
Query: 76 VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-PYIVKCHQIFTKPSGEVSILMEY 134
+A+ LK ++ E+ +++ I+ T+ G + +++EY
Sbjct: 98 PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEY 156
Query: 135 MDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
G+L Y+++R +LS + + + QV +G+ Y+ S+ +HRD
Sbjct: 157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 216
Query: 179 IKPANVLINEKMEHPCGYSC----------LYESGEARHRKHG------------GYNGF 216
+ NVL+ E ++ + +G +
Sbjct: 217 LAARNVLVTE------DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270
Query: 217 --AADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
+D+WSFGV + E++ +G P+ PG + L +L R P + + +
Sbjct: 271 THQSDVWSFGVLLWEIFTLGGSPY--PGVPVEELFKLLKEGHRMDK--PSNCTNELYMMM 326
Query: 274 RCCLQKGDPSKRWTASQLLSH 294
R C PS+R T QL+
Sbjct: 327 RDCWHA-VPSQRPTFKQLVED 346
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 56/298 (18%), Positives = 104/298 (34%), Gaps = 74/298 (24%)
Query: 57 SQLEKLQVLGQGNGGTVFK-----VRHKQTLALYALKVMQCDRGTPPNP----QELNILR 107
LE +VLG G G V + A+K+++ ++ EL ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 103
Query: 108 QTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR------------------- 147
Q S IV T SG + ++ EY G L Y++S+
Sbjct: 104 QLGSHENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 148 ----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----- 198
L+ + + + QV KG+ ++ ++ VHRD+ NVL+ G
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH------GKVVKICDF 216
Query: 199 -----LYESGEARHRKHG------------GYNGF--AADIWSFGVTMMELY-MGY--YP 236
+ R + + +D+WS+G+ + E++ +G YP
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 237 FLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ ++ F+ P ++E+ ++ C D KR + L S
Sbjct: 277 GIPVDAN---FYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAF-DSRKRPSFPNLTSF 328
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 43/201 (21%), Positives = 74/201 (36%), Gaps = 32/201 (15%)
Query: 65 LGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCHQIFTK 123
+G G+ G ++ + QT A+K+ P E I R I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVR--WFG 72
Query: 124 PSGEVSIL-MEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181
G+ ++L M+ + SLE R LS + ++ Q++ + ++HS++ +HRDIKP
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
Query: 182 ANVLINEKMEHPC------GYSCLY-ESGEARHRK------------------HGGYN-G 215
N L+ G + Y ++ +H H G
Sbjct: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS 191
Query: 216 FAADIWSFGVTMMELYMGYYP 236
D+ S G +M G P
Sbjct: 192 RRDDLESLGYVLMYFLRGSLP 212
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 3e-11
Identities = 35/229 (15%), Positives = 69/229 (30%), Gaps = 60/229 (26%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---------------- 100
+L++ + +G+G G VF+ T A+K++ + N
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 101 QELNILR-----------QTNSPYIVK---------------------CHQIFTKPSGEV 128
+EL++L NS + V+ + ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 129 SILMEYMDAG-SLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLI 186
I++E+ G LE S +I Q+ L + HRD+ NVL+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 187 NEKMEHPCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYY 235
L+ + + G I + ++ +E
Sbjct: 196 K-----KTSLKKLHYTLNGKSSTIPSC-GLQVSIIDYTLSRLERDGIVV 238
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 59/288 (20%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVR-----HKQTLALYALKVMQCDRGTPPNPQELNIL 106
+D + ++ V+G+GN G V K R + A+ +K EL +L
Sbjct: 21 VLD-WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 79
Query: 107 RQTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICT-------- 157
+ P I+ G + + +EY G+L +++ L D
Sbjct: 80 CKLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 158 --------ISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------LYESG 203
+ V +G+ Y+ + +HRD+ N+L+ E Y L
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE------NYVAKIADFGLSRGQ 192
Query: 204 EARHRKHGG-------------YNGF--AADIWSFGVTMMELY-MGYYPFLEPGQEPDFL 247
E +K G Y+ + +D+WS+GV + E+ +G P+ G L
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAEL 250
Query: 248 SLMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
L +R E P C E + D +R C ++ P +R + +Q+L
Sbjct: 251 YEKLPQGYRLEKP--LNCDDEVY-DLMRQCWRE-KPYERPSFAQILVS 294
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 53/274 (19%), Positives = 95/274 (34%), Gaps = 69/274 (25%)
Query: 23 PRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLEKLQVLGQGNGGTVFK------- 75
P L+ P P+ + E + +E ++ +G+G G VF+
Sbjct: 14 PSELLLDRLHPNPMYQRMPLLLNPKLLSLEYP-RNNIEYVRDIGEGAFGRVFQARAPGLL 72
Query: 76 -VRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134
+A+ LK +E ++ + ++P IVK + + +L EY
Sbjct: 73 PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFEY 131
Query: 135 MDAGSLEIYVKSR------------------------GRLSEDIICTISRQVLKGLFYMH 170
M G L +++S LS I+RQV G+ Y+
Sbjct: 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 191
Query: 171 SRNIVHRDIKPANVLINEKMEHPCGYSC----------LYESGEARHRKHGG-------- 212
R VHRD+ N L+ E +Y + ++ G
Sbjct: 192 ERKFVHRDLATRNCLVGE------NMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWM 243
Query: 213 ------YNGF--AADIWSFGVTMMELY-MGYYPF 237
YN + +D+W++GV + E++ G P+
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 34/220 (15%), Positives = 70/220 (31%), Gaps = 50/220 (22%)
Query: 65 LGQGNGGTVFKVRHKQTLAL--------YALKV------------MQCDRGTPPNPQELN 104
+ N G +++ TL ++LK+ P +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 105 ILRQTNSPYIVKCHQIFTKPSGEVSIL-MEYMDAGSLEIYVK--SRGRLSEDIICTISRQ 161
L T I C F + L + + SL+ + + LSE + ++ +
Sbjct: 110 KLYSTPLLAIPTCMG-FGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-----GYSCLYESG----EARHRKHGG 212
+L L ++H VH ++ N+ ++ + + G++ Y
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 213 YNG---FAA-------------DIWSFGVTMMELYMGYYP 236
+ G F + D+ S G M++ G+ P
Sbjct: 228 HEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 56/264 (21%), Positives = 96/264 (36%), Gaps = 52/264 (19%)
Query: 64 VLGQGNGGTVFK-VRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVK--- 116
+G+G G V+K + T+A+ L M Q E+ ++ + +V+
Sbjct: 38 KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 117 -CHQIFTKPSGEVSILM-EYMDAGSLEIY---VKSRGRLSEDIICTISRQVLKGLFYMHS 171
G+ L+ YM GSL + LS + C I++ G+ ++H
Sbjct: 98 FSSD------GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 172 RNIVHRDIKPANVLINEKMEHP----CGYSCLYESGEARH---RKHGGYNGFAA------ 218
+ +HRDIK AN+L++E G + E R G + A
Sbjct: 152 NHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTT-AYMAPEALRG 209
Query: 219 ------DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP--------PSLPEC 264
DI+SFGV ++E+ G ++ +EP L + E + +
Sbjct: 210 EITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268
Query: 265 SSEKFRDFIRC---CLQKGDPSKR 285
S CL + +KR
Sbjct: 269 DSTSVEAMYSVASQCLHE-KKNKR 291
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 35/151 (23%), Positives = 54/151 (35%), Gaps = 25/151 (16%)
Query: 65 LGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQ 119
+GQG G ++ + A +KV D P EL ++ P ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAKPEQIQKWI 100
Query: 120 IFTKPSG-----------EVSILMEY----MDA--GSLE-IYVKSRGRLSEDIICTISRQ 161
K Y MD L+ IY + R S + +S +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192
+L L Y+H VH DIK +N+L+N K
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 7e-08
Identities = 35/147 (23%), Positives = 58/147 (39%), Gaps = 39/147 (26%)
Query: 133 EYMDAGSLE--IYVKSRG--------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPA 182
+YM+ G+L+ +Y RL IC +GL Y+H+R I+HRD+K
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLE---ICI---GAARGLHYLHTRAIIHRDVKSI 168
Query: 183 NVLINEKMEHP----CGYSCLYESGEARH---RKHGGYNGFAA-------------DIWS 222
N+L++E P G S + H G G+ D++S
Sbjct: 169 NILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTL-GYIDPEYFIKGRLTEKSDVYS 226
Query: 223 FGVTMMELYMGYYPFLEPGQEPDFLSL 249
FGV + E+ + + ++L
Sbjct: 227 FGVVLFEVLCARSA-IVQSLPREMVNL 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 37/176 (21%), Positives = 71/176 (40%), Gaps = 39/176 (22%)
Query: 146 SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------- 198
+ L+ + + S QV KG+ ++ SR +HRD+ N+L++E
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE------KNVVKICDFGL 239
Query: 199 ---LYESGEARHRKHG------------GYNGFAA--DIWSFGVTMMELY-MGY--YPFL 238
+Y+ + + + D+WSFGV + E++ +G YP +
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
Query: 239 EPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ +E L R P+ ++ + + C +PS+R T S+L+ H
Sbjct: 300 KIDEE---FCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHG-EPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 33/155 (21%), Positives = 56/155 (36%), Gaps = 13/155 (8%)
Query: 57 SQLEKLQVLGQGNGGTVF--------KVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ 108
+L+ + LG+G G V K +T+A+ LK EL IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 109 TNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLF 167
+V TKP G + +++E+ G+L Y++S+ R T + +G
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKTKGARFRQGKD 140
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYES 202
Y+ + D+K I +S
Sbjct: 141 YV---GAIPVDLKRRLDSITSSQSSASSGFVEEKS 172
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 35/148 (23%), Positives = 58/148 (39%), Gaps = 39/148 (26%)
Query: 133 EYMDAGSLE--IYVKSRGRLSED------IICTISRQVLKGLFYMH---SRNIVHRDIKP 181
YM GS+ + + + D I +R GL Y+H I+HRD+K
Sbjct: 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR----GLAYLHDHCDPKIIHRDVKA 162
Query: 182 ANVLINEKMEHPC----GYSCLYESGEARH---RKHG--GY-------NGFA---ADIWS 222
AN+L++E+ E G + L + + H G G+ G + D++
Sbjct: 163 ANILLDEEFE-AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 220
Query: 223 FGVTMMELYMGYYPF---LEPGQEPDFL 247
+GV ++EL G F + L
Sbjct: 221 YGVMLLELITGQRAFDLARLANDDDVML 248
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 6e-06
Identities = 39/317 (12%), Positives = 83/317 (26%), Gaps = 77/317 (24%)
Query: 1 DAIQGKIPGLSQPASIASSVRKPRHLVTQLNIPKPVSCPNLVHTEAASYGQEIDGLSQLE 60
I+ + S + R + Q+ VS + L +L
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL-------KLRQALLELR 148
Query: 61 KLQ-VLGQGNGGTVFKVRHKQTLALYA----------------LKVMQCDRGTPPNPQEL 103
+ VL G G+ K +AL L + C+
Sbjct: 149 PAKNVLIDGVLGS-----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 104 NILRQTNSPYIVKCHQIFTKP------SGEVSILMEYMD-AGSLEIYVKSRGRLSEDIIC 156
+L Q + + + E+ L++ L + L +
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV-------L--LNVQ 254
Query: 157 TISRQVLKGLFYMHSRNIV-HRDIKPANVLINEKMEHPC--GYSCLYESGEARHRKHGGY 213
+ + F + + ++ R + + L H +S E +
Sbjct: 255 --NAKAWNA-FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK------- 304
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLPE----CSS 266
+++ Y+ P P + L+I R+ + + +
Sbjct: 305 ------------SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 267 EKFRDFIRCCLQKGDPS 283
+K I L +P+
Sbjct: 353 DKLTTIIESSLNVLEPA 369
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 300 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.49 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.75 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.52 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.09 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 84.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 81.47 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.62 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-62 Score=414.61 Aligned_cols=235 Identities=26% Similarity=0.414 Sum_probs=200.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.++|++++.||+|+||+||+|+++.+++.||||++.... ....+.+|+.+|++++|||||++++++.++. .+|+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEE
Confidence 367999999999999999999999999999999997432 2223468999999999999999999999865 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc----------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---------------- 194 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---------------- 194 (300)
|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999998889999999999999999999999999999999999999988755322
Q ss_pred -----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 195 -----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 195 -----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
.++..|++||... +..++.++|||||||++|||+||+.||...+. ......+. .....+|..+++++
T Consensus 190 ~~~~~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~-~~~~~~p~~~s~~~ 261 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLT---EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----GLIFAKII-KLEYDFPEKFFPKA 261 (311)
T ss_dssp CBCCCCSCGGGCCHHHHH---HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HTCCCCCTTCCHHH
T ss_pred cccCcccCcccCCHHHHc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-cCCCCCCcccCHHH
Confidence 2345566776654 55678899999999999999999999965432 22333333 33467788899999
Q ss_pred HHHHHHHhccCCCCCCCCHHH------HhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTASQ------LLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~------~l~hpw~~~~ 300 (300)
++||.+||+. ||++|||++| +++||||+++
T Consensus 262 ~dli~~lL~~-dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 262 RDLVEKLLVL-DATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHHHSCS-SGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHccC-CHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 9999999999 9999999987 5899999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-61 Score=415.32 Aligned_cols=237 Identities=24% Similarity=0.365 Sum_probs=197.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..+++|++++.||+|+||.||+|+++.+|+.||||++....... .+.+|+.+|++++|||||++++++.++. .+|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-SLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-EEE
Confidence 35789999999999999999999999999999999997654332 3467999999999999999999998765 899
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------
Q 040812 130 ILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------ 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------ 195 (300)
||||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+++
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999999754 357999999999999999999999999999999999999988765332
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++..|++||... +..++.++||||||||+|||+||+.||...+ ..+.+..+.....+..+..++++
T Consensus 180 ~~~~~~~GT~~YmAPE~l~---~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~~~~~~~~~~~s~~ 252 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICE---NKPYNNKSDIWALGCVLYELCTLKHAFEAGS----MKNLVLKIISGSFPPVSLHYSYD 252 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHTCCCCCCTTSCHH
T ss_pred ccccccCCCccccCHHHHC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHcCCCCCCCccCCHH
Confidence 344577777654 5678899999999999999999999996543 23444455556666778889999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++||.+||+. ||++|||++|+++||||++
T Consensus 253 ~~~li~~~L~~-dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 253 LRSLVSQLFKR-NPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHTCS-SGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHccC-ChhHCcCHHHHhcCHHhhc
Confidence 99999999999 9999999999999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=412.59 Aligned_cols=235 Identities=27% Similarity=0.398 Sum_probs=198.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
..+.|+++++||+|+||.||+|+++.+|+.||||++...... ..+.+|+.+|++++|||||++++++.++. .+||||
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~ivm 150 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 150 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 346799999999999999999999999999999999754332 34578999999999999999999998865 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc------------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------------ 194 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------------ 194 (300)
|||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 99999999999976 47999999999999999999999999999999999999998765422
Q ss_pred -cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC--CCCCCChHHHH
Q 040812 195 -GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS--LPECSSEKFRD 271 (300)
Q Consensus 195 -~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 271 (300)
.++..|++||... +..++.++|||||||++|||+||++||.+.+. .+.+..+....++. .+..+++++++
T Consensus 230 ~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 230 LVGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp CCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred cccCcCcCCHHHHC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 2345567777654 55688999999999999999999999975432 23333333343333 34568999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||.+||+. ||++|||++|+++||||++
T Consensus 303 li~~~L~~-dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 303 FLDRLLVR-DPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp HHHHHSCS-STTTSCCHHHHTTCGGGGG
T ss_pred HHHHHcCC-ChhHCcCHHHHhcCHhhcC
Confidence 99999999 9999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-60 Score=398.59 Aligned_cols=233 Identities=25% Similarity=0.386 Sum_probs=191.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+++|++++.||+|+||.||+|+++.+++.||+|++....... .+.+|+.+|++++|||||++++++.++. .+|+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-EIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EEEE
Confidence 468999999999999999999999999999999997644322 2367999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc----------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---------------- 194 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---------------- 194 (300)
||||| +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence 99999 5799999998889999999999999999999999999999999999999998765422
Q ss_pred --cceeeccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 195 --GYSCLYESGEARHRKHGG-YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 195 --~~~~~~~~~~~~~~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
.++..|++||... +. +++.++|||||||++|||+||+.||...+. ......+. .....+|..+++++++
T Consensus 170 ~~~GT~~Y~APE~~~---~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~-~~~~~~p~~~s~~~~~ 241 (275)
T 3hyh_A 170 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNIS-NGVYTLPKFLSPGAAG 241 (275)
T ss_dssp -----CTTSCHHHHS---SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HTCCCCCTTSCHHHHH
T ss_pred CeeECcccCChhhhc---CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-cCCCCCCCCCCHHHHH
Confidence 2345577777654 33 346799999999999999999999965322 22333332 3456678889999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||.+||+. ||++|||++|+++||||+.
T Consensus 242 li~~~L~~-dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 242 LIKRMLIV-NPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHSCS-SGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHccC-ChhHCcCHHHHHcCccccc
Confidence 99999999 9999999999999999963
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-60 Score=404.64 Aligned_cols=236 Identities=28% Similarity=0.442 Sum_probs=195.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCC----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDR----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|++++.||+|+||.||+|++. .+++.||+|+++... ....+.+|+.+|++++|||||++++++.++. .
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-K 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT-E
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-E
Confidence 3478999999999999999999984 468899999986432 2234577999999999999999999998865 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------- 194 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------- 194 (300)
+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999999998889999999999999999999999999999999999999998765422
Q ss_pred ------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 195 ------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 195 ------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
.++..|++||... +..++.++|||||||++|||+||+.||...+.. +.+..+. ...+.+|..++++
T Consensus 181 ~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~-~~~~~~p~~~s~~ 252 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVN---RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----ETMTMIL-KAKLGMPQFLSPE 252 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHH---TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTSCHH
T ss_pred ccccccccCcccCCHHHhc---cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----HHHHHHH-cCCCCCCCcCCHH
Confidence 2355577777654 566888999999999999999999999754332 3333333 3455678889999
Q ss_pred HHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
+++||.+||+. ||++||| ++|+++||||+++
T Consensus 253 ~~~li~~~L~~-dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 253 AQSLLRMLFKR-NPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHHTCS-SGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHccc-CHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999999 9999998 5899999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-59 Score=410.99 Aligned_cols=235 Identities=27% Similarity=0.404 Sum_probs=198.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
..+.|++++.||+|+||.||+|+++.+|+.||||++....... .+.+|+.+|++++|||||+++++|.++. .+||||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~iVm 227 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 227 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-EEEEEE
Confidence 4567999999999999999999999999999999997544332 3468999999999999999999998865 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG----------------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~----------------- 195 (300)
|||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.++..+++
T Consensus 228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 999999999999754 69999999999999999999999999999999999999987654322
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--CCCCCCChHHHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP--SLPECSSEKFRD 271 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 271 (300)
++..|++||... +..|+.++|||||||++|||+||+.||.+.+. ...+..+.....+ ..+..+++++++
T Consensus 307 ~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 307 LVGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CEECTTTCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred cccCcCcCCHHHHC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 344566777654 56688999999999999999999999965432 2333333334333 344578999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||.+||+. ||++|||++|+|+||||++
T Consensus 380 li~~~L~~-dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 380 FLDRLLVR-DPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp HHHHHSCS-STTTSCCHHHHTTCGGGGG
T ss_pred HHHHHcCC-ChhHCcCHHHHhcCHHhcC
Confidence 99999999 9999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-59 Score=395.27 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=194.1
Q ss_pred Ccc-eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC---CCcE
Q 040812 57 SQL-EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP---SGEV 128 (300)
Q Consensus 57 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~ 128 (300)
++| ++.++||+|+||.||+|.++.+++.||+|.+....... .+.+|+.+|++++|||||++++++... .+.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 67788999999999999999999999999997544322 346799999999999999999998642 2368
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecC-CCCCC---c--------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINE-KMEHP---C-------- 194 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~-~~~~~---~-------- 194 (300)
|||||||+||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++..+ +
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999999998889999999999999999999999998 999999999999974 44432 2
Q ss_pred ------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-CCCCCCCCCCh
Q 040812 195 ------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSE 267 (300)
Q Consensus 195 ------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 267 (300)
.++..|++||... + .++.++|||||||++|||+||+.||.+..... .+...+... .++..+...++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~---~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYE---E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG---T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHTTTCCCGGGGGCCCH
T ss_pred CccCCcccCccccCHHHcC---C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH---HHHHHHHcCCCCCCCCccCCH
Confidence 2456688888653 3 47889999999999999999999996543322 223333323 23345667889
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++++||.+||.. ||++|||++|+++||||++
T Consensus 258 ~~~~li~~~L~~-dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 258 EVKEIIEGCIRQ-NKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCS-SGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccC-ChhHCcCHHHHhcCccccC
Confidence 999999999999 9999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=398.94 Aligned_cols=236 Identities=27% Similarity=0.331 Sum_probs=200.2
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
...+.|++.++||+|+||.||+|+++.+|+.||||+++.+. ...+|+.+|++++|||||++++++.++. .+|||||
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~---~~~~E~~il~~l~HpnIV~l~~~~~~~~-~~~ivmE 130 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPRIVPLYGAVREGP-WVNIFME 130 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCTHHHHTTTTCCCTTBCCEEEEEEETT-EEEEEEC
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH---hHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEEe
Confidence 35677999999999999999999999999999999997643 2357999999999999999999998765 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-C---Ccc--------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-H---PCG-------------- 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-~---~~~-------------- 195 (300)
||+||+|.++++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9999999999998889999999999999999999999999999999999999987753 2 222
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++..|++||... +..++.++|||||||++|||+||+.||...........+.... .....++..+++.
T Consensus 211 ~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVM---GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PPIREIPPSCAPL 285 (336)
T ss_dssp ---CCCCCCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CGGGGSCTTSCHH
T ss_pred ecCCccccCccccCHHHHC---CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CCchhcCccCCHH
Confidence 344567777654 5678899999999999999999999998765554443333211 1112467789999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH-------------hcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQL-------------LSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~-------------l~hpw~~~ 299 (300)
+++||.+||+. ||++|||+.|+ ++|||+.+
T Consensus 286 ~~~li~~~L~~-dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 286 TAQAIQEGLRK-EPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHHHTCS-SGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHHHccC-CHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 99999999999 99999999997 68999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=396.98 Aligned_cols=239 Identities=26% Similarity=0.355 Sum_probs=191.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC-----CCc
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP-----SGE 127 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 127 (300)
++|++++.||+|+||.||+|+++.+|+.||||+++...... .+.+|+.+|++++|||||++++++... .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999997543322 235799999999999999999987542 247
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------- 194 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------- 194 (300)
+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 999999996 589999998889999999999999999999999999999999999999987754322
Q ss_pred ----------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh---------
Q 040812 195 ----------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF--------- 255 (300)
Q Consensus 195 ----------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------- 255 (300)
.++..|++||.... ..+++.++||||+|||+|||+||++||.+.+.......+......
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~--~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLS--LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTT--CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred cccccccccceeChHhcCHHHhcC--CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 23445667765432 235688999999999999999999999765433222222221110
Q ss_pred ----------CCCCCC-------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 ----------REPPSL-------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 ----------~~~~~~-------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+... ....++++.+||.+||+. ||++|||++|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~-dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRF-EPSARISAAAALRHPFLAK 350 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCS-STTTSCCHHHHTTSGGGTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcC-ChhHCcCHHHHhcCHhhCc
Confidence 001111 124688999999999999 9999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=386.91 Aligned_cols=237 Identities=24% Similarity=0.309 Sum_probs=189.9
Q ss_pred CcceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||+|+++ .+++.||+|.+..........+|+.+|+.+ +||||+++++++.+.. ++|+||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~-~~~lvm 99 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND-HVVIAM 99 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT-EEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC-EEEEEE
Confidence 56999999999999999999875 467899999987654444456899999988 6999999999998765 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC-CC---CCcc-------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-ME---HPCG------------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~-~~---~~~~------------- 195 (300)
|||+||+|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.+ +. .++|
T Consensus 100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 176 (361)
T 4f9c_A 100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176 (361)
T ss_dssp ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG
T ss_pred eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc
Confidence 9999999999984 59999999999999999999999999999999999999865 22 1222
Q ss_pred -------------------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 040812 196 -------------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP 244 (300)
Q Consensus 196 -------------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 244 (300)
++..|.+||.... ...++.++||||+|||+|||+||+.||....++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK--CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGC--------------------------CCCCGGGCCHHHHTT--CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 3455777776542 2357889999999999999999999997655443
Q ss_pred hHHHHHHHHhh--------------------------------------------------CCCCCCCCCCChHHHHHHH
Q 040812 245 DFLSLMLAICF--------------------------------------------------REPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 245 ~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~l~~li~ 274 (300)
+....+..... ......+..++++++|||.
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 33222211100 0001123457899999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+||+. ||++|+|++|+|+||||+++
T Consensus 335 ~lL~~-dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 335 KLLDL-NPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHTCS-CTTTSCCHHHHHTSGGGTTC
T ss_pred HHCcC-ChhHCcCHHHHhcCcccCCC
Confidence 99999 99999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-56 Score=380.74 Aligned_cols=234 Identities=23% Similarity=0.332 Sum_probs=185.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC--------
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS-------- 125 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 125 (300)
++|++++.||+|+||.||+|+++.+++.||||+++..... ..+.+|+.+|++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5799999999999999999999999999999999754322 23467999999999999999999986433
Q ss_pred ---CcEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----
Q 040812 126 ---GEVSILMEYMDAGSLEIYVKSRGR---LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---- 195 (300)
Q Consensus 126 ---~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---- 195 (300)
..+|+|||||++|+|.+++..... .++..++.++.||+.||.|||++||+||||||+|||++.++..+++
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 247999999999999999987654 4556789999999999999999999999999999999987654322
Q ss_pred ---------------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q 040812 196 ---------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS 248 (300)
Q Consensus 196 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 248 (300)
++..|++||... +..++.++|||||||++|||++ ||... .+...
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvilyell~---Pf~~~---~~~~~ 235 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH---GNSYSHKVDIFSLGLILFELLY---PFSTQ---MERVR 235 (299)
T ss_dssp C--------------------------CCCTTSCHHHHT---TCCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHc---CCCCCCHHHHHHHHHHHHHHcc---CCCCc---cHHHH
Confidence 344577777654 5678899999999999999996 77432 12222
Q ss_pred HHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 249 LMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.+..+.....+..+...++.+.+||.+||+. ||++|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~-dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSP-SPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCS-SGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCC-ChhHCcCHHHHhcCHhhCCC
Confidence 3333333333333344567789999999999 99999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=375.22 Aligned_cols=229 Identities=21% Similarity=0.356 Sum_probs=190.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|.+.+.||+|+||.||+|++. .+++.||||+++.... ...+.+|+.+|++++|||||++++++.++. .
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 89 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-P 89 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-E
Confidence 3568999999999999999999975 3578999999974322 123568999999999999999999998754 8
Q ss_pred EEEEEeccCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc
Q 040812 128 VSILMEYMDAGSLEIYVKSR-------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC 194 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~ 194 (300)
.|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++..++
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999999753 36999999999999999999999999999999999999998765433
Q ss_pred cc---------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 040812 195 GY---------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLA 252 (300)
Q Consensus 195 ~~---------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 252 (300)
++ +..|++||... ++.++.++|||||||++|||+| |+.||.+... .+++..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~---~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Confidence 22 33466776654 4568899999999999999999 8999976432 344555
Q ss_pred HhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 253 ICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
+..+..+..|..+++++.+||.+||+. ||++|||+++++
T Consensus 243 i~~~~~~~~p~~~~~~~~~li~~cl~~-dP~~RPs~~~i~ 281 (299)
T 4asz_A 243 ITQGRVLQRPRTCPQEVYELMLGCWQR-EPHMRKNIKGIH 281 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHcCC-ChhHCcCHHHHH
Confidence 555667778889999999999999999 999999999984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=372.54 Aligned_cols=240 Identities=22% Similarity=0.325 Sum_probs=190.8
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
+....+++++.++||+|+||+||+|+++. .||||+++..... ..+.+|+.+|++++|||||++++++.. +.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--Ce
Confidence 34456889999999999999999998764 5899998754332 234679999999999999999998754 36
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc------------
Q 040812 128 VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------ 194 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------ 194 (300)
+|||||||+||+|.+++.. ...+++..+..|+.||+.||.|||+++|+||||||+|||++.++..++
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 8999999999999999975 457999999999999999999999999999999999999997754322
Q ss_pred ---------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-hCCCCCCCCC
Q 040812 195 ---------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPEC 264 (300)
Q Consensus 195 ---------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 264 (300)
.++..|++||.......+.++.++|||||||++|||+||+.||.+..........+.... ....+..+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 234557788876544455688899999999999999999999976544322222222111 1112345667
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHH------hcCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQL------LSHPFL 297 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~------l~hpw~ 297 (300)
+++.+.+||.+||+. ||++|||+.|+ ++|++-
T Consensus 266 ~~~~l~~li~~cl~~-dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 266 CPKAMKRLVADCVKK-VKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp SCHHHHHHHHHHTCS-SSTTSCCHHHHHHHHHHHHTTCC
T ss_pred chHHHHHHHHHHcCC-CHhHCcCHHHHHHHHHHHhccCC
Confidence 899999999999999 99999999976 467664
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-55 Score=403.30 Aligned_cols=241 Identities=24% Similarity=0.391 Sum_probs=201.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHH---HHHHHHhcCCCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQ---ELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~---E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
..+++|++++.||+|+||.||+|+++.+|+.||||++.+.... ....+ ++.+++.++|||||+++++|.++.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3578999999999999999999999999999999999753211 11123 456677789999999999999865
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-----------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC----------- 194 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~----------- 194 (300)
.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 266 -~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 -KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred -EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 89999999999999999998889999999999999999999999999999999999999998765422
Q ss_pred ------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 195 ------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 195 ------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
.++..|++||.... +..++.++||||||||+|||+||.+||....... ...+... .......+|..++++
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~--~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~-i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRM-TLTMAVELPDSFSPE 420 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHH-HHHCCCCCCTTSCHH
T ss_pred CCCCCccCCcCccCHHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHh-hcCCCCCCCccCCHH
Confidence 23556777776532 3467889999999999999999999997643332 2233322 334556778889999
Q ss_pred HHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
+++||.+||+. ||++|++ ++|+++||||+++
T Consensus 421 a~dLI~~lL~~-dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 421 LRSLLEGLLQR-DVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHTCS-CGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHHccC-CHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999999 9999998 7999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=374.76 Aligned_cols=231 Identities=22% Similarity=0.366 Sum_probs=192.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|.+.++||+|+||.||+|+++ .+++.||||+++.... ...+.+|+.+|++++|||||++++++.+.. .
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 117 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-P 117 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-E
Confidence 3467899999999999999999975 3688999999964321 123578999999999999999999998764 8
Q ss_pred EEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 128 VSILMEYMDAGSLEIYVKSR---------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
+|||||||++|+|.+++... +.+++..+..|+.||+.||.|||+++|+||||||+|||++.++..
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 99999999999999999753 358999999999999999999999999999999999999987654
Q ss_pred Ccc---------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 040812 193 PCG---------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLM 250 (300)
Q Consensus 193 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 250 (300)
+++ ++..|++||... +..++.++|||||||++|||+| |+.||..... .+.+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~---~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL---YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----TEAI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHT---TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhc---CCCCCccccccchHHHHHHHHcCCCCCCCCCCH----HHHH
Confidence 322 233466776654 5678899999999999999999 8999975432 2444
Q ss_pred HHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..+..+..+..|..+++++.++|.+||+. ||++|||++|++++
T Consensus 271 ~~i~~g~~~~~p~~~~~~~~~li~~cl~~-dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQGRELERPRACPPEVYAIMRGCWQR-EPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHCCS-STTTSCCHHHHHHH
T ss_pred HHHHcCCCCCCcccccHHHHHHHHHHcCc-ChhHCcCHHHHHHH
Confidence 44555667788899999999999999999 99999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=371.00 Aligned_cols=231 Identities=22% Similarity=0.330 Sum_probs=191.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..+++++.+.||+|+||.||+|.+. .+++.||||+++..... ..+.+|+.+|++++|||||++++++..+.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~- 102 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ- 102 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-
Confidence 4677899999999999999999964 46789999999754332 23568999999999999999999998754
Q ss_pred cEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 127 EVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
..|+|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||+++++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 899999999999999999643 3589999999999999999999999999999999999999876
Q ss_pred CCCccc---------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 040812 191 EHPCGY---------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLS 248 (300)
Q Consensus 191 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 248 (300)
..++++ +..|++||... ++.++.++|||||||++|||+| |..||.+... .+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~ 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM---YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QD 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHh---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 543332 23466666554 4568899999999999999999 8999975432 24
Q ss_pred HHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 249 LMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
++..+..+..+..|..+++.+.++|.+||.. ||++|||+.||+++
T Consensus 256 ~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~-dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRNRQVLPCPDDCPAWVYALMIECWNE-FPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCcccchHHHHHHHHHHcCC-ChhHCcCHHHHHHH
Confidence 4444555666778889999999999999999 99999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=374.11 Aligned_cols=235 Identities=24% Similarity=0.345 Sum_probs=194.8
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCC---CCCHHHHHHHHhcCC-CceeEeceeeeC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGT---PPNPQELNILRQTNS-PYIVKCHQIFTK 123 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h-~niv~~~~~~~~ 123 (300)
..+.++|++.+.||+|+||.||+|.+..+ ++.||||.++..... ..+.+|+.+|.+++| ||||++++++..
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 44678999999999999999999998754 468999998754332 234679999999976 899999999876
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN 187 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~ 187 (300)
+.+.+|+|||||++|+|.++++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 655799999999999999999752 2489999999999999999999999999999999999999
Q ss_pred CCCCCCccc---------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040812 188 EKMEHPCGY---------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPD 245 (300)
Q Consensus 188 ~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 245 (300)
.++..++++ +..|++||... +..++.++|||||||++|||+| |+.||.+......
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh---cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 876543322 23466666654 4568899999999999999998 9999976554433
Q ss_pred HHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 246 FLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.. ..+..+..+..|..+++++.++|.+||+. ||++|||++|+++|
T Consensus 297 ~~---~~i~~g~~~~~p~~~~~~~~~li~~c~~~-dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FC---RRLKEGTRMRAPDYTTPEMYQTMLDCWHG-EPSQRPTFSELVEH 341 (353)
T ss_dssp HH---HHHHHTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HH---HHHHcCCCCCCCccCCHHHHHHHHHHcCc-ChhHCcCHHHHHHH
Confidence 33 33344667788889999999999999999 99999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=394.40 Aligned_cols=238 Identities=30% Similarity=0.429 Sum_probs=195.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+++|++++.||+|+||.||+|+++.+|+.||+|++...... ....+|+.+|+.++|||||+++++|.++. .+|+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-EMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-EEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEEEe
Confidence 46899999999999999999999999999999998754322 23467999999999999999999998765 8999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC--CCC---Ccc------------
Q 040812 134 YMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK--MEH---PCG------------ 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~--~~~---~~~------------ 195 (300)
||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.. ++|
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 9999999999964 4579999999999999999999999999999999999999864 222 222
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++..|++||... +..++.++|||||||++|||++|+.||.+.+... ....+.......+...+..+++++++|
T Consensus 315 ~~~GT~~y~APEv~~---~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 315 VTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp EECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred eeEECccccCHHHhC---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 244566777654 5678899999999999999999999997644322 111121111122233345689999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||+. ||++|||++|+|+||||+.
T Consensus 391 i~~~L~~-dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 391 IRKLLLA-DPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp HHTTSCS-SGGGSCCHHHHHHSTTTSC
T ss_pred HHHHccC-ChhHCcCHHHHhcCcCcCC
Confidence 9999999 9999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=349.92 Aligned_cols=236 Identities=26% Similarity=0.407 Sum_probs=196.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+|+.++++++||||+++++++.... ..|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-TLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-EEEE
Confidence 4678999999999999999999999999999999997644322 2357999999999999999999998754 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 999999999999998888999999999999999999999999999999999999999876543322
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||.... ....+.++|||||||++|+|+||+.||...+. ......+. ......|...++++.++
T Consensus 172 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~-~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRERVL-RGKYRIPFYMSTDCENL 244 (328)
T ss_dssp TTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HCCCCCCTTSCHHHHHH
T ss_pred cccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH-hCCCCCCCCCCHHHHHH
Confidence 333555555431 22345799999999999999999999965432 22222222 33456677889999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||++|+++||||+.
T Consensus 245 i~~~L~~-dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 245 LKRFLVL-NPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp HHHHCCS-STTTSCCHHHHTTCTTTTT
T ss_pred HHHHCCC-ChhHCcCHHHHhcCHhhcC
Confidence 9999999 9999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=349.50 Aligned_cols=236 Identities=26% Similarity=0.439 Sum_probs=198.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++++.||+|+||.||+|+++.+++.||+|+++... ......+|+.++++++||||+++++++.... ..|
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~ 81 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-EEE
Confidence 3578999999999999999999999999999999997532 1223467999999999999999999998765 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc--------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------- 195 (300)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 999999999999999888889999999999999999999999999999999999999877654222
Q ss_pred -----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 196 -----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...+.. .....+. .....+|..+++++.
T Consensus 162 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~s~~~~ 233 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELIL-MEEIRFPRTLSPEAK 233 (337)
T ss_dssp BCCCEECGGGCCGGGGS---SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTSCHHHH
T ss_pred ccccccChhhCChhhhc---CCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHHHH-cCCCCCCCCCCHHHH
Confidence 233466666653 556788999999999999999999999654322 2222222 344567788999999
Q ss_pred HHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
++|.+||.. ||++|| +++++++||||+++
T Consensus 234 ~li~~lL~~-dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 234 SLLAGLLKK-DPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCS-STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhc-CHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999 999999 89999999999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=353.35 Aligned_cols=242 Identities=27% Similarity=0.462 Sum_probs=200.2
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
..+++|++++.||+|+||.||+|+++.+++.||+|+++..... ....+|..++.++ +||||+++++++.+.. .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-~ 127 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-R 127 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS-E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC-E
Confidence 3578899999999999999999999999999999999864322 2235789998876 8999999999998765 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------ 195 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------ 195 (300)
.|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++.
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999999988889999999999999999999999999999999999999987654322
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC----chHHHHHHHHhhCCCCCCCCC
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE----PDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 264 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...... ......+..........+|..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~---~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CccccccCCcccCCchhhc---CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 233455666543 556788999999999999999999999643211 111222333333456677888
Q ss_pred CChHHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTA------SQLLSHPFLADA 300 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~------~~~l~hpw~~~~ 300 (300)
+++++++||.+||+. ||++||++ +|+++||||+++
T Consensus 285 ~s~~~~~li~~lL~~-dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 285 LSVKAASVLKSFLNK-DPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp SCHHHHHHHHHHTCS-CTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CCHHHHHHHHHHhcC-CHhHcCCCCCCCCHHHHhcCccccCC
Confidence 999999999999999 99999985 899999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=352.81 Aligned_cols=234 Identities=29% Similarity=0.429 Sum_probs=193.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--------CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--------PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
++|++.+.||+|+||.||+|.++.+++.||+|+++...... .+.+|+.++++++||||+++++++.+.. ..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~ 90 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-DV 90 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-EE
Confidence 56999999999999999999999999999999998654332 2357999999999999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC----C---Ccc------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME----H---PCG------ 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~----~---~~~------ 195 (300)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999999999999988888999999999999999999999999999999999999987652 2 222
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---CCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---PPSLPE 263 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~ 263 (300)
++..|.+||... +..++.++|||||||++|+|++|..||...... .....+.... +...+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHTTCCCCCHHHHT
T ss_pred CCCccccCCCCccEECchHHc---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCchhcc
Confidence 233355665543 456788999999999999999999999764332 2222222111 122235
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+++.+++||.+||.. ||++|||++|+++||||++
T Consensus 244 ~~s~~~~~li~~~L~~-dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 244 QTSELAKDFIRKLLVK-ETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TSCHHHHHHHHHHSCS-STTTSCCHHHHHTSTTTSC
T ss_pred CCCHHHHHHHHHHCCC-ChhHCcCHHHHhcCcCcCC
Confidence 6789999999999999 9999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=346.37 Aligned_cols=236 Identities=23% Similarity=0.433 Sum_probs=198.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++.+.||+|+||.||+|+++.+++.||+|+++... ......+|+.+++.++||||+++++++.+.. ..|
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~~ 82 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIF 82 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-EEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-EEE
Confidence 3578999999999999999999999999999999997532 1122357999999999999999999998764 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence 9999999999999999888899999999999999999999999999999999999998876543322
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+..|.+||... +..++.++|||||||++|||++|+.||...+.. .....+. .....+|...++++.++|
T Consensus 163 ~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 163 LCGTPDYIAPEVVS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKIL-NAELRFPPFFNEDVKDLL 234 (318)
T ss_dssp CCSCTTTCCHHHHT---TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-HCCCCCCTTSCHHHHHHH
T ss_pred ccCCccccCHhHhc---CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hCCCCCCCCCCHHHHHHH
Confidence 33355666543 456788999999999999999999999754332 2222222 234566778899999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 274 RCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 274 ~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
.+||.. ||++|| +++++++||||+++
T Consensus 235 ~~lL~~-dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 235 SRLITR-DLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHTCS-CTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHhcc-CHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999 999999 89999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=354.07 Aligned_cols=237 Identities=27% Similarity=0.456 Sum_probs=196.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
..+++|++++.||+|+||.||+|+++.+++.||+|+++... ......+|..+++.+ +||||+++++++.+.. .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-~ 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-R 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC-E
Confidence 35688999999999999999999999999999999997532 122235689999987 7999999999998765 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
.|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999999999999999888899999999999999999999999999999999999999876543322
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...+.. .....+. .....+|...+++
T Consensus 179 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~ 250 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQ---EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAIL-NDEVVYPTWLHED 250 (353)
T ss_dssp -------CCGGGCCHHHHH---HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTSCHH
T ss_pred ccccccCCCcCeEChhhcC---CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----HHHHHHH-cCCCCCCCCCCHH
Confidence 33355665543 344678999999999999999999999754332 2222222 3455667789999
Q ss_pred HHHHHHHHhccCCCCCCCCH------HHHhcCCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTA------SQLLSHPFLADA 300 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~------~~~l~hpw~~~~ 300 (300)
+.++|.+||.. ||++||++ +++++||||+++
T Consensus 251 ~~~li~~lL~~-dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 251 ATGILKSFMTK-NPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHHTCS-SGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHHhhh-CHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999999 99999998 899999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=347.88 Aligned_cols=239 Identities=28% Similarity=0.427 Sum_probs=190.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.++|++.+.||+|+||.||+|++..+++.||+|+++.......+.+|+.++++++||||+++++++.... ..++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-EISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSS-EEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCC-eEEEEEEeC
Confidence 3569999999999999999999999999999999987665566778999999999999999999998764 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC---CCCCCc---c--------------
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE---KMEHPC---G-------------- 195 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~---~~~~~~---~-------------- 195 (300)
++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++...+ |
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 332221 1
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
++..|.+||... +..++.++|||||||++|||+||..||............+..............++.++.+||.
T Consensus 211 ~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 211 CGTPGYCAPEILR---GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp --CGGGSCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred cCCCCccCHHHhc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 233456666543 5567889999999999999999999997654432222222211111222334568899999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. ||++|||+.++++||||.+
T Consensus 288 ~~L~~-dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 288 KLIVL-DPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp TTSCS-SGGGSCCHHHHHHSTTTTS
T ss_pred HHccC-ChhhCcCHHHHhcCcccCC
Confidence 99999 9999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=341.30 Aligned_cols=237 Identities=27% Similarity=0.414 Sum_probs=195.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..|+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEEEEE
Confidence 4568999999999999999999999999999999987543322 2367999999999999999999998765 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++...+.+
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 999999999999765 699999999999999999999999999999999999998776543322
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+..|.+||... +..++.++|||||||++|||+||+.||............. .........+..+++.+.++|
T Consensus 176 ~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 176 MVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CCSCGGGCCHHHHH---CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HHCSCCCSCGGGSCHHHHHHH
T ss_pred ccCCcCccChhhhc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCccccCHHHHHHH
Confidence 33355555543 4567889999999999999999999996543322211111 122233445677899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||.. ||++|||++|+++||||+.
T Consensus 251 ~~~l~~-dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 251 NRCLEM-DVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHSCS-STTTSCCHHHHTTCGGGGG
T ss_pred HHHccC-ChhHCcCHHHHhhChhhcc
Confidence 999999 9999999999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=345.23 Aligned_cols=241 Identities=28% Similarity=0.471 Sum_probs=197.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhc-CCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQT-NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 128 (300)
.+++|++++.||+|+||.||+|+++.+++.||+|+++...... ...+|..++.++ +||||+++++++.+.. ..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-~~ 85 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RL 85 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC-EE
Confidence 4678999999999999999999999999999999998654332 135689999887 8999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999999999998878899999999999999999999999999999999999998876543322
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHHHHHhhCCCCCCCCCC
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP----DFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 265 (300)
+..|.+||... +..++.++|||||||++|||+||+.||....... .....+..........+|...
T Consensus 166 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp CBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred cccccCCCccccCccccC---CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 33355555543 4567889999999999999999999996432111 111222222234456678889
Q ss_pred ChHHHHHHHHHhccCCCCCCCCH------HHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTA------SQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~------~~~l~hpw~~~~ 300 (300)
+.+++++|.+||.. ||++||++ +++++||||+++
T Consensus 243 s~~~~~li~~lL~~-dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 243 SVKAASVLKSFLNK-DPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CHHHHHHHHHHTCS-STTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcC-CHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 99999999999999 99999995 899999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=348.73 Aligned_cols=243 Identities=23% Similarity=0.407 Sum_probs=204.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++||||+++++++.+.. ..
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~ 90 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-DM 90 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EE
Confidence 35688999999999999999999999999999999986432 1123457999999999999999999998765 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc--------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-------------- 194 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~-------------- 194 (300)
|+||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 999999999999999998888999999999999999999999999999999999999987765422
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.++..|.+||......+..++.++|||||||++|||+||+.||....... ....... ........|..+++.+.
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~-~~~~~~~~p~~~s~~~~ 248 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHT-FETTVVTYPSAWSQEMV 248 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHH-HHHCCCCCCTTSCHHHH
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHH-HhhcccCCCCcCCHHHH
Confidence 23445778887665445667889999999999999999999997543332 2222222 23445667788999999
Q ss_pred HHHHHHhccCCCCCCCC-HHHHhcCCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWT-ASQLLSHPFLADA 300 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt-~~~~l~hpw~~~~ 300 (300)
++|.+||.. ||++||+ ++++++||||+++
T Consensus 249 ~li~~lL~~-dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 249 SLLKKLLEP-NPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHSCS-SGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHHhcC-CHhHhcccHHHHHcChhhhcC
Confidence 999999999 9999998 9999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=337.03 Aligned_cols=241 Identities=27% Similarity=0.442 Sum_probs=189.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++|++.+.||+|+||.||+|++..+++.||+|++........ +.+|+.++++++||||+++++++.... ..|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-EEEEE
Confidence 3689999999999999999999999999999999976554332 357999999999999999999998765 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 99998744444444467899999999999999999999999999999999999999876543222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC--------------
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP-------------- 258 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 258 (300)
+..|.+||.... ...++.++|||||||++|+|+||..||............+........
T Consensus 160 ~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp SCCSCGGGCCHHHHTT--CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred CCccccCCcChHHHcC--CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 233555555431 233688999999999999999998887655444333333322211111
Q ss_pred -----------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 259 -----------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 259 -----------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.......++.+++||.+||+. ||++|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKC-NPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhcc-ChhhCCCHHHHhcCcccccC
Confidence 011224678999999999999 99999999999999999873
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=347.73 Aligned_cols=236 Identities=24% Similarity=0.418 Sum_probs=196.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|+++.+++.||+|+++... .......|..++..+ +||||+++++++.+.. ..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-~~ 93 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NL 93 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-EE
Confidence 4678999999999999999999999999999999997532 112235688888876 9999999999998765 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999999999999878899999999999999999999999999999999999998876543222
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+..|.+||... +..++.++|||||||++|||+||..||...+.. .....+. ...+.+|..+++++
T Consensus 174 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~s~~~ 245 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIR-MDNPFYPRWLEKEA 245 (345)
T ss_dssp CBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTSCHHH
T ss_pred cccCCCCCcccCChhhhc---CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHH-hCCCCCCcccCHHH
Confidence 33355555543 456788999999999999999999999754332 2222222 33456778899999
Q ss_pred HHHHHHHhccCCCCCCCCHH-HHhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTAS-QLLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~-~~l~hpw~~~~ 300 (300)
+++|.+||.. ||++||++. ++++||||+++
T Consensus 246 ~~li~~lL~~-dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 246 KDLLVKLFVR-EPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHHSCS-SGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcC-CHhHcCCChHHHHcCccccCC
Confidence 9999999999 999999998 99999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=350.35 Aligned_cols=246 Identities=26% Similarity=0.301 Sum_probs=194.9
Q ss_pred CccCCCCcceeeeeecCC--cceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC
Q 040812 51 QEIDGLSQLEKLQVLGQG--NGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP 124 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~ 124 (300)
......++|++.+.||+| +||.||+|+++.+++.||+|++....... .+.+|+.++++++||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 344567899999999999 99999999999999999999997654332 234699999999999999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----- 197 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----- 197 (300)
. ..|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++...+.++
T Consensus 99 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 99 N-ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp T-EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred C-EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 5 899999999999999999875 57999999999999999999999999999999999999997765433222
Q ss_pred ---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-
Q 040812 198 ---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF- 255 (300)
Q Consensus 198 ---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 255 (300)
..|.+||..... ...++.++|||||||++|||+||+.||..................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eccccccccccccccccccccccccCHHHHhcc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 225666655421 145788999999999999999999999765544333222211000
Q ss_pred ----------------------------------------CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 040812 256 ----------------------------------------REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295 (300)
Q Consensus 256 ----------------------------------------~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hp 295 (300)
......+..+++.+.+||.+||+. ||++|||++|+++||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~-dP~~Rpta~ell~hp 335 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR-NPDARPSASTLLNHS 335 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCS-CTTTSCCHHHHTTSG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc-CcccCCCHHHHhcCH
Confidence 001123456788999999999999 999999999999999
Q ss_pred CCCC
Q 040812 296 FLAD 299 (300)
Q Consensus 296 w~~~ 299 (300)
||++
T Consensus 336 ~f~~ 339 (389)
T 3gni_B 336 FFKQ 339 (389)
T ss_dssp GGGG
T ss_pred HHHH
Confidence 9975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=344.72 Aligned_cols=240 Identities=28% Similarity=0.408 Sum_probs=194.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ....+|+.++++++||||+++++++.... ..|+|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-EEEEEEE
Confidence 457899999999999999999999999999999999764432 23468999999999999999999998764 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC--CC---cc-------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME--HP---CG------------- 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~--~~---~~------------- 195 (300)
|+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. .+ +|
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 176 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence 9999999999988888999999999999999999999999999999999999987654 22 22
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-CCCCCCCCChHHHHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-PPSLPECSSEKFRDF 272 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 272 (300)
++..|.+||.... ....+.++|||||||++|+|+||+.||............+..+.... .......+++.+.+|
T Consensus 177 ~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ----CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 2234556655431 22334459999999999999999999987666555555554443222 222233578999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
|.+||.. ||++|||++|+++||||.
T Consensus 255 i~~~L~~-dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 255 ISRIFVA-DPATRISIPEIKTHSWFL 279 (361)
T ss_dssp HHHHSCS-CTTTSCCHHHHHTSHHHH
T ss_pred HHHHccC-ChhHCcCHHHHHhCcchh
Confidence 9999999 999999999999999994
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=345.89 Aligned_cols=237 Identities=27% Similarity=0.423 Sum_probs=199.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+++|++++.||+|+||.||+|+++.+++.||+|++.... ......+|+.++++++||||+++++++.+.. ..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-EE
Confidence 35688999999999999999999999999999999986532 1123457999999999999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 9999999999999999988889999999999999999999999999999999999999887654322
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++..|.+||... +..++.++|||||||++|||+||..||...... .....+. .....+|..+++++.++
T Consensus 197 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 197 TLCGTPEALAPEIIL---SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIV-SGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp CCEECGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTCCHHHHHH
T ss_pred cccCCccccCHHHhc---CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----HHHHHHH-cCCCCCCCCCCHHHHHH
Confidence 233466666554 456788999999999999999999999754322 2222222 23456778899999999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 273 IRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
|.+||.. ||++||+ ++++++||||+++
T Consensus 269 i~~lL~~-dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 269 LRNLLQV-DLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHSCS-CTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHhhc-CHHhccCCccCCHHHHHhCcCcCCC
Confidence 9999999 9999998 9999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=354.26 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=199.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeec-----CCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-----DRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++.+.||+|+||.||+|+++.+++.||+|+++. ......+.+|..++..++||||+++++++.+.. ..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN-NL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS-EE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-EE
Confidence 456789999999999999999999999999999999864 223344678999999999999999999998765 89
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------
Q 040812 129 SILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------ 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------ 195 (300)
|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++.
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999999987 5689999999999999999999999999999999999999977654322
Q ss_pred --------ceeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 196 --------YSCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 196 --------~~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
++..|.+||..... .++.++.++|||||||++|||+||+.||...+.......++........+.....+
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 23446666665421 13457889999999999999999999997654333333333222222233334558
Q ss_pred ChHHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSK--RWTASQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~--Rpt~~~~l~hpw~~~~ 300 (300)
++++++||.+||.. +|++ |++++|+++||||+++
T Consensus 310 s~~~~dLi~~lL~~-~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 310 SENAKDLIRRLICS-REHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CHHHHHHHHTTSSC-GGGCTTTTTTHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcc-cccccCCCCHHHHhCCCccCCC
Confidence 99999999999988 8888 9999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=341.36 Aligned_cols=237 Identities=28% Similarity=0.448 Sum_probs=192.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--------CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--------PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
++|++.+.||+|+||.||+|.+..+++.||+|+++...... .+.+|+.++++++||||+++++++.... ..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-DV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EE
Confidence 56999999999999999999999999999999997654321 2357999999999999999999998754 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC----CCC---cc------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM----EHP---CG------ 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~----~~~---~~------ 195 (300)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ... +|
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999998765 221 22
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
++..|.+||... +..++.++|||||||++|+|+||..||....... ....+.......+...+...+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCccccccCCcCcCCceeec---CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcCCCcCccccccCC
Confidence 123345555443 4567889999999999999999999996543221 111111111111112235678
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.+.+||.+||.. ||++|||++++++||||++
T Consensus 246 ~~~~~li~~~L~~-dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 246 ALAKDFIRRLLVK-DPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHHHHHHHHSCS-SGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHHccC-ChhhCCCHHHHhcCCCccC
Confidence 9999999999999 9999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=336.66 Aligned_cols=239 Identities=23% Similarity=0.387 Sum_probs=188.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++|++++.||+|+||.||+|++.. ++.||+|++....... .+.+|+.++++++||||+++++++.... ..|+|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-CLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-CEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-EEEEE
Confidence 5789999999999999999999964 8899999987554332 2357999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 132 MEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 999986 788777654 4599999999999999999999999999999999999998876543222
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC-----------
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS----------- 260 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----------- 260 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...........+........+..
T Consensus 177 ~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMG--SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp -CCCCCCTTCCHHHHTT--CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cCCcccCCcCCHHHhcC--CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 233555555431 24568899999999999999999999987665554444433222111111
Q ss_pred --------------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 261 --------------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 261 --------------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.....++++.+||.+||.. ||++|||++|+++||||+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCF-DPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCS-CTTTSCCHHHHHTSGGGTTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCC-ChhHCCCHHHHhcCcccccC
Confidence 1123578899999999999 99999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=340.36 Aligned_cols=239 Identities=21% Similarity=0.268 Sum_probs=194.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
-.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++||||+++++++.... ..|+|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-eEEEE
Confidence 35789999999999999999999999999999999865432 234578999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99999999999998877899999999999999999999999999999999999999876543322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||.... ....+.++|||||||++|+|+||+.||.............. ...........+++.+.
T Consensus 164 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp BCSCCSCGGGSCHHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH--TTCTTSTTGGGSCHHHH
T ss_pred cCCCccCcCccCcHHhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cccccCCccccCCHHHH
Confidence 223455555431 22346789999999999999999999976554433222221 11222233456889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.+||.. ||++|||++|+++||||++
T Consensus 240 ~li~~~L~~-dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 240 ALLHKILVE-NPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHHHHHSCS-STTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHccC-ChhhCcCHHHHhhChhhcc
Confidence 999999999 9999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=342.37 Aligned_cols=232 Identities=18% Similarity=0.216 Sum_probs=176.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCC--HHHHHHHHhcCCCceeEeceeeeCCCC---cEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--PQELNILRQTNSPYIVKCHQIFTKPSG---EVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~lv 131 (300)
.+|.+.+.||+|+||.||+|+++ |+.||||+++..... .+ ..|+..+.+++|||||++++++..+.+ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 46889999999999999999984 789999998654322 22 235666678899999999999875432 48999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC--------CccccCCCCCceeecCCCCCCcc--------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR--------NIVHRDIKPANVLINEKMEHPCG-------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~i~H~Dlkp~Nill~~~~~~~~~-------- 195 (300)
||||++|+|.++++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++..+++
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999865 689999999999999999999987 99999999999999987654322
Q ss_pred ---------------ceeeccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----------C-chH
Q 040812 196 ---------------YSCLYESGEARHRKH---GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ----------E-PDF 246 (300)
Q Consensus 196 ---------------~~~~~~~~~~~~~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~----------~-~~~ 246 (300)
++..|++||...... ...++.++|||||||++|||+||..||..... . ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 344577777654321 12356799999999999999999887643221 1 111
Q ss_pred HHHHHHHh-hCCCCCCCCCC-----ChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 247 LSLMLAIC-FREPPSLPECS-----SEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 247 ~~~~~~~~-~~~~~~~~~~~-----~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
......+. ....+.+|... ++.+.++|.+||.. ||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~-dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA-NGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHccc-CHhHCcCHHHHHH
Confidence 22222222 23344444332 34688999999999 9999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=346.09 Aligned_cols=236 Identities=27% Similarity=0.389 Sum_probs=191.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHH-HHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNI-LRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++++.||+|+||.||+|+++.+++.||+|+++..... ....+|..+ ++.++||||+++++++.... ..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~-~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS-EE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC-EE
Confidence 467899999999999999999999999999999999764322 223446665 46789999999999998765 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 99999999999999999888899999999999999999999999999999999999999876543322
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+..|.+||... +..++.++|||||||++|||++|..||...+.. .....+. .....++..+++.+
T Consensus 195 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~-~~~~~~~~~~~~~~ 266 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNIL-NKPLQLKPNITNSA 266 (373)
T ss_dssp CCCSBSCCCCCCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----HHHHHHH-HSCCCCCSSSCHHH
T ss_pred ccccccCCccccCHHHhC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHH-hcccCCCCCCCHHH
Confidence 33355555543 456788999999999999999999999654322 2222222 23456677899999
Q ss_pred HHHHHHHhccCCCCCCCCH----HHHhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTA----SQLLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~----~~~l~hpw~~~~ 300 (300)
+++|.+||+. ||++||++ +++++||||+++
T Consensus 267 ~~li~~lL~~-dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 267 RHLLEGLLQK-DRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHTCS-SGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHccc-CHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999999 99999986 699999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=350.11 Aligned_cols=238 Identities=28% Similarity=0.443 Sum_probs=187.2
Q ss_pred CCCcceee-eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHH-hcCCCceeEeceeeeC---CCCcEE
Q 040812 55 GLSQLEKL-QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILR-QTNSPYIVKCHQIFTK---PSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~---~~~~~~ 129 (300)
.+++|.+. +.||+|+||.||+|.+..+++.||||+++.. ....+|+.++. ..+||||+++++++.. +.+.+|
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 35678887 7899999999999999999999999998632 23467888874 4589999999998764 234689
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC---CCCCC---cc------
Q 040812 130 ILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE---KMEHP---CG------ 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~---~~~~~---~~------ 195 (300)
+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++..+ +|
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999999999998753 5999999999999999999999999999999999999987 33322 22
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc---hHHHHHHHHhhCCCCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP---DFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 263 (300)
++..|.+||... +..++.++|||||||++|||+||+.||....... .....+.......+...+.
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp -----------CTTCCGGGSC---CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred CCCccccCCCCCCccCHhhcC---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence 133466666543 5567889999999999999999999997654322 1222222111112222335
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+++++.+||.+||.. ||++|||++++++||||.+
T Consensus 293 ~~s~~~~~li~~~L~~-dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 293 EVSEEVKMLIRNLLKT-EPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TSCHHHHHHHHTTSCS-SGGGSCCHHHHHHSHHHHT
T ss_pred cCCHHHHHHHHHHCCC-ChhHCcCHHHHhcCccccC
Confidence 6899999999999999 9999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=343.18 Aligned_cols=237 Identities=25% Similarity=0.405 Sum_probs=196.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
..+++|++++.||+|+||.||+|+++.+++.||+|+++... ......+|..++..+ +||||+++++++.... .
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-~ 95 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-R 95 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS-E
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC-E
Confidence 35688999999999999999999999999999999997532 112235688899887 7999999999998765 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------ 195 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------ 195 (300)
.|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999987889999999999999999999999999999999999999887654322
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++..|.+||... +..++.++|||||||++|||++|+.||...+.. .....+. .....+|..++++
T Consensus 176 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~s~~ 247 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIM-EHNVAYPKSMSKE 247 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHT---TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTSCHH
T ss_pred cccccccCCccccChhhhc---CCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----HHHHHHH-hCCCCCCCCCCHH
Confidence 233455666543 456788999999999999999999999754322 2222222 3345677889999
Q ss_pred HHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
+.++|.+||.. ||++||+ ++++++||||+++
T Consensus 248 ~~~li~~lL~~-dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 248 AVAICKGLMTK-HPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHHTCS-CTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhc-CHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999999 9999994 6999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=350.55 Aligned_cols=236 Identities=25% Similarity=0.367 Sum_probs=191.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++++.+.. ..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-HHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-EEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-EEEEEE
Confidence 5799999999999999999999999999999998764422 12357999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC---CCC---Ccc-----------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK---MEH---PCG----------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~---~~~---~~~----------- 195 (300)
|||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.. ++|
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 999999999999988899999999999999999999999999999999999999853 221 111
Q ss_pred -----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 196 -----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
++..|.+||... +..++.++|||||||++|+|++|..||...+.. .....+.......+......++++++
T Consensus 170 ~~~~~gt~~Y~APE~l~---~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLR---KDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp CCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred eecccCCcccCCHHHhc---CCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCCccccccCCHHHH
Confidence 234466666543 456788999999999999999999999654332 22222221111222233356899999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+||.+||.. ||++|||++|+++||||+
T Consensus 246 ~li~~~L~~-dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 246 DLINKMLTI-NPSKRITAAEALKHPWIS 272 (444)
T ss_dssp HHHHHHSCS-STTTSCCHHHHHHSCTTH
T ss_pred HHHHHHcCC-ChhHCCCHHHHhcCcccc
Confidence 999999999 999999999999999995
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=338.21 Aligned_cols=236 Identities=27% Similarity=0.447 Sum_probs=192.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCC------CCCCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDR------GTPPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
..++|++.+.||+|+||.||+|++. .+++.||+|+++... ....+.+|+.++++++||||+++++++....
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 4578999999999999999999985 678999999987542 1223467999999999999999999998754
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 95 -KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred -EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 8999999999999999999888899999999999999999999999999999999999998876543322
Q ss_pred ----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 197 ----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 197 ----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
+..|.+||... +..++.++|||||||++|+|++|+.||...... .....+. .....++..++
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~-~~~~~~p~~~~ 245 (327)
T 3a62_A 174 DGTVTHTFCGTIEYMAPEILM---RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK----KTIDKIL-KCKLNLPPYLT 245 (327)
T ss_dssp -----CTTSSCCTTSCHHHHT---TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH-HTCCCCCTTSC
T ss_pred CCccccccCCCcCccCHhhCc---CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----HHHHHHH-hCCCCCCCCCC
Confidence 23355555443 455788999999999999999999999754332 2222222 23455677889
Q ss_pred hHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
+++.++|.+||.. ||++|| +++++++||||+++
T Consensus 246 ~~~~~li~~~L~~-dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 246 QEARDLLKKLLKR-NAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHHSCS-CGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHHhc-CHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999 999999 89999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=347.09 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=196.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeec-----CCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-----DRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++++.||+|+||.||+|+++.+++.||+|+++. ......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-YL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EE
Confidence 456789999999999999999999999999999999864 223344578999999999999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
|+|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++..++.
T Consensus 145 ~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999999999999999764 69999999999999999999999999999999999999887654222
Q ss_pred -------ceeeccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 196 -------YSCLYESGEARHRKH-GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
++..|.+||...... .+.++.++|||||||++|||+||+.||...+.......++... ..........+++
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-NSLTFPDDNDISK 302 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HHCCCCTTCCCCH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-ccccCCCcccccH
Confidence 234466666654322 1236789999999999999999999997654332222222211 1122223346899
Q ss_pred HHHHHHHHHhccCCCCC--CCCHHHHhcCCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSK--RWTASQLLSHPFLADA 300 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~--Rpt~~~~l~hpw~~~~ 300 (300)
++++||.+||.. +|.+ |++++|+++||||+++
T Consensus 303 ~~~~li~~lL~~-~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 303 EAKNLICAFLTD-REVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHSSC-GGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHccC-hhhhCCCCCHHHHhcCccccCC
Confidence 999999999998 9998 9999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=341.50 Aligned_cols=236 Identities=24% Similarity=0.385 Sum_probs=190.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.++.++ +||||+++++++.+.. ..|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGK-YVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSS-EEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCC-EEEEEEeC
Confidence 467999999999999999999999999999999997543 3457899999888 7999999999998754 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC----C---Cccc-----------
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME----H---PCGY----------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~----~---~~~~----------- 196 (300)
|+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..... . ++|.
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 999999999998888999999999999999999999999999999999999854321 1 2221
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---CCCCCCCCChH
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---PPSLPECSSEK 268 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 268 (300)
+..|.+||... +..++.++|||||||++|||++|..||...... ....+...+.... ....+..++++
T Consensus 178 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~ 253 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLE---RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILARIGSGKFSLSGGYWNSVSDT 253 (342)
T ss_dssp CCSSCCSSCCCHHHHH---HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred eccCCCccccCHHHhc---CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHHHccCCcccCccccccCCHH
Confidence 22344444433 223567999999999999999999999754322 2223333333222 22234568999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++||.+||.. ||++|||++++++||||.+
T Consensus 254 ~~~li~~~L~~-dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 254 AKDLVSKMLHV-DPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHTCS-STTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHCCC-ChhHCcCHHHHhcCCeecC
Confidence 99999999999 9999999999999999954
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=350.48 Aligned_cols=241 Identities=27% Similarity=0.368 Sum_probs=194.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC----------CCCCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR----------GTPPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 357999999999999999999999999999999987532 11234689999999999999999999864
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Cc-----
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PC----- 194 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~----- 194 (300)
+..|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 368999999999999999988888999999999999999999999999999999999999975432 1 11
Q ss_pred ----------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 195 ----------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 195 ----------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
.++..|.+||.........++.++|||||||++|+|+||..||............+........+..+..
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 1244577777764333456778999999999999999999999765554444444332221222223356
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++.+.+||.+||.. ||++|||++++++||||++
T Consensus 372 ~~~~~~~li~~~L~~-dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 372 VSEKALDLVKKLLVV-DPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp SCHHHHHHHHHHSCS-STTTSCCHHHHHHSGGGCC
T ss_pred cCHHHHHHHHHHccC-ChhHCcCHHHHhCCcccCC
Confidence 789999999999999 9999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=344.47 Aligned_cols=233 Identities=25% Similarity=0.395 Sum_probs=193.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecC-----CCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-----RGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+.+++.++||||+++++++..+. ..|+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-DIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEE
Confidence 57899999999999999999999999999999998643 12223468999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 99999 679999998888899999999999999999999999999999999999999876543322
Q ss_pred ----eeeccccccccccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 197 ----SCLYESGEARHRKHGGY-NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+..|.+||... +.. .+.++|||||||++|+|+||+.||......... ..........|...++.+.+
T Consensus 166 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----~~i~~~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 166 TSCGSPNYAAPEVIN---GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----KKVNSCVYVMPDFLSPGAQS 237 (336)
T ss_dssp CCTTSTTTSCGGGSC---CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----CCCCSSCCCCCTTSCHHHHH
T ss_pred cccCCcCcCCHHHHc---CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----HHHHcCCCCCcccCCHHHHH
Confidence 33455666543 333 367999999999999999999999754332111 01112344567788999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+|.+||.. ||++|||++|+++||||+.
T Consensus 238 li~~~L~~-dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 238 LIRRMIVA-DPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp HHHTTSCS-SGGGSCCHHHHTTCHHHHT
T ss_pred HHHHHcCC-ChhHCcCHHHHHhChhhcc
Confidence 99999999 9999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=344.26 Aligned_cols=234 Identities=27% Similarity=0.376 Sum_probs=192.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++.+.||+|+||.||+|.++.+++.||+|++....... .+.+|+.++++++||||+++++++.+.. ..|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEEEE
Confidence 57999999999999999999999999999999997654321 2357999999999999999999998764 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Ccc-----------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PCG----------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~~----------- 195 (300)
||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. . ++|
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99999999999988888999999999999999999999999999999999999986532 1 122
Q ss_pred ----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC---CCCCCCCCCChH
Q 040812 196 ----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR---EPPSLPECSSEK 268 (300)
Q Consensus 196 ----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 268 (300)
++..|.+||... +..++.++|||||||++|+|+||..||...+.. .....+... .+...+..++++
T Consensus 188 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp CCSCSCTTTCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred ccCCCCccccCHHHHc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCcccccCCCHH
Confidence 233455666543 456788999999999999999999999754322 222222212 122223467899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++||.+||.. ||++|||+.++++||||.+
T Consensus 261 ~~~li~~~L~~-dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTV-NPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCS-SGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCC-ChhhCcCHHHHhcCcccCC
Confidence 99999999999 9999999999999999963
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=335.49 Aligned_cols=239 Identities=25% Similarity=0.401 Sum_probs=188.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----------------------------CCCCHHHHHHH
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----------------------------TPPNPQELNIL 106 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~~~E~~~l 106 (300)
.+++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45789999999999999999999999999999999875432 12246799999
Q ss_pred HhcCCCceeEeceeeeCC-CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCcee
Q 040812 107 RQTNSPYIVKCHQIFTKP-SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVL 185 (300)
Q Consensus 107 ~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nil 185 (300)
++++||||+++++++... .+..|+||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 999999999999998763 347999999999999987654 347999999999999999999999999999999999999
Q ss_pred ecCCCCCCcc-------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchH
Q 040812 186 INEKMEHPCG-------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF 246 (300)
Q Consensus 186 l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 246 (300)
++.++...+. ++..|.+||.........++.++|||||||++|+|++|+.||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---- 245 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---- 245 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH----
Confidence 9877553222 23346666665432222347789999999999999999999965322
Q ss_pred HHHHHHHhhC-CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 247 LSLMLAICFR-EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
......+... ........+++.+.++|.+||.. ||++|||+.|+++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK-NPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCS-CTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhc-ChhhCCCHHHHhcCccccC
Confidence 2222222212 12222346889999999999999 9999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=329.85 Aligned_cols=238 Identities=24% Similarity=0.391 Sum_probs=189.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++|++++.||+|+||.||+|++ .+++.||+|.+...... ..+.+|+.++++++||||+++++++.... ..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-eEEEE
Confidence 36899999999999999999999 56889999998654322 22357999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 132 MEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999986 999988764 5799999999999999999999999999999999999999876543322
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC------------
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP------------ 259 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 259 (300)
+..|.+||.... ...++.++|||||||++|||+||+.||...........+..........
T Consensus 158 ~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ----CCCTTCCHHHHTT--CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccCchheeC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 233556665431 2346889999999999999999999997654332222222211110000
Q ss_pred ------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 260 ------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 260 ------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.....+++.+.+||.+||.. ||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKL-DPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS-STTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCC-CcccCCCHHHHhcCcchhh
Confidence 11234688999999999999 9999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=337.85 Aligned_cols=241 Identities=21% Similarity=0.377 Sum_probs=190.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+++|++.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+|+.++++++||||+++++++.... ..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-RLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-EEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-EEEE
Confidence 467899999999999999999999999999999998754332 34578999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-----C---Ccc-------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-----H---PCG------- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-----~---~~~------- 195 (300)
||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|
T Consensus 111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9999985 99999998888999999999999999999999999999999999999964332 1 111
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC-----
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL----- 261 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 261 (300)
++..|.+||.... ...++.++|||||||++|||+||+.||...........+............
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLG--SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ----------CCTTCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccccCCCcCCccccCHHHhcC--CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 1333666665432 234788999999999999999999999765443333333222111111110
Q ss_pred --------------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 262 --------------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 262 --------------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+...++++.+||.+||.. ||++|||++|+++||||++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEM-DPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCS-SGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccC-ChhhCCCHHHHhCCcccCCC
Confidence 112578899999999999 99999999999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=342.91 Aligned_cols=235 Identities=25% Similarity=0.351 Sum_probs=190.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.+++.++||||+++++++.+.. ..|+||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-ELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-EEEEEEEe
Confidence 46899999999999999999999999999999998643221 12357999999999999999999998765 89999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC--CCCCC---ccc------------
Q 040812 135 MDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE--KMEHP---CGY------------ 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~--~~~~~---~~~------------ 196 (300)
|++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++... +|.
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 99999999997653 6999999999999999999999999999999999999986 33322 221
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC---CCCCCCChHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP---SLPECSSEKFR 270 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 270 (300)
+..|.+||... +..++.++|||||||++|+|+||..||...... .....+...... ..+..+++++.
T Consensus 163 ~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 163 LFTAPEYYAPEVHQ---HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp EESCGGGSCHHHHT---TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred ccCChhhcCcHHhc---CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHcCCCCCChhhhccCCHHHH
Confidence 22355555443 455788999999999999999999999764332 222222222211 12246789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++|.+||.. ||++|||++|+++||||++
T Consensus 236 ~li~~~L~~-dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 236 DFVDRLLVK-ERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHTTSCS-SGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHcCC-ChhHCcCHHHHhcChhhcc
Confidence 999999999 9999999999999999965
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=352.25 Aligned_cols=236 Identities=26% Similarity=0.443 Sum_probs=192.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecC-----CCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-----RGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+|+.++++++||||+++++++.... ..|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-EEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-EEE
Confidence 457899999999999999999999999999999998753 12234567999999999999999999998765 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccc------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++...+.+
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 999999999999999888889999999999999999999998 9999999999999999876543322
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...+.. .....+. .....+|..+++++
T Consensus 305 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~~~~~ 376 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL-MEEIRFPRTLGPEA 376 (446)
T ss_dssp --CCSSSCGGGCCHHHHH---TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTSCHHH
T ss_pred ccccccCCccccCHhhcC---CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHH-hCCCCCCccCCHHH
Confidence 33455665543 556788999999999999999999999654332 2222222 34456777899999
Q ss_pred HHHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
.+||.+||.. ||++|| +++|+++||||+++
T Consensus 377 ~~li~~~L~~-dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 377 KSLLSGLLKK-DPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHTCS-STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHccc-CHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999 999999 99999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=345.08 Aligned_cols=233 Identities=27% Similarity=0.394 Sum_probs=188.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-------CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-------GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+.+|+.++++++||||+++++++.... ..|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG-MLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEE
Confidence 57999999999999999999999999999999986421 1123467999999999999999999998764 899
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Ccc----
Q 040812 130 ILMEYMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PCG---- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~~---- 195 (300)
+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998887642 35899999999999999999999999999999999999986543 1 111
Q ss_pred ------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC---C
Q 040812 196 ------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP---S 260 (300)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~ 260 (300)
++..|.+||... +..++.++|||||||++|+|+||..||.... . .....+...... .
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~---~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVK---REPYGKPVDVWGCGVILFILLSGCLPFYGTK--E---RLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--H---HHHHHHHHTCCCCCHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHc---CCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--H---HHHHHHHcCCCCCCcc
Confidence 233456666543 4557889999999999999999999996532 1 222222222211 1
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+..+++.+++||.+||.. ||++|||+.++++||||++
T Consensus 255 ~~~~~s~~~~~li~~~L~~-dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLML-DPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCS-STTTSCCHHHHHTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCC-ChhHCcCHHHHhcChhhcC
Confidence 2246789999999999999 9999999999999999964
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=335.69 Aligned_cols=240 Identities=28% Similarity=0.380 Sum_probs=194.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----------CCCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----------TPPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++++++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 579999999999999999999999999999999865321 12346799999999999999999998753
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Ccc-----
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PCG----- 195 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~~----- 195 (300)
..|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 48999999999999999988888999999999999999999999999999999999999987543 2 222
Q ss_pred ----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 196 ----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
++..|.+||......+..++.++|||||||++|+|+||..||............+........+..+..+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 2334666666533334567789999999999999999999997665544444333322111122233567
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.+.++|.+||.. ||++|||++++++||||++
T Consensus 248 ~~~~~~li~~~l~~-dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 248 SEKALDLVKKLLVV-DPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CHHHHHHHHHHSCS-STTTSCCHHHHHTSGGGCC
T ss_pred CHHHHHHHHHHccc-CHhhCCCHHHHhhCcCcCC
Confidence 89999999999999 9999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=334.46 Aligned_cols=239 Identities=28% Similarity=0.442 Sum_probs=175.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++++.||+|+||.||+|.++.+++.||+|+++...... .+.+|+.++++++||||+++++++..+. ..|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-KLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-EEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-eEEEEE
Confidence 468999999999999999999999999999999997654332 2367999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 133 EYMDAGSLEIYVKSR------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..++++
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 99985 999998753 3589999999999999999999999999999999999998876543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC----------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---------- 257 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------- 257 (300)
+..|.+||.... ...++.++|||||||++|||+||+.||...........+........
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMG--SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred cccCCCCcccccccCchHhhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 223555554431 23568899999999999999999999976543322222222111000
Q ss_pred -------------------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 258 -------------------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 258 -------------------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+..+...++++.+||.+||+. ||++|||++|+++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~-dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQL-NPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCS-SGGGSCCHHHHTTSGGGGG
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCC-CcccCCCHHHHhCChhhhc
Confidence 0011235678999999999999 9999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=335.14 Aligned_cols=234 Identities=28% Similarity=0.416 Sum_probs=192.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--------CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--------PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-DV 90 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-EE
Confidence 56999999999999999999999999999999997654322 1357999999999999999999998754 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC----CC---cc------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME----HP---CG------ 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~----~~---~~------ 195 (300)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++. .. +|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999999999999998888999999999999999999999999999999999999987752 21 22
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---CCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---PPSLPE 263 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~ 263 (300)
++..|.+||... +..++.++|||||||++|+|+||..||...... .....+.... +...+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHTTCCCCCHHHHT
T ss_pred ccccccccCCCCCccCccccc---CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcccccChhhhc
Confidence 223355555543 456788999999999999999999999654322 2222222111 112235
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..++.+.++|.+||.. ||++|||++++++||||++
T Consensus 244 ~~~~~~~~li~~~l~~-dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVK-ETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCS-STTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCC-ChhhCcCHHHHhcCccccC
Confidence 6789999999999999 9999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=330.94 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=185.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcC---CCceeEeceeeeCCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTN---SPYIVKCHQIFTKPS 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 125 (300)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ....+|+.++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 46899999999999999999999999999999998753321 12346887777664 999999999987644
Q ss_pred C----cEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---
Q 040812 126 G----EVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--- 196 (300)
Q Consensus 126 ~----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--- 196 (300)
. ..++||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 2 48999999975 99999987654 99999999999999999999999999999999999998776543322
Q ss_pred ---------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 197 ---------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 197 ---------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...........+............
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHH---TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCCcccCCccccccccCchHHc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 33455665543 455788999999999999999999999765443333333322211111111
Q ss_pred ----------------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 ----------------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 ----------------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....++.+.+||.+||.. ||++|||+.|+++||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF-NPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS-STTTSCCHHHHHTSTTC--
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC-CCccCCCHHHHhcCccccC
Confidence 124678999999999999 9999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=335.22 Aligned_cols=239 Identities=25% Similarity=0.371 Sum_probs=188.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+++|++++.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++++++||||+++++++.... ..|+||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-SLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-CEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-EEEEEe
Confidence 36899999999999999999999999999999998654322 24457999999999999999999998764 899999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 133 EYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 99985 8988887644 589999999999999999999999999999999999999876543322
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC-----------
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL----------- 261 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------- 261 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...........+............
T Consensus 159 ~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLG--STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ----CGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccCcccccChhhhcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 233555555431 245688999999999999999999999765433222222221111111111
Q ss_pred --------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 --------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 --------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+++++.+||.+||+. ||++|||++|+++||||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQF-EGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCS-SGGGSCCHHHHTTSGGGGG
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCc-CcccCCCHHHHhcChhhhh
Confidence 124578899999999999 9999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=345.12 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=195.0
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecC-----CCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD-----RGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+|..++.+++||||+++++++.+.. ..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN-YL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS-EE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-EE
Confidence 4568899999999999999999999999999999999642 22344578999999999999999999998765 89
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-------------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------- 194 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------- 194 (300)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999999874 47999999999999999999999999999999999999998755322
Q ss_pred -------cceeeccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 195 -------GYSCLYESGEARHRKH----GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 195 -------~~~~~~~~~~~~~~~~----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
.++..|.+||...... +..++.++|||||||++|||+||+.||...+....+..+.........+..+.
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 2344466777654211 24578899999999999999999999976543322222222111122333446
Q ss_pred CCChHHHHHHHHHhccCCCCCC---CCHHHHhcCCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKR---WTASQLLSHPFLADA 300 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~R---pt~~~~l~hpw~~~~ 300 (300)
.+++++++||.+||. +|++| ++++|+++||||+++
T Consensus 297 ~~s~~~~dli~~lL~--~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC--PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CCCHHHHHHHHTTSS--CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHcC--ChhhcCCCCCHHHHhcCCCcCCC
Confidence 789999999999995 78887 599999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=333.86 Aligned_cols=228 Identities=25% Similarity=0.373 Sum_probs=192.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----------CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----------PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+|+.++++++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 36799999999999999999999999999999999865422 23467999999999999999999998754
Q ss_pred CcEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------
Q 040812 126 GEVSILMEYMDAG-SLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--------- 195 (300)
..++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 103 -~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 103 -FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp -EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred -EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 899999999776 999999988889999999999999999999999999999999999999987654322
Q ss_pred ---------ceeeccccccccccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGY-NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
++..|.+||... +.. .+.++|||||||++|+|++|..||..... ........+..+
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~ 247 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLM---GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------TVEAAIHPPYLV 247 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHT---TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GTTTCCCCSSCC
T ss_pred CCCceeccCCCccccChhhhc---CCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------HHhhccCCCccc
Confidence 233455666543 333 37899999999999999999999964211 112233446668
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++++.+||.+||.. ||++|||++++++||||++
T Consensus 248 ~~~l~~li~~~L~~-dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 248 SKELMSLVSGLLQP-VPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CHHHHHHHHHHTCS-SGGGSCCHHHHHHCTTTTC
T ss_pred CHHHHHHHHHHccC-ChhhCcCHHHHhcCccccC
Confidence 99999999999999 9999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=323.47 Aligned_cols=234 Identities=28% Similarity=0.439 Sum_probs=187.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
++|++.+.||+|+||.||+|.+..+++.+|+|++....... .+.+|+.++++++||||+++++++.... ..|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-NMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-eEEEEEE
Confidence 57999999999999999999999999999999997654332 2367999999999999999999998754 8999999
Q ss_pred ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC---CCC---Ccc--------
Q 040812 134 YMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK---MEH---PCG-------- 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~---~~~---~~~-------- 195 (300)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ +.. ++|
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9999999998854 3579999999999999999999999999999999999999543 222 111
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC--CCCCCCCC
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP--PSLPECSS 266 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 266 (300)
++..|.+||... +.++.++|||||||++|+|++|+.||...... ........... .......+
T Consensus 181 ~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK----RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp ------CTTGGGCCHHHHT----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCC--CCCC
T ss_pred ccCcCcccccCcCChHHhc----cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH----HHHhhhccCCcccccccCcCC
Confidence 233356666542 34678999999999999999999999654321 22222221211 11223468
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+.+.++|.+||.. ||++|||++|+++||||++|
T Consensus 253 ~~~~~li~~~L~~-dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 253 PQAVDLLKQMLTK-DPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp HHHHHHHHHHTCS-CTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHHHccC-ChhhCcCHHHHhcCHHhhcC
Confidence 9999999999999 99999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=325.39 Aligned_cols=238 Identities=26% Similarity=0.373 Sum_probs=193.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-EEEEE
Confidence 467999999999999999999999999999999997654321 2357999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Ccc----------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PCG---------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~~---------- 195 (300)
|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++. . ++|
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988888999999999999999999999999999999999999986543 2 111
Q ss_pred -----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 196 -----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
++..|.+||... +..++.++|||||||++|+|++|+.||...... .....+.......+......+++++.
T Consensus 164 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp CCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred ccCCCCCcCCcCchhhc---CCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhccccCCchhhcccCHHHH
Confidence 233355555543 456788999999999999999999999654332 22222222122223333456889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++|.+||.. ||++|||++|+++||||++
T Consensus 240 ~li~~~l~~-dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 240 SLIDSMLTV-NPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHHHHSCS-STTTSCCHHHHTTSHHHHS
T ss_pred HHHHHHccc-ChhhCCCHHHHhcCccccC
Confidence 999999999 9999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=337.90 Aligned_cols=235 Identities=26% Similarity=0.414 Sum_probs=181.4
Q ss_pred cceee---eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEEEEe
Q 040812 58 QLEKL---QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 58 ~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+|++. +.||+|+||.||+|.++.+++.||+|++.... .....+|+.+++.+. ||||+++++++.+.. ..|+|||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-~~~lv~e 86 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-EANTQKEITALKLCEGHPNIVKLHEVFHDQL-HTFLVME 86 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-EEEEEEE
Confidence 45554 78999999999999999999999999986532 223467999999997 999999999998764 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC---CC---Cccc-----------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM---EH---PCGY----------- 196 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~---~~---~~~~----------- 196 (300)
|+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .. ++|.
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 999999999999888899999999999999999999999999999999999997653 11 2221
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC---chHHHHHHHHhhCCCCCCC----CC
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE---PDFLSLMLAICFREPPSLP----EC 264 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~----~~ 264 (300)
+..|.+||... +..++.++|||||||++|+|+||..||...... .........+.... ...+ ..
T Consensus 167 ~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~ 242 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLN---QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-FSFEGEAWKN 242 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-CCCCSHHHHT
T ss_pred cccCCCcCccCHHHhc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-CCCCcccccC
Confidence 33456666543 556788999999999999999999999754321 12223333333222 2222 35
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++++++||.+||.. ||++|||++++++||||++
T Consensus 243 ~s~~~~~li~~~L~~-dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTV-DPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp SCHHHHHHHHHHHCC-CTTTCCCTTTSTTCGGGCT
T ss_pred CCHHHHHHHHHHCCC-ChhHCCCHHHHhcChhhcc
Confidence 789999999999999 9999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=341.01 Aligned_cols=238 Identities=27% Similarity=0.407 Sum_probs=192.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++++.... ..|+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-EMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-EEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-EEEEEEE
Confidence 46799999999999999999999999999999998754321 23467999999999999999999998754 8999999
Q ss_pred ccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC--CC---Ccc------------
Q 040812 134 YMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM--EH---PCG------------ 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~--~~---~~~------------ 195 (300)
|+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+. .. ++|
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 999999999997653 699999999999999999999999999999999999997532 22 222
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++..|.+||... +..++.++|||||||++|||+||..||...... .....+..............+++++.+|
T Consensus 209 ~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 209 VTTATAEFAAPEIVD---REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp EECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred eeccCCCccCchhcc---CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 233355665543 456788999999999999999999999754322 1111221111122333445689999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||++++++||||++
T Consensus 285 i~~~L~~-dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 285 IKNLLQK-EPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHTTSCS-SGGGSCCHHHHHTSTTTSS
T ss_pred HHHHcCC-ChhHCcCHHHHhhCccccC
Confidence 9999999 9999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.47 Aligned_cols=241 Identities=23% Similarity=0.363 Sum_probs=200.0
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+|+.+|++++||||+++++++.+.. ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-AL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-EE
Confidence 35678999999999999999999999999999999986532 1122467999999999999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-----------
Q 040812 129 SILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG----------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~----------- 195 (300)
|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++...++
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999998754 39999999999999999999999999999999999999987654322
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
++..|.+||... +..++.++|||||||++|||+||..||...........+.. .....+..++..++++
T Consensus 340 ~~~~~~~GT~~Y~APEvl~---~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~-~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVK---NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVPEEYSERFSPQ 415 (576)
T ss_dssp CCEECCCSCGGGCCHHHHT---TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-HHHHCCCCCCTTSCHH
T ss_pred ccccccCCCccccCHHHHc---CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-HhhcccccCCccCCHH
Confidence 233355665543 45578899999999999999999999976544333323332 2334556677889999
Q ss_pred HHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
+++||.+||.. ||++|| +++|+++||||+++
T Consensus 416 ~~dLI~~lL~~-dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 416 ARSLCSQLLCK-DPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHHTCS-SGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHHHhccC-CHHHcCCCCCCCHHHHHhChhhccC
Confidence 99999999999 999999 79999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=350.56 Aligned_cols=235 Identities=30% Similarity=0.443 Sum_probs=195.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ......+|+.+++.++||||+++++++.... ..|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~ 92 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-DIF 92 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEE
Confidence 3578999999999999999999999999999999996532 1123467999999999999999999998765 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 9999999999999998888899999999999999999999999999999999999999876543322
Q ss_pred -----eeeccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 -----SCLYESGEARHRKHGG-YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||... +. +.+.++|||||||++|+|+||..||...... .....+. ......|..+++++.
T Consensus 173 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~-~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 173 RTSCGSPNYAAPEVIS---GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKIC-DGIFYTPQYLNPSVI 244 (476)
T ss_dssp CCCCSCSTTCCHHHHT---TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHHH-TTCCCCCTTCCHHHH
T ss_pred cccCCCcCeEChhhcc---CCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHHh-cCCcCCCccCCHHHH
Confidence 23345555433 33 3467999999999999999999999754332 2222222 334456777899999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.+||.. ||++|||++++++||||++
T Consensus 245 ~Li~~~L~~-dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 245 SLLKHMLQV-DPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHTCS-STTTSCCHHHHHTCHHHHT
T ss_pred HHHHHHcCC-CchhCcCHHHHHhCHHhhh
Confidence 999999999 9999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=328.57 Aligned_cols=240 Identities=24% Similarity=0.355 Sum_probs=189.8
Q ss_pred Ccceee-eeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHh-cCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKL-QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQ-TNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++. +.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++.+ .+||||+++++++.... ..|+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-RFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-EEEEEE
Confidence 568885 7899999999999999999999999999754322 223679999988 47999999999998765 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---CC---cc-----------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---HP---CG----------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~~---~~----------- 195 (300)
||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. .. +|
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999999999988888999999999999999999999999999999999999987653 11 11
Q ss_pred ------------ceeeccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc----------h-HHHHH
Q 040812 196 ------------YSCLYESGEARHRKH--GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP----------D-FLSLM 250 (300)
Q Consensus 196 ------------~~~~~~~~~~~~~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~----------~-~~~~~ 250 (300)
++..|.+||...... +..++.++|||||||++|||+||+.||....... . .....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 233456666543210 1335679999999999999999999997643321 0 11112
Q ss_pred HHHhhCCCCCCC----CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 251 LAICFREPPSLP----ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 251 ~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+. .....++ ..+++.+++||.+||.. ||++|||++|+++||||++
T Consensus 251 ~~i~-~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 251 ESIQ-EGKYEFPDKDWAHISCAAKDLISKLLVR-DAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHH-HCCCCCCHHHHTTSCHHHHHHHHHHSCS-STTTSCCHHHHHHSTTCC-
T ss_pred HHHh-ccCcccCchhcccCCHHHHHHHHHHhhC-ChhhCCCHHHHhcChhhcC
Confidence 2222 2223333 35789999999999999 9999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=332.15 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=191.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++|++++.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-RLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-eEEEE
Confidence 368999999999999999999999999999999986544321 2357999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++...+++
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 99999999999998888899999999999999999999999999999999999999876543222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh----------------C
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF----------------R 256 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------~ 256 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...........+...... .
T Consensus 161 ~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 161 DEVATRWYRSPELLVG--DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -----GGGCCHHHHHT--CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred CCcCCccccChHHHhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 223555555431 245688999999999999999999999765433222222111100 0
Q ss_pred CCCCC----------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 257 EPPSL----------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 257 ~~~~~----------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
..... ...+++.+.+||.+||.. ||++|||++|+++||||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHM-DPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCS-STTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccC-ChhhcCCHHHHhcChHHHhc
Confidence 00000 134678899999999999 99999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=329.28 Aligned_cols=235 Identities=27% Similarity=0.402 Sum_probs=196.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC-EEE
Confidence 4678999999999999999999999999999999986432 1223467999999999999999999998764 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++...+.++
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 165 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccccc
Confidence 99999999999999988888999999999999999999999999999999999999988766543332
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
..|.+||... +..++.++||||||+++|+|++|..||...... ..... ........+...++.+.++
T Consensus 166 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKR-ISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp --CCCCTTCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHH-HHHTCCCCCTTSCHHHHHH
T ss_pred ccCCCCCccCHhHhc---cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----HHHHH-HHhCCCCCCCcCCHHHHHH
Confidence 2344555433 556778999999999999999999999653321 22222 2234456677889999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||++|+++||||++
T Consensus 238 i~~~l~~-~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 238 ISRLLKH-NPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHHHCCS-SGGGSCCHHHHHHCHHHHH
T ss_pred HHHHhcc-ChhhCCCHHHHhhCccccC
Confidence 9999999 9999999999999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=325.81 Aligned_cols=237 Identities=28% Similarity=0.419 Sum_probs=192.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+|+.++++++||||+++++++.... ..|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-HYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-EEEEEEEc
Confidence 5799999999999999999999999999999999754322 23468999999999999999999998754 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee---cCCCCCCcc----------------
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI---NEKMEHPCG---------------- 195 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill---~~~~~~~~~---------------- 195 (300)
+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||++ +.++...++
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHH
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccc
Confidence 9999999999888889999999999999999999999999999999999999 444332221
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
++..|.+||... +..++.++|||||||++|+|+||..||...... .....+...........+..+++.+.++|.
T Consensus 168 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 168 CGTPGYVAPEVLA---QKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEFESPFWDDISESAKDFIC 243 (304)
T ss_dssp HSCCCBCCTTTBS---SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred cCCCCccChHHhc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence 233466666553 556788999999999999999999999654322 122222211112233445678899999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. ||++|||++++++||||++
T Consensus 244 ~~l~~-dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 244 HLLEK-DPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHCS-STTTSCCHHHHHTSHHHHS
T ss_pred HHcCC-ChhHCcCHHHHhcCccccC
Confidence 99999 9999999999999999964
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=360.39 Aligned_cols=236 Identities=25% Similarity=0.417 Sum_probs=198.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 128 (300)
.+++|++++.||+|+||.||+|+++.+++.||||+++... .......|..++..+ +||+|+++++++.+.. .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~-~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS-EE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC-EE
Confidence 5678999999999999999999999999999999997532 222335688888887 7999999999998754 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++.+
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 99999999999999999888899999999999999999999999999999999999999876543322
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...+.. .....+ ......+|..+++++
T Consensus 498 ~~~~~~GT~~Y~APE~l~---~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~i-~~~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSI-MEHNVAYPKSMSKEA 569 (674)
T ss_dssp CBCCCCSCSSSCCHHHHT---CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH-HSSCCCCCTTSCHHH
T ss_pred ccccccCCCcccCHhhhc---CCCCCccceEechHHHHHHHHcCCCCCCCCCHH----HHHHHH-HhCCCCCCccCCHHH
Confidence 33455666543 556788999999999999999999999764332 222222 245567788899999
Q ss_pred HHHHHHHhccCCCCCCCCH-----HHHhcCCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTA-----SQLLSHPFLADA 300 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~-----~~~l~hpw~~~~ 300 (300)
.+||.+||+. ||++||++ +|+++||||+++
T Consensus 570 ~~li~~lL~~-dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 570 VAICKGLMTK-HPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHSCS-SSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHHHccC-CHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999 99999997 999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=332.99 Aligned_cols=235 Identities=21% Similarity=0.344 Sum_probs=185.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC-------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS------- 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 125 (300)
+++|++.+.||+|+||.||+|+++.+++.||||+++..... ..+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35799999999999999999999999999999999754422 22467999999999999999999875432
Q ss_pred -------------------------------------------------CcEEEEEeccCCCCHHHHHHhCCC---CCHH
Q 040812 126 -------------------------------------------------GEVSILMEYMDAGSLEIYVKSRGR---LSED 153 (300)
Q Consensus 126 -------------------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~---l~~~ 153 (300)
...++|||||++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 138999999999999999987543 5666
Q ss_pred HHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------------------------ceeeccc
Q 040812 154 IICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------------------------YSCLYES 202 (300)
Q Consensus 154 ~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------------------------~~~~~~~ 202 (300)
.++.++.||+.||.|||++||+||||||+|||++.++...++ ++..|.+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999977554322 2334555
Q ss_pred cccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCC
Q 040812 203 GEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDP 282 (300)
Q Consensus 203 ~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp 282 (300)
||... +..++.++|||||||++|||+||..|+. ..............+..+...++.+.++|.+||.. ||
T Consensus 245 PE~~~---~~~~~~~~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-~p 314 (332)
T 3qd2_B 245 PEQIH---GNNYSHKVDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSP-SP 314 (332)
T ss_dssp HHHHH---CCCCCTHHHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCS-SG
T ss_pred hHHhc---CCCCcchhhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccCCCcccccCChhHHHHHHHHccC-CC
Confidence 65543 4567889999999999999999877652 12222222222323333344577889999999999 99
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 040812 283 SKRWTASQLLSHPFLADA 300 (300)
Q Consensus 283 ~~Rpt~~~~l~hpw~~~~ 300 (300)
++|||++|+++||||+++
T Consensus 315 ~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 315 TERPEATDIIENAIFENL 332 (332)
T ss_dssp GGSCCHHHHHHSTTCCCC
T ss_pred CcCCCHHHHhhchhhhcC
Confidence 999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=322.77 Aligned_cols=234 Identities=23% Similarity=0.316 Sum_probs=188.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~l 130 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+|+..+.++ +||||+++++++.... ..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-HMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-EEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-eEEE
Confidence 367999999999999999999999999999999987643322 235688888888 9999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC----------------
Q 040812 131 LMEYMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM---------------- 190 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~---------------- 190 (300)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999764 5699999999999999999999999999999999999998543
Q ss_pred ---CC---Ccc------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 040812 191 ---EH---PCG------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA 252 (300)
Q Consensus 191 ---~~---~~~------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 252 (300)
.. ++| ++..|.+||.... ...++.++|||||||++|+|++|.+|+... . ....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~---~~~~ 239 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQE--NYTHLPKADIFALALTVVCAAGAEPLPRNG----D---QWHE 239 (289)
T ss_dssp -CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTT--CCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H---HHHH
T ss_pred CceEEEEcccccccccCCccccCCCccccChhHhcC--CCCCCchhhHHHHHHHHHHHhcCCCCCcch----h---HHHH
Confidence 11 111 2334566665432 224567999999999999999998877432 1 1222
Q ss_pred HhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 253 ICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+.....+..+..+++.+.++|.+||.. ||++|||+.++++||||.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~-dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQGRLPRIPQVLSQEFTELLKVMIHP-DPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHTTCCCCCSSCCCHHHHHHHHHHTCS-SGGGSCCHHHHHTCTTC---
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHhCC-CcccCCCHHHHhhChHhhhh
Confidence 334555677888999999999999999 99999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=345.50 Aligned_cols=241 Identities=26% Similarity=0.308 Sum_probs=176.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC----Cc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----GE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 127 (300)
.++|++++.||+|+||.||+|+++.+++.||||++...... ..+.+|+.+|++++||||+++++++.... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999999999999999998653322 12357999999999999999999985332 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++..++.+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999999995 59999999888899999999999999999999999999999999999999876543222
Q ss_pred -----------------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh---------
Q 040812 197 -----------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM--------- 232 (300)
Q Consensus 197 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt--------- 232 (300)
+..|.+||... .+..++.++||||||||+|||+|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL--LQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHT--TCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhh--CCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 22356666432 24457889999999999999999
Q ss_pred --CCCCCCCCCCC-------------------chHHHHHHHHhhC--------------------CC-------CCCCCC
Q 040812 233 --GYYPFLEPGQE-------------------PDFLSLMLAICFR--------------------EP-------PSLPEC 264 (300)
Q Consensus 233 --g~~pf~~~~~~-------------------~~~~~~~~~~~~~--------------------~~-------~~~~~~ 264 (300)
|+++|.+.... .+....+...... .+ ......
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 66666443210 0111111111100 00 001234
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.++++.+||.+||.. ||++|||++|+|+||||+++
T Consensus 369 ~s~~~~dLl~~mL~~-dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 369 SSADAIHLLKRMLVF-NPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp SCHHHHHHHHHHSCS-STTTSCCHHHHHHSGGGTTT
T ss_pred CCHHHHHHHHHHhcc-CccccCCHHHHhcCHhhhhc
Confidence 588999999999999 99999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=323.35 Aligned_cols=235 Identities=24% Similarity=0.416 Sum_probs=183.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++++++||||+++++++.... ..|
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-YVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-EEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-eEE
Confidence 35789999999999999999999999999999999864321 123467999999999999999999998754 899
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++...+++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999999875 5799999999999999999999999999999999999998876543222
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHH
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||......... ... .......+..++.++
T Consensus 168 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~ 239 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIAT---RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKV-VLADYEMPSFLSIEA 239 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------C-CSSCCCCCTTSCHHH
T ss_pred cceeccCCCCcCCcchhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHH-hhcccCCccccCHHH
Confidence 22345555443 455678999999999999999999999765433211 111 122334567789999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.++|.+||.. ||++|||++++++||||.+
T Consensus 240 ~~li~~~l~~-dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 240 KDLIHQLLRR-NPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp HHHHHHHSCS-SGGGSCCHHHHTTSTTTC-
T ss_pred HHHHHHHccc-CHhhCCCHHHHhcCccccC
Confidence 9999999999 9999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=348.56 Aligned_cols=241 Identities=28% Similarity=0.394 Sum_probs=199.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...++|++.+.||+|+||.||+|+++.+++.||+|++..... ...+.+|+.++++++||||+++++++.... .+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-DL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-EE
Confidence 356789999999999999999999999999999999965321 123467999999999999999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------
Q 040812 129 SILMEYMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--------- 195 (300)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999763 369999999999999999999999999999999999999987654222
Q ss_pred ----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 196 ----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...........+...+. .....+|..+
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~-~~~~~~p~~~ 416 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLL---GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL-EQAVTYPDKF 416 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH-HCCCCCCTTS
T ss_pred CCCcccccccCCccccChhhhc---CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh-hcccCCCccc
Confidence 233455555543 45678899999999999999999999977544333333333333 3455677889
Q ss_pred ChHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
++.++++|.+||.. ||++||+ ++++++||||+++
T Consensus 417 s~~~~~li~~lL~~-dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 417 SPASKDFCEALLQK-DPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp CHHHHHHHHHHSCS-SGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred CHHHHHHHHHhccC-CHhHCCCCcccCHHHHHcCccccCC
Confidence 99999999999999 9999996 5899999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=332.78 Aligned_cols=235 Identities=26% Similarity=0.358 Sum_probs=195.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..++|++.+.||+|+||.||++.+..+++.||+|++....... .+.+|+.++++++|+||+++++++.... ..|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-FVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-eEE
Confidence 4578999999999999999999999999999999987653322 2356999999999999999999998754 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999999999998878899999999999999999999999999999999999999876543222
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...... .....+. .....++..+++.+.
T Consensus 198 ~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~ 269 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIK-KNEYSIPKHINPVAA 269 (335)
T ss_dssp BCCCCSCCSSCCHHHHH---TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-HTCCCCCTTSCHHHH
T ss_pred ccccCCCccccCHHHhc---cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHh-cCCCCCCccCCHHHH
Confidence 22244555433 445678999999999999999999999654322 2222222 234456778899999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++|.+||.. ||++|||++++++||||.+
T Consensus 270 ~li~~~l~~-dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 270 SLIQKMLQT-DPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHHHHHTCS-SGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHHccC-ChhHCcCHHHHhcCccccC
Confidence 999999999 9999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=331.61 Aligned_cols=242 Identities=29% Similarity=0.448 Sum_probs=197.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCC------CCCCCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDR------GTPPNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
..+++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+|+.+++++ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 35689999999999999999999984 578999999986432 223456799999999 69999999999887
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------- 196 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------- 196 (300)
.. ..|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 131 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 131 ET-KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp TT-EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred Cc-eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 65 8999999999999999999888899999999999999999999999999999999999999876543322
Q ss_pred -------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 197 -------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 197 -------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
+..|.+||..... ...++.++|||||||++|||+||+.||...........+..... ...+..+.
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 287 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQ 287 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCCCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-ccCCCCCc
Confidence 2234555544311 12356799999999999999999999976554444434433333 34556677
Q ss_pred CCChHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~ 299 (300)
.+++.+.+||.+||.. ||++|| +++++++||||++
T Consensus 288 ~~~~~~~~li~~~L~~-dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMK-DPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp TSCHHHHHHHHHHTCS-SGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ccCHHHHHHHHHHhhh-CHHHhcCCCCCCHHHHHcCcchhc
Confidence 8899999999999999 999999 9999999999976
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=339.94 Aligned_cols=236 Identities=25% Similarity=0.373 Sum_probs=181.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
++...+.||+|+||.||+|.+..+++.||+|+++.... ...+.+|+.++++++||||+++++++.... ..|+||||+
T Consensus 90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~E~~ 168 (373)
T 2x4f_A 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-DIVLVMEYV 168 (373)
T ss_dssp EEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEEECC
T ss_pred eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEEEeCC
Confidence 34446789999999999999999999999999976432 123467999999999999999999998754 899999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec--CCCCC---Ccc--------------
Q 040812 136 DAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN--EKMEH---PCG-------------- 195 (300)
Q Consensus 136 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~--~~~~~---~~~-------------- 195 (300)
++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.. ++|
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence 999999988654 4699999999999999999999999999999999999994 32222 222
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
++..|.+||... +..++.++|||||||++|||+||..||...........+... ...........+++++.+||.
T Consensus 249 ~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 249 FGTPEFLAPEVVN---YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-RWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CSSCTTCCHHHHT---TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCSCSGGGTTSCHHHHHHHH
T ss_pred cCCCcEeChhhcc---CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCChhhhccCCHHHHHHHH
Confidence 233455666543 456788999999999999999999999764432222222111 111112223467899999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. ||++|||++|+++||||++
T Consensus 325 ~~L~~-dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 325 KLLIK-EKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TTSCS-SGGGSCCHHHHHHSHHHHC
T ss_pred HHcCC-ChhhCCCHHHHhcCcCcCC
Confidence 99999 9999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=332.97 Aligned_cols=240 Identities=25% Similarity=0.368 Sum_probs=188.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCC------
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKP------ 124 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~------ 124 (300)
..++|++.+.||+|+||.||+|++..+++.||+|++........ +.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 46789999999999999999999999999999999865543332 35799999999999999999998753
Q ss_pred -CCcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------
Q 040812 125 -SGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------ 196 (300)
Q Consensus 125 -~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------ 196 (300)
.+..|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 2368999999986 77776665 35799999999999999999999999999999999999999776543322
Q ss_pred -----------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC
Q 040812 197 -----------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP 259 (300)
Q Consensus 197 -----------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (300)
+..|.+||.... ...++.++|||||||++|+|+||..||...... .....+.......++
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP 250 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTT--CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred ccccccccccccCCcccccCccCchhhcC--CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCh
Confidence 223556655431 234678999999999999999999999764432 222333333322222
Q ss_pred CCCCC----------------------------CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 260 SLPEC----------------------------SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 260 ~~~~~----------------------------~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... .++.+.+||.+||.. ||++|||++|+++||||.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL-DPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGGS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC-ChhhCCCHHHHhCCCCcCC
Confidence 22111 267799999999999 9999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=320.07 Aligned_cols=238 Identities=21% Similarity=0.281 Sum_probs=193.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-EEEEEE
Confidence 36799999999999999999999999999999998754432 22357999999999999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++...+.+
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999999998777899999999999999999999999999999999999999875543221
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+..|.+||.... ....+.++|||||||++|+|+||+.||............... ..........+++.+.+
T Consensus 165 ~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp CCCCSCGGGCCGGGGTC--SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT--TCTTSTTGGGSCHHHHH
T ss_pred cCCccccCccChHHHhc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh--cccccCchhhcCHHHHH
Confidence 223556655431 123467899999999999999999999765544332222211 11122223467899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+|.+||.. ||++|||++++++||||++
T Consensus 241 li~~~l~~-~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 241 LLHKILVE-NPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp HHHHHSCS-STTTSCCHHHHTTCTTTTC
T ss_pred HHHHHCCC-CchhCCCHHHHhcCccccC
Confidence 99999999 9999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=347.36 Aligned_cols=233 Identities=28% Similarity=0.423 Sum_probs=187.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
++|++++.||+|+||.||+|+++.+++.||+|++...... ..+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-NYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEEEE
Confidence 4699999999999999999999999999999999764322 22367999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Ccc-----------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PCG----------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~~----------- 195 (300)
|||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..+. . ++|
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 99999999999988888999999999999999999999999999999999999976432 1 222
Q ss_pred ----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---CCCCCCCCChH
Q 040812 196 ----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---PPSLPECSSEK 268 (300)
Q Consensus 196 ----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 268 (300)
++..|.+||... +.++.++|||||||++|+|++|..||...... .....+.... ....+..+++.
T Consensus 196 ~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR----KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp CCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred cccCCCcCeeCHHHHc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCchhcccCCHH
Confidence 233466666542 34778999999999999999999999754332 2222222221 22223468899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++||.+||+. ||++|||++++++||||++
T Consensus 268 ~~~li~~~L~~-dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 268 AKDLIKQMLQF-DSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHTCS-STTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHCCC-ChhhCccHHHHhcCccccc
Confidence 99999999999 9999999999999999963
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=340.16 Aligned_cols=239 Identities=24% Similarity=0.341 Sum_probs=179.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcC-CCceeEeceeeeCCC-CcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTN-SPYIVKCHQIFTKPS-GEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~~ 129 (300)
.++|++++.||+|+||.||+|.+..+++.||+|.+....... ...+|+.+++++. ||||+++++++..+. ..+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 468999999999999999999999999999999986432221 2356999999997 999999999987543 3699
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+|||||++ +|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 99999985 89998876 4799999999999999999999999999999999999999876543222
Q ss_pred ---------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 040812 197 ---------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL 249 (300)
Q Consensus 197 ---------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 249 (300)
+..|.+||.... ...++.++|||||||++|||+||++||...+.......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG--STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 223556655431 245788999999999999999999999765433222222
Q ss_pred HHHHhhCC--------------------------C----------------CCCCCCCChHHHHHHHHHhccCCCCCCCC
Q 040812 250 MLAICFRE--------------------------P----------------PSLPECSSEKFRDFIRCCLQKGDPSKRWT 287 (300)
Q Consensus 250 ~~~~~~~~--------------------------~----------------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt 287 (300)
+....... . ...+...++++.+||.+||+. ||++|||
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~-dP~~R~t 322 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF-NPNKRIS 322 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS-SGGGSCC
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc-CcccCCC
Confidence 21110000 0 001225688999999999999 9999999
Q ss_pred HHHHhcCCCCCC
Q 040812 288 ASQLLSHPFLAD 299 (300)
Q Consensus 288 ~~~~l~hpw~~~ 299 (300)
++|+++||||+.
T Consensus 323 ~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 323 ANDALKHPFVSI 334 (388)
T ss_dssp HHHHTTSTTTTT
T ss_pred HHHHhCCHHHHH
Confidence 999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=324.10 Aligned_cols=235 Identities=26% Similarity=0.412 Sum_probs=195.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++||||+++++++.... ..|
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 90 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-RIY 90 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-EEE
Confidence 4678999999999999999999999999999999986432 1223467999999999999999999998754 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++...+.+
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBC
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccccc
Confidence 9999999999999998888899999999999999999999999999999999999998776543322
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++||||||+++|+|++|..||...... .....+ ......++..+++.+.++
T Consensus 171 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIE---GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----ETHRRI-VNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp CCCSCGGGCCHHHHT---TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH-HTTCCCCCTTSCHHHHHH
T ss_pred cccCCCCcCCHHHhc---cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh----HHHHHH-hccccCCCCcCCHHHHHH
Confidence 22345555443 455778999999999999999999999654322 222222 233455677889999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||++++++||||++
T Consensus 243 i~~~l~~-~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 243 ISKLLRY-HPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HHHHSCS-SGGGSCCHHHHHTCHHHHH
T ss_pred HHHHhhc-CHhhCCCHHHHhhCHHHHh
Confidence 9999999 9999999999999999963
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=324.48 Aligned_cols=232 Identities=28% Similarity=0.435 Sum_probs=190.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.|+..+.||+|+||.||+|++..+|+.||||++....... .+.+|+.++++++||||+++++++.... ..|+||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-ELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-EEEEEEecC
Confidence 4788889999999999999999999999999987544322 2457999999999999999999998765 899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------------
Q 040812 136 DAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------- 196 (300)
Q Consensus 136 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------- 196 (300)
++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 99999998865 4799999999999999999999999999999999999999775543222
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC--CCCCCChHHHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS--LPECSSEKFRDFIR 274 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 274 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...... .....+.....+. .+..+++.+.++|.
T Consensus 204 t~~y~aPE~~~---~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 204 TPYWMAPEVIS---RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred CccccCHhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 23355555543 456788999999999999999999999654322 2222333233322 23457889999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. ||++|||++++++||||.+
T Consensus 277 ~~l~~-dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 277 RMLVR-DPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHSCS-STTTSCCHHHHHTSGGGGG
T ss_pred HHccC-ChhhCcCHHHHhcChhhcc
Confidence 99999 9999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=345.20 Aligned_cols=238 Identities=24% Similarity=0.340 Sum_probs=184.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
-.++|++++.||+|+||.||+|.+..+++.||||++...... ....+|+.+++.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999754221 22357999999999999999999986543
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
..+|+||||+++ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++..++.+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 357999999987 56666643 589999999999999999999999999999999999999876543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh------------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF------------ 255 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------ 255 (300)
+..|.+||... +..++.++|||||||++|||++|+.||.+.+.......++.....
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp CCCC----CCCTTCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CcccCCCcccccccCHHHHc---CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 33356666554 456788999999999999999999999765433222222221110
Q ss_pred -----CCCCCC---------CCC-----------CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 -----REPPSL---------PEC-----------SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 -----~~~~~~---------~~~-----------~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+.. +.. .++++.+||.+||+. ||++|||++|+++||||+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~-dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI-DPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS-STTTSCCHHHHHTSTTTGG
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC-ChhhCCCHHHHhcChhhhh
Confidence 000000 000 045789999999999 9999999999999999963
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=345.30 Aligned_cols=234 Identities=30% Similarity=0.427 Sum_probs=192.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++++++||||+++++++.... ..|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-EEEEE
Confidence 3679999999999999999999999999999999864321 223467999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Cc-----------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PC----------- 194 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~----------- 194 (300)
||||.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.... . ++
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 999999999999988888999999999999999999999999999999999999964321 1 11
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-C--CCCCCCCCCh
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-E--PPSLPECSSE 267 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~ 267 (300)
.++..|.+||... + .++.++|||||||++|+|+||..||...... .....+... . ....+..+++
T Consensus 180 ~~~~~gt~~y~aPE~~~---~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLR---G-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp --CCTTGGGGCCGGGGG---S-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCSCSGGGGGSCH
T ss_pred cCCCcCCCCCCCHHHhC---C-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCCcccCCCCH
Confidence 1344577777653 2 4788999999999999999999999754332 222222222 1 1222346789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++++||.+||.. ||++|||+.++++||||++
T Consensus 252 ~~~~li~~~L~~-dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 252 DAKDLIRKMLTF-HPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp HHHHHHHHHTCS-STTTSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHcCC-ChhhCcCHHHHhcCHhhcc
Confidence 999999999999 9999999999999999963
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=321.56 Aligned_cols=236 Identities=23% Similarity=0.386 Sum_probs=191.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC---CCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP---SGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~ 128 (300)
...|++.+.||+|+||.||+|.+..++..||+|.+....... .+.+|+.++++++||||+++++++... ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456899999999999999999999999999999987544332 235799999999999999999987542 3468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeec-CCCCCCcc----------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLIN-EKMEHPCG---------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~-~~~~~~~~---------- 195 (300)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++| ++||||||+|||++ .++...++
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999998788999999999999999999999999 99999999999997 44433221
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-CCCCCCCCCCh
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSE 267 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 267 (300)
++..|.+||... +.++.++|||||||++|+|+||+.||........ ........ .+...+...++
T Consensus 185 ~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGGCCCH
T ss_pred cccccccCCcCcCCHHHHh----ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---HHHHHhccCCccccCCCCCH
Confidence 234466666543 3477899999999999999999999976443322 22222222 23345566788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.++|.+||.. ||++|||++++++||||++
T Consensus 258 ~l~~li~~~l~~-dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQ-NKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCS-SGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccC-ChhhCCCHHHHhhCccccc
Confidence 999999999999 9999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=338.45 Aligned_cols=242 Identities=26% Similarity=0.317 Sum_probs=186.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC----C
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS----G 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 126 (300)
-.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+|++++|+||+++++++.... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357899999999999999999999999999999999754322 12357999999999999999999987653 4
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|+||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++..++.+
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 69999999975 9999999888899999999999999999999999999999999999998876543222
Q ss_pred -------------------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-------
Q 040812 197 -------------------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFL------- 238 (300)
Q Consensus 197 -------------------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~------- 238 (300)
+..|.+||... .+..++.++||||||||+|||+||..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL--LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHT--TCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHh--cCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 22355666432 24457889999999999999998544442
Q ss_pred ----CCCCC----------------chHHHHHHHHh--------------------hCCCCCC-------CCCCChHHHH
Q 040812 239 ----EPGQE----------------PDFLSLMLAIC--------------------FREPPSL-------PECSSEKFRD 271 (300)
Q Consensus 239 ----~~~~~----------------~~~~~~~~~~~--------------------~~~~~~~-------~~~~~~~l~~ 271 (300)
+.+.. .+....+.... ...+... ....++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 21100 00111111100 0011111 1347899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
||.+||.. ||++|||++|+|+||||++.
T Consensus 341 Ll~~mL~~-dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 341 LLESMLKF-NPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHSCS-STTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhcC-CcccCCCHHHHhcChhhhhc
Confidence 99999999 99999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=347.77 Aligned_cols=234 Identities=26% Similarity=0.390 Sum_probs=188.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---------------CCCHHHHHHHHhcCCCceeEecee
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---------------PPNPQELNILRQTNSPYIVKCHQI 120 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~ 120 (300)
.++|++++.||+|+||.||+|.++.+++.||+|++...... ..+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46799999999999999999999999999999999754322 123579999999999999999999
Q ss_pred eeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Cc
Q 040812 121 FTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PC 194 (300)
Q Consensus 121 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~ 194 (300)
+.... ..|+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++
T Consensus 115 ~~~~~-~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKK-YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSS-EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCC-EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 98754 89999999999999999988888999999999999999999999999999999999999987642 1 22
Q ss_pred c---------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC-
Q 040812 195 G---------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP- 258 (300)
Q Consensus 195 ~---------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~- 258 (300)
| ++..|.+||... +.++.++|||||||++|+|++|..||...... .....+.....
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~ 265 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKKVEKGKYY 265 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCC
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc----cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCC
Confidence 2 233456666543 34778999999999999999999999754332 22222222221
Q ss_pred --CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 259 --PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 259 --~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+..+++++++||.+||.. ||++|||++|+++||||++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~-dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTY-DYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCS-STTTSCCHHHHHTSHHHHH
T ss_pred CCccccCCCCHHHHHHHHHHcCC-ChhHCCCHHHHhcCHhhhh
Confidence 112256889999999999999 9999999999999999953
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=322.26 Aligned_cols=232 Identities=28% Similarity=0.375 Sum_probs=189.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
++|++.+.||+|+||.||+|.+..++..||+|.+...... ..+.+|+.++++++||||+++++++.... ..|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 87 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-DIYLVMEL 87 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEEEEC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eEEEEEec
Confidence 5699999999999999999999999999999998764332 23467999999999999999999998754 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee---cCCCCCC---cc-------------
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI---NEKMEHP---CG------------- 195 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill---~~~~~~~---~~------------- 195 (300)
+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||++ +.++... +|
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~ 167 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCC
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhc
Confidence 9999999999888889999999999999999999999999999999999999 4443322 12
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC----CCCChHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP----ECSSEKF 269 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l 269 (300)
++..|.+||... +.++.++|||||||++|+|+||+.||...... .....+... ....+ ..+++.+
T Consensus 168 ~~~t~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 168 KVGTPYYVSPQVLE----GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS----EVMLKIREG-TFTFPEKDWLNVSPQA 238 (277)
T ss_dssp CCSCTTTCCHHHHT----TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cCCCCCccChHHhc----ccCCchhhehhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhC-CCCCCchhhhcCCHHH
Confidence 223355555432 23678999999999999999999999654332 222222222 22222 2578999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.++|.+||.. ||++|||+.++++||||++
T Consensus 239 ~~li~~~l~~-dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 239 ESLIRRLLTK-SPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHTCS-STTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHccC-ChhhCcCHHHHhcCHHHhc
Confidence 9999999999 9999999999999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=332.02 Aligned_cols=237 Identities=27% Similarity=0.400 Sum_probs=193.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++++++||||+++++++.... ..|+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-eEEE
Confidence 35699999999999999999999999999999998754322 12457999999999999999999998764 8999
Q ss_pred EEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc--------------
Q 040812 131 LMEYMDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------- 195 (300)
||||+.| +|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++...++
T Consensus 132 v~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 210 (348)
T 1u5q_A 132 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 210 (348)
T ss_dssp EEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred EEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcc
Confidence 9999985 7877775 45679999999999999999999999999999999999999976543222
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-CCCCCCCCCChHHHHHH
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSEKFRDFI 273 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 273 (300)
++..|.+||......++.++.++|||||||++|||+||+.||...... .....+... .+...+..+++.+.++|
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 244567777654334556788999999999999999999999654322 222222223 33334567899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||.. ||++|||++++++||||..
T Consensus 287 ~~~l~~-dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 287 DSCLQK-IPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHTCS-SGGGSCCHHHHTTCHHHHS
T ss_pred HHHccc-ChhhCcCHHHHhhChhhhc
Confidence 999999 9999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=331.96 Aligned_cols=240 Identities=26% Similarity=0.332 Sum_probs=184.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
-.++|++.+.||+|+||.||+|.+..+|+.||||.+....... .+.+|+.++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999999999999999986543221 2357999999999999999999987643
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---------- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---------- 195 (300)
...|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++..++.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 2469999999 7799999976 479999999999999999999999999999999999999987654322
Q ss_pred ------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh--------------
Q 040812 196 ------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF-------------- 255 (300)
Q Consensus 196 ------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------- 255 (300)
++..|.+||.... ...++.++|||||||++|||++|+.||...+.......+......
T Consensus 181 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ccCcCcCCCCcCCHHHHhC--CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 2334566665442 245788999999999999999999999764432222222211100
Q ss_pred ---------C---CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 ---------R---EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 ---------~---~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
. .........++.+.+||.+||.. ||++|||++++++||||++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~-dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL-DAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS-STTTSCCHHHHHHSGGGTT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccC-ChhHCCCHHHHhcChHHHh
Confidence 0 00112345688999999999999 9999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=319.38 Aligned_cols=243 Identities=31% Similarity=0.480 Sum_probs=195.6
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..+..++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++++.... ..|
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 92 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KLW 92 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEE
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-eEE
Confidence 345567899999999999999999999999999999998654322 23457999999999999999999998764 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++...+++
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999999999875 45799999999999999999999999999999999999999876543332
Q ss_pred -------eeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--CCCCCC
Q 040812 197 -------SCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP--SLPECS 265 (300)
Q Consensus 197 -------~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 265 (300)
+..|.+||.... ..+..++.++|||||||++|+|+||..||...... ...........+ ..+..+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCCSSGGGS
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHHHhccCCcccCCcccc
Confidence 334666665431 12455778999999999999999999999654322 222222223322 235667
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+..+.++|.+||.. ||++|||++++++||||++.
T Consensus 249 ~~~l~~li~~~l~~-dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 249 SVEFRDFLKIALDK-NPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp CHHHHHHHHHHSCS-CTTTSCCHHHHTTSTTTTTC
T ss_pred CHHHHHHHHHHccc-ChhhCCCHHHHhcChHHhhh
Confidence 89999999999999 99999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=322.75 Aligned_cols=235 Identities=26% Similarity=0.357 Sum_probs=195.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-FVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-EEE
Confidence 4578999999999999999999999999999999987654322 2356999999999999999999998754 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++...+.+
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999999999998878899999999999999999999999999999999999999876543322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||... +..++.++||||||+++|+|+||+.||...... ...... .......+...++.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~ 243 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRI-KKNEYSIPKHINPVAA 243 (294)
T ss_dssp BCCCCSCCSSCCHHHHT---TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH-HTTCCCCCTTSCHHHH
T ss_pred cccccCCCCcCCcchhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-hhccCCCccccCHHHH
Confidence 22244444432 455678999999999999999999999654322 222222 2334566778899999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++|.+||.. ||++|||++++++||||.+
T Consensus 244 ~li~~~l~~-~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 244 SLIQKMLQT-DPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHHHHHTCS-SGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHHccc-ChhhCcCHHHHhhChheec
Confidence 999999999 9999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=322.62 Aligned_cols=237 Identities=31% Similarity=0.466 Sum_probs=190.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--------CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--------PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
++|++.+.||+|+||.||+|.+..+++.||+|+++...... .+.+|+.++++++||||+++++++.... ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT-DV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC-eE
Confidence 46999999999999999999999999999999997654321 2357999999999999999999998754 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC----CCC---cc------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM----EHP---CG------ 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~----~~~---~~------ 195 (300)
++||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++ ... +|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998877899999999999999999999999999999999999998765 221 21
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
++..|.+||... +..++.++||||||+++|+|+||..||...... .....+...........+...+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp --------CCCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCCCCCHHHHTTCC
T ss_pred CCCcccccCCCcCccCcceec---CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhcccCCcchhcccCC
Confidence 122355555443 456788999999999999999999999654322 1111111111111112234678
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.+.++|.+||.. ||++|||+.++++||||++
T Consensus 240 ~~~~~li~~~l~~-dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 240 ELAKDFIRRLLVK-DPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHTTSCS-SGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHHccC-CHhHCcCHHHHHhCHHHHH
Confidence 8999999999999 9999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=345.12 Aligned_cols=232 Identities=30% Similarity=0.397 Sum_probs=191.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|++..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..|+|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 104 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-YFYLV 104 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEEEE
Confidence 57999999999999999999999999999999997654321 2357999999999999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC---CCCCC---cc----------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE---KMEHP---CG---------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~---~~~~~---~~---------- 195 (300)
||||.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++... +|
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 999999999999998889999999999999999999999999999999999999953 22221 22
Q ss_pred -----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---CCCCCCCCCh
Q 040812 196 -----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---PPSLPECSSE 267 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 267 (300)
++..|.+||... + .++.++|||||||++|+|+||..||...... .....+.... ....+..+++
T Consensus 185 ~~~~~gt~~y~aPE~~~---~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLH---G-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----DILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp HHHHTTGGGTCCHHHHH---T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCSGGGGGSCH
T ss_pred cccCCCCccccCceeec---C-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCCCcccccCCH
Confidence 244566777653 2 4778999999999999999999999754332 2222222221 1222356899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+++||.+||.. ||++|||+.++++||||+
T Consensus 257 ~~~~li~~~L~~-dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 257 SAKDLIRKMLTY-VPSMRISARDALDHEWIQ 286 (484)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHTSHHHH
T ss_pred HHHHHHHHHCCC-ChhHCcCHHHHhhChhhc
Confidence 999999999999 999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=331.69 Aligned_cols=239 Identities=38% Similarity=0.622 Sum_probs=194.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++++.... ..|+||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-EEEEEE
Confidence 46899999999999999999999999999999999764321 12357999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCccc---------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||+++++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++...+.+
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 190 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence 9999999999999888899999999999999999999986 999999999999999876543332
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc------------------------------
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP------------------------------ 244 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~------------------------------ 244 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||.......
T Consensus 191 ~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 191 VGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp CCCCTTCCHHHHT---TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred CCCCCeECHHHHc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 23355555543 5567889999999999999999999996533211
Q ss_pred --------hHHHHHHHHhhCCCCCCC-CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 245 --------DFLSLMLAICFREPPSLP-ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 245 --------~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..............+..+ ..+++++.+||.+||.. ||++|||++++++||||++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCS-STTTSCCHHHHHTSHHHHH
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhc-ChhhCCCHHHHhhChHhhc
Confidence 011122222223333333 34788999999999999 9999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=318.37 Aligned_cols=234 Identities=29% Similarity=0.410 Sum_probs=192.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++||||+++++++.... ..|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-DFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-eEEE
Confidence 578999999999999999999999999999999986532 1123457999999999999999999988754 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++...+.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence 999999999999998888899999999999999999999999999999999999999876543322
Q ss_pred ----eeeccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 197 ----SCLYESGEARHRKHGG-YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+..|.+||... +. ..+.++||||||+++|+|++|..||..... ......+. ......+...+..+.+
T Consensus 169 ~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 169 TSCGSPNYAAPEVIS---GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKIR-GGVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------CCTGGGT---TSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HCCCCCCTTSCHHHHH
T ss_pred cccCCccccCHHHHc---CCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhh-cCcccCchhcCHHHHH
Confidence 23355666543 33 236799999999999999999999965322 12222222 2344567778999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+|.+||.. ||++|||++++++||||++
T Consensus 241 li~~~l~~-~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 241 LLMHMLQV-DPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHTCS-SGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHccC-ChhhCCCHHHHHhChhhcc
Confidence 99999999 9999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=324.87 Aligned_cols=240 Identities=22% Similarity=0.341 Sum_probs=188.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC-CCceeEeceeeeCC-CCcEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN-SPYIVKCHQIFTKP-SGEVSIL 131 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv 131 (300)
...++|++.+.||+|+||.||+|++..+++.||+|+++... ...+.+|+.++++++ ||||+++++++... ....++|
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 34578999999999999999999999999999999986432 234568999999997 99999999998863 3468999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-CC---Cccc-----------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-EH---PCGY----------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-~~---~~~~----------- 196 (300)
|||+++++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .. ++|.
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 99999999999885 489999999999999999999999999999999999998654 22 2222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh---------hC-------
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---------FR------- 256 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------~~------- 256 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||............+.... ..
T Consensus 189 ~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 189 VRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp SCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccChhhhcC--CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 223455554421 24578899999999999999999999965443322221111100 00
Q ss_pred -----------------CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 257 -----------------EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 257 -----------------~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.....+..+++++.+||.+||.. ||++|||++|+++||||+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY-DHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCS-SGGGSCCHHHHHTSGGGTTC
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcC-CcccCCCHHHHhcCccHhhh
Confidence 01111233689999999999999 99999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=334.70 Aligned_cols=238 Identities=24% Similarity=0.351 Sum_probs=184.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCC-----------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKP----------- 124 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------- 124 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++..+. ....+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 468999999999999999999999999999999987543 2345799999999999999999988432
Q ss_pred --------------------------CCcEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhHhCCc
Q 040812 125 --------------------------SGEVSILMEYMDAGSLEIYVK----SRGRLSEDIICTISRQVLKGLFYMHSRNI 174 (300)
Q Consensus 125 --------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 174 (300)
..+.++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 2248999999985 7766664 35679999999999999999999999999
Q ss_pred cccCCCCCceeecC-CCCCC---cc---------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 040812 175 VHRDIKPANVLINE-KMEHP---CG---------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYY 235 (300)
Q Consensus 175 ~H~Dlkp~Nill~~-~~~~~---~~---------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~ 235 (300)
+||||||+|||++. ++... +| ++..|.+||.... ...++.++|||||||++|||++|+.
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG--ATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC--CCCCCcchhhhhHHHHHHHHHhCCC
Confidence 99999999999973 43322 22 1233556655431 2347889999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHhhC---------------CC---------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHH
Q 040812 236 PFLEPGQEPDFLSLMLAICFR---------------EP---------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQL 291 (300)
Q Consensus 236 pf~~~~~~~~~~~~~~~~~~~---------------~~---------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~ 291 (300)
||...........++...... .. ..++...++++.+||.+||.. ||++|||+.|+
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~ 319 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY-EPDLRINPYEA 319 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS-SGGGSCCHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC-ChhhCCCHHHH
Confidence 997654433333332211100 00 013456788999999999999 99999999999
Q ss_pred hcCCCCCC
Q 040812 292 LSHPFLAD 299 (300)
Q Consensus 292 l~hpw~~~ 299 (300)
++||||++
T Consensus 320 l~hp~f~~ 327 (383)
T 3eb0_A 320 MAHPFFDH 327 (383)
T ss_dssp HTSGGGHH
T ss_pred hcCHHHHH
Confidence 99999964
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=322.66 Aligned_cols=236 Identities=33% Similarity=0.508 Sum_probs=189.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
..++|++.+.||+|+||.||+|.+..+++.||+|.+........+.+|+.++++++||||+++++++.... ..|+||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-DLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-EEEEEeec
Confidence 34679999999999999999999999999999999987655555678999999999999999999988754 89999999
Q ss_pred cCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 135 MDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
+++++|.+++. ....+++..++.++.||+.||.|||+.|++|+||||+||+++.++...+.+
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 185 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence 99999999997 356799999999999999999999999999999999999998775543222
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC--CCCCCCCChHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP--PSLPECSSEKFRDF 272 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 272 (300)
+..|.+||... +..++.++|||||||++|+|+||..||...... ........... ...+..+++.+.++
T Consensus 186 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 186 IGTPFWMAPEVIQ---EIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp CSCGGGCCHHHHS---SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred CCCCCccChhhcC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 22344555433 445778999999999999999999999654322 22222222222 23355678999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||+.++++||||++
T Consensus 259 i~~~l~~-dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 259 VKQCLVK-SPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHHHTCS-CTTTSCCHHHHTTSHHHHT
T ss_pred HHHHccC-ChhhCcCHHHHHhCHHHhc
Confidence 9999999 9999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=332.33 Aligned_cols=237 Identities=29% Similarity=0.426 Sum_probs=191.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----------CCCHHHHHHHHhc-CCCceeEeceeeeCCC
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----------PPNPQELNILRQT-NSPYIVKCHQIFTKPS 125 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 125 (300)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5699999999999999999999989999999998765422 1235689999998 7999999999988754
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---c-------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---G------- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---~------- 195 (300)
..|+||||+++++|.+++.....+++..++.++.||+.||.|||+.|++||||||+|||++.++...+ |
T Consensus 174 -~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 -FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp -EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred -EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 89999999999999999998788999999999999999999999999999999999999998765322 2
Q ss_pred --------ceeecccccccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-CCC--C
Q 040812 196 --------YSCLYESGEARHRK---HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-PPS--L 261 (300)
Q Consensus 196 --------~~~~~~~~~~~~~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~--~ 261 (300)
++..|.+||..... ....++.++|||||||++|+|+||..||...... .....+.... ... .
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----LMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCHHH
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCCcc
Confidence 23346666654322 1234678999999999999999999999654321 2222222121 111 1
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+...++.+.++|.+||.. ||++|||++++++||||+.
T Consensus 329 ~~~~~~~~~~li~~~L~~-dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQV-DPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HSSSCHHHHHHHHHHSCS-STTTSCCHHHHHHSGGGCC
T ss_pred cccCCHHHHHHHHHHcCC-ChhHCcCHHHHhcCcccCC
Confidence 246788999999999999 9999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=328.90 Aligned_cols=240 Identities=24% Similarity=0.387 Sum_probs=183.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++++.... .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-N 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-C
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC-c
Confidence 357899999999999999999999999999999998753221 23457999999999999999999998754 8
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 128 VSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
.++||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++...+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999987 898888764 3689999999999999999999999999999999999999876543332
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL------ 261 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------ 261 (300)
+..|.+||.... ...++.++|||||||++|||++|.+||...........+............
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFG--ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTT--CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccCCcccccccccCchHhhC--CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 222455554321 234678999999999999999999999765433332222222111111110
Q ss_pred -----------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 -----------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 -----------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....++++.+||.+||.. ||++|||++|+++||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF-NPCARITATQALKMKYFSN 297 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS-STTTSCCHHHHHTSGGGTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhcc-ChhhCCCHHHHhcChhhhc
Confidence 134578999999999999 9999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=320.31 Aligned_cols=242 Identities=28% Similarity=0.424 Sum_probs=193.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----------CCHHHHHHHHhcC-CCceeEeceeee
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----------PNPQELNILRQTN-SPYIVKCHQIFT 122 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~E~~~l~~l~-h~niv~~~~~~~ 122 (300)
-.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999999999999999997654221 2246899999995 999999999998
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------
Q 040812 123 KPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------ 196 (300)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------ 196 (300)
... ..++||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++...+.+
T Consensus 95 ~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 95 TNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp CSS-EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cCC-eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 754 8999999999999999999888899999999999999999999999999999999999998876543222
Q ss_pred ------------eeecccccccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 197 ------------SCLYESGEARHRK---HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
+..|.+||..... ....++.++|||||||++|+|++|..||...... .....+...........
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCTTT
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhcCCcccCccc
Confidence 2335556554311 2345678999999999999999999999654322 11111111111111222
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+++.+.++|.+||.. ||++|||++++++||||++
T Consensus 253 ~~~~~~~l~~li~~~l~~-dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVV-QPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp GGGSCHHHHHHHHHHCCS-SGGGSCCHHHHTTSGGGCT
T ss_pred ccccCHHHHHHHHHHccC-CcccCCCHHHHHhChHhhh
Confidence 246789999999999999 9999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=333.19 Aligned_cols=236 Identities=27% Similarity=0.406 Sum_probs=184.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcC-----CCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTN-----SPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~ 129 (300)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ......|+.+++.++ ||||+++++++.... ..|
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~-~~~ 112 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD-HMC 112 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT-EEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC-eeE
Confidence 4689999999999999999999999999999999864221 122356999999986 999999999998765 899
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-------------------
Q 040812 130 ILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE------------------- 188 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~------------------- 188 (300)
+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 999999 889999998754 5999999999999999999999999999999999999975
Q ss_pred ------CCCC---Ccc-------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchH
Q 040812 189 ------KMEH---PCG-------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF 246 (300)
Q Consensus 189 ------~~~~---~~~-------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 246 (300)
++.. ++| ++..|.+||... +..++.++|||||||++|+|+||+.||...... ..
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~ 267 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL---NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM-EH 267 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred cccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHc---CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH-HH
Confidence 2222 111 234466666554 556788999999999999999999999754332 22
Q ss_pred HHHHHHHhhCCC----------------------CCCC--------------------CCCChHHHHHHHHHhccCCCCC
Q 040812 247 LSLMLAICFREP----------------------PSLP--------------------ECSSEKFRDFIRCCLQKGDPSK 284 (300)
Q Consensus 247 ~~~~~~~~~~~~----------------------~~~~--------------------~~~~~~l~~li~~~l~~~dp~~ 284 (300)
...+.......+ ...+ ...++.+.+||.+||+. ||++
T Consensus 268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~-dP~~ 346 (360)
T 3llt_A 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI-DPTL 346 (360)
T ss_dssp HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS-SGGG
T ss_pred HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC-Chhh
Confidence 222221111100 0001 11236788999999999 9999
Q ss_pred CCCHHHHhcCCCCC
Q 040812 285 RWTASQLLSHPFLA 298 (300)
Q Consensus 285 Rpt~~~~l~hpw~~ 298 (300)
|||++|+|+||||+
T Consensus 347 Rpta~elL~hp~f~ 360 (360)
T 3llt_A 347 RPSPAELLKHKFLE 360 (360)
T ss_dssp SCCHHHHTTSGGGC
T ss_pred CCCHHHHhcCcccC
Confidence 99999999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=333.76 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=187.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-------CCCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-------TPPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
-.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++++++||||+++++++.... .
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ-Y 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-E
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC-e
Confidence 34679999999999999999999999999999999865321 123457999999999999999999998754 8
Q ss_pred EEEEEeccCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 040812 128 VSILMEYMDAGSLEIYVKS----------------------------------------RGRLSEDIICTISRQVLKGLF 167 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~~l~ 167 (300)
.|+||||+++|+|.+++.. ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998852 112367788999999999999
Q ss_pred HhHhCCccccCCCCCceeecCCC--CC---Cccc--------------------eeeccccccccccCCCCCCchhhHHH
Q 040812 168 YMHSRNIVHRDIKPANVLINEKM--EH---PCGY--------------------SCLYESGEARHRKHGGYNGFAADIWS 222 (300)
Q Consensus 168 ~lH~~~i~H~Dlkp~Nill~~~~--~~---~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~DiwS 222 (300)
|||++||+||||||+|||++.++ .. ++|. +..|.+||.... .+..++.++||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Diws 261 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT-TNESYGPKCDAWS 261 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC-SSSCCCTHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc-CCCCCCcHHHHHH
Confidence 99999999999999999998665 22 2221 223556665431 1256778999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 223 FGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 223 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|||++|||+||+.||............... ...........+++.+.++|.+||.. ||++|||+.++++||||++
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNK-KLCFENPNYNVLSPLARDLLSNLLNR-NVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCTTSGGGGGSCHHHHHHHHHHSCS-CTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhc-ccccCCcccccCCHHHHHHHHHHcCC-ChhHCCCHHHHhcChhhcc
Confidence 999999999999999765433222222211 11111112234789999999999999 9999999999999999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=322.66 Aligned_cols=238 Identities=30% Similarity=0.449 Sum_probs=176.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC---CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR---GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.++++++||||+++++++.... ..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-CEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEE
Confidence 34678999999999999999999999889999999986532 2334567999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------
Q 040812 131 LMEYMDAGSLEIYVKS--------RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------ 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------ 196 (300)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++...+++
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999999974 34689999999999999999999999999999999999998876543332
Q ss_pred ------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 197 ------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 197 ------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||............. ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~ 244 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQ--VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL----QNDP 244 (303)
T ss_dssp CC---------------CCCTTCCHHHHHH--HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH----TSSC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhcc--ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh----ccCC
Confidence 223555555432 1246779999999999999999999997654332222111 1111
Q ss_pred C---------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 259 P---------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 259 ~---------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+ .....+++.+.++|.+||.. ||++|||++++++||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQK-DPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCS-SGGGSCCHHHHHTSTTC--
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccC-ChhhCcCHHHHhhChhhhc
Confidence 1 22345788999999999999 9999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=322.16 Aligned_cols=230 Identities=27% Similarity=0.352 Sum_probs=182.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQT-NSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|++..+++.||||++........ ...|+..+.++ +|+||+++++++.... ..|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-ILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-EEEEE
Confidence 579999999999999999999999999999998765432211 12355555444 8999999999998754 89999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------------
Q 040812 132 MEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--------------- 195 (300)
|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+++
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 9999 56898888764 469999999999999999999999999999999999999877554322
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++..|.+||... + .++.++|||||||++|||++|..|+.... . ...+ .....++..+..+++.+.++
T Consensus 215 ~~~gt~~y~aPE~~~---~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~-~~~~--~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQ---G-SYGTAADVFSLGLTILEVACNMELPHGGE---G-WQQL--RQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp CCCCCGGGCCGGGGG---T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H-HHHH--TTTCCCHHHHTTSCHHHHHH
T ss_pred ccCCCccccCHhHhc---C-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H-HHHH--hccCCCcccccCCCHHHHHH
Confidence 234577777653 3 57889999999999999999977664321 1 1111 11112233456688999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||++|+++||||++
T Consensus 285 i~~~L~~-dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEP-DPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCS-STTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCC-ChhhCcCHHHHHhCccccC
Confidence 9999999 9999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=330.06 Aligned_cols=243 Identities=25% Similarity=0.365 Sum_probs=193.5
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
...+++|++.+.||+|+||.||+|++..+++.||+|++........ +.+|+.++++++||||+++++++.... ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-RW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-EE
Confidence 3467899999999999999999999999999999999865443321 247999999999999999999998754 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++...+++
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999999999888777899999999999999999999999999999999999998876543322
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-------------
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR------------- 256 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------- 256 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...........+.......
T Consensus 180 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVG--DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ----CCCCCTTCCHHHHTT--CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccCCCcCCccccCcccccC--CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 222455554431 2256789999999999999999999997654333222222111000
Q ss_pred -CCCCC------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 -EPPSL------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 -~~~~~------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... ...+++.+.+||.+||.. ||++|||++|+++||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~-dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI-DPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCS-SGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhcc-CcccCCCHHHHhcCchhcc
Confidence 00000 124688999999999999 9999999999999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=336.00 Aligned_cols=238 Identities=21% Similarity=0.314 Sum_probs=183.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCC-----CCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKP-----SGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~l 130 (300)
..+|++.+.||+|+||.||+|++..+++.||||.+..+. ....+|+.+|++++||||+++++++... ..++++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 347999999999999999999999999999999986543 2345799999999999999999987431 124789
Q ss_pred EEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-CC---Cccc------
Q 040812 131 LMEYMDAGSLEIYVK----SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-EH---PCGY------ 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-~~---~~~~------ 196 (300)
||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+. .. ++|.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9999987 6665554 356799999999999999999999999999999999999998543 22 2222
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh---------C--
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF---------R-- 256 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------~-- 256 (300)
+..|.+||.... ...++.++|||||||++|||++|+.||..........+++..... .
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred CCCceeeeeCCCcCCHHHHcC--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 223555555431 235788999999999999999999999765433333333321110 0
Q ss_pred -CCCC------------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 -EPPS------------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 -~~~~------------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.... ++...++++.+||.+||.. ||++|||+.|+++||||++
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~-dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY-TPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccC-ChhHCCCHHHHhCCHhhcc
Confidence 0011 2335688999999999999 9999999999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=327.66 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=191.5
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC-
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS- 125 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 125 (300)
+...+-.++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++++....
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 44455557899999999999999999999999999999998643321 22357999999999999999999986542
Q ss_pred ---CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------
Q 040812 126 ---GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------- 195 (300)
Q Consensus 126 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------- 195 (300)
...|+||||+++ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 100 ~~~~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 100 EQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccceEEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 368999999975 999988764 69999999999999999999999999999999999999887554222
Q ss_pred ---------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----
Q 040812 196 ---------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF----- 255 (300)
Q Consensus 196 ---------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----- 255 (300)
++..|.+||... .+..++.++|||||||++|+|+||+.||...........+......
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHH--TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhc--CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 233355665432 1334678999999999999999999999765544333322211100
Q ss_pred --------------CC--CCC-----CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 --------------RE--PPS-----LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 --------------~~--~~~-----~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.. ... .....++++.+||.+||.. ||++|||++|+++||||++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF-NPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCS-STTTSCCHHHHHTSGGGTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCC-ChhhCCCHHHHhcCcchhh
Confidence 00 000 1235688999999999999 9999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=324.15 Aligned_cols=237 Identities=22% Similarity=0.366 Sum_probs=190.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCC--CceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNS--PYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~ 128 (300)
.-++|++.+.||+|+||.||+|.+. +++.||+|++....... .+.+|+.++++++| +||+++++++.... ..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC-EE
Confidence 3467999999999999999999985 48899999997654332 23579999999987 99999999988754 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---c-----------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP---C----------- 194 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~---~----------- 194 (300)
|+|||+ .+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ ... +
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~-~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-EEEECCCSSSCCC-----
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECC-cEEEeecccccccCcccc
Confidence 999995 577999999998899999999999999999999999999999999999999743 111 1
Q ss_pred -------cceeecccccccccc--------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC
Q 040812 195 -------GYSCLYESGEARHRK--------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP 259 (300)
Q Consensus 195 -------~~~~~~~~~~~~~~~--------~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (300)
.++..|.+||..... ....++.++|||||||++|||+||+.||...... ..............
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEI 240 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHCTTSCC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHhcCCccc
Confidence 134456677765421 1255788999999999999999999999653322 22222223334455
Q ss_pred CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 260 SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 260 ~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
..+...++.+.++|.+||.. ||++|||+.++++||||+
T Consensus 241 ~~~~~~~~~l~~li~~~L~~-dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKR-DPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCS-STTTSCCHHHHHTSHHHH
T ss_pred CCcccCCHHHHHHHHHHcCC-ChhHCCCHHHHHhCcccc
Confidence 66777889999999999999 999999999999999995
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=324.38 Aligned_cols=239 Identities=26% Similarity=0.357 Sum_probs=189.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCC-CcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPS-GEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv 131 (300)
-++|++.+.||+|+||.||+|++..+++.||+|++....... .+.+|+.++++++||||+++++++.... ...|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999999999999999987543222 2357999999999999999999987543 368999
Q ss_pred EeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee----cCCCCC---Ccc------
Q 040812 132 MEYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI----NEKMEH---PCG------ 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill----~~~~~~---~~~------ 195 (300)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.. ++|
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999999998643 39999999999999999999999999999999999998 443221 111
Q ss_pred ---------ceeecccccccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC--
Q 040812 196 ---------YSCLYESGEARHRK-----HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-- 259 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~-----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 259 (300)
++..|.+||..... .+..++.++|||||||++|||+||+.||............+..+....+.
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 23456666654321 24567889999999999999999999997655444444444444433322
Q ss_pred ----------------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 040812 260 ----------------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295 (300)
Q Consensus 260 ----------------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hp 295 (300)
.++...++.+.++|.+||+. ||++|||++|+++||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~-dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA-DQEKCWGFDQFFAET 304 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC-CTTTSCCHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccC-ChhhhccHHHhhhcc
Confidence 11223356789999999999 999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=323.63 Aligned_cols=237 Identities=25% Similarity=0.362 Sum_probs=190.5
Q ss_pred Ccceee-eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEE
Q 040812 57 SQLEKL-QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 57 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~l 130 (300)
++|.+. +.||+|+||.||+|.+..+++.||+|+++...... .+.+|+.+++++. ||||+++++++.... ..|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~-~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS-EIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC-eEEE
Confidence 457776 89999999999999999999999999987644332 2357999999985 699999999998754 8999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC---CCCCCcc----------
Q 040812 131 LMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE---KMEHPCG---------- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~---~~~~~~~---------- 195 (300)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++...+.
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998643 57999999999999999999999999999999999999987 3332221
Q ss_pred --------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 196 --------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 196 --------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
++..|.+||... +..++.++|||||||++|+|+||+.||......... ..+..............+++
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILN---YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-LNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp -------CCCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTCCCCCTTTTTTSCH
T ss_pred ccccccccCCcCccCCeeec---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHhcccccCchhhcccCH
Confidence 233455555543 556788999999999999999999999664432222 22222222334444567899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+.++|.+||.. ||++|||++++++||||++
T Consensus 263 ~~~~li~~~L~~-dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 263 LATDFIQSLLVK-NPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp HHHHHHHHHSCS-SGGGSCCHHHHTTCGGGCC
T ss_pred HHHHHHHHHcCC-ChhhCcCHHHHhCCHhhcc
Confidence 999999999999 9999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=316.57 Aligned_cols=239 Identities=30% Similarity=0.430 Sum_probs=185.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
..++|++.+.||+|+||.||+|++..+++.||+|+++....... ..++...++.++||||+++++++.... ..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-SEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-CEEE
Confidence 45789999999999999999999999999999999865432211 123444577789999999999998754 8999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCccc---------
Q 040812 131 LMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
||||+++ +|.+++.. ...+++..++.++.||+.||.|||++ |++||||||+||+++.++...+++
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999985 88777653 56799999999999999999999998 999999999999999876543322
Q ss_pred ---------eeeccccccccc-cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 197 ---------SCLYESGEARHR-KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 197 ---------~~~~~~~~~~~~-~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
+..|.+||.... ..+..++.++|||||||++|+|+||+.||...... ............+...+..++
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHHhccCCCCcccccCC
Confidence 333566665422 13456788999999999999999999999653322 112222222233333345689
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
+++.++|.+||.. ||++|||++++++||||+
T Consensus 241 ~~~~~li~~~l~~-~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 241 AEFVDFTSQCLKK-NSKERPTYPELMQHPFFT 271 (290)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHHhhc-ChhhCcCHHHHHhCcccc
Confidence 9999999999999 999999999999999996
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=321.61 Aligned_cols=242 Identities=31% Similarity=0.469 Sum_probs=192.9
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhc-CCCceeEeceeeeCC-----C
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQT-NSPYIVKCHQIFTKP-----S 125 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~ 125 (300)
.+..++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++++ +||||+++++++... .
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34568899999999999999999999999999999998754322 2346799999998 799999999998753 3
Q ss_pred CcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc--------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------- 195 (300)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++...+.
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 4799999999999999999864 469999999999999999999999999999999999999877554322
Q ss_pred -----------ceeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-CCCCC
Q 040812 196 -----------YSCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSL 261 (300)
Q Consensus 196 -----------~~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 261 (300)
++..|.+||..... .+..++.++|||||||++|+|+||..||...... .....+... .+...
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 255 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIPRNPAPRLK 255 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCCS
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHhhcCccccCC
Confidence 23335666654321 1345678999999999999999999999654322 222222222 23333
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+..+++.+.++|.+||.. ||++|||++++++||||++
T Consensus 256 ~~~~~~~l~~li~~~l~~-dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVK-NHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp CSCSCHHHHHHHHHHCCS-SGGGSCCHHHHHTSHHHHC
T ss_pred ccccCHHHHHHHHHHhcc-ChhhCCCHHHHhhChHHhh
Confidence 566789999999999999 9999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=327.91 Aligned_cols=237 Identities=22% Similarity=0.359 Sum_probs=189.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcC--CCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTN--SPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~ 129 (300)
..+|++.+.||+|+||.||+|.+.. ++.||||++...... ..+.+|+.++++++ |+||+++++++.... .+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-EEE
Confidence 3569999999999999999999876 889999999765432 22467999999997 499999999988765 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC----------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP---------------- 193 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~---------------- 193 (300)
+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++. ..+
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSS-CEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECC-eEEEEecCccccccCCCcc
Confidence 9999 5577999999988889999999999999999999999999999999999999643 221
Q ss_pred -----ccceeecccccccccc--------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC
Q 040812 194 -----CGYSCLYESGEARHRK--------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS 260 (300)
Q Consensus 194 -----~~~~~~~~~~~~~~~~--------~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (300)
..++..|.+||..... ....++.++||||||||+|||+||+.||....... ..............
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIIDPNHEIE 288 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHCTTSCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HHHHHHhCccccCC
Confidence 1234457777765421 12357889999999999999999999996543221 11122222234455
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+...++++.+||.+||.. ||++|||+.|+++||||+.
T Consensus 289 ~~~~~~~~~~~li~~~L~~-dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKR-DPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCS-STTTSCCHHHHHTSHHHHS
T ss_pred CCccchHHHHHHHHHHccc-ChhhCCCHHHHhhCcCccc
Confidence 6777789999999999999 9999999999999999953
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=335.47 Aligned_cols=237 Identities=26% Similarity=0.443 Sum_probs=185.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhc------CCCceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQT------NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~ 128 (300)
..+|++.+.||+|+||.||+|.+..+++.||||+++..... ....+|+.+++.+ +|+||+++++++.... ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN-HI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT-EE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC-eE
Confidence 35799999999999999999999999999999998653211 2235688888776 5779999999998764 89
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC--C---Ccc------
Q 040812 129 SILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME--H---PCG------ 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~--~---~~~------ 195 (300)
|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99999996 59999987653 4999999999999999999999999999999999999998765 2 222
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC----------
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP---------- 258 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 258 (300)
++..|.+||... +..++.++|||||||++|||+||..||...+.......++.. ....+
T Consensus 254 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~-~~~p~~~~~~~~~~~ 329 (429)
T 3kvw_A 254 QRVYTYIQSRFYRAPEVIL---GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMPSQKLLDASKRA 329 (429)
T ss_dssp CCCCSSCSCGGGCCHHHHH---TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCCCHHHHHTBTTH
T ss_pred CcccccCCCCCccChHHHh---CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCCHHHHHhhhhh
Confidence 233466666654 556788999999999999999999999765433222222211 10000
Q ss_pred --------------------------------------C-------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 259 --------------------------------------P-------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 259 --------------------------------------~-------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+ .++...++.+.+||.+||+. ||++|||++|+|+
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~-dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW-DPAVRMTPGQALR 408 (429)
T ss_dssp HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS-STTTSCCHHHHHT
T ss_pred hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC-ChhhCCCHHHHhC
Confidence 0 01123477899999999999 9999999999999
Q ss_pred CCCCCC
Q 040812 294 HPFLAD 299 (300)
Q Consensus 294 hpw~~~ 299 (300)
||||++
T Consensus 409 Hpw~~~ 414 (429)
T 3kvw_A 409 HPWLRR 414 (429)
T ss_dssp STTTC-
T ss_pred Chhhcc
Confidence 999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=321.15 Aligned_cols=236 Identities=29% Similarity=0.464 Sum_probs=182.4
Q ss_pred CCcceee-eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHH-HhcCCCceeEeceeeeC---CCCcEEE
Q 040812 56 LSQLEKL-QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNIL-RQTNSPYIVKCHQIFTK---PSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~---~~~~~~l 130 (300)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ....+|+.++ +..+||||+++++++.. ..+..|+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 4668887 7899999999999999999999999998642 2346788888 56699999999998865 2347999
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceeeccccccccc
Q 040812 131 LMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHR 208 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 208 (300)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++..... +...+.+++.+...
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN--AILKLTDFGFAKET 170 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT--CCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCC--CcEEEecccccccc
Confidence 999999999999998754 69999999999999999999999999999999999999973210 22333344433322
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC----CCCChHHHHHHHHHhccCCCCC
Q 040812 209 KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP----ECSSEKFRDFIRCCLQKGDPSK 284 (300)
Q Consensus 209 ~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~dp~~ 284 (300)
.+..++.++|||||||++|||+||..||........... ............+ ..+++++.++|.+||.. ||++
T Consensus 171 -~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dP~~ 247 (299)
T 3m2w_A 171 -TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT-EPTQ 247 (299)
T ss_dssp -TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCS-STTT
T ss_pred -ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-HHHHHhhccccCCchhcccCCHHHHHHHHHHccc-Chhh
Confidence 245678899999999999999999999965432210000 0000011111222 45789999999999999 9999
Q ss_pred CCCHHHHhcCCCCCC
Q 040812 285 RWTASQLLSHPFLAD 299 (300)
Q Consensus 285 Rpt~~~~l~hpw~~~ 299 (300)
|||++|+++||||.+
T Consensus 248 Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 248 RMTITEFMNHPWIMQ 262 (299)
T ss_dssp SCCHHHHHTSHHHHT
T ss_pred CCCHHHHhcChhhcc
Confidence 999999999999965
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=313.79 Aligned_cols=236 Identities=26% Similarity=0.352 Sum_probs=193.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeC-CCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTK-PSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~l 130 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|.+....... .+.+|+.++++++||||+++++++.. ..+..|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 578999999999999999999999999999999997654322 23579999999999999999998743 2347999
Q ss_pred EEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhHhCC-----ccccCCCCCceeecCCCCCCccc-----
Q 040812 131 LMEYMDAGSLEIYVKSR----GRLSEDIICTISRQVLKGLFYMHSRN-----IVHRDIKPANVLINEKMEHPCGY----- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~-----i~H~Dlkp~Nill~~~~~~~~~~----- 196 (300)
||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++...+.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 34999999999999999999999999 99999999999999876543332
Q ss_pred --------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC
Q 040812 197 --------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 197 --------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (300)
+..|.+||... +..++.++|||||||++|+|+||..||..... ......+........+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIP 237 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHH---CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCC
T ss_pred eeccccccccccCCCccccChHHhc---cCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHHHHHhhcccccCC
Confidence 22355555543 44577899999999999999999999965432 2333334445555677
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+++.+.++|.+||.. ||++|||++++++|+|+.+
T Consensus 238 ~~~~~~l~~li~~~l~~-~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNL-KDYHRPSVEEILENPLILE 273 (279)
T ss_dssp TTSCHHHHHHHHHHTCS-SGGGSCCHHHHHTSTTCCG
T ss_pred cccCHHHHHHHHHHcCC-CcccCCCHHHHHhChhhhh
Confidence 78899999999999999 9999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=315.30 Aligned_cols=233 Identities=35% Similarity=0.544 Sum_probs=195.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+.|++++.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-KLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence 456999999999999999999999999999999997654332 2367999999999999999999998754 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------------- 196 (300)
||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++...+.+
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 99999999999865 4799999999999999999999999999999999999998876543222
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+..|.+||... +..++.++|||||||++|+|+||..||..... ......+.....+..+..++..+.++|
T Consensus 179 ~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li 251 (303)
T 3a7i_A 179 FVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIPKNNPPTLEGNYSKPLKEFV 251 (303)
T ss_dssp CCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCCCCCSSCCHHHHHHH
T ss_pred cCCCcCccCHHHHh---cCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHHhhcCCCCCCccccCHHHHHHH
Confidence 22345555443 45577899999999999999999999965332 223333444556677788999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+||.. ||++|||++++++||||.
T Consensus 252 ~~~l~~-dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 252 EACLNK-EPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp HHHCCS-SGGGSCCHHHHTTCHHHH
T ss_pred HHHcCC-ChhhCcCHHHHhhChhhh
Confidence 999999 999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=332.47 Aligned_cols=238 Identities=24% Similarity=0.368 Sum_probs=173.8
Q ss_pred ccee-eeeecCCcceEEEEEEEc--cCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeC-CCCcEEEEEe
Q 040812 58 QLEK-LQVLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTK-PSGEVSILME 133 (300)
Q Consensus 58 ~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e 133 (300)
.|++ .++||+|+||.||+|+++ .+++.||+|++........+.+|+.+|++++||||+++++++.. .....|+|||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 4665 458999999999999976 56889999999766555556789999999999999999999853 2347999999
Q ss_pred ccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec----CCCCCC---cc--
Q 040812 134 YMDAGSLEIYVKSR---------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN----EKMEHP---CG-- 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~----~~~~~~---~~-- 195 (300)
|+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+. .++... +|
T Consensus 101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 9976 888777531 2489999999999999999999999999999999999993 333322 22
Q ss_pred -----------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--------chHHHHH
Q 040812 196 -----------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE--------PDFLSLM 250 (300)
Q Consensus 196 -----------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--------~~~~~~~ 250 (300)
++..|.+||.... ...++.++|||||||++|||+||+.||...... .+....+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp C----------------CCCTTCCHHHHTT--CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcC--CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 1233566665431 235788999999999999999999999654332 1111111
Q ss_pred HHHhhCCCCCC----------------------------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 040812 251 LAICFREPPSL----------------------------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPF 296 (300)
Q Consensus 251 ~~~~~~~~~~~----------------------------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw 296 (300)
........... ....++.+.+||.+||.. ||++|||++|+|+|||
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~-dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM-DPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCS-SGGGSCCHHHHHTSGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccC-CcccCCCHHHHhcChh
Confidence 11111111100 111267889999999999 9999999999999999
Q ss_pred CCC
Q 040812 297 LAD 299 (300)
Q Consensus 297 ~~~ 299 (300)
|.+
T Consensus 337 f~~ 339 (405)
T 3rgf_A 337 FLE 339 (405)
T ss_dssp GTS
T ss_pred hcc
Confidence 975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=336.74 Aligned_cols=234 Identities=17% Similarity=0.206 Sum_probs=178.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHH---HHHHhcCCCceeEec-------e
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQEL---NILRQTNSPYIVKCH-------Q 119 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~---~~l~~l~h~niv~~~-------~ 119 (300)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+|+ ..+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999999999999999997543322 235788 455566899999998 5
Q ss_pred eeeCCCC----------------cEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHhHhCCccc
Q 040812 120 IFTKPSG----------------EVSILMEYMDAGSLEIYVKSRGRLSE-------DIICTISRQVLKGLFYMHSRNIVH 176 (300)
Q Consensus 120 ~~~~~~~----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~qi~~~l~~lH~~~i~H 176 (300)
++..++. ..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 5554321 388999999 5799999987555555 788889999999999999999999
Q ss_pred cCCCCCceeecCCCCCCccce---------------eecccccccccc--------CCCCCCchhhHHHHHHHHHHHHhC
Q 040812 177 RDIKPANVLINEKMEHPCGYS---------------CLYESGEARHRK--------HGGYNGFAADIWSFGVTMMELYMG 233 (300)
Q Consensus 177 ~Dlkp~Nill~~~~~~~~~~~---------------~~~~~~~~~~~~--------~~~~~~~~~DiwSlG~il~elltg 233 (300)
|||||+|||++.++..+++++ ..|.+||..... ....++.++|||||||++|||+||
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 999999999998765533322 345666665422 001578899999999999999999
Q ss_pred CCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 234 YYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 234 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.||........... + ...+..+++.+.++|.+||.. ||++|||+.++++||||++
T Consensus 310 ~~Pf~~~~~~~~~~~----~-----~~~~~~~~~~~~~li~~~L~~-dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 310 DLPITKDAALGGSEW----I-----FRSCKNIPQPVRALLEGFLRY-PKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp SCCC------CCSGG----G-----GSSCCCCCHHHHHHHHHHTCS-SGGGCCCHHHHHTSHHHHH
T ss_pred CCCCcccccccchhh----h-----hhhccCCCHHHHHHHHHHcCC-CchhCCCHHHHhhChHHHH
Confidence 999965443221111 1 112356789999999999999 9999999999999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=326.51 Aligned_cols=235 Identities=23% Similarity=0.293 Sum_probs=190.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCC---c
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSG---E 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 127 (300)
.++|++.+.||+|+||.||+|++..+++.||+|+++...... .+.+|+.++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 367999999999999999999999999999999997654332 23578999999999999999998865431 3
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
.|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 599999999999999999888899999999999999999999999999999999999998876543322
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC---CCC
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP---SLP 262 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~ 262 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...... ............ ...
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------CCTTCCHHHHH---TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCHHHHS
T ss_pred cccccccccCcCcccCCHHHhc---CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCCCccccc
Confidence 23355555543 556788999999999999999999999654332 222222212111 123
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
..+++++.++|.+||.. ||++||++.+++.|+|++
T Consensus 244 ~~~~~~l~~li~~~l~~-dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 244 EGLSADLDAVVLKALAK-NPENRYQTAAEMRADLVR 278 (311)
T ss_dssp TTCCHHHHHHHHHHTCS-SGGGSCSSHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhc-CHhhChhhHHHHHHHHHH
Confidence 45789999999999999 999999999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=325.22 Aligned_cols=234 Identities=23% Similarity=0.330 Sum_probs=193.4
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
.+....++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+|+.+|++++||||+++++++.... .
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-P 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-C
Confidence 344566789999999999999999999998999999999875422 235678999999999999999999987654 8
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------
Q 040812 128 VSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------- 198 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------- 198 (300)
.|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++..++.+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999999998643 69999999999999999999999999999999999999987654332221
Q ss_pred -------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 199 -------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
.|.+||... ++.++.++|||||||++|||+| |..||..... ......+........|..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALN---YGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTREFVEKGGRLPCPEL 339 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHHHHHHHTTCCCCCCTT
T ss_pred ceeecCCCCCCCcCcCCHhHhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCCC
Confidence 255555543 3456789999999999999998 9999965432 223333344556667788
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+.++|.+||.. ||++|||++++++
T Consensus 340 ~~~~l~~li~~cl~~-dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAY-EPGQRPSFSTIYQ 367 (377)
T ss_dssp CCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCC-CchhCcCHHHHHH
Confidence 999999999999999 9999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=311.69 Aligned_cols=235 Identities=23% Similarity=0.298 Sum_probs=190.6
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
+.+....++|++.+.||+|+||.||+|.+. ++..||+|+++..... ..+.+|+.++++++||||+++++++.... ..
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 94 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PI 94 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-Ce
Confidence 344456789999999999999999999887 4778999999754422 33468999999999999999999987754 89
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 129 SILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++...+.++
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999986 457999999999999999999999999999999999999998765433222
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
..|.+||... +..++.++|||||||++|+|+| |+.||..... ......+........+...+
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~ 247 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGLRLYRPHLAS 247 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCCCCCCTTCC
T ss_pred cccccCCccCcccCCHHHhc---cCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHHHHHhcccCCCCCCcCC
Confidence 2255555543 3457889999999999999998 9999965432 23333444455666677889
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.+.++|.+||.. ||++|||++++++|
T Consensus 248 ~~l~~li~~~l~~-~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHE-KADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccC-ChhHCcCHHHHHHH
Confidence 9999999999999 99999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=317.20 Aligned_cols=240 Identities=25% Similarity=0.394 Sum_probs=187.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEc-cCCeEEEEEEeecCCCC----CCCHHHHHHHHhc---CCCceeEeceeeeC----
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHK-QTLALYALKVMQCDRGT----PPNPQELNILRQT---NSPYIVKCHQIFTK---- 123 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 123 (300)
.++|++.+.||+|+||.||+|++. .+++.||+|+++..... ....+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999995 67899999998754322 2345788887776 89999999998861
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----- 196 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----- 196 (300)
..+..++||||++ |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++...+.+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 2347999999998 59999998643 499999999999999999999999999999999999998876543322
Q ss_pred -------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC------
Q 040812 197 -------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE------ 257 (300)
Q Consensus 197 -------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------ 257 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...........+........
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccCCCCccccccccceeCHHHHh---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 22344554433 45578899999999999999999999976543322222222111000
Q ss_pred ----------------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 258 ----------------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 258 ----------------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.......+++.+.+||.+||.. ||++|||+.++++||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF-NPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS-STTTSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCC-CcccCCCHHHHhcCcccccc
Confidence 0112345788999999999999 99999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=324.03 Aligned_cols=232 Identities=22% Similarity=0.328 Sum_probs=189.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-------cCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeee
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-------QTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFT 122 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~ 122 (300)
...++|++.+.||+|+||.||+|++. .++..||+|+++..... ..+.+|+.+++++ +||||+++++++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34678999999999999999999975 34668999998754322 1246799999999 8999999999988
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 123 KPSGEVSILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
... ..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 158 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 158 QDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSS-SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred cCC-CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 754 8999999999999999998643 47899999999999999999999999999999999999
Q ss_pred cCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 187 NEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 187 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
+.++..++.++ ..|.+||... +..++.++|||||||++|||+| |..||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH---TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc---CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 88765433222 2355555543 4567889999999999999999 99999764332
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.....+.....+..+..+++.+.++|.+||.. ||++|||+.|++++
T Consensus 313 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 313 ---ELFKLLKEGHRMDKPANCTNELYMMMRDCWHA-VPSQRPTFKQLVED 358 (370)
T ss_dssp ---GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred ---HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 22333344556677788999999999999999 99999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=325.11 Aligned_cols=235 Identities=25% Similarity=0.359 Sum_probs=192.6
Q ss_pred cCCCCcceeeeeecCCcceEEEEEE-----EccCCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVR-----HKQTLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
....++|++.+.||+|+||.||+|+ ...+++.||||+++...... .+.+|+.++.++ +||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3456889999999999999999999 45567899999997543222 246799999999 78999999999887
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhCCC------------------------------------------------------
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSRGR------------------------------------------------------ 149 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 149 (300)
..+..++|||||++|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 66569999999999999999986432
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------------------
Q 040812 150 ------------LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------------------- 197 (300)
Q Consensus 150 ------------l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------------------- 197 (300)
+++..++.++.||+.||.|||++||+||||||+|||++.++...++++
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 899999999999999999999999999999999999987655433222
Q ss_pred -eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHH
Q 040812 198 -CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275 (300)
Q Consensus 198 -~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (300)
..|.+||... +..++.++|||||||++|||+| |..||............ .........+..+++++.++|.+
T Consensus 258 t~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 258 PLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---LKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp CGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH---HHHTCCCCCCTTCCHHHHHHHHH
T ss_pred CceeEChhhhc---CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH---HHcCCCCCCCCCCCHHHHHHHHH
Confidence 2355555543 4557889999999999999999 99999766544433332 33355666778899999999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 040812 276 CLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~h 294 (300)
||.. ||++|||++++++|
T Consensus 332 ~l~~-dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 332 CWHG-EPSQRPTFSELVEH 349 (359)
T ss_dssp HTCS-SGGGSCCHHHHHHH
T ss_pred HccC-ChhhCCCHHHHHHH
Confidence 9999 99999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=319.18 Aligned_cols=230 Identities=24% Similarity=0.319 Sum_probs=185.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|++..+++.||+|.+....... .+.+|+.++++++||||+++++++.... ..|+|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 89 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-CYYLV 89 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-EEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-eEEEE
Confidence 57999999999999999999999999999999986543322 2357999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
|||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++...+.+
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 99999999999999888899999999999999999999999999999999999998876543222
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC----CCCCCCCh
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP----SLPECSSE 267 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 267 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...... ...........+ ..+..+++
T Consensus 170 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAK---GEATDECTDIYSIGIVLYEMLVGEPPFNGETAV----SIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----CCSSCCHHHHH---TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----HHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred CccccCccccCHhHhc---CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhhccCCCcchhcccCCCH
Confidence 33355555443 456778999999999999999999999654332 112222222222 23456789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHP 295 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hp 295 (300)
.+.++|.+||.. ||++||+..+.+.+.
T Consensus 243 ~l~~li~~~l~~-dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 243 SLSNVILRATEK-DKANRYKTIQEMKDD 269 (294)
T ss_dssp HHHHHHHHHSCS-SGGGSCSSHHHHHHH
T ss_pred HHHHHHHHHhcC-CHhHccccHHHHHHH
Confidence 999999999999 999999555444443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=329.54 Aligned_cols=233 Identities=25% Similarity=0.356 Sum_probs=194.9
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.+....++|++.+.||+|+||.||+|.+. ++.||||+++.......+.+|+.+|++++||||+++++++....+..|+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 34456789999999999999999999986 6799999998766555667899999999999999999998766557999
Q ss_pred EEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 131 LMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++..++.++
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 344 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccccc
Confidence 9999999999999987543 799999999999999999999999999999999999998765433322
Q ss_pred -----eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 198 -----CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 198 -----~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
..|.+||... +..++.++|||||||++|||+| |+.||....... ....+..+.....|..+++.+.+
T Consensus 345 ~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 345 TGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --CCCTTTSCHHHHH---SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CCCCCcceeCHHHhc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCCCCCCCCcCCHHHHH
Confidence 2355555543 4567889999999999999998 999997654432 22333445566778889999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 040812 272 FIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+|.+||.. ||++|||+.++++
T Consensus 418 li~~cl~~-dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHL-DAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHcCC-ChhHCcCHHHHHH
Confidence 99999999 9999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=328.21 Aligned_cols=239 Identities=26% Similarity=0.344 Sum_probs=179.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCC-----C
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPS-----G 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 126 (300)
.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++++++||||+++++++.... +
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999999999999999998653322 12357999999999999999999986531 3
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|+|||++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++..++.+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 589999999 6799998875 5799999999999999999999999999999999999999876543332
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh---------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF--------------- 255 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------- 255 (300)
+..|.+||.... ...++.++|||||||++|||+||+.||.+.+.......+......
T Consensus 186 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 186 MTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -----CCCTTCCHHHHTT--CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred CCCcCcCcCccChHHHcC--CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 333566665431 245788999999999999999999999764432222222111100
Q ss_pred ----CCC--CC-----CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 ----REP--PS-----LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 ----~~~--~~-----~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+ +. .....++.+.+||.+||.. ||++|||++++++||||++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~-dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL-DSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGTT
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCC-CcccCcCHHHHhcChhhhh
Confidence 000 00 1124578899999999999 9999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=314.02 Aligned_cols=234 Identities=31% Similarity=0.456 Sum_probs=189.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.... ..|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC-eEEEE
Confidence 367999999999999999999999999999999987543322 2357999999999999999999988754 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Cccc---------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PCGY--------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~~~--------- 196 (300)
|||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++. . ++|.
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 999999999999988778999999999999999999999999999999999999976432 2 1221
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC-CCCC--CCCCCh
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE-PPSL--PECSSE 267 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~ 267 (300)
+..|.+||... +.++.++||||||+++|+|+||..||...... .....+.... .... ...+++
T Consensus 180 ~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLR----GTYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp CSCHHHHHTTCCHHHHT----TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCSGGGTTSCH
T ss_pred cccccCcccccChHHhc----CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCchhhhhcCH
Confidence 22245555432 23678999999999999999999999754322 2222222221 1222 246789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.++|.+||.. ||++|||++++++||||++
T Consensus 252 ~~~~li~~~l~~-dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 252 DAKDLIRKMLTF-HPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHHHccc-ChhhCcCHHHHhcCHHHhc
Confidence 999999999999 9999999999999999964
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=308.08 Aligned_cols=234 Identities=21% Similarity=0.323 Sum_probs=192.0
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+....++|++.+.||+|+||.||+|.+.. ++.||+|++...... ..+.+|+.++++++||||+++++++.+.. ..|
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~ 81 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PIC 81 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ceE
Confidence 344566889999999999999999999975 678999999754422 23468999999999999999999988754 899
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++...+.++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999999999753 46899999999999999999999999999999999999987755432221
Q ss_pred ---------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 198 ---------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 198 ---------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
..|.+||... +..++.++|||||||++|+|+| |..||..... ......+........+...++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDISTGFRLYKPRLAST 234 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCCCCCCTTSCH
T ss_pred ccccCcccccccCCHHHhc---CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHhcCccCCCCCcCCH
Confidence 1355555543 4457889999999999999999 9999965332 233444444556666778899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+.++|.+||.. ||++|||+.++++|
T Consensus 235 ~~~~li~~~l~~-~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRE-RPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccC-CcccCcCHHHHHHH
Confidence 999999999999 99999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=317.56 Aligned_cols=241 Identities=20% Similarity=0.304 Sum_probs=181.1
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCe---EEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeC
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLA---LYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTK 123 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 123 (300)
......++|++.+.||+|+||.||+|.+..++. .||+|+++...... .+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334456789999999999999999999887665 89999987543222 24679999999999999999999876
Q ss_pred CCC-----cEEEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 124 PSG-----EVSILMEYMDAGSLEIYVKSRG------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 124 ~~~-----~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
... ..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++..
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 541 1399999999999999996532 58999999999999999999999999999999999999987654
Q ss_pred Ccccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 040812 193 PCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLM 250 (300)
Q Consensus 193 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 250 (300)
.+++++ .|.+||... +..++.++|||||||++|||+| |..||....... ..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~ 249 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA---DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IY 249 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhc---CCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HH
Confidence 333222 244444433 4457889999999999999999 999997654432 23
Q ss_pred HHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCC-------HHHHhcCCCCCC
Q 040812 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWT-------ASQLLSHPFLAD 299 (300)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt-------~~~~l~hpw~~~ 299 (300)
..+........+..+++.+.++|.+||.. ||++||| ++++++|||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSA-DPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCS-SGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHHhcCCCCCCCCccCHHHHHHHHHHccC-ChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 33334455666778899999999999999 9999999 888899999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=317.00 Aligned_cols=230 Identities=26% Similarity=0.408 Sum_probs=190.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--------CCCHHHHHHHHhcC--CCceeEeceeeeCCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--------PPNPQELNILRQTN--SPYIVKCHQIFTKPS 125 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 125 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++ |+||+++++++..+.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 56799999999999999999999999999999999764322 34467999999996 599999999998765
Q ss_pred CcEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec-CCCCCCcc--------
Q 040812 126 GEVSILMEYMDA-GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN-EKMEHPCG-------- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~-~~~~~~~~-------- 195 (300)
..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++...++
T Consensus 122 -~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 122 -SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp -EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred -cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 89999999976 89999999888899999999999999999999999999999999999998 44333222
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
++..|.+||.... +...+.++|||||||++|||+||+.||.... ... ......+..++
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~-----~~~~~~~~~~~ 267 (320)
T 3a99_A 201 KDTVYTDFDGTRVYSPPEWIRY--HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII-----RGQVFFRQRVS 267 (320)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH-----HCCCCCSSCCC
T ss_pred ccccccCCCCCccCCChHHhcc--CCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh-----cccccccccCC
Confidence 2334566665432 2234678999999999999999999995321 111 22344567789
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
+++.++|.+||.. ||++|||++++++||||++.
T Consensus 268 ~~~~~li~~~l~~-dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 268 SECQHLIRWCLAL-RPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccC-ChhhCcCHHHHhcCHhhcCc
Confidence 9999999999999 99999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=313.93 Aligned_cols=229 Identities=24% Similarity=0.338 Sum_probs=188.9
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
...++|++.+.||+|+||.||+|++. ++.||+|++....... .+.+|+.++++++||||+++++++.... ..+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-CCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-ceE
Confidence 45688999999999999999999874 7889999987544322 2357999999999999999999998765 799
Q ss_pred EEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCCCCCCccc--------
Q 040812 130 ILMEYMDAGSLEIYVKSRGR---LSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKMEHPCGY-------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~~~~~~~~-------- 196 (300)
+||||+++|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++.++...+.+
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999987553 999999999999999999999999 99999999999999876543322
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHH-HhhCCCCCCCCC
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLA-ICFREPPSLPEC 264 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 264 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...... ..... .........+..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp -----------CCTTSCHHHHT---TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHSCCCCCCCTT
T ss_pred ccccccccCCCCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCCCcc
Confidence 23355555543 555788999999999999999999999654322 22222 223455677888
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+.++|.+||.. ||++|||++++++
T Consensus 264 ~~~~l~~li~~~l~~-dP~~Rps~~~ll~ 291 (309)
T 3p86_A 264 LNPQVAAIIEGCWTN-EPWKRPSFATIMD 291 (309)
T ss_dssp SCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccC-ChhhCcCHHHHHH
Confidence 999999999999999 9999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=316.99 Aligned_cols=229 Identities=26% Similarity=0.401 Sum_probs=183.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--------CCCCHHHHHHHHhc----CCCceeEeceeeeC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--------TPPNPQELNILRQT----NSPYIVKCHQIFTK 123 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~E~~~l~~l----~h~niv~~~~~~~~ 123 (300)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++.++ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 4679999999999999999999999999999999975432 23456799999998 89999999999877
Q ss_pred CCCcEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec-CCCCCCccc-----
Q 040812 124 PSGEVSILMEY-MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN-EKMEHPCGY----- 196 (300)
Q Consensus 124 ~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~-~~~~~~~~~----- 196 (300)
.. ..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++...+++
T Consensus 110 ~~-~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 110 QE-GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred CC-eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 54 78999999 78999999999888899999999999999999999999999999999999998 554332222
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
+..|.+||.... +...+.++|||||||++|+|+||+.||... .... .....++..
T Consensus 189 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~-----~~~~~~~~~ 255 (312)
T 2iwi_A 189 LLHDEPYTDFDGTRVYSPPEWISR--HQYHALPATVWSLGILLYDMVCGDIPFERD------QEIL-----EAELHFPAH 255 (312)
T ss_dssp ECCSSCBCCCCSCTTTSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHH-----HTCCCCCTT
T ss_pred hcccCcccccCCcccccCceeeec--CCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHh-----hhccCCccc
Confidence 223455554331 223355899999999999999999999532 1111 233456677
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++..+.++|.+||.. ||++|||++++++||||++
T Consensus 256 ~~~~~~~li~~~l~~-~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 256 VSPDCCALIRRCLAP-KPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp SCHHHHHHHHHHTCS-STTTSCCHHHHHHSTTTCC
T ss_pred CCHHHHHHHHHHccC-ChhhCcCHHHHhcChhhcC
Confidence 899999999999999 9999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=327.82 Aligned_cols=238 Identities=25% Similarity=0.343 Sum_probs=184.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC-----
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS----- 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 125 (300)
-.++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3578999999999999999999999999999999997543221 2357999999999999999999987543
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
...|+||||+++ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++..++++
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 268999999976 78888863 589999999999999999999999999999999999999876543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh------------
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF------------ 255 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------ 255 (300)
+..|.+||... +..++.++|||||||++|+|+||..||...+.......++.....
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ----------CTTCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccccCCceecCCccCHHHhc---CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 22355555543 456788999999999999999999999764432222111110000
Q ss_pred -----CCCCCC--------------CC------CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 -----REPPSL--------------PE------CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 -----~~~~~~--------------~~------~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+.. +. ..++.+++||.+||.. ||++|||++|+++||||++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~-dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI-DASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS-SGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcC-ChhhCCCHHHHhCCcchhh
Confidence 000000 00 0146789999999999 9999999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=322.69 Aligned_cols=233 Identities=25% Similarity=0.408 Sum_probs=190.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------------------CCCHHHHHHHHhcCCCceeE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------------------PPNPQELNILRQTNSPYIVK 116 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~E~~~l~~l~h~niv~ 116 (300)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... ..+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 57899999999999999999999 7999999998753211 33467999999999999999
Q ss_pred eceeeeCCCCcEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeec
Q 040812 117 CHQIFTKPSGEVSILMEYMDAGSLEIY------VKS--RGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLIN 187 (300)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~ 187 (300)
+++++.... ..|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++
T Consensus 108 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 108 CEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CSEEEESSS-EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEEeeCC-eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999998764 89999999999999998 655 5679999999999999999999999 9999999999999998
Q ss_pred CCCCCCccc-----------------eeeccccccccccCCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q 040812 188 EKMEHPCGY-----------------SCLYESGEARHRKHGG-YNGF-AADIWSFGVTMMELYMGYYPFLEPGQEPDFLS 248 (300)
Q Consensus 188 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~-~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 248 (300)
.++...+++ +..|.+||... +. .++. ++|||||||++|+|+||..||...........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFS---NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGS---SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCCcEEEeccccccccccccccCCCCCcCccCchhhc---CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 876543322 23356666544 22 3444 99999999999999999999976554333222
Q ss_pred HHHHHhhCCCCCCC-------------------CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 249 LMLAICFREPPSLP-------------------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 249 ~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+ . ......+ ..+++.+.++|.+||.. ||++|||++++++||||++
T Consensus 264 ~i---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~-dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 264 NI---R-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK-NPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HH---T-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCS-SGGGSCCHHHHHTSGGGTT
T ss_pred HH---h-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccC-ChhhCCCHHHHhcCccccC
Confidence 22 2 2222333 56789999999999999 9999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=317.13 Aligned_cols=237 Identities=28% Similarity=0.443 Sum_probs=185.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCC-----------
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKP----------- 124 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------- 124 (300)
++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+.++++++||||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 579999999999999999999999999999999864321 12346799999999999999999987542
Q ss_pred -CCcEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----
Q 040812 125 -SGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----- 197 (300)
Q Consensus 125 -~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----- 197 (300)
.+..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++...++++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 236899999999999999998643 5788999999999999999999999999999999999988765433322
Q ss_pred ----------------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 040812 198 ----------------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL 249 (300)
Q Consensus 198 ----------------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 249 (300)
..|.+||.... .+.++.++|||||||++|+|++ ||............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp TTC-------------------------CTTSCHHHHTS--CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred cccccchhccccccccccccccccCCCcccccCcccccC--CCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 22445554331 2356789999999999999998 66432211122222
Q ss_pred HHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+.......++..+...++.+.++|.+||.. ||++|||++++++||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDH-DPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHSTTCCCCTTCCTTTSHHHHHHHHHHTCS-SGGGSCCHHHHHHSSCSCC
T ss_pred ccccccccCccccccchHHHHHHHHHHHhc-CcccCcCHHHHhCCCCcCC
Confidence 222222334445566778899999999999 9999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=326.99 Aligned_cols=238 Identities=26% Similarity=0.342 Sum_probs=180.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCC-----CcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPS-----GEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~~l 130 (300)
..+|++.+.||+|+||.||+|++..+++ +|+|.+.... ....+|+.+++.++||||+++++++.... ...|+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK--RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc--chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 3579999999999999999999988766 7788775433 23357999999999999999999985332 23889
Q ss_pred EEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec-CCCCCC---ccc-------
Q 040812 131 LMEYMDAGSLEIYV---KSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN-EKMEHP---CGY------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~-~~~~~~---~~~------- 196 (300)
||||++++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++..+ +|.
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 99999875443332 2356799999999999999999999999999999999999998 454322 222
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh------------C
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF------------R 256 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------~ 256 (300)
+..|.+||.... ...++.++|||||||++|||++|+.||...........++..... .
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCcccccCcCccCHHHHcC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 233566665431 234788999999999999999999999765433333333221100 0
Q ss_pred CCC------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 EPP------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 ~~~------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
... .++...++++.+||.+||.. ||++|||+.|+++||||++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY-TPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS-SGGGSCCHHHHHTSGGGST
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCC-ChhhCCCHHHHhcChhhhh
Confidence 000 12334788999999999999 9999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=316.61 Aligned_cols=236 Identities=25% Similarity=0.446 Sum_probs=187.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC------CCCCCHHHHHHHHhcCCCceeEeceeeeCC-CCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR------GTPPNPQELNILRQTNSPYIVKCHQIFTKP-SGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~ 128 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+|+.++++++||||+++++++... .+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999986532 112346799999999999999999997432 3479
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-----------
Q 040812 129 SILMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG----------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~----------- 195 (300)
|+||||++++ |.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++...++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999885 7777765 3469999999999999999999999999999999999999877554322
Q ss_pred ----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 196 ----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
++..|.+||..... ....+.++|||||||++|+|+||+.||..... ......+. ......+..+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~-~~~~~~~~~~ 236 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----YKLFENIG-KGSYAIPGDC 236 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH-HCCCCCCSSS
T ss_pred ccccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHHh-cCCCCCCCcc
Confidence 22335555544311 12346799999999999999999999965332 22222222 3345567788
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.+.++|.+||.. ||++|||++++++||||++
T Consensus 237 ~~~l~~li~~~l~~-dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 237 GPPLSDLLKGMLEY-EPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp CHHHHHHHHHHTCS-STTTSCCHHHHHHSHHHHS
T ss_pred CHHHHHHHHHHccC-ChhhCCCHHHHhcCccccc
Confidence 99999999999999 9999999999999999965
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=309.26 Aligned_cols=239 Identities=31% Similarity=0.453 Sum_probs=191.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
.++|.....||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++||||+++++++.... ..++|||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 99 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-FIKIFME 99 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-cEEEEEE
Confidence 44556667899999999999999999999999998764322 22357999999999999999999998754 8999999
Q ss_pred ccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-CCCCCcc--------------
Q 040812 134 YMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-KMEHPCG-------------- 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~-~~~~~~~-------------- 195 (300)
|+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++. ++...++
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999999998642 4678999999999999999999999999999999999986 4433221
Q ss_pred -----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 196 -----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 196 -----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
++..|.+||..... ...++.++|||||||++|+|+||+.||........ ...........+..+..+++.+.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKG-PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKVGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHG-GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHHHHHHCCCCCCCTTSCHHHH
T ss_pred ccccCCCccccChhhhcCC-CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHhhccccccccccccCCHHHH
Confidence 12335555554321 12367799999999999999999999965332211 22222333556677888999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++|.+||.. ||++|||++++++||||+.
T Consensus 257 ~li~~~l~~-dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 257 AFILKCFEP-DPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHHHHTTCS-STTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHccC-ChhhCCCHHHHhcChhhhh
Confidence 999999999 9999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=314.16 Aligned_cols=220 Identities=14% Similarity=0.114 Sum_probs=177.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++.+++||||+++++++.... ..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-GGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-cEEEE
Confidence 67999999999999999999999999999999997654432 3467999999999999999999998764 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceeeccccccccccCC
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHG 211 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (300)
|||++|++|.+++... .....+..++.||+.||.|||++||+||||||+|||++.++...+++.. + .
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-~----------~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-T----------M 176 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-C----------C
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-c----------c
Confidence 9999999999999643 4666788999999999999999999999999999999988766554221 1 2
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC---CCCCCCChHHHHHHHHHhccCCCCCCCCH
Q 040812 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP---SLPECSSEKFRDFIRCCLQKGDPSKRWTA 288 (300)
Q Consensus 212 ~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~dp~~Rpt~ 288 (300)
..++.++|||||||++|||+||+.||............... ...... .....+++.+.++|.+||.. ||++| |+
T Consensus 177 ~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dP~~R-s~ 253 (286)
T 3uqc_A 177 PDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQISAVAARSVQG-DGGIR-SA 253 (286)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-TTSCBCCHHHHCTTSCHHHHHHHHHHHCT-TSSCC-CH
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-hccCCCChhhcccCCCHHHHHHHHHHccc-CCccC-CH
Confidence 24678999999999999999999999765432211000000 001111 22356789999999999999 99999 99
Q ss_pred HHHhc
Q 040812 289 SQLLS 293 (300)
Q Consensus 289 ~~~l~ 293 (300)
+++++
T Consensus 254 ~el~~ 258 (286)
T 3uqc_A 254 STLLN 258 (286)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99885
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=322.40 Aligned_cols=241 Identities=24% Similarity=0.280 Sum_probs=173.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCC------Cc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPS------GE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 127 (300)
.+++|++.+.||+|+||.||+|++..+++.||||++..+... ....+|+..+..++||||+++++++.... ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 457899999999999999999999999999999998654332 23356777788899999999999985422 13
Q ss_pred EEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhH--hCCccccCCCCCceeecC-CCCCCcc-----
Q 040812 128 VSILMEYMDAGSLEIYVK----SRGRLSEDIICTISRQVLKGLFYMH--SRNIVHRDIKPANVLINE-KMEHPCG----- 195 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~lH--~~~i~H~Dlkp~Nill~~-~~~~~~~----- 195 (300)
.++||||+++ +|...+. ....+++..++.++.|++.||.||| ++||+||||||+|||++. ++...++
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 8899999987 5544433 4567899999999999999999999 999999999999999986 4433221
Q ss_pred -------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC------
Q 040812 196 -------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR------ 256 (300)
Q Consensus 196 -------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------ 256 (300)
++..|.+||.... ...++.++|||||||++|+|+||+.||...........+.......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFG--NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcC--CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 2334566665431 2346889999999999999999999997654333222222211000
Q ss_pred ---------------------CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 257 ---------------------EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 257 ---------------------~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.....+...++++.+||.+||+. ||++|||+.|+++||||++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY-LPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCS-SGGGSCCHHHHTTSGGGGG
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhcc-CccccCCHHHHhcCccccc
Confidence 00112223567899999999999 9999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=323.52 Aligned_cols=238 Identities=27% Similarity=0.358 Sum_probs=186.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCC-----
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSG----- 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 126 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.++++++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368999999999999999999999999999999987543322 23579999999999999999999876542
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 121 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCE-EHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccc-cHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 13999999974 88887743 599999999999999999999999999999999999999876543322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh---------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF--------------- 255 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------------- 255 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...+.......+......
T Consensus 198 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 198 MTGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp --CTTCCCTTSCHHHHSC--CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCCcccCccccCHHHhcC--CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 334566665432 245788999999999999999999999764432222222111000
Q ss_pred ----CCC--C-----CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 ----REP--P-----SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 ----~~~--~-----~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+ + ..+...++.+.+||.+||+. ||++|||++|+++||||++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL-DVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS-CTTTSCCHHHHHTSGGGTT
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCC-ChhhcCCHHHHhcCccccc
Confidence 000 0 01235688999999999999 9999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=323.82 Aligned_cols=241 Identities=19% Similarity=0.236 Sum_probs=186.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-------------CCHHHHHHHHhcCCCceeEeceee
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-------------PNPQELNILRQTNSPYIVKCHQIF 121 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~E~~~l~~l~h~niv~~~~~~ 121 (300)
..++|++.+.||+|+||.||+|.+.. ++.||+|.+....... .+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 35789999999999999999999876 8899999986543322 235799999999999999999998
Q ss_pred eCC----CCcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc
Q 040812 122 TKP----SGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY 196 (300)
Q Consensus 122 ~~~----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~ 196 (300)
... ....|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 432 2368999999985 888887754 3699999999999999999999999999999999999998776543322
Q ss_pred ------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh----
Q 040812 197 ------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---- 254 (300)
Q Consensus 197 ------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---- 254 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...........+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQ--FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp TTC---------------CGGGCCHHHHTT--CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCcccccccccccceecccceecCcHHhcC--CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 233566665432 24578899999999999999999999976443222222211100
Q ss_pred ---------------hCCCC--------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 255 ---------------FREPP--------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 255 ---------------~~~~~--------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
..... ......++.+.+||.+||.. ||++|||++++++||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF-NPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCS-SGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcC-ChhhCCCHHHHHcCchhhhc
Confidence 00000 11234578899999999999 99999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=318.68 Aligned_cols=238 Identities=27% Similarity=0.365 Sum_probs=186.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCC----CCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKP----SGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~ 128 (300)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++++++||||+++++++... .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46899999999999999999999999999999998643221 1235799999999999999999987643 2479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------ 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------ 196 (300)
|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 90 ~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 90 YIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 999999975 99998876 4799999999999999999999999999999999999998775543221
Q ss_pred -----------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC-
Q 040812 197 -----------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP- 258 (300)
Q Consensus 197 -----------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~- 258 (300)
+..|.+||... .+..++.++|||||||++|+|++|+.||...........+. .......
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~ 244 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVML--TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF-GIIGTPHS 244 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHH--SCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCS
T ss_pred cccCccccccchhhccccccccCCeeec--cCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-HHhCCCch
Confidence 22355666432 13567889999999999999999999997643222111111 1110000
Q ss_pred -------------------C--------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 259 -------------------P--------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 259 -------------------~--------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+ .....+++++.++|.+||.. ||++|||++++++||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF-DPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGTT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCc-CcccCCCHHHHhcCccccc
Confidence 0 01235788999999999999 9999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=323.59 Aligned_cols=235 Identities=21% Similarity=0.300 Sum_probs=190.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEE-----ccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRH-----KQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
...++|++.+.||+|+||.||+|++ ..+++.||||+++...... .+.+|+.++++++||||+++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3467899999999999999999994 4567899999986432221 2457999999999999999999988754
Q ss_pred CcEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---CC--
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR-------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---HP-- 193 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~~-- 193 (300)
..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+
T Consensus 148 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 148 -PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp -SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred -CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 789999999999999999864 24899999999999999999999999999999999999985543 22
Q ss_pred -ccc------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH
Q 040812 194 -CGY------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 194 -~~~------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 253 (300)
+|. +..|.+||... +..++.++|||||||++|||+| |..||..... ......+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----~~~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 221 22366666544 4557889999999999999998 9999965432 2344444
Q ss_pred hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
........+..+++.+.++|.+||.. ||++|||+.++++|.|+
T Consensus 300 ~~~~~~~~~~~~~~~l~~li~~~l~~-dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 300 TSGGRMDPPKNCPGPVYRIMTQCWQH-QPEDRPNFAIILERIEY 342 (367)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCC-CHhHCcCHHHHHHHHHH
Confidence 45556667788899999999999999 99999999999988653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=329.12 Aligned_cols=239 Identities=27% Similarity=0.379 Sum_probs=181.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcC--------CCceeEeceeeeC---
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTN--------SPYIVKCHQIFTK--- 123 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~--------h~niv~~~~~~~~--- 123 (300)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+|+.++++++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 3679999999999999999999999999999999864321 123357999999885 7889999998862
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCC----------
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKM---------- 190 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~---------- 190 (300)
.....|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 23479999999954 666666543 4699999999999999999999998 999999999999998653
Q ss_pred ---------------------------------------CC---Ccc-------------ceeeccccccccccCCCCCC
Q 040812 191 ---------------------------------------EH---PCG-------------YSCLYESGEARHRKHGGYNG 215 (300)
Q Consensus 191 ---------------------------------------~~---~~~-------------~~~~~~~~~~~~~~~~~~~~ 215 (300)
.. ++| ++..|.+||... +..++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~ 271 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI---GSGYN 271 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH---TSCCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc---CCCCC
Confidence 11 111 234466666554 45578
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCCch-----HHHHHHHHhhCCC--------------------------------
Q 040812 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPD-----FLSLMLAICFREP-------------------------------- 258 (300)
Q Consensus 216 ~~~DiwSlG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~~-------------------------------- 258 (300)
.++|||||||++|||+||+.||........ ....+.......+
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 899999999999999999999975443221 1111111111100
Q ss_pred ------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 259 ------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 259 ------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+...++.+.+||.+||.. ||++|||++|+++||||++
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLEL-IPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCS-SGGGSCCHHHHHTSGGGGC
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhcc-ChhhcCCHHHHhhCccccC
Confidence 011222346788999999999 9999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=307.03 Aligned_cols=233 Identities=21% Similarity=0.320 Sum_probs=189.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC-CCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP-SGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 129 (300)
..++|++.+.||+|+||.||+|++. ++.||+|+++...... .+.+|+.++++++||||+++++++... .+..+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 5678999999999999999999986 7889999987654322 245799999999999999999998765 24789
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCCCCCCc-----------
Q 040812 130 ILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKMEHPC----------- 194 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~~~~~~----------- 194 (300)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||++| ++||||||+||+++.++...+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999998765 4899999999999999999999999 999999999999998755322
Q ss_pred ---cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 195 ---GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 195 ---~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
.++..|.+||.........++.++|||||||++|||+||+.||....... ...........+..+..+++.+.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 242 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGMKVALEGLRPTIPPGISPHVSK 242 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HHHHHHHSCCCCCCCTTCCHHHHH
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HHHHHHhcCCCCCCCCCCCHHHHH
Confidence 12445777777653333334458999999999999999999996543321 112223345566778889999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 040812 272 FIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+|.+||.. ||++|||++++++
T Consensus 243 li~~~l~~-~p~~Rps~~~il~ 263 (271)
T 3kmu_A 243 LMKICMNE-DPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHcCC-ChhhCcCHHHHHH
Confidence 99999999 9999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=314.75 Aligned_cols=230 Identities=23% Similarity=0.350 Sum_probs=188.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCe---EEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLA---LYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|.+..+++ .||||+++..... ..+.+|+.++++++||||+++++++.... ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 125 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-LA 125 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-CC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-cc
Confidence 45789999999999999999999985544 5999998754322 23467999999999999999999987654 79
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee---------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------- 198 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~--------- 198 (300)
|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++...+++++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999999754 579999999999999999999999999999999999999887654332211
Q ss_pred -------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 199 -------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
.|.+||... +..++.++|||||||++|||++ |..||..... ......+........+..
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 278 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIA---FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEEGYRLPAPMG 278 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHHHHTTCCCCCCTT
T ss_pred cceeeccCCCCcccccCHhHhc---CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcCCCCCCCCC
Confidence 255555543 3456789999999999999999 9999965432 233444444556667778
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+.++|.+||.. ||++|||+.++++
T Consensus 279 ~~~~l~~li~~~l~~-dp~~Rps~~eil~ 306 (325)
T 3kul_A 279 CPHALHQLMLDCWHK-DRAQRPRFSQIVS 306 (325)
T ss_dssp CCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccC-ChhhCcCHHHHHH
Confidence 999999999999999 9999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=306.03 Aligned_cols=230 Identities=23% Similarity=0.338 Sum_probs=189.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..++|++.+.||+|+||.||+|.+.. +..||+|+++..... ..+.+|+.++++++||||+++++++.... ..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-PIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-ceEEEEE
Confidence 45789999999999999999998874 678999999765432 23468999999999999999999987654 8999999
Q ss_pred ccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee--------------
Q 040812 134 YMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC-------------- 198 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~-------------- 198 (300)
|+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++...+.+++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 999999999998654 59999999999999999999999999999999999999887654332211
Q ss_pred ------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 199 ------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 199 ------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
.|.+||... +..++.++|||||||++|+|+| |..||...... ..............+...++.+.+
T Consensus 164 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFH---YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp SCCCCGGGCCHHHHH---HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CCCcCcccCCHHHHh---ccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----HHHHHHHcCCCCCCCCcChHHHHH
Confidence 245555443 3456779999999999999999 99999654322 333334445566667778999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+|.+||.. ||++|||+.+++++
T Consensus 237 li~~~l~~-~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHE-LPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHcCC-ChhhCcCHHHHHHH
Confidence 99999999 99999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=308.02 Aligned_cols=232 Identities=17% Similarity=0.157 Sum_probs=187.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+|+.+++++ +|+|++++++++.... ..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-HNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-EEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-eeEEEEEe
Confidence 357999999999999999999999999999999998776666778999999999 7999999999987654 89999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-----C---Cccc---------
Q 040812 135 MDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-----H---PCGY--------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-----~---~~~~--------- 196 (300)
+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|.
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9 889999998754 5999999999999999999999999999999999999987653 2 1221
Q ss_pred --------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HHHHhhCCCC
Q 040812 197 --------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL---MLAICFREPP 259 (300)
Q Consensus 197 --------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~ 259 (300)
+..|.+||... +..++.++|||||||++|||+||+.||............ ..........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred cccccccCccCCCCCcccCCchhhc---CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 22344554432 455788999999999999999999999765433222111 1111112222
Q ss_pred CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 260 SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 260 ~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.....+++.+.++|.+||.. ||++|||++++++
T Consensus 244 ~~~~~~~~~l~~li~~~l~~-dp~~RP~~~~l~~ 276 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNL-AFDATPDYDYLQG 276 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHC-CTTCCCCHHHHHH
T ss_pred HHHhhCcHHHHHHHHHHhcC-CcccCCCHHHHHH
Confidence 23446789999999999999 9999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=330.94 Aligned_cols=234 Identities=20% Similarity=0.304 Sum_probs=192.5
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+....++|++.+.||+|+||.||+|.++.++..||||+++..... ..+.+|+.+|++++||||+++++++.... ..|
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-cEE
Confidence 3444567899999999999999999999999999999999754322 33568999999999999999999988754 899
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 130 ILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++..++.++
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999999863 35899999999999999999999999999999999999987755432221
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
..|.+||... +..++.++|||||||++|||+| |..||...... . ....+........+..++
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~---~~~~~~~~~~~~~~~~~~ 445 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-Q---VYELLEKDYRMERPEGCP 445 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-G---HHHHHHTTCCCCCCTTCC
T ss_pred eeecCCCcCCcceeCHhHHh---cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-H---HHHHHHcCCCCCCCCCCC
Confidence 2355555443 3456789999999999999999 99999765432 2 222333455566778899
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.+.++|.+||.. ||++|||+.++++
T Consensus 446 ~~l~~li~~cl~~-dP~~RPs~~el~~ 471 (495)
T 1opk_A 446 EKVYELMRACWQW-NPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCc-ChhHCcCHHHHHH
Confidence 9999999999999 9999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=327.00 Aligned_cols=240 Identities=17% Similarity=0.162 Sum_probs=169.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHH---HHHHhcCCCceeEec-------ee
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQEL---NILRQTNSPYIVKCH-------QI 120 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~---~~l~~l~h~niv~~~-------~~ 120 (300)
..+|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+ ..|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 456999999999999999999999999999999998754321 123564 45555 799988755 33
Q ss_pred eeCCC----------------CcEEEEEeccCCCCHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHhHhCCcccc
Q 040812 121 FTKPS----------------GEVSILMEYMDAGSLEIYVKSRG-RLSEDII------CTISRQVLKGLFYMHSRNIVHR 177 (300)
Q Consensus 121 ~~~~~----------------~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~------~~i~~qi~~~l~~lH~~~i~H~ 177 (300)
+..+. ...|+||||++ |+|.+++...+ .++.... ..++.||+.||.|||++||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 33221 23899999998 79999998632 3444445 5777999999999999999999
Q ss_pred CCCCCceeecCCCCCCccc----------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 040812 178 DIKPANVLINEKMEHPCGY----------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG 241 (300)
Q Consensus 178 Dlkp~Nill~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 241 (300)
||||+|||++.++..++++ +..|.+||.... ....++.++|||||||++|||+||+.||....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNA-STATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTC-SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccC-CCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999876653322 234566665531 01457889999999999999999999997653
Q ss_pred CCchH--HHHHHHH--hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 242 QEPDF--LSLMLAI--CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 242 ~~~~~--~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... ....... ........+..+++.+.+||.+||.. ||++|||+.++++||||++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF-DRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCS-STTTCCCHHHHTTSHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCC-ChhhCCCHHHHhcCHHHHH
Confidence 22110 0000000 00111222346799999999999999 9999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=312.87 Aligned_cols=231 Identities=22% Similarity=0.285 Sum_probs=186.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
..++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.++++++||||+++++++..+. ..++||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 86 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-RLNFIT 86 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-eeEEEE
Confidence 46789999999999999999999999999999998854221 123457999999999999999999998764 899999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 133 EYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++...+.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999999987 56799999999999999999999999999999999999999876543222
Q ss_pred ------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHH-HHHHHHhhCC
Q 040812 197 ------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFL-SLMLAICFRE 257 (300)
Q Consensus 197 ------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~ 257 (300)
+..|.+||... +..++.++|||||||++|||++|..||.......... .......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--- 240 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMIN---GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--- 240 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---
T ss_pred ccccccccccccccccCCCcceeCHHHhc---CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---
Confidence 22356666543 5567889999999999999999999986532221100 0011100
Q ss_pred CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 258 PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 258 ~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
....+..+++.+.++|.+||.. ||++|||++++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~-dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDL-DPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccC-ChhhCcCHHHHHH
Confidence 1123566788999999999999 9999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=313.58 Aligned_cols=233 Identities=23% Similarity=0.304 Sum_probs=188.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
...++|++.+.||+|+||.||+|.+. .+++.||+|+++..... ..+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 35688999999999999999999973 45778999999754322 2246799999999 899999999998875
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCC
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRG-----------------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp 181 (300)
. ..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 122 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 122 G-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp S-SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred C-ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 4 8999999999999999998643 278999999999999999999999999999999
Q ss_pred CceeecCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 040812 182 ANVLINEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLE 239 (300)
Q Consensus 182 ~Nill~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 239 (300)
+|||++.++...++++ ..|.+||... +..++.++|||||||++|+|+| |..||..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc---cCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999987755432221 1355666543 4557889999999999999998 9999977
Q ss_pred CCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 240 PGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..........+ ........+...++.+.++|.+||.. ||++|||+.++++|
T Consensus 278 ~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 278 IPVDANFYKLI---QNGFKMDQPFYATEEIYIIMQSCWAF-DSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCSHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CCcHHHHHHHH---hcCCCCCCCCCCCHHHHHHHHHHcCC-CchhCcCHHHHHHH
Confidence 65544333332 33445566777899999999999999 99999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=318.46 Aligned_cols=237 Identities=27% Similarity=0.413 Sum_probs=172.8
Q ss_pred CCcceeee-eecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHH-HHHHhcCCCceeEeceeeeCC---CCcEEE
Q 040812 56 LSQLEKLQ-VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQEL-NILRQTNSPYIVKCHQIFTKP---SGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~---~~~~~l 130 (300)
.++|++.+ .||+|+||.||+|.++.+++.||+|++.... ...+|+ ..++.++||||+++++++... ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 46799965 6999999999999999999999999986432 123343 345677999999999998641 235899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Cccc------
Q 040812 131 LMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PCGY------ 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~~~------ 196 (300)
||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|.
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999999999998754 6999999999999999999999999999999999999986432 2 1221
Q ss_pred --------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHH---HHHHHhhCCCCCCCCCC
Q 040812 197 --------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS---LMLAICFREPPSLPECS 265 (300)
Q Consensus 197 --------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 265 (300)
+..|.+||... +..++.++|||||||++|+|+||..||........... .+.......+......+
T Consensus 184 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred cccccCCCCcCccChhhhC---CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence 23355565542 45567899999999999999999999965443221111 11111112223333568
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++.+.+||.+||.. ||++|||++++++||||++
T Consensus 261 ~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 261 SEDAKQLIRLLLKT-DPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp CHHHHHHHHHHSCS-SGGGSCCHHHHHHSHHHHT
T ss_pred CHHHHHHHHHHCCC-ChhHCcCHHHHhcCccccc
Confidence 99999999999999 9999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=313.71 Aligned_cols=229 Identities=19% Similarity=0.187 Sum_probs=183.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEecc
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++++ +||||+++++++.... ..|+||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~~~lv~e~~ 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-YNAMVLELL 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETT-EEEEEEECC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCC-ccEEEEEeC
Confidence 67999999999999999999999999999999998776666778999999999 9999999999988754 899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-----CC---ccc----------
Q 040812 136 DAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-----HP---CGY---------- 196 (300)
Q Consensus 136 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-----~~---~~~---------- 196 (300)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. .. +|.
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 8899999986 457999999999999999999999999999999999999987654 22 221
Q ss_pred -------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh---hCCCC-
Q 040812 197 -------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPP- 259 (300)
Q Consensus 197 -------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~- 259 (300)
+..|.+||... +..++.++|||||||++|||+||+.||....... ....+..+. ...+.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHL---GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKIGDTKRATPIE 242 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHHHHHHHHSCHH
T ss_pred ccccccccCCcCCCccccChHHHc---CCCCCchhHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHHHhhhccCCHH
Confidence 22334444332 4557889999999999999999999997654332 222222211 11111
Q ss_pred CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 260 SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 260 ~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
......+ ++.++|..||.. ||.+||+++++++
T Consensus 243 ~~~~~~p-~~~~li~~~l~~-~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRL-DFFEKPDYDYLRK 274 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHC-CTTCCCCHHHHHH
T ss_pred HHhccCh-HHHHHHHHHHhC-CCCCCCCHHHHHH
Confidence 1122234 999999999999 9999999998875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=316.90 Aligned_cols=238 Identities=26% Similarity=0.338 Sum_probs=186.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCC-----
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSG----- 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 126 (300)
.++|.+.+.||+|+||.||+|.+..+|+.||||++....... .+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999999999999999987543221 23579999999999999999999876542
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
..|+||||+++ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+||+++.++...+.+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 25999999975 88877753 599999999999999999999999999999999999999876543322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh----------------
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---------------- 254 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 254 (300)
+..|.+||.... ...++.++|||||||++|+|+||+.||...+.......+.....
T Consensus 180 ~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ----CCSBCCSCHHHHSC--CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred ccccccCcCcCCHHHHhC--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 333566665432 24567899999999999999999999976443222211111100
Q ss_pred -------hC---CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 -------FR---EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 -------~~---~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.. .........++.+.++|.+||.. ||++|||++++++||||++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL-DVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCS-CTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCC-CcccCCCHHHHhcCcchhh
Confidence 00 01122345789999999999999 9999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=314.05 Aligned_cols=232 Identities=23% Similarity=0.375 Sum_probs=190.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
...++|++.+.||+|+||.||+|++. .+++.||+|+++..... ..+.+|+.++++++||||+++++++....
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 35678999999999999999999997 45589999998754322 22467999999999999999999988754
Q ss_pred CcEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCC
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR------------------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp 181 (300)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 124 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 124 -PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred -ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 899999999999999999763 4689999999999999999999999999999999
Q ss_pred CceeecCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 040812 182 ANVLINEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLE 239 (300)
Q Consensus 182 ~Nill~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 239 (300)
+|||++.++...+.++ ..|.+||... +..++.++|||||||++|||+| |..||..
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc---cCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 9999987765433222 2255555543 3457889999999999999999 9999965
Q ss_pred CCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 240 PGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
... ......+........+..+++.+.++|.+||.. ||++|||+.+++++
T Consensus 280 ~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAH----EEVIYYVRDGNILACPENCPLELYNLMRLCWSK-LPADRPSFCSIHRI 329 (343)
T ss_dssp SCH----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CCh----HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHccc-CcccCCCHHHHHHH
Confidence 432 233344444555667788999999999999999 99999999998764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=310.71 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=190.2
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcC--CCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTN--SPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 127 (300)
...++|++.+.||+|+||.||+|.+.. ++.||+|++...... ..+.+|+.++++++ |+||+++++++.... .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-Y 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS-E
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC-E
Confidence 345679999999999999999999865 889999999764432 22357999999997 499999999988755 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------- 194 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------- 194 (300)
.|+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++. ...+
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-EEEECCCSSSCC-----
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECC-eEEEeeccccccccCcc
Confidence 999999 5577999999988889999999999999999999999999999999999999753 2211
Q ss_pred --------cceeecccccccccc--------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC
Q 040812 195 --------GYSCLYESGEARHRK--------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 195 --------~~~~~~~~~~~~~~~--------~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (300)
.++..|.+||..... ....++.++|||||||++|+|+||..||...... .............
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~ 258 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHE 258 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHCTTSC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHHHHHHhcccc
Confidence 123446667665421 1245778999999999999999999999654332 1122222223344
Q ss_pred CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 259 ~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
...+...++.+.++|.+||.. ||++|||++++++||||+.
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKR-DPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCS-STTTSCCHHHHHTSHHHHC
T ss_pred cCCcccchHHHHHHHHHHccC-CcccCcCHHHHhcCccccC
Confidence 556777789999999999999 9999999999999999965
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=317.97 Aligned_cols=239 Identities=28% Similarity=0.385 Sum_probs=179.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCC---------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKP--------- 124 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~--------- 124 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 36799999999999999999999999999999998654311 2345799999999999999999987422
Q ss_pred ----CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-CCCCC---ccc
Q 040812 125 ----SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-KMEHP---CGY 196 (300)
Q Consensus 125 ----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~-~~~~~---~~~ 196 (300)
.+..|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++... +|.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 247899999998 499999865 57999999999999999999999999999999999999974 32322 221
Q ss_pred -------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh---
Q 040812 197 -------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC--- 254 (300)
Q Consensus 197 -------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--- 254 (300)
+..|.+||.... +..++.++|||||||++|||+||+.||...........+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS--PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHC--TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccCCCcccccccccccccccccCcHHhcC--cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 222445554321 24577899999999999999999999976543222211111100
Q ss_pred -----------------hCCCC-----CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 -----------------FREPP-----SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 -----------------~~~~~-----~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....+ ..+..+++++.++|.+||.. ||++|||++++++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF-SPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCS-SGGGSCCHHHHHTSHHHHT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCC-CccccCCHHHHhCCccccc
Confidence 00000 11245789999999999999 9999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=317.77 Aligned_cols=236 Identities=25% Similarity=0.390 Sum_probs=182.8
Q ss_pred CcceeeeeecCCcceEEEEEEE-ccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCC------ceeEeceeeeCCCCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRH-KQTLALYALKVMQCDRG-TPPNPQELNILRQTNSP------YIVKCHQIFTKPSGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~ 128 (300)
++|++.+.||+|+||.||+|.+ ..+++.||+|+++.... .....+|+.+++.++|+ +++++++++.... ..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~-~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG-HI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-EE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-cE
Confidence 5799999999999999999998 56789999999864321 12335689999888665 4999999988764 89
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC----------------
Q 040812 129 SILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM---------------- 190 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~---------------- 190 (300)
|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++...
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999 789999998765 689999999999999999999999999999999999998632
Q ss_pred ---CC---Ccc-------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 040812 191 ---EH---PCG-------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLML 251 (300)
Q Consensus 191 ---~~---~~~-------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 251 (300)
.. ++| ++..|.+||... +..++.++|||||||++|||+||..||...+.. .....+.
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~ 247 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL---ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK-EHLAMME 247 (339)
T ss_dssp SCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT---TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-HHHHHHH
T ss_pred cCCCceEeeCcccccCccccccccCCccccChHHhh---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 22 111 233456666543 556788999999999999999999999654332 2222222
Q ss_pred HHhhCCCC----------------------------------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHH
Q 040812 252 AICFREPP----------------------------------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQL 291 (300)
Q Consensus 252 ~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~ 291 (300)
......+. ..+...++.+.+||.+||.. ||++|||++|+
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~-dP~~Rpt~~el 326 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY-DPAKRITLREA 326 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS-STTTSCCHHHH
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc-CcccccCHHHH
Confidence 22111100 01122346789999999999 99999999999
Q ss_pred hcCCCCCC
Q 040812 292 LSHPFLAD 299 (300)
Q Consensus 292 l~hpw~~~ 299 (300)
++||||++
T Consensus 327 l~hp~f~~ 334 (339)
T 1z57_A 327 LKHPFFDL 334 (339)
T ss_dssp TTSGGGGG
T ss_pred hcCHHHHH
Confidence 99999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=315.66 Aligned_cols=232 Identities=23% Similarity=0.331 Sum_probs=190.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEcc-------CCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeee
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQ-------TLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFT 122 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~ 122 (300)
...++|++.+.||+|+||.||+|++.. .+..||+|+++..... ..+.+|+.+++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 345789999999999999999999753 3468999998765332 2235799999999 9999999999998
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 123 KPSGEVSILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
... ..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 146 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 146 QDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSS-SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCC-ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 754 8999999999999999998643 48999999999999999999999999999999999999
Q ss_pred cCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 187 NEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 187 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
+.++...+.++ ..|.+||... +..++.++|||||||++|+|+| |..||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH---SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 98765433222 2245555443 5567889999999999999999 9999965432
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
......+........+..+++++.++|.+||.. ||++|||+.+++++
T Consensus 300 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 --EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHA-VPSQRPTFKQLVED 346 (382)
T ss_dssp --HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 234444445556677888999999999999999 99999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=311.39 Aligned_cols=232 Identities=22% Similarity=0.332 Sum_probs=187.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
...++|++.+.||+|+||.||+|.+. .+++.||+|+++..... ..+.+|+.++++++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34678999999999999999999983 45689999998754321 12357999999999999999999987754
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHhHhCCccccCCCC
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGR------------------------LSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp 181 (300)
..|+||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||
T Consensus 100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 100 -PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred -ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 89999999999999999986433 89999999999999999999999999999999
Q ss_pred CceeecCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 040812 182 ANVLINEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLE 239 (300)
Q Consensus 182 ~Nill~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 239 (300)
+||+++.++...++++ ..|.+||... +..++.++|||||||++|||+| |..||..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc---CCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999997754332221 1244555443 3456789999999999999999 9999976
Q ss_pred CCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 240 PGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.... . ....+........+..+++.+.++|.+||.. ||++|||+++++++
T Consensus 256 ~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPE-R---LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQ-EPDKRPVFADISKD 305 (314)
T ss_dssp CCGG-G---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CCHH-H---HHHHhhcCCcCCCCccCCHHHHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 5432 2 2222333455667778999999999999999 99999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=305.93 Aligned_cols=234 Identities=21% Similarity=0.308 Sum_probs=192.1
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+....++|++.+.||+|+||.||+|.+..+++.||+|.+..+... ..+.+|+.++++++||||+++++++.... ..|
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CEE
Confidence 3444678899999999999999999999999999999998754322 23467999999999999999999988754 899
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 130 ILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++...+.++
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999999863 35899999999999999999999999999999999999987765432221
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
..|.+||... +..++.++|||||||++|+|++ |..||...... . .............+..++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~---~~~~~~~~~~~~~~~~~~ 238 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-Q---VYELLEKDYRMERPEGCP 238 (288)
T ss_dssp SEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-G---HHHHHHTTCCCCCCTTCC
T ss_pred cccccCCccccCcCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-H---HHHHHhccCCCCCCCCCC
Confidence 1255555443 4457889999999999999999 99999664432 2 222233344566677889
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.+.++|.+||.. ||++|||++++++
T Consensus 239 ~~l~~li~~~l~~-dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 239 EKVYELMRACWQW-NPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCC-ChhhCcCHHHHHH
Confidence 9999999999999 9999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=301.90 Aligned_cols=233 Identities=22% Similarity=0.305 Sum_probs=188.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---------CCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---------PNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
..++|++.+.||+|+||.||+|++..+++.||+|++....... .+.+|+.++++++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3478999999999999999999999999999999986544322 2357999999999999999999986533
Q ss_pred CcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCCCC-----CCcc--
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKME-----HPCG-- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~~~-----~~~~-- 195 (300)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++. ..++
T Consensus 97 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 ---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp ---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999888654 46999999999999999999999999 999999999999986553 2111
Q ss_pred --------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 196 --------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 196 --------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
++..|.+||.... .+..++.++|||||||++|+|+||+.||........ ............+..
T Consensus 174 g~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 174 GLSQQSVHSVSGLLGNFQWMAPETIGA-EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREEGLRPTI 251 (287)
T ss_dssp TTCBCCSSCEECCCCCCTTSCGGGSSC-SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHHSCCCCCC
T ss_pred CccccccccccccCCCccccCchhhcc-CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhccCCCCCC
Confidence 2334666665421 234567899999999999999999999976544322 112222334556677
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+..+++.+.++|.+||.. ||++|||++++++
T Consensus 252 ~~~~~~~l~~li~~~l~~-dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSG-DPKKRPHFSYIVK 282 (287)
T ss_dssp CTTSCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred CcccCHHHHHHHHHHhcC-ChhhCcCHHHHHH
Confidence 888999999999999999 9999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=305.72 Aligned_cols=231 Identities=25% Similarity=0.362 Sum_probs=188.5
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
....++|++.+.||+|+||.||+|.+. ++.||+|+++.......+.+|+.++++++||||+++++++....+..|+||
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 345789999999999999999999885 789999999766555556789999999999999999998766555799999
Q ss_pred eccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------
Q 040812 133 EYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------- 197 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------- 197 (300)
||+++++|.+++...+. +++..+..++.|++.||.|||++|++||||||+||+++.++...++++
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 99999999999986543 899999999999999999999999999999999999998765433322
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
..|.+||... +..++.++|||||||++|+|+| |..||...... .....+........+..+++.+.++|
T Consensus 175 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 175 KLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEKGYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp -CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred CccccccCHHHhC---CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 2245555443 3456789999999999999998 99999654332 22233334455667788899999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 040812 274 RCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+||.. ||++|||+.++++
T Consensus 248 ~~~l~~-~p~~Rps~~~l~~ 266 (278)
T 1byg_A 248 KNCWHL-DAAMRPSFLQLRE 266 (278)
T ss_dssp HHHTCS-SGGGSCCHHHHHH
T ss_pred HHHhcC-ChhhCCCHHHHHH
Confidence 999999 9999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=304.57 Aligned_cols=233 Identities=18% Similarity=0.189 Sum_probs=184.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+|+.+++.++|++++..+..+....+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 46899999999999999999999999999999999876666667889999999999887777776655555889999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec---CCCCCCc---c-------------
Q 040812 136 DAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN---EKMEHPC---G------------- 195 (300)
Q Consensus 136 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~---~~~~~~~---~------------- 195 (300)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++...+ |
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence 8899999974 45799999999999999999999999999999999999994 4333221 1
Q ss_pred ----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC---chHHHHHHHHhhCCCCCCC
Q 040812 196 ----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE---PDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~ 262 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...... .....+............+
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 167 IPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCCCCSCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred cccccccccccccccCChhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 122344444433 455788999999999999999999999764322 2222222222222222234
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+++.+.++|.+||.. ||++|||++++++
T Consensus 244 ~~~~~~l~~li~~~l~~-dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSL-RFDDKPDYSYLRQ 273 (296)
T ss_dssp TTSCHHHHHHHHHHHTS-CTTCCCCHHHHHH
T ss_pred hhCCHHHHHHHHHHHhc-CcCcCCCHHHHHH
Confidence 56789999999999999 9999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=299.87 Aligned_cols=233 Identities=21% Similarity=0.319 Sum_probs=190.7
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+....++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+|+.++++++||||+++++++.... ..++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 80 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICL 80 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SCEE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CeEE
Confidence 3445688999999999999999999997 4678999999765432 23467999999999999999999988754 8999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce------------
Q 040812 131 LMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------ 197 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------ 197 (300)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++...++++
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999999864 46899999999999999999999999999999999999987755432221
Q ss_pred --------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 198 --------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 198 --------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
..|.+||... +..++.++||||||+++|+|+| |..||..... ......+........+...++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDISTGFRLYKPRLASTH 233 (267)
T ss_dssp STTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCCCCCCTTSCHH
T ss_pred ccccccccccccChhhhc---CCCccchhchhhhHHHHHHHhccCCCCCCCCCH----HHHHHHHhcCCcCCCCccCcHH
Confidence 1255555443 3456789999999999999999 8999965432 2333334444555667778999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.++|.+||.. ||++|||+++++++
T Consensus 234 l~~li~~~l~~-~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRE-RPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 99999999999 99999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=307.71 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=186.8
Q ss_pred CCCcceeeeeecCCcceEEEEEE----EccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCC-CCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVR----HKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKP-SGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~ 127 (300)
..++|++++.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.++++++||||+++++++... ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 35789999999999999999999 5668999999998643321 2346799999999999999999987543 235
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 128 VSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++...+.++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 899999999999999998754 5999999999999999999999999999999999999987754332221
Q ss_pred -------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----------Cc--hHHHHHHH
Q 040812 198 -------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ----------EP--DFLSLMLA 252 (300)
Q Consensus 198 -------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~----------~~--~~~~~~~~ 252 (300)
..|.+||... +..++.++|||||||++|||+||..||..... .. ........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp --------CTTCGGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhc---CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 1255665543 44578899999999999999999999853210 00 11122233
Q ss_pred HhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 253 ICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.........+..+++++.++|.+||.. ||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~el~~ 284 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNN-NVNQRPSFRDLAL 284 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCS-SGGGSCCHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCC-ChhhCCCHHHHHH
Confidence 344555667788999999999999999 9999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.87 Aligned_cols=231 Identities=23% Similarity=0.303 Sum_probs=187.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeE----EEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLAL----YALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
...++|++.+.||+|+||.||+|.+..+++. ||+|.+..... ...+.+|+.++++++||||+++++++.. +
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--S 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--S
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 3457899999999999999999999887775 77777654332 2345789999999999999999998863 3
Q ss_pred cEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------
Q 040812 127 EVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------- 198 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------- 198 (300)
..++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 689999999999999999864 579999999999999999999999999999999999999887654332222
Q ss_pred --------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 199 --------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 199 --------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
.|.+||... +..++.++|||||||++|+|+| |..||...... .....+........+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIH---FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLLEKGERLAQPQ 240 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHHHHTTCBCCCCT
T ss_pred ccccccccCCCCcccccChHHhc---cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHHHHcCCCCCCCC
Confidence 244444433 3457889999999999999999 99999765433 2223333445566677
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.++.++.++|.+||.. ||++|||+.++++|
T Consensus 241 ~~~~~~~~li~~~l~~-dp~~Rps~~el~~~ 270 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMI-DENIRPTFKELANE 270 (325)
T ss_dssp TBCTTTTHHHHHHTCS-CTTTSCCHHHHHHH
T ss_pred cCcHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 7889999999999999 99999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=307.35 Aligned_cols=231 Identities=17% Similarity=0.258 Sum_probs=183.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCC-------eEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTL-------ALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
..++|++.+.||+|+||.||+|.+..++ ..||+|++...... ..+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3578999999999999999999998776 57999998653321 23467999999999999999999988754
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC--------CCccc
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGR-LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME--------HPCGY 196 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~--------~~~~~ 196 (300)
..++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++. ..+.+
T Consensus 86 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 86 -ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp -CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred -CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 78999999999999999987654 999999999999999999999999999999999999987764 22111
Q ss_pred ---------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 197 ---------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 197 ---------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
+..|.+||.... ...++.++|||||||++|||+||..|+............. ......
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-----~~~~~~ 237 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIEN--PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-----EDRHQL 237 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHC--GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-----HTTCCC
T ss_pred CcccccccCccccCCcCcccCHHHhCC--CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-----hccCCC
Confidence 222555555431 1457889999999999999999655554433322221111 234455
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+...++++.++|.+||.. ||++|||++++++|
T Consensus 238 ~~~~~~~l~~li~~~l~~-dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 238 PAPKAAELANLINNCMDY-EPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCSSCTTHHHHHHHSCS-SGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCC-ChhHCcCHHHHHHH
Confidence 666788999999999999 99999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.35 Aligned_cols=232 Identities=22% Similarity=0.310 Sum_probs=189.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEE--EEEEeecCCC---CCCCHHHHHHHHhc-CCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALY--ALKVMQCDRG---TPPNPQELNILRQT-NSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 127 (300)
..+++|++.+.||+|+||.||+|++..++..+ |+|.++.... ...+.+|+.+++++ +||||+++++++.... .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-Y 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-E
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-c
Confidence 35688999999999999999999999888865 9998875322 22346799999999 8999999999998764 8
Q ss_pred EEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC
Q 040812 128 VSILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME 191 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~ 191 (300)
.|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999998653 6899999999999999999999999999999999999988765
Q ss_pred CCcccee------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 040812 192 HPCGYSC------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLA 252 (300)
Q Consensus 192 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 252 (300)
..+.+++ .|.+||... +..++.++|||||||++|||+| |..||..... ......
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~~~~ 253 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEK 253 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHH
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhc---cccCCchhcchHHHHHHHHHHcCCCCCCCCCcH----HHHHHH
Confidence 4332221 244555432 3446789999999999999998 9999965432 233444
Q ss_pred HhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 253 ICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+........+..+++.+.++|.+||.. ||++|||+++++++
T Consensus 254 ~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGYRLEKPLNCDDEVYDLMRQCWRE-KPYERPSFAQILVS 294 (327)
T ss_dssp GGGTCCCCCCTTBCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 444555666778899999999999999 99999999999865
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=319.22 Aligned_cols=237 Identities=24% Similarity=0.397 Sum_probs=180.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcC-CC-----ceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTN-SP-----YIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~ 128 (300)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+|+.+++.++ |+ +|+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN-HL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT-EE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC-ce
Confidence 5789999999999999999999999999999999864321 112345888888775 44 4999999988764 89
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhH--hCCccccCCCCCceeecC--CCCC---Ccc----
Q 040812 129 SILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMH--SRNIVHRDIKPANVLINE--KMEH---PCG---- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH--~~~i~H~Dlkp~Nill~~--~~~~---~~~---- 195 (300)
|+||||+++ +|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++. ++.. ++|
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999999965 999999865 35999999999999999999999 579999999999999964 3222 222
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC-------C
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP-------P 259 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------~ 259 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...........+..... ..+ +
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 286 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLL---GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG-IPPAHILDQAP 286 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-SCCHHHHTTCT
T ss_pred cccccccccCCccccChHHHc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHHHhhH
Confidence 233466666554 55678899999999999999999999976543322222222110 000 0
Q ss_pred -------CCCC------------------C----------------------------CChHHHHHHHHHhccCCCCCCC
Q 040812 260 -------SLPE------------------C----------------------------SSEKFRDFIRCCLQKGDPSKRW 286 (300)
Q Consensus 260 -------~~~~------------------~----------------------------~~~~l~~li~~~l~~~dp~~Rp 286 (300)
.++. . ..+++.+||.+||+. ||++||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~-dP~~Rp 365 (382)
T 2vx3_A 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY-DPKTRI 365 (382)
T ss_dssp THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS-CTTTSC
T ss_pred HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC-ChhhCC
Confidence 0000 0 013789999999999 999999
Q ss_pred CHHHHhcCCCCCC
Q 040812 287 TASQLLSHPFLAD 299 (300)
Q Consensus 287 t~~~~l~hpw~~~ 299 (300)
|++|+|+||||++
T Consensus 366 ta~e~L~hp~f~~ 378 (382)
T 2vx3_A 366 QPYYALQHSFFKK 378 (382)
T ss_dssp CHHHHTTSGGGCC
T ss_pred CHHHHhcCccccc
Confidence 9999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=309.37 Aligned_cols=230 Identities=20% Similarity=0.271 Sum_probs=183.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++++++||||+++++++..+. ..|
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG-QLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC-eEE
Confidence 467899999999999999999999999999999998754322 22457999999999999999999988754 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------- 196 (300)
+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++...+.+
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 9999999999999999888899999999999999999999999999999999999998776543222
Q ss_pred -------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC--CCCCCCCCCCh
Q 040812 197 -------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR--EPPSLPECSSE 267 (300)
Q Consensus 197 -------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 267 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||...... ......... .....+..+++
T Consensus 191 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFS---ESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------CCGGGCCGGGTC---C----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCCGGGTSTTCCT
T ss_pred cccccCCCcCccCHHHHc---CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCCccccCCCCCH
Confidence 22355666543 456778999999999999999999999653221 111111111 12234567889
Q ss_pred HHHHHHHHHhccCCCCCCC-CHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRW-TASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rp-t~~~~l~ 293 (300)
.+.++|.+||.. ||++|| +++++++
T Consensus 264 ~l~~li~~~l~~-dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAK-NPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCS-SGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccC-CHHHHHHhHHHHHH
Confidence 999999999999 999999 7888764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=302.05 Aligned_cols=233 Identities=18% Similarity=0.190 Sum_probs=181.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+|+.+++.++|++++..+..+....+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 46799999999999999999999999999999998877766777899999999999888877776655555899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee---cCCCCCCc---c-------------
Q 040812 136 DAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI---NEKMEHPC---G------------- 195 (300)
Q Consensus 136 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill---~~~~~~~~---~------------- 195 (300)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++...+ |
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~ 166 (296)
T 4hgt_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence 8899999985 4579999999999999999999999999999999999999 44433221 1
Q ss_pred ----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc---hHHHHHHHHhhCCCCCCC
Q 040812 196 ----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP---DFLSLMLAICFREPPSLP 262 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~ 262 (300)
++..|.+||... +..++.++|||||||++|+|+||+.||....... ..................
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 4hgt_A 167 IPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCCCCSCCCCSCGGGCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred CCCCcccccCCCccccchHHhc---CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence 233344555433 4567889999999999999999999997643322 222222222222222233
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+++.+.++|.+||.. ||++|||++++++
T Consensus 244 ~~~~~~l~~li~~~l~~-~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 244 KGYPSEFATYLNFCRSL-RFDDKPDYSYLRQ 273 (296)
T ss_dssp TTSCHHHHHHHHHHHTS-CTTCCCCHHHHHH
T ss_pred ccCCHHHHHHHHHHHhc-CCCCCCCHHHHHH
Confidence 56789999999999999 9999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=307.46 Aligned_cols=233 Identities=23% Similarity=0.313 Sum_probs=189.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEE-----ccCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRH-----KQTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
...++|++.+.||+|+||.||+|.+ ..+++.||+|+++..... ..+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3567899999999999999999995 456789999999754321 2345799999999 999999999998875
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRG------------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
. ..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 100 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 100 G-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp S-SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C-CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 4 8999999999999999998653 38999999999999999999999999999999999999
Q ss_pred cCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 187 NEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 187 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
+.++...++++ ..|.+||... +..++.++|||||||++|+|+| |..||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc---CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 87755322221 2355555443 4457789999999999999999 999997665544
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
....... .......+...++.+.++|.+||.. ||++|||+++++++
T Consensus 256 ~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDA-DPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHH---HTCCCCCCTTSCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHhc---cCCCCCCcccCCHHHHHHHHHHcCC-CchhCcCHHHHHHH
Confidence 3333332 2344555677899999999999999 99999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=308.70 Aligned_cols=234 Identities=25% Similarity=0.365 Sum_probs=190.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEE-----ccCCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRH-----KQTLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
...++|++.+.||+|+||.||+|.+ ..+++.||+|+++...... .+.+|+.+++++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3567899999999999999999985 3567899999987543221 235799999999 789999999998876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRGR----------------LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE 188 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~ 188 (300)
.+..++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 6579999999999999999987543 899999999999999999999999999999999999987
Q ss_pred CCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchH
Q 040812 189 KMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDF 246 (300)
Q Consensus 189 ~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~ 246 (300)
++...++++ ..|.+||... +..++.++|||||||++|+|+| |..||.........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhc---cccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 655432221 1355555543 4457789999999999999998 99999765544333
Q ss_pred HHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 247 LSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.. ..........+...++.+.++|.+||.. ||++|||+.++++|
T Consensus 261 ~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CR---RLKEGTRMRAPDYTTPEMYQTMLDCWHG-EPSQRPTFSELVEH 304 (316)
T ss_dssp HH---HHHHTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HH---HhccCccCCCCCCCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 32 2333445666777899999999999999 99999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=310.29 Aligned_cols=237 Identities=21% Similarity=0.257 Sum_probs=185.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeC---CCCcE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTK---PSGEV 128 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~ 128 (300)
...++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++++++||||+++++++.. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 456789999999999999999999999999999999865321 1234679999999999999999999863 22368
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------
Q 040812 129 SILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------- 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------- 196 (300)
|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++...+.+
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999999975 45799999999999999999999999999999999999998876543322
Q ss_pred --------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHHHHhh
Q 040812 197 --------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-PDFLSLMLAICF 255 (300)
Q Consensus 197 --------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~ 255 (300)
+..|.+||.........++.++|||||||++|+|++|+.||...... ....... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~ 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---QN 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---HC
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---hc
Confidence 33367777654332233578999999999999999999999532111 1111111 11
Q ss_pred CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 256 REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
......+...++.+.++|.+||.. ||++|||+++++++
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTV-DPHQRPHIPLLLSQ 300 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhc-ChhhCCCHHHHHHH
Confidence 223333456789999999999999 99999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=318.93 Aligned_cols=232 Identities=24% Similarity=0.342 Sum_probs=189.4
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+....++|++.+.||+|+||.||+|.++. +..||||+++.... ...+.+|+.+|++++||||+++++++.. +..|
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~ 258 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIY 258 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeC--CccE
Confidence 344567889999999999999999999975 67899999975432 2235689999999999999999999863 3789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 130 ILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++..++.++
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999999753 36899999999999999999999999999999999999998765433221
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
..|.+||... ++.++.++|||||||++|||+| |+.||..... .+....+........+..++
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALERGYRMPRPENCP 411 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHHTCCCCCCTTSC
T ss_pred eeccCCCcccccccCHHHhc---cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCC
Confidence 2355555543 3457889999999999999999 9999965432 23333344455566678899
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.+.++|.+||.. ||++|||++++++
T Consensus 412 ~~l~~li~~cl~~-dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKN-RPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccC-ChhHCcCHHHHHH
Confidence 9999999999999 9999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=302.67 Aligned_cols=234 Identities=26% Similarity=0.366 Sum_probs=184.2
Q ss_pred CCcceeeeeecCCcceEEEEEE----EccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCC-Cc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVR----HKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPS-GE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 127 (300)
..+|++.+.||+|+||.||+|+ +..+++.||+|+++...... .+.+|+.++++++||||+++++++.... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4569999999999999999999 56789999999997554322 2367999999999999999999987653 36
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 128 VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++...+.++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 8999999999999999954 457999999999999999999999999999999999999987754332221
Q ss_pred -------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----------CCCchHHHHHHHH
Q 040812 198 -------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEP-----------GQEPDFLSLMLAI 253 (300)
Q Consensus 198 -------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-----------~~~~~~~~~~~~~ 253 (300)
..|.+||... +..++.++|||||||++|+|+||..|+... .............
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLM---QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeec---CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 1244554432 344667999999999999999999987421 1112222333444
Q ss_pred hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
........+..+++.+.++|.+||.. ||++|||++++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEF-QPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCS-SGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCHHHHHH
Confidence 45556667788999999999999999 9999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=302.91 Aligned_cols=231 Identities=26% Similarity=0.305 Sum_probs=186.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
...++|++.+.||+|+||.||+|.+..+ +..||+|.++..... ..+.+|+.++++++||||+++++++.. +.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 89 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NP 89 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--Cc
Confidence 3457899999999999999999998653 567999987643221 124579999999999999999999753 36
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 128 VSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
.|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++...+.++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 899999999999999998654 6999999999999999999999999999999999999997654332221
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
..|.+||... +..++.++|||||||++|||++ |..||....... ....+........+..+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~ 242 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNC 242 (281)
T ss_dssp ---------CCGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTCCCCCCTTC
T ss_pred cccccccCCCcccccChhhcc---cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHHHHHcCCCCCCCCCC
Confidence 2356666543 4457789999999999999997 999997654332 22233334556677789
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
++.+.++|.+||.. ||++|||+.+++++
T Consensus 243 ~~~l~~li~~~l~~-~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 243 PPTLYSLMTKCWAY-DPSRRPRFTELKAQ 270 (281)
T ss_dssp CHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 99999999999999 99999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.52 Aligned_cols=231 Identities=21% Similarity=0.291 Sum_probs=182.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeE----EEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLAL----YALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
...++|++.+.||+|+||.||+|++..+++. ||+|.+...... ..+.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 3457899999999999999999999877765 477776543322 2346799999999999999999998863
Q ss_pred cEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 127 EVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
..++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++...+++
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 58899999999999999986 45799999999999999999999999999999999999998875543222
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
+..|.+||... +..++.++|||||||++|||+| |+.||...... .. ...+........+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~---~~~~~~~~~~~~~~ 242 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EI---SSILEKGERLPQPP 242 (327)
T ss_dssp TCC-------CCCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GH---HHHHHTTCCCCCCT
T ss_pred CcccccccCCCccccccChHHhc---cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HH---HHHHHcCCCCCCCc
Confidence 22456666544 4567889999999999999999 99999754332 22 22233344556677
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.++..+.+++.+||.. ||++|||+.+++++
T Consensus 243 ~~~~~~~~li~~~l~~-~p~~Rps~~ell~~ 272 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMI-DADSRPKFRELIIE 272 (327)
T ss_dssp TBCHHHHHHHHHHTCS-CGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCC-ChhhCCCHHHHHHH
Confidence 7899999999999999 99999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=301.06 Aligned_cols=233 Identities=28% Similarity=0.378 Sum_probs=184.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++.+.||+|+||.||+|.+..+++.||+|+++...... .+.+|+.++++++||||+++++++.... ..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-cEE
Confidence 4678999999999999999999999999999999987533222 2357999999999999999999998754 899
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------
Q 040812 130 ILMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------- 197 (300)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++...+.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 456899999999999999999999999999999999999998765433322
Q ss_pred -----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC-CCCCCC
Q 040812 198 -----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP-SLPECS 265 (300)
Q Consensus 198 -----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 265 (300)
..|.+||... +..++.++|||||||++|+|+||..||...... .......+.....+ ..+..+
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp ----------CCSSCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTS
T ss_pred CCccccccCCCeeEeChHHhC---CCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCccccc
Confidence 2244555433 456788999999999999999999999754332 22233333322222 233568
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
++++.++|.+||.. ||++|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~-dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINP-DPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCC-ChhhCCCHHHHHHH
Confidence 89999999999999 99999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=301.62 Aligned_cols=231 Identities=24% Similarity=0.313 Sum_probs=186.1
Q ss_pred cCCCCcceeee-eecCCcceEEEEEEE--ccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 53 IDGLSQLEKLQ-VLGQGNGGTVFKVRH--KQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 53 ~~~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
....++|++.+ .||+|+||.||+|.+ ..+++.||+|+++...... .+.+|+.++++++||||+++++++..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-- 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--
Confidence 34567899998 999999999999954 5668899999997654322 24579999999999999999999843
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce--------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS-------- 197 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~-------- 197 (300)
+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++...+.++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 478999999999999999998888999999999999999999999999999999999999987754322211
Q ss_pred --------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCC
Q 040812 198 --------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 198 --------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (300)
..|.+||... +..++.++|||||||++|+|+| |+.||..... ......+.....+..+
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 242 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMGCP 242 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCC
T ss_pred CCCcccccccCCCCceeeChHHhc---cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 2245555443 3346779999999999999999 9999965432 2333334445556677
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+++.+.++|.+||.. ||++|||+.++++
T Consensus 243 ~~~~~~l~~li~~~l~~-dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTY-DVENRPGFAAVEL 272 (291)
T ss_dssp TTCCHHHHHHHHHHTCS-STTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCC-ChhhCcCHHHHHH
Confidence 88999999999999999 9999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=314.79 Aligned_cols=230 Identities=24% Similarity=0.344 Sum_probs=185.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|++. .++..||||.++..... ..+.+|+.++++++||||+++++++.... ..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 121 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK-PV 121 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-ce
Confidence 4568999999999999999999987 56778999998754321 23467999999999999999999988754 89
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee---------
Q 040812 129 SILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC--------- 198 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~--------- 198 (300)
|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++...+.+++
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999999998754 69999999999999999999999999999999999999987654332221
Q ss_pred -------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 199 -------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
.|.+||... +..++.++|||||||++|||++ |+.||..... ......+........+..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~~~~i~~~~~~~~~~~ 274 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIA---YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPPPMD 274 (373)
T ss_dssp ------------CTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHHHHHHHTTEECCCCTT
T ss_pred ccceeccCCCcCCCccChhhhc---cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCcc
Confidence 255555543 4457789999999999999998 9999965432 223333333444455667
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++..+.++|.+||.. ||++||++.++++
T Consensus 275 ~~~~l~~li~~cl~~-dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQK-DRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCc-ChhhCcCHHHHHH
Confidence 889999999999999 9999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=304.34 Aligned_cols=237 Identities=21% Similarity=0.306 Sum_probs=185.9
Q ss_pred CCccCCCCcceeeeeecCCcceEEEEEEEcc---CCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeee
Q 040812 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFT 122 (300)
Q Consensus 50 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~ 122 (300)
.......++|++.+.||+|+||.||+|.+.. +++.||+|.++...... .+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444566889999999999999999998765 56689999987554332 2457999999999999999999987
Q ss_pred CCCC----cEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 123 KPSG----EVSILMEYMDAGSLEIYVKS------RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 123 ~~~~----~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
.... ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++..
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 6432 35999999999999999943 3469999999999999999999999999999999999999987654
Q ss_pred Ccccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 040812 193 PCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLM 250 (300)
Q Consensus 193 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 250 (300)
.+++++ .|.+||... +..++.++|||||||++|+|+| |..||....... ..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~ 259 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MY 259 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHH---SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhc---CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HH
Confidence 333222 244444432 4567889999999999999999 899996654332 22
Q ss_pred HHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
...........+..+++.+.++|.+||.. ||++|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLLHGHRLKQPEDCLDELYEIMYSCWRT-DPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTTCCCCCBTTCCHHHHHHHHHTTCS-SGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccccHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 23334455667778899999999999999 99999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=307.36 Aligned_cols=240 Identities=29% Similarity=0.525 Sum_probs=180.3
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..+++|++.+.||+|+||.||+|.+..+++.||+|++........ ..++..+++.++||||+++++++.... ..|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-DVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-cEE
Confidence 456889999999999999999999999999999999975433211 123445677889999999999998764 899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCccc-----------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
+||||+ ++.+..+... ...+++..++.++.||+.||.|||++ |++||||||+||+++.++...+++
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999999 5566666554 56799999999999999999999995 999999999999998876543322
Q ss_pred -------eeecccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC--CCC
Q 040812 197 -------SCLYESGEARHRK--HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP--ECS 265 (300)
Q Consensus 197 -------~~~~~~~~~~~~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 265 (300)
+..|.+||..... .+..++.++|||||||++|+|+||+.||....... ...........+..+ ..+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---EVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHHSCCCCCCSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---HHHHHHhccCCCCCCccCCC
Confidence 2335566654321 23456789999999999999999999997543322 233333334444444 357
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++++.++|.+||.. ||++|||++++++||||++
T Consensus 257 ~~~l~~li~~~l~~-dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 257 SGDFQSFVKDCLTK-DHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CHHHHHHHHHHTCS-CTTTSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHccC-ChhHCcCHHHHhhCHHHHh
Confidence 89999999999999 9999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=308.71 Aligned_cols=234 Identities=21% Similarity=0.303 Sum_probs=185.6
Q ss_pred CCCcceeeeeecCCcceEEEEEE-----EccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVR-----HKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+...... ..+.+|+.++++++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence 45789999999999999999999 5567889999998643221 12357999999999999999999988754
Q ss_pred cEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---CCccc
Q 040812 127 EVSILMEYMDAGSLEIYVKSRG-------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGY 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~~~~~ 196 (300)
..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+++
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 7899999999999999998653 4899999999999999999999999999999999999985432 21111
Q ss_pred ---------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 040812 197 ---------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC 254 (300)
Q Consensus 197 ---------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 254 (300)
+..|.+||... +..++.++|||||||++|+|+| |..||..... ......+.
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~ 259 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEFVT 259 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH----HHHHHHHh
Confidence 22356666543 4457889999999999999998 9999965432 23333344
Q ss_pred hCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.......+..+++.+.++|.+||.. ||++|||+.++++|.|+
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQH-QPEDRPNFAIILERIEY 301 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcC-ChhhCcCHHHHHHHHHH
Confidence 4555666778899999999999999 99999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=303.19 Aligned_cols=228 Identities=25% Similarity=0.369 Sum_probs=187.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
..++|++.+.||+|+||.||+|++. ++.||+|.+........+.+|+.++++++||||+++++++.+ ..|+||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEc
Confidence 4578999999999999999999986 678999998755444445789999999999999999998763 47899999
Q ss_pred cCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHh---CCccccCCCCCceeecCCCC-CCccc-----------
Q 040812 135 MDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHS---RNIVHRDIKPANVLINEKME-HPCGY----------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~---~~i~H~Dlkp~Nill~~~~~-~~~~~----------- 196 (300)
+++++|.+++.... .++...+..++.|++.||.|||+ +||+||||||+|||++.++. .++++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 99999999998754 37899999999999999999999 89999999999999987654 22222
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
+..|.+||... +..++.++|||||||++|||+||+.||...... .............+..+..+++.+.+
T Consensus 161 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFE---GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp ----CCTTSSCHHHHT---CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred ccCCCCCceEChhhhC---CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHHhcCCCCCcccccCHHHHH
Confidence 23355555543 556788999999999999999999999754332 22333344445566677788999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 040812 272 FIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+|.+||.. ||++|||++++++
T Consensus 236 li~~~l~~-dp~~Rps~~ell~ 256 (307)
T 2eva_A 236 LMTRCWSK-DPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHhcC-ChhhCcCHHHHHH
Confidence 99999999 9999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=296.56 Aligned_cols=229 Identities=23% Similarity=0.386 Sum_probs=180.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC------CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP------PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|.+. ++.||+|+++...... .+.+|+.+++.++||||+++++++.... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP-NL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---C
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-ce
Confidence 4678999999999999999999986 7899999987543221 2357999999999999999999988754 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC---ccccCCCCCceeecCC--------CCCC---c
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN---IVHRDIKPANVLINEK--------MEHP---C 194 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---i~H~Dlkp~Nill~~~--------~~~~---~ 194 (300)
|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++| ++||||||+||+++.. +... +
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999999864 47999999999999999999999999 8999999999999862 2221 1
Q ss_pred c--------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC
Q 040812 195 G--------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS 260 (300)
Q Consensus 195 ~--------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (300)
| ++..|.+||... +..++.++|||||||++|+|+||+.||...... ..............
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIR---ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAYGVAMNKLALP 234 (271)
T ss_dssp CC-------------CCGGGSCHHHHH---HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHHTSCCCCC
T ss_pred CcccccccccccCCCCccceeCHHHhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHhhhcCCCCCC
Confidence 1 223355555543 445788999999999999999999999654322 11222223344556
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+..+++.+.++|.+||.. ||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~-~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNP-DPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcC-CcccCcCHHHHHHH
Confidence 6778899999999999999 99999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=304.34 Aligned_cols=232 Identities=20% Similarity=0.327 Sum_probs=188.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
...++|++.+.||+|+||.||+|.+. .+++.||+|.+....... .+.+|+.++++++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999987 467899999986443221 2457999999999999999999987754
Q ss_pred CcEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR----------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~ 195 (300)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++...+.
T Consensus 102 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 102 -PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred -ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 899999999999999999752 357899999999999999999999999999999999999987654332
Q ss_pred ce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH
Q 040812 196 YS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 196 ~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 253 (300)
++ ..|.+||... +..++.++|||||||++|+|+| |..||..... ......+
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~ 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFV 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhc---cCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----HHHHHHH
Confidence 21 1255555443 4457889999999999999999 8999965432 2333333
Q ss_pred hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
........+..+++.+.++|.+||.. ||++|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEGGLLDKPDNCPDMLFELMRMCWQY-NPKMRPSFLEIISS 293 (322)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCC-CcccCcCHHHHHHH
Confidence 44445566778899999999999999 99999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=317.30 Aligned_cols=231 Identities=23% Similarity=0.307 Sum_probs=189.3
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+....++|++.+.||+|+||.||+|.+.. +..||||+++..... ..+.+|+.+|++++||||+++++++.. +..|+
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~i 255 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYI 255 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEE
Confidence 34456789999999999999999999986 467999998764422 245789999999999999999999865 37899
Q ss_pred EEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 131 LMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++..++.++
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999999974 346999999999999999999999999999999999999987755432221
Q ss_pred ---------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 198 ---------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 198 ---------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
..|.+||... ++.++.++|||||||++|||+| |+.||..... .+....+........+..+++
T Consensus 336 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i~~~~~~~~~~~~~~ 408 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVERGYRMPCPPECPE 408 (452)
T ss_dssp -------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCCTTSCH
T ss_pred ecccCCcccccccCHhHHh---cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCH
Confidence 2355555543 3457889999999999999999 9999965432 233344444555667778999
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+.++|.+||.. ||++|||++++++
T Consensus 409 ~l~~li~~cl~~-dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 409 SLHDLMCQCWRK-EPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHccC-ChhhCcCHHHHHH
Confidence 999999999999 9999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=313.59 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=179.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC-eEEEEEEeecCCC-CCCCHHHHHHHHhcCCCc------eeEeceeeeCCCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTL-ALYALKVMQCDRG-TPPNPQELNILRQTNSPY------IVKCHQIFTKPSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~ 127 (300)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++.... .....+|+.++++++|++ ++.+++++.... .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG-H 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT-E
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC-e
Confidence 368999999999999999999998776 7999999864321 122356899999887655 888989887754 8
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-----------------
Q 040812 128 VSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE----------------- 188 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~----------------- 188 (300)
.|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999999 55777777654 36999999999999999999999999999999999999943
Q ss_pred --CCCCC---c-------------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH
Q 040812 189 --KMEHP---C-------------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLM 250 (300)
Q Consensus 189 --~~~~~---~-------------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 250 (300)
++... + .++..|.+||... +..++.++|||||||++|||+||..||........ ...+
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~ 251 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL---ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-LVMM 251 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeee---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 22221 1 1234466666654 55678899999999999999999999975433221 1222
Q ss_pred HHHhhCCCC----------------------------------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHH
Q 040812 251 LAICFREPP----------------------------------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQ 290 (300)
Q Consensus 251 ~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~ 290 (300)
.......+. ......+..+.+||.+||.. ||++|||++|
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~-dP~~Rpt~~e 330 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF-DPAQRITLAE 330 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS-STTTSCCHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC-ChhhCcCHHH
Confidence 221111000 00111235788999999999 9999999999
Q ss_pred HhcCCCCCC
Q 040812 291 LLSHPFLAD 299 (300)
Q Consensus 291 ~l~hpw~~~ 299 (300)
+++||||++
T Consensus 331 ~l~hp~f~~ 339 (355)
T 2eu9_A 331 ALLHPFFAG 339 (355)
T ss_dssp HTTSGGGGG
T ss_pred HhcChhhcC
Confidence 999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=306.42 Aligned_cols=232 Identities=22% Similarity=0.321 Sum_probs=186.8
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-------cCCeEEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeee
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-------QTLALYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFT 122 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~ 122 (300)
...++|++.+.||+|+||.||+|.+. .+++.||+|+++..... ..+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 35688999999999999999999986 45778999998754322 1235799999999 8999999999988
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 123 KPSGEVSILMEYMDAGSLEIYVKSRG----------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 123 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
... ..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 112 ~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 112 QDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp SSS-CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cCC-ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 754 8999999999999999998643 38999999999999999999999999999999999999
Q ss_pred cCCCCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 187 NEKMEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 187 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
+.++...++++ ..|.+||... +..++.++|||||||++|+|+| |..||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhc---CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence 87765433221 1245555433 3456789999999999999999 9999965432
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
......+........+..++..+.++|.+||.. ||++|||+.+++++
T Consensus 266 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 --EELFKLLKEGHRMDKPANCTNELYMMMRDCWHA-VPSQRPTFKQLVED 312 (334)
T ss_dssp --HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred --HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 233333444555667778899999999999999 99999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=318.21 Aligned_cols=240 Identities=29% Similarity=0.402 Sum_probs=181.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcC-----------CCceeEeceeee
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTN-----------SPYIVKCHQIFT 122 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 122 (300)
..++|++.+.||+|+||.||+|++..+++.||+|++..+.. .....+|+.++++++ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35789999999999999999999999999999999864321 122356888888876 899999999986
Q ss_pred CCC---CcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCC------
Q 040812 123 KPS---GEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKM------ 190 (300)
Q Consensus 123 ~~~---~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~------ 190 (300)
... ...++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 432 2689999999 78999999863 4599999999999999999999998 999999999999995322
Q ss_pred CC---Ccc-------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc-----hHHHH
Q 040812 191 EH---PCG-------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-----DFLSL 249 (300)
Q Consensus 191 ~~---~~~-------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-----~~~~~ 249 (300)
.. ++| ++..|.+||... +..++.++|||||||++|||+||+.||....... .....
T Consensus 176 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH---TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEEEcccccccccCCCCCCCCCCccccCcHHHh---CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 11 122 234466666654 4567889999999999999999999997543211 11111
Q ss_pred HHHHhhC--------------------------------------CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHH
Q 040812 250 MLAICFR--------------------------------------EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQL 291 (300)
Q Consensus 250 ~~~~~~~--------------------------------------~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~ 291 (300)
+...... ....++...++++.+||.+||+. ||++|||++|+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rpt~~el 331 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL-DPRKRADAGGL 331 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS-STTTCBCHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc-CccccCCHHHH
Confidence 1111100 01123334467899999999999 99999999999
Q ss_pred hcCCCCCC
Q 040812 292 LSHPFLAD 299 (300)
Q Consensus 292 l~hpw~~~ 299 (300)
++||||++
T Consensus 332 l~hp~f~~ 339 (373)
T 1q8y_A 332 VNHPWLKD 339 (373)
T ss_dssp HTCGGGTT
T ss_pred hhChhhhc
Confidence 99999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.94 Aligned_cols=239 Identities=25% Similarity=0.295 Sum_probs=178.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+..+|++.+.||+|+||.|+. ....+++.||||.+.... .....+|+.+++++ +||||+++++++.+.. ..|+||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQ-FQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCC-EEEEEE
Confidence 3456799999999999999764 444568899999986533 23457899999999 7999999999988754 899999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC---C-----CCcc--------
Q 040812 133 EYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM---E-----HPCG-------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~---~-----~~~~-------- 195 (300)
|||.+ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ . .++|
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99975 9999998654 456667789999999999999999999999999999995321 1 1222
Q ss_pred -----------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 196 -----------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 196 -----------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
++..|.+||......+..++.++|||||||++|||+| |..||..... .................+.
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQANILLGACSLDCLHPEK 254 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--HHHHHHTTCCCCTTSCTTC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--HHHHHHhccCCccccCccc
Confidence 2344667776654334556779999999999999999 9999954322 1111111110011111122
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..+..+.+||.+||.. ||++|||++++++||||.+
T Consensus 255 ~~~~~~~~li~~~L~~-dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 255 HEDVIARELIEKMIAM-DPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHHSCS-SGGGSCCHHHHHTSTTTCC
T ss_pred cccHHHHHHHHHHHhC-CHhhCCCHHHHHhCccccC
Confidence 2345689999999999 9999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.40 Aligned_cols=239 Identities=28% Similarity=0.438 Sum_probs=176.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHH-HHHhcCCCceeEeceeeeCCCCcEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELN-ILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
...++|++.+.||+|+||.||+|.++.+++.||+|+++...... ....|+. +++.++||||+++++++.... ..+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-~~~ 97 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-DCW 97 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-EEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-ceE
Confidence 35678999999999999999999999999999999997543221 1233554 667789999999999998764 899
Q ss_pred EEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhHhC-CccccCCCCCceeecCCCCCCcc--------
Q 040812 130 ILMEYMDAGSLEIYVKS-----RGRLSEDIICTISRQVLKGLFYMHSR-NIVHRDIKPANVLINEKMEHPCG-------- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~-~i~H~Dlkp~Nill~~~~~~~~~-------- 195 (300)
+||||+++ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++...++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999986 88887763 56799999999999999999999998 99999999999999877554322
Q ss_pred ----------ceeecccccccccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC---
Q 040812 196 ----------YSCLYESGEARHRK-HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL--- 261 (300)
Q Consensus 196 ----------~~~~~~~~~~~~~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 261 (300)
++..|.+||..... .+..++.++|||||||++|+|+||+.||....... ...........+.+
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCc
Confidence 23346677665321 24457789999999999999999999996543221 11112222222222
Q ss_pred -CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 262 -PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 262 -~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
...+++.+.++|.+||.. ||++|||+.++++||||.
T Consensus 254 ~~~~~~~~l~~li~~~l~~-dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTK-DESKRPKYKELLKHPFIL 290 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCS-SGGGSCCHHHHTTSHHHH
T ss_pred ccccCCHHHHHHHHHHhhC-ChhhCcCHHHHHhChHHH
Confidence 235789999999999999 999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=318.08 Aligned_cols=237 Identities=26% Similarity=0.345 Sum_probs=183.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC-CcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS-GEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~lv 131 (300)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++++++||||+++++++.... ...|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 46799999999999999999999999999999999754322 22357999999999999999999987653 268999
Q ss_pred EeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee----cCCCCC---Ccc------
Q 040812 132 MEYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI----NEKMEH---PCG------ 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill----~~~~~~---~~~------ 195 (300)
|||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.. ++|
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999999997643 39999999999999999999999999999999999998 443222 222
Q ss_pred ---------ceeeccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC-
Q 040812 196 ---------YSCLYESGEARHRKH-----GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS- 260 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 260 (300)
++..|.+||...... +..++.++|||||||++|||+||+.||............+..+....+..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 233455555433110 13456789999999999999999999976544444444454444343321
Q ss_pred -----------------------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 261 -----------------------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 261 -----------------------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++...+..+.++|.+||.. ||++||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~-dP~~R~s~~e~l~ 302 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA-DQEKCWGFDQFFA 302 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC-CTTTSCCHHHHHH
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhcc-ChhhhccHHHHHH
Confidence 1122345789999999999 9999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=303.45 Aligned_cols=229 Identities=22% Similarity=0.308 Sum_probs=185.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEE----EEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALY----ALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|++.+.||+|+||.||+|.+..+++.+ |+|.+....... .+.+|+.++++++||||+++++++... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--T 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--S
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--C
Confidence 4578999999999999999999998887765 566554332222 235799999999999999999998863 5
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 128 VSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
.++|++|+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 8899999999999999986 45799999999999999999999999999999999999998765433221
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
+..|.+||... +..++.++|||||||++|||+| |..||...... .. ...+........+..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~---~~~~~~~~~~~~~~~ 243 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EI---SSILEKGERLPQPPI 243 (327)
T ss_dssp ---------CCCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GH---HHHHHTTCCCCCCTT
T ss_pred cccccccCCCccccccCHHHHc---CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HH---HHHHHcCCCCCCCcc
Confidence 11355555544 4567889999999999999999 99999764432 22 222333455566777
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.++.++|.+||.. ||++|||+.++++
T Consensus 244 ~~~~l~~li~~~l~~-dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMI-DADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCC-ChhHCcCHHHHHH
Confidence 899999999999999 9999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=299.53 Aligned_cols=233 Identities=22% Similarity=0.377 Sum_probs=181.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
.-++|++.+.||+|+||.||+|++.. .||+|+++...... .+.+|+.++++++||||++++++... +..++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~l 96 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAI 96 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEE
Confidence 35689999999999999999998754 49999987554332 24679999999999999999997543 36899
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc--------------
Q 040812 131 LMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------- 195 (300)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++...+.
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999999999999964 4469999999999999999999999999999999999999877543222
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-hCCCCCCCCCCCh
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPECSSE 267 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 267 (300)
++..|.+||......+..++.++|||||||++|+|+||+.||................. ..........+++
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence 23345666665444456678899999999999999999999976554433333332211 1112233456789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+.++|.+||.. ||++|||+.++++
T Consensus 257 ~l~~li~~~l~~-~p~~Rps~~ell~ 281 (289)
T 3og7_A 257 RMKRLMAECLKK-KRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHccC-ChhhCCCHHHHHH
Confidence 999999999999 9999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=304.36 Aligned_cols=234 Identities=21% Similarity=0.297 Sum_probs=189.0
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCe-----EEEEEEeecCCCC---CCCHHHHHHHHhc-CCCceeEeceeeeC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLA-----LYALKVMQCDRGT---PPNPQELNILRQT-NSPYIVKCHQIFTK 123 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~ 123 (300)
....++|++.+.||+|+||.||+|.+..+++ .||+|.+...... ..+.+|+.+++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3456889999999999999999999977654 7999998754321 2245799999999 89999999999887
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSR--------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK 189 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~ 189 (300)
.. ..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 122 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 122 GG-PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SS-SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred CC-ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 54 899999999999999999752 357999999999999999999999999999999999999876
Q ss_pred CCCCccce---------------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 040812 190 MEHPCGYS---------------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFL 247 (300)
Q Consensus 190 ~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~ 247 (300)
+...+.++ ..|.+||... +..++.++|||||||++|||+| |..||..........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhc---cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 54322221 2355555443 4457889999999999999999 999997655443333
Q ss_pred HHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 248 SLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
... ........+...++.+.++|.+||.. ||++|||+.+++++
T Consensus 278 ~~~---~~~~~~~~~~~~~~~l~~li~~~l~~-~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLV---KDGYQMAQPAFAPKNIYSIMQACWAL-EPTHRPTFQQICSF 320 (333)
T ss_dssp HHH---HHTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHH---hcCCCCCCCCCCCHHHHHHHHHHhcc-ChhhCcCHHHHHHH
Confidence 332 23445556677899999999999999 99999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.21 Aligned_cols=234 Identities=18% Similarity=0.202 Sum_probs=177.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-----CeEEEEEEeecCCCC-------------CCCHHHHHHHHhcCCCceeE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGT-------------PPNPQELNILRQTNSPYIVK 116 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-------------~~~~~E~~~l~~l~h~niv~ 116 (300)
..++|++.+.||+|+||.||+|.+..+ ++.||+|++...... .....|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999765 588999998754311 01123455566778999999
Q ss_pred eceeeeCC---CCcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec--CCC
Q 040812 117 CHQIFTKP---SGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN--EKM 190 (300)
Q Consensus 117 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~--~~~ 190 (300)
+++++... ....|+||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998653 13589999999 89999999875 5799999999999999999999999999999999999998 444
Q ss_pred CC---Ccc-----------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 040812 191 EH---PCG-----------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP 244 (300)
Q Consensus 191 ~~---~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 244 (300)
.. ++| ++..|.+||... +..++.++|||||||++|||+||+.||.......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN---GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC---CCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 32 222 233455555443 5557889999999999999999999997654444
Q ss_pred hHHHHHHHHhhCCCC------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 245 DFLSLMLAICFREPP------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
............... .....+++++.++|..||.. ||++||+++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~-~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLL-DYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTC-CTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcC-CCCCCCCHHHHHH
Confidence 333222211111100 01246789999999999999 9999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=305.76 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=189.7
Q ss_pred cCCCCcceeeeeecCCcceEEEEEE----EccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeC-CC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVR----HKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTK-PS 125 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 125 (300)
+...++|++.+.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.++++++|+||+++++++.. ..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 3456789999999999999999999 4678999999998654321 124679999999999999999998763 23
Q ss_pred CcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------
Q 040812 126 GEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------- 197 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------- 197 (300)
+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++...+.++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 468999999999999999986 446999999999999999999999999999999999999987755432221
Q ss_pred ---------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------CCchHHHHHH
Q 040812 198 ---------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG-----------QEPDFLSLML 251 (300)
Q Consensus 198 ---------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-----------~~~~~~~~~~ 251 (300)
..|.+||... +..++.++|||||||++|+|+||..||.... ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhc---cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 1145555432 3446789999999999999999999985321 1112223334
Q ss_pred HHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 252 AICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..........+..+++.+.++|.+||.. ||++|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~-dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAP-SPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 4445556667788999999999999999 99999999999654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.01 Aligned_cols=231 Identities=24% Similarity=0.346 Sum_probs=187.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCC----eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTL----ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
..++|++.+.||+|+||.||+|.+..++ ..||+|.++..... ..+.+|+.++++++||||+++++++.... .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 120 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-P 120 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-S
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC-C
Confidence 4578999999999999999999987543 46999998754322 12357999999999999999999987754 8
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 128 VSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++...+.++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999999764 57999999999999999999999999999999999999998765432221
Q ss_pred -------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 198 -------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 198 -------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
..|.+||... +..++.++|||||||++|||+| |..||..... ......+........+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~~~~~~~~~~~~~~~ 273 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGFRLPTPM 273 (333)
T ss_dssp ----------CCCGGGSCHHHHH---SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCCCCCCT
T ss_pred cccccccCCCCccccccCchhcc---cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHCCCcCCCcc
Confidence 1355555543 4567889999999999999999 9999965432 23333344444555677
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+++.+.++|.+||.. ||++||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~-~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQ-ERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCS-STTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 7899999999999999 99999999998763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=309.78 Aligned_cols=230 Identities=20% Similarity=0.285 Sum_probs=183.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
..|++.+.||+|+||.||+|.+..+ +..||+|.++..... ..+.+|+.++++++||||+++++++....+..|+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4588899999999999999998643 346899988643322 1245799999999999999999987655557899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-----------
Q 040812 131 LMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------- 198 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~----------- 198 (300)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++..++.+++
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999864 358999999999999999999999999999999999999987654333221
Q ss_pred ------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 199 ------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 199 ------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
.|.+||... +..++.++|||||||++|||+| |.+||....... ... ..........+..+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~~~---~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITV---YLLQGRRLLQPEYC 321 (373)
T ss_dssp ---------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-HHH---HHHTTCCCCCCTTC
T ss_pred cccccCCCCCcccccChHHhc---CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-HHH---HHHcCCCCCCCCCC
Confidence 255555443 4557889999999999999999 677886544432 222 22334455667788
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
++.+.++|.+||.. ||++|||+++++++
T Consensus 322 ~~~l~~li~~cl~~-dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHP-KAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCC-ChhhCcCHHHHHHH
Confidence 99999999999999 99999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=307.43 Aligned_cols=229 Identities=15% Similarity=0.236 Sum_probs=179.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc--------CCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeE-----------
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ--------TLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVK----------- 116 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 116 (300)
.++|++.+.||+|+||.||+|++.. .++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 4789999999999999999999987 4889999998754 45678999999999999988
Q ss_pred ----eceeeeCCCCcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 117 ----CHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 117 ----~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
+++++....+..|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence 4555554455899999999 89999999875 6799999999999999999999999999999999999999875
Q ss_pred --CCCc---cc-----------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 040812 191 --EHPC---GY-----------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQ 242 (300)
Q Consensus 191 --~~~~---~~-----------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 242 (300)
...+ |. +..|.+||... +..++.++|||||||++|||+||+.||.....
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK---GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 3222 21 22344444332 45678899999999999999999999976543
Q ss_pred CchH-HHHHHHHhhCCCCCCC------CCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 243 EPDF-LSLMLAICFREPPSLP------ECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 243 ~~~~-~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.... ........ .....+. ..+++.+.++|.+||.. ||++|||++++++
T Consensus 274 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~l~~ 329 (352)
T 2jii_A 274 NTEDIMKQKQKFV-DKPGPFVGPCGHWIRPSETLQKYLKVVMAL-TYEEKPPYAMLRN 329 (352)
T ss_dssp CHHHHHHHHHHHH-HSCCCEECTTSCEECCCHHHHHHHHHHHTC-CTTCCCCHHHHHH
T ss_pred CHHHHHHHHHhcc-CChhhhhhhccccCCCcHHHHHHHHHHHhC-ChhhCCCHHHHHH
Confidence 3222 22222222 2222222 24689999999999999 9999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=322.32 Aligned_cols=229 Identities=21% Similarity=0.263 Sum_probs=185.9
Q ss_pred CCCcceeee-eecCCcceEEEEEEEc--cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQ-VLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..+++.+.+ .||+|+||.||+|.++ .++..||||+++..... ..+.+|+.+|++++||||+++++++.. +..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~ 410 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EAL 410 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCe
Confidence 344566666 8999999999999876 45678999999764322 234679999999999999999999875 369
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++..++.++
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999999754 45999999999999999999999999999999999999987754332221
Q ss_pred ------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 198 ------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 198 ------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
..|.+||... +..++.++|||||||++|||+| |+.||...... +....+..+.....+..
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~---~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~~i~~~~~~~~p~~ 563 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQGKRMECPPE 563 (613)
T ss_dssp -----------CCTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHHHHHHTTCCCCCCTT
T ss_pred ceeeeccCCCCccceeCHhhhc---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHcCCCCCCCCc
Confidence 2355555543 4567889999999999999998 99999765432 33344445566677888
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+.++|.+||.. ||++||++.++++
T Consensus 564 ~~~~l~~li~~cl~~-dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 564 CPPELYALMSDCWIY-KWEDRPDFLTVEQ 591 (613)
T ss_dssp CCHHHHHHHHHTTCS-STTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCC-ChhHCcCHHHHHH
Confidence 999999999999999 9999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=299.06 Aligned_cols=226 Identities=22% Similarity=0.388 Sum_probs=184.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeC-------------
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTK------------- 123 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------------- 123 (300)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 57999999999999999999999999999999987543 456789999999999999999998753
Q ss_pred --CCCcEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc----
Q 040812 124 --PSGEVSILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG---- 195 (300)
Q Consensus 124 --~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~---- 195 (300)
.....|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++...+.
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 168 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGL 168 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchh
Confidence 123589999999999999999754 579999999999999999999999999999999999999876543222
Q ss_pred --------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC
Q 040812 196 --------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261 (300)
Q Consensus 196 --------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (300)
++..|.+||... +..++.++|||||||++|+|+||..||... ........ ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~---~~~~ 236 (284)
T 2a19_B 169 VTSLKNDGKRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALGLILAELLHVCDTAFET------SKFFTDLR---DGII 236 (284)
T ss_dssp CEESSCCSCCCCCCSCCTTSCHHHHH---CSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHH---TTCC
T ss_pred heeccccccccccCCcccccChhhhc---cCCCcchhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhh---cccc
Confidence 223355555443 455678999999999999999999888421 11122221 1234
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
+..++..+.++|.+||.. ||++|||+.++++|.|.
T Consensus 237 ~~~~~~~~~~li~~~l~~-dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSK-KPEDRPNTSEILRTLTV 271 (284)
T ss_dssp CTTSCHHHHHHHHHHTCS-SGGGSCCHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHccC-ChhhCcCHHHHHHHHHH
Confidence 566889999999999999 99999999999998664
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=298.28 Aligned_cols=230 Identities=24% Similarity=0.278 Sum_probs=185.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc---CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CC
Confidence 45789999999999999999999754 3457999998754321 2345799999999999999999998653 57
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++...+.+
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 8999999999999999764 4599999999999999999999999999999999999998765432222
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
+..|.+||... +..++.++|||||||++|+|+| |+.||....... .. ...........+..++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~---~~~~~~~~~~~~~~~~ 240 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESIN---FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VI---GVLEKGDRLPKPDLCP 240 (281)
T ss_dssp -----CCCCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HH---HHHHHTCCCCCCTTCC
T ss_pred ccccccCCCCcceeCchhhc---cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HH---HHHhcCCCCCCCCCCC
Confidence 12355665543 4457789999999999999998 999997544332 22 2223344556677789
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.+.++|.+||.. ||++|||+.+++++
T Consensus 241 ~~l~~li~~~l~~-~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDY-DPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccC-CchhCcCHHHHHHH
Confidence 9999999999999 99999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=299.53 Aligned_cols=232 Identities=21% Similarity=0.259 Sum_probs=186.5
Q ss_pred CCCCcceeee-eecCCcceEEEEEEEc--cCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 54 DGLSQLEKLQ-VLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
...++|.+.+ .||+|+||.||+|.+. .+++.||+|+++..... ..+.+|+.++++++||||+++++++.. +.
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 83 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EA 83 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CC
Confidence 3456788887 9999999999999864 46788999999764321 123579999999999999999999853 36
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 128 VSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++...+.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 89999999999999999753 4699999999999999999999999999999999999998765432221
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
+..|.+||... +..++.++|||||||++|+|+| |+.||...... .....+.....+..+.
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~i~~~~~~~~~~ 236 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQGKRMECPP 236 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHHHHTTCCCCCCT
T ss_pred cceeeccccccccccccCHHHhc---cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHhcCCcCCCCC
Confidence 12255555443 3456789999999999999999 99999664432 2333344455567778
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hp 295 (300)
.+++.+.++|.+||.. ||++||++.++++|.
T Consensus 237 ~~~~~l~~li~~~l~~-~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 237 ECPPELYALMSDCWIY-KWEDRPDFLTVEQRM 267 (287)
T ss_dssp TCCHHHHHHHHHTTCS-SGGGSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCC-ChhhCcCHHHHHHHH
Confidence 8999999999999999 999999999999763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=297.49 Aligned_cols=230 Identities=21% Similarity=0.297 Sum_probs=181.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
..+|++.+.||+|+||.||+|.+..+ ...+|+|.+...... ..+.+|+.++++++||||+++++++....+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45799999999999999999997543 346899988653321 223579999999999999999998665556899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee----------
Q 040812 130 ILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC---------- 198 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~---------- 198 (300)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++...+.+++
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999999976 3468999999999999999999999999999999999999987654333222
Q ss_pred -------------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 199 -------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 199 -------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
.|.+||... +..++.++|||||||++|+|+| |.+||...... .. ............+..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~ 256 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DI---TVYLLQGRRLLQPEY 256 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-TH---HHHHHTTCCCCCCTT
T ss_pred hccccccCCCCCccccChHHhc---CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HH---HHHHhcCCCCCCCcc
Confidence 244444432 4457789999999999999999 55666544332 22 222333455566777
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+++.+.++|.+||.. ||++|||++++++
T Consensus 257 ~~~~l~~li~~~l~~-~p~~Rps~~ell~ 284 (298)
T 3f66_A 257 CPDPLYEVMLKCWHP-KAEMRPSFSELVS 284 (298)
T ss_dssp CCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCC-ChhhCcCHHHHHH
Confidence 899999999999999 9999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=324.19 Aligned_cols=221 Identities=24% Similarity=0.331 Sum_probs=183.7
Q ss_pred eeecCCcceEEEEEEE--ccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRH--KQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
+.||+|+||.||+|.+ +.+++.||||+++..... ..+.+|+.+|++++||||+++++++.. . ..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~-~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C-CEEEEEEccC
Confidence 4899999999999965 456789999999764432 234679999999999999999999864 3 6899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------------
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------------- 197 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------------- 197 (300)
+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++..++.++
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 9999999998888999999999999999999999999999999999999988765432221
Q ss_pred ---eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 198 ---CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 198 ---~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
..|.+||... +..++.++|||||||++|||+| |+.||..... ......+........+..+++++.++|
T Consensus 533 ~~t~~y~APE~~~---~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 533 KWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp --CGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred CCceeeeChhhhc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 2255666553 4457889999999999999998 9999965433 233444445566777888999999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 040812 274 RCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+||.. ||++||+++++++
T Consensus 606 ~~cl~~-dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTY-DVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCS-STTTSCCHHHHHH
T ss_pred HHHcCC-CHhHCcCHHHHHH
Confidence 999999 9999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=296.06 Aligned_cols=229 Identities=21% Similarity=0.296 Sum_probs=182.0
Q ss_pred cceeeeeecCCcceEEEEEEEccCCe---EEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLA---LYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
.|++.+.||+|+||.||+|.+..+++ .||+|.+...... ..+.+|+.++++++||||+++++++....+..++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46778999999999999999765444 7999998643321 22357999999999999999999998766556999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------ 198 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------ 198 (300)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++...+++++
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999999999999986 4568999999999999999999999999999999999999987654333222
Q ss_pred -----------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 199 -----------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 199 -----------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
.|.+||.. .+..++.++|||||||++|+|+||..|+........... ..........+..+++
T Consensus 182 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESL---QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH---FLAQGRRLPQPEYCPD 255 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHH---TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH---HHHTTCCCCCCTTCCH
T ss_pred cccCcCCCCCccccChhhh---ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH---HhhcCCCCCCCccchH
Confidence 23333333 245678899999999999999996666544443333332 2333445566778899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.+.++|.+||.. ||++|||+.++++
T Consensus 256 ~l~~li~~~l~~-~p~~Rps~~~ll~ 280 (298)
T 3pls_A 256 SLYQVMQQCWEA-DPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHccC-ChhhCcCHHHHHH
Confidence 999999999999 9999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=305.94 Aligned_cols=239 Identities=20% Similarity=0.255 Sum_probs=179.9
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCC---C
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPS---G 126 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~ 126 (300)
+.....++|++.+.||+|+||.||+|++. ++.||||++...... ....+|+.++++++||||+++++++.... .
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 34456789999999999999999999886 789999998643221 12245888899999999999999987643 2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC----------CccccCCCCCceeecCCCCCCcc-
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR----------NIVHRDIKPANVLINEKMEHPCG- 195 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~----------~i~H~Dlkp~Nill~~~~~~~~~- 195 (300)
..|+||||+++|+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++..+++
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 479999999999999999764 599999999999999999999999 99999999999999887554322
Q ss_pred --------------------ceeeccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc---------
Q 040812 196 --------------------YSCLYESGEARHRKH--GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP--------- 244 (300)
Q Consensus 196 --------------------~~~~~~~~~~~~~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~--------- 244 (300)
++..|.+||...... ...++.++|||||||++|||+||+.||.......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 233455665543211 1234568899999999999999999997543221
Q ss_pred ---hHHHHHHHHh-hCCCCCCCCC-----CChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 245 ---DFLSLMLAIC-FREPPSLPEC-----SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 245 ---~~~~~~~~~~-~~~~~~~~~~-----~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.......... ....+..+.. .++.+.++|.+||.. ||++|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-dP~~Rps~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH-DAEARLSAGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccC-ChhhCcCHHHHHH
Confidence 1111111111 1122222221 134599999999999 9999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=295.69 Aligned_cols=230 Identities=23% Similarity=0.362 Sum_probs=185.7
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
....++|++.+.||+|+||.||+|.+.. ++.||+|.++..... ..+.+|+.++++++||||+++++++.. +..++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEE
Confidence 3456789999999999999999999864 678999998754322 234679999999999999999998764 368999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-----------
Q 040812 132 MEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC----------- 198 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~----------- 198 (300)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++...+.+++
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999999997543 69999999999999999999999999999999999999987654322211
Q ss_pred ---------eccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChH
Q 040812 199 ---------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268 (300)
Q Consensus 199 ---------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (300)
.|.+||... ++.++.++|||||||++|||+| |..||..... ......+........+..+++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQNLERGYRMVRPDNCPEE 238 (279)
T ss_dssp CCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccCCCCccCccChhhhc---cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----HHHHHHHhcccCCCCcccccHH
Confidence 244444432 3456779999999999999999 9999965432 2333333444556667788999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.++|.+||.. ||++|||++++++
T Consensus 239 l~~li~~~l~~-~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 239 LYQLMRLCWKE-RPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHhcc-ChhhCCCHHHHHH
Confidence 99999999999 9999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=305.20 Aligned_cols=236 Identities=21% Similarity=0.271 Sum_probs=182.2
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
....++|++.+.||+|+||.||+|.+. +++.||+|.+...... ..+.+|+.++++++||||+++++++.... ..++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN-EMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT-CCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-eEEE
Confidence 345678999999999999999999975 5889999987654322 22467999999999999999999987654 8999
Q ss_pred EEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc----------
Q 040812 131 LMEYMDAGSLEIYVKSRG----RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY---------- 196 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~---------- 196 (300)
||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++...+++
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999986543 589999999999999999999999999999999999998875543222
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch--HHHHHHHHhhCC------
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPD--FLSLMLAICFRE------ 257 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~------ 257 (300)
+..|.+||... +..++.++|||||||++|||+||+.||........ ............
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFI---KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHH---HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred cccccccccCCCccccCHHHhc---CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 23355555443 34577899999999999999999999976433221 111111111000
Q ss_pred ----CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 258 ----PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 258 ----~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
....+...+..+.+++.+||.. ||++|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~-dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLAL-SSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCC-CcccCcCHHHHHHH
Confidence 1111223356789999999999 99999999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.86 Aligned_cols=232 Identities=23% Similarity=0.306 Sum_probs=189.6
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+....++|++.+.||+|+||.||+|.+.. +..||||+++..... ..+.+|+.+|++++|+||+++++++.. +..|+
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~l 338 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYI 338 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceE
Confidence 34456789999999999999999999986 467999999764422 345789999999999999999999865 37899
Q ss_pred EEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-----------
Q 040812 131 LMEYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS----------- 197 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~----------- 197 (300)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++..++.++
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999999974 346999999999999999999999999999999999999987755432221
Q ss_pred ---------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 198 ---------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 198 ---------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
..|.+||... ++.++.++|||||||++|||+| |+.||..... .+....+........+..+++
T Consensus 419 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~~~~i~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVERGYRMPCPPECPE 491 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHHHHHHHTTCCCCCCTTCCH
T ss_pred ecccCCcCcccccCHHHhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCH
Confidence 2355555543 3457889999999999999999 9999965432 233344444555666778999
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+.++|.+||.. ||++|||++++++.
T Consensus 492 ~l~~li~~cl~~-dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 492 SLHDLMCQCWRK-EPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCC-ChhHCcCHHHHHHH
Confidence 999999999999 99999999998863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=305.41 Aligned_cols=233 Identities=18% Similarity=0.160 Sum_probs=175.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc---CCeEEEEEEeecCCCC-------------CCCHHHHHHHHhcCCCceeEece
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQ---TLALYALKVMQCDRGT-------------PPNPQELNILRQTNSPYIVKCHQ 119 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-------------~~~~~E~~~l~~l~h~niv~~~~ 119 (300)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++...... ..+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7889999998754321 11245777888889999999999
Q ss_pred eeeCC---CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC--CCC-
Q 040812 120 IFTKP---SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM--EHP- 193 (300)
Q Consensus 120 ~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~--~~~- 193 (300)
++... .+..|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98762 34799999999 889999998777899999999999999999999999999999999999998765 322
Q ss_pred --ccc-----------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q 040812 194 --CGY-----------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS 248 (300)
Q Consensus 194 --~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 248 (300)
+|. +..|.+||... +..++.++|||||||++|||+||+.||...........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK---GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH---TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhc---CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 222 22344444433 45678899999999999999999999965433332222
Q ss_pred HHHH-HhhCCCCC-----CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 249 LMLA-ICFREPPS-----LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 249 ~~~~-~~~~~~~~-----~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.... .....+.. ....+++++.++|.+||.. ||++|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSL-AYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTC-CTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhc-CcccCCCHHHHHH
Confidence 2221 11111111 1126789999999999999 9999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=300.44 Aligned_cols=237 Identities=22% Similarity=0.320 Sum_probs=180.9
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
....++|++.+.||+|+||.||+|++. +++.||+|++....... .+.+|+.++++++||||+++++++.... ..+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 103 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERL 103 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-CCE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC-ceE
Confidence 345678999999999999999999865 58899999987644322 3468999999999999999999988754 789
Q ss_pred EEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhHhC---CccccCCCCCceeecCCCCCCccc------
Q 040812 130 ILMEYMDAGSLEIYVKSRG----RLSEDIICTISRQVLKGLFYMHSR---NIVHRDIKPANVLINEKMEHPCGY------ 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~i~H~Dlkp~Nill~~~~~~~~~~------ 196 (300)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++...+++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999998643 389999999999999999999999 999999999999999876543222
Q ss_pred --------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC----CCCCchHHHHHHHHhhCCC
Q 040812 197 --------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLE----PGQEPDFLSLMLAICFREP 258 (300)
Q Consensus 197 --------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~----~~~~~~~~~~~~~~~~~~~ 258 (300)
+..|.+||... +..++.++|||||||++|+|+||+.||.. ...................
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHH---HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred cCcccccccccccCCcCccCHHHhc---cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 23345555443 34567899999999999999999999951 1122222222211111110
Q ss_pred ----------CCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 040812 259 ----------PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295 (300)
Q Consensus 259 ----------~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hp 295 (300)
...+...++.+.+++.+||.. ||++|||+.++++|-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-dP~~Rps~~ell~~L 306 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQS-SPMERPKMSEVVRML 306 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCS-CGGGSCCHHHHHHHH
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCc-CCccCCCHHHHHHHh
Confidence 111122246799999999999 999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=301.02 Aligned_cols=231 Identities=23% Similarity=0.322 Sum_probs=174.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcC-CCceeEeceeee-------CC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTN-SPYIVKCHQIFT-------KP 124 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~-h~niv~~~~~~~-------~~ 124 (300)
.-.+|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++++. ||||+++++++. ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 345899999999999999999999999999999998654321 22357999999996 999999999883 22
Q ss_pred CCcEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecCCCCCCcc----
Q 040812 125 SGEVSILMEYMDAGSLEIYVKS---RGRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINEKMEHPCG---- 195 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~~~~~~~~---- 195 (300)
....++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++...++
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 335899999996 599888864 457999999999999999999999999 9999999999999987554322
Q ss_pred ---------------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHH
Q 040812 196 ---------------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS 248 (300)
Q Consensus 196 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 248 (300)
++..|.+||......+..++.++|||||||++|+|+||+.||...... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~ 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----R 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----H
Confidence 233367777664444666788999999999999999999999653321 1
Q ss_pred HHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 249 LMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
... .......+...+..+.++|.+||.. ||++|||++++++|
T Consensus 261 ~~~---~~~~~~~~~~~~~~~~~li~~~l~~-~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 261 IVN---GKYSIPPHDTQYTVFHSLIRAMLQV-NPEERLSIAEVVHQ 302 (337)
T ss_dssp --------CCCCTTCCSSGGGHHHHHHHSCS-SGGGSCCHHHHHHH
T ss_pred hhc---CcccCCcccccchHHHHHHHHHccC-ChhhCcCHHHHHHH
Confidence 111 1222334456778899999999999 99999999999976
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.02 Aligned_cols=233 Identities=20% Similarity=0.269 Sum_probs=176.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHh--cCCCceeEeceeeeCC---CCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ--TNSPYIVKCHQIFTKP---SGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~---~~~~~l 130 (300)
.++|++.+.||+|+||.||+|++ +++.||+|++..... ....+|.+++.. ++||||+++++++... .+..|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE-KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc-hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46899999999999999999988 488999999865321 223456666665 8999999999986432 235899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH--------hCCccccCCCCCceeecCCCCCCcc-------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH--------SRNIVHRDIKPANVLINEKMEHPCG------- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~~i~H~Dlkp~Nill~~~~~~~~~------- 195 (300)
||||+++|+|.++++. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++...++
T Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 9999999999999964 47999999999999999999999 9999999999999999977654322
Q ss_pred ----------------ceeeccccccccccCCC---CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCCCchH
Q 040812 196 ----------------YSCLYESGEARHRKHGG---YNGFAADIWSFGVTMMELYMG----------YYPFLEPGQEPDF 246 (300)
Q Consensus 196 ----------------~~~~~~~~~~~~~~~~~---~~~~~~DiwSlG~il~elltg----------~~pf~~~~~~~~~ 246 (300)
++..|.+||........ .++.++|||||||++|||+|| ..||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 23345666654422111 344689999999999999999 8888665433333
Q ss_pred HHHHHHHh--hCCCCCCCC-----CCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 247 LSLMLAIC--FREPPSLPE-----CSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 247 ~~~~~~~~--~~~~~~~~~-----~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
...+.... ....+..+. ..++.+.++|.+||.. ||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ-NPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCS-SGGGSCCHHHHHH
T ss_pred hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhc-ChhhCCCHHHHHH
Confidence 33332221 122233332 2346799999999999 9999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=295.89 Aligned_cols=232 Identities=19% Similarity=0.257 Sum_probs=183.2
Q ss_pred ccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC----CCCCHHHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG----TPPNPQELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 52 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
.....++|++.+.||+|+||.||+|.+.. .+|+|+++.... ...+.+|+.++++++|+||+++++++.... .
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-H 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-C
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-c
Confidence 34457889999999999999999999864 489999865332 234578999999999999999999998765 8
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG----------- 195 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~----------- 195 (300)
.++||||+++++|.+++...+ .+++..++.++.||+.||.|||++|++||||||+||+++.+ ...++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~-~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCC-CEEEeecCCccccccc
Confidence 999999999999999998754 69999999999999999999999999999999999999843 32222
Q ss_pred -------------ceeecccccccccc------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC
Q 040812 196 -------------YSCLYESGEARHRK------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR 256 (300)
Q Consensus 196 -------------~~~~~~~~~~~~~~------~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 256 (300)
++..|.+||..... ....++.++|||||||++|||+||+.||...... .........
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~ 258 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIWQMGTG 258 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----HHHHHHHTT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhccC
Confidence 22335666654321 1234678999999999999999999999654322 222233333
Q ss_pred CCCC-CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 257 EPPS-LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 257 ~~~~-~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+. .+..+++.+.++|.+||.. ||++|||+.++++
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~-~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAF-EQEERPTFTKLMD 295 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCS-STTTSCCHHHHHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcC-ChhhCcCHHHHHH
Confidence 3333 2346788999999999999 9999999999885
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=310.72 Aligned_cols=233 Identities=19% Similarity=0.207 Sum_probs=181.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+|+.+++.++|.+.+..+.++....+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 36799999999999999999999999999999998877777777899999999998655544444444445899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeec---CCCCCC---ccc------------
Q 040812 136 DAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLIN---EKMEHP---CGY------------ 196 (300)
Q Consensus 136 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~---~~~~~~---~~~------------ 196 (300)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++... +|.
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence 8899999985 45799999999999999999999999999999999999994 443322 221
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHH---HHHHHhhCCCCCCC
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS---LMLAICFREPPSLP 262 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~ 262 (300)
+..|.+||... +..++.++|||||||++|||++|+.||........... +...........+.
T Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 165 IPYRENKNLTGTARYASVNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred cccccccccCCCccccCHHHhc---CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 22344444432 45678899999999999999999999976544322211 11111112222233
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+++++.++|..||.. ||++||+++++++
T Consensus 242 ~~~p~~l~~li~~cl~~-dP~~RPs~~el~~ 271 (483)
T 3sv0_A 242 RGYPTEFASYFHYCRSL-RFDDKPDYSYLKR 271 (483)
T ss_dssp TTSCHHHHHHHHHHHTC-CTTCCCCHHHHHH
T ss_pred cCCcHHHHHHHHHHhcC-ChhhCcCHHHHHH
Confidence 56789999999999999 9999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=301.44 Aligned_cols=230 Identities=25% Similarity=0.376 Sum_probs=181.7
Q ss_pred ceeeeeecCCcceEEEEEEE----ccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCC-CCcEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRH----KQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKP-SGEVSI 130 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~l 130 (300)
|++++.||+|+||.||++.+ ..+++.||+|+++..... ..+.+|+.++++++||||+++++++... ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999988764 457899999999755321 1246799999999999999999998764 246899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------------- 197 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------------- 197 (300)
||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++...+.++
T Consensus 113 v~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp EECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred EEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence 99999999999999765 5999999999999999999999999999999999999998765433221
Q ss_pred ---------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-----------chHHHHHHHHhhCC
Q 040812 198 ---------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-----------PDFLSLMLAICFRE 257 (300)
Q Consensus 198 ---------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-----------~~~~~~~~~~~~~~ 257 (300)
..|.+||... +..++.++|||||||++|+|+||..||...... ..............
T Consensus 192 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLK---EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp EC---CCCCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred ccccCCCCCceeeChHHhc---CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 1244444433 344667999999999999999999999542110 11112222333445
Q ss_pred CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 258 PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 258 ~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
....+..+++.+.++|.+||.. ||++|||++++++
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~-dP~~Rps~~ell~ 303 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWET-EASFRPTFENLIP 303 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCC-CcccCcCHHHHHH
Confidence 5667788999999999999999 9999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=314.73 Aligned_cols=233 Identities=23% Similarity=0.268 Sum_probs=172.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
.|.+.+.||+|+||+||.+. ..+|+.||||.+..+.. ....+|+.+++++ +||||+++++++.... ..|+|||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~-~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC-DIALMEIKLLTESDDHPNVIRYYCSETTDR-FLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGH-HHHHHHHHHHHHHTTSTTBCCEEEEEECSS-EEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHH-HHHHHHHHHHHhccCCCCcCeEEEEEecCC-eEEEEEecCC
Confidence 35667899999999998754 45689999999865421 2346799999876 8999999999988754 8999999996
Q ss_pred CCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-------------CC---C
Q 040812 137 AGSLEIYVKSRGRL-------SEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-------------EH---P 193 (300)
Q Consensus 137 ~~~L~~~l~~~~~l-------~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-------------~~---~ 193 (300)
|+|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.++ .. +
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 5999999865432 2334578999999999999999999999999999997532 11 1
Q ss_pred cc--------------------ceeecccccccccc----CCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 040812 194 CG--------------------YSCLYESGEARHRK----HGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLS 248 (300)
Q Consensus 194 ~~--------------------~~~~~~~~~~~~~~----~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 248 (300)
+| ++..|.+||..... ....++.++|||||||++|||+| |..||...... ...
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~ 249 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--ESN 249 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--HHH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--HHH
Confidence 21 23346677765431 12557889999999999999999 99999654322 112
Q ss_pred HHHHHhhCCCCCC----CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 249 LMLAICFREPPSL----PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 249 ~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+..... ..... +..+++++.++|.+||.. ||++|||+.++++||||.+
T Consensus 250 i~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~-dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 250 IIRGIF--SLDEMKCLHDRSLIAEATDLISQMIDH-DPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHTCC--CCCCCTTCCCHHHHHHHHHHHHHHTCS-SGGGSCCHHHHHTSGGGSC
T ss_pred HhcCCC--CcccccccccccchHHHHHHHHHHhhC-ChhhCCCHHHHHhCCccCC
Confidence 222111 11111 112357899999999999 9999999999999999964
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=298.31 Aligned_cols=235 Identities=23% Similarity=0.354 Sum_probs=182.9
Q ss_pred CCCcceeeeeecCCcceEEEEEE----EccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCC-Cc
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVR----HKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPS-GE 127 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 127 (300)
..++|++++.||+|+||.||+|+ +..+++.||+|.+...... ..+.+|+.++++++||||+++++++.... ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 34679999999999999999999 4567999999998753321 13467999999999999999999876543 36
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce---------
Q 040812 128 VSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS--------- 197 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~--------- 197 (300)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++...+.++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 89999999999999999875 46999999999999999999999999999999999999987654322211
Q ss_pred -------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------CCchH--HHHHHH
Q 040812 198 -------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPG----------QEPDF--LSLMLA 252 (300)
Q Consensus 198 -------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~----------~~~~~--~~~~~~ 252 (300)
..|.+||... +..++.++|||||||++|||+||..||.... ..... ......
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhc---CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 1244554433 3346779999999999999999999985321 11011 112222
Q ss_pred HhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 253 ICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.........+..+++.+.++|.+||.. ||++|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~-dP~~Rps~~el~~ 315 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNN-NVNQRPSFRDLAL 315 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCS-SGGGSCCHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCC-ChhhCcCHHHHHH
Confidence 333344556778899999999999999 9999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=328.88 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=180.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeC-----CCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTK-----PSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 127 (300)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+|+.++++++||||+++++++.. ..+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999999999999998654221 123569999999999999999998654 1346
Q ss_pred EEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC------CCcc---
Q 040812 128 VSILMEYMDAGSLEIYVKSRG---RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME------HPCG--- 195 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~------~~~~--- 195 (300)
.|+||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. .++|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999998744 5899999999999999999999999999999999999986543 1122
Q ss_pred ------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHH-----HHHHH-Hh---
Q 040812 196 ------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFL-----SLMLA-IC--- 254 (300)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~-----~~~~~-~~--- 254 (300)
++..|.+||... +..++.++|||||||++|+|+||..||........+. ..... ..
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLE---QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSC---CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred ccccccccccccCCcccCChHHhc---cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 233456666543 5667889999999999999999999996431110000 00000 00
Q ss_pred ------h----CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 ------F----REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 ------~----~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
. ..+..++..+++.+.+||.+||.. ||++|||++++++||||++
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~-DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW-HQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCS-SCC---CCTTCCCCTTHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccC-CHhhCcCHHHHhcCHHHHH
Confidence 0 001112333567899999999999 9999999999999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=293.02 Aligned_cols=231 Identities=22% Similarity=0.308 Sum_probs=175.5
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEcc-CC--eEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQ-TL--ALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPS 125 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~ 125 (300)
...++|++.+.||+|+||.||+|.+.. ++ ..||+|+++...... .+.+|+.++++++||||+++++++..+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-
Confidence 355789999999999999999998743 33 368999987543222 235799999999999999999998764
Q ss_pred CcEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce-------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS------- 197 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~------- 197 (300)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++...+.++
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 488999999999999999764 56999999999999999999999999999999999999987654322211
Q ss_pred ---------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh-hCCCCC
Q 040812 198 ---------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAIC-FREPPS 260 (300)
Q Consensus 198 ---------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 260 (300)
..|.+||... +..++.++|||||||++|+|+| |..||...... .....+. ......
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGERLP 245 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTSCCCCC
T ss_pred ccccchhhhccCCCCceeeCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHHHHHccCCCCC
Confidence 1255555443 3446789999999999999999 99999654322 2222222 233445
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+..+++.+.++|.+||.. ||++|||+.+++++
T Consensus 246 ~~~~~~~~l~~li~~~l~~-~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 246 RPEDCPQDIYNVMVQCWAH-KPEDRPTFVALRDF 278 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CCcCcCHHHHHHHHHHccC-CcccCcCHHHHHHH
Confidence 5667899999999999999 99999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=288.89 Aligned_cols=232 Identities=22% Similarity=0.281 Sum_probs=179.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC------CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP------PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
....|...+.||+|+||.||+|.+ +++.||+|.+....... .+.+|+.++++++||||+++++++.... ..
T Consensus 29 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 105 (307)
T 2nru_A 29 ERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-DL 105 (307)
T ss_dssp CSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SC
T ss_pred cccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC-ce
Confidence 334466679999999999999987 47799999986543211 2357999999999999999999988754 89
Q ss_pred EEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 129 SILMEYMDAGSLEIYVKS---RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++...+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence 999999999999999974 34689999999999999999999999999999999999998875443222
Q ss_pred ------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC--------
Q 040812 197 ------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-------- 256 (300)
Q Consensus 197 ------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------- 256 (300)
+..|.+||... +.++.++|||||||++|+|+||..||...........+.......
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEALR----GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI 261 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHHT----TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHS
T ss_pred ccccccccccCCCcCcCChHHhc----CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhc
Confidence 23355555432 235779999999999999999999997654443332322221111
Q ss_pred --CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 257 --EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 257 --~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.....+...++.+.+++.+||.. ||++|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~cl~~-~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 262 DKKMNDADSTSVEAMYSVASQCLHE-KKNKRPDIKKVQQL 300 (307)
T ss_dssp CSSCSCCCHHHHHHHHHHHHHHTCS-STTTSCCHHHHHHH
T ss_pred cccccccchHHHHHHHHHHHHHcCC-CcccCcCHHHHHHH
Confidence 11122333456799999999999 99999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=299.34 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=174.4
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHH--HHhcCCCceeEeceeee----CCCCc
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNI--LRQTNSPYIVKCHQIFT----KPSGE 127 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~----~~~~~ 127 (300)
..+++|++.+.||+|+||.||+|++ +++.||+|++..... ..+..|..+ +..++|+||+++++.+. .....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 3568899999999999999999977 578999999864321 122334444 44589999999987542 22235
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC---------CccccCCCCCceeecCCCCCCcc---
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR---------NIVHRDIKPANVLINEKMEHPCG--- 195 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~---------~i~H~Dlkp~Nill~~~~~~~~~--- 195 (300)
.|+||||+++|+|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|||++.++...++
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 78999999999999999765 458999999999999999999999 99999999999999987554322
Q ss_pred ------------------------ceeeccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchH-
Q 040812 196 ------------------------YSCLYESGEARHRKHG----GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF- 246 (300)
Q Consensus 196 ------------------------~~~~~~~~~~~~~~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~- 246 (300)
++..|.+||....... ..++.++|||||||++|||+||..||.........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 2334556665432110 23456899999999999999998877543322111
Q ss_pred ------------HHHHHH--HhhCCCCCCCCCC------ChHHHHHHHHHhccCCCCCCCCHHHHh------cCCCCCC
Q 040812 247 ------------LSLMLA--ICFREPPSLPECS------SEKFRDFIRCCLQKGDPSKRWTASQLL------SHPFLAD 299 (300)
Q Consensus 247 ------------~~~~~~--~~~~~~~~~~~~~------~~~l~~li~~~l~~~dp~~Rpt~~~~l------~hpw~~~ 299 (300)
...... ......+.++... ++.+.++|.+||.. ||++|||++|++ .++|-++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ-DAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS-SGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC-ChhhCcchHHHHHHHHHHHHHHHhc
Confidence 011111 1122234444433 34799999999999 999999999994 4677654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=314.54 Aligned_cols=229 Identities=26% Similarity=0.309 Sum_probs=186.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|.+..+ +..||+|.++..... ..+.+|+.++++++||||+++++++.. +..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cce
Confidence 457899999999999999999998643 567999987643321 234679999999999999999999853 368
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 129 SILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++...++++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 99999999999999998654 6899999999999999999999999999999999999987654332221
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
..|.+||... +..++.++|||||||++|||++ |..||..... ......+........+..++
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 618 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENGERLPMPPNCP 618 (656)
T ss_dssp --------CCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHHTCCCCCCTTCC
T ss_pred ceeccCCCCCcceeCHHHhc---CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCCCCcccc
Confidence 2356666543 4457889999999999999997 9999965432 23333444455666788899
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+.+.++|.+||.. ||++|||+.++++
T Consensus 619 ~~l~~li~~~l~~-dP~~RPs~~el~~ 644 (656)
T 2j0j_A 619 PTLYSLMTKCWAY-DPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCC-ChhHCcCHHHHHH
Confidence 9999999999999 9999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=293.06 Aligned_cols=233 Identities=21% Similarity=0.298 Sum_probs=174.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHh--cCCCceeEeceeeeCCC---CcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ--TNSPYIVKCHQIFTKPS---GEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~---~~~~lv 131 (300)
++|++.+.||+|+||.||+|++. ++.||+|++..... ....+|..++.. ++||||+++++++.... +..|+|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 67999999999999999999986 78999999864332 122345555554 49999999999987652 379999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC--------CccccCCCCCceeecCCCCCCcc--------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR--------NIVHRDIKPANVLINEKMEHPCG-------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~i~H~Dlkp~Nill~~~~~~~~~-------- 195 (300)
|||+++|+|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++...++
T Consensus 114 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 9999999999999765 699999999999999999999998 99999999999999877554322
Q ss_pred ---------------ceeeccccccccccCCCC---CCchhhHHHHHHHHHHHHhC----------CCCCCCCCCCchHH
Q 040812 196 ---------------YSCLYESGEARHRKHGGY---NGFAADIWSFGVTMMELYMG----------YYPFLEPGQEPDFL 247 (300)
Q Consensus 196 ---------------~~~~~~~~~~~~~~~~~~---~~~~~DiwSlG~il~elltg----------~~pf~~~~~~~~~~ 247 (300)
++..|.+||......... .+.++|||||||++|||+|| ..||..........
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 272 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence 233455666543211111 11249999999999999999 77775543332222
Q ss_pred HHHHHH--hhCCCCCCCC-----CCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 248 SLMLAI--CFREPPSLPE-----CSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 248 ~~~~~~--~~~~~~~~~~-----~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
...... .....+..+. .+++.+.++|.+||.. ||++|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~-dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH-NPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCS-SGGGSCCHHHHHHH
T ss_pred hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhh-ChhhCCCHHHHHHH
Confidence 222221 1222333333 3456799999999999 99999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=297.28 Aligned_cols=223 Identities=14% Similarity=0.163 Sum_probs=171.3
Q ss_pred CCCcceeeeeecCCcceEEEEE-----EEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC---CCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKV-----RHKQTLALYALKVMQCDRGTPPNPQELNILRQTN---SPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~ 126 (300)
..++|++.+.||+|+||.||+| .+..+++.||+|+++... ...+.+|+.+++.++ |+||+.+++++....
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~- 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN- 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS-
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC-
Confidence 4578999999999999999999 467789999999986432 223456888888887 899999999988765
Q ss_pred cEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC-----------CC
Q 040812 127 EVSILMEYMDAGSLEIYVKS-----RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE-----------KM 190 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~-----------~~ 190 (300)
..|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 89999999999999999974 456999999999999999999999999999999999999987 43
Q ss_pred CCC---cc------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 040812 191 EHP---CG------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL 249 (300)
Q Consensus 191 ~~~---~~------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 249 (300)
... +| ++..|.+||... +..++.++|||||||++|||+||+.||.........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--- 294 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS---NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--- 294 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT---TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc---CCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---
Confidence 332 22 123345555443 556788999999999999999999999643322110
Q ss_pred HHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
........ ..++.+.+++..||.. +|.+|++..+.+
T Consensus 295 ----~~~~~~~~--~~~~~~~~~~~~~l~~-~p~~r~~~~~~l 330 (365)
T 3e7e_A 295 ----PEGLFRRL--PHLDMWNEFFHVMLNI-PDCHHLPSLDLL 330 (365)
T ss_dssp ----ECSCCTTC--SSHHHHHHHHHHHHCC-CCTTCCCCHHHH
T ss_pred ----echhcccc--CcHHHHHHHHHHHcCC-CCCCcchHHHHH
Confidence 00111111 2467899999999999 999997654443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.26 Aligned_cols=233 Identities=18% Similarity=0.255 Sum_probs=178.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHh--cCCCceeEeceeeeCCCC---cEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ--TNSPYIVKCHQIFTKPSG---EVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~---~~~lv 131 (300)
++|++.+.||+|+||.||+|++. ++.||+|++.... ...+.+|..++.. ++||||+++++++....+ ..|+|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh-HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 57999999999999999999984 8899999986432 2234568888887 799999999999876542 68999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH--------hCCccccCCCCCceeecCCCCCCcc--------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH--------SRNIVHRDIKPANVLINEKMEHPCG-------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~~i~H~Dlkp~Nill~~~~~~~~~-------- 195 (300)
|||+++|+|.+++... .+++..++.++.|++.||.||| +.||+||||||+|||++.++...+.
T Consensus 119 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197 (342)
T ss_dssp ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred EeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence 9999999999999764 6899999999999999999999 8999999999999999877654322
Q ss_pred ---------------ceeeccccccccccCCC---CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCCCchHH
Q 040812 196 ---------------YSCLYESGEARHRKHGG---YNGFAADIWSFGVTMMELYMG----------YYPFLEPGQEPDFL 247 (300)
Q Consensus 196 ---------------~~~~~~~~~~~~~~~~~---~~~~~~DiwSlG~il~elltg----------~~pf~~~~~~~~~~ 247 (300)
++..|.+||........ .++.++|||||||++|||+|| ..||..........
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 277 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence 22345555554321110 223689999999999999999 78887654332222
Q ss_pred HH-HHHHh-hCCCCCCCC-----CCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 248 SL-MLAIC-FREPPSLPE-----CSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 248 ~~-~~~~~-~~~~~~~~~-----~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.. ..... ....+..+. ..++.+.++|.+||.. ||++|||++++++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA-NGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhcc-ChhhCCCHHHHHHH
Confidence 22 22221 222333332 2335799999999999 99999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=299.18 Aligned_cols=234 Identities=16% Similarity=0.166 Sum_probs=172.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCC-Ccee-------------
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNS-PYIV------------- 115 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h-~niv------------- 115 (300)
...+|...+.||+|+||.||+|.+..+++.||||++....... .+.+|+.+++.++| .|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4456889999999999999999999999999999987433222 23578999998877 2211
Q ss_pred --E------eceeeeCC----CCcEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHhHhCCccc
Q 040812 116 --K------CHQIFTKP----SGEVSILMEYMDAGSLEIYVKS-------RGRLSEDIICTISRQVLKGLFYMHSRNIVH 176 (300)
Q Consensus 116 --~------~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H 176 (300)
. +..++... ....+++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1 11111110 12467888877 4699998851 224778889999999999999999999999
Q ss_pred cCCCCCceeecCCCCCCccce---------------eecccccccccc-------CCCCCCchhhHHHHHHHHHHHHhCC
Q 040812 177 RDIKPANVLINEKMEHPCGYS---------------CLYESGEARHRK-------HGGYNGFAADIWSFGVTMMELYMGY 234 (300)
Q Consensus 177 ~Dlkp~Nill~~~~~~~~~~~---------------~~~~~~~~~~~~-------~~~~~~~~~DiwSlG~il~elltg~ 234 (300)
|||||+|||++.++..++.++ ..|.+||..... .+..++.++|||||||++|||+||+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999998866533322 346677765311 3445678999999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 235 YPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 235 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.||.......... .+. .....+++.+.++|.+||.. ||++||++.++++||||++
T Consensus 315 ~Pf~~~~~~~~~~----~~~-----~~~~~~~~~~~~li~~~l~~-dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 315 LPNTDDAALGGSE----WIF-----RSCKNIPQPVRALLEGFLRY-PKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CCCCTTGGGSCSG----GGG-----SSCCCCCHHHHHHHHHHTCS-SGGGSCCHHHHTTSHHHHH
T ss_pred CCCCCcchhhhHH----HHH-----hhcccCCHHHHHHHHHHccC-ChhhCcCHHHHHhCHHHHH
Confidence 9996543221111 111 11235679999999999999 9999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=301.04 Aligned_cols=227 Identities=17% Similarity=0.200 Sum_probs=168.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----------CCCHHHHHHHHhcC---------CCcee
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----------PPNPQELNILRQTN---------SPYIV 115 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~---------h~niv 115 (300)
..++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999998 5799999999865432 22367999998886 55555
Q ss_pred Ee-----------------ceeeeC------------CCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 040812 116 KC-----------------HQIFTK------------PSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166 (300)
Q Consensus 116 ~~-----------------~~~~~~------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l 166 (300)
++ ++++.. +.+..|+|||||++|++.+.+.. ..+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 54 444433 13589999999999976655543 5689999999999999999
Q ss_pred HHhH-hCCccccCCCCCceeecCCC--------------------CC---Ccc-----------ceeeccccccccccCC
Q 040812 167 FYMH-SRNIVHRDIKPANVLINEKM--------------------EH---PCG-----------YSCLYESGEARHRKHG 211 (300)
Q Consensus 167 ~~lH-~~~i~H~Dlkp~Nill~~~~--------------------~~---~~~-----------~~~~~~~~~~~~~~~~ 211 (300)
.||| ++||+||||||+|||++.++ .. ++| ++..|.+||... +
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~---g 251 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT---G 251 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC---C
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc---C
Confidence 9999 99999999999999999875 22 222 234467777654 3
Q ss_pred CCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCchHHH-HHHHHhhC--CCC----CCCCCCChHHHHHHHHHhccCCCC
Q 040812 212 GYNGFAADIWSFGVT-MMELYMGYYPFLEPGQEPDFLS-LMLAICFR--EPP----SLPECSSEKFRDFIRCCLQKGDPS 283 (300)
Q Consensus 212 ~~~~~~~DiwSlG~i-l~elltg~~pf~~~~~~~~~~~-~~~~~~~~--~~~----~~~~~~~~~l~~li~~~l~~~dp~ 283 (300)
.. +.++||||||++ .+++++|..||... .+.. ........ ... ..+..+++++++||.+||+. |
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~-d-- 323 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF-S-- 323 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS-S--
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc-C--
Confidence 33 789999998777 77889999998321 1101 11111111 111 11224678899999999998 6
Q ss_pred CCCCHHHHh-cCCCCC
Q 040812 284 KRWTASQLL-SHPFLA 298 (300)
Q Consensus 284 ~Rpt~~~~l-~hpw~~ 298 (300)
|++|++ +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.86 Aligned_cols=221 Identities=20% Similarity=0.267 Sum_probs=173.5
Q ss_pred CcceeeeeecCCcceEEEEEEEcc-CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCc----E
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQ-TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGE----V 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~ 128 (300)
++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+|+.++++++||||+++++++...... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999976 7899999988643221 1235799999999999999999998765421 7
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---cc----------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP---CG---------- 195 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~---~~---------- 195 (300)
|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+ +|
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~~ 236 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY 236 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCCSC
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccCCc
Confidence 999999999999988765 79999999999999999999999999999999999999875 221 11
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC-CCCCChHHHHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL-PECSSEKFRDF 272 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l 272 (300)
++..|.+||... ++ ++.++|||||||++|+|++|..||....... .+... ....++.+.++
T Consensus 237 ~~gt~~y~aPE~~~---~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 237 LYGTPGFQAPEIVR---TG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------LPEDDPVLKTYDSYGRL 300 (681)
T ss_dssp CCCCTTTSCTTHHH---HC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------CCTTCHHHHHCHHHHHH
T ss_pred cCCCccccCHHHHc---CC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------ccccccccccCHHHHHH
Confidence 344567777653 22 3779999999999999999999986422110 00000 01135789999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
|.+||.. ||++||++.+.+.|+|+
T Consensus 301 i~~~l~~-dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 301 LRRAIDP-DPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHHHTCS-SGGGSCSSHHHHHHHHH
T ss_pred HhhhccC-ChhhCCCHHHHHHHHHH
Confidence 9999999 99999999888888775
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=225.82 Aligned_cols=164 Identities=15% Similarity=0.071 Sum_probs=115.3
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC------------CCHHHHHHHHhc-CCCceeEeceeeeCCCCcEE
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP------------PNPQELNILRQT-NSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 129 (300)
...+.|++|.+..++....|+.||+|++..+.... .+.+|+++|+++ .|+||++++++++++. ..|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~-~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ-SGW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-EEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-EEE
Confidence 45778888888888888889999999997654322 245699999999 7999999999998865 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceeecccccccccc
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRK 209 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 209 (300)
|||||++|++|.+++...+.+++. .|+.||+.||.|+|++||+||||||+|||++.++..++.++++ +....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGl-----Ar~~~ 390 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGS-----IVTTP 390 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTT-----EESCC
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeeccc-----CeeCC
Confidence 999999999999999998888865 4789999999999999999999999999999987654443332 22111
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCC
Q 040812 210 HGGYNGFAADIWSFGVTMMELYMGYYP 236 (300)
Q Consensus 210 ~~~~~~~~~DiwSlG~il~elltg~~p 236 (300)
.. .....+++||.|++..|+++|+.+
T Consensus 391 ~~-~~~~~t~vGTp~YmAPE~l~g~~~ 416 (569)
T 4azs_A 391 QD-CSWPTNLVQSFFVFVNELFAENKS 416 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC-----
T ss_pred CC-CccccCceechhhccHHHhCCCCC
Confidence 11 112245555555555555555443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=198.80 Aligned_cols=164 Identities=12% Similarity=0.073 Sum_probs=114.8
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----------CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----------PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
...+.||+|+||.||+|.. .++.+++|......... .+.+|+.++++++||||+++..+..... ..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-NKR 415 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-TTE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-ccE
Confidence 3457899999999999944 46788999865433221 1367999999999999995444444433 679
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---ccc----------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP---CGY---------- 196 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~---~~~---------- 196 (300)
+||||+++++|.+++.. +..++.|++.||.|||++||+||||||+|||++. ..+ +|.
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999999875 5689999999999999999999999999999987 332 222
Q ss_pred -------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 040812 197 -------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF 237 (300)
Q Consensus 197 -------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf 237 (300)
+..|.+||...... ..|+..+|+||..+-..+.+.++-+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~-~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFL-EGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHH-HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHH-HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22334444433211 12445678999888888887777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-24 Score=181.00 Aligned_cols=120 Identities=19% Similarity=0.265 Sum_probs=96.1
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--------------------CCHHHHHHHHhcCCCceeEec
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--------------------PNPQELNILRQTNSPYIVKCH 118 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~E~~~l~~l~h~niv~~~ 118 (300)
|++.+.||+|+||.||+|.+ .+++.||+|+++...... .+.+|+.++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 45569999999999999999 789999999986432211 1357999999999 5 6666
Q ss_pred eeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
+++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ ++..
T Consensus 168 ~~~~~--~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 168 KVYAW--EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp CEEEE--ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred eEEec--cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 76544 35799999999999987 42 123557999999999999999999999999999999 6443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=157.82 Aligned_cols=123 Identities=16% Similarity=0.160 Sum_probs=95.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeE--EEEEEeecCCCC--------------------------CCCHHHHHHHHhc
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLAL--YALKVMQCDRGT--------------------------PPNPQELNILRQT 109 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~--------------------------~~~~~E~~~l~~l 109 (300)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ..+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999999777888 999997543211 0235699999999
Q ss_pred CCCce--eEeceeeeCCCCcEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH-hCCccccCCCC
Q 040812 110 NSPYI--VKCHQIFTKPSGEVSILMEYMDA-G----SLEIYVKSRGRLSEDIICTISRQVLKGLFYMH-SRNIVHRDIKP 181 (300)
Q Consensus 110 ~h~ni--v~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~i~H~Dlkp 181 (300)
.|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.||.+|| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88764 333332 256899999942 3 67766432 235567899999999999999 99999999999
Q ss_pred CceeecC
Q 040812 182 ANVLINE 188 (300)
Q Consensus 182 ~Nill~~ 188 (300)
+|||++.
T Consensus 200 ~NILl~~ 206 (258)
T 1zth_A 200 YNIMYID 206 (258)
T ss_dssp TSEEESS
T ss_pred HHEEEcC
Confidence 9999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3.5e-19 Score=155.44 Aligned_cols=139 Identities=13% Similarity=0.128 Sum_probs=93.3
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------C-----CC------------HHHHHHHHhcCCCce
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------P-----PN------------PQELNILRQTNSPYI 114 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~-----~~------------~~E~~~l~~l~h~ni 114 (300)
|++.+.||+|+||.||+|.+. +|+.||||+++..... . .. ..|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999986 4899999997642110 0 00 124444444433332
Q ss_pred eEeceeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc
Q 040812 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC 194 (300)
Q Consensus 115 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~ 194 (300)
.-.. .+.. . ..++||||++|++|..+.. ...+..++.||+.+|.+||++||+||||||.|||++.++...-
T Consensus 176 ~vp~-p~~~-~-~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPE-PIAQ-S-RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCC-EEEE-E-TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCe-eeec-c-CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 1111 1111 1 2379999999988865432 2345678999999999999999999999999999988753211
Q ss_pred -----cceeecccccccc
Q 040812 195 -----GYSCLYESGEARH 207 (300)
Q Consensus 195 -----~~~~~~~~~~~~~ 207 (300)
......++|.+..
T Consensus 247 ~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECCCTTCEE
T ss_pred ccccccceEEEEeCCccc
Confidence 1234556665544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=3.9e-12 Score=106.20 Aligned_cols=107 Identities=14% Similarity=0.026 Sum_probs=82.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecC--CCCCCCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCD--RGTPPNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e 133 (300)
..|++...++.|+++.||++... ++.+++|+.... .......+|+.+++.+. +..+.+++++.... +..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-CceEEEEE
Confidence 45788899999999999999754 578999998652 22334678999999885 56777888887664 48999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~ 171 (300)
+++|.+|.+.+. +......++.++..+|..||+
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhC
Confidence 999999887531 122345788899999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=9.1e-11 Score=97.48 Aligned_cols=105 Identities=12% Similarity=0.044 Sum_probs=71.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEeceeeeCCCCcEEEEEec
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~ 134 (300)
..+.+....+.|..+.||++.. .+|+.+++|+.... ......+|+.+++.+.+.+ +.+++++.... +..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEEEe
Confidence 3455544445666799999965 45678999997654 2344578999999886544 45577776654 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC
Q 040812 135 MDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172 (300)
Q Consensus 135 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 172 (300)
++|.+|. .. ..+ ...++.+++..|..||+.
T Consensus 97 i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 97 VPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp CSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTS
T ss_pred cCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCC
Confidence 9998884 21 112 235667777777777764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=6.4e-10 Score=97.06 Aligned_cols=108 Identities=14% Similarity=0.159 Sum_probs=77.7
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEee--cCC---CCCCCHHHHHHHHhcCC--CceeEeceeeeCCC--CcEEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQ--CDR---GTPPNPQELNILRQTNS--PYIVKCHQIFTKPS--GEVSI 130 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~---~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~~l 130 (300)
..++.|+.|.++.||++... +..+++|... ... ......+|..+++.+.. ..+++++.++.+.. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678999999999998865 3577888865 322 12345679999999874 45677887765442 45899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~ 171 (300)
||||++|..+.+.. ...++......++.+++..|..||.
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 99999998775321 1246788888999999999999996
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=2.1e-10 Score=97.85 Aligned_cols=103 Identities=16% Similarity=0.172 Sum_probs=69.0
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC-CCc--eeEeceeeeCCC--CcEEEEEeccC
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN-SPY--IVKCHQIFTKPS--GEVSILMEYMD 136 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~--~~~~lv~e~~~ 136 (300)
++.++.|....||++. ..+++|+...........+|..+|+.+. +.. +.+++....... +..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568999999999873 4578998643311223467999998873 322 334444332222 23589999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~ 171 (300)
|.+|...... .++......++.|++..|..||+
T Consensus 100 G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 100 GVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CeECCccccc--cCCHHHHHHHHHHHHHHHHHHHc
Confidence 9888754432 46777778888888888888885
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=3.6e-07 Score=77.83 Aligned_cols=102 Identities=14% Similarity=0.100 Sum_probs=64.0
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCC---ceeEeceeeeCCCCcEEEEEeccCCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSP---YIVKCHQIFTKPSGEVSILMEYMDAG 138 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~~ 138 (300)
++.++.|....||+. +..+++|+...........+|..+|+.+.+. .+.+.+.+.....+..++|||+++|.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888999999988 4567889853221122346799999998753 24556665543455789999999998
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhH
Q 040812 139 SLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170 (300)
Q Consensus 139 ~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH 170 (300)
.+...... .++......++.++...|..||
T Consensus 99 ~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 99 ILGEDGMA--VLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp ECHHHHHT--TSCHHHHHHHHHHHHHHHHHHH
T ss_pred ECchhhhh--hCCHHHHHHHHHHHHHHHHHHh
Confidence 88763221 2344444444444444444444
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=9.8e-06 Score=67.36 Aligned_cols=80 Identities=13% Similarity=0.105 Sum_probs=55.4
Q ss_pred eecCCcce-EEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC-CceeEeceeeeCCCCcEEEEEeccCCCCHH
Q 040812 64 VLGQGNGG-TVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLE 141 (300)
Q Consensus 64 ~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~~~~L~ 141 (300)
.+..|..| .||+......+..+++|+-.... .....+|...|+.+.. --+.+++.+..++ +..|+|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-ANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH-HHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC-HhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCcccc
Confidence 34555555 69998887777888999865321 1223568888887743 2356677776665 4789999999998877
Q ss_pred HHHH
Q 040812 142 IYVK 145 (300)
Q Consensus 142 ~~l~ 145 (300)
+...
T Consensus 109 ~~~~ 112 (272)
T 4gkh_A 109 QVLE 112 (272)
T ss_dssp HHHH
T ss_pred cccc
Confidence 6553
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.8e-05 Score=69.70 Aligned_cols=75 Identities=16% Similarity=0.115 Sum_probs=47.4
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---------CCCCHHHHHHHHhcCC--Cc-eeEeceeeeCCCCcE
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---------TPPNPQELNILRQTNS--PY-IVKCHQIFTKPSGEV 128 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~ 128 (300)
..+.||.|.++.||++....+++.+++|....... ......|..+++.+.. +. +.+++.+ .. . ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~-~-~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT-E-MA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET-T-TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cC-C-cc
Confidence 35789999999999998766677899998643211 1112568888887643 33 3445543 32 2 45
Q ss_pred EEEEeccCCC
Q 040812 129 SILMEYMDAG 138 (300)
Q Consensus 129 ~lv~e~~~~~ 138 (300)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=8.8e-06 Score=70.56 Aligned_cols=81 Identities=14% Similarity=0.134 Sum_probs=54.6
Q ss_pred eeeeee-cCCcceEEEEEEEc--c----CCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCC---CceeEeceeeeCC
Q 040812 60 EKLQVL-GQGNGGTVFKVRHK--Q----TLALYALKVMQCDR-----GTPPNPQELNILRQTNS---PYIVKCHQIFTKP 124 (300)
Q Consensus 60 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~ 124 (300)
...+.| +.|....+|+.... . +++.+++|+..... ......+|..+++.+.. -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88999999988754 1 15678899865432 12345679999888743 2466677765443
Q ss_pred C--CcEEEEEeccCCCCH
Q 040812 125 S--GEVSILMEYMDAGSL 140 (300)
Q Consensus 125 ~--~~~~lv~e~~~~~~L 140 (300)
. +..|+|||+++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 2 457899999988654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00025 Score=59.46 Aligned_cols=76 Identities=12% Similarity=0.070 Sum_probs=52.0
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--CCHHHHHHHHhcCCC---ceeEeceeeeCCCCcEEEEEe
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--PNPQELNILRQTNSP---YIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e 133 (300)
..-++.+|.|..+.||+.... +|+.|.+|+........ .+..|...|+.+... -+.+++++ . .-++|||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~---~~~lv~e 90 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D---DRTLAME 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E---TTEEEEE
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c---CceEEEE
Confidence 345688999999999999875 47889999865443222 246799999887432 23444443 1 2378999
Q ss_pred ccCCCCH
Q 040812 134 YMDAGSL 140 (300)
Q Consensus 134 ~~~~~~L 140 (300)
+++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00047 Score=58.97 Aligned_cols=75 Identities=9% Similarity=0.094 Sum_probs=41.3
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC--CceeEecee-----eeCCCCcEEEEEec
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS--PYIVKCHQI-----FTKPSGEVSILMEY 134 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~-----~~~~~~~~~lv~e~ 134 (300)
++.|+.|..+.||++.... + .+++|+..... .....|..+++.+.. -.+.+++.. +....+..++||+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~~--~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDS-G-AVCLKRIHRPE--KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETT-E-EEEEEEECSCH--HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCC-C-CEEEEecCCCH--HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4567777889999987643 3 48899886421 112345666665532 123444431 11123478999999
Q ss_pred cCCCCH
Q 040812 135 MDAGSL 140 (300)
Q Consensus 135 ~~~~~L 140 (300)
++|..+
T Consensus 113 i~G~~~ 118 (346)
T 2q83_A 113 IEGRPF 118 (346)
T ss_dssp CCCBCC
T ss_pred ecCccC
Confidence 998643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0021 Score=51.06 Aligned_cols=130 Identities=13% Similarity=-0.015 Sum_probs=83.2
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCccce------eecccccccccc
Q 040812 138 GSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCGYS------CLYESGEARHRK 209 (300)
Q Consensus 138 ~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~~~------~~~~~~~~~~~~ 209 (300)
-+|.+.+.. +.++++.++|.++.|.+.+|.-+-. +.-..+=+-|..|++..+|...+... ..+.+|+...
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~s~~~~~~~~~pe~~~-- 110 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADDAGEPPPVAGKLGY-- 110 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC------------CCSS--
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccccccccccCCCChhhcc--
Confidence 378999976 5589999999999999999877622 22112333467888888766543321 1223333221
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccC---------
Q 040812 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKG--------- 280 (300)
Q Consensus 210 ~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~--------- 280 (300)
...+.+.=|||||+++|..+.=..| ...+..+++.+..||..|...-
T Consensus 111 --~~~te~~~IysLG~tLY~ALDygL~----------------------e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG 166 (229)
T 2yle_A 111 --SQCMETEVIESLGIIIYKALDYGLK----------------------ENEERELSPPLEQLIDHMANTVEADGSNDEG 166 (229)
T ss_dssp --SSSCHHHHHHHHHHHHHHHHTTTCC----------------------TTEEECCCHHHHHHHHHHTTCCC--------
T ss_pred --ccchHHHHHHHHHHHHHHHhhcCCC----------------------cccchhhCHHHHHHHHHHHhccccccccccc
Confidence 1234678899999999988852222 2334457888888888886440
Q ss_pred ---------------CCCCCCCHHHHhc
Q 040812 281 ---------------DPSKRWTASQLLS 293 (300)
Q Consensus 281 ---------------dp~~Rpt~~~~l~ 293 (300)
.+..|.+..+|++
T Consensus 167 ~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 167 YEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccCcCCHHHHHH
Confidence 2357888888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0016 Score=57.73 Aligned_cols=72 Identities=18% Similarity=0.108 Sum_probs=43.6
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---C------CCCHHHHHHHHhc---CCCceeEeceeeeCCCCcE
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---T------PPNPQELNILRQT---NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 128 (300)
..+.||.|..+.||++.. +++.+++|....... . .....|..++..+ ....+.+++.+. + +..
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~-~~~ 112 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--R-TMA 112 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--T-TTT
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--C-Ccc
Confidence 357799999999999964 466889994322110 0 1112344444332 223456666653 2 357
Q ss_pred EEEEecc-CC
Q 040812 129 SILMEYM-DA 137 (300)
Q Consensus 129 ~lv~e~~-~~ 137 (300)
++|||++ ++
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 8999999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0042 Score=52.24 Aligned_cols=70 Identities=13% Similarity=0.121 Sum_probs=44.5
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCce-eEeceeeeCCCCcEEEEEecc-CCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYI-VKCHQIFTKPSGEVSILMEYM-DAG 138 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~-~~~ 138 (300)
++.|+.|....+|++ ..+++|+....... -...+|..+++.+...++ .++++.. +. .-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~-~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA-TGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT-TCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC-CCEEEEeecCCCc
Confidence 688999999999999 35788987643211 122568888887643333 3455442 22 346899999 665
Q ss_pred CH
Q 040812 139 SL 140 (300)
Q Consensus 139 ~L 140 (300)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0019 Score=54.74 Aligned_cols=78 Identities=10% Similarity=0.063 Sum_probs=45.7
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEeceee-----eCCCCcEEEEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQIF-----TKPSGEVSILM 132 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~-----~~~~~~~~lv~ 132 (300)
.-++.|+.|....+|++...+ + .+++|+............|..+++.+...+ +.+++... ....+..++||
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEESS-C-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 446778889999999987653 3 678998865323333456888887764322 33333221 00124678999
Q ss_pred eccCCCC
Q 040812 133 EYMDAGS 139 (300)
Q Consensus 133 e~~~~~~ 139 (300)
++++|..
T Consensus 103 ~~l~G~~ 109 (322)
T 2ppq_A 103 SFLEGMW 109 (322)
T ss_dssp ECCCCBC
T ss_pred EeCCCcC
Confidence 9998854
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.018 Score=49.06 Aligned_cols=77 Identities=10% Similarity=0.023 Sum_probs=40.3
Q ss_pred eeecCCcceE-EEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEeceeeeCCCCcEEEEEeccCCCC
Q 040812 63 QVLGQGNGGT-VFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 63 ~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
+.|+.|.... +|+.... +++.+++|...... ......|+.+++.+...+ +.+++.+ ....+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~-d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAE-EHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEE-ETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeee-cCCCC--EEEEeeCCCcc
Confidence 4565555444 5666532 25567777654322 144567888888774323 4455554 23333 68999998766
Q ss_pred HHHHH
Q 040812 140 LEIYV 144 (300)
Q Consensus 140 L~~~l 144 (300)
+.+.+
T Consensus 99 l~~~l 103 (333)
T 3csv_A 99 FTEVI 103 (333)
T ss_dssp HHHHH
T ss_pred hHHHh
Confidence 65443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0065 Score=51.47 Aligned_cols=96 Identities=11% Similarity=0.068 Sum_probs=68.9
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC---CCceeEeceeeeCCCCcEEEEEeccC
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN---SPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
.-.+.|+.|....+|+... ++..+++|+..... ...+..|...|+.+. ...+++++.+.... +..++|||+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~-~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY-RSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG-HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc-HHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEecc
Confidence 3457799999999999875 35678899876432 223466888888774 34577777776554 57999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 173 (300)
|..+.. ....++...|..||..+
T Consensus 115 G~~~~~--------------~~~~~lG~~LA~LH~~~ 137 (312)
T 3jr1_A 115 KSKNKQ--------------SSFTIFAEKIAQLHQIQ 137 (312)
T ss_dssp CCCCCT--------------THHHHHHHHHHHHHHCC
T ss_pred CCCCCc--------------hhHHHHHHHHHHHHcCC
Confidence 976421 24567888889999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0075 Score=51.20 Aligned_cols=75 Identities=9% Similarity=0.063 Sum_probs=45.3
Q ss_pred eeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcCCCc--eeEecee----eeCCCCcEEEEEecc
Q 040812 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTNSPY--IVKCHQI----FTKPSGEVSILMEYM 135 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~h~n--iv~~~~~----~~~~~~~~~lv~e~~ 135 (300)
..++ |....||++... +|+.+++|....... ......|..+++.+...+ +++++.. +....+..++||+++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 788899987654 356788999864321 122345778777764322 3444443 001134678899999
Q ss_pred CCCC
Q 040812 136 DAGS 139 (300)
Q Consensus 136 ~~~~ 139 (300)
+|..
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.014 Score=50.43 Aligned_cols=73 Identities=11% Similarity=0.149 Sum_probs=44.0
Q ss_pred eeeecCCcceEEEEEEEccC--------CeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCc-eeEeceeeeCCCCcEEEE
Q 040812 62 LQVLGQGNGGTVFKVRHKQT--------LALYALKVMQCDRGT-PPNPQELNILRQTNSPY-IVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv 131 (300)
.+.|+.|....+|++..... ++.+++|+....... .....|..+++.+...+ +.++++.. + + ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N-G--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T-T--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C-C--cEE
Confidence 46788888899999987541 267889987543211 12256888888775434 34555543 2 2 689
Q ss_pred EeccCCCC
Q 040812 132 MEYMDAGS 139 (300)
Q Consensus 132 ~e~~~~~~ 139 (300)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.52 E-value=0.3 Score=43.18 Aligned_cols=98 Identities=19% Similarity=0.215 Sum_probs=59.7
Q ss_pred eeeeecCCcceEEEEEEEcc-------CCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCce-eEeceeeeCCCCcEEEE
Q 040812 61 KLQVLGQGNGGTVFKVRHKQ-------TLALYALKVMQCDRGT-PPNPQELNILRQTNSPYI-VKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv 131 (300)
-++.|+.|-...+|++.... .++.+++|+.... .. ....+|..+++.+...++ .++++.+. + .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---CEE
Confidence 35678889999999998753 2568899987432 11 233568888887754443 45665542 3 289
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 172 (300)
+||++|.+|... .+. -..++.+++..|.-||..
T Consensus 151 ~e~l~G~~l~~~-----~l~---~~~~~~~ia~~La~LH~~ 183 (429)
T 1nw1_A 151 EEYIPSRPLSCH-----EIS---LAHMSTKIAKRVAKVHQL 183 (429)
T ss_dssp ECCCCEEECCTT-----GGG---SHHHHHHHHHHHHHHTTC
T ss_pred EEEeCCcccChh-----hcC---CHHHHHHHHHHHHHHhCC
Confidence 999987554311 000 012455666666666653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.17 E-value=0.021 Score=51.09 Aligned_cols=58 Identities=10% Similarity=-0.022 Sum_probs=16.8
Q ss_pred eeeeecCCcceEEEEEEEccCCeEEEE------EEeecCCCC----CCCHHHHHHHHhcCCCceeEeceee
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTLALYAL------KVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIF 121 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~ 121 (300)
+.+.|| ||.||++.+......||+ |..+..... ..+.+|..+++.++|+|+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 345666 999999999865568888 665432211 2356788888889999999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.09 E-value=1.6 Score=38.90 Aligned_cols=99 Identities=19% Similarity=0.252 Sum_probs=62.9
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-CCHHHHHHHHhcCCCce-eEeceeeeCCCCcEEEEEeccCCCC
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-PNPQELNILRQTNSPYI-VKCHQIFTKPSGEVSILMEYMDAGS 139 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~~~ 139 (300)
++.|+.|-...+|++.....+..+++|+........ ...+|..+++.+...++ .++++.+ +++ +||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G---~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TNG---RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE---EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe---EEEEeeCCcc
Confidence 567888999999999876545788899874432111 11579999999876555 4566655 232 5999999865
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC
Q 040812 140 LEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN 173 (300)
Q Consensus 140 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 173 (300)
|.. ..+.. ..++.+++..|+.||...
T Consensus 188 l~~-----~~l~~---~~~~~~ia~~La~LH~~~ 213 (458)
T 2qg7_A 188 LSR-----EDIKN---PKFQKLIAKNLKLLHDIK 213 (458)
T ss_dssp CCT-----TTTTS---HHHHHHHHHHHHHHHTCC
T ss_pred CCh-----hhcCC---HHHHHHHHHHHHHHhcCC
Confidence 531 11111 245677788888888643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=84.76 E-value=6 Score=33.37 Aligned_cols=92 Identities=15% Similarity=0.118 Sum_probs=55.7
Q ss_pred cCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC---CceeEeceee-----eCCCCcEEEEEeccCC
Q 040812 66 GQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS---PYIVKCHQIF-----TKPSGEVSILMEYMDA 137 (300)
Q Consensus 66 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~-----~~~~~~~~lv~e~~~~ 137 (300)
|.|....||+..... | .+++|+..... ...|+..++.+.. +.+++.+... ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~-g-~~vLK~~~~~~----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSES-K-SYFIKLKYGYH----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSS-C-EEEEEEEECSS----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCC-C-CEEEEEecCcc----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 344468999997653 4 78999876543 2468887777632 2244554321 1123578999999998
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC
Q 040812 138 GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172 (300)
Q Consensus 138 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 172 (300)
..+.. ..++... +.++...|.-||..
T Consensus 106 ~~~~~-----~~~~~~~----~~~lg~~La~LH~~ 131 (339)
T 3i1a_A 106 PNGFT-----QNLTGKQ----WKQLGKVLRQIHET 131 (339)
T ss_dssp CBTTT-----SCCCHHH----HHHHHHHHHHHHTC
T ss_pred CcCcc-----cCCCHHH----HHHHHHHHHHHhCc
Confidence 76621 1233332 34666677777754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.93 E-value=3.4 Score=35.91 Aligned_cols=34 Identities=15% Similarity=0.262 Sum_probs=23.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccC-------CeEEEEEEee
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQT-------LALYALKVMQ 91 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~ 91 (300)
++++ ++.|+-|-.-.+|++..... .+.|.+++..
T Consensus 53 ~~l~-v~~lsGG~SN~~y~v~~~~~~~~~~~~~~~~llRi~g 93 (401)
T 3g15_A 53 DEFH-ISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYG 93 (401)
T ss_dssp GGCE-EEEEECSSEEEEEEEECCTTCCCSSSCCSEEEEEEEE
T ss_pred CCEE-EEEeCCccccceEEEEECCCCcccccCCCeEEEEeCC
Confidence 3444 46777788889999986532 3568888764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=81.47 E-value=0.85 Score=39.49 Aligned_cols=98 Identities=14% Similarity=0.162 Sum_probs=53.7
Q ss_pred eeeecCCcceEEEEEEEcc-------CCeEEEEEEeecCC-CCCCCHHHHHHHHhcCCCce-eEeceeeeCCCCcEEEEE
Q 040812 62 LQVLGQGNGGTVFKVRHKQ-------TLALYALKVMQCDR-GTPPNPQELNILRQTNSPYI-VKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~ 132 (300)
++.|..|-...+|++.... .++.+++|+..... ......+|..+++.+..-++ .++++.+. ++ +||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~g---~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--EG---RLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--TE---EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--Cc---cEE
Confidence 3567778888999998742 34688899863311 11112468888887743232 45565543 32 999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhC
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 172 (300)
||++|..|..- .+.. ..+..+++..|+-||+.
T Consensus 130 e~i~G~~l~~~-----~l~~---p~~~~~ia~~La~LH~~ 161 (379)
T 3feg_A 130 QYIPSRPLKTQ-----ELRE---PVLSAAIATKMAQFHGM 161 (379)
T ss_dssp ECCSEEECCGG-----GGGC---HHHHHHHHHHHHHHHTC
T ss_pred EEecCccCChh-----HhCC---HHHHHHHHHHHHHHhCC
Confidence 99998665310 0110 13455666677777754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.62 E-value=2.6 Score=33.15 Aligned_cols=120 Identities=11% Similarity=0.092 Sum_probs=73.6
Q ss_pred HHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccC
Q 040812 100 PQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDA-GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178 (300)
Q Consensus 100 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~D 178 (300)
..|+..|.. .||+.+.. .+-..++ .+.+.++.-+. .++.. ++ .++....++++.+|+....++ ..-+|--
T Consensus 34 ~~el~LL~~-~~~~Fl~~-~I~e~eD-~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~ 104 (215)
T 4ann_A 34 FHLMYLLEQ-HSPYFIDA-ELTELRD-SFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFV 104 (215)
T ss_dssp GGGGGGGGS-CCTTBCCE-EEEECSS-EEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGG--GSSEECC
T ss_pred HHHHHHHhc-cCCcccce-EEEEccc-EEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHh--cCceEEE
Confidence 445555543 67777755 3333333 55555655442 23333 32 478889999999998876444 3347788
Q ss_pred CCCCceeecCCCCCCccceee--ccccccccccCCCCCCchhh-HHHHHHHHHHHHhCCCCC
Q 040812 179 IKPANVLINEKMEHPCGYSCL--YESGEARHRKHGGYNGFAAD-IWSFGVTMMELYMGYYPF 237 (300)
Q Consensus 179 lkp~Nill~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~D-iwSlG~il~elltg~~pf 237 (300)
|.|+||+++.++.+.+..-+. ..+|.. .+ .-| .-..=|++..+++++..|
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik~~l~P~~--------~~-ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQNVVDPLP--------VS-EAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEETTTBSCCC--------CC-HHHHHHHHHHHHHHHHCTTCCH
T ss_pred EecceEEEcCCCCEEEEEccCccCCCCCC--------CC-HHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999997655443222 122221 11 333 335777888899998888
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 300 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-46 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-43 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-59
Identities = 75/265 (28%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKC 117
E + LG G G V+K ++K+T L A KV+ E++IL + P IVK
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 118 HQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
F + IL+E+ G++ + ++ L+E I + +Q L L Y+H I+H
Sbjct: 75 LDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133
Query: 177 RDIKPANVLINEKME--------------------HPCGYSCLYESGE--ARHRKHGGYN 214
RD+K N+L + G + + E
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPY 192
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS--SEKFRDF 272
+ AD+WS G+T++E+ P E + + ++L I EPP+L + S S F+DF
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPH----HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
++ CL+K + RWT SQLL HPF+
Sbjct: 249 LKKCLEK-NVDARWTTSQLLQHPFV 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (477), Expect = 1e-58
Identities = 64/260 (24%), Positives = 109/260 (41%), Gaps = 29/260 (11%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTNSPYI 114
L+ +G G+ G V+ R + + A+K M +E+ L++ P
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
++ + + ++MEY + ++ + L E I ++ L+GL Y+HS N+
Sbjct: 78 IQYRGCYLRE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 175 VHRDIKPANVLINEKME----------------HPCGYSCLYESGEARHRKHGGYNGFAA 218
+HRD+K N+L++E G + + + E G
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG-TPYWMAPEVILAMDEGQYDGKV 195
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS-SEKFRDFIRCCL 277
D+WS G+T +EL P + +S + I E P+L SE FR+F+ CL
Sbjct: 196 DVWSLGITCIELAERKPPL----FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 278 QKGDPSKRWTASQLLSHPFL 297
QK P R T+ LL H F+
Sbjct: 252 QK-IPQDRPTSEVLLKHRFV 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-58
Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 37/269 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
E L +G G+ G K+R K + K + T Q E+N+LR+ P IV
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 116 KCHQIFT-KPSGEVSILMEYMDAGSLEIYV----KSRGRLSEDIICTISRQVLKGLFYMH 170
+ + + + + I+MEY + G L + K R L E+ + + Q+ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 171 SRN-----IVHRDIKPANVLINEKMEHPC----GYSCLYESGEARHRK------------ 209
R+ ++HRD+KPANV ++ K + G + + + +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 210 -HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEK 268
+ +DIWS G + EL PF L I + +P S++
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPF----TAFSQKELAGKIREGKFRRIPYRYSDE 241
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ I L R + ++L +P +
Sbjct: 242 LNEIITRMLNL-KDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-58
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 26/261 (9%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTN 110
L E + LG+G G V+ R KQ+ + ALKV+ + +E+ I
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
P I++ + F V +++EY G++ ++ + E T ++ L Y H
Sbjct: 65 HPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 171 SRNIVHRDIKPANVLINEKMEHP---CGYSCLYESGEARHRK-----------HGGYNGF 216
S+ ++HRDIKP N+L+ E G+S S G +
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
D+WS GV E +G PF + + I R + P+ +E RD I
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRIS-RVEFTFPDFVTEGARDLISRL 238
Query: 277 LQKGDPSKRWTASQLLSHPFL 297
L+ +PS+R ++L HP++
Sbjct: 239 LKH-NPSQRPMLREVLEHPWI 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-58
Identities = 93/298 (31%), Positives = 138/298 (46%), Gaps = 59/298 (19%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVK 116
EK+ LG GNGG VFKV HK + + A K++ + Q EL +L + NSPYIV
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN-IV 175
+ F GE+SI ME+MD GSL+ +K GR+ E I+ +S V+KGL Y+ ++ I+
Sbjct: 69 FYGAFYSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 176 HRDIKPANVLINEKMEHPC---GYSCLYESGEARHRK-----------HGGYNGFAADIW 221
HRD+KP+N+L+N + E G S A G + +DIW
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDFL---------------------------------- 247
S G++++E+ +G YP P + L
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 248 ----SLMLAICFREPPSLPE-CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
L+ I PP LP S +F+DF+ CL K +P++R QL+ H F+ +
Sbjct: 248 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFIKRS 304
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (473), Expect = 1e-57
Identities = 70/264 (26%), Positives = 106/264 (40%), Gaps = 23/264 (8%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--PQELNILRQTNSPY 113
L + + LG G G V +V + T +A K + + +E+ + P
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84
Query: 114 IVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
+V H F E+ ++ E+M G L E ++SED RQV KGL +MH
Sbjct: 85 LVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 173 NIVHRDIKPANVLINEKMEHPC-----GYSCLYESGEARHRK------------HGGYNG 215
N VH D+KP N++ K + G + + ++ G G
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
+ D+WS GV L G PF + + L + + + S SE +DFIR
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGEN-DDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 276 CLQKGDPSKRWTASQLLSHPFLAD 299
L DP+ R T Q L HP+L
Sbjct: 263 LLLA-DPNTRMTIHQALEHPWLTP 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-56
Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 23/259 (8%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--QELNILRQTNSPYIVKC 117
+ + +GQG GTV+ T A++ M + E+ ++R+ +P IV
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ E+ ++MEY+ GSL V + E I + R+ L+ L ++HS ++HR
Sbjct: 83 LDSYLVG-DELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 178 DIKPANVLINEKME---HPCGYSCLYESGEARHRKHGGYN-------------GFAADIW 221
DIK N+L+ G+ +++ G G DIW
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 222 SFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGD 281
S G+ +E+ G P+ + P ++A PE S FRDF+ CL D
Sbjct: 201 SLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM-D 257
Query: 282 PSKRWTASQLLSHPFLADA 300
KR +A +LL H FL A
Sbjct: 258 VEKRGSAKELLQHQFLKIA 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 183 bits (465), Expect = 4e-56
Identities = 59/272 (21%), Positives = 114/272 (41%), Gaps = 32/272 (11%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--------PQELNILR 107
++ +++G+G G V+ R T +YA+K + R L+++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLF 167
+ P+IV F P ++S +++ M+ G L ++ G SE + + +++ GL
Sbjct: 63 TGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 168 YMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRK------------HGG 212
+MH+R +V+RD+KPAN+L++E G +C + + G
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
+AD +S G + +L G+ PF + + + LP+ S + R
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239
Query: 273 IRCCLQKGDPSKRWT-----ASQLLSHPFLAD 299
+ LQ+ D ++R A ++ PF
Sbjct: 240 LEGLLQR-DVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 180 bits (458), Expect = 5e-56
Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 36/271 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-----------ELNILRQ 108
E ++LG+G V + HK T YA+K++ G + + E++ILR+
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 109 TNS-PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLF 167
+ P I++ + + ++ + M G L Y+ + LSE I R +L+ +
Sbjct: 66 VSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHP---CGYSCLYESGEARHRKHG------------- 211
+H NIVHRD+KP N+L+++ M G+SC + GE G
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 212 -----GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266
G D+WS GV M L G PF ++ L ++++ ++ + S
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSPEWDDYS 243
Query: 267 EKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ +D + L P KR+TA + L+HPF
Sbjct: 244 DTVKDLVSRFLVV-QPQKRYTAEEALAHPFF 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 9e-56
Identities = 61/273 (22%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 50 GQEIDG-LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELN 104
G DG + + +G+G+ TV+K +T A +Q + T Q E
Sbjct: 3 GMSNDGRFLKFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60
Query: 105 ILRQTNSPYIVKCHQIF---TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQ 161
+L+ P IV+ + + K + ++ E M +G+L+ Y+K + ++ + RQ
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120
Query: 162 VLKGLFYMHSRN--IVHRDIKPANVLINEKMEHPC----GYSCLYESGEARHRK------ 209
+LKGL ++H+R I+HRD+K N+ I G + L + A+
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM 180
Query: 210 -----HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264
Y+ + D+++FG+ M+E+ YP+ E + + +P S +
Sbjct: 181 APEMYEEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVKPASFDKV 237
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
+ + ++ I C+++ + +R++ LL+H F
Sbjct: 238 AIPEVKEIIEGCIRQ-NKDERYSIKDLLNHAFF 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-55
Identities = 59/269 (21%), Positives = 109/269 (40%), Gaps = 36/269 (13%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYI 114
+ ++LG+G+ TV R T YA+K+++ N +E +++ + + P+
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 115 VKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
VK + F ++ + Y G L Y++ G E + +++ L Y+H + I
Sbjct: 71 VKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 175 VHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKH---------------GGYNGF 216
+HRD+KP N+L+NE M G + + + R +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 217 AADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
++D+W+ G + +L G PF + + + I + PE K RD +
Sbjct: 190 SSDLWALGCIIYQLVAGLPPF----RAGNEYLIFQKII-KLEYDFPEKFFPKARDLVEKL 244
Query: 277 LQKGDPSKRWTASQ------LLSHPFLAD 299
L D +KR + L +HPF
Sbjct: 245 LVL-DATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-55
Identities = 50/260 (19%), Positives = 93/260 (35%), Gaps = 26/260 (10%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVK 116
+ +Q LG+G G V ++ T A+K++ R E+ I + N +VK
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ + + +EY G L ++ + E Q++ G+ Y+H I H
Sbjct: 68 FYGHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 177 RDIKPANVLINEKMEHP---CGYSCLYESGEARHR----------------KHGGYNGFA 217
RDIKP N+L++E+ G + ++ K ++
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277
D+WS G+ + + G P+ +P S P + + L
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKIL 244
Query: 278 QKGDPSKRWTASQLLSHPFL 297
+ +PS R T + +
Sbjct: 245 VE-NPSARITIPDIKKDRWY 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (454), Expect = 1e-54
Identities = 64/258 (24%), Positives = 104/258 (40%), Gaps = 23/258 (8%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--PQELNILRQTNSPYIVKC 117
+ L+ LG G G V + K T ++ K + E++I+ Q + P ++
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVH 176
H F E+ +++E++ G L + + ++SE + RQ +GL +MH +IVH
Sbjct: 92 HDAFEDK-YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 150
Query: 177 RDIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG------------GYNGFAAD 219
DIKP N++ K G + E GF D
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 220 IWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQK 279
+W+ GV L G PF + + L + + S + +DFI+ LQK
Sbjct: 211 MWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269
Query: 280 GDPSKRWTASQLLSHPFL 297
+P KR T L HP+L
Sbjct: 270 -EPRKRLTVHDALEHPWL 286
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-54
Identities = 57/260 (21%), Positives = 105/260 (40%), Gaps = 22/260 (8%)
Query: 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT 109
G ++ + +L+ LQ +G+G G V ++ A+K ++ D E +++ Q
Sbjct: 1 GWALN-MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQL 57
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLF 167
+V+ + + G + I+ EYM GSL Y++SRGR L D + S V + +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 168 YMHSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHRKHGGYN---------- 214
Y+ N VHRD+ NVL++E G + S + + +
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKF 177
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
+D+WSFG+ + E+Y P ++ + P+ + ++
Sbjct: 178 STKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 275 CCLQKGDPSKRWTASQLLSH 294
C D + R + QL
Sbjct: 235 NCWHL-DAAMRPSFLQLREQ 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-54
Identities = 55/257 (21%), Positives = 99/257 (38%), Gaps = 22/257 (8%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIVKCH 118
+ LG+G G V + + Y K ++ +E++IL I+ H
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHR 177
+ F E+ ++ E++ + + + L+E I + QV + L ++HS NI H
Sbjct: 68 ESFESM-EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 178 DIKPANVLINEKMEHPC-----GYSCLYESGEARHRKHG------------GYNGFAADI 220
DI+P N++ + G + + G+ A D+
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDM 186
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKG 280
WS G + L G PFL + + ++ + + S + DF+ L K
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK- 244
Query: 281 DPSKRWTASQLLSHPFL 297
+ R TAS+ L HP+L
Sbjct: 245 ERKSRMTASEALQHPWL 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (446), Expect = 6e-54
Identities = 69/260 (26%), Positives = 103/260 (39%), Gaps = 24/260 (9%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP---QELNILRQTNSPYIVK 116
+ VLG G V K+T L A+K + E+ +L + P IV
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 117 CHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVH 176
I+ G + ++M+ + G L + +G +E + QVL + Y+H IVH
Sbjct: 72 LDDIYESG-GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 177 RDIKPANVLINEKMEHP------CGYSCLYESGE------------ARHRKHGGYNGFAA 218
RD+KP N+L E G S + + G A A
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278
D WS GV L GY PF + +L + + S+ +DFIR ++
Sbjct: 191 DCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249
Query: 279 KGDPSKRWTASQLLSHPFLA 298
K DP KR+T Q L HP++A
Sbjct: 250 K-DPEKRFTCEQALQHPWIA 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-53
Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 31/265 (11%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNIL-RQTNSPYIVKCHQIF 121
QVLG G G V ++ +K+T +ALK++ + P +E+ + R + P+IV+ ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 122 ---TKPSGEVSILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVH 176
+ I+ME +D G L ++ RG +E I + + + + Y+HS NI H
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 177 RDIKPANVLINEKMEHP------CGYSCLYESGEARHRKH------------GGYNGFAA 218
RD+KP N+L K + G++ S + +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---FREPPSLPECSSEKFRDFIRC 275
D+WS GV M L GY PF + I + P SE+ + IR
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254
Query: 276 CLQKGDPSKRWTASQLLSHPFLADA 300
L+ +P++R T ++ ++HP++ +
Sbjct: 255 LLKT-EPTQRMTITEFMNHPWIMQS 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-51
Identities = 55/267 (20%), Positives = 108/267 (40%), Gaps = 30/267 (11%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELN------ILRQT 109
+ ++LG+G+ G VF K+T +A+K ++ D + E +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYM 169
P++ F + +MEY++ G L +++S + + +++ GL ++
Sbjct: 61 EHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 170 HSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHRKH-------------GGY 213
HS+ IV+RD+K N+L+++ G G+A+ G
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273
+ D WSFGV + E+ +G PF GQ+ + + + P P ++ +D +
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPF--HGQDEE---ELFHSIRMDNPFYPRWLEKEAKDLL 234
Query: 274 RCCLQKGDPSKRWTA-SQLLSHPFLAD 299
+ +P KR + HP +
Sbjct: 235 VKLFVR-EPEKRLGVRGDIRQHPLFRE 260
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-51
Identities = 54/270 (20%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILR 107
EI Q+ Q +G G+ GTV+K + A+K++ TP Q E+ +LR
Sbjct: 4 EIP-DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 108 QTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGL 166
+T I+ T P +++I+ ++ + SL ++ + + I+RQ +G+
Sbjct: 60 KTRHVNILLFMGYSTAP--QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHR--------------- 208
Y+H+++I+HRD+K N+ ++E + G + + H+
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 209 ---KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLML-AICFREPPSLPEC 264
+ F +D+++FG+ + EL G P+ + ++ + +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ + + CL+K +R Q+L+
Sbjct: 238 CPKAMKRLMAECLKK-KRDERPLFPQILAS 266
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 5e-51
Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 30/267 (11%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP--------QELNILRQTNS 111
+ + LG G V K R K T YA K ++ R +E++IL++
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 112 PYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
P ++ H+++ +V +++E + G L ++ + L+E+ +Q+L G++Y+HS
Sbjct: 73 PNVITLHEVYENK-TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 172 RNIVHRDIKPANVLINEKMEHPC-------GYSCLYESGEARHRKHG------------G 212
I H D+KP N+++ ++ G + + G G
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
G AD+WS GV L G PFL + + L+ + A+ + +S +DF
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299
IR L K DP KR T L HP++
Sbjct: 251 IRRLLVK-DPKKRMTIQDSLQHPWIKP 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 8e-50
Identities = 62/287 (21%), Positives = 109/287 (37%), Gaps = 49/287 (17%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-------QELNILRQTNSP 112
EKL LG+G TV+K R K T + A+K ++ + +E+ +L++ + P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 113 YIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSR 172
I+ F +S++ ++M+ I + L+ I L+GL Y+H
Sbjct: 61 NIIGLLDAFGHK-SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 173 NIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHGG--------------YNG 215
I+HRD+KP N+L++E G + + S + G
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 216 FAADIWSFGVTMMELYMGYYPF------------------LEPGQEPDFLSLMLAICFRE 257
D+W+ G + EL + Q PD SL + F+
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 258 PPSLP-----ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
P +P + + D I+ +P R TA+Q L + ++
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLF-NPCARITATQALKMKYFSN 285
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 61/270 (22%), Positives = 109/270 (40%), Gaps = 33/270 (12%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTN 110
++ + L++LG+G G V VR K T YA+K+++ + + E +L+ T
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
P++ F + +MEY + G L ++ +E+ +++ L Y+H
Sbjct: 64 HPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 171 SRNIVHRDIKPANVLINEKME---HPCGYSCLYESGE-------------ARHRKHGGYN 214
SR++V+RDIK N+++++ G S A
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 215 GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274
G A D W GV M E+ G PF Q+ + + + E P S + + +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF--YNQDHE---RLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 275 CCLQKGDPSKRW-----TASQLLSHPFLAD 299
L+K DP +R A +++ H F
Sbjct: 238 GLLKK-DPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-49
Identities = 58/270 (21%), Positives = 117/270 (43%), Gaps = 31/270 (11%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTN 110
E+ L+ ++ LG G G V+ + A+K ++ +P E N+++Q
Sbjct: 9 EVP-RETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFY 168
+V+ + + T+ + I+ EYM+ GSL ++K+ +L+ + + ++ Q+ +G+ +
Sbjct: 67 HQRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 169 MHSRNIVHRDIKPANVLINEKMEHP---CGYSCLYESGEARHRKH--------------G 211
+ RN +HRD++ AN+L+++ + G + L E E R+
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
G +D+WSFG+ + E+ P+ ++ + P+ E+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERGYRMVRPDNCPEELYQ 241
Query: 272 FIRCCLQKGDPSKRWTASQL---LSHPFLA 298
+R C ++ P R T L L F A
Sbjct: 242 LMRLCWKE-RPEDRPTFDYLRSVLEDFFTA 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-48
Identities = 62/269 (23%), Positives = 111/269 (41%), Gaps = 38/269 (14%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN--------PQELNILRQ 108
SQ + +LG G G+V+ A+K ++ DR + P E+ +L++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 109 TNSPY--IVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGL 166
+S + +++ F +P V IL L ++ RG L E++ + QVL+ +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHP----CGYSCLYESGEARHR------------KH 210
+ H+ ++HRDIK N+LI+ G L + ++
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 211 GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270
Y+G +A +WS G+ + ++ G PF E R + S + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEE---------IIRGQVFFRQRVSSECQ 232
Query: 271 DFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
IR CL PS R T ++ +HP++ D
Sbjct: 233 HLIRWCLAL-RPSDRPTFEEIQNHPWMQD 260
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (412), Expect = 1e-48
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 30/272 (11%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNI 105
Q L Q ++++ LG G+ G V V+HK++ YA+K++ + E I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 106 LRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKG 165
L+ N P++VK F S + ++MEY+ G + +++ GR SE + Q++
Sbjct: 95 LQAVNFPFLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 166 LFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKHGGYN----------- 214
Y+HS ++++RD+KP N+LI+++ + + R G
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSK 213
Query: 215 --GFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
A D W+ GV + E+ GY PF +P + P S +D
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF--FADQPI---QIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 273 IRCCLQKGDPSKRW-----TASQLLSHPFLAD 299
+R LQ D +KR+ + + +H + A
Sbjct: 269 LRNLLQV-DLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 5e-48
Identities = 55/267 (20%), Positives = 109/267 (40%), Gaps = 30/267 (11%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQTN 110
L + L+ LG G+ G V +R + YA+KV++ + E +L
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
P+I++ F ++ ++M+Y++ G L ++ R + + +V L Y+H
Sbjct: 63 HPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 171 SRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHGGYN----------GFA 217
S++I++RD+KP N+L+++ G++ Y +
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277
D WSFG+ + E+ GY PF + + + I P +E +D + +
Sbjct: 182 IDWWSFGILIYEMLAGYTPF----YDSNTMKTYEKIL-NAELRFPPFFNEDVKDLLSRLI 236
Query: 278 QKGDPSKRW-----TASQLLSHPFLAD 299
+ D S+R + +HP+ +
Sbjct: 237 TR-DLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (402), Expect = 8e-48
Identities = 53/265 (20%), Positives = 93/265 (35%), Gaps = 29/265 (10%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-----PQELNILRQTNSPYI 114
E ++LG G V R + A+KV++ D P+ +E N P I
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 115 VKCHQIF---TKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS 171
V + T I+MEY+D +L V + G ++ + + L + H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 172 RNIVHRDIKPANVLINEKME----HPCGYSCLYESGEARHRKH---------------GG 212
I+HRD+KPAN++I+ + +SG + + G
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 213 YNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272
+D++S G + E+ G PF + P + E S
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHEGLSADLDAV 248
Query: 273 IRCCLQKGDPSKRWTASQLLSHPFL 297
+ L K +P R+ + + +
Sbjct: 249 VLKALAK-NPENRYQTAAEMRADLV 272
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-47
Identities = 70/280 (25%), Positives = 115/280 (41%), Gaps = 39/280 (13%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRH---KQTLALYALKVMQCDRGTPPNP------QELNI 105
G+ E L+VLG G G VF VR T LYA+KV++ E +
Sbjct: 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 106 LRQTN-SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLK 164
L SP++V H F ++ ++++Y++ G L ++ R R +E + +++
Sbjct: 82 LEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 165 GLFYMHSRNIVHRDIKPANVLINE--------------------KMEHPCGYSCLYESGE 204
L ++H I++RDIK N+L++ + + + Y + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 205 ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264
G+ A D WS GV M EL G PF G E + + + + P P+
Sbjct: 201 IVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDG-EKNSQAEISRRILKSEPPYPQE 258
Query: 265 SSEKFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLAD 299
S +D I+ L K DP KR A ++ H F
Sbjct: 259 MSALAKDLIQRLLMK-DPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-46
Identities = 52/289 (17%), Positives = 101/289 (34%), Gaps = 52/289 (17%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQ 119
+V+G G+ G V++ + + L A+K + D+ +EL I+R+ + IV+
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--KNRELQIMRKLDHCNIVRLRY 80
Query: 120 IFTKPSGE-----VSILMEYMDAGSLEI---YVKSRGRLSEDIICTISRQVLKGLFYMHS 171
F + ++++++Y+ + Y +++ L + Q+ + L Y+HS
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 172 RNIVHRDIKPANVLINEKMEHPC----GYSCLYESGE-------------ARHRKHGGYN 214
I HRDIKP N+L++ G + GE
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
Query: 215 GFAADIWSFGVTMMELYMGYYPF----------------------LEPGQEPDFLSLMLA 252
+ D+WS G + EL +G F P++
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260
Query: 253 ICFREPPS--LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
P + + + L+ P+ R T + +H F +
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEY-TPTARLTPLEACAHSFFDE 308
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-46
Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 48/286 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
+K++ +G+G G V+K R+K T + ALK ++ D T P E+++L++ N P IV
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLE-IYVKSRGRLSEDIICTISRQVLKGLFYMHSRNI 174
K + ++ ++ E++ + + + + +I + Q+L+GL + HS +
Sbjct: 65 KLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 175 VHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKH-----------------GGYNGFA 217
+HRD+KP N+LIN + L + R + Y A
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 218 ADIWSFGVTMMELYMGYYPF------------------------LEPGQEPDFLSLMLAI 253
DIWS G E+ F PD+
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
++ + E R + L DP+KR +A L+HPF D
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHY-DPNKRISAKAALAHPFFQD 288
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-46
Identities = 65/286 (22%), Positives = 117/286 (40%), Gaps = 48/286 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
EKL+ +G+G GTVFK ++++T + ALK ++ D P E+ +L++ IV
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
+ H + +++++ E+ D + + G L +I+ + Q+LKGL + HSRN++
Sbjct: 65 RLHDVLHSDK-KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 176 HRDIKPANVLINEKMEH---PCGYSCLYESGEARHRKHG--------------GYNGFAA 218
HRD+KP N+LIN E G + + + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 219 DIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP------------------- 259
D+WS G EL P D L + +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 260 ------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
++ + RD ++ L+ +P +R +A + L HP+ +D
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKC-NPVQRISAEEALQHPYFSD 288
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-46
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 52/289 (17%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
LQ +G G G V +T A A+K + + + EL +L+ ++
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 116 KCHQIFTKPS-----GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
+FT + ++M +M G+ + +L ED I + Q+LKGL Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138
Query: 171 SRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKH--------------GGYNGF 216
+ I+HRD+KP N+ +NE E L ++ +
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 217 AADIWSFGVTMMELYMGYYPF--------------------------LEPGQEPDFLSLM 250
DIWS G M E+ G F L+ + +++ +
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 251 LAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+ ++ S+ +S + + L D +R TA + L+HP+
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVL-DAEQRVTAGEALAHPYFES 306
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 6e-45
Identities = 56/258 (21%), Positives = 99/258 (38%), Gaps = 27/258 (10%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIV 115
L L+ LG G G V + + A+K+++ + +E ++ + +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVK-SRGRLSEDIICTISRQVLKGLFYMHSRNI 174
+ + + TK + I+ EYM G L Y++ R R + + + V + + Y+ S+
Sbjct: 63 QLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 175 VHRDIKPANVLINEKME---HPCGYSCLYESGEARHRK--------------HGGYNGFA 217
+HRD+ N L+N++ G S E
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 218 ADIWSFGVTMMELY-MGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCC 276
+DIW+FGV M E+Y +G P+ + I P +SEK + C
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPY----ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 277 LQKGDPSKRWTASQLLSH 294
+ +R T LLS+
Sbjct: 238 WHE-KADERPTFKILLSN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (383), Expect = 8e-45
Identities = 58/285 (20%), Positives = 104/285 (36%), Gaps = 48/285 (16%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
L+ +G+G G V+K ++ +ALK ++ ++ P E++IL++ IV
Sbjct: 5 HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
K + + + ++ E++D ++ G L + Q+L G+ Y H R ++
Sbjct: 64 KLYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 176 HRDIKPANVLINEKMEHPC---GYSCLYESGEARHR--------------KHGGYNGFAA 218
HRD+KP N+LIN + E G + + ++
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 219 DIWSFGVTMMELYMGYYPF------------------------LEPGQEPDFLSLMLAIC 254
DIWS G E+ G F + P +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 255 FREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
S + E D + L+ DP++R TA Q L H + +
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKL-DPNQRITAKQALEHAYFKE 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-45
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 36/262 (13%)
Query: 64 VLGQGNGGTVFKVRH--KQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIVKC 117
LG GN GTV K + K+ + A+K+++ + P E N+++Q ++PYIV+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 118 HQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
I S ++ME + G L Y++ + + I + QV G+ Y+ N VHR
Sbjct: 74 IGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 178 DIKPANVLINEKMEHPC---GYSCLYESGEARHRK----------------HGGYNGFAA 218
D+ NVL+ + G S + E ++ + +
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 219 DIWSFGVTMME-LYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277
D+WSFGV M E G P+ + + + E P + D + C
Sbjct: 192 DVWSFGVLMWEAFSYGQKPY----RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247
Query: 278 QKGDPSKRWTASQL---LSHPF 296
D R + + L + +
Sbjct: 248 TY-DVENRPGFAAVELRLRNYY 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 56/290 (19%), Positives = 97/290 (33%), Gaps = 51/290 (17%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLA-LYALKVMQCDRGTPPNP-------QELNILRQTNS 111
E + +G+G G VFK R + ALK ++ G P L L
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 112 PYIVKCHQIFTKPSGE----VSILMEYMDAGSLE-IYVKSRGRLSEDIICTISRQVLKGL 166
P +V+ + T + ++++ E++D + + + I + Q+L+GL
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 167 FYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKH---------------G 211
++HS +VHRD+KP N+L+ + L +
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLE----------------------PGQEPDFLSL 249
D+WS G E++ F P
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 250 MLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
+ + E +D + CL +P+KR +A LSHP+ D
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTF-NPAKRISAYSALSHPYFQD 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-44
Identities = 60/269 (22%), Positives = 105/269 (39%), Gaps = 30/269 (11%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTN 110
EI L LGQG G V+ T A+K ++ +P QE ++++
Sbjct: 13 EIP-RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR 70
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR--LSEDIICTISRQVLKGLFY 168
+V+ + + ++ + I+ EYM GSL ++K L + ++ Q+ G+ Y
Sbjct: 71 HEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 169 MHSRNIVHRDIKPANVLINEKMEH---PCGYSCLYESGEARHRKH--------------G 211
+ N VHRD++ AN+L+ E + G + L E E R+
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
G +D+WSFG+ + EL P ++ + P E D
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 272 FIRCCLQKGDPSKRWTASQLLS--HPFLA 298
+ C +K +P +R T L + +
Sbjct: 246 LMCQCWRK-EPEERPTFEYLQAFLEDYFT 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 3e-44
Identities = 52/262 (19%), Positives = 102/262 (38%), Gaps = 26/262 (9%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTN 110
E++ + + LG G G V++ K+ A+K ++ D +E ++++
Sbjct: 13 EME-RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 71
Query: 111 SPYIVKCHQIFTKPSGEVSILMEYMDAGSLE--IYVKSRGRLSEDIICTISRQVLKGLFY 168
P +V+ + T+ I+ E+M G+L + +R +S ++ ++ Q+ + Y
Sbjct: 72 HPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 169 MHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGE--------------ARHRKHG 211
+ +N +HRD+ N L+ E G S L A
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271
+D+W+FGV + E+ P D + + PE EK +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 272 FIRCCLQKGDPSKRWTASQLLS 293
+R C Q +PS R + +++
Sbjct: 248 LMRACWQW-NPSDRPSFAEIHQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-43
Identities = 49/276 (17%), Positives = 96/276 (34%), Gaps = 42/276 (15%)
Query: 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP-----QELNILRQ-T 109
+ ++ V+G+GN G V K R K+ + + + EL +L +
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVK----------------SRGRLSED 153
+ P I+ G + + +EY G+L +++ + LS
Sbjct: 69 HHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 154 IICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKH--- 210
+ + V +G+ Y+ + +HRD+ N+L+ E L E +K
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 211 ------------GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP 258
+D+WS+GV + E+ P L +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQGYR 244
Query: 259 PSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
P ++ D +R C ++ P +R + +Q+L
Sbjct: 245 LEKPLNCDDEVYDLMRQCWRE-KPYERPSFAQILVS 279
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-43
Identities = 46/257 (17%), Positives = 98/257 (38%), Gaps = 25/257 (9%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPN-PQELNILRQTNSPYIV 115
S+L +Q +G G G V A+K ++ + + +E ++ + + P +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 116 KCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRL-SEDIICTISRQVLKGLFYMHSRNI 174
+ + + + + ++ E+M+ G L Y++++ L + + + + V +G+ Y+ +
Sbjct: 64 QLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 175 VHRDIKPANVLINEKMEH---PCGYSCLYESGEARHRKH--------------GGYNGFA 217
+HRD+ N L+ E G + +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 218 ADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCL 277
+D+WSFGV M E++ P + ++ I P +S + C
Sbjct: 183 SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 278 QKGDPSKRWTASQLLSH 294
++ P R S+LL
Sbjct: 240 KE-RPEDRPAFSRLLRQ 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-43
Identities = 52/265 (19%), Positives = 97/265 (36%), Gaps = 36/265 (13%)
Query: 65 LGQGNGGTVFKVRHKQT--LALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVKCHQ 119
LG GN G+V + ++ A+KV++ + E I+ Q ++PYIV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRD 178
+ + ++ME G L ++ R + + + QV G+ Y+ +N VHRD
Sbjct: 77 VCQAE--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134
Query: 179 IKPANVLINEKMEHPC---GYSCLYESGEARHRKH----------------GGYNGFAAD 219
+ NVL+ + G S + ++ + +D
Sbjct: 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194
Query: 220 IWSFGVTMME-LYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQ 278
+WS+GVTM E L G P+ ++ +M I + P + + C
Sbjct: 195 VWSYGVTMWEALSYGQKPY----KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWI 250
Query: 279 KGDPSKRWTASQL---LSHPFLADA 300
R + + + + A
Sbjct: 251 Y-KWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-43
Identities = 62/267 (23%), Positives = 98/267 (36%), Gaps = 31/267 (11%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTL-ALYALKVMQCDRGTPPNP-----QELNI 105
EI ++E + +G+G G V + + A+ + C T + QE
Sbjct: 3 EIQ-RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 106 LRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLK 164
+RQ + P+IVK + T+ V I+ME G L + L + + Q+
Sbjct: 62 MRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 165 GLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGE-----------------ARH 207
L Y+ S+ VHRDI NVL++ G L E A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 208 RKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267
+ A+D+W FGV M E+ M P Q ++ I E +P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 268 KFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ C DPS+R ++L +
Sbjct: 237 TLYSLMTKCWAY-DPSRRPRFTELKAQ 262
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 148 bits (374), Expect = 3e-43
Identities = 53/292 (18%), Positives = 101/292 (34%), Gaps = 57/292 (19%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQ-TNSPYIVKCH 118
+ ++ LG+G VF+ + +K+++ + +E+ IL P I+
Sbjct: 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITLA 96
Query: 119 QIFTKPSGE-VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHR 177
I P +++ E+++ + + L++ I ++LK L Y HS I+HR
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 178 DIKPANVLINEKMEHPC----GYSCLYESGEARHRKHGG-------------YNGFAADI 220
D+KP NV+I+ + G + Y G+ + + ++ D+
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 213
Query: 221 WSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE----------------------- 257
WS G + + PF D L + + E
Sbjct: 214 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 273
Query: 258 ----------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299
S + DF+ L+ D R TA + + HP+
Sbjct: 274 HSRKRWERFVHSENQHLVSPEALDFLDKLLRY-DHQSRLTAREAMEHPYFYT 324
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 7e-43
Identities = 59/273 (21%), Positives = 106/273 (38%), Gaps = 36/273 (13%)
Query: 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGTPPNPQ---ELN 104
+EID +S ++ QV+G G G V K A+K ++ E +
Sbjct: 21 KEID-ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 79
Query: 105 ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVL 163
I+ Q + P ++ + TK V I+ E+M+ GSL+ +++ G+ + + + R +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKH---------- 210
G+ Y+ N VHRD+ N+L+N + G S E +
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 211 --------GGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSL 261
A+D+WS+G+ M E+ G P+ + ++ AI
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMTNQDVINAIEQDYRLPP 254
Query: 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
P + C QK D + R Q+++
Sbjct: 255 PMDCPSALHQLMLDCWQK-DRNHRPKFGQIVNT 286
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-43
Identities = 62/305 (20%), Positives = 106/305 (34%), Gaps = 62/305 (20%)
Query: 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNP----QELNILRQ 108
D +S+ EKL +GQG G VFK RH++T ALK + + P +E+ IL+
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 109 TNSPYIVKCHQIFTKPS-------GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQ 161
+V +I + G + ++ ++ + + + + I + +
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 162 VLKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKH-------- 210
+L GL+Y+H I+HRD+K ANVLI G + + +
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 211 ----------GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS 260
G D+W G M E++ + E L+L+ +C P
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPE 244
Query: 261 L----------------------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292
+ D I L DP++R + L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL-DPAQRIDSDDAL 303
Query: 293 SHPFL 297
+H F
Sbjct: 304 NHDFF 308
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-42
Identities = 52/275 (18%), Positives = 98/275 (35%), Gaps = 37/275 (13%)
Query: 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGTPPNP-----QELNIL 106
G L L+ LG G+ G V + A+K ++ D + P +E+N +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 107 RQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKG 165
+ +++ + + + + ++ E GSL + K +G + + QV +G
Sbjct: 66 HSLDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 166 LFYMHSRNIVHRDIKPANVLINEKMEHPC---GYSCLYESGEARHRKH------------ 210
+ Y+ S+ +HRD+ N+L+ + G + +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 211 ----GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECS 265
A+D W FGVT+ E++ P + ++ I E PE
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 266 SEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300
+ + + C P R T L FL +A
Sbjct: 241 PQDIYNVMVQCWAH-KPEDRPTFVALRD--FLLEA 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 65/304 (21%), Positives = 102/304 (33%), Gaps = 58/304 (19%)
Query: 50 GQEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ---ELNIL 106
GQ D + L +G+G G V A+K + + E+ IL
Sbjct: 1 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60
Query: 107 RQTNSPYIVKCHQIFTKPSGE----VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQV 162
+ I+ + I P+ E V ++ M A ++ LS D IC Q+
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQI 118
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKH--------- 210
L+GL Y+HS N++HRD+KP+N+L+N + G + + +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 211 --------GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262
+ DIWS G + E+ F D L+ +L I
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK-HYLDQLNHILGILGSPSQEDL 237
Query: 263 ECS---------------------------SEKFRDFIRCCLQKGDPSKRWTASQLLSHP 295
C K D + L +P KR Q L+HP
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF-NPHKRIEVEQALAHP 296
Query: 296 FLAD 299
+L
Sbjct: 297 YLEQ 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 2e-42
Identities = 39/269 (14%), Positives = 79/269 (29%), Gaps = 33/269 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQ 119
+ +G G+ G ++ A+K+ P E I + + +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
++ME + +++ + S + ++ Q++ + Y+HS+N +HRD+
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 129
Query: 180 KPANVLINEK------MEHPCGYSCLYESGEARHRKH--------------------GGY 213
KP N L+ G + Y G
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 214 NGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---PPSLPECSSEKFR 270
D+ S G +M +G P+ + L + +F
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFA 249
Query: 271 DFIRCCLQKGDPSKRWTAS---QLLSHPF 296
++ C + S QL + F
Sbjct: 250 TYLNFCRSL-RFDDKPDYSYLRQLFRNLF 277
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-41
Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 57/305 (18%)
Query: 49 YGQEIDGL-----SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-- 101
Y QE++ + + L +G G G+V +T A+K + + + +
Sbjct: 5 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 64
Query: 102 --ELNILRQTNSPYIVKCHQIFTKPS----GEVSILMEYMDAGSLEIYVKSRGRLSEDII 155
EL +L+ ++ +FT L+ ++ L VK +L++D +
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHV 123
Query: 156 CTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKH----- 210
+ Q+L+GL Y+HS +I+HRD+KP+N+ +NE E L + +
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183
Query: 211 ---------GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL 261
+ DIWS G M EL G F D L L+L + L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 242
Query: 262 PECS---------------------------SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ + D + L D KR TA+Q L+H
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL-DSDKRITAAQALAH 301
Query: 295 PFLAD 299
+ A
Sbjct: 302 AYFAQ 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-40
Identities = 56/294 (19%), Positives = 100/294 (34%), Gaps = 57/294 (19%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQT-----LALYALKVMQCDRGTPPNPQ---EL 103
E LE +VLG G G V A+K+++ + EL
Sbjct: 33 EFP-RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 91
Query: 104 NILRQ-TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSR--------------- 147
++ Q + IV T G + ++ EY G L Y++S+
Sbjct: 92 KMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 148 --------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---GY 196
L+ + + + QV KG+ ++ ++ VHRD+ NVL+ G
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 197 SCLYESGEARHRKH---------------GGYNGFAADIWSFGVTMME-LYMGYYPFLEP 240
+ S + G +D+WS+G+ + E +G P+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 241 GQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ +F L+ P ++E+ ++ C D KR + L S
Sbjct: 271 PVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAF-DSRKRPSFPNLTSF 320
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-40
Identities = 56/286 (19%), Positives = 98/286 (34%), Gaps = 50/286 (17%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVR-----HKQTLALYALKVMQCDRGTPPNPQ---EL 103
E ++L + LG G G V + A+K+++ EL
Sbjct: 19 EFP-RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 104 NILRQ-TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG-------------- 148
+L N IV T G ++ EY G L +++ +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 149 ----RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP---CGYSCLYE 201
L + + + S QV KG+ ++ S+N +HRD+ N+L+ G + +
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 202 SGEARHRK---------------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF 246
+ K F +D+WS+G+ + EL+
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 247 LSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292
M+ FR PE + + D ++ C DP KR T Q++
Sbjct: 257 FYKMIKEGFR--MLSPEHAPAEMYDIMKTCWDA-DPLKRPTFKQIV 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 51/265 (19%), Positives = 94/265 (35%), Gaps = 34/265 (12%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVM--QCDRGTPPN-----PQELNILRQT 109
++ +K++VLG G GTV+K + V + T P E ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 110 NSPYIVKCHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFY 168
++P++ + I + V ++ + M G L + + + + + Q+ KG+ Y
Sbjct: 69 DNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 169 MHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHR----------------K 209
+ R +VHRD+ NVL+ G + L + E +
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 210 HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKF 269
H Y +D+WS+GVT+ EL P + + E P +
Sbjct: 187 HRIYT-HQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 270 RDFIRCCLQKGDPSKRWTASQLLSH 294
+ C D R +L+
Sbjct: 243 YMIMVKCWMI-DADSRPKFRELIIE 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 9e-40
Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 33/269 (12%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQT----LALYALKVMQCDRGTPPNPQ---ELN 104
EI S + + +V+G G G V+K K + A+K ++ E
Sbjct: 3 EIH-PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61
Query: 105 ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGS-LEIYVKSRGRLSEDIICTISRQVL 163
I+ Q + I++ + +K + I+ EYM+ G+ + + G S + + R +
Sbjct: 62 IMGQFSHHNIIRLEGVISKY-KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 164 KGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESGEARHRKHGGYNG----- 215
G+ Y+ + N VHRD+ N+L+N + G S + E G
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 216 -----------FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264
A+D+WSFG+ M E+ P E +M AI P
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVMKAINDGFRLPTPMD 237
Query: 265 SSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
+ C Q+ + ++R + ++S
Sbjct: 238 CPSAIYQLMMQCWQQ-ERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-39
Identities = 48/259 (18%), Positives = 89/259 (34%), Gaps = 31/259 (11%)
Query: 63 QVLGQGNGGTVFKVRH---KQTLALYALKVMQCDRGTPPNPQ---ELNILRQTNSPYIVK 116
+V+G+G+ G V+ A+K + Q E I++ + P ++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 117 CHQIFTKPSGEVSILMEYMDAGSL-EIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIV 175
I + G +++ YM G L + + QV KG+ ++ S+ V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 176 HRDIKPANVLINEKMEHP---CGYSCLYESGEARHRK-----------------HGGYNG 215
HRD+ N +++EK G + E
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 216 FAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRC 275
+D+WSFGV + EL P P + + + + + PE + + +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269
Query: 276 CLQKGDPSKRWTASQLLSH 294
C R + S+L+S
Sbjct: 270 CWHP-KAEMRPSFSELVSR 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (347), Expect = 2e-39
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 55/287 (19%)
Query: 57 SQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGTPPNPQ---ELNILRQ 108
+ +E ++ +G+G G VF+ R + + A+K+++ + E ++ +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 109 TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR------------------- 149
++P IVK + + +L EYM G L +++S
Sbjct: 73 FDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 150 -----LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME------------- 191
LS I+RQV G+ Y+ R VHRD+ N L+ E M
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 192 -----HPCGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF 246
G + +D+W++GV + E++ P
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---PYYGMAH 248
Query: 247 LSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293
++ + + PE + + +R C K P+ R + +
Sbjct: 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSK-LPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-39
Identities = 54/288 (18%), Positives = 99/288 (34%), Gaps = 51/288 (17%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQT-------LALYALKVMQCDRGTPPNPQ--- 101
E+ +L + LG+G G V + A+K+++ D
Sbjct: 9 ELP-RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 67
Query: 102 ELNILRQ-TNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRG------------ 148
E+ +++ I+ T+ G + +++EY G+L Y+++R
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 149 ----RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCLYESGE 204
+LS + + + QV +G+ Y+ S+ +HRD+ NVL+ E L
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 205 ------------------ARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF 246
A +D+WSFGV + E++ P
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPV 243
Query: 247 LSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
L + P + + +R C PS+R T QL+
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHA-VPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-39
Identities = 54/286 (18%), Positives = 108/286 (37%), Gaps = 47/286 (16%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVR-----HKQTLALYALKVMQCDRGTPPNPQELN-- 104
E +L+ + LG+G G V + T A+K+++ + ++
Sbjct: 9 EFP-RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67
Query: 105 --ILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR------------- 149
++ + +V TKP G + +++E+ G+L Y++S+
Sbjct: 68 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 150 ---LSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---HPCGYSCLYESG 203
L+ + + S QV KG+ ++ SR +HRD+ N+L++EK G +
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 204 EARHRK---------------HGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLS 248
RK +D+WSFGV + E++ + +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E 245
Query: 249 LMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
+ P+ ++ + + C +PS+R T S+L+ H
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG-EPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-39
Identities = 52/279 (18%), Positives = 109/279 (39%), Gaps = 42/279 (15%)
Query: 52 EIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLA-----LYALKVM---QCDRGTPPNPQEL 103
E+ ++ + LGQG+ G V++ K + A+K + R E
Sbjct: 16 EVA-REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 74
Query: 104 NILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGR----------LSED 153
+++++ N ++V+ + ++ ++ME M G L+ Y++S S
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 154 IICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE----KMEHPCGYSCLYESGEARHRK 209
+ ++ ++ G+ Y+++ VHRD+ N ++ E K+ +YE+ R
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 210 HG--------------GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF 255
G G +D+WSFGV + E+ P Q ++ +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVME 250
Query: 256 REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294
P+ + + +R C Q +P R + +++S
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQY-NPKMRPSFLEIISS 288
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-38
Identities = 55/299 (18%), Positives = 96/299 (32%), Gaps = 65/299 (21%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ----ELNILRQTNSPYIV 115
+ L+ +G G G V A+K + + + EL +++ N I+
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 116 KCHQIFTKPS-----GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMH 170
+FT +V ++ME MDA ++ + L + + + Q+L G+ ++H
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 136
Query: 171 SRNIVHRDIKPANVLINEKMEHPCGYSCLYESGEARHRKH---------------GGYNG 215
S I+HRD+KP+N+++ L + G
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 216 FAADIWSFGVTMMELYMGYYPF-------------------------------------L 238
DIWS G M E+ F
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 239 EPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297
F L F + + + RD + L DP+KR + L HP++
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI-DPAKRISVDDALQHPYI 314
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (315), Expect = 8e-35
Identities = 34/265 (12%), Positives = 77/265 (29%), Gaps = 32/265 (12%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQ 119
+ + +G+G+ G +F+ + A+K P E + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 120 IFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDI 179
F + ++++ + ++ + S + ++Q+L + +H +++V+RDI
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 127
Query: 180 KPANVLINEKMEHPCGYSCLYESGEARHRK----------------------------HG 211
KP N LI + + G + + G
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 212 GYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS---SEK 268
D+ + G M G P+ + ++ L E E+
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 247
Query: 269 FRDFIRCCLQKGDPSKRWTASQLLS 293
F ++ L
Sbjct: 248 FYKYMHYARNL-AFDATPDYDYLQG 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (295), Expect = 2e-31
Identities = 61/319 (19%), Positives = 106/319 (33%), Gaps = 80/319 (25%)
Query: 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ-ELNILRQTNSPYIVK-- 116
++ LG G+ TV+ + A+K+++ D+ + E+ +L++ N K
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 117 -----------CHQIFTKPSGEVSILM--EYMDAGSLEIYVKSRGRLSEDIICTISRQVL 163
H P+G +++ + I + + IS+Q+L
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 164 KGLFYM-HSRNIVHRDIKPANVLINE-------------------KMEHPCGYSCLYESG 203
GL YM I+H DIKP NVL+ + S
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 204 EARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF-----LEPGQEPDFLSLMLAIC---- 254
+ G G ADIWS + EL G + F ++ D ++ ++ +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 255 ----------------------------------FREPPSLPECSSEKFRDFIRCCLQKG 280
E + +++ DF+ LQ
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL- 314
Query: 281 DPSKRWTASQLLSHPFLAD 299
DP KR A L++HP+L D
Sbjct: 315 DPRKRADAGGLVNHPWLKD 333
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-31
Identities = 45/290 (15%), Positives = 95/290 (32%), Gaps = 59/290 (20%)
Query: 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQC-DRGTPPNPQELNILRQTNSPYIVK 116
+ + +G+G G V++ + + A+K+ + + E+ I+
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 117 CHQIFTKPSG---EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-- 171
K +G ++ ++ +Y + GSL Y+ R ++ + + ++ GL ++H
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 172 ------RNIVHRDIKPANVLINEKME------------------------HPCGYSCLY- 200
I HRD+K N+L+ + H G
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 201 -ESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPF--LEPGQEPDFLSLMLAICFRE 257
E + + ADI++ G+ E+ E Q P + + E
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 258 ----------PPSLPEC-----SSEKFRDFIRCCLQKGDPSKRWTASQLL 292
P++P + +R C + + R TA ++
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA-NGAARLTALRIK 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 1e-13
Identities = 28/199 (14%), Positives = 57/199 (28%), Gaps = 45/199 (22%)
Query: 63 QVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQE-------------------- 102
+++G+G VF ++ +K + + +E
Sbjct: 6 KLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 103 LNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQV 162
L++ + K + ++LME +DA L + +
Sbjct: 65 FRALQKLQGLAVPKVYAWE-----GNAVLMELIDAKELYRVRVENPD-------EVLDMI 112
Query: 163 LKGLFYMHSRNIVHRDIKPANVLINEKM------------EHPCGYSCLYESGEARHRKH 210
L+ + + R IVH D+ NVL++E+ L
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 211 GGYNGFAADIWSFGVTMME 229
DI S +++
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 300 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.0 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-60 Score=394.87 Aligned_cols=233 Identities=27% Similarity=0.408 Sum_probs=199.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+++|++++.||+|+||.||+|+++.+++.||+|++.... ....+.+|+.++++++||||+++++++.++. ..|+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-EEEE
Confidence 578999999999999999999999999999999986422 2223467999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc----------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---------------- 194 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---------------- 194 (300)
|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 163 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEE
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccc
Confidence 9999999999999998889999999999999999999999999999999999999998765422
Q ss_pred -cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 195 -GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 195 -~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
.++..|.+||... +..++.++|||||||++|||+||+.||...+. ......+ ......+|..+++++++||
T Consensus 164 ~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i-~~~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 164 LCGTLDYLPPEMIE---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYKRI-SRVEFTFPDFVTEGARDLI 235 (263)
T ss_dssp TTEEGGGCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHH-HTTCCCCCTTSCHHHHHHH
T ss_pred cCCCCcccCHHHHc---CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----HHHHHHH-HcCCCCCCccCCHHHHHHH
Confidence 2345577777654 55678899999999999999999999965332 2222222 3455677888999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
.+||.. ||++|||++|+++||||.
T Consensus 236 ~~~L~~-dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 236 SRLLKH-NPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp HHHTCS-SGGGSCCHHHHHTCHHHH
T ss_pred HHHccC-CHhHCcCHHHHHcCcCcC
Confidence 999999 999999999999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=392.42 Aligned_cols=238 Identities=21% Similarity=0.284 Sum_probs=196.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++++.||+|+||.||+|+++.+++.||||++..... ...+.+|+.+|++++||||+++++++.+++ ..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-eeEEEE
Confidence 5689999999999999999999999999999999875432 234578999999999999999999998865 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---c--------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---G-------------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---~-------------- 195 (300)
|||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++ |
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99999999999988888999999999999999999999999999999999999987755322 1
Q ss_pred ----ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHH
Q 040812 196 ----YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRD 271 (300)
Q Consensus 196 ----~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (300)
++..|.+||.... ..+++.++|||||||++|||+||+.||.............. ........+..+++++.+
T Consensus 163 ~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp CCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--TTCTTSTTGGGSCHHHHH
T ss_pred cceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCCCccccCCHHHHH
Confidence 3445677776542 22356789999999999999999999976554433322221 112223334567999999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 272 FIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 272 li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||.+||+. ||++|||++|+++||||++
T Consensus 239 li~~~L~~-dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 239 LLHKILVE-NPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHSCS-STTTSCCHHHHTTCTTTTC
T ss_pred HHHHHcCC-ChhHCcCHHHHhcCHhhCc
Confidence 99999999 9999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-58 Score=390.65 Aligned_cols=236 Identities=28% Similarity=0.411 Sum_probs=195.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
.++|++++.||+|+||.||+|+++.+|+.||||+++...... .+.+|+.+|++++||||+++++++..++ ..|+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEEEE
Confidence 457999999999999999999999999999999987543322 3468999999999999999999998865 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-------------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------------- 194 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------------- 194 (300)
||+||+|.+++..+ .+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 98 y~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 99999999988764 6999999999999999999999999999999999999987755322
Q ss_pred cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 195 GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
.++..|.+||... +..++.++|||||||++|+|+||+.||.+.+.......... ........+..+++++++||.
T Consensus 177 ~gt~~Y~aPE~~~---~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 177 VGTPYWMAPEVVT---RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--NGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CSCGGGCCHHHHS---SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--HCSCCCSSGGGSCHHHHHHHH
T ss_pred ccCCCccChhhhc---CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCCCcccCCHHHHHHHH
Confidence 1344466666654 56678899999999999999999999965433221111111 112234456778999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 275 CCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 275 ~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+||.. ||++|||++|+++||||+.
T Consensus 252 ~~L~~-dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDM-DVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCS-STTTSCCHHHHTTCGGGGG
T ss_pred HHccC-ChhHCcCHHHHhcCHhhCC
Confidence 99999 9999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=389.39 Aligned_cols=239 Identities=31% Similarity=0.470 Sum_probs=199.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.-+.|++++.||+|+||.||+|+++.+++.||+|++..... ...+.+|+.+|++++|||||++++++.+++ ..|+||
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lvm 88 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILI 88 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-eEEEEE
Confidence 34569999999999999999999999999999999975432 245678999999999999999999998765 899999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---cc-------------
Q 040812 133 EYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP---CG------------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~---~~------------- 195 (300)
|||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++..+ +|
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999999999765 45699999999999999999999999999999999999999876542 22
Q ss_pred ---ceeeccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC--CCCCCCCChH
Q 040812 196 ---YSCLYESGEARHR--KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP--PSLPECSSEK 268 (300)
Q Consensus 196 ---~~~~~~~~~~~~~--~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 268 (300)
++..|.+||.... ..+..++.++|||||||++|||+||+.||.+.+..... ..+....+ ...+..++++
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL----LKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH----HHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCCCCCccccCCHH
Confidence 3445778876532 23456788999999999999999999999765543322 22233333 3345678999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 269 FRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 269 l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
+++||.+||+. ||++|||++|+++||||+.
T Consensus 245 ~~~li~~~L~~-dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 245 FKDFLKKCLEK-NVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHSCS-STTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHccC-ChhHCcCHHHHhcCcccCC
Confidence 99999999999 9999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=390.86 Aligned_cols=234 Identities=26% Similarity=0.424 Sum_probs=198.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
++|++++.||+|+||.||+|+++.+++.||||++.... ....+.+|+.+|++++||||+++++++.+++ .+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-EEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-EEEEE
Confidence 57999999999999999999999999999999986432 2223468999999999999999999998765 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-----------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC----------------- 194 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~----------------- 194 (300)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++..++
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999999999998889999999999999999999999999999999999999998755322
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.++..|.+||... +..++.++|||||||++|||+||+.||...+. ......+. .....+|..++++++
T Consensus 167 ~~~~~GT~~Y~APE~~~---~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~-~~~~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLT---EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKII-KLEYDFPEKFFPKAR 238 (288)
T ss_dssp ---CCCCGGGCCHHHHH---TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-TTCCCCCTTCCHHHH
T ss_pred cccccCCccccCceeec---cCCCCcccceehhhHHHHHHhhCCCCCCCcCH----HHHHHHHH-cCCCCCCccCCHHHH
Confidence 1344567777654 55678899999999999999999999975432 22333332 345677888999999
Q ss_pred HHHHHHhccCCCCCCCCHHH------HhcCCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQ------LLSHPFLADA 300 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~------~l~hpw~~~~ 300 (300)
+||.+||+. ||++|||++| +++||||+++
T Consensus 239 ~li~~~L~~-dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 239 DLVEKLLVL-DATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHHTTSCS-SGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHccC-CHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999 9999999988 5899999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=388.35 Aligned_cols=234 Identities=27% Similarity=0.429 Sum_probs=194.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC--------CCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP--------PNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
++|++++.||+|+||.||+|+++.+|+.||||+++...... .+.+|+.+|++++|||||++++++.++. ..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-DV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EE
Confidence 46999999999999999999999999999999997643322 1357999999999999999999998865 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-------Cc-------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-------PC------- 194 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-------~~------- 194 (300)
|+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.. ++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 9999999999999999988899999999999999999999999999999999999999866431 11
Q ss_pred --------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---CCCCCC
Q 040812 195 --------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE---PPSLPE 263 (300)
Q Consensus 195 --------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~ 263 (300)
.++..|.+||... +..++.++|||||||++|||+||+.||.+.+.. +.+..+.... +...+.
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~---~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHTTCCCCCHHHHT
T ss_pred CCccccccCCCCcccCHHHHc---CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----HHHHHHHhcCCCCCchhcC
Confidence 2244466666654 556788999999999999999999999754332 2222222221 222335
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+++.+++||.+||.. ||++|||++|+++||||++
T Consensus 242 ~~s~~~~~li~~~L~~-dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVK-DPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TSCHHHHHHHHTTSCS-SGGGSCCHHHHHHSTTTCC
T ss_pred CCCHHHHHHHHHHccC-ChhHCcCHHHHhcCcccCC
Confidence 6889999999999999 9999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-57 Score=387.78 Aligned_cols=237 Identities=27% Similarity=0.394 Sum_probs=192.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC---CCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG---TPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+.|++.+.||+|+||.||+|+++.+++.||||++..... ...+.+|+.+|++++||||+++++++.++. .+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-HLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS-EEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEEe
Confidence 459999999999999999999999999999999975432 234568999999999999999999998764 8999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC---CCCC---Cc-------------
Q 040812 134 YMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE---KMEH---PC------------- 194 (300)
Q Consensus 134 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~---~~~~---~~------------- 194 (300)
||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+.. ++.. ++
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 9999999999998889999999999999999999999999999999999999964 2222 12
Q ss_pred --cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 195 --GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 195 --~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
.++..|.+||... +..++.++|||||||++|||+||+.||.+.... .....+.......+...+..+++++++|
T Consensus 168 ~~~GT~~y~APE~~~---~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 168 TACGTPGYVAPEVLA---QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp -----CTTSCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred eeeeCccccCcHHHc---CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 2345577777654 556788999999999999999999999654322 1111121111122234456789999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||++|+++||||++
T Consensus 244 i~~~L~~-dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 244 IRHLMEK-DPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHSCS-SGGGSCCHHHHHHSTTTTS
T ss_pred HHHHccC-CHhHCcCHHHHhcCHhhCC
Confidence 9999999 9999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=381.55 Aligned_cols=234 Identities=26% Similarity=0.344 Sum_probs=191.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC-CCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP-SGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~l 130 (300)
.++|++++.||+|+||.||+|+++.+|+.||+|++......+ .+.+|+.+|++++||||+++++++.+. .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999999999999999987654332 235799999999999999999988643 346899
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhHhCC-----ccccCCCCCceeecCCCCCCc-------
Q 040812 131 LMEYMDAGSLEIYVKS----RGRLSEDIICTISRQVLKGLFYMHSRN-----IVHRDIKPANVLINEKMEHPC------- 194 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~-----i~H~Dlkp~Nill~~~~~~~~------- 194 (300)
|||||++|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++..++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 457999999999999999999999876 999999999999998765432
Q ss_pred ------------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC
Q 040812 195 ------------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 195 ------------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (300)
.++..|.+||... +..++.++|||||||++|||+||+.||...+. .+....+.....+..|
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~~~~~~i~~~~~~~~~ 235 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIP 235 (269)
T ss_dssp HC-----------CCCSCCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCCCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHc---CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 2345577777654 55688999999999999999999999965332 2344444555666778
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
..+++++.+||.+||+. ||++|||++|+++|||+
T Consensus 236 ~~~s~~l~~li~~~L~~-dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNL-KDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCS-SGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCC-ChhHCcCHHHHHhCCcC
Confidence 88999999999999999 99999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-58 Score=391.68 Aligned_cols=237 Identities=26% Similarity=0.386 Sum_probs=199.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
..|++++.||+|+||.||+|++..+++.||||++....... .+.+|+.+|++++|||||++++++.++. ..|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-EEEEE
Confidence 45999999999999999999999999999999987654322 2467999999999999999999998765 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---------------cc
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---------------GY 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---------------~~ 196 (300)
||||.+|+|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++..++ .+
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~G 173 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG 173 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCS
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCcccc
Confidence 999999999888888888999999999999999999999999999999999999997755322 23
Q ss_pred eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC-CCCCCCCChHHHHHHHH
Q 040812 197 SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP-PSLPECSSEKFRDFIRC 275 (300)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 275 (300)
+..|.+||.......+.++.++|||||||++|||+||+.||.+.... ..+..+..... ...+..+++++++||.+
T Consensus 174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 55688888765444456788999999999999999999999754332 33333333333 33455689999999999
Q ss_pred HhccCCCCCCCCHHHHhcCCCCCC
Q 040812 276 CLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 276 ~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
||+. ||++|||++|+++||||.+
T Consensus 250 ~L~~-dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 250 CLQK-IPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HTCS-SGGGSCCHHHHTTCHHHHS
T ss_pred HCcC-ChhHCcCHHHHHhCHHhcC
Confidence 9999 9999999999999999953
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=389.96 Aligned_cols=236 Identities=26% Similarity=0.441 Sum_probs=201.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++++.||+|+||.||+|+++.+++.||+|++++.. ......+|+.+|++++||||+++++++.+.. .+|
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~ 81 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-ccc
Confidence 4678999999999999999999999999999999997532 1223467999999999999999999999865 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--------------- 194 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~--------------- 194 (300)
+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999999999999999889999999999999999999999999999999999999998765322
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.++..|.+||... +..++.++|||||||++|||+||++||...+.. .....+ ......+|..++++++
T Consensus 162 ~~~~~GT~~Y~aPE~~~---~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~i-~~~~~~~p~~~s~~~~ 233 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELI-LMEEIRFPRTLSPEAK 233 (337)
T ss_dssp BCCCEECGGGCCGGGGS---SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH-HHCCCCCCTTSCHHHH
T ss_pred cccceeCHHHhhhhhcc---CCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----HHHHHH-hcCCCCCCccCCHHHH
Confidence 2345577777654 566889999999999999999999999764432 222222 2345677889999999
Q ss_pred HHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
+||.+||+. ||++|++ ++|+++||||+++
T Consensus 234 dli~~~L~~-dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 234 SLLAGLLKK-DPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCS-STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHhhccC-CchhhcccccccHHHHHcCcccccC
Confidence 999999999 9999994 8999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=392.81 Aligned_cols=239 Identities=38% Similarity=0.609 Sum_probs=197.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.++|++++.||+|+||.||+|+++.+|+.||+|+++...... .+.+|+.+|++++|||||++++++.++. .+|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 467999999999999999999999999999999997643321 2367999999999999999999998765 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCCCcc----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEHPCG---------------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~~~~---------------- 195 (300)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++..++.
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence 999999999999988889999999999999999999997 599999999999999987654322
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchH----------------------------
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDF---------------------------- 246 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~---------------------------- 246 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...+.....
T Consensus 164 ~GT~~Y~APEvl~---~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 164 VGTRSYMSPERLQ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp CCSSCCCCHHHHH---CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred cCCccccCchHHc---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 345577777665 567889999999999999999999999764432111
Q ss_pred ----------HHHHHHHhhCCCCCCCC-CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 247 ----------LSLMLAICFREPPSLPE-CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 247 ----------~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+.........++..+. ..+.++.+||.+||+. ||++|||++|+|+||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~-dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCS-STTTSCCHHHHHTSHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCC-ChhHCcCHHHHhhCHhhCc
Confidence 11111122223333333 3578999999999999 9999999999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-57 Score=385.79 Aligned_cols=235 Identities=23% Similarity=0.440 Sum_probs=200.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~l 130 (300)
+++|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+|+.+|++++||||+++++++.++. ..|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-EEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-eeee
Confidence 578999999999999999999999999999999987432 2223467999999999999999999998765 8999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc---------------
Q 040812 131 LMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG--------------- 195 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~--------------- 195 (300)
|||||+||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++..++.
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 161 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccccccc
Confidence 99999999999999998899999999999999999999999999999999999999987664322
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHH
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIR 274 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 274 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...+. ......+. .....+|..++++++++|.
T Consensus 162 ~Gt~~Y~APE~l~---~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~-~~~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 162 CGTPDYIAPEVVS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKIL-NAELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp CSCTTTCCHHHHT---TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHH-HCCCCCCTTSCHHHHHHHH
T ss_pred cCcccccCHHHHc---CCCCCchhhccccchhHHHHHhCCCCCCCcCH----HHHHHHHH-cCCCCCCCCCCHHHHHHHH
Confidence 344567777654 56678899999999999999999999965432 23333333 2345667789999999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 275 CCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 275 ~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
+||.. ||++|+ |++++++||||+++
T Consensus 234 ~~L~~-dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITR-DLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCS-CTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhh-CHHhccccchhhHHHHHcCcccccC
Confidence 99999 999996 89999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-56 Score=377.76 Aligned_cols=240 Identities=28% Similarity=0.422 Sum_probs=194.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC-----------CHHHHHHHHhcC-CCceeEeceeeeCC
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP-----------NPQELNILRQTN-SPYIVKCHQIFTKP 124 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~E~~~l~~l~-h~niv~~~~~~~~~ 124 (300)
++|++.+.||+|+||+||+|+++.+++.||||+++....... +.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 689999999999999999999999999999999986554322 357999999997 99999999999875
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------- 196 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------- 196 (300)
. .+|+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++++
T Consensus 83 ~-~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 T-FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp S-EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred c-ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 4 8999999999999999999888999999999999999999999999999999999999999876543222
Q ss_pred ----------eeeccccccccc---cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 197 ----------SCLYESGEARHR---KHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 197 ----------~~~~~~~~~~~~---~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
+..|.+||.... .....++.++||||+||++|||+||+.||...+..... ..+.......+.....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-RMIMSGNYQFGSPEWD 240 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTCCCCCTTTGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-HHHHhCCCCCCCcccc
Confidence 233444444321 11234577999999999999999999999765432211 1111111122233345
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+++++++||.+||+. ||++|||++|+++||||++
T Consensus 241 ~~s~~~~~li~~~L~~-~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVV-QPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCHHHHHHHHHHCCS-SGGGSCCHHHHTTSGGGCT
T ss_pred cCCHHHHHHHHHHccC-ChhHCcCHHHHHcCHHHHH
Confidence 7899999999999999 9999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=376.24 Aligned_cols=232 Identities=23% Similarity=0.381 Sum_probs=191.7
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC---CCcEEEE
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP---SGEVSIL 131 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~lv 131 (300)
|++.+.||+|+||+||+|.++.+++.||+|.+....... .+.+|+++|++++|||||++++++... .+.+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367788999999999999999999999999987654322 246799999999999999999998642 3368999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCC--ccccCCCCCceeecC-CCCCC---c-----------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRN--IVHRDIKPANVLINE-KMEHP---C----------- 194 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--i~H~Dlkp~Nill~~-~~~~~---~----------- 194 (300)
||||++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++..+ +
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~ 170 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc
Confidence 999999999999998888999999999999999999999998 999999999999974 43321 1
Q ss_pred ---cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC-CCCCCCCCCChHHH
Q 040812 195 ---GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR-EPPSLPECSSEKFR 270 (300)
Q Consensus 195 ---~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 270 (300)
.++..|.+||... + .++.++|||||||++|||+||+.||....... .+...+... .+..++...+++++
T Consensus 171 ~~~~GT~~Y~aPE~~~---~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMYE---E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp EESCSSCCCCCGGGGG---T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred CCcccCccccCHHHhC---C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH---HHHHHHHcCCCCcccCccCCHHHH
Confidence 2355678888653 2 47889999999999999999999996543322 223333323 23345667889999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSHPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~hpw~~ 298 (300)
++|.+||.. ||++|||++|+++||||+
T Consensus 244 ~li~~~l~~-dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQ-NKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCS-SGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccC-CHhHCcCHHHHhCCcccC
Confidence 999999999 999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-56 Score=390.41 Aligned_cols=238 Identities=30% Similarity=0.433 Sum_probs=193.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEe
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+++|++++.||+|+||.||+|+++.+|+.||||++...... ..+.+|+.+|++++|||||++++++.+++ .+|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-EMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-EEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEEE
Confidence 56899999999999999999999999999999998654321 22357999999999999999999998765 8999999
Q ss_pred ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC--CCC---Ccc------------
Q 040812 134 YMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK--MEH---PCG------------ 195 (300)
Q Consensus 134 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~--~~~---~~~------------ 195 (300)
||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.. ++|
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 9999999999954 4579999999999999999999999999999999999999653 222 222
Q ss_pred ---ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHH
Q 040812 196 ---YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDF 272 (300)
Q Consensus 196 ---~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...+.. .....+.......+......+++++++|
T Consensus 184 ~~~gT~~Y~aPEv~~---~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 184 VTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp EECSCTTTCCHHHHH---TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred eecCcccccCHHHHc---CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 244566666654 566788999999999999999999999654332 2222221111122233335689999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 273 IRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 273 i~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
|.+||.. ||++|||++|+++||||++
T Consensus 260 i~~~L~~-dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 260 IRKLLLA-DPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp HHHHCCS-SGGGSCCHHHHHHSTTTSC
T ss_pred HHHHccC-ChhHCcCHHHHhcCcccCC
Confidence 9999999 9999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-56 Score=389.58 Aligned_cols=237 Identities=27% Similarity=0.403 Sum_probs=192.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
++|++++.||+|+||.||+|+++.+|+.||||+++..... ..+.+|+.+|++++||||+++++++.++. .+|+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-EMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-EEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEEEc
Confidence 5699999999999999999999999999999998754322 12357999999999999999999998764 89999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC--CCCC---Ccc-------------
Q 040812 135 MDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE--KMEH---PCG------------- 195 (300)
Q Consensus 135 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~--~~~~---~~~------------- 195 (300)
|+||+|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++. ++.. ++|
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 99999998876544 6999999999999999999999999999999999999974 2322 222
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
++..|.+||... +..++.++|||||||++|||+||+.||.+.+.... ...+.......+...+..+++++++||
T Consensus 188 ~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 188 TTATAEFAAPEIVD---REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp ECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ccCcccccCHHHHc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 233355555543 56688999999999999999999999965433221 112221111223344567899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 274 RCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+||+. ||++|||++|+++||||++
T Consensus 264 ~~~L~~-dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 264 KNLLQK-EPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HTTSCS-SGGGSCCHHHHHTSTTTSS
T ss_pred HHHccC-ChhHCcCHHHHhcCHhhCC
Confidence 999999 9999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=383.32 Aligned_cols=234 Identities=24% Similarity=0.415 Sum_probs=196.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHH-hcCCCceeEeceeeeCCCCcEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILR-QTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~ 129 (300)
+++|++++.||+|+||+||+|+++.+++.||||+++.+. ......+|..++. .++||||+++++++.+.. .+|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLF 79 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-cee
Confidence 368999999999999999999999999999999997532 1112345666655 689999999999998865 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--------------- 194 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~--------------- 194 (300)
+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 99999999999999998889999999999999999999999999999999999999998755422
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.++..|.+||... +..++.++|||||||++|||+||+.||.+.+.. .....+. ...+.+|..++++++
T Consensus 160 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~-~~~~~~p~~~s~~~~ 231 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIR-MDNPFYPRWLEKEAK 231 (320)
T ss_dssp BCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH-HCCCCCCTTSCHHHH
T ss_pred ccccCCCCCcCCHHHHc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHH-cCCCCCCccCCHHHH
Confidence 2244466666554 566888999999999999999999999754332 2233332 345677888999999
Q ss_pred HHHHHHhccCCCCCCCCHH-HHhcCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTAS-QLLSHPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~-~~l~hpw~~~ 299 (300)
+||.+||+. ||++|||+. ++++||||++
T Consensus 232 dli~~~L~~-dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 232 DLLVKLFVR-EPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHHSCS-SGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHhccc-CCCCCcCHHHHHHhCchhcc
Confidence 999999999 999999996 8999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.8e-56 Score=387.34 Aligned_cols=239 Identities=25% Similarity=0.409 Sum_probs=198.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-----CCCCH---HHHHHHHhcCCCceeEeceeeeCCCCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-----TPPNP---QELNILRQTNSPYIVKCHQIFTKPSGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~ 127 (300)
+++|++++.||+|+||.||+|+++.+|+.||||++..... ...+. +|+.+++.++||||+++++++..+. .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~-~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-K 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC-E
Confidence 6789999999999999999999999999999999864321 11122 3467777889999999999998765 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc-------------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------- 194 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------- 194 (300)
+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 9999999999999999998889999999999999999999999999999999999999998765422
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
.++..|.+||.... +..++.++|||||||++|||+||+.||...... .... +...........+..++++++
T Consensus 162 ~~~~~GT~~y~APE~~~~--~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~-~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHE-IDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp CCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHHH-HHHHSSSCCCCCCSSSCHHHH
T ss_pred ccccccccccchhHHhhc--CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHhcccCCCCCCCCCCHHHH
Confidence 23455667776532 346788999999999999999999999765433 2222 223334556677888999999
Q ss_pred HHHHHHhccCCCCCCCC-----HHHHhcCCCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWT-----ASQLLSHPFLADA 300 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt-----~~~~l~hpw~~~~ 300 (300)
+||.+||+. ||++||| ++|+++||||+++
T Consensus 238 ~li~~~L~~-dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQR-DVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCS-STTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHccc-CHHHhCCCcccCHHHHHcCccccCC
Confidence 999999999 9999999 7999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-56 Score=385.88 Aligned_cols=236 Identities=27% Similarity=0.433 Sum_probs=200.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCC-----CCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDR-----GTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+|+.+|++++||||+++++++.... ..+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~ 117 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-ccc
Confidence 3678999999999999999999999999999999986432 1223468999999999999999999998765 899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc--------------
Q 040812 130 ILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG-------------- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~-------------- 195 (300)
+||||+.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++.
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~ 197 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence 999999999999999988899999999999999999999999999999999999999987654322
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
++..|.+||... +..++.++|||||||++|||+||+.||...+. ......+. ...+..|..+++++.+||
T Consensus 198 ~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~-~~~~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 198 LCGTPEALAPEIIL---SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIV-SGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp CEECGGGCCHHHHT---TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HCCCCCCTTCCHHHHHHH
T ss_pred ccCccccCCHHHHc---CCCCCccccccchhHHHHHHHhCCCCCCCcCH----HHHHHHHh-cCCCCCCccCCHHHHHHH
Confidence 344567777654 56678899999999999999999999965432 22333333 334566788999999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 274 RCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 274 ~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
.+||.. ||++|+ |++++++||||+++
T Consensus 270 ~~~L~~-dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 270 RNLLQV-DLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHSCS-CTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHhhh-CHHhccccccccHHHHHcCccccCC
Confidence 999999 999995 89999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-57 Score=387.18 Aligned_cols=234 Identities=24% Similarity=0.362 Sum_probs=191.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
.++|++++.||+|+||+||+|.++.+++.||+|+++...... .+.+|+.+|++++||||+++++++.++. .+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-ELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEEEec
Confidence 578999999999999999999999999999999997543221 2358999999999999999999998765 89999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC-----Cccc------------
Q 040812 135 MDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH-----PCGY------------ 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~-----~~~~------------ 196 (300)
|+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+... ++|.
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99999999998765 79999999999999999999999999999999999999865421 2222
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCC----CCCCChHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSL----PECSSEKF 269 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l 269 (300)
+..|.+||.. .+..++.++|||||||++|+|+||..||...+.. .....+... ...+ +..+++++
T Consensus 163 ~~~t~~y~ape~~---~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----~~~~~i~~~-~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 163 LFTAPEYYAPEVH---QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNA-EYTFDEEAFKEISIEA 234 (321)
T ss_dssp EESCGGGSCHHHH---TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHT-CCCCCHHHHTTSCHHH
T ss_pred cccccccccchhc---cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhC-CCCCChhhccCCCHHH
Confidence 2223333332 3556788999999999999999999999764432 222222222 2222 23678999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 270 RDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 270 ~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
++||.+||.. ||++|||++|+++||||++
T Consensus 235 ~~li~~~L~~-dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 235 MDFVDRLLVK-ERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHTTSCS-SGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHccC-ChhHCcCHHHHhcCHhhcc
Confidence 9999999999 9999999999999999963
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=371.47 Aligned_cols=241 Identities=27% Similarity=0.423 Sum_probs=185.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++|++++.||+|+||+||+|++..+++.||||+++...... .+.+|+++|++++||||+++++++.+.. .+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-KLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-ceeEE
Confidence 468999999999999999999999999999999997544322 2367999999999999999999998765 89999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc----------------
Q 040812 132 MEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---------------- 194 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---------------- 194 (300)
|||+.++.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 999977544433333 446999999999999999999999999999999999999987755322
Q ss_pred ---cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC-------------
Q 040812 195 ---GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP------------- 258 (300)
Q Consensus 195 ---~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------- 258 (300)
.++..|.+||.... ..+++.++|||||||++|+|+||+.||...+.......+.........
T Consensus 160 ~~~~gt~~y~apE~~~~--~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp TCCBCCCTTCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eeecccceeeehhhhcc--ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 23344555554332 335678999999999999999999999765433322222222111000
Q ss_pred CCC-----------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 259 PSL-----------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 259 ~~~-----------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
... ....++++++||.+||+. ||++|||++|+++||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~-dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY-DPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCS-STTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccC-ChhHCcCHHHHhCCHhhccC
Confidence 000 124568899999999999 99999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=376.03 Aligned_cols=236 Identities=23% Similarity=0.371 Sum_probs=185.2
Q ss_pred eeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-------CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 60 EKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-------PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
+.++.||+|+||+||+|+++.+|+.||||+++..... ..+.+|+.+|++++|||||++++++..+. .+|+||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-ceeehh
Confidence 3568899999999999999999999999998654321 22468999999999999999999998765 899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-----------------
Q 040812 133 EYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG----------------- 195 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~----------------- 195 (300)
|||.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++..+++
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 999998888777767789999999999999999999999999999999999999987554322
Q ss_pred --ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCC-------------
Q 040812 196 --YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPS------------- 260 (300)
Q Consensus 196 --~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------------- 260 (300)
++..|.+||... .+..++.++|||||||++|||+||.+||...........+...........
T Consensus 160 ~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 160 QVVTRWYRAPELLF--GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp SCCCCTTCCHHHHT--TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred eecChhhccHHHHc--cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 234456666543 234578899999999999999999999976543322222222111000000
Q ss_pred ----------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 261 ----------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 261 ----------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.....++++.+||.+||+. ||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~-dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLF-NPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCS-STTTSCCHHHHHTSGGGTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccC-ChhhCcCHHHHhCCHhhCC
Confidence 0124578999999999999 9999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=365.70 Aligned_cols=229 Identities=26% Similarity=0.413 Sum_probs=191.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC--------CCCHHHHHHHHhcC--CCceeEeceeeeCCCC
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT--------PPNPQELNILRQTN--SPYIVKCHQIFTKPSG 126 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 126 (300)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+|++++ ||||+++++++.++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~- 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence 5799999999999999999999999999999998754322 23468999999987 899999999998765
Q ss_pred cEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCC-CCC---Cc-------
Q 040812 127 EVSILMEYMDA-GSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEK-MEH---PC------- 194 (300)
Q Consensus 127 ~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~-~~~---~~------- 194 (300)
..|+||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.. ++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 89999999976 6888899888899999999999999999999999999999999999999854 222 12
Q ss_pred -------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 195 -------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 195 -------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
.++..|.+||.... ..+++.++|||||||++|||+||+.||.... .+. .....++..+++
T Consensus 163 ~~~~~~~~GT~~y~aPE~~~~--~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~-----~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 163 DTVYTDFDGTRVYSPPEWIRY--HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII-----RGQVFFRQRVSS 229 (273)
T ss_dssp SSCBCCCCSCGGGSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH-----HCCCCCSSCCCH
T ss_pred cccccccccCCCcCCHHHHcC--CCCCCcccccccceeeehhHhhCCCCCCCch------HHh-----hcccCCCCCCCH
Confidence 23455666665432 2345678999999999999999999995421 111 234556778999
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
++++||.+||.. ||++|||++|+++||||+++
T Consensus 230 ~~~~li~~~L~~-dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 230 ECQHLIRWCLAL-RPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHccC-CHhHCcCHHHHhcCHhhCCC
Confidence 999999999999 99999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-54 Score=366.49 Aligned_cols=239 Identities=23% Similarity=0.372 Sum_probs=190.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++|++++.||+|+||+||+|+++ +++.||||+++..... ..+.+|+.+|++++||||+++++++..+. ..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEE
Confidence 468999999999999999999986 6799999999764322 23468999999999999999999998765 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------------- 196 (300)
||++.++++..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++..++.+
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 99999988887777778899999999999999999999999999999999999999876643222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---------------
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE--------------- 257 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------------- 257 (300)
+..|.+||.... ...++.++|||||||++|||+||+.||...+.......+........
T Consensus 159 ~~~~~~~y~~pE~~~~--~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp ---CCCTTCCHHHHTT--CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred eecccchhhhHHHHhC--CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 223444444321 34568899999999999999999999975443322222222111000
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 258 ---------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 258 ---------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
........++.+++||.+||+. ||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~-dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKL-DPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS-STTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccC-ChhHCcCHHHHhcCcccCc
Confidence 0112345678999999999999 9999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-54 Score=364.99 Aligned_cols=235 Identities=20% Similarity=0.263 Sum_probs=194.8
Q ss_pred CccCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 51 QEIDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 51 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
.+....++|++.+.||+|+||.||+|.++.+++.||||+++.+... ..+.+|+.+|++++|||||++++++.++. ..|
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCC-eeE
Confidence 3444568899999999999999999999999999999998754432 23578999999999999999999998754 899
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 130 ILMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+++++
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999999754 46899999999999999999999999999999999999998765433322
Q ss_pred ----------eeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCCh
Q 040812 198 ----------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSE 267 (300)
Q Consensus 198 ----------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (300)
..|.+||... ++.++.++|||||||++|||+||..||....... .....+.....+..+..+++
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~---~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp SEEETTEEECGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHTTCCCCCCTTCCH
T ss_pred ceeeccccccccccChHHHc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---HHHHHHhcCCCCCCCccchH
Confidence 2344555443 4567889999999999999999877775544332 23333444566778888999
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 268 KFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 268 ~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.+||.+||+. ||++|||++++++
T Consensus 244 ~l~~li~~cl~~-dP~~Rps~~ei~~ 268 (287)
T d1opja_ 244 KVYELMRACWQW-NPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC-CHhHCcCHHHHHH
Confidence 999999999999 9999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=364.94 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=187.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccC-CeEEEEEEeecCCCC----CCCHHHHHHHHhc---CCCceeEeceeeeC----C
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQT-LALYALKVMQCDRGT----PPNPQELNILRQT---NSPYIVKCHQIFTK----P 124 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~----~~~~~E~~~l~~l---~h~niv~~~~~~~~----~ 124 (300)
++|++++.||+|+||+||+|++..+ ++.||||+++..... ....+|+.+|+.+ +||||+++++++.. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999654 778999998754322 2345788887766 79999999998852 2
Q ss_pred CCcEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---------
Q 040812 125 SGEVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC--------- 194 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~--------- 194 (300)
.+..+++|||++++++...... ...+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 2468999999998777655443 446999999999999999999999999999999999999987654322
Q ss_pred ---------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhC---------
Q 040812 195 ---------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFR--------- 256 (300)
Q Consensus 195 ---------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 256 (300)
.++..|.+||... +..++.++|||||||++|||+||+.||...+.......+.......
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~---~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred cccccCCCcccChhhcCcchhc---CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 2355677777654 5668899999999999999999999997654333222222211100
Q ss_pred -------------CCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 257 -------------EPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 257 -------------~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
....++...++.+++||.+||+. ||++|||++|+|+||||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~-dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF-NPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCS-STTTSCCHHHHHTSGGGTTC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcC-ChhHCcCHHHHhcChhhcCc
Confidence 00113445688999999999999 99999999999999999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=374.14 Aligned_cols=236 Identities=28% Similarity=0.438 Sum_probs=186.7
Q ss_pred CCcceeee-eecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhc-CCCceeEeceeeeC---CCCcEEE
Q 040812 56 LSQLEKLQ-VLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQT-NSPYIVKCHQIFTK---PSGEVSI 130 (300)
Q Consensus 56 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---~~~~~~l 130 (300)
+++|+++. .||+|+||.||+|++..+++.||||+++.. ....+|+.++.++ +||||++++++|.+ ....+|+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 46899875 599999999999999999999999998642 2346799987654 89999999999864 2346999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC---C---Cc--------
Q 040812 131 LMEYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME---H---PC-------- 194 (300)
Q Consensus 131 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~---~---~~-------- 194 (300)
|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+.. . ++
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccC
Confidence 99999999999999874 36999999999999999999999999999999999999986432 1 11
Q ss_pred -------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCC----C
Q 040812 195 -------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLP----E 263 (300)
Q Consensus 195 -------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~ 263 (300)
.++..|.+||... +..++.++|||||||++|+|+||+.||...............+ ......+| .
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~---~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 167 HNSLTTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-RMGQYEFPNPEWS 242 (335)
T ss_dssp CCCCCCCSCCCSSCCCCCCC---GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-CSCSSSCCTTHHH
T ss_pred CCccccccCCcccCCcHHHc---CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-hcCCCCCCCcccc
Confidence 2345566777654 5568889999999999999999999997654433222222211 12222222 3
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.+++++++||.+||+. ||++|||++|+++||||.+
T Consensus 243 ~~s~~~~~li~~~L~~-dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKT-EPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HSCHHHHHHHHHHSCS-STTTSCCHHHHHHSHHHHT
T ss_pred cCCHHHHHHHHHHccC-ChhHCcCHHHHHcCHHhhC
Confidence 5789999999999999 9999999999999999954
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=360.34 Aligned_cols=240 Identities=27% Similarity=0.437 Sum_probs=193.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCCCCcEEEE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKPSGEVSIL 131 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv 131 (300)
+++|++++.||+|+||+||+|++..+++.||||+++....... +.+|+.+|++++||||+++++++.... ..++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEE
Confidence 4689999999999999999999999999999999976554332 258999999999999999999998865 89999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcccee-------------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSC------------- 198 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~------------- 198 (300)
++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++..++++++
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 9999999999999888899999999999999999999999999999999999999877554332222
Q ss_pred ------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCC---------------
Q 040812 199 ------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFRE--------------- 257 (300)
Q Consensus 199 ------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------------- 257 (300)
.+.+||... ....++.++|||||||++|||++|+.||.......+....+.......
T Consensus 160 ~~~~~~~~~~pe~~~--~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 160 AEVVTLWYRPPDVLF--GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp SCCSCGGGCCHHHHT--TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred eeccccchhhhhHhc--cCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 122222221 123467899999999999999999999866544433333322221110
Q ss_pred ----------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 258 ----------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 258 ----------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
........++.+.+||.+||+. ||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~-dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKC-NPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS-SGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccC-ChhHCcCHHHHhcChhhcC
Confidence 1112334578899999999999 9999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=357.82 Aligned_cols=235 Identities=22% Similarity=0.337 Sum_probs=188.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
...++|++.+.||+|+||.||+|+++. .||||+++...... .+.+|+.+|++++|||||++++++.. +.+|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEE
Confidence 456789999999999999999998653 59999987554333 23579999999999999999998654 3689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc--------------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC-------------- 194 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~-------------- 194 (300)
+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999999754 56999999999999999999999999999999999999988755422
Q ss_pred -------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-hCCCCCCCCCCC
Q 040812 195 -------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-FREPPSLPECSS 266 (300)
Q Consensus 195 -------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 266 (300)
.++..|.+||.......+.++.++|||||||++|||+||+.||.+..........+.... .......+..++
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 234557888876544445678899999999999999999999976544333222222111 111123466789
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+++.++|.+||.. ||++|||+++++++
T Consensus 240 ~~l~~li~~cl~~-dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKK-KRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCC-CHhHCcCHHHHHHH
Confidence 9999999999999 99999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=362.44 Aligned_cols=243 Identities=29% Similarity=0.448 Sum_probs=197.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc---cCCeEEEEEEeecCC------CCCCCHHHHHHHHhcCC-CceeEeceeeeC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK---QTLALYALKVMQCDR------GTPPNPQELNILRQTNS-PYIVKCHQIFTK 123 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 123 (300)
.++++|++++.||+|+||+||+|++. .+|+.||||+++... ....+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 35789999999999999999999973 468999999985422 23345689999999977 799999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccceee----
Q 040812 124 PSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYSCL---- 199 (300)
Q Consensus 124 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~~~---- 199 (300)
.. ..++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+.+++.
T Consensus 101 ~~-~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 ET-KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TT-EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CC-ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 65 8999999999999999999888999999999999999999999999999999999999999887654333222
Q ss_pred ----------------ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 040812 200 ----------------YESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPE 263 (300)
Q Consensus 200 ----------------~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (300)
|.+||.... ....++.++|||||||+||||+||+.||...........+.... ....+..|.
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~-~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~ 257 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKSEPPYPQ 257 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTT-CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-HHCCCCCCT
T ss_pred cccccccccccccccccchhHHhhc-CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-ccCCCCCcc
Confidence 222222211 12245679999999999999999999998766555554444433 344566777
Q ss_pred CCChHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRW-----TASQLLSHPFLADA 300 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rp-----t~~~~l~hpw~~~~ 300 (300)
..++++.+||.+||.. ||++|| |++|+++||||+++
T Consensus 258 ~~s~~~~~li~~~l~~-dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMK-DPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp TSCHHHHHHHHHHTCS-SGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHccc-CHHHcCCCCcccHHHHHcCHhhcCC
Confidence 8999999999999999 999999 58999999999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-53 Score=360.31 Aligned_cols=233 Identities=23% Similarity=0.298 Sum_probs=187.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCC---CcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPS---GEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~ 128 (300)
++|++.+.||+|+||.||+|++..+++.||||+++...... .+.+|+.++++++||||+++++++.... ...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56999999999999999999999999999999997654432 2467999999999999999999986543 248
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCC---------------
Q 040812 129 SILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHP--------------- 193 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~--------------- 193 (300)
|+|||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 99999999999999999888999999999999999999999999999999999999998764421
Q ss_pred -------ccceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCC---CCCCC
Q 040812 194 -------CGYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREP---PSLPE 263 (300)
Q Consensus 194 -------~~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~ 263 (300)
..++..|.+||... +..+++++|||||||++|||+||+.||...+.. +.........+ .....
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ------------TTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCGGGTSS
T ss_pred cccccccccCcccccCHHHHc---CCCCCcceecccchHHHHHHHhCCCCCCCcCHH----HHHHHHHhcCCCCCchhcc
Confidence 12355677777654 567889999999999999999999999654332 22222222222 23346
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFL 297 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~ 297 (300)
.+++++.++|.+||.. ||++||+..+.+.|+|+
T Consensus 240 ~~s~~l~~li~~~L~~-dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAK-NPENRYQTAAEMRADLV 272 (277)
T ss_dssp SCCHHHHHHHHHHTCS-SGGGSCSSHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccC-CHhHCHhHHHHHHHHHH
Confidence 7899999999999999 99999954444446654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=361.80 Aligned_cols=233 Identities=23% Similarity=0.311 Sum_probs=190.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCe-----EEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLA-----LYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
.+.++|++.+.||+|+||.||+|++..+++ .||+|.+....... .+.+|+.+|.++ +|||||++++++.++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 356789999999999999999999876543 69999986543322 346799999998 899999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCC
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSR-----------------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKP 181 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~-----------------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp 181 (300)
. .+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 114 ~-~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 114 G-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp S-SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred C-eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 5 899999999999999999754 2488999999999999999999999999999999
Q ss_pred CceeecCCCCCCccc---------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 040812 182 ANVLINEKMEHPCGY---------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLE 239 (300)
Q Consensus 182 ~Nill~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 239 (300)
+|||++.++..++++ +..|.+||... ++.++.++|||||||++|||+| |+.||.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc---CCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999998776543222 33466666544 4567889999999999999998 8999977
Q ss_pred CCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 240 PGQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.........++ .....+..|..+++++++||.+||+. ||++|||++||++|
T Consensus 270 ~~~~~~~~~~~---~~~~~~~~p~~~~~~l~~li~~cl~~-dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLI---QNGFKMDQPFYATEEIYIIMQSCWAF-DSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHH---hcCCCCCCCCcCCHHHHHHHHHHcCC-ChhHCcCHHHHHHH
Confidence 65554443333 33556677888999999999999999 99999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=350.19 Aligned_cols=230 Identities=20% Similarity=0.302 Sum_probs=189.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
-++|++++.||+|+||.||+|++.+ ++.||||+++..... ..+.+|+.++++++||||+++++++..+. ..|+||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEEEe
Confidence 4679999999999999999999874 678999998754332 33578999999999999999999998764 89999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 135 MDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++..++++
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999999998754 4689999999999999999999999999999999999999876543322
Q ss_pred ---eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 ---SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 ---~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+..|.+||... +..++.++|||||||++|||+|+..|+...... .++...+.....+..|..+++++.++|
T Consensus 162 ~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 162 TKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp ---CTTSCCHHHHT---TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred eecCcccCChHHhc---CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 23356666544 556888999999999999999954444333222 234444555667777888999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 040812 274 RCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+||+. ||++|||++|+++|
T Consensus 236 ~~cl~~-~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 236 NHCWKE-RPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHccC-CHhHCcCHHHHHHH
Confidence 999999 99999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-52 Score=356.73 Aligned_cols=231 Identities=24% Similarity=0.358 Sum_probs=189.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCe---EEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLA---LYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||+||+|+++.+++ .||||.+...... ..+.+|+.+|++++|||||++++++..+. ..
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~ 102 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PV 102 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SC
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EE
Confidence 45789999999999999999999986654 6888987654332 23568999999999999999999997754 89
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccce----------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGYS---------- 197 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~~---------- 197 (300)
|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++..+++++
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999988864 46999999999999999999999999999999999999998866533322
Q ss_pred --------------eeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCC
Q 040812 198 --------------CLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLP 262 (300)
Q Consensus 198 --------------~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (300)
..|.+||... ++.++.++|||||||++|||+| |+.||.+... .+++..+.....+..+
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~~ 255 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQDYRLPPP 255 (299)
T ss_dssp -------------CGGGSCHHHHH---SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCCCCCC
T ss_pred CcceeeecccccCCccccCHHHHh---cCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 2355555543 5567889999999999999998 8999965432 2444445556667778
Q ss_pred CCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 263 ECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 263 ~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..+++.+.++|.+||.. ||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~-~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQK-DRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCS-STTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCC-CHhHCcCHHHHHHH
Confidence 88999999999999999 99999999888753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=355.91 Aligned_cols=225 Identities=25% Similarity=0.376 Sum_probs=184.4
Q ss_pred eeecCCcceEEEEEEEc--cCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 63 QVLGQGNGGTVFKVRHK--QTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 63 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
++||+|+||.||+|.+. .+++.||||+++...... .+.+|+.+|++++|||||++++++..+ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS--SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC--CEEEEEEcCC
Confidence 57999999999999864 456889999997544332 346799999999999999999998653 5799999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---c------------------
Q 040812 137 AGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---G------------------ 195 (300)
Q Consensus 137 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---~------------------ 195 (300)
+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++...+ |
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999998888999999999999999999999999999999999999987654322 1
Q ss_pred -ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 196 -YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
++..|.+||... +..++.++|||||||++|||+| |+.||.+... .++...+..+..+..|..+++++.+||
T Consensus 171 ~gt~~y~APE~l~---~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i~~~~~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 171 KWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMGCPAGCPREMYDLM 243 (277)
T ss_dssp CCCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred CCCceecCchhhc---CCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 233466666554 4457889999999999999998 8999975432 234444555677788889999999999
Q ss_pred HHHhccCCCCCCCCHHHH---hcCCCC
Q 040812 274 RCCLQKGDPSKRWTASQL---LSHPFL 297 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~---l~hpw~ 297 (300)
.+||.. ||++|||++++ |+|+|+
T Consensus 244 ~~cl~~-dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 244 NLCWTY-DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHTCS-STTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCC-CHhHCcCHHHHHHHhhCHHh
Confidence 999999 99999999998 466664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=358.82 Aligned_cols=242 Identities=25% Similarity=0.370 Sum_probs=186.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCC----CHHHHHHHHhcCCCceeEeceeeeCC-----
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPP----NPQELNILRQTNSPYIVKCHQIFTKP----- 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~----- 124 (300)
+..++|++++.||+|+||+||+|+++.+|+.||||++........ +.+|+.+|++++||||+++++++...
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 347899999999999999999999999999999999865543332 35899999999999999999987542
Q ss_pred --CCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------
Q 040812 125 --SGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------- 195 (300)
Q Consensus 125 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------- 195 (300)
.+.+|+|||||+++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++..+++
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 23689999999987777666666789999999999999999999999999999999999999887553222
Q ss_pred ----------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCC
Q 040812 196 ----------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPP 259 (300)
Q Consensus 196 ----------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (300)
++..|.+||.... ...+++++|||||||++|||+||+.||...... .....+.........
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP 243 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTT--CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred cccccccccccccceecCHHHhhHHHHcC--CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHHHhcCCCCh
Confidence 2344566665432 235788999999999999999999999654332 222222222222111
Q ss_pred CCCC----------------------------CCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 260 SLPE----------------------------CSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 260 ~~~~----------------------------~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
.... ..++++.+||.+||+. ||++|||++|+|+||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~-dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL-DPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS-STTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC-ChhHCcCHHHHHcChhhcc
Confidence 1111 1256788999999999 9999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=348.38 Aligned_cols=228 Identities=24% Similarity=0.321 Sum_probs=192.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEecc
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
++|++.++||+|+||.||+|+++ +++.||||+++..... ..+.+|+.++++++||||+++++++.++. .+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-SEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-ceEEEEEcc
Confidence 68899999999999999999986 6789999999865432 34578999999999999999999998754 899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc------------------
Q 040812 136 DAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY------------------ 196 (300)
Q Consensus 136 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~------------------ 196 (300)
++|+|.+++.. ...+++..+..++.||++||.|||++||+||||||+|||++.++..++++
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 99999999765 45689999999999999999999999999999999999999876543322
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+..|.+||... +..++.++|||||||++|||+| |+.||..... .+....+........|...++++.+||
T Consensus 162 ~~t~~y~aPE~~~---~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~~~~~i~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 162 KFPVRWSPPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred CCCCCcCCcHHhc---CCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HHHHHHHHhCCCCCCcccccHHHHHHH
Confidence 23355555544 4557889999999999999998 8999965432 234444555667778889999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 040812 274 RCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+||+. ||++|||++++++|
T Consensus 235 ~~cl~~-dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 235 YSCWHE-KADERPTFKILLSN 254 (258)
T ss_dssp HHTTCS-SGGGSCCHHHHHHH
T ss_pred HHHccC-CHhHCcCHHHHHHH
Confidence 999999 99999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=351.74 Aligned_cols=232 Identities=24% Similarity=0.357 Sum_probs=192.3
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
....++|++++.||+|+||.||+|+++ |..||||+++.+...+.+.+|+.++++++||||+++++++.++.+.+|+||
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 345778999999999999999999985 678999999876666667889999999999999999998865555789999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 133 EYMDAGSLEIYVKSRG--RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
||+++|+|.+++...+ .+++..++.++.||+.||.|||+.+|+||||||+|||++.++...++.
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 9999999999997543 489999999999999999999999999999999999999886643322
Q ss_pred --eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHHHHH
Q 040812 197 --SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFRDFI 273 (300)
Q Consensus 197 --~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (300)
+..|.+||... ++.++.++|||||||++|||+| |++||...... ++...+..+..+.++..+++++.++|
T Consensus 161 ~~~~~y~aPE~l~---~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 161 KLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEKGYKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCChHHHh---CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 23356666544 4567899999999999999998 68888654322 33344455677788889999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 040812 274 RCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 274 ~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.+||.. ||++|||+.+++++
T Consensus 234 ~~cl~~-dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 234 KNCWHL-DAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHccc-CHhHCcCHHHHHHH
Confidence 999999 99999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=355.00 Aligned_cols=235 Identities=22% Similarity=0.328 Sum_probs=191.6
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
.+.++|++.+.||+|+||.||+|.++ +++.||||+++..... +.+.+|+.+|++++|||||++++++.+ +..|+||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEE
Confidence 35678999999999999999999986 4678999999754332 235789999999999999999998754 3679999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 133 EYMDAGSLEIYVKSR--GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++..++++
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999999987543 3599999999999999999999999999999999999999876543322
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||... ++.++.++|||||||++|||+||..|+...... ......+.....+..|..+++++.
T Consensus 167 ~~~~~gt~~y~APE~~~---~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---~~~~~~i~~~~~~~~p~~~~~~l~ 240 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPDNCPEELY 240 (272)
T ss_dssp CTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccCCcccccChHHHh---CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCCCCCcccChHHHH
Confidence 22355555543 345788999999999999999976655443332 234444555667778889999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc--CCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS--HPFLA 298 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~--hpw~~ 298 (300)
+||.+||+. ||++|||++++++ |+||.
T Consensus 241 ~li~~cl~~-~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 241 QLMRLCWKE-RPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHTCS-SGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCC-CHhHCcCHHHHHHHhhhhhh
Confidence 999999999 9999999999998 77774
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=361.93 Aligned_cols=237 Identities=21% Similarity=0.319 Sum_probs=181.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCC-----CCcEEEEE
Q 040812 58 QLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKP-----SGEVSILM 132 (300)
Q Consensus 58 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~lv~ 132 (300)
+|+.+++||+|+||+||+|+++.+++.||||++..+. ....+|+.+|++++||||+++++++... ..++|+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6899999999999999999999999999999997654 2345899999999999999999988432 23589999
Q ss_pred eccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC-CC---Cccc---------
Q 040812 133 EYMDAGSLEIYV---KSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM-EH---PCGY--------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l---~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~-~~---~~~~--------- 196 (300)
|||+++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .. ++|.
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 999876444333 3455799999999999999999999999999999999999998764 32 2332
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----------C-CC
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF-----------R-EP 258 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~-~~ 258 (300)
+..|.+||... ....++.++|||||||++|||+||+.||...........+...... . ..
T Consensus 179 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIF--GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp CCSCCSCTTSCCHHHHT--TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccChHHhh--cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 22233333322 1345788999999999999999999999765433222222211000 0 00
Q ss_pred C------------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 259 P------------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 259 ~------------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
. ......++++.+||.+||+. ||++|||+.|+|+||||++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~-dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY-TPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccC-ChhHCcCHHHHhcCHhhcc
Confidence 0 11234688999999999999 9999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=355.30 Aligned_cols=233 Identities=22% Similarity=0.294 Sum_probs=189.1
Q ss_pred CCCcceeeee-ecCCcceEEEEEEEcc--CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQV-LGQGNGGTVFKVRHKQ--TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|.+.+. ||+|+||.||+|.++. ++..||||+++..... ..+.+|+.+|++++|||||++++++..+ ..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~ 83 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--AL 83 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--eE
Confidence 4467788884 9999999999998754 4568999998754322 2346799999999999999999998753 68
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 129 SILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
|+|||||++|+|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++..++++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999999865 45799999999999999999999999999999999999999876543222
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCC
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPEC 264 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (300)
+..|.+||... ++.++.++|||||||++|||+| |+.||.+... . ++...+..+..+..|..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~---~~~~~i~~~~~~~~p~~ 236 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-P---EVMAFIEQGKRMECPPE 236 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-H---HHHHHHHTTCCCCCCTT
T ss_pred cccccccccccCccccChHHHh---CCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-H---HHHHHHHcCCCCCCCCc
Confidence 22355555543 4457889999999999999998 9999976443 2 33444455667788889
Q ss_pred CChHHHHHHHHHhccCCCCCCCCHHHH---hcCCCC
Q 040812 265 SSEKFRDFIRCCLQKGDPSKRWTASQL---LSHPFL 297 (300)
Q Consensus 265 ~~~~l~~li~~~l~~~dp~~Rpt~~~~---l~hpw~ 297 (300)
+++++.++|.+||.. ||++|||+.++ |+|+|+
T Consensus 237 ~~~~l~~li~~cl~~-~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 237 CPPELYALMSDCWIY-KWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCHHHHHHHHHTTCS-SGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCC-CHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999 99999999888 566665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.4e-52 Score=358.99 Aligned_cols=240 Identities=22% Similarity=0.328 Sum_probs=188.0
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcC-CCceeEeceeeeCC-CCcEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTN-SPYIVKCHQIFTKP-SGEVSIL 131 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv 131 (300)
...++|+++++||+|+||+||+|+++.+++.||||+++... .....+|+.+|++++ ||||+++++++... ...+++|
T Consensus 32 ~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 35678999999999999999999999999999999986533 234568999999995 99999999998743 3469999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC-C---Cccc-----------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME-H---PCGY----------- 196 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~-~---~~~~----------- 196 (300)
||||++++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. . ++|.
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 9999999998764 46999999999999999999999999999999999999986542 2 2222
Q ss_pred ----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh-----------------
Q 040812 197 ----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF----------------- 255 (300)
Q Consensus 197 ----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------- 255 (300)
+..|.+||.... ...++.++||||+||++|||++|+.||............+.....
T Consensus 188 ~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 188 VRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp SCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccCccccCcccccC--CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 333455554332 234678999999999999999999999765443322221111100
Q ss_pred ----------------CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCCC
Q 040812 256 ----------------REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLADA 300 (300)
Q Consensus 256 ----------------~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~~ 300 (300)
.........+++++.|||.+||.. ||++|||++|+|+||||+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~-dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY-DHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGTTS
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccC-ChhHCcCHHHHhcCcccCCC
Confidence 001112234678899999999999 99999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=362.76 Aligned_cols=239 Identities=26% Similarity=0.344 Sum_probs=182.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCCC-----C
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKPS-----G 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 126 (300)
.++|++++.||+|+||+||+|.++.+|+.||||+++...... ...+|+.+|++++|||||++++++.... .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999997543322 2357999999999999999999987543 2
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc------------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC------------ 194 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~------------ 194 (300)
.+|+||||| +.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++..++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 479999999 5578777654 57999999999999999999999999999999999999998755422
Q ss_pred ----cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh----------------
Q 040812 195 ----GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC---------------- 254 (300)
Q Consensus 195 ----~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------- 254 (300)
.++..|.+||.... ...++.++||||+||++|+|++|+.||...+.............
T Consensus 175 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 175 MTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp CCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred cccccccccccCHHHHcC--CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 23445667766532 24567899999999999999999999976533222111111000
Q ss_pred -------h---CCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 -------F---REPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 -------~---~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
. ..........++++.+||.+||.. ||++|||++|+|+||||++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~-dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL-DAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS-STTTSCCHHHHHHSGGGTT
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcC-ChhHCcCHHHHhcChhhCc
Confidence 0 000112345688999999999999 9999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=348.21 Aligned_cols=236 Identities=22% Similarity=0.297 Sum_probs=193.9
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEE
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILM 132 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~ 132 (300)
...++|++.+.||+|+||.||+|+++.+ +.||||+++..... ..+.+|+.++++++|||||++++++.+ . ..|+||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~-~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-PIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-C-CeEEEE
Confidence 3468999999999999999999999865 57999999755433 245789999999999999999999854 3 689999
Q ss_pred eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc--------------
Q 040812 133 EYMDAGSLEIYVKS--RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY-------------- 196 (300)
Q Consensus 133 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~-------------- 196 (300)
|||++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++..++++
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999999988864 35699999999999999999999999999999999999999876543332
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||... ++.++.++|||||||++|||+||..||....... +.+..+.....+..+..++++++
T Consensus 171 ~~~~~gt~~y~aPE~~~---~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~l~ 244 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRMPCPPECPESLH 244 (285)
T ss_dssp -----CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTCCCCCCTTSCHHHH
T ss_pred eccccccccccChHHHh---CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCCCCcccCHHHH
Confidence 23355555543 4557889999999999999999766665544332 33333444556677888999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc--CCCCCC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLS--HPFLAD 299 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~--hpw~~~ 299 (300)
++|.+||+. ||++|||++++++ ++||..
T Consensus 245 ~li~~cl~~-dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 245 DLMCQCWRK-EPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHTCS-SGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHccc-CHhHCcCHHHHHHHHhhhhcC
Confidence 999999999 9999999999998 889864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=355.95 Aligned_cols=242 Identities=25% Similarity=0.360 Sum_probs=182.4
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCC----
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPS---- 125 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 125 (300)
++-.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|+.+|++++||||+++++++..+.
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 34446799999999999999999999999999999998654322 13457999999999999999999986542
Q ss_pred CcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc---c-------
Q 040812 126 GEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC---G------- 195 (300)
Q Consensus 126 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~---~------- 195 (300)
...|+| +|+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++..++ |
T Consensus 84 ~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 84 KDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 134555 556688999999764 7999999999999999999999999999999999999987755322 1
Q ss_pred ------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH----------
Q 040812 196 ------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAI---------- 253 (300)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---------- 253 (300)
++..|.+||.... +..++.++||||+||++|||+||+.||................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTT--BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCccceeeccccccceechHHHhhc--CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 2334566665432 3456789999999999999999999996543221111111100
Q ss_pred ---------hhCCCC-------CCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 254 ---------CFREPP-------SLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 254 ---------~~~~~~-------~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....+. ......++++++||.+||+. ||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~-dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF-NPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCS-STTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccC-ChhHCcCHHHHhcCHhhcc
Confidence 000000 11235678899999999999 9999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=358.40 Aligned_cols=240 Identities=25% Similarity=0.308 Sum_probs=186.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC----CCc
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP----SGE 127 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~ 127 (300)
.++|++++.||+|+||+||+|++..+|+.||||+++...... ...+|+.+|++++||||+++++++... .+.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999999999999999987543321 235799999999999999999998532 123
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 128 VSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 128 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
.+++|+|+.+|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++...+..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~ 175 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCccc
Confidence 4566777789999999864 4799999999999999999999999999999999999999876543332
Q ss_pred -----eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhh----------------
Q 040812 197 -----SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICF---------------- 255 (300)
Q Consensus 197 -----~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------- 255 (300)
+..|.+||... ....++.++|||||||++|+|++|+.||...+.......+......
T Consensus 176 ~~~~g~~~y~apE~~~--~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 176 TGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp SSSCHHHHTSCHHHHT--TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccCchhhc--CCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 22344444432 1335678999999999999999999999754432222222111100
Q ss_pred --CCCCC--------CCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 256 --REPPS--------LPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 256 --~~~~~--------~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
..... .....++++++||.+||.. ||++|||++|+|+||||++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~-dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL-DSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCS-SGGGSCCHHHHHTSGGGTT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcC-ChhhCcCHHHHhcCHhhCC
Confidence 00000 1134688999999999999 9999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=343.70 Aligned_cols=230 Identities=25% Similarity=0.311 Sum_probs=188.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
..++|++.+.||+|+||.||+|.+..+ +..||||.++..... ..+.+|+.+|++++||||+++++++.+ +..
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 82 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV 82 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeE
Confidence 457899999999999999999998654 456889887543322 234679999999999999999999864 378
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 129 SILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++..++++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999998765 44699999999999999999999999999999999999999875543322
Q ss_pred ---------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 197 ---------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 197 ---------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
+..|.+||... ++.++.++|||||||++|||+| |.+||...... +....+..+..+..|..++
T Consensus 163 ~~~~~~~~gt~~y~apE~l~---~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~~i~~~~~~~~~~~~~ 235 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPMPPNCP 235 (273)
T ss_dssp --------CCGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHTTCCCCCCTTCC
T ss_pred ceeccceecCcccchhhHhc---cCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCC
Confidence 33455555544 4567889999999999999998 89999765433 2333344566677888999
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+++.+||.+||.. ||++|||++|+++|
T Consensus 236 ~~~~~li~~cl~~-dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAY-DPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCC-CHhHCcCHHHHHHH
Confidence 9999999999999 99999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=357.63 Aligned_cols=237 Identities=23% Similarity=0.311 Sum_probs=182.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCC----CCHHHHHHHHhcCCCceeEeceeeeCC-----CC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTP----PNPQELNILRQTNSPYIVKCHQIFTKP-----SG 126 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 126 (300)
+++|+++++||+|+||+||+|+++.+|+.||||+++...... ...+|+.++++++||||+++++++... .+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999999999999999997654332 235799999999999999999998643 24
Q ss_pred cEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-----------
Q 040812 127 EVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG----------- 195 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~----------- 195 (300)
.+|+|||||.++.+ +.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++...+.
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHH-Hhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 79999999977544 4443 468999999999999999999999999999999999999987553222
Q ss_pred -------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh--------------
Q 040812 196 -------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAIC-------------- 254 (300)
Q Consensus 196 -------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------------- 254 (300)
++..|.+||... +..+++++||||+||++|+|++|+.||...+.......++....
T Consensus 173 ~~~~~~~~t~~y~aPE~l~---~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp --------CCTTCCHHHHT---TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cccccccccccccChhhhc---CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 234566666654 56788899999999999999999999975432222111111110
Q ss_pred ----hCCCCCC-------------------CCCCChHHHHHHHHHhccCCCCCCCCHHHHhcCCCCCC
Q 040812 255 ----FREPPSL-------------------PECSSEKFRDFIRCCLQKGDPSKRWTASQLLSHPFLAD 299 (300)
Q Consensus 255 ----~~~~~~~-------------------~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~hpw~~~ 299 (300)
....... +...++++.+||.+||.. ||++|||++|+|+||||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~-dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI-DPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS-STTTSCCHHHHHTSTTTGG
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcC-ChhHCcCHHHHhcCcccCC
Confidence 0100000 011256789999999999 9999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=339.25 Aligned_cols=230 Identities=23% Similarity=0.300 Sum_probs=188.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC----eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcE
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTL----ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 128 (300)
.+.|++.+.||+|+||.||+|.++.++ ..||||.++..... ..+.+|+.++++++|||||++++++.... ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-PM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-ce
Confidence 467899999999999999999987654 47999998654322 13468999999999999999999988754 89
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------
Q 040812 129 SILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------- 196 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------- 196 (300)
++|||||.++++.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++..++++
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999999999888754 5799999999999999999999999999999999999999876543322
Q ss_pred -----------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCC
Q 040812 197 -----------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECS 265 (300)
Q Consensus 197 -----------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (300)
+..|.+||... ++.++.++|||||||++|||+||..|+...... .++...+..+..+..+..+
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRLPTPMDC 238 (283)
T ss_dssp ---------CCCGGGSCHHHHH---SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCTTC
T ss_pred ccceEeccCCCCccccCHHHHc---cCCCCCcccccccHHHHHHHHhCCCCccccCCH---HHHHHHHhccCCCCCchhh
Confidence 23466666554 556788999999999999999976666543332 2344445556677788889
Q ss_pred ChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 266 SEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 266 ~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
++.+.++|.+||.. ||++|||+.|+++
T Consensus 239 ~~~l~~li~~cl~~-~p~~RPt~~eil~ 265 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQ-ERARRPKFADIVS 265 (283)
T ss_dssp BHHHHHHHHHHTCS-STTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCcC-CHhHCcCHHHHHH
Confidence 99999999999999 9999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=344.04 Aligned_cols=228 Identities=21% Similarity=0.308 Sum_probs=184.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCe----EEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCCCCcEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLA----LYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 129 (300)
++|++++.||+|+||.||+|.+..+|+ .||+|.++...... .+.+|+.++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cee
Confidence 579999999999999999999987776 57888776433222 346899999999999999999998763 678
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCcc-------------
Q 040812 130 ILMEYMDAGSLEIYVKSR-GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCG------------- 195 (300)
Q Consensus 130 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~------------- 195 (300)
++|||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+++
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999999888764 579999999999999999999999999999999999999987544222
Q ss_pred --------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCC
Q 040812 196 --------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAICFREPPSLPECSS 266 (300)
Q Consensus 196 --------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (300)
++..|.+||... ++.++.++|||||||++|||+| |.+||...... . +...+..+..+..|..++
T Consensus 167 ~~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~---~~~~i~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E---ISSILEKGERLPQPPICT 239 (317)
T ss_dssp --------CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-G---HHHHHHHTCCCCCCTTBC
T ss_pred cccccccccCccccChHHHh---cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-H---HHHHHHcCCCCCCCcccC
Confidence 234566666554 4567889999999999999999 78888654332 2 223334456677788899
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 267 EKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 267 ~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
+.+.++|.+||.. ||++|||+.|+++|
T Consensus 240 ~~~~~li~~cl~~-dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 240 IDVYMIMVKCWMI-DADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCC-ChhhCcCHHHHHHH
Confidence 9999999999999 99999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=342.32 Aligned_cols=231 Identities=21% Similarity=0.308 Sum_probs=189.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCeE--EEEEEeecCC---CCCCCHHHHHHHHhc-CCCceeEeceeeeCCCCcE
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQTLAL--YALKVMQCDR---GTPPNPQELNILRQT-NSPYIVKCHQIFTKPSGEV 128 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 128 (300)
++++|++.+.||+|+||.||+|.++.++.. ||||.++... ....+.+|+.+|.++ +||||+++++++.+.+ ..
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-~~ 86 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YL 86 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-EE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-ee
Confidence 568899999999999999999999988764 6777765432 223457899999998 7999999999998754 89
Q ss_pred EEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCC
Q 040812 129 SILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEH 192 (300)
Q Consensus 129 ~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~ 192 (300)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++..
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999999753 468999999999999999999999999999999999999887554
Q ss_pred Cccc------------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCchHHHHHHHH
Q 040812 193 PCGY------------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYY-PFLEPGQEPDFLSLMLAI 253 (300)
Q Consensus 193 ~~~~------------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~-pf~~~~~~~~~~~~~~~~ 253 (300)
++++ +..|.+||... ++.++.++|||||||++|||+||.. ||... ....+...+
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSfGvil~ell~~~~~p~~~~----~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHG
T ss_pred EEccccccccccccccccceecCCcccchHHhc---cCCCCccceeehhHHHHHHHHhcCCCCCCCC----CHHHHHHHH
Confidence 3322 33355555543 4557889999999999999999765 56432 233445555
Q ss_pred hhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 254 CFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
..+..+..+..+++++++||.+||.. ||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~-dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGYRLEKPLNCDDEVYDLMRQCWRE-KPYERPSFAQILVS 279 (309)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HhcCCCCCCccCCHHHHHHHHHHcCC-ChhHCcCHHHHHHH
Confidence 56677788888999999999999999 99999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=342.20 Aligned_cols=234 Identities=24% Similarity=0.348 Sum_probs=185.7
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
.+.++|++.+.||+|+||.||+|.+.. +++.||||+++...... .+.+|...+.++ +|+||+.+++++..+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999999764 45789999986433221 234577777776 688999999988766
Q ss_pred CCcEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecC
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINE 188 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~ 188 (300)
.+.+++|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 66799999999999999999753 24889999999999999999999999999999999999997
Q ss_pred CCCCCcc---------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCchH
Q 040812 189 KMEHPCG---------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMG-YYPFLEPGQEPDF 246 (300)
Q Consensus 189 ~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~ 246 (300)
++..+++ ++..|.+||... ++.++.++|||||||++|||+|| .+||.........
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 7554322 334466666554 45678899999999999999997 5677655444333
Q ss_pred HHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 247 LSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.. .+..+..+..|..+++++.++|.+||.. ||++|||++|+++|
T Consensus 247 ~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~-dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CR---RLKEGTRMRAPDYTTPEMYQTMLDCWHG-EPSQRPTFSELVEH 290 (299)
T ss_dssp HH---HHHHTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HH---HHhcCCCCCCCccCCHHHHHHHHHHcCC-ChhHCcCHHHHHHH
Confidence 33 3344566778888999999999999999 99999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=340.26 Aligned_cols=232 Identities=23% Similarity=0.324 Sum_probs=184.2
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEccCC-------eEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceee
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQTL-------ALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIF 121 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~ 121 (300)
..+.++|++.+.||+|+||.||+|+...++ ..||||+++.+.... .+.+|...+.++ +|||||++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 345689999999999999999999976544 479999987644322 235688888887 799999999999
Q ss_pred eCCCCcEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCcee
Q 040812 122 TKPSGEVSILMEYMDAGSLEIYVKSR----------------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVL 185 (300)
Q Consensus 122 ~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nil 185 (300)
.++. .+++|||||++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 89 ~~~~-~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 89 TQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp CSSS-SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ccCC-eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 8754 899999999999999999754 24899999999999999999999999999999999999
Q ss_pred ecCCCCCCcc---------------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040812 186 INEKMEHPCG---------------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQE 243 (300)
Q Consensus 186 l~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 243 (300)
++.++..+++ ++..|.+||... ++.++.++|||||||++|||+| |.+||.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~---~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc---CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 9887653222 233355555543 4568899999999999999998 6888854332
Q ss_pred chHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 244 PDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
..+...+..+..+..|..+++++.+||.+||+. ||++|||+.|+++
T Consensus 244 ---~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~-dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 ---EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHA-VPSQRPTFKQLVE 289 (299)
T ss_dssp ---HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred ---HHHHHHHHcCCCCCCCccchHHHHHHHHHHccC-CHhHCcCHHHHHH
Confidence 233444455677788889999999999999999 9999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=338.81 Aligned_cols=230 Identities=23% Similarity=0.362 Sum_probs=188.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
+.++|++++.||+|+||.||+|+++. +++.||||+++..... ..+.+|+.+|++++||||+++++++....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK- 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC-
Confidence 56789999999999999999999863 5689999998754322 23578999999999999999999998754
Q ss_pred cEEEEEeccCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCC
Q 040812 127 EVSILMEYMDAGSLEIYVKSRG------------------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPA 182 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~ 182 (300)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 8999999999999999996532 3789999999999999999999999999999999
Q ss_pred ceeecCCCCCCcccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCC
Q 040812 183 NVLINEKMEHPCGYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGY-YPFLEP 240 (300)
Q Consensus 183 Nill~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~ 240 (300)
|||++.++..++++++ .|.+||... +..++.++|||||||++|||+||. +||...
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc---cCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999987665433322 344554443 456788999999999999999996 566543
Q ss_pred CCCchHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 241 GQEPDFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.. .++...+..+..+..|..+++++.++|.+||.. ||++|||+.|+++
T Consensus 247 ~~----~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~-~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 247 AH----EEVIYYVRDGNILACPENCPLELYNLMRLCWSK-LPADRPSFCSIHR 294 (301)
T ss_dssp CH----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred CH----HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCC-ChhHCcCHHHHHH
Confidence 22 234444555666778888999999999999999 9999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=335.28 Aligned_cols=229 Identities=22% Similarity=0.325 Sum_probs=176.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC---CeEEEEEEeecCCCCC-----CCHHHHHHHHhcCCCceeEeceeeeCCCC
Q 040812 55 GLSQLEKLQVLGQGNGGTVFKVRHKQT---LALYALKVMQCDRGTP-----PNPQELNILRQTNSPYIVKCHQIFTKPSG 126 (300)
Q Consensus 55 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 126 (300)
+.++|++++.||+|+||.||+|+...+ ...||||+++.+.... .+.+|+.+|++++||||+++++++.++
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-- 83 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-- 83 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--
Confidence 457899999999999999999987533 3478999987654322 346799999999999999999999653
Q ss_pred cEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc---------
Q 040812 127 EVSILMEYMDAGSLEIYVKS-RGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY--------- 196 (300)
Q Consensus 127 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~--------- 196 (300)
..++|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++..++++
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999988765 44699999999999999999999999999999999999999876543222
Q ss_pred -------------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH-hhCCCCCC
Q 040812 197 -------------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEPDFLSLMLAI-CFREPPSL 261 (300)
Q Consensus 197 -------------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 261 (300)
+..|.+||... +..++.++|||||||++|||+| |+.||...+.. +....+ .....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGERLPR 236 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHH---HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTSCCCCCC
T ss_pred CCCcceecCccccCcccCCHHHHh---CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHHHhCCCCCCC
Confidence 22345555443 4567889999999999999998 89999654332 233332 23345566
Q ss_pred CCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 262 PECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 262 ~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
+..+++.+.++|.+||.. ||++|||++++++
T Consensus 237 ~~~~~~~l~~li~~cl~~-dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 237 PEDCPQDIYNVMVQCWAH-KPEDRPTFVALRD 267 (273)
T ss_dssp CTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred cccccHHHHHHHHHHcCC-ChhHCcCHHHHHH
Confidence 788999999999999999 9999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=335.70 Aligned_cols=232 Identities=23% Similarity=0.323 Sum_probs=187.1
Q ss_pred CCCCcceeeeeecCCcceEEEEEEEc-----cCCeEEEEEEeecCCCCC---CCHHHHHHHHhc-CCCceeEeceeeeCC
Q 040812 54 DGLSQLEKLQVLGQGNGGTVFKVRHK-----QTLALYALKVMQCDRGTP---PNPQELNILRQT-NSPYIVKCHQIFTKP 124 (300)
Q Consensus 54 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~h~niv~~~~~~~~~ 124 (300)
...++|++.+.||+|+||.||+|++. .+++.||||+++...... .+.+|+.+++++ +|||||++++++...
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 35579999999999999999999864 467899999997544221 246799999998 699999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceee
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSRG------------------RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLI 186 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill 186 (300)
. ..|+|||||++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 100 ~-~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 100 G-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp S-SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C-EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 5 7999999999999999997532 58999999999999999999999999999999999999
Q ss_pred cCCCCCCc---------------------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040812 187 NEKMEHPC---------------------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYM-GYYPFLEPGQEP 244 (300)
Q Consensus 187 ~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 244 (300)
+.++..++ .++..|.+||... ++.++.++|||||||++|||+| |.+||.......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc---CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 87654322 2233455555543 4567889999999999999999 555554444433
Q ss_pred hHHHHHHHHhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc
Q 040812 245 DFLSLMLAICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS 293 (300)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~ 293 (300)
.....+ ..+..+..+...++.+.+||.+||+. ||++|||++++++
T Consensus 256 ~~~~~i---~~~~~~~~~~~~~~~l~~Li~~cl~~-dP~~RPs~~~il~ 300 (311)
T d1t46a_ 256 KFYKMI---KEGFRMLSPEHAPAEMYDIMKTCWDA-DPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHH---HHTCCCCCCTTSCHHHHHHHHHHTCS-SGGGSCCHHHHHH
T ss_pred HHHHHH---hcCCCCCCcccccHHHHHHHHHHcCC-ChhHCcCHHHHHH
Confidence 333333 34566777788999999999999999 9999999999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=335.20 Aligned_cols=237 Identities=20% Similarity=0.309 Sum_probs=191.4
Q ss_pred cCCCCcceeeeeecCCcceEEEEEEEcc-----CCeEEEEEEeecCCCCC---CCHHHHHHHHhcCCCceeEeceeeeCC
Q 040812 53 IDGLSQLEKLQVLGQGNGGTVFKVRHKQ-----TLALYALKVMQCDRGTP---PNPQELNILRQTNSPYIVKCHQIFTKP 124 (300)
Q Consensus 53 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~ 124 (300)
....++|++.+.||+|+||.||+|.++. ++..||||+++...... .+.+|+.++++++||||+++++++..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3446899999999999999999999863 35789999987543222 246899999999999999999998765
Q ss_pred CCcEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCc
Q 040812 125 SGEVSILMEYMDAGSLEIYVKSR----------GRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPC 194 (300)
Q Consensus 125 ~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~ 194 (300)
. ..++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++..++
T Consensus 96 ~-~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 96 Q-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred C-ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 4 899999999999999998642 24688999999999999999999999999999999999998876543
Q ss_pred ccee---------------------eccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCchHHHHHHH
Q 040812 195 GYSC---------------------LYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGY-YPFLEPGQEPDFLSLMLA 252 (300)
Q Consensus 195 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~ 252 (300)
++++ .|.+||... ++.++.++|||||||++|||+||. +||..... .+....
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~---~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----~~~~~~ 247 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRF 247 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHc---cCCCCcccccccHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 3322 234443332 456778999999999999999985 66744322 233444
Q ss_pred HhhCCCCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhc------CCCCC
Q 040812 253 ICFREPPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLS------HPFLA 298 (300)
Q Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~------hpw~~ 298 (300)
+.....+..|..+++.+.++|.+||+. ||++|||++++++ +|+|+
T Consensus 248 i~~~~~~~~p~~~~~~l~~li~~cl~~-~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 248 VMEGGLLDKPDNCPDMLFELMRMCWQY-NPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCS-SGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHhCCCCCCcccchHHHHHHHHHHcCC-ChhHCcCHHHHHHHHHHhcCCCCc
Confidence 455666777888999999999999999 9999999999997 77765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=332.38 Aligned_cols=227 Identities=20% Similarity=0.280 Sum_probs=181.0
Q ss_pred eeeeecCCcceEEEEEEEccCC---eEEEEEEeecCCCC---CCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEec
Q 040812 61 KLQVLGQGNGGTVFKVRHKQTL---ALYALKVMQCDRGT---PPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEY 134 (300)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~ 134 (300)
..++||+|+||+||+|.+..++ ..||||.++..... ..+.+|+.+|++++||||+++++++....+..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3578999999999999986543 36899998643222 23578999999999999999999977655689999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCCCCccc-----------------
Q 040812 135 MDAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKMEHPCGY----------------- 196 (300)
Q Consensus 135 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~~~~~~----------------- 196 (300)
|++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||+++++..++++
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 99999999988543 578889999999999999999999999999999999999876543332
Q ss_pred ------eeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhhCCCCCCCCCCChHHH
Q 040812 197 ------SCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLMLAICFREPPSLPECSSEKFR 270 (300)
Q Consensus 197 ------~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (300)
+..|.+||... ++.++.++|||||||++|||+||..||.......+. ...+..+..+..|..+++.+.
T Consensus 191 ~~~~~gt~~y~aPE~~~---~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp TTCSSCCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C---HHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccChHHHh---cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcCCCCCCcccCcHHHH
Confidence 23345555433 445788999999999999999988888654433332 233344566777888999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 040812 271 DFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 271 ~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
++|.+||.. ||++|||+.|+++|
T Consensus 265 ~li~~cl~~-dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHP-KAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHcCC-CHhHCcCHHHHHHH
Confidence 999999999 99999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-48 Score=328.16 Aligned_cols=236 Identities=18% Similarity=0.201 Sum_probs=180.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCceeEeceeeeCCCCcEEEEEeccC
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPYIVKCHQIFTKPSGEVSILMEYMD 136 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~ 136 (300)
++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.++++++|+|++..+..+....+..++||||+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 47999999999999999999999999999999988776666778899999999988766655554444558999999995
Q ss_pred CCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC------CCcc--------------
Q 040812 137 AGSLEIYVK-SRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME------HPCG-------------- 195 (300)
Q Consensus 137 ~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~------~~~~-------------- 195 (300)
+ +|...+. ....+++..+..++.|++.||.|||++||+||||||+|||++..+. .++|
T Consensus 87 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (299)
T d1ckia_ 87 P-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165 (299)
T ss_dssp C-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred C-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence 5 6665554 4567999999999999999999999999999999999999864321 1222
Q ss_pred ---------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHH---HHhhCCCCCCCC
Q 040812 196 ---------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSLML---AICFREPPSLPE 263 (300)
Q Consensus 196 ---------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~ 263 (300)
++..|.+||... +..++.++|||||||++|||+||+.||.............. .......+....
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 166 PYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp CCCBCCSCCCCSSSCCHHHHT---TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred eccccCCcCCCccccCHHHHh---CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence 234455665543 55688999999999999999999999976544333222211 111122233456
Q ss_pred CCChHHHHHHHHHhccCCCCCCCCHHH---HhcCCCC
Q 040812 264 CSSEKFRDFIRCCLQKGDPSKRWTASQ---LLSHPFL 297 (300)
Q Consensus 264 ~~~~~l~~li~~~l~~~dp~~Rpt~~~---~l~hpw~ 297 (300)
.+++++.++|..||.. ||++||++++ +|+|+|.
T Consensus 243 ~~p~~~~~li~~cl~~-~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 243 GYPSEFATYLNFCRSL-RFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TSCHHHHHHHHHHHHS-CTTCCCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccC-ChhHCcCHHHHHHHHHHHHH
Confidence 7889999999999999 9999999875 4566553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-45 Score=312.68 Aligned_cols=230 Identities=17% Similarity=0.158 Sum_probs=184.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC-CceeEeceeeeCCCCcEEEEEecc
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS-PYIVKCHQIFTKPSGEVSILMEYM 135 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~ 135 (300)
++|++.+.||+|+||.||+|++..+++.||||++..........+|+..++.++| +|++.+++++.... ..|+||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-HNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-EEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC-ccEEEEEec
Confidence 5799999999999999999999999999999998776666667889999999976 89999999887654 899999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCCC--------CCcc-----------
Q 040812 136 DAGSLEIYVKSRG-RLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKME--------HPCG----------- 195 (300)
Q Consensus 136 ~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~~--------~~~~----------- 195 (300)
+++|.+++...+ .++...+..++.|++.||.|||++||+||||||+|||++.... .++|
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 579999987644 6999999999999999999999999999999999999975311 1122
Q ss_pred ------------ceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HHHHhhCCCCC
Q 040812 196 ------------YSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEPDFLSL---MLAICFREPPS 260 (300)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~ 260 (300)
++..|.+||... +..++.++|||||||++|||+||+.||............ ...........
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~---~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cceeecccCceEEchhhcCHHHhc---CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 344566666544 566889999999999999999999999765444332221 11111122223
Q ss_pred CCCCCChHHHHHHHHHhccCCCCCCCCHHHHh
Q 040812 261 LPECSSEKFRDFIRCCLQKGDPSKRWTASQLL 292 (300)
Q Consensus 261 ~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l 292 (300)
+...+++++.+++..|+.. +|++||+.+.+.
T Consensus 240 l~~~~p~~l~~ii~~~~~~-~~~~rP~y~~l~ 270 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNL-AFDATPDYDYLQ 270 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHC-CTTCCCCHHHHH
T ss_pred hcCCCCHHHHHHHHHHhcC-CcccCcCHHHHH
Confidence 3456789999999999999 999999977654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=317.12 Aligned_cols=233 Identities=18% Similarity=0.202 Sum_probs=172.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHH--HHHHHHhcCCCceeEeceeeeCCCC---cEEEE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQ--ELNILRQTNSPYIVKCHQIFTKPSG---EVSIL 131 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~~---~~~lv 131 (300)
.+|.+.+.||+|+||.||+|+. +|+.||||+++.+... .+.+ |+..+.+++||||+++++++..+.+ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4688899999999999999987 4789999998654322 2223 4555567899999999999875432 58999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHh--------CCccccCCCCCceeecCCCCCCcc--------
Q 040812 132 MEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHS--------RNIVHRDIKPANVLINEKMEHPCG-------- 195 (300)
Q Consensus 132 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~--------~~i~H~Dlkp~Nill~~~~~~~~~-------- 195 (300)
||||++|+|.+++++. .+++..+..++.|++.||.|||+ +||+||||||+|||++.++..+++
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999865 68999999999999999999996 599999999999999987665332
Q ss_pred ---------------ceeeccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-----------chH
Q 040812 196 ---------------YSCLYESGEARHRKH---GGYNGFAADIWSFGVTMMELYMGYYPFLEPGQE-----------PDF 246 (300)
Q Consensus 196 ---------------~~~~~~~~~~~~~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-----------~~~ 246 (300)
++..|.+||...... ...++.++|||||||++|||+||..||...... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 234456666543211 112467899999999999999999887432211 111
Q ss_pred HHHHHHHh-hCCCCCCCCCC-----ChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 247 LSLMLAIC-FREPPSLPECS-----SEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 247 ~~~~~~~~-~~~~~~~~~~~-----~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
........ ....+.++... ...+.+++.+||+. ||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~-dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA-NGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCS-SGGGSCCHHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHccc-CHhHCcCHHHHHHH
Confidence 11111111 12233333322 24589999999999 99999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-45 Score=319.12 Aligned_cols=240 Identities=28% Similarity=0.383 Sum_probs=172.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC-CCCCHHHHHHHHhcC-----------CCceeEeceeeeCC
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG-TPPNPQELNILRQTN-----------SPYIVKCHQIFTKP 124 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~ 124 (300)
++|+++++||+|+||+||+|+++.+|+.||||+++.+.. .+...+|+.+++.++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 469999999999999999999999999999999975432 123357888888775 57899999887542
Q ss_pred -CCcEEEEEeccCCCCHHHH-HH--hCCCCCHHHHHHHHHHHHHHHHHhHh-CCccccCCCCCceeecCCCCC-------
Q 040812 125 -SGEVSILMEYMDAGSLEIY-VK--SRGRLSEDIICTISRQVLKGLFYMHS-RNIVHRDIKPANVLINEKMEH------- 192 (300)
Q Consensus 125 -~~~~~lv~e~~~~~~L~~~-l~--~~~~l~~~~~~~i~~qi~~~l~~lH~-~~i~H~Dlkp~Nill~~~~~~------- 192 (300)
....+++|+++..+..... .. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++..
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 2356777777655443322 22 24478999999999999999999997 899999999999999754321
Q ss_pred --Cc-------------cceeeccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc-----hHHHHHHH
Q 040812 193 --PC-------------GYSCLYESGEARHRKHGGYNGFAADIWSFGVTMMELYMGYYPFLEPGQEP-----DFLSLMLA 252 (300)
Q Consensus 193 --~~-------------~~~~~~~~~~~~~~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-----~~~~~~~~ 252 (300)
++ .++..|.+||... +..++.++||||+||++++|++|+.||....... +.......
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHH---TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred EeecccccccccccccccccccccChhhcc---ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 11 2344466666544 4456789999999999999999999996432211 00010000
Q ss_pred HhhC-----------------------C---------------CCCCCCCCChHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 040812 253 ICFR-----------------------E---------------PPSLPECSSEKFRDFIRCCLQKGDPSKRWTASQLLSH 294 (300)
Q Consensus 253 ~~~~-----------------------~---------------~~~~~~~~~~~l~~li~~~l~~~dp~~Rpt~~~~l~h 294 (300)
.... . ....+...++++.|||.+||.. ||.+|||++|+|+|
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~-dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL-DPRKRADAGGLVNH 328 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS-STTTCBCHHHHHTC
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC-ChhHCcCHHHHhcC
Confidence 0000 0 0111222356799999999999 99999999999999
Q ss_pred CCCCCC
Q 040812 295 PFLADA 300 (300)
Q Consensus 295 pw~~~~ 300 (300)
|||+++
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=5.9e-25 Score=174.00 Aligned_cols=119 Identities=21% Similarity=0.264 Sum_probs=94.0
Q ss_pred ceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCC----C--------C--------CHHHHHHHHhcCCCceeEec
Q 040812 59 LEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGT----P--------P--------NPQELNILRQTNSPYIVKCH 118 (300)
Q Consensus 59 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~--------~--------~~~E~~~l~~l~h~niv~~~ 118 (300)
+.+.++||+|+||.||+|.+. +|+.||||+++..... . . ..+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999986 5889999987642211 0 0 02477888899999998887
Q ss_pred eeeeCCCCcEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhHhCCccccCCCCCceeecCCC
Q 040812 119 QIFTKPSGEVSILMEYMDAGSLEIYVKSRGRLSEDIICTISRQVLKGLFYMHSRNIVHRDIKPANVLINEKM 190 (300)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i~H~Dlkp~Nill~~~~ 190 (300)
++. ..++||||+++..+. .++...+..++.|++.+|.|||++||+||||||+|||+++++
T Consensus 81 ~~~-----~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~ 140 (191)
T d1zara2 81 AWE-----GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG 140 (191)
T ss_dssp EEE-----TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE
T ss_pred Eec-----CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC
Confidence 652 237999999886553 245566788999999999999999999999999999998754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.07 E-value=2.5e-05 Score=62.52 Aligned_cols=84 Identities=13% Similarity=0.005 Sum_probs=55.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCC--CCCCHHHHHHHHhcC-CCceeEeceeeeCCCCcEEEEEe
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRG--TPPNPQELNILRQTN-SPYIVKCHQIFTKPSGEVSILME 133 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e 133 (300)
+.|+..+..+-++.+.||+... ++..+++|....... .....+|...+..+. +--+.+++.+...+ +..++||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC-CceEEEEE
Confidence 4566666655555678998763 345677888765432 223467888888764 32356667766554 48899999
Q ss_pred ccCCCCHHHH
Q 040812 134 YMDAGSLEIY 143 (300)
Q Consensus 134 ~~~~~~L~~~ 143 (300)
+++|.++.+.
T Consensus 91 ~l~G~~~~~~ 100 (263)
T d1j7la_ 91 EADGVLCSEE 100 (263)
T ss_dssp CCSSEEHHHH
T ss_pred eccccccccc
Confidence 9999877543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.73 E-value=3.9e-05 Score=65.38 Aligned_cols=75 Identities=15% Similarity=0.077 Sum_probs=46.3
Q ss_pred eeeecCCcceEEEEEEEccCCeEEEEEEeecC------CCC---CCCHHHHHHHHhcC-C--CceeEeceeeeCCCCcEE
Q 040812 62 LQVLGQGNGGTVFKVRHKQTLALYALKVMQCD------RGT---PPNPQELNILRQTN-S--PYIVKCHQIFTKPSGEVS 129 (300)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~---~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 129 (300)
.+.||.|....||++.+..+++.+++|.-... ... .....|...|+.+. + ..+++++.+ .. . ..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~-~-~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT-E-MAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET-T-TTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cC-C-CCE
Confidence 46799999999999998888889999975321 111 11235888887653 2 235555554 32 2 457
Q ss_pred EEEeccCCCC
Q 040812 130 ILMEYMDAGS 139 (300)
Q Consensus 130 lv~e~~~~~~ 139 (300)
+|||++++..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.49 E-value=0.00025 Score=56.10 Aligned_cols=74 Identities=14% Similarity=0.094 Sum_probs=49.3
Q ss_pred eecCCc-ceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCc--eeEeceeeeCCCCcEEEEEeccCCCCH
Q 040812 64 VLGQGN-GGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNSPY--IVKCHQIFTKPSGEVSILMEYMDAGSL 140 (300)
Q Consensus 64 ~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~~~L 140 (300)
.+..|. -+.||+..... +..+++|...... ......|...++.+...+ +.+++.+..++ +..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~-~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA-LNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT-TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC-HhHHHHHHHHHHHHHhcCCCCCceeeecccc-cceEEEEEeeecccc
Confidence 344454 36889887654 6668889865432 334567888888775433 45667665554 478999999988655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.20 E-value=0.0026 Score=52.23 Aligned_cols=67 Identities=10% Similarity=0.084 Sum_probs=40.3
Q ss_pred ceEEEEEEEccCCeEEEEEEeecCCCC-CCCHHHHHHHHhcCCCce--eEecee-----eeCCCCcEEEEEeccCCC
Q 040812 70 GGTVFKVRHKQTLALYALKVMQCDRGT-PPNPQELNILRQTNSPYI--VKCHQI-----FTKPSGEVSILMEYMDAG 138 (300)
Q Consensus 70 ~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~h~ni--v~~~~~-----~~~~~~~~~lv~e~~~~~ 138 (300)
--.||++... +|+.|++|+....... .....|...+..|...++ +..+.. +.. .+..+.|+++++|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~-~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH-QGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE-TTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee-eeEEEEEEeecCCc
Confidence 3589999875 4778999997654322 223567787777643322 111111 112 34688899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.83 E-value=0.02 Score=46.27 Aligned_cols=54 Identities=11% Similarity=0.154 Sum_probs=32.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCeEEEEEEeecCCCCCCCHHHHHHHHhcCC
Q 040812 56 LSQLEKLQVLGQGNGGTVFKVRHKQTLALYALKVMQCDRGTPPNPQELNILRQTNS 111 (300)
Q Consensus 56 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h 111 (300)
+++..-.+.|..|---+.|+..... | .+++|++...........|+.++..+..
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVEKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC---CCHHHHHHHHHHHHHH
T ss_pred CCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCCCHHHHHHHHHHHHhhhh
Confidence 4445556677788888899988764 4 4789998654333333557777777643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.00 E-value=0.013 Score=49.15 Aligned_cols=78 Identities=19% Similarity=0.173 Sum_probs=49.6
Q ss_pred CcceeeeeecCCcceEEEEEEEcc-------CCeEEEEEEeecCCCCCCCHHHHHHHHhcCCCce-eEeceeeeCCCCcE
Q 040812 57 SQLEKLQVLGQGNGGTVFKVRHKQ-------TLALYALKVMQCDRGTPPNPQELNILRQTNSPYI-VKCHQIFTKPSGEV 128 (300)
Q Consensus 57 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~ 128 (300)
+++++ +.|+-|-.-.+|++.... ..+.|.+++...........+|..+++.+.-.++ .++++++. +
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C---
Confidence 34444 678889999999998753 2456777876532211122468888887754444 45666653 2
Q ss_pred EEEEeccCCCCH
Q 040812 129 SILMEYMDAGSL 140 (300)
Q Consensus 129 ~lv~e~~~~~~L 140 (300)
.+|+||++|..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 488999987544
|